{"text_format":"1","workbook":"xlsx","n_sheets":2,"sheets":["Overview","Detail"],"not_rendered":{"charts":0,"images":0,"macros":1,"external_links":0,"defined_names":3,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Overview","index":0,"n_rows":1253,"n_cols":561,"rows_kept":139,"cut":true,"hidden":false,"merged":[],"bounds":{"rows_first":62,"rows_last":15,"rows_between":62,"halvings":5}}
["Overview"]
["How to use: double-click on article count to see articles"]
["Chemical","chemuid","LinkName","CAS RN","DSSToxID","dsstoxid","PMID Ct","Seizures","Nervous System Diseases","Peripheral Nervous System Diseases","Brain Diseases","Muscular Diseases","Basal Ganglia Diseases","Parkinson Disease, Secondary","Coma","Hallucinations","Tremor","Memory Disorders","Central Nervous System Diseases","Delirium","Cerebral Hemorrhage","Paresthesia","Dystonia","Myoclonus","Ataxia","Epilepsy","Hearing Loss","Paralysis","Confusion","Status Epilepticus","Sleep Wake Disorders","Hyperalgesia","Epilepsy, Tonic-Clonic","Sleep Initiation and Maintenance Disorders","Hearing Disorders","Stroke","Blindness","Hearing Loss, Sensorineural","Polyneuropathies","Movement Disorders","Syncope","Hepatic Encephalopathy","Brain Edema","Hypotension, Orthostatic","Parkinsonian Disorders","Inappropriate ADH Syndrome","Deafness","Intracranial Hemorrhages","Amnesia","Neuromuscular Diseases","Optic Neuritis","Alzheimer Disease","Hyperprolactinemia","Demyelinating Diseases","Spasm","Learning Disorders","Hyperkinesis","Neural Tube Defects","Optic Nerve Diseases","Cerebrovascular Disorders","Catalepsy","Muscle Rigidity","Spinal Cord Diseases","Cerebellar Diseases","MPTP Poisoning","Tinnitus","Muscle Weakness","Psychomotor Disorders","Nystagmus, Pathologic","Disorders of Excessive Somnolence","Chorea","Unconsciousness","Neuralgia","Neurodegenerative Diseases","Meningitis, Aseptic","Dementia","Brain Damage, Chronic","Consciousness Disorders","Brain Ischemia","Reye Syndrome","Sensation Disorders","Pseudotumor Cerebri","Catatonia","Brain Neoplasms","Cerebral Infarction","Cerebellar Ataxia","Myositis","Encephalitis","Autonomic Nervous System Diseases","Taste Disorders","Papilledema","Eye Burns","Meningitis","Migraine Disorders","Quadriplegia","Muscular Atrophy","Diplopia","Leukoencephalopathies","Muscle Hypotonia","Color Vision Defects","Speech Disorders","Muscle Cramp","Myelitis","Optic Atrophy","Dysarthria","Fasciculation","Epilepsies, Myoclonic","Leukoencephalopathy, Progressive Multifocal","Posterior Leukoencephalopathy Syndrome","Myasthenia Gravis","Ophthalmoplegia","Paraplegia","Subarachnoid Hemorrhage","Epilepsy, Temporal Lobe","Arachnoiditis","Olfaction Disorders","Hypesthesia","Restless Legs Syndrome","Hearing Loss, Bilateral","Scotoma","Epilepsies, Partial","Ischemic Attack, Transient","Intellectual Disability","Hydrocephalus","Athetosis","Gait Disorders, Neurologic","Hemiplegia","Ocular Motility Disorders","Hearing Loss, High-Frequency","Perceptual Disorders","Neuritis","Hematoma, Subdural","Pituitary Neoplasms","Microcephaly","Miosis","Paresis","Respiratory Paralysis","Somnambulism","Huntington Disease","Epilepsy, Absence","Facial Paralysis","Hypoxia, Brain","Epilepsy, Generalized","Optic Neuropathy, Ischemic","Cranial Nerve Diseases","Aphasia","Tetany","Dermatomyositis","Polyradiculoneuropathy","Trismus","Intracranial Embolism and Thrombosis","Brain Diseases, Metabolic","Mitochondrial Myopathies","Torticollis","Amyotrophic Lateral Sclerosis","Dysgeusia","Reflex, Abnormal","Muscle Spasticity","Lethargy","Spinal Dysraphism","Tic Disorders","Tourette Syndrome","Myalgia","Eye Injuries","Polyradiculopathy","Stuttering","Intracranial Hypertension","Sleep Apnea Syndromes","Ageusia","Multiple Sclerosis","Amblyopia","Encephalocele","Hearing Loss, Sudden","Hematoma, Epidural, Cranial","Motor Neuron Disease","Tics","Reflex Sympathetic Dystrophy","Anisocoria","Myotonia","Acrodynia","Sinus Thrombosis, Intracranial","Anencephaly","Horner Syndrome","Hypokinesia","Dystonic Disorders","Hyperesthesia","Intracranial Thrombosis","Nervous System Malformations","Amnesia, Retrograde","Hemianopsia","Language Development Disorders","Meningoencephalitis","Spina Bifida Occulta","Muscle Hypertonia","Carpal Tunnel Syndrome","Carotid Artery Diseases","Gait Ataxia","Language Disorders","Blindness, Cortical","Spinal Cord Compression","Strabismus","Radiculopathy","Apraxias","Guillain-Barre Syndrome","Pituitary Diseases","Polymyositis","Pupil Disorders","Carotid Artery Thrombosis","Encephalomalacia","Epilepsy, Complex Partial","Hoarseness","Meningioma","Nerve Compression Syndromes","Cerebral Palsy","Headache Disorders","Hypertensive Encephalopathy","Peripheral Nervous System Neoplasms","Prolactinoma","Spinal Cord Injuries","Stupor","Akinetic Mutism","Amnesia, Anterograde","Creutzfeldt-Jakob Syndrome","Diabetic Neuropathies","Esotropia","Mutism","Myelinolysis, Central Pontine","Nervous System Neoplasms","Brain Infarction","Meningeal Neoplasms","Narcolepsy","REM Sleep Behavior Disorder","Sleep Deprivation","Cluster Headache","Dementia, Vascular","Encephalomyelitis","Holoprosencephaly","Intracranial Embolism","Meningomyelocele","Myelitis, Transverse","Photophobia","Sleep Apnea, Central","Somatosensory Disorders","Spinal Cord Neoplasms","Trigeminal Neuralgia","Auditory Perceptual Disorders","Cerebral Arterial Diseases","Central Nervous System Neoplasms","Cerebrospinal Fluid Rhinorrhea","Encephalomyelitis, Autoimmune, Experimental","Fatigue Syndrome, Chronic","Hearing Loss, Noise-Induced","Hepatolenticular Degeneration","Seizures, Febrile","Sleep Bruxism","Syncope, Vasovagal","Abducens Nerve Diseases","Chronobiology Disorders","Decerebrate State","Essential Tremor","Hearing Loss, Functional","Kernicterus","Neurogenic Inflammation","Paraparesis","Amnesia, Transient Global","Aphasia, Broca","Giant Cell Arteritis","Infarction, Middle Cerebral Artery","Meige Syndrome","Sciatic Neuropathy","Urinary Bladder, Neurogenic","Cataplexy","Intracranial Hemorrhage, Traumatic","Leukomalacia, Periventricular","Meningocele","Sleep Apnea, Obstructive","Spasms, Infantile","Down Syndrome","Dyssomnias","Headache Disorders, Secondary","Hearing Loss, Central","Hearing Loss, Conductive","Hypokalemic Periodic Paralysis","Meningism","Parasomnias","Tardive Dyskinesia","Alcohol-Induced Disorders, Nervous System","Bulbar Palsy, Progressive","Facial Injuries","Facial Nerve Diseases","Fibromyalgia","Hypopituitarism","Migraine without Aura","Oculomotor Nerve Diseases","Pituitary Apoplexy","Subacute Combined Degeneration","Aphonia","Muscular Atrophy, Spinal","Nocturnal Myoclonus Syndrome","Peripheral Nerve Injuries","Persistent Vegetative State","Agnosia","Carotid Artery, Internal, Dissection","Dystonia Musculorum Deformans","Hypoxia-Ischemia, Brain","Migraine with Aura","Night Terrors","Putaminal Hemorrhage","Sleep Disorders, Circadian Rhythm","Alcohol Withdrawal Seizures","Brain Stem Infarctions","Causalgia","Emergence Delirium","Exotropia","Hematoma, Subdural, Acute","Hypothalamic Diseases","Meningitis, Cryptococcal","Mitochondrial Encephalomyopathies","Muscular Dystrophies","Myotonic Dystrophy","Striatonigral Degeneration","Arnold-Chiari Malformation","Carotid Stenosis","Charcot-Marie-Tooth Disease","Corneal Injuries","Corneal Perforation","Dysautonomia, Familial","Eosinophilia-Myalgia Syndrome","Epilepsy, Reflex","Femoral Neuropathy","Insulin Coma","Intracranial Aneurysm","Intracranial Hemorrhage, Hypertensive","Intracranial Hypotension","Mononeuropathies","Multiple System Atrophy","Neurologic Manifestations","Rett Syndrome","Spina Bifida Cystica","Tauopathies","Thalamic Diseases","Uveomeningoencephalitic Syndrome","Articulation Disorders","Bell Palsy","Brain Abscess","Facial Nerve Injuries","Headache Disorders, Primary","Hyperglycinemia, Nonketotic","Intracranial Arteriosclerosis","Mandibular Fractures","Median Neuropathy","Mobius Syndrome","Paralyses, Familial Periodic","Sagittal Sinus Thrombosis","Sarcopenia","Supranuclear Palsy, Progressive","Syringomyelia","Trigeminal Nerve Diseases","Acute Febrile Encephalopathy","Alcoholic Neuropathy","Amaurosis Fugax","Anomia","Autoimmune Diseases of the Nervous System","Brachial Plexus Neuritis","Cranial Nerve Injuries","Cranial Nerve Neoplasms","Dandy-Walker Syndrome","Duane Retraction Syndrome","Empty Sella Syndrome","Encephalitis, Herpes Simplex","Encephalomyelitis, Acute Disseminated","Epilepsy, Frontal Lobe","Hearing Loss, Unilateral","Hematoma, Subdural, Intracranial","Homocystinuria","Hydrocephalus, Normal Pressure","Leigh Disease","Leukoencephalitis, Acute Hemorrhagic","Myokymia","Neurofibroma","Neuromyelitis Optica","Optic Atrophy, Hereditary, Leber","Paraparesis, Spastic","Paraparesis, Tropical Spastic","Paroxysmal Hemicrania","Phantom Limb","Presbycusis","Sciatica","Spinal Cord Ischemia","Spinocerebellar Degenerations","Vagus Nerve Diseases","AIDS Dementia Complex","Alcohol Amnestic Disorder","Auditory Diseases, Central","Basal Ganglia Cerebrovascular Disease","Basal Ganglia Hemorrhage","Brachial Plexus Neuropathies","Deaf-Blind Disorders","Diffuse Cerebral Sclerosis of Schilder","Dysphonia","Echolalia","Encephalitis, Viral","Epilepsy, Partial, Motor","Facial Neuralgia","Galactosemias","Hematoma, Subdural, Chronic","Hydranencephaly","Hyperacusis","Lesch-Nyhan Syndrome","Malformations of Cortical Development","Myoclonic Epilepsy, Juvenile","Orbital Myositis","Polyradiculoneuropathy, Chronic Inflammatory Demyelinating","Spinal Cord Vascular Diseases","Subdural Effusion","Trauma, Nervous System","Ulnar Neuropathies","Agraphia","Alcohol Withdrawal Delirium","Alice in Wonderland Syndrome","Anterior Spinal Artery Syndrome","Apraxia, Ideomotor","Arachnoid Cysts","Botulism","Canavan Disease","Cavernous Sinus Thrombosis","Central Nervous System Protozoal Infections","Cerebellar Neoplasms","Cerebrospinal Fluid Otorrhea","Dyskinesia, Drug-Induced","Encephalitis, Varicella Zoster","Epilepsy, Rolandic","Eye Injuries, Penetrating","High Pressure Neurological Syndrome","Illusions","Infarction, Anterior Cerebral Artery","Infectious Encephalitis","Isaacs Syndrome","Kearns-Sayre Syndrome","Korsakoff Syndrome","Lambert-Eaton Myasthenic Syndrome","Meningitis, Bacterial","Meningitis, Meningococcal","Microscopic Polyangiitis","Multiple Sclerosis, Relapsing-Remitting","Myasthenic Syndromes, Congenital","Myotonic Disorders","Neuralgia, Postherpetic","Neuroma, Acoustic","Nystagmus, Congenital","Opsoclonus-Myoclonus Syndrome","Optic Nerve Injuries","Orthostatic Intolerance","Paraneoplastic Polyneuropathy","Peroneal Neuropathies","Pituitary ACTH Hypersecretion","Primary Dysautonomias","Prion Diseases","Sleep Arousal Disorders","SUNCT Syndrome","Tension-Type Headache","Tibial Neuropathy","Tuberculosis, Meningeal","Acromegaly","Alexander Disease","Alexia, Pure","Anti-N-Methyl-D-Aspartate Receptor Encephalitis","Aphasia, Wernicke","Bilateral Vestibulopathy","Brown-Sequard Syndrome","Carotid Artery Injuries","Central Nervous System Cysts","Central Nervous System Infections","Central Nervous System Vascular Malformations","Cerebral Amyloid Angiopathy","Cerebrospinal Fluid Leak","Cogan Syndrome","Communication Disorders","Complex Regional Pain Syndromes","Dyslexia","Epidural Neoplasms","Epilepsia Partialis Continua","Epilepsy, Benign Neonatal","Esthesioneuroblastoma, Olfactory","Fabry Disease","Facial Hemiatrophy","Gangliosidoses","Gerstmann Syndrome","Hemangioma, Cavernous, Central Nervous System","Hemifacial Spasm","Hereditary Sensory and Autonomic Neuropathies","Hereditary Sensory and Motor Neuropathy","Heredodegenerative Disorders, Nervous System","Intracranial Arterial Diseases","Intracranial Arteriovenous Malformations","Kluver-Bucy Syndrome","Lateral Medullary Syndrome","Lennox Gastaut Syndrome","Lewy Body Disease","Limbic Encephalitis","Megalencephaly","MELAS Syndrome","Meningeal Carcinomatosis","Meningitis, Pneumococcal","Menkes Kinky Hair Syndrome","Mevalonate Kinase Deficiency","Miller Fisher Syndrome","Muscular Disorders, Atrophic","Muscular Dystrophy, Facioscapulohumeral","Myoclonic Cerebellar Dyssynergia","Myopathies, Nemaline","Myositis, Inclusion Body","Myotonia Congenita","Nerve Sheath Neoplasms","Neuroaspergillosis","Neurofibromatosis 1","Neuromuscular Junction Diseases","Niemann-Pick Diseases","Olivopontocerebellar Atrophies","Ophthalmoplegia, Chronic Progressive External","Optic Atrophies, Hereditary","Optic Disk Drusen","Paralysis, Hyperkalemic Periodic","Phenylketonurias","Piriformis Muscle Syndrome","Postural Orthostatic Tachycardia Syndrome","Prosopagnosia","Pseudobulbar Palsy","Pudendal Neuralgia","Pyomyositis","Radial Neuropathy","REM Sleep Parasomnias","Sleep-Wake Transition Disorders","Small Fiber Neuropathy","Sphingolipidoses","Spinocerebellar Ataxias","Stiff-Person Syndrome","Subacute Sclerosing Panencephalitis","Subarachnoid Hemorrhage, Traumatic","Subclavian Steal Syndrome","Sweating, Gustatory","Tuberculosis, Central Nervous System","Tuberous Sclerosis","Ulnar Nerve Compression Syndromes","Demyelinating Autoimmune Diseases, CNS","Vascular Headaches","Vasculitis, Central Nervous System","Vasospasm, Intracranial","Vertebral Artery Dissection","Vertebrobasilar Insufficiency","Vertigo","Vestibular Neuronitis","Vestibulocochlear Nerve Diseases","Vestibulocochlear Nerve Injuries","Vision Disorders","Vision, Low","Vocal Cord Paralysis","Voice Disorders","Waterhouse-Friderichsen Syndrome","Wernicke Encephalopathy","Williams Syndrome"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B4,C4)","v":"Cisplatin"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F4,F4)","v":"DTXSID4024983"},"DTXSID4024983",{"$f":"SUM(H4:UO4)","v":1032},20,47,140,13,0,4,1,1,0,1,2,4,0,0,18,1,0,1,1,231,3,1,2,1,15,2,0,77,5,14,106,7,1,0,0,1,2,0,17,29,0,1,2,6,0,1,3,1,0,0,0,3,5,0,0,6,0,0,33,0,0,3,0,0,1,8,0,0,0,0,0,3,0,7,0,0,0,10,0,0,1,4,0,2,0,0,0,1,3,0,0,0,1,0,1,0,1,0,0,0,3,3,1,1,0,0,0,0,3,2,0,27,0,2,2,0,1,0,0,0,1,44,0,1,0,0,0,0,2,0,0,0,1,1,0,1,0,2,1,4,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,2,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,1,2,0,0,2,0,0,1,0,1,2,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,3,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,1,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B5,C5)","v":"Ethanol"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F5,F5)","v":"DTXSID9020584"},"DTXSID9020584",{"$f":"SUM(H5:UO5)","v":768},100,23,11,18,26,1,3,20,6,17,54,2,6,4,2,2,2,44,12,3,2,5,1,10,5,3,1,2,6,3,1,1,3,3,4,5,3,1,0,1,0,14,1,4,2,3,1,3,18,17,11,7,8,2,1,1,6,0,0,2,8,5,1,0,5,4,15,0,9,12,4,2,0,2,0,3,1,2,4,0,7,5,1,0,1,0,3,1,2,0,0,1,0,1,1,0,0,1,0,0,0,0,0,3,0,3,1,0,0,0,0,0,1,0,4,4,0,0,2,0,1,0,1,0,0,2,8,1,0,0,2,0,0,4,1,0,0,0,0,0,0,0,2,1,2,0,0,0,0,0,0,0,1,0,2,0,1,1,0,0,6,0,0,1,0,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,3,2,0,2,0,0,0,0,0,3,0,0,0,0,0,1,0,2,0,0,0,0,1,0,0,0,0,0,0,0,3,0,2,0,1,0,0,0,0,1,0,0,0,0,0,2,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,9,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,6,0,0,2,0,5,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B6,C6)","v":"Lead"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F6,F6)","v":"DTXSID2024161"},"DTXSID2024161",{"$f":"SUM(H6:UO6)","v":740},28,107,68,102,4,2,2,1,3,4,19,30,2,6,2,0,1,6,2,4,8,2,0,0,0,2,1,4,0,6,4,13,2,0,0,14,0,1,0,1,0,0,12,4,7,0,9,0,37,20,3,2,5,0,0,2,7,0,0,0,9,1,1,1,1,0,5,0,6,6,0,0,0,1,0,1,8,0,0,0,6,4,1,1,1,3,0,1,0,0,0,1,1,1,0,0,1,0,1,1,0,0,0,1,0,0,0,0,2,1,0,1,0,0,0,42,1,1,0,0,1,0,2,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,0,1,0,0,0,0,0,0,0,0,0,1,0,0,4,1,1,0,0,3,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,5,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,2,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,6,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B7,C7)","v":"Lithium"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F7,F7)","v":"DTXSID5036761"},"DTXSID5036761",{"$f":"SUM(H7:UO7)","v":689},30,50,9,22,5,36,13,25,6,93,12,15,23,0,1,3,14,16,10,1,3,22,15,6,0,5,1,0,0,0,0,1,15,2,0,0,1,1,1,0,0,6,11,1,0,0,1,1,0,4,2,0,0,0,5,0,21,0,0,2,4,17,1,9,1,0,1,0,1,5,2,0,0,0,7,0,0,0,11,0,1,0,3,6,0,0,1,1,1,2,0,6,0,8,3,0,1,9,0,1,0,0,3,2,0,0,3,0,0,0,2,0,0,4,0,1,0,7,0,0,0,0,1,0,0,0,0,0,0,0,3,0,2,1,0,1,0,2,6,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,7,0,0,0,2,0,0,0,0,1,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B8,C8)","v":"Valproic Acid"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F8,F8)","v":"DTXSID70227388"},"DTXSID70227388",{"$f":"SUM(H8:UO8)","v":666},32,10,3,65,6,10,18,45,5,18,4,2,10,2,0,1,3,8,8,3,0,12,10,5,0,1,3,0,0,0,2,0,5,0,30,14,1,14,6,0,3,0,0,0,1,0,0,0,4,2,82,0,0,0,0,1,1,0,2,1,2,1,4,5,10,0,0,0,9,0,9,2,13,0,2,1,0,0,2,0,2,0,0,0,0,0,1,0,0,1,0,1,1,1,0,0,0,1,0,3,0,0,0,0,0,0,0,0,1,1,0,0,0,2,0,6,2,0,3,0,1,0,0,0,0,0,1,0,0,1,0,0,5,0,0,3,0,1,0,0,0,0,0,0,18,0,2,0,0,0,0,2,10,0,0,0,0,0,1,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,2,0,0,1,0,23,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,2,0,6,5,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B9,C9)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F9,F9)","v":"DTXSID8040933"},"DTXSID8040933",{"$f":"SUM(H9:UO9)","v":638},1,24,0,11,0,6,289,0,0,5,0,1,0,0,0,4,0,1,3,0,0,0,1,1,0,0,0,0,0,0,0,0,3,0,0,0,0,33,0,0,0,0,1,0,2,0,0,0,0,4,0,0,0,5,1,1,0,214,0,0,0,0,0,2,0,0,4,0,1,1,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B10,C10)","v":"Vincristine"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F10,F10)","v":"DTXSID8044331"},"DTXSID8044331",{"$f":"SUM(H10:UO10)","v":567},17,59,125,15,5,1,1,5,3,2,1,8,0,0,25,0,0,2,3,0,17,1,0,0,21,5,0,0,0,4,4,22,4,0,1,0,5,0,14,2,0,0,7,0,0,0,6,0,0,0,1,5,0,1,0,1,1,0,0,5,0,0,0,0,2,29,0,0,0,0,0,0,0,3,0,0,0,1,0,1,0,3,0,0,0,0,0,13,2,1,0,1,0,0,1,1,4,0,0,0,0,1,0,5,5,0,0,0,0,0,0,2,0,1,0,0,0,1,4,0,0,0,0,2,0,0,0,0,1,2,0,0,0,3,0,0,0,9,0,0,0,1,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,2,0,0,0,0,0,2,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,23,2,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B11,C11)","v":"Phenytoin"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F11,F11)","v":"DTXSID8020541"},"DTXSID8020541",{"$f":"SUM(H11:UO11)","v":560},37,24,25,16,9,3,1,9,3,8,4,6,3,2,1,4,7,45,7,0,2,3,9,0,0,3,0,1,0,1,0,3,10,1,4,1,0,3,2,0,0,0,3,0,0,0,1,1,4,6,2,1,0,0,0,0,37,0,0,2,6,45,0,25,2,0,0,0,1,1,1,1,0,0,1,0,2,1,28,3,3,1,0,1,0,0,0,0,2,6,1,0,2,7,0,0,0,3,0,0,0,0,4,10,0,0,1,0,0,0,0,0,0,2,0,5,1,23,0,4,1,0,0,1,0,0,2,0,1,0,0,0,3,0,0,0,0,0,2,1,1,0,0,2,0,0,0,0,0,2,1,0,1,0,0,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,1,0,4,0,1,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B12,C12)","v":"Haloperidol"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F12,F12)","v":"DTXSID4034150"},"DTXSID4034150",{"$f":"SUM(H12:UO12)","v":555},6,6,1,10,6,153,51,4,4,11,1,0,10,0,0,52,5,2,3,0,0,1,0,1,0,3,1,0,1,0,0,0,22,0,0,0,2,9,4,0,0,1,2,0,0,10,0,1,2,5,0,0,0,75,17,0,1,1,0,0,3,1,1,1,0,0,1,0,0,0,1,1,0,0,0,15,0,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,1,0,0,1,0,2,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,0,0,0,0,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B13,C13)","v":"Cocaine"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F13,F13)","v":"DTXSID2038443"},"DTXSID2038443",{"$f":"SUM(H13:UO13)","v":530},151,16,0,8,0,2,3,3,8,6,12,11,11,30,0,10,0,1,4,0,2,1,10,7,0,9,0,0,15,1,1,1,0,2,2,5,1,0,0,0,0,5,1,0,0,1,0,0,7,10,2,1,20,1,0,1,0,0,1,0,2,0,0,0,2,0,2,0,1,7,0,6,0,0,0,0,0,11,1,0,0,0,0,1,0,0,3,1,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,0,0,7,2,0,0,1,0,1,0,2,6,0,0,0,5,0,3,0,2,0,0,0,5,0,0,0,0,0,0,1,1,0,0,2,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,2,1,0,0,0,0,0,1,0,0,0,1,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,4,0,0,11,0,0,2,0,1,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,3,0,0,0,0,0,0,5,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B14,C14)","v":"Aspirin"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F14,F14)","v":"DTXSID5020108"},"DTXSID5020108",{"$f":"SUM(H14:UO14)","v":489},8,3,0,3,2,2,0,9,4,1,0,5,0,80,0,0,1,1,0,14,0,7,1,1,0,1,0,8,29,0,4,0,0,5,5,4,0,0,0,11,41,0,1,0,0,0,0,1,1,3,3,0,11,0,0,2,0,0,23,0,0,1,0,0,2,0,1,2,2,0,1,8,124,0,1,0,0,5,1,0,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,2,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,1,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B15,C15)","v":"Paclitaxel"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F15,F15)","v":"DTXSID9023413"},"DTXSID9023413",{"$f":"SUM(H15:UO15)","v":485},4,43,217,9,14,0,0,0,0,0,1,2,0,0,13,0,0,4,0,0,0,1,0,1,53,1,0,1,0,0,3,7,0,0,3,0,1,0,1,0,0,0,4,0,0,0,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,0,0,0,0,53,0,0,0,0,1,0,0,9,0,0,0,2,0,2,0,2,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,1,0,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,1,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B16,C16)","v":"Aluminum"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F16,F16)","v":"DTXSID3040273"},"DTXSID3040273",{"$f":"SUM(H16:UO16)","v":477},13,41,1,105,4,0,0,1,0,1,13,12,0,0,0,0,4,1,2,0,1,1,2,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,3,0,147,0,3,0,2,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,18,0,49,1,0,0,0,0,0,0,1,0,0,2,2,1,0,0,0,0,0,1,1,0,0,0,0,5,0,0,0,3,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B17,C17)","v":"Lidocaine"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F17,F17)","v":"DTXSID80209953"},"DTXSID80209953",{"$f":"SUM(H17:UO17)","v":464},150,26,15,3,2,0,0,8,4,6,2,10,3,0,7,0,2,4,6,0,8,3,2,1,5,16,0,0,0,13,0,0,0,7,0,0,1,0,1,0,0,0,0,0,0,0,1,4,0,0,3,0,0,0,1,1,0,0,4,5,1,4,1,0,3,2,0,0,0,0,2,0,0,11,0,0,0,0,2,1,0,0,2,0,2,0,0,0,1,13,0,2,0,2,0,0,0,1,0,0,0,1,0,6,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,1,5,0,0,1,5,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,13,0,0,0,0,1,0,0,1,3,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,0,5,0,1,1,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B18,C18)","v":"Methotrexate"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F18,F18)","v":"DTXSID4020822"},"DTXSID4020822",{"$f":"SUM(H18:UO18)","v":451},17,25,1,79,4,0,1,5,0,1,9,18,1,1,0,0,0,3,2,0,6,3,3,0,0,3,0,1,5,1,0,0,0,0,1,13,0,0,1,0,2,0,0,0,0,0,15,0,2,0,3,2,5,0,0,11,4,0,0,2,1,0,1,2,1,0,1,1,4,3,0,0,0,2,1,0,3,0,0,0,3,0,1,1,0,1,0,4,0,1,22,0,1,1,0,1,3,5,0,0,21,7,0,1,12,0,0,6,1,1,0,0,2,1,2,3,0,0,1,6,0,0,1,1,1,0,0,0,9,0,0,0,0,3,0,0,0,0,2,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,2,1,0,0,0,0,2,3,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B19,C19)","v":"Mercury"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F19,F19)","v":"DTXSID1024172"},"DTXSID1024172",{"$f":"SUM(H19:UO19)","v":450},6,79,22,23,2,3,5,2,2,38,7,25,1,0,1,0,4,6,2,2,2,1,0,3,1,1,4,1,2,2,1,10,7,0,0,0,1,0,0,1,0,1,5,0,10,0,1,0,1,0,0,0,0,1,0,0,4,0,0,2,11,1,0,2,0,0,10,0,2,6,1,0,0,0,0,0,2,0,3,0,0,1,1,0,0,0,0,2,1,0,0,1,8,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,4,4,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,7,0,0,1,2,1,0,0,0,0,2,0,0,0,0,10,0,1,0,0,2,0,0,0,1,26,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,3,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,12,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B20,C20)","v":"Kainic Acid"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F20,F20)","v":"DTXSID7040526"},"DTXSID7040526",{"$f":"SUM(H20:UO20)","v":441},205,21,0,16,0,0,0,0,0,2,13,1,0,0,0,0,1,0,43,0,4,0,47,1,1,5,0,0,0,0,2,0,0,0,0,1,0,1,0,1,0,8,3,0,0,0,1,0,1,1,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,7,0,0,4,0,1,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,30,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B21,C21)","v":"Risperidone"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F21,F21)","v":"DTXSID8045193"},"DTXSID8045193",{"$f":"SUM(H21:UO21)","v":408},4,0,0,0,0,135,11,1,9,3,1,1,10,0,1,27,0,1,0,0,0,5,0,5,0,1,7,0,12,0,0,0,0,1,0,1,5,3,2,0,0,0,1,0,1,87,0,0,0,3,0,0,5,3,4,0,0,0,0,1,4,0,4,1,0,0,0,0,0,0,0,1,0,0,2,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,0,0,0,0,0,2,0,3,0,0,3,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B22,C22)","v":"Carbamazepine"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F22,F22)","v":"DTXSID00235052"},"DTXSID00235052",{"$f":"SUM(H22:UO22)","v":403},29,21,4,9,1,3,4,28,7,5,5,3,2,0,0,10,8,19,9,0,0,6,10,5,0,4,0,6,0,0,1,0,4,5,2,0,0,0,22,0,0,0,0,0,0,0,0,0,1,1,6,0,0,0,0,0,2,0,1,0,5,15,5,3,1,0,0,4,2,2,3,0,0,0,0,2,0,0,4,0,1,0,1,0,0,2,1,0,0,8,0,0,3,1,0,0,0,1,0,7,0,1,2,5,0,0,2,0,0,0,1,1,0,3,0,3,0,2,1,1,2,0,0,0,0,0,1,0,1,0,0,0,11,0,0,3,0,0,0,1,0,1,0,0,1,0,0,0,0,0,1,0,5,4,1,0,0,0,0,0,0,1,1,0,0,1,0,1,2,2,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,7,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B23,C23)","v":"Warfarin"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F23,F23)","v":"DTXSID5023742"},"DTXSID5023742",{"$f":"SUM(H23:UO23)","v":392},0,1,2,1,6,0,0,1,0,0,0,1,0,136,0,0,0,0,0,0,1,2,0,0,0,0,0,0,37,3,0,0,0,0,0,0,0,0,0,1,105,0,0,0,0,0,0,0,0,0,0,1,2,0,0,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,5,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,23,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B24,C24)","v":"Clozapine"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F24,F24)","v":"DTXSID5022855"},"DTXSID5022855",{"$f":"SUM(H24:UO24)","v":364},64,1,0,1,1,55,12,7,5,6,1,5,15,0,0,16,16,0,13,0,1,6,1,7,0,15,3,0,0,0,0,0,2,6,2,0,5,1,0,0,0,1,1,0,0,2,0,1,0,1,0,0,0,3,1,0,1,0,0,0,1,0,7,1,4,0,0,0,1,0,0,0,0,0,0,12,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,2,11,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,3,0,1,0,1,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,9,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B25,C25)","v":"Carbon Monoxide"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F25,F25)","v":"DTXSID5027273"},"DTXSID5027273",{"$f":"SUM(H25:UO25)","v":352},5,29,3,59,7,8,17,14,0,2,10,11,1,2,0,0,1,1,3,2,2,4,1,0,0,0,0,2,0,2,4,2,1,2,0,7,0,3,0,4,0,15,1,0,0,0,3,0,6,1,0,1,2,0,1,0,1,0,0,2,5,1,1,3,2,0,0,0,5,13,2,2,0,1,0,0,0,3,0,0,0,0,0,1,0,0,1,0,0,0,4,1,2,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,2,2,1,0,1,1,2,0,0,0,0,0,2,1,0,0,0,0,12,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,4,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B26,C26)","v":"Manganese"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F26,F26)","v":"DTXSID2024169"},"DTXSID2024169",{"$f":"SUM(H26:UO26)","v":328},3,62,4,16,1,18,66,0,0,7,10,9,0,0,1,1,2,2,1,1,3,0,0,1,0,0,0,0,0,0,0,3,9,0,2,2,0,26,0,1,0,0,2,0,4,0,0,0,4,1,0,0,0,1,1,1,1,1,0,0,3,1,0,6,0,0,11,0,1,0,0,1,0,1,0,1,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,4,1,0,0,0,0,0,1,0,1,9,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B27,C27)","v":"oxaliplatin"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F27,F27)","v":"DTXSID0036760"},"DTXSID0036760",{"$f":"SUM(H27:UO27)","v":327},0,11,148,4,0,0,0,1,0,0,2,1,0,1,20,0,0,1,0,5,2,0,0,0,42,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,30,0,0,0,0,0,0,0,12,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0,3,0,0,0,1,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0,0,1,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B28,C28)","v":"Ethambutol"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F28,F28)","v":"DTXSID8023006"},"DTXSID8023006",{"$f":"SUM(H28:UO28)","v":318},2,3,13,1,0,0,0,0,0,0,1,1,0,0,2,0,0,0,2,0,0,0,0,0,0,0,0,1,0,11,0,1,0,0,1,0,0,0,0,3,0,0,0,85,0,0,0,0,0,0,0,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,13,0,0,3,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,65,5,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B29,C29)","v":"Methanol"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F29,F29)","v":"DTXSID2021731"},"DTXSID2021731",{"$f":"SUM(H29:UO29)","v":318},6,8,0,14,0,10,12,17,0,4,3,4,0,11,0,2,0,1,0,0,1,1,0,0,0,0,0,1,0,41,0,1,2,0,0,11,0,2,0,0,3,0,1,6,1,0,1,1,0,0,3,28,0,0,1,1,0,0,0,0,0,1,0,0,2,0,2,0,0,1,0,1,0,1,0,0,0,5,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,17,2,0,0,1,0,0,0,0,2,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,45,3,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B30,C30)","v":"Morphine"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F30,F30)","v":"DTXSID1048914"},"DTXSID1048914",{"$f":"SUM(H30:UO30)","v":302},17,0,1,1,0,1,0,2,11,5,13,2,9,1,0,1,21,2,2,0,3,4,3,5,54,4,0,0,1,0,1,0,3,0,1,0,3,0,0,0,0,6,0,0,0,0,1,7,1,9,1,0,0,15,5,4,0,0,0,2,0,6,2,0,5,2,0,0,0,1,1,0,0,2,0,5,0,0,0,0,0,1,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,8,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,1,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,2,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B31,C31)","v":"Isoniazid"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F31,F31)","v":"DTXSID3020758"},"DTXSID3020758",{"$f":"SUM(H31:UO31)","v":301},77,8,28,10,1,0,1,19,4,0,3,6,2,1,4,0,4,2,5,1,0,3,15,0,0,7,0,0,0,1,0,10,0,0,13,3,0,0,0,0,0,0,0,13,0,0,0,1,1,1,0,4,0,0,0,0,4,0,0,1,1,1,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,0,5,0,1,0,0,1,0,0,0,0,1,1,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,2,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,5,1,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B32,C32)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F32,F32)","v":"DTXSID5048893"},"DTXSID5048893",{"$f":"SUM(H32:UO32)","v":298},28,19,0,11,0,2,9,5,8,5,70,4,1,5,0,2,1,0,1,0,0,1,1,6,0,3,1,0,4,0,1,0,0,1,2,14,1,7,10,0,1,4,0,0,0,0,0,0,2,4,0,0,4,0,0,2,0,0,1,0,4,1,0,0,1,0,3,0,0,5,1,2,0,0,0,3,0,1,1,0,0,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,1,0,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B33,C33)","v":"Succinylcholine"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F33,F33)","v":"DTXSID7048455"},"DTXSID7048455",{"$f":"SUM(H33:UO33)","v":293},2,2,0,1,78,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,5,0,0,0,0,31,0,0,0,0,0,0,23,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,5,0,0,0,76,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,1,0,0,0,0,4,0,0,14,0,0,1,0,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B34,C34)","v":"Amiodarone"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F34,F34)","v":"DTXSID7037185"},"DTXSID7037185",{"$f":"SUM(H34:UO34)","v":291},1,20,37,2,7,3,5,4,0,10,0,1,5,0,5,0,1,12,0,0,0,0,0,2,0,0,1,0,2,6,0,7,2,5,3,0,2,2,8,0,0,0,8,3,0,0,3,0,0,1,0,36,1,1,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,2,0,6,0,0,0,1,1,0,1,0,18,0,0,0,0,0,0,0,2,2,0,1,0,4,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,6,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,14,2,1,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B35,C35)","v":"Fluoxetine"},"D005473","Fluoxetine","59333-67-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F35,F35)","v":"DTXSID7020635"},"DTXSID7020635",{"$f":"SUM(H35:UO35)","v":269},21,4,0,2,1,24,10,3,9,12,4,1,10,1,3,15,9,3,1,1,0,3,2,6,0,7,17,0,0,0,0,0,1,4,0,0,6,0,24,0,0,2,0,0,0,5,0,1,0,0,0,0,0,0,1,0,0,0,0,1,2,0,3,3,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,3,0,0,0,0,1,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,3,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1,1,0,0,0,1,0,0,0,1,0,1,2,1,0,0,0,3,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,2,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B36,C36)","v":"Clioquinol"},"D007464","Clioquinol","130-26-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F36,F36)","v":"DTXSID7022837"},"DTXSID7022837",{"$f":"SUM(H36:UO36)","v":268},0,18,12,4,0,0,0,0,0,0,1,3,0,0,6,0,0,5,1,0,2,1,0,0,0,0,0,0,0,3,0,3,0,0,0,0,0,0,0,0,0,4,4,76,0,0,4,0,0,0,0,5,0,0,0,14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63,17,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B37,C37)","v":"Bupivacaine"},"D002045","Bupivacaine","14252-80-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F37,F37)","v":"DTXSID0030877"},"DTXSID0030877",{"$f":"SUM(H37:UO37)","v":262},88,10,7,1,19,0,1,2,0,1,0,7,1,0,3,0,6,0,0,1,10,2,0,0,1,6,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,2,1,0,0,0,0,0,0,0,3,0,0,1,2,0,1,0,0,2,2,0,4,0,0,0,0,0,5,0,0,0,0,0,1,1,1,0,0,0,3,0,1,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,5,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2,2,0,0,0,2,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B38,C38)","v":"Ketamine"},"D007649","Ketamine","1867-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F38,F38)","v":"DTXSID4040137"},"DTXSID4040137",{"$f":"SUM(H38:UO38)","v":250},24,3,2,3,1,0,0,2,82,5,25,1,14,0,0,1,1,6,2,0,0,2,0,5,6,1,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,6,0,0,0,0,0,0,2,1,0,0,0,3,1,4,0,0,0,0,1,3,0,0,2,0,5,0,1,2,2,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,2,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B39,C39)","v":"olanzapine"},"C076029","olanzapine","132539-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F39,F39)","v":"DTXSID9023388"},"DTXSID9023388",{"$f":"SUM(H39:UO39)","v":250},9,2,0,0,0,74,7,7,6,5,2,1,24,0,1,12,1,0,0,0,0,0,2,7,0,0,2,0,4,0,1,0,0,0,0,0,1,4,1,0,1,1,0,0,0,16,0,0,0,0,0,0,1,1,5,0,0,0,0,0,2,0,6,1,3,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,1,1,1,2,0,0,0,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B40,C40)","v":"Thalidomide"},"D013792","Thalidomide","50-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F40,F40)","v":"DTXSID9022524"},"DTXSID9022524",{"$f":"SUM(H40:UO40)","v":250},0,23,96,3,0,0,0,0,1,5,1,3,0,0,9,0,0,0,2,1,2,0,0,2,0,0,2,0,2,0,0,17,0,1,1,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2,0,0,6,0,0,0,0,0,1,0,0,0,0,5,0,0,0,2,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,0,1,0,0,5,0,0,0,0,0,1,2,0,2,0,1,0,0,4,0,0,1,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,0,0,4,0,0,0,0,0,1,0,2,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B41,C41)","v":"Arsenic"},"D001151","Arsenic","7440-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F41,F41)","v":"DTXSID4023886"},"DTXSID4023886",{"$f":"SUM(H41:UO41)","v":249},2,38,60,14,3,0,0,1,1,0,7,7,1,1,9,0,0,2,0,2,1,1,0,0,0,0,1,4,3,2,1,12,1,0,1,0,0,0,0,2,0,0,0,1,2,0,3,0,2,1,8,0,2,0,0,1,0,0,0,0,1,2,0,0,0,0,1,0,1,1,1,1,0,0,0,0,0,0,0,0,1,2,0,1,0,1,0,2,1,1,0,0,1,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,4,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B42,C42)","v":"Propofol"},"D015742","Propofol","2078-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F42,F42)","v":"DTXSID6023523"},"DTXSID6023523",{"$f":"SUM(H42:UO42)","v":247},49,2,0,0,3,2,0,5,11,2,12,2,17,0,2,10,16,2,12,0,0,3,3,3,0,11,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,11,0,0,0,0,0,12,1,0,0,0,0,0,3,0,0,0,0,1,0,1,0,3,6,0,0,0,0,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0,1,3,0,0,0,0,0,1,0,0,0,0,0,1,0,0,2,0,0,0,0,0,0,2,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,1,0,0,0,2,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B43,C43)","v":"Tacrolimus"},"D016559","Tacrolimus","104987-11-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F43,F43)","v":"DTXSID5046354"},"DTXSID5046354",{"$f":"SUM(H43:UO43)","v":247},14,19,6,22,0,0,0,5,0,13,0,1,1,1,2,0,0,1,2,1,0,4,3,1,2,3,5,0,0,3,0,6,0,0,0,10,0,1,4,1,1,0,0,0,0,0,8,0,0,0,1,5,0,0,0,0,1,0,0,3,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,1,1,2,1,0,0,0,0,0,0,2,0,0,5,0,0,2,0,0,0,2,0,0,4,20,0,0,0,3,2,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,2,0,0,0,0,4,3,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,3,1,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B44,C44)","v":"Chloroquine"},"D002738","Chloroquine","54-05-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F44,F44)","v":"DTXSID2040446"},"DTXSID2040446",{"$f":"SUM(H44:UO44)","v":239},16,8,10,3,34,5,1,4,3,0,0,2,1,0,1,1,1,0,3,2,0,0,2,0,0,4,1,2,0,5,3,2,5,3,0,1,0,0,0,3,0,1,21,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,2,2,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,1,0,1,1,2,0,0,1,0,0,0,0,0,2,0,1,8,0,1,0,1,0,0,0,0,0,9,1,0,0,0,0,0,1,0,0,13,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B45,C45)","v":"Fentanyl"},"D005283","Fentanyl","990-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F45,F45)","v":"DTXSID80243933"},"DTXSID80243933",{"$f":"SUM(H45:UO45)","v":236},22,0,0,3,1,1,0,11,3,3,0,0,18,0,0,2,10,1,1,0,1,4,1,2,21,6,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,3,0,0,0,0,0,6,0,0,0,0,0,2,51,0,0,0,0,1,0,2,1,0,6,1,0,1,1,1,1,1,0,0,2,2,0,1,0,0,0,0,0,0,0,0,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,3,1,3,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,2,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B46,C46)","v":"Lithium Carbonate"},"D016651","Lithium Carbonate","554-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F46,F46)","v":"DTXSID1023784"},"DTXSID1023784",{"$f":"SUM(H46:UO46)","v":230},5,13,6,10,2,14,7,5,1,13,4,4,8,0,0,1,6,7,1,1,0,7,1,1,0,1,2,0,0,0,0,1,1,2,0,0,1,3,0,0,0,1,4,1,1,0,0,1,0,0,2,0,0,0,1,1,8,0,1,0,3,7,1,5,0,0,0,0,1,0,1,0,0,0,8,1,0,0,6,0,0,0,0,5,0,0,0,0,0,1,0,0,0,3,1,0,1,6,0,1,0,0,0,2,0,0,1,0,0,0,0,0,0,2,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,1,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B47,C47)","v":"Metoclopramide"},"D008787","Metoclopramide","2576-84-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F47,F47)","v":"DTXSID20180434"},"DTXSID20180434",{"$f":"SUM(H47:UO47)","v":229},3,7,0,1,5,47,37,0,0,5,0,1,1,1,0,59,7,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,5,1,0,0,0,0,0,0,0,0,0,0,0,8,0,4,0,2,0,0,0,0,2,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,4,0,1,0,3,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B48,C48)","v":"Diazepam"},"D003975","Diazepam","439-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F48,F48)","v":"DTXSID4020406"},"DTXSID4020406",{"$f":"SUM(H48:UO48)","v":228},33,3,1,1,2,1,2,19,5,4,8,0,3,1,1,5,2,9,1,0,0,0,2,4,0,3,3,0,0,0,0,0,4,3,1,0,3,1,1,0,0,25,0,0,0,0,0,4,3,2,2,0,0,0,1,0,1,0,0,0,4,3,1,1,2,0,0,0,1,1,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,6,0,5,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,2,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B49,C49)","v":"Theophylline"},"D013806","Theophylline","58-55-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F49,F49)","v":"DTXSID5021336"},"DTXSID5021336",{"$f":"SUM(H49:UO49)","v":225},113,13,0,6,1,0,0,3,0,13,1,4,0,1,0,0,0,0,9,0,0,1,12,4,0,8,1,0,0,0,1,0,1,0,0,0,1,0,3,1,0,1,0,0,0,0,0,0,4,1,0,0,0,0,1,0,0,0,1,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B50,C50)","v":"Pentylenetetrazole"},"D010433","Pentylenetetrazole","54-95-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F50,F50)","v":"DTXSID7041091"},"DTXSID7041091",{"$f":"SUM(H50:UO50)","v":222},163,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,32,0,0,0,5,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B51,C51)","v":"Bismuth"},"D001729","Bismuth","7440-69-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F51,F51)","v":"DTXSID3052484"},"DTXSID3052484",{"$f":"SUM(H51:UO51)","v":220},5,3,0,84,0,0,0,1,6,7,5,1,4,0,2,0,50,4,3,0,0,11,0,0,0,0,2,2,0,0,0,0,5,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,2,0,1,0,0,0,0,0,0,0,2,0,3,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B52,C52)","v":"Metrizamide"},"D008793","Metrizamide","31112-62-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F52,F52)","v":"DTXSID1023310"},"DTXSID1023310",{"$f":"SUM(H52:UO52)","v":218},37,5,0,14,0,1,0,2,1,0,1,5,3,1,2,0,3,0,10,0,5,8,6,0,0,6,0,0,0,0,1,0,8,0,0,1,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,15,1,0,0,2,0,0,0,3,1,3,0,1,0,2,0,0,0,1,1,0,0,18,0,0,0,1,1,1,0,0,1,0,0,5,0,0,2,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,8,0,0,1,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B53,C53)","v":"Metronidazole"},"D008795","Metronidazole","69198-10-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F53,F53)","v":"DTXSID70219228"},"DTXSID70219228",{"$f":"SUM(H53:UO53)","v":218},11,11,28,36,0,1,0,2,3,1,0,5,0,1,7,1,0,4,1,0,1,7,0,0,0,0,0,0,0,0,2,4,2,0,0,4,0,0,0,3,0,0,2,1,0,0,1,0,0,0,0,1,0,0,0,0,12,0,2,1,1,1,0,0,0,1,0,2,0,0,1,1,0,2,0,0,0,0,8,0,1,1,5,0,0,1,0,0,0,1,1,0,0,0,0,0,0,7,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,2,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,4,0,0,0,0,3,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B54,C54)","v":"Methamphetamine"},"D008694","Methamphetamine","537-46-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F54,F54)","v":"DTXSID8037128"},"DTXSID8037128",{"$f":"SUM(H54:UO54)","v":216},19,13,1,7,0,1,7,1,20,0,26,2,4,10,2,0,0,0,0,0,0,1,0,1,0,4,0,0,5,2,0,0,2,0,0,6,0,4,0,0,2,0,0,0,0,0,1,0,8,11,0,1,2,2,0,0,0,1,0,0,5,0,0,2,1,0,5,0,0,0,1,2,0,0,0,0,0,3,0,0,4,1,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,1,0,0,0,1,1,0,0,2,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B55,C55)","v":"Pilocarpine"},"D010862","Pilocarpine","54-71-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F55,F55)","v":"DTXSID2041096"},"DTXSID2041096",{"$f":"SUM(H55:UO55)","v":212},55,0,1,1,0,0,0,0,1,2,0,0,0,0,0,0,0,0,30,0,0,1,72,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,35,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B56,C56)","v":"Chlorpromazine"},"D002746","Chlorpromazine","580-48-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F56,F56)","v":"DTXSID6041765"},"DTXSID6041765",{"$f":"SUM(H56:UO56)","v":210},10,5,0,2,8,41,17,7,0,10,0,1,2,1,0,9,0,0,0,0,1,2,1,1,0,4,2,0,0,2,0,0,12,3,0,0,11,2,1,0,0,0,0,0,0,2,0,2,0,2,0,0,0,6,2,1,0,0,0,0,0,1,0,0,2,0,0,0,0,0,1,0,0,0,0,4,0,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,1,1,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,0,0,1,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B57,C57)","v":"Caffeine"},"D002110","Caffeine","58-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F57,F57)","v":"DTXSID0020232"},"DTXSID0020232",{"$f":"SUM(H57:UO57)","v":207},29,5,0,2,1,0,3,3,4,9,5,1,4,2,3,1,2,2,4,0,2,0,1,20,2,6,24,0,2,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,2,2,5,0,0,0,0,0,0,0,2,1,1,0,1,1,1,0,0,0,0,0,1,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,3,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,1,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,4,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,2,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B58,C58)","v":"Amitriptyline"},"D000639","Amitriptyline","17086-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F58,F58)","v":"DTXSID60168958"},"DTXSID60168958",{"$f":"SUM(H58:UO58)","v":204},28,3,6,2,1,3,2,20,6,5,1,3,14,1,4,2,6,1,4,0,1,5,3,3,0,4,2,1,1,0,0,1,0,8,0,0,3,0,7,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,4,0,1,1,3,2,2,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,2,0,0,0,0,1,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,1,1,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B59,C59)","v":"Fluorouracil"},"D005472","Fluorouracil","51-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F59,F59)","v":"DTXSID2020634"},"DTXSID2020634",{"$f":"SUM(H59:UO59)","v":198},7,16,7,26,1,0,1,3,0,1,0,4,0,0,16,2,0,7,0,0,1,3,0,0,0,0,0,0,2,1,0,0,0,0,0,3,0,0,2,1,0,0,1,1,0,0,9,2,0,0,0,2,0,0,0,0,4,0,0,0,0,1,0,0,1,1,0,0,0,1,1,1,0,0,0,0,0,1,10,0,0,0,1,0,0,0,0,0,0,0,13,0,0,1,0,0,0,0,0,0,13,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,0,2,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,2,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B60,C60)","v":"Toluene"},"D014050","Toluene","108-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F60,F60)","v":"DTXSID7021360"},"DTXSID7021360",{"$f":"SUM(H60:UO60)","v":195},6,17,8,5,2,0,1,3,1,4,8,11,1,0,0,0,1,2,0,17,5,1,1,1,0,2,0,8,0,0,2,0,1,0,0,0,0,0,0,0,0,1,2,1,0,1,1,0,4,3,0,4,0,0,0,2,3,0,0,2,4,2,1,1,0,0,0,0,3,6,0,0,0,0,0,0,0,1,4,0,0,1,0,0,0,0,0,2,0,0,3,2,6,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,2,0,0,0,0,5,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B61,C61)","v":"Cytarabine"},"D003561","Cytarabine","69-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F61,F61)","v":"DTXSID5024891"},"DTXSID5024891",{"$f":"SUM(H61:UO61)","v":190},2,14,10,16,0,1,3,1,0,2,2,12,0,0,2,0,0,4,0,0,3,1,0,0,0,1,0,1,2,1,0,1,0,1,0,0,1,0,0,0,0,0,0,1,0,1,2,0,0,1,0,0,0,0,0,6,30,0,0,1,1,3,0,0,0,0,0,3,0,0,0,0,0,1,3,0,0,0,6,0,0,0,0,1,0,3,0,1,0,1,0,0,0,0,0,1,1,3,0,0,2,0,0,1,5,0,0,2,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B62,C62)","v":"Fluphenazine"},"D005476","Fluphenazine","69-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F62,F62)","v":"DTXSID2023068"},"DTXSID2023068",{"$f":"SUM(H62:UO62)","v":190},5,2,0,2,1,51,30,4,0,3,0,0,2,0,0,8,0,0,0,0,0,0,1,5,0,0,1,0,0,0,0,0,39,0,0,0,0,1,3,0,0,0,1,0,0,1,0,0,0,0,0,0,0,3,6,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,6,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B78,C78)","v":"Carbon Disulfide"},"D002246","Carbon Disulfide","75-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F78,F78)","v":"DTXSID6023947"},"DTXSID6023947",{"$f":"SUM(H78:UO78)","v":149},0,36,21,7,0,1,2,0,0,3,1,8,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,4,0,0,1,14,2,0,0,0,0,1,0,0,0,0,4,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,3,1,0,0,0,0,0,0,1,0,0,2,2,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B82,C82)","v":"Imipramine"},"D007099","Imipramine","50-49-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F82,F82)","v":"DTXSID1043881"},"DTXSID1043881",{"$f":"SUM(H82:UO82)","v":139},21,0,0,0,0,2,1,10,8,9,1,2,4,0,0,1,3,0,6,0,0,4,0,3,0,6,6,0,0,0,0,1,0,1,1,1,13,0,7,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,5,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B101,C101)","v":"Cimetidine"},"D002927","Cimetidine","51481-61-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F101,F101)","v":"DTXSID4020329"},"DTXSID4020329",{"$f":"SUM(H101:UO101)","v":119},4,7,3,6,1,1,1,3,4,1,0,7,9,0,1,2,0,0,1,0,0,39,0,1,0,1,1,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,2,1,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,2,0,2,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B126,C126)","v":"Furosemide"},"D005665","Furosemide","41733-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F126,F126)","v":"DTXSID90194528"},"DTXSID90194528",{"$f":"SUM(H126:UO126)","v":98},1,0,0,0,0,0,0,0,0,0,0,0,0,1,3,0,0,0,0,9,3,0,0,0,0,0,0,22,0,0,11,0,0,2,3,0,1,0,0,16,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,1,0,0,0,0,2,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B145,C145)","v":"Erythromycin"},"D004917","Erythromycin","114-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F145,F145)","v":"DTXSID4022991"},"DTXSID4022991",{"$f":"SUM(H145:UO145)","v":89},2,0,1,0,0,1,0,0,2,2,0,1,0,0,1,0,0,2,0,11,0,0,0,0,0,0,0,12,0,0,17,0,0,1,0,0,0,0,1,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B164,C164)","v":"Linezolid"},"D000069349","Linezolid","165800-03-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F164,F164)","v":"DTXSID5046489"},"DTXSID5046489",{"$f":"SUM(H164:UO164)","v":82},0,2,22,2,0,0,0,0,2,1,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,27,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B189,C189)","v":"Zinc"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F189,F189)","v":"DTXSID7035012"},"DTXSID7035012",{"$f":"SUM(H189:UO189)","v":68},4,3,5,1,1,0,0,1,1,0,1,1,0,0,6,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,1,0,0,0,0,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B208,C208)","v":"Maprotiline"},"D008376","Maprotiline","58902-67-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F208,F208)","v":"DTXSID30207646"},"DTXSID30207646",{"$f":"SUM(H208:UO208)","v":61},19,0,0,0,0,0,0,3,3,1,0,1,2,0,0,0,1,0,4,0,0,1,2,1,0,11,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B214,C214)","v":"cefepime"},"C043266","cefepime","123171-59-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F214,F214)","v":"DTXSID7045603"},"DTXSID7045603",{"$f":"SUM(H214:UO214)","v":59},5,2,0,9,0,0,0,1,2,1,0,0,3,0,0,0,6,0,2,0,0,5,12,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B233,C233)","v":"1-Naphthylamine"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F233,F233)","v":"DTXSID7020920"},"DTXSID7020920",{"$f":"SUM(H233:UO233)","v":53},2,2,0,1,0,3,4,1,2,3,0,1,1,0,1,4,2,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,12,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B252,C252)","v":"Alprazolam"},"D000525","Alprazolam","28981-97-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F252,F252)","v":"DTXSID4022577"},"DTXSID4022577",{"$f":"SUM(H252:UO252)","v":49},9,2,1,0,0,0,0,4,1,0,2,0,5,0,0,1,1,3,0,0,0,1,1,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B277,C277)","v":"1-Methyl-4-phenylpyridinium"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F277,F277)","v":"DTXSID8041826"},"DTXSID8041826",{"$f":"SUM(H277:UO277)","v":44},0,4,0,2,0,1,22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B296,C296)","v":"Picrotoxin"},"D010852","Picrotoxin","124-87-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F296,F296)","v":"DTXSID7045605"},"DTXSID7045605",{"$f":"SUM(H296:UO296)","v":41},24,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,1,5,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B315,C315)","v":"Aluminum Hydroxide"},"D000536","Aluminum Hydroxide","21645-51-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F315,F315)","v":"DTXSID2036405"},"DTXSID2036405",{"$f":"SUM(H315:UO315)","v":38},1,0,0,14,2,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B340,C340)","v":"Potassium Cyanide"},"D011190","Potassium Cyanide","151-50-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F340,F340)","v":"DTXSID0024268"},"DTXSID0024268",{"$f":"SUM(H340:UO340)","v":36},8,0,1,5,1,1,4,4,0,2,0,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B359,C359)","v":"Chloralose"},"D002698","Chloralose","15879-93-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F359,F359)","v":"DTXSID4020088"},"DTXSID4020088",{"$f":"SUM(H359:UO359)","v":33},4,0,0,0,0,0,0,10,0,0,0,0,0,0,0,0,9,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B384,C384)","v":"Hydrochlorothiazide"},"D006852","Hydrochlorothiazide","58-93-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F384,F384)","v":"DTXSID2020713"},"DTXSID2020713",{"$f":"SUM(H384:UO384)","v":30},1,1,0,1,2,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,1,0,3,0,0,0,0,0,0,0,0,0,0,4,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B403,C403)","v":"Pemoline"},"D010389","Pemoline","2152-34-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F403,F403)","v":"DTXSID3023427"},"DTXSID3023427",{"$f":"SUM(H403:UO403)","v":28},1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B422,C422)","v":"Sulfamethoxazole"},"D013420","Sulfamethoxazole","723-46-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F422,F422)","v":"DTXSID8026064"},"DTXSID8026064",{"$f":"SUM(H422:UO422)","v":27},1,0,0,0,0,0,0,0,1,2,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B428,C428)","v":"Cilastatin"},"D015377","Cilastatin","82009-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F428,F428)","v":"DTXSID8048238"},"DTXSID8048238",{"$f":"SUM(H428:UO428)","v":26},14,0,0,1,0,0,0,0,0,2,0,3,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B447,C447)","v":"Hydromorphone"},"D004091","Hydromorphone","466-99-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F447,F447)","v":"DTXSID8023133"},"DTXSID8023133",{"$f":"SUM(H447:UO447)","v":24},2,0,0,1,0,0,0,1,0,1,0,0,1,0,0,0,5,0,0,0,0,0,1,1,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B472,C472)","v":"Glyburide"},"D005905","Glyburide","10238-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F472,F472)","v":"DTXSID0037237"},"DTXSID0037237",{"$f":"SUM(H472:UO472)","v":22},3,0,0,1,0,0,0,5,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B491,C491)","v":"Cyproterone Acetate"},"D017373","Cyproterone Acetate","427-51-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F491,F491)","v":"DTXSID5020366"},"DTXSID5020366",{"$f":"SUM(H491:UO491)","v":21},0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B510,C510)","v":"Griseofulvin"},"D006118","Griseofulvin","126-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F510,F510)","v":"DTXSID8020674"},"DTXSID8020674",{"$f":"SUM(H510:UO510)","v":20},0,0,1,0,1,0,0,0,1,0,0,0,2,0,1,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B535,C535)","v":"methamidophos"},"C014655","methamidophos","10265-92-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F535,F535)","v":"DTXSID6024177"},"DTXSID6024177",{"$f":"SUM(H535:UO535)","v":19},0,2,8,0,1,0,0,1,0,3,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B554,C554)","v":"cypermethrin"},"C017160","cypermethrin","65732-07-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F554,F554)","v":"DTXSID8058247"},"DTXSID8058247",{"$f":"SUM(H554:UO554)","v":18},4,1,2,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B573,C573)","v":"EMLA"},"C036626","EMLA","101362-25-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F573,F573)","v":"DTXSID60893697"},"DTXSID60893697",{"$f":"SUM(H573:UO573)","v":17},3,0,0,0,0,0,0,4,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B579,C579)","v":"Labetalol"},"D007741","Labetalol","36894-69-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F579,F579)","v":"DTXSID2023191"},"DTXSID2023191",{"$f":"SUM(H579:UO579)","v":17},0,1,0,0,1,0,0,0,0,1,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B598,C598)","v":"Nitroprusside"},"D009599","Nitroprusside","14402-89-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F598,F598)","v":"DTXSID2036794"},"DTXSID2036794",{"$f":"SUM(H598:UO598)","v":16},1,0,0,1,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B623,C623)","v":"Nomifensine"},"D009627","Nomifensine","24526-64-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F623,F623)","v":"DTXSID0023377"},"DTXSID0023377",{"$f":"SUM(H623:UO623)","v":15},4,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,2,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B642,C642)","v":"Cisapride"},"D020117","Cisapride","81098-60-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F642,F642)","v":"DTXSID3022825"},"DTXSID3022825",{"$f":"SUM(H642:UO642)","v":14},1,1,0,0,0,1,1,0,0,1,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B663,C663)","v":"normeperidine"},"C002752","normeperidine","77-17-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F663,F663)","v":"DTXSID50227806"},"DTXSID50227806",{"$f":"SUM(H663:UO663)","v":14},5,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B685,C685)","v":"fenvalerate"},"C017690","fenvalerate","66267-77-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F685,F685)","v":"DTXSID3058450"},"DTXSID3058450",{"$f":"SUM(H685:UO685)","v":13},2,0,1,0,0,0,0,0,0,1,0,0,0,0,6,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B704,C704)","v":"Thiothixene"},"D013888","Thiothixene","5591-45-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F704,F704)","v":"DTXSID6023658"},"DTXSID6023658",{"$f":"SUM(H704:UO704)","v":13},0,0,0,0,0,4,2,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B723,C723)","v":"fludarabine phosphate"},"C042382","fludarabine phosphate","75607-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F723,F723)","v":"DTXSID2023060"},"DTXSID2023060",{"$f":"SUM(H723:UO723)","v":12},0,2,0,3,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B729,C729)","v":"ioversol"},"C054871","ioversol","87771-40-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F729,F729)","v":"DTXSID2045521"},"DTXSID2045521",{"$f":"SUM(H729:UO729)","v":12},1,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B748,C748)","v":"Alendronate"},"D019386","Alendronate","66376-36-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F748,F748)","v":"DTXSID5022568"},"DTXSID5022568",{"$f":"SUM(H748:UO748)","v":11},1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B773,C773)","v":"Potassium Permanganate"},"D011196","Potassium Permanganate","7722-64-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F773,F773)","v":"DTXSID2034839"},"DTXSID2034839",{"$f":"SUM(H773:UO773)","v":11},0,0,0,1,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B792,C792)","v":"butane"},"C046888","butane","106-97-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F792,F792)","v":"DTXSID7024665"},"DTXSID7024665",{"$f":"SUM(H792:UO792)","v":10},0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B811,C811)","v":"pyriminil"},"C012598","pyriminil","53558-25-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F811,F811)","v":"DTXSID1042360"},"DTXSID1042360",{"$f":"SUM(H811:UO811)","v":10},0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B836,C836)","v":"barium carbonate"},"C006685","barium carbonate","513-77-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F836,F836)","v":"DTXSID1029623"},"DTXSID1029623",{"$f":"SUM(H836:UO836)","v":9},0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B855,C855)","v":"Glycyrrhetinic Acid"},"D006034","Glycyrrhetinic Acid","471-53-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F855,F855)","v":"DTXSID9020669"},"DTXSID9020669",{"$f":"SUM(H855:UO855)","v":9},0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B861,C861)","v":"lime"},"C016538","lime","1305-78-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F861,F861)","v":"DTXSID5029631"},"DTXSID5029631",{"$f":"SUM(H861:UO861)","v":9},0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B880,C880)","v":"Triflupromazine"},"D014273","Triflupromazine","146-54-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F880,F880)","v":"DTXSID9023704"},"DTXSID9023704",{"$f":"SUM(H880:UO880)","v":9},2,0,0,0,1,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B899,C899)","v":"desmethylmisonidazole"},"C009997","desmethylmisonidazole","13551-92-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F899,F899)","v":"DTXSID50875669"},"DTXSID50875669",{"$f":"SUM(H899:UO899)","v":8},0,3,3,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B924,C924)","v":"Pentamidine"},"D010419","Pentamidine","140-64-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F924,F924)","v":"DTXSID5023796"},"DTXSID5023796",{"$f":"SUM(H924:UO924)","v":8},0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B943,C943)","v":"trovafloxacin"},"C080163","trovafloxacin","147059-72-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F943,F943)","v":"DTXSID0041145"},"DTXSID0041145",{"$f":"SUM(H943:UO943)","v":8},1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B962,C962)","v":"Cycloheximide"},"D003513","Cycloheximide","66-81-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F962,F962)","v":"DTXSID6024882"},"DTXSID6024882",{"$f":"SUM(H962:UO962)","v":7},0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B987,C987)","v":"Metaproterenol"},"D009921","Metaproterenol","586-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F987,F987)","v":"DTXSID8048529"},"DTXSID8048529",{"$f":"SUM(H987:UO987)","v":7},0,0,0,0,1,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1006,C1006)","v":"Ruthenium Red"},"D012430","Ruthenium Red","11103-72-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1006,F1006)","v":"DTXSID80108179"},"DTXSID80108179",{"$f":"SUM(H1006:UO1006)","v":7},2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1012,C1012)","v":"Sulfisoxazole"},"D013444","Sulfisoxazole","6155-81-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1012,F1012)","v":"DTXSID10210537"},"DTXSID10210537",{"$f":"SUM(H1012:UO1012)","v":7},0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1031,C1031)","v":"acivicin"},"C006303","acivicin","42228-92-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1031,F1031)","v":"DTXSID0046010"},"DTXSID0046010",{"$f":"SUM(H1031:UO1031)","v":6},0,1,0,1,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1050,C1050)","v":"Cromolyn Sodium"},"D004205","Cromolyn Sodium","16110-51-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1050,F1050)","v":"DTXSID4022860"},"DTXSID4022860",{"$f":"SUM(H1050:UO1050)","v":6},1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1075,C1075)","v":"Methylprednisolone Hemisuccinate"},"D008776","Methylprednisolone Hemisuccinate","2921-57-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1075,F1075)","v":"DTXSID80183466"},"DTXSID80183466",{"$f":"SUM(H1075:UO1075)","v":6},0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1094,C1094)","v":"Procaterol"},"D017265","Procaterol","72332-33-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1094,F1094)","v":"DTXSID5045673"},"DTXSID5045673",{"$f":"SUM(H1094:UO1094)","v":6},0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1119,C1119)","v":"9-fluoroprednisolone"},"C010958","9-fluoroprednisolone","(blank)",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1119,F1119)","v":"DTXSID101009333"},"DTXSID101009333",{"$f":"SUM(H1119:UO1119)","v":5},0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1138,C1138)","v":"Bisoprolol"},"D017298","Bisoprolol","66722-44-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1138,F1138)","v":"DTXSID6022682"},"DTXSID6022682",{"$f":"SUM(H1138:UO1138)","v":5},0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1157,C1157)","v":"Diminazene"},"D004133","Diminazene","536-71-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1157,F1157)","v":"DTXSID7043792"},"DTXSID7043792",{"$f":"SUM(H1157:UO1157)","v":5},0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1163,C1163)","v":"epothilone B"},"C093788","epothilone B","152044-54-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1163,F1163)","v":"DTXSID4046862"},"DTXSID4046862",{"$f":"SUM(H1163:UO1163)","v":5},0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1182,C1182)","v":"Ketorolac"},"D020910","Ketorolac","74103-06-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1182,F1182)","v":"DTXSID8023189"},"DTXSID8023189",{"$f":"SUM(H1182:UO1182)","v":5},0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1201,C1201)","v":"n-heptane"},"C028618","n-heptane","142-82-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1201,F1201)","v":"DTXSID6024127"},"DTXSID6024127",{"$f":"SUM(H1201:UO1201)","v":5},0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1226,C1226)","v":"propylene oxide"},"C009068","propylene oxide","75-56-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1226,F1226)","v":"DTXSID5021207"},"DTXSID5021207",{"$f":"SUM(H1226:UO1226)","v":5},0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1239,C1239)","v":"suvorexant"},"C551624","suvorexant","1030377-33-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1239,F1239)","v":"DTXSID90145616"},"DTXSID90145616",{"$f":"SUM(H1239:UO1239)","v":5},0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1240,C1240)","v":"Synephrine"},"D013578","Synephrine","94-07-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1240,F1240)","v":"DTXSID0030588"},"DTXSID0030588",{"$f":"SUM(H1240:UO1240)","v":5},0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1241,C1241)","v":"tandospirone"},"C055267","tandospirone","87760-53-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1241,F1241)","v":"DTXSID6048836"},"DTXSID6048836",{"$f":"SUM(H1241:UO1241)","v":5},0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1242,C1242)","v":"Terazosin"},"C041226","Terazosin","63590-64-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1242,F1242)","v":"DTXSID3023639"},"DTXSID3023639",{"$f":"SUM(H1242:UO1242)","v":5},0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1243,C1243)","v":"Thiabendazole"},"D013827","Thiabendazole","148-79-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1243,F1243)","v":"DTXSID0021337"},"DTXSID0021337",{"$f":"SUM(H1243:UO1243)","v":5},0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1244,C1244)","v":"Thioacetazone"},"D013828","Thioacetazone","104-06-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1244,F1244)","v":"DTXSID2022593"},"DTXSID2022593",{"$f":"SUM(H1244:UO1244)","v":5},0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1245,C1245)","v":"Ticagrelor"},"C503700","Ticagrelor","(blank)",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1245,F1245)","v":"DTXSID901009337"},"DTXSID901009337",{"$f":"SUM(H1245:UO1245)","v":5},0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1246,C1246)","v":"Toluene 2,4-Diisocyanate"},"D014051","Toluene 2,4-Diisocyanate","26471-62-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1246,F1246)","v":"DTXSID0024341"},"DTXSID0024341",{"$f":"SUM(H1246:UO1246)","v":5},0,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1247,C1247)","v":"trichloronate"},"C004372","trichloronate","327-98-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1247,F1247)","v":"DTXSID9038420"},"DTXSID9038420",{"$f":"SUM(H1247:UO1247)","v":5},0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1248,C1248)","v":"triethyltin"},"C031575","triethyltin","997-50-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1248,F1248)","v":"DTXSID1032226"},"DTXSID1032226",{"$f":"SUM(H1248:UO1248)","v":5},0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1249,C1249)","v":"Trinitrotoluene"},"D014303","Trinitrotoluene","118-96-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1249,F1249)","v":"DTXSID7024372"},"DTXSID7024372",{"$f":"SUM(H1249:UO1249)","v":5},1,2,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1250,C1250)","v":"Vilazodone Hydrochloride"},"D000069503","Vilazodone Hydrochloride","(blank)",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1250,F1250)","v":"DTXSID80936833"},"DTXSID80936833",{"$f":"SUM(H1250:UO1250)","v":5},3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1251,C1251)","v":"vorapaxar"},"C530299","vorapaxar","(blank)",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1251,F1251)","v":"DTXSID201009336"},"DTXSID201009336",{"$f":"SUM(H1251:UO1251)","v":5},0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1252,C1252)","v":"Win 55212-2"},"C070417","Win 55212-2","131543-22-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1252,F1252)","v":"DTXSID40894849"},"DTXSID40894849",{"$f":"SUM(H1252:UO1252)","v":5},0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & B1253,C1253)","v":"zipeprol"},"C013341","zipeprol","(blank)",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & F1253,F1253)","v":"DTXSID00865732"},"DTXSID00865732",{"$f":"SUM(H1253:UO1253)","v":5},3,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]

{"sheet":"Detail","index":1,"n_rows":53787,"n_cols":14,"rows_kept":4500,"cut":true,"hidden":false,"merged":[],"bounds":{"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0}}
["Detail"]
["Chemical","Disease","chemuid","ChemName","CAS RN","DSSToxID","Pub Yr","PMID","Title","LinkPMID","Descriptor","disuid","BioEff","DSSToxID"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3,D3)","v":"(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3,M3)","v":"Hallucinations"},"C586710","(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone","1199943-44-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3,N3)","v":"DTXSID60152635"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3,J3)","v":"28283378"},"The effects of synthetic cannabinoid UR-144 on the human body-A review of 39 cases.","28283378","Neurologic Manifestations","D006212","Hallucinations","DTXSID60152635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4,D4)","v":"(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4,M4)","v":"Seizures"},"C586710","(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone","1199943-44-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4,N4)","v":"DTXSID60152635"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4,J4)","v":"28283378"},"The effects of synthetic cannabinoid UR-144 on the human body-A review of 39 cases.","28283378","Neurologic Manifestations","D012640","Seizures","DTXSID60152635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5,D5)","v":"(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5,M5)","v":"Speech Disorders"},"C586710","(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone","1199943-44-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5,N5)","v":"DTXSID60152635"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5,J5)","v":"28283378"},"The effects of synthetic cannabinoid UR-144 on the human body-A review of 39 cases.","28283378","Neurologic Manifestations","D013064","Speech Disorders","DTXSID60152635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6,D6)","v":"(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6,M6)","v":"Syncope"},"C586710","(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone","1199943-44-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6,N6)","v":"DTXSID60152635"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6,J6)","v":"28283378"},"The effects of synthetic cannabinoid UR-144 on the human body-A review of 39 cases.","28283378","Neurologic Manifestations","D013575","Syncope","DTXSID60152635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7,D7)","v":"(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7,M7)","v":"Unconsciousness"},"C586710","(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone","1199943-44-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7,N7)","v":"DTXSID60152635"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7,J7)","v":"28283378"},"The effects of synthetic cannabinoid UR-144 on the human body-A review of 39 cases.","28283378","Neurologic Manifestations","D014474","Unconsciousness","DTXSID60152635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8,D8)","v":"1-(3-chlorophenyl)piperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8,M8)","v":"Autonomic Nervous System Diseases"},"C015068","1-(3-chlorophenyl)piperazine","6640-24-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8,N8)","v":"DTXSID9045138"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8,J8)","v":"9704867"},"Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine.","9704867","Autonomic Nervous System Diseases","D001342","Autonomic Nervous System Diseases","DTXSID9045138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9,D9)","v":"1-(3-chlorophenyl)piperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9,M9)","v":"Dystonia"},"C015068","1-(3-chlorophenyl)piperazine","6640-24-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9,N9)","v":"DTXSID9045138"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9,J9)","v":"8480838"},"Precipitation of dystonia by m-CPP in a schizophrenic patient treated with haloperidol.","8480838","Neurologic Manifestations","D004421","Dystonia","DTXSID9045138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10,D10)","v":"1-(3-chlorophenyl)piperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10,M10)","v":"Hyperkinesis"},"C015068","1-(3-chlorophenyl)piperazine","6640-24-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10,N10)","v":"DTXSID9045138"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10,J10)","v":"15234597"},"A 5-HT2C agonist elicits hyperactivity and oral dyskinesia with hypophagia in rabbits.","15234597","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID9045138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11,D11)","v":"1-(3-chlorophenyl)piperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11,M11)","v":"Migraine Disorders"},"C015068","1-(3-chlorophenyl)piperazine","6640-24-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11,N11)","v":"DTXSID9045138"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11,J11)","v":"1575270"},"Trazodone induction of migraine headache through mCPP.","1575270","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID9045138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12,D12)","v":"1-(3-chlorophenyl)piperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12,M12)","v":"Migraine Disorders"},"C015068","1-(3-chlorophenyl)piperazine","6640-24-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12,N12)","v":"DTXSID9045138"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12,J12)","v":"10891925"},"The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: A controlled study.","10891925","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID9045138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13,D13)","v":"1-(3-chlorophenyl)piperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13,M13)","v":"Myoclonus"},"C015068","1-(3-chlorophenyl)piperazine","6640-24-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13,N13)","v":"DTXSID9045138"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13,J13)","v":"9704867"},"Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine.","9704867","Neurologic Manifestations","D009207","Myoclonus","DTXSID9045138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14,D14)","v":"1-(3-trifluoromethylphenyl)piperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14,M14)","v":"Hallucinations"},"C018406","1-(3-trifluoromethylphenyl)piperazine","15532-75-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14,N14)","v":"DTXSID10165876"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14,J14)","v":"19329546"},"Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol.","19329546","Neurologic Manifestations","D006212","Hallucinations","DTXSID10165876"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15,D15)","v":"1-(3-trifluoromethylphenyl)piperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15,M15)","v":"Migraine Disorders"},"C018406","1-(3-trifluoromethylphenyl)piperazine","15532-75-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15,N15)","v":"DTXSID10165876"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15,J15)","v":"19329546"},"Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol.","19329546","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID10165876"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16,D16)","v":"1-(3-trifluoromethylphenyl)piperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16,M16)","v":"Seizures"},"C018406","1-(3-trifluoromethylphenyl)piperazine","15532-75-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16,N16)","v":"DTXSID10165876"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16,J16)","v":"21495881"},"The clinical toxicology of the designer \"party pills\" benzylpiperazine and trifluoromethylphenylpiperazine.","21495881","Neurologic Manifestations","D012640","Seizures","DTXSID10165876"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17,D17)","v":"1-(3-trifluoromethylphenyl)piperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17,M17)","v":"Sleep Initiation and Maintenance Disorders"},"C018406","1-(3-trifluoromethylphenyl)piperazine","15532-75-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17,N17)","v":"DTXSID10165876"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17,J17)","v":"19329546"},"Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol.","19329546","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID10165876"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18,D18)","v":"1-(3-trifluoromethylphenyl)piperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18,M18)","v":"Somatosensory Disorders"},"C018406","1-(3-trifluoromethylphenyl)piperazine","15532-75-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18,N18)","v":"DTXSID10165876"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18,J18)","v":"19329546"},"Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol.","19329546","Neurologic Manifestations","D020886","Somatosensory Disorders","DTXSID10165876"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19,D19)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19,M19)","v":"Brain Damage, Chronic"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19,N19)","v":"DTXSID0021381"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19,J19)","v":"8331433"},"Toxic encephalopathy due to 1,1,1-trichloroethane.","8331433","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20,D20)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20,M20)","v":"Brain Damage, Chronic"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20,N20)","v":"DTXSID0021381"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20,J20)","v":"8791934"},"MR in trichloroethane poisoning.","8791934","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21,D21)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21,M21)","v":"Brain Diseases"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21,N21)","v":"DTXSID0021381"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21,J21)","v":"8160661"},"Toxic encephalopathy due to 1,1,1-trichloroethane exposure.","8160661","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22,D22)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22,M22)","v":"Brain Diseases"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22,N22)","v":"DTXSID0021381"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22,J22)","v":"7605490"},"Toxic encephalopathy due to 1,1,1-trichloroethane exposure.","7605490","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23,D23)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23,M23)","v":"Brain Edema"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23,N23)","v":"DTXSID0021381"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23,J23)","v":"2231588"},"Fatal cerebral oedema following trichloroethane abuse.","2231588","Central Nervous System Diseases","D001929","Brain Edema","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24,D24)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24,M24)","v":"Cerebral Infarction"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24,N24)","v":"DTXSID0021381"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24,J24)","v":"6662442"},"Fatal poisoning by 1,1,1-trichloroethane after prolonged survival.","6662442","Central Nervous System Diseases","D002544","Cerebral Infarction","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25,D25)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25,M25)","v":"Coma"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25,N25)","v":"DTXSID0021381"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25,J25)","v":"8791934"},"MR in trichloroethane poisoning.","8791934","Neurologic Manifestations","D003128","Coma","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26,D26)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26,M26)","v":"Hypoxia, Brain"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26,N26)","v":"DTXSID0021381"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26,J26)","v":"6662442"},"Fatal poisoning by 1,1,1-trichloroethane after prolonged survival.","6662442","Central Nervous System Diseases","D002534","Hypoxia, Brain","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27,D27)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27,M27)","v":"Nervous System Diseases"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27,N27)","v":"DTXSID0021381"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27,J27)","v":"8277925"},"Neurotoxicologic examination of rats exposed to 1,1,1-trichloroethane vapor for 13 weeks.","8277925","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28,D28)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28,M28)","v":"Paresthesia"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28,N28)","v":"DTXSID0021381"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28,J28)","v":"8673514"},"Paresthesias and sensory neuropathy due to 1,1,1-trichloroethane.","8673514","Neurologic Manifestations","D010292","Paresthesia","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29,D29)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29,M29)","v":"Paresthesia"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29,N29)","v":"DTXSID0021381"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29,J29)","v":"8185391"},"Peripheral sensory neuropathy associated with 1,1,1-trichloroethane.","8185391","Neurologic Manifestations","D010292","Paresthesia","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30,D30)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30,M30)","v":"Peripheral Nervous System Diseases"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30,N30)","v":"DTXSID0021381"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30,J30)","v":"8673514"},"Paresthesias and sensory neuropathy due to 1,1,1-trichloroethane.","8673514","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31,D31)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31,M31)","v":"Peripheral Nervous System Diseases"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31,N31)","v":"DTXSID0021381"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31,J31)","v":"8185391"},"Peripheral sensory neuropathy associated with 1,1,1-trichloroethane.","8185391","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32,D32)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32,M32)","v":"Peripheral Nervous System Diseases"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32,N32)","v":"DTXSID0021381"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32,J32)","v":"7605490"},"Toxic encephalopathy due to 1,1,1-trichloroethane exposure.","7605490","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33,D33)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33,M33)","v":"Peripheral Nervous System Diseases"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33,N33)","v":"DTXSID0021381"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33,J33)","v":"2845159"},"Peripheral neuropathy in two workers exposed to 1,1,1-trichloroethane.","2845159","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34,D34)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34,M34)","v":"Seizures"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34,N34)","v":"DTXSID0021381"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34,J34)","v":"8888022"},"Functional observational battery comparing effects of ethanol, 1,1,1-trichloroethane, ether, and flurothyl.","8888022","Neurologic Manifestations","D012640","Seizures","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35,D35)","v":"1,1,1-trichloroethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35,M35)","v":"Sensation Disorders"},"C024566","1,1,1-trichloroethane","71-55-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35,N35)","v":"DTXSID0021381"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35,J35)","v":"8673514"},"Paresthesias and sensory neuropathy due to 1,1,1-trichloroethane.","8673514","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID0021381"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36,D36)","v":"1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36,M36)","v":"Hyperkinesis"},"C084924","1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline","57680-86-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36,N36)","v":"DTXSID30360922"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36,J36)","v":"26303030"},"Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.","26303030","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID30360922"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37,D37)","v":"1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37,M37)","v":"Hyperkinesis"},"C084924","1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline","57680-86-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37,N37)","v":"DTXSID30360922"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37,J37)","v":"24842650"},"1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous neurotoxic compound, disturbs the behavioral and biochemical effects of L-DOPA: in vivo and ex vivo studies in the rat.","24842650","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID30360922"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38,D38)","v":"1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38,M38)","v":"Parkinson Disease, Secondary"},"C084924","1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline","57680-86-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38,N38)","v":"DTXSID30360922"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38,J38)","v":"8905742"},"Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate.","8905742","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID30360922"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39,D39)","v":"1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39,M39)","v":"Parkinson Disease, Secondary"},"C084924","1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline","57680-86-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39,N39)","v":"DTXSID30360922"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39,J39)","v":"11430895"},"Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.","11430895","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID30360922"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40,D40)","v":"1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40,M40)","v":"Parkinsonian Disorders"},"C084924","1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline","57680-86-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40,N40)","v":"DTXSID30360922"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40,J40)","v":"26303030"},"Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.","26303030","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID30360922"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41,D41)","v":"1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41,M41)","v":"Parkinsonian Disorders"},"C084924","1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline","57680-86-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41,N41)","v":"DTXSID30360922"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41,J41)","v":"14739562"},"Salsolinol causing parkinsonism activates endoplasmic reticulum-stress signaling pathways in human dopaminergic SK-N-SH cells.","14739562","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID30360922"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42,D42)","v":"1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42,M42)","v":"Catalepsy"},"C014843","1,2,3,4-tetrahydroisoquinoline","91-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42,N42)","v":"DTXSID6026115"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42,J42)","v":"11041279"},"Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.","11041279","Neurologic Manifestations","D002375","Catalepsy","DTXSID6026115"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43,D43)","v":"1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43,M43)","v":"Hypokinesia"},"C014843","1,2,3,4-tetrahydroisoquinoline","91-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43,N43)","v":"DTXSID6026115"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43,J43)","v":"11723179"},"Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.","11723179","Neurologic Manifestations","D018476","Hypokinesia","DTXSID6026115"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44,D44)","v":"1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44,M44)","v":"Parkinson Disease, Secondary"},"C014843","1,2,3,4-tetrahydroisoquinoline","91-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44,N44)","v":"DTXSID6026115"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44,J44)","v":"8093578"},"Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.","8093578","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID6026115"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45,D45)","v":"1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45,M45)","v":"Parkinson Disease, Secondary"},"C014843","1,2,3,4-tetrahydroisoquinoline","91-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45,N45)","v":"DTXSID6026115"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45,J45)","v":"2630145"},"[Tetrahydroisoquinoline and parkinsonism].","2630145","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID6026115"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46,D46)","v":"1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46,M46)","v":"Parkinson Disease, Secondary"},"C014843","1,2,3,4-tetrahydroisoquinoline","91-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46,N46)","v":"DTXSID6026115"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46,J46)","v":"2584300"},"Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods.","2584300","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID6026115"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47,D47)","v":"1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47,M47)","v":"Parkinson Disease, Secondary"},"C014843","1,2,3,4-tetrahydroisoquinoline","91-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47,N47)","v":"DTXSID6026115"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47,J47)","v":"11041279"},"Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.","11041279","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID6026115"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48,D48)","v":"1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48,M48)","v":"Parkinson Disease, Secondary"},"C014843","1,2,3,4-tetrahydroisoquinoline","91-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48,N48)","v":"DTXSID6026115"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48,J48)","v":"10705483"},"A chiral synthesis of four stereoisomers of 1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline, an inducer of Parkinson-like syndrome.","10705483","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID6026115"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49,D49)","v":"1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49,M49)","v":"Parkinsonian Disorders"},"C014843","1,2,3,4-tetrahydroisoquinoline","91-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49,N49)","v":"DTXSID6026115"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49,J49)","v":"11723179"},"Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.","11723179","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID6026115"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50,D50)","v":"1,2-diacetylbenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50,M50)","v":"Amyotrophic Lateral Sclerosis"},"C048792","1,2-diacetylbenzene","704-00-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50,N50)","v":"DTXSID20220667"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50,J50)","v":"15759132"},"A new murine model of giant proximal axonopathy.","15759132","Central Nervous System Diseases","D000690","Amyotrophic Lateral Sclerosis","DTXSID20220667"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51,D51)","v":"1,2-diacetylbenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51,M51)","v":"Central Nervous System Diseases"},"C048792","1,2-diacetylbenzene","704-00-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51,N51)","v":"DTXSID20220667"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51,J51)","v":"1447480"},"Alteration of brainstem auditory evoked potentials in diethylbenzene and diacetylbenzene-treated rats.","1447480","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID20220667"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52,D52)","v":"1,2-diacetylbenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52,M52)","v":"Nervous System Diseases"},"C048792","1,2-diacetylbenzene","704-00-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52,N52)","v":"DTXSID20220667"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52,J52)","v":"1939999"},"Possible involvement of 1,2-diacetylbenzene in diethylbenzene-induced neuropathy in rats.","1939999","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID20220667"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53,D53)","v":"1,2-diacetylbenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53,M53)","v":"Nervous System Diseases"},"C048792","1,2-diacetylbenzene","704-00-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53,N53)","v":"DTXSID20220667"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53,J53)","v":"11740911"},"1,2-diacetylbenzene, the neurotoxic metabolite of a chromogenic aromatic solvent, induces proximal axonopathy.","11740911","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID20220667"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C54,D54)","v":"1,2-diacetylbenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L54,M54)","v":"Nervous System Diseases"},"C048792","1,2-diacetylbenzene","704-00-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N54,N54)","v":"DTXSID20220667"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J54,J54)","v":"11890826"},"Theoretical determination of chromophores in the chromogenic effects of aromatic neurotoxicants.","11890826","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID20220667"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C55,D55)","v":"1,3-butadiene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L55,M55)","v":"Brain Neoplasms"},"C031763","1,3-butadiene","106-99-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N55,N55)","v":"DTXSID3020203"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J55,J55)","v":"3966163"},"Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure.","3966163","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID3020203"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C56,D56)","v":"1,3-butadiene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L56,M56)","v":"Brain Neoplasms"},"C031763","1,3-butadiene","106-99-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N56,N56)","v":"DTXSID3020203"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J56,J56)","v":"15814359"},"Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice.","15814359","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID3020203"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C57,D57)","v":"1,3-butadiene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L57,M57)","v":"Brain Neoplasms"},"C031763","1,3-butadiene","106-99-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N57,N57)","v":"DTXSID3020203"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J57,J57)","v":"16860786"},"Evaluation of genetic alterations in cancer-related genes in lung and brain tumors from B6C3F1 mice exposed to 1,3-butadiene or chloroprene.","16860786","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID3020203"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C58,D58)","v":"1,3-butadiene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L58,M58)","v":"Central Nervous System Diseases"},"C031763","1,3-butadiene","106-99-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N58,N58)","v":"DTXSID3020203"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J58,J58)","v":"18220155"},"Clinical evaluation of 1,3-butadiene neurotoxicity in humans.","18220155","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID3020203"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C59,D59)","v":"1,3-butadiene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L59,M59)","v":"Central Nervous System Neoplasms"},"C031763","1,3-butadiene","106-99-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N59,N59)","v":"DTXSID3020203"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J59,J59)","v":"26443468"},"Differences in environmental exposure assignment due to residential mobility among children with a central nervous system tumor: Texas, 1995-2009.","26443468","Nervous System Neoplasms","D016543","Central Nervous System Neoplasms","DTXSID3020203"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C60,D60)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L60,M60)","v":"Ataxia"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N60,N60)","v":"DTXSID2024666"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J60,J60)","v":"19655283"},"1,4-Butanediol content of aqua dots children's craft toy beads.","19655283","Neurologic Manifestations","D001259","Ataxia","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C61,D61)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L61,M61)","v":"Catalepsy"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N61,N61)","v":"DTXSID2024666"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J61,J61)","v":"23104245"},"Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration.","23104245","Neurologic Manifestations","D002375","Catalepsy","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C62,D62)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L62,M62)","v":"Coma"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N62,N62)","v":"DTXSID2024666"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J62,J62)","v":"19915428"},"Coma in a 20-month-old child from an ingestion of a toy containing 1,4-butanediol, a precursor of gamma-hydroxybutyrate.","19915428","Neurologic Manifestations","D003128","Coma","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C63,D63)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L63,M63)","v":"Coma"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N63,N63)","v":"DTXSID2024666"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J63,J63)","v":"19655283"},"1,4-Butanediol content of aqua dots children's craft toy beads.","19655283","Neurologic Manifestations","D003128","Coma","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C64,D64)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L64,M64)","v":"Coma"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N64,N64)","v":"DTXSID2024666"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J64,J64)","v":"11493842"},"Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol.","11493842","Neurologic Manifestations","D003128","Coma","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C65,D65)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L65,M65)","v":"Coma"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N65,N65)","v":"DTXSID2024666"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J65,J65)","v":"11990207"},"Treatment of a 1,4-butanediol poisoning with fomepizole.","11990207","Neurologic Manifestations","D003128","Coma","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C66,D66)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L66,M66)","v":"Seizures"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N66,N66)","v":"DTXSID2024666"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J66,J66)","v":"18226321"},"Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.","18226321","Neurologic Manifestations","D012640","Seizures","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C67,D67)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L67,M67)","v":"Seizures"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N67,N67)","v":"DTXSID2024666"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J67,J67)","v":"15298490"},"Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.","15298490","Neurologic Manifestations","D012640","Seizures","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C68,D68)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L68,M68)","v":"Seizures"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N68,N68)","v":"DTXSID2024666"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J68,J68)","v":"15953232"},"Survival of massive gamma-hydroxybutyrate/1,4-butanediol overdose.","15953232","Neurologic Manifestations","D012640","Seizures","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C69,D69)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L69,M69)","v":"Seizures"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N69,N69)","v":"DTXSID2024666"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J69,J69)","v":"19655283"},"1,4-Butanediol content of aqua dots children's craft toy beads.","19655283","Neurologic Manifestations","D012640","Seizures","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C70,D70)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L70,M70)","v":"Seizures"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N70,N70)","v":"DTXSID2024666"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J70,J70)","v":"11138892"},"Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature.","11138892","Neurologic Manifestations","D012640","Seizures","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C71,D71)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L71,M71)","v":"Seizures"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N71,N71)","v":"DTXSID2024666"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J71,J71)","v":"11493842"},"Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol.","11493842","Neurologic Manifestations","D012640","Seizures","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C72,D72)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L72,M72)","v":"Seizures"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N72,N72)","v":"DTXSID2024666"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J72,J72)","v":"11990207"},"Treatment of a 1,4-butanediol poisoning with fomepizole.","11990207","Neurologic Manifestations","D012640","Seizures","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C73,D73)","v":"1,4-butanediol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L73,M73)","v":"Unconsciousness"},"C039681","1,4-butanediol","110-63-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N73,N73)","v":"DTXSID2024666"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J73,J73)","v":"11150358"},"Adverse events, including death, associated with the use of 1,4-butanediol.","11150358","Neurologic Manifestations","D014474","Unconsciousness","DTXSID2024666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C74,D74)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L74,M74)","v":"Brain Damage, Chronic"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N74,N74)","v":"DTXSID2045941"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J74,J74)","v":"8748897"},"Carmofur-induced leukoencephalopathy: MRI.","8748897","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C75,D75)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L75,M75)","v":"Brain Diseases"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N75,N75)","v":"DTXSID2045941"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J75,J75)","v":"3937066"},"[A case of toxic leucoencephalopathy induced by 5FU derivatives].","3937066","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C76,D76)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L76,M76)","v":"Brain Diseases"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N76,N76)","v":"DTXSID2045941"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J76,J76)","v":"2667512"},"Leukoencephalopathy following treatment with carmofur: a case report and review of the Japanese literature.","2667512","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C77,D77)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L77,M77)","v":"Brain Diseases"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N77,N77)","v":"DTXSID2045941"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J77,J77)","v":"3379758"},"[A case of leukoencephalopathy caused by HCFU].","3379758","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C78,D78)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L78,M78)","v":"Brain Diseases"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N78,N78)","v":"DTXSID2045941"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J78,J78)","v":"18306661"},"[Leukoencephalopathy caused by antineoplastic drugs].","18306661","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C79,D79)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L79,M79)","v":"Brain Diseases"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N79,N79)","v":"DTXSID2045941"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J79,J79)","v":"11734966"},"Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy.","11734966","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C80,D80)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L80,M80)","v":"Brain Diseases"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N80,N80)","v":"DTXSID2045941"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J80,J80)","v":"11725511"},"[A case of reversible carmofur-induced leukoencephalopathy].","11725511","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C81,D81)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L81,M81)","v":"Brain Edema"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N81,N81)","v":"DTXSID2045941"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J81,J81)","v":"17682013"},"Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients.","17682013","Central Nervous System Diseases","D001929","Brain Edema","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C82,D82)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L82,M82)","v":"Central Nervous System Diseases"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N82,N82)","v":"DTXSID2045941"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J82,J82)","v":"3814445"},"[Central nervous system toxicity of carmofur, an antineoplastic drug].","3814445","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C83,D83)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L83,M83)","v":"Dementia, Vascular"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N83,N83)","v":"DTXSID2045941"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J83,J83)","v":"17682013"},"Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients.","17682013","Central Nervous System Diseases","D015140","Dementia, Vascular","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C84,D84)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L84,M84)","v":"Demyelinating Diseases"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N84,N84)","v":"DTXSID2045941"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J84,J84)","v":"8748897"},"Carmofur-induced leukoencephalopathy: MRI.","8748897","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C85,D85)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L85,M85)","v":"Encephalomalacia"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N85,N85)","v":"DTXSID2045941"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J85,J85)","v":"11734966"},"Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy.","11734966","Central Nervous System Diseases","D004678","Encephalomalacia","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C86,D86)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L86,M86)","v":"Leukoencephalopathy, Progressive Multifocal"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N86,N86)","v":"DTXSID2045941"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J86,J86)","v":"3329075"},"[Report on an autopsy of a cancer patient with Carmofur (HCFU) leukoencephalopathy].","3329075","Central Nervous System Diseases","D007968","Leukoencephalopathy, Progressive Multifocal","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C87,D87)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L87,M87)","v":"Leukoencephalopathy, Progressive Multifocal"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N87,N87)","v":"DTXSID2045941"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J87,J87)","v":"3309192"},"Subacute leucoencephalopathy induced by carmofur, a 5-fluorouracil derivative.","3309192","Central Nervous System Diseases","D007968","Leukoencephalopathy, Progressive Multifocal","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C88,D88)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L88,M88)","v":"Leukoencephalopathy, Progressive Multifocal"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N88,N88)","v":"DTXSID2045941"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J88,J88)","v":"3080815"},"Reversible leukoencephalopathy caused by 5-fluorouracil derivatives, presenting as akinetic mutism.","3080815","Central Nervous System Diseases","D007968","Leukoencephalopathy, Progressive Multifocal","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C89,D89)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L89,M89)","v":"Leukoencephalopathy, Progressive Multifocal"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N89,N89)","v":"DTXSID2045941"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J89,J89)","v":"2487975"},"A case of carmofur-induced leukoencephalopathy--MR images and CT findings.","2487975","Central Nervous System Diseases","D007968","Leukoencephalopathy, Progressive Multifocal","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C90,D90)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L90,M90)","v":"Leukoencephalopathy, Progressive Multifocal"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N90,N90)","v":"DTXSID2045941"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J90,J90)","v":"2096243"},"Carmofur-induced organic mental disorders.","2096243","Central Nervous System Diseases","D007968","Leukoencephalopathy, Progressive Multifocal","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C91,D91)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L91,M91)","v":"Nervous System Diseases"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N91,N91)","v":"DTXSID2045941"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J91,J91)","v":"11410695"},"5-fluorouracil-induced leukoencephalopathy in patients with breast cancer.","11410695","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C92,D92)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L92,M92)","v":"Nervous System Diseases"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N92,N92)","v":"DTXSID2045941"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J92,J92)","v":"11528249"},"A phase I study of raltitrexed (Tomudex) combined with carmofur in metastatic colorectal cancer.","11528249","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C93,D93)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L93,M93)","v":"Paresthesia"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N93,N93)","v":"DTXSID2045941"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J93,J93)","v":"7448823"},"Phase I study of a new antitumor drug, 1-hexylcarbamoyl-5-fluorouracil (HCFU), administered orally: an HCFU clinical study group report.","7448823","Neurologic Manifestations","D010292","Paresthesia","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C94,D94)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L94,M94)","v":"Posterior Leukoencephalopathy Syndrome"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N94,N94)","v":"DTXSID2045941"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J94,J94)","v":"18074566"},"[Drug-induced leukoencephalopathy].","18074566","Central Nervous System Diseases","D054038","Posterior Leukoencephalopathy Syndrome","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C95,D95)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L95,M95)","v":"Speech Disorders"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N95,N95)","v":"DTXSID2045941"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J95,J95)","v":"6093712"},"[Clinical evaluation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in hepatocellular carcinoma].","6093712","Neurologic Manifestations","D013064","Speech Disorders","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C96,D96)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L96,M96)","v":"Stroke"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N96,N96)","v":"DTXSID2045941"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J96,J96)","v":"17682013"},"Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients.","17682013","Central Nervous System Diseases","D020521","Stroke","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C97,D97)","v":"1-hexylcarbamoyl-5-fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L97,M97)","v":"Unconsciousness"},"C017367","1-hexylcarbamoyl-5-fluorouracil","61422-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N97,N97)","v":"DTXSID2045941"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J97,J97)","v":"6093712"},"[Clinical evaluation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in hepatocellular carcinoma].","6093712","Neurologic Manifestations","D014474","Unconsciousness","DTXSID2045941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C98,D98)","v":"1-methyl-1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L98,M98)","v":"Hyperkinesis"},"C050386","1-methyl-1,2,3,4-tetrahydroisoquinoline","4965-09-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N98,N98)","v":"DTXSID70897161"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J98,J98)","v":"26303030"},"Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.","26303030","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID70897161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C99,D99)","v":"1-methyl-1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L99,M99)","v":"Hypokinesia"},"C050386","1-methyl-1,2,3,4-tetrahydroisoquinoline","4965-09-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N99,N99)","v":"DTXSID70897161"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J99,J99)","v":"11723179"},"Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.","11723179","Neurologic Manifestations","D018476","Hypokinesia","DTXSID70897161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C100,D100)","v":"1-methyl-1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L100,M100)","v":"Parkinson Disease, Secondary"},"C050386","1-methyl-1,2,3,4-tetrahydroisoquinoline","4965-09-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N100,N100)","v":"DTXSID70897161"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J100,J100)","v":"8093578"},"Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.","8093578","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID70897161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C101,D101)","v":"1-methyl-1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L101,M101)","v":"Parkinsonian Disorders"},"C050386","1-methyl-1,2,3,4-tetrahydroisoquinoline","4965-09-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N101,N101)","v":"DTXSID70897161"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J101,J101)","v":"26303030"},"Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.","26303030","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID70897161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C102,D102)","v":"1-methyl-1,2,3,4-tetrahydroisoquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L102,M102)","v":"Parkinsonian Disorders"},"C050386","1-methyl-1,2,3,4-tetrahydroisoquinoline","4965-09-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N102,N102)","v":"DTXSID70897161"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J102,J102)","v":"11723179"},"Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.","11723179","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID70897161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C103,D103)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L103,M103)","v":"Brain Diseases"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N103,N103)","v":"DTXSID70877241"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J103,J103)","v":"7683168"},"Neuroprotective effects of alpha-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","7683168","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C104,D104)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L104,M104)","v":"MPTP Poisoning"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N104,N104)","v":"DTXSID70877241"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J104,J104)","v":"8094427"},"Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys.","8094427","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C105,D105)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L105,M105)","v":"MPTP Poisoning"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N105,N105)","v":"DTXSID70877241"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J105,J105)","v":"9396088"},"Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents.","9396088","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C106,D106)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L106,M106)","v":"MPTP Poisoning"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N106,N106)","v":"DTXSID70877241"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J106,J106)","v":"2253695"},"Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.","2253695","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C107,D107)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L107,M107)","v":"MPTP Poisoning"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N107,N107)","v":"DTXSID70877241"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J107,J107)","v":"2204050"},"The neurotoxicity of MPTP and the relevance to Parkinson's disease.","2204050","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C108,D108)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L108,M108)","v":"MPTP Poisoning"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N108,N108)","v":"DTXSID70877241"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J108,J108)","v":"1362875"},"Molecular basis of discrepancies in neurotoxic properties among 1-methyl-4-aryl-1,2,3,6-tetrahydropyridines.","1362875","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C109,D109)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L109,M109)","v":"Nervous System Diseases"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N109,N109)","v":"DTXSID70877241"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J109,J109)","v":"8534316"},"Relative resistance of rabbits to MPTP neurotoxicity.","8534316","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C110,D110)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L110,M110)","v":"Nervous System Diseases"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N110,N110)","v":"DTXSID70877241"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J110,J110)","v":"8102929"},"Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.","8102929","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C111,D111)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L111,M111)","v":"Nervous System Diseases"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N111,N111)","v":"DTXSID70877241"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J111,J111)","v":"2325834"},"Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke.","2325834","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C112,D112)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L112,M112)","v":"Nervous System Diseases"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N112,N112)","v":"DTXSID70877241"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J112,J112)","v":"2485822"},"The neurotoxicity of MPTP and its relationship to the pathophysiology of Parkinson's disease.","2485822","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C113,D113)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L113,M113)","v":"Nervous System Diseases"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N113,N113)","v":"DTXSID70877241"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J113,J113)","v":"1974854"},"Differential recovery of dopamine synthetic enzymes following MPTP and the consequences of GM1 ganglioside treatment.","1974854","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C114,D114)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L114,M114)","v":"Nervous System Diseases"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N114,N114)","v":"DTXSID70877241"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J114,J114)","v":"2117541"},"1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset.","2117541","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C115,D115)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L115,M115)","v":"Nervous System Diseases"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N115,N115)","v":"DTXSID70877241"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J115,J115)","v":"1364057"},"Comparative studies of the neurotoxicity of MPTP in rats of different ages.","1364057","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C116,D116)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L116,M116)","v":"Parkinson Disease, Secondary"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N116,N116)","v":"DTXSID70877241"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J116,J116)","v":"8094427"},"Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys.","8094427","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C117,D117)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L117,M117)","v":"Parkinson Disease, Secondary"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N117,N117)","v":"DTXSID70877241"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J117,J117)","v":"9396088"},"Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents.","9396088","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C118,D118)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L118,M118)","v":"Parkinson Disease, Secondary"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N118,N118)","v":"DTXSID70877241"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J118,J118)","v":"2253695"},"Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.","2253695","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C119,D119)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L119,M119)","v":"Parkinson Disease, Secondary"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N119,N119)","v":"DTXSID70877241"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J119,J119)","v":"2204050"},"The neurotoxicity of MPTP and the relevance to Parkinson's disease.","2204050","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C120,D120)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L120,M120)","v":"Parkinson Disease, Secondary"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N120,N120)","v":"DTXSID70877241"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J120,J120)","v":"1362875"},"Molecular basis of discrepancies in neurotoxic properties among 1-methyl-4-aryl-1,2,3,6-tetrahydropyridines.","1362875","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C121,D121)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L121,M121)","v":"Parkinsonian Disorders"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N121,N121)","v":"DTXSID70877241"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J121,J121)","v":"12379867"},"Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons.","12379867","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C122,D122)","v":"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L122,M122)","v":"Parkinsonian Disorders"},"C048977","1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine","102417-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N122,N122)","v":"DTXSID70877241"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J122,J122)","v":"12410250"},"Neural stem cells, scaffolds, and chaperones.","12410250","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID70877241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C123,D123)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L123,M123)","v":"Alzheimer Disease"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N123,N123)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J123,J123)","v":"8512193"},"The goldfish as a drug discovery vehicle for Parkinson's disease and other neurodegenerative disorders.","8512193","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C124,D124)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L124,M124)","v":"Alzheimer Disease"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N124,N124)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J124,J124)","v":"21413090"},"The herbal preparation Padma® 28 protects against neurotoxicity in PC12 cells.","21413090","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C125,D125)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L125,M125)","v":"Amyotrophic Lateral Sclerosis"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N125,N125)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J125,J125)","v":"17985252"},"Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?","17985252","Central Nervous System Diseases","D000690","Amyotrophic Lateral Sclerosis","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C126,D126)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L126,M126)","v":"Ataxia"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N126,N126)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J126,J126)","v":"21804220"},"Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.","21804220","Neurologic Manifestations","D001259","Ataxia","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C127,D127)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L127,M127)","v":"Basal Ganglia Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N127,N127)","v":"DTXSID8040933"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J127,J127)","v":"9163560"},"Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.","9163560","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C128,D128)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L128,M128)","v":"Basal Ganglia Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N128,N128)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J128,J128)","v":"2858007"},"Neurological consequence of industrial exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","2858007","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C129,D129)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L129,M129)","v":"Basal Ganglia Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N129,N129)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J129,J129)","v":"2437428"},"Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).","2437428","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C130,D130)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L130,M130)","v":"Basal Ganglia Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N130,N130)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J130,J130)","v":"19319673"},"MPTP intoxication in mice: a useful model of Leigh syndrome to study mitochondrial diseases in childhood.","19319673","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C131,D131)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L131,M131)","v":"Basal Ganglia Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N131,N131)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J131,J131)","v":"1956587"},"A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.","1956587","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C132,D132)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L132,M132)","v":"Basal Ganglia Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N132,N132)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J132,J132)","v":"1317497"},"Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity.","1317497","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C133,D133)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L133,M133)","v":"Brain Damage, Chronic"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N133,N133)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J133,J133)","v":"18328580"},"Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission.","18328580","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C134,D134)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L134,M134)","v":"Brain Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N134,N134)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J134,J134)","v":"6607092"},"Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey.","6607092","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C135,D135)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L135,M135)","v":"Brain Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N135,N135)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J135,J135)","v":"8149986"},"Methamphetamine protects against MPTP neurotoxicity in C57BL mice.","8149986","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C136,D136)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L136,M136)","v":"Brain Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N136,N136)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J136,J136)","v":"7513362"},"The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.","7513362","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C137,D137)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L137,M137)","v":"Brain Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N137,N137)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J137,J137)","v":"7683168"},"Neuroprotective effects of alpha-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","7683168","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C138,D138)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L138,M138)","v":"Brain Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N138,N138)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J138,J138)","v":"8512600"},"Effect of acetyl-L-carnitine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.","8512600","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C139,D139)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L139,M139)","v":"Brain Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N139,N139)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J139,J139)","v":"9848095"},"Manganese superoxide dismutase overexpression attenuates MPTP toxicity.","9848095","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C140,D140)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L140,M140)","v":"Brain Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N140,N140)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J140,J140)","v":"2882814"},"Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice.","2882814","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C141,D141)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L141,M141)","v":"Brain Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N141,N141)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J141,J141)","v":"2872936"},"Neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the cat. Tyrosine hydroxylase immunohistochemistry.","2872936","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C142,D142)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L142,M142)","v":"Brain Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N142,N142)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J142,J142)","v":"1815982"},"MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.","1815982","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C143,D143)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L143,M143)","v":"Brain Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N143,N143)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J143,J143)","v":"2417166"},"The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.","2417166","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C144,D144)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L144,M144)","v":"Brain Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N144,N144)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J144,J144)","v":"1684822"},"Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the substantia nigra and the locus coeruleus in BALB/c mice.","1684822","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C145,D145)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L145,M145)","v":"Catalepsy"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N145,N145)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J145,J145)","v":"2616897"},"Maneb enhances MPTP neurotoxicity in mice.","2616897","Neurologic Manifestations","D002375","Catalepsy","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C146,D146)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L146,M146)","v":"Catalepsy"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N146,N146)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J146,J146)","v":"2532697"},"Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice.","2532697","Neurologic Manifestations","D002375","Catalepsy","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C147,D147)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L147,M147)","v":"Catalepsy"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N147,N147)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J147,J147)","v":"1649252"},"Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.","1649252","Neurologic Manifestations","D002375","Catalepsy","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C148,D148)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L148,M148)","v":"Catalepsy"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N148,N148)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J148,J148)","v":"22912680"},"Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.","22912680","Neurologic Manifestations","D002375","Catalepsy","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C149,D149)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L149,M149)","v":"Catalepsy"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N149,N149)","v":"DTXSID8040933"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J149,J149)","v":"10802035"},"Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.","10802035","Neurologic Manifestations","D002375","Catalepsy","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C150,D150)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L150,M150)","v":"Catatonia"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N150,N150)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J150,J150)","v":"19666045"},"Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats.","19666045","Neurologic Manifestations","D002389","Catatonia","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C151,D151)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L151,M151)","v":"Central Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N151,N151)","v":"DTXSID8040933"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J151,J151)","v":"11778669"},"Neurotoxicology of the brain barrier system: new implications.","11778669","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C152,D152)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L152,M152)","v":"Chorea"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N152,N152)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J152,J152)","v":"7688878"},"Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.","7688878","Central Nervous System Diseases","D002819","Chorea","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C153,D153)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L153,M153)","v":"Chorea"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N153,N153)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J153,J153)","v":"2296255"},"Induction of chorea and dystonia in parkinsonian primates.","2296255","Central Nervous System Diseases","D002819","Chorea","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C154,D154)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L154,M154)","v":"Chronobiology Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N154,N154)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J154,J154)","v":"23292542"},"A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson's disease.","23292542","Chronobiology Disorders","D021081","Chronobiology Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C155,D155)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L155,M155)","v":"Dementia"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N155,N155)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J155,J155)","v":"17985252"},"Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?","17985252","Central Nervous System Diseases","D003704","Dementia","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C156,D156)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L156,M156)","v":"Dystonia"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N156,N156)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J156,J156)","v":"7688878"},"Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.","7688878","Neurologic Manifestations","D004421","Dystonia","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C157,D157)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L157,M157)","v":"Dystonia"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N157,N157)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J157,J157)","v":"18842698"},"Neuropathological changes induced by neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in male Swiss albino mice.","18842698","Neurologic Manifestations","D004421","Dystonia","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C158,D158)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L158,M158)","v":"Dystonia"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N158,N158)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J158,J158)","v":"2296255"},"Induction of chorea and dystonia in parkinsonian primates.","2296255","Neurologic Manifestations","D004421","Dystonia","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C159,D159)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L159,M159)","v":"Dystonia"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N159,N159)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J159,J159)","v":"2296259"},"Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.","2296259","Neurologic Manifestations","D004421","Dystonia","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C160,D160)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L160,M160)","v":"Encephalitis"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N160,N160)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J160,J160)","v":"22035588"},"Microglia-inhibiting activity of Parkinson's disease drug amantadine.","22035588","Central Nervous System Diseases","D004660","Encephalitis","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C161,D161)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L161,M161)","v":"Epilepsy"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N161,N161)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J161,J161)","v":"2598030"},"MPTP is proconvulsant acutely but has no long-term effect in rodent models of seizure and epilepsy.","2598030","Central Nervous System Diseases","D004827","Epilepsy","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C162,D162)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L162,M162)","v":"Epilepsy"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N162,N162)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J162,J162)","v":"2615919"},"Evidence for an epileptogenic action of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine.","2615919","Central Nervous System Diseases","D004827","Epilepsy","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C163,D163)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L163,M163)","v":"Epilepsy"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N163,N163)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J163,J163)","v":"1713316"},"The acute convulsant effect of MPTP is dependent on intracerebral MPP+.","1713316","Central Nervous System Diseases","D004827","Epilepsy","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C164,D164)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L164,M164)","v":"Gait Disorders, Neurologic"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N164,N164)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J164,J164)","v":"28363982"},"Deficiency in Neuronal TGF-β Signaling Leads to Nigrostriatal Degeneration and Activation of TGF-β Signaling Protects against MPTP Neurotoxicity in Mice.","28363982","Neurologic Manifestations","D020233","Gait Disorders, Neurologic","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C165,D165)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L165,M165)","v":"Gait Disorders, Neurologic"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N165,N165)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J165,J165)","v":"20478277"},"Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.","20478277","Neurologic Manifestations","D020233","Gait Disorders, Neurologic","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C166,D166)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L166,M166)","v":"Huntington Disease"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N166,N166)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J166,J166)","v":"17127354"},"Mitochondrial toxins and neurodegenerative diseases.","17127354","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C167,D167)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L167,M167)","v":"Hyperkinesis"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N167,N167)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J167,J167)","v":"26111725"},"Chronic MPTP treatment produces hyperactivity in male mice which is not alleviated by concurrent trehalose treatment.","26111725","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C168,D168)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L168,M168)","v":"Hyperkinesis"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N168,N168)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J168,J168)","v":"17351422"},"Plasma levels of rotigotine and the reversal of motor deficits in MPTP-treated primates.","17351422","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C169,D169)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L169,M169)","v":"Hyperkinesis"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N169,N169)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J169,J169)","v":"18657593"},"Effects of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity.","18657593","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C170,D170)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L170,M170)","v":"Hyperkinesis"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N170,N170)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J170,J170)","v":"23737982"},"Electro-acupuncture stimulation improves spontaneous locomotor hyperactivity in MPTP intoxicated mice.","23737982","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C171,D171)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L171,M171)","v":"Hypokinesia"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N171,N171)","v":"DTXSID8040933"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J171,J171)","v":"15707778"},"Acanthopanax senticosus Harms as a prophylactic for MPTP-induced Parkinson's disease in rats.","15707778","Neurologic Manifestations","D018476","Hypokinesia","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C172,D172)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L172,M172)","v":"Hypokinesia"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N172,N172)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J172,J172)","v":"21736911"},"The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease.","21736911","Neurologic Manifestations","D018476","Hypokinesia","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C173,D173)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L173,M173)","v":"Hypokinesia"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N173,N173)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J173,J173)","v":"22850123"},"The food reaching test: a sensitive test of behavioral improvements by deep brain stimulation in MPTP-treated monkey.","22850123","Neurologic Manifestations","D018476","Hypokinesia","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C174,D174)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L174,M174)","v":"Hypokinesia"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N174,N174)","v":"DTXSID8040933"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J174,J174)","v":"14978195"},"S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole.","14978195","Neurologic Manifestations","D018476","Hypokinesia","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C175,D175)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L175,M175)","v":"Hypothalamic Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N175,N175)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J175,J175)","v":"3486388"},"The dopamine neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces histological lesions in the hypothalamus of the common marmoset.","3486388","Central Nervous System Diseases","D007027","Hypothalamic Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C176,D176)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L176,M176)","v":"Leigh Disease"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N176,N176)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J176,J176)","v":"27787743"},"Respiratory chain inhibition: one more feature to propose MPTP intoxication as a Leigh syndrome model.","27787743","Central Nervous System Diseases","D007888","Leigh Disease","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C177,D177)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L177,M177)","v":"Leigh Disease"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N177,N177)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J177,J177)","v":"19319673"},"MPTP intoxication in mice: a useful model of Leigh syndrome to study mitochondrial diseases in childhood.","19319673","Central Nervous System Diseases","D007888","Leigh Disease","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C178,D178)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L178,M178)","v":"Movement Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N178,N178)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J178,J178)","v":"2785168"},"Deficits in reaction times and movement times as correlates of hypokinesia in monkeys with MPTP-induced striatal dopamine depletion.","2785168","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C179,D179)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L179,M179)","v":"Movement Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N179,N179)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J179,J179)","v":"3498531"},"MPTP, impairment of motor performance and amine accumulation in Macaca fascicularis.","3498531","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C180,D180)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L180,M180)","v":"Movement Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N180,N180)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J180,J180)","v":"2417166"},"The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.","2417166","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C181,D181)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L181,M181)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N181,N181)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J181,J181)","v":"7911652"},"Glutamate and Parkinson's disease.","7911652","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C182,D182)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L182,M182)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N182,N182)","v":"DTXSID8040933"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J182,J182)","v":"8588064"},"Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors.","8588064","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C183,D183)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L183,M183)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N183,N183)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J183,J183)","v":"8420136"},"MPTP and aging. Studies in the C57BL/6 mouse.","8420136","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C184,D184)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L184,M184)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N184,N184)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J184,J184)","v":"8413979"},"Gangliosides and parkinsonism.","8413979","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C185,D185)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L185,M185)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N185,N185)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J185,J185)","v":"8380523"},"Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. New vistas.","8380523","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C186,D186)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L186,M186)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N186,N186)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J186,J186)","v":"7925842"},"Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.","7925842","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C187,D187)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L187,M187)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N187,N187)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J187,J187)","v":"8210225"},"MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.","8210225","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C188,D188)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L188,M188)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N188,N188)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J188,J188)","v":"7688878"},"Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.","7688878","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C189,D189)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L189,M189)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N189,N189)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J189,J189)","v":"8615126"},"Excitatory amino acids and MPTP toxicity.","8615126","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C190,D190)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L190,M190)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N190,N190)","v":"DTXSID8040933"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J190,J190)","v":"7672436"},"Might environmental factors contribute to neurodegenerative diseases?","7672436","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C191,D191)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L191,M191)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N191,N191)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J191,J191)","v":"8744121"},"[Effect of interferon on the development of Parkinson's syndrome, caused by administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57Bl/6 mice].","8744121","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C192,D192)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L192,M192)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N192,N192)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J192,J192)","v":"8179773"},"Long-term MPTP-treated monkeys are resistant to GM1 systemic therapy.","8179773","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C193,D193)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L193,M193)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N193,N193)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J193,J193)","v":"8618687"},"Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes.","8618687","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C194,D194)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L194,M194)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N194,N194)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J194,J194)","v":"8197222"},"[MPTP--neurotoxin and model substance in Parkinson research].","8197222","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C195,D195)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L195,M195)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N195,N195)","v":"DTXSID8040933"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J195,J195)","v":"8544992"},"Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.","8544992","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C196,D196)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L196,M196)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N196,N196)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J196,J196)","v":"8309350"},"Development of a model for Parkinson's disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion.","8309350","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C197,D197)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L197,M197)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N197,N197)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J197,J197)","v":"8263513"},"Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis.","8263513","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C198,D198)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L198,M198)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N198,N198)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J198,J198)","v":"8289584"},"The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's disease.","8289584","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C199,D199)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L199,M199)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N199,N199)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J199,J199)","v":"8714707"},"Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.","8714707","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C200,D200)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L200,M200)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N200,N200)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J200,J200)","v":"7580173"},"The effects of electroconvulsive shock on dopamine-1 and dopamine-2 receptor ligand binding activity in MPTP-treated mice.","7580173","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C201,D201)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L201,M201)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N201,N201)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J201,J201)","v":"8028787"},"Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys.","8028787","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C202,D202)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L202,M202)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N202,N202)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J202,J202)","v":"8469305"},"Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons.","8469305","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C203,D203)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L203,M203)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N203,N203)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J203,J203)","v":"8028778"},"Alteration of pallidal cholinergic activity in MPTP-treated monkeys: effect of dihydro-alpha-ergocryptine (DEK).","8028778","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C204,D204)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L204,M204)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N204,N204)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J204,J204)","v":"8247275"},"Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?","8247275","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C205,D205)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L205,M205)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N205,N205)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J205,J205)","v":"7851473"},"Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-dopa and as chronic treatment.","7851473","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C206,D206)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L206,M206)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N206,N206)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J206,J206)","v":"8243537"},"L-deprenyl confers specific protection against MPTP-induced Parkinson's disease-like movement disorder in the goldfish.","8243537","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C207,D207)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L207,M207)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N207,N207)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J207,J207)","v":"7838312"},"Potential parkinsonian protoxicants within and without.","7838312","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C208,D208)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L208,M208)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N208,N208)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J208,J208)","v":"8263548"},"Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.","8263548","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C209,D209)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L209,M209)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N209,N209)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J209,J209)","v":"8512193"},"The goldfish as a drug discovery vehicle for Parkinson's disease and other neurodegenerative disorders.","8512193","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C210,D210)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L210,M210)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N210,N210)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J210,J210)","v":"7970192"},"MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.","7970192","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C211,D211)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L211,M211)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N211,N211)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J211,J211)","v":"8095431"},"Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.","8095431","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C212,D212)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L212,M212)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N212,N212)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J212,J212)","v":"8177363"},"Parkinson-like disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in Macaca fascicularis: synaptosomal metabolism and action of dihydroergocriptine.","8177363","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C213,D213)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L213,M213)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N213,N213)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J213,J213)","v":"8094427"},"Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys.","8094427","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C214,D214)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L214,M214)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N214,N214)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J214,J214)","v":"8098931"},"Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys.","8098931","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C215,D215)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L215,M215)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N215,N215)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J215,J215)","v":"8684621"},"Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.","8684621","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C216,D216)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L216,M216)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N216,N216)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J216,J216)","v":"8105418"},"Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.","8105418","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C217,D217)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L217,M217)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N217,N217)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J217,J217)","v":"7509198"},"6-[18F]fluoro-L-dopa and cerebral blood flow in unilaterally MPTP-treated monkeys.","7509198","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C218,D218)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L218,M218)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N218,N218)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J218,J218)","v":"9280455"},"[The effect of liposomal form of L-Dopa on the level of dopamine, its metabolites, and phospholipid metabolism in the striatum of mice with experimental parkinsonian syndrome].","9280455","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C219,D219)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L219,M219)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N219,N219)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J219,J219)","v":"9518590"},"Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey.","9518590","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C220,D220)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L220,M220)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N220,N220)","v":"DTXSID8040933"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J220,J220)","v":"9163560"},"Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.","9163560","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C221,D221)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L221,M221)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N221,N221)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J221,J221)","v":"8819134"},"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model.","8819134","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C222,D222)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L222,M222)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N222,N222)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J222,J222)","v":"9756328"},"Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice.","9756328","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C223,D223)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L223,M223)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N223,N223)","v":"DTXSID8040933"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J223,J223)","v":"9398471"},"Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice.","9398471","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C224,D224)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L224,M224)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N224,N224)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J224,J224)","v":"8974482"},"[Sleep disorders and impaired learning ability in rats with parkinsonian syndrome induced by MPTP].","8974482","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C225,D225)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L225,M225)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N225,N225)","v":"DTXSID8040933"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J225,J225)","v":"9195598"},"Species differences in the role of excitatory amino acids in experimental parkinsonism.","9195598","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C226,D226)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L226,M226)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N226,N226)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J226,J226)","v":"9613716"},"Mechanisms of MPTP toxicity.","9613716","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C227,D227)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L227,M227)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N227,N227)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J227,J227)","v":"9635986"},"N-methyl-(R)-salsolinol and Parkinson's disease.","9635986","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C228,D228)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L228,M228)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N228,N228)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J228,J228)","v":"9668361"},"Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.","9668361","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C229,D229)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L229,M229)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N229,N229)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J229,J229)","v":"9473580"},"MPTP-Parkinsonism is accompanied by persistent expression of a delta-FosB-like protein in dopaminergic pathways.","9473580","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C230,D230)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L230,M230)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N230,N230)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J230,J230)","v":"9754903"},"Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).","9754903","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C231,D231)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L231,M231)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N231,N231)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J231,J231)","v":"9710523"},"Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys.","9710523","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C232,D232)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L232,M232)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N232,N232)","v":"DTXSID8040933"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J232,J232)","v":"9126147"},"Neuroprotective therapy for Parkinson's disease.","9126147","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C233,D233)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L233,M233)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N233,N233)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J233,J233)","v":"9860271"},"Efferent synaptic connections of dopaminergic neurons grafted into the caudate nucleus of experimentally induced parkinsonian monkeys are different from those of control animals.","9860271","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C234,D234)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L234,M234)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N234,N234)","v":"DTXSID8040933"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J234,J234)","v":"9396088"},"Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents.","9396088","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C235,D235)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L235,M235)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N235,N235)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J235,J235)","v":"9001722"},"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.","9001722","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C236,D236)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L236,M236)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N236,N236)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J236,J236)","v":"9710520"},"MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose.","9710520","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C237,D237)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L237,M237)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N237,N237)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J237,J237)","v":"8915594"},"Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys.","8915594","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C238,D238)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L238,M238)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N238,N238)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J238,J238)","v":"2689379"},"Animal models of parkinsonism using selective neurotoxins: clinical and basic implications.","2689379","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C239,D239)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L239,M239)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N239,N239)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J239,J239)","v":"26205255"},"Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression.","26205255","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C240,D240)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L240,M240)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N240,N240)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J240,J240)","v":"2586750"},"Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","2586750","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C241,D241)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L241,M241)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N241,N241)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J241,J241)","v":"26451750"},"Dopaminergic lesioning impairs adult hippocampal neurogenesis by distinct modification of α-synuclein.","26451750","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C242,D242)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L242,M242)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N242,N242)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J242,J242)","v":"27213850"},"Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease.","27213850","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C243,D243)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L243,M243)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N243,N243)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J243,J243)","v":"26431624"},"Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.","26431624","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C244,D244)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L244,M244)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N244,N244)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J244,J244)","v":"27395789"},"Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.","27395789","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C245,D245)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L245,M245)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N245,N245)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J245,J245)","v":"26511587"},"Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease.","26511587","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C246,D246)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L246,M246)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N246,N246)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J246,J246)","v":"2687716"},"Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey.","2687716","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C247,D247)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L247,M247)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N247,N247)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J247,J247)","v":"27182044"},"MPTP neurotoxicity is highly concordant between the sexes among BXD recombinant inbred mouse strains.","27182044","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C248,D248)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L248,M248)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N248,N248)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J248,J248)","v":"25665403"},"[Moving activity and wakefulness-sleep cycle changes in a mouse MPTP model of Parkinson's disease].","25665403","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C249,D249)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L249,M249)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N249,N249)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J249,J249)","v":"28181071"},"Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson's disease: The Role of MAPK, PI3K-Akt-GSK3β and mTOR Signalling Pathways.","28181071","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C250,D250)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L250,M250)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N250,N250)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J250,J250)","v":"28082123"},"Nicotine suppresses the neurotoxicity by MPP+/MPTP through activating α7nAChR/PI3K/Trx-1 and suppressing ER stress.","28082123","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C251,D251)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L251,M251)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N251,N251)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J251,J251)","v":"25581060"},"Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.","25581060","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C252,D252)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L252,M252)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N252,N252)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J252,J252)","v":"26500044"},"Chronic and progressive Parkinson's disease MPTP model in adult and aged mice.","26500044","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C253,D253)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L253,M253)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N253,N253)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J253,J253)","v":"25857436"},"Ferulic acid pretreatment mitigates MPTP-induced motor impairment and histopathological alterations in C57BL/6 mice.","25857436","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C254,D254)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L254,M254)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N254,N254)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J254,J254)","v":"2622529"},"Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions.","2622529","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C255,D255)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L255,M255)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N255,N255)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J255,J255)","v":"26215120"},"Transiently impaired neurogenesis in MPTP mouse model of Parkinson's disease.","26215120","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C256,D256)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L256,M256)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N256,N256)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J256,J256)","v":"26453962"},"Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.","26453962","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C257,D257)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L257,M257)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N257,N257)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J257,J257)","v":"26996132"},"Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.","26996132","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C258,D258)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L258,M258)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N258,N258)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J258,J258)","v":"26415982"},"The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets.","26415982","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C259,D259)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L259,M259)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N259,N259)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J259,J259)","v":"26979073"},"Long Non-coding RNA HOTAIR Promotes Parkinson's Disease Induced by MPTP Through up-regulating the Expression of LRRK2.","26979073","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C260,D260)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L260,M260)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N260,N260)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J260,J260)","v":"26918675"},"A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain.","26918675","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C261,D261)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L261,M261)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N261,N261)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J261,J261)","v":"26961958"},"Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's Disease.","26961958","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C262,D262)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L262,M262)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N262,N262)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J262,J262)","v":"2637935"},"MPTP-induced Parkinson-like disease in sheep: clinical and pathologic findings.","2637935","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C263,D263)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L263,M263)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N263,N263)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J263,J263)","v":"27265894"},"Neuroprotective and anti-inflammatory effects of morin in a murine model of Parkinson's disease.","27265894","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C264,D264)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L264,M264)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N264,N264)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J264,J264)","v":"27012392"},"Physical exercise counteracts MPTP-induced changes in neural precursor cell proliferation in the hippocampus and restores spatial learning but not memory performance in the water maze.","27012392","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C265,D265)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L265,M265)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N265,N265)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J265,J265)","v":"25796140"},"HIF1α is necessary for exercise-induced neuroprotection while HIF2α is needed for dopaminergic neuron survival in the substantia nigra pars compacta.","25796140","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C266,D266)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L266,M266)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N266,N266)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J266,J266)","v":"25680233"},"Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice.","25680233","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C267,D267)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L267,M267)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N267,N267)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J267,J267)","v":"2790469"},"Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism.","2790469","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C268,D268)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L268,M268)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N268,N268)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J268,J268)","v":"26117365"},"Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate.","26117365","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C269,D269)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L269,M269)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N269,N269)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J269,J269)","v":"2790166"},"[Evaluation of the capability of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pyridine derivatives to evoke parkinsonism].","2790166","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C270,D270)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L270,M270)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N270,N270)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J270,J270)","v":"27806193"},"Neuroprotective Effect of a New 7,8-Dihydroxycoumarin-Based Fe2+/Cu2+ Chelator in Cell and Animal Models of Parkinson's Disease.","27806193","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C271,D271)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L271,M271)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N271,N271)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J271,J271)","v":"2614476"},"Transplantation of human sympathetic neurons and adrenal chromaffin cells into parkinsonian monkeys: no reversal of clinical symptoms.","2614476","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C272,D272)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L272,M272)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N272,N272)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J272,J272)","v":"2597310"},"MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.","2597310","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C273,D273)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L273,M273)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N273,N273)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J273,J273)","v":"28108849"},"Toll Like Receptor 4 Affects the Cerebral Biochemical Changes Induced by MPTP Treatment.","28108849","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C274,D274)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L274,M274)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N274,N274)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J274,J274)","v":"25907446"},"Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease.","25907446","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C275,D275)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L275,M275)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N275,N275)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J275,J275)","v":"28442167"},"Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP.","28442167","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C276,D276)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L276,M276)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N276,N276)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J276,J276)","v":"28734031"},"Downregulation of DEC1 contributes to the neurotoxicity induced by MPP+ by suppressing PI3K/Akt/GSK3β pathway.","28734031","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C277,D277)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L277,M277)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N277,N277)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J277,J277)","v":"18036149"},"Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP.","18036149","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C278,D278)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L278,M278)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N278,N278)","v":"DTXSID8040933"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J278,J278)","v":"17067307"},"Effects of nicotinic therapies on attention and executive functions in chronic low-dose MPTP-treated monkeys.","17067307","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C279,D279)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L279,M279)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N279,N279)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J279,J279)","v":"18381061"},"Globus pallidus plays a critical role in neurotrophic factor induced functional improvements in hemiparkinsonian monkeys.","18381061","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C280,D280)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L280,M280)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N280,N280)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J280,J280)","v":"18700057"},"Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation.","18700057","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C281,D281)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L281,M281)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N281,N281)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J281,J281)","v":"18648323"},"Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys.","18648323","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C282,D282)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L282,M282)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N282,N282)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J282,J282)","v":"17583437"},"Unique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult.","17583437","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C283,D283)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L283,M283)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N283,N283)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J283,J283)","v":"17127354"},"Mitochondrial toxins and neurodegenerative diseases.","17127354","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C284,D284)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L284,M284)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N284,N284)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J284,J284)","v":"18577498"},"Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.","18577498","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C285,D285)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L285,M285)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N285,N285)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J285,J285)","v":"18007638"},"A model of MPTP-induced Parkinson's disease in the goldfish.","18007638","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C286,D286)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L286,M286)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N286,N286)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J286,J286)","v":"18657577"},"A novel adenosine A(1) and A(2A) receptor antagonist ASP5854 ameliorates motor impairment in MPTP-treated marmosets: comparison with existing anti-Parkinson's disease drugs.","18657577","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C287,D287)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L287,M287)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N287,N287)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J287,J287)","v":"17439923"},"Manganese does not alter the severe neurotoxicity of MPTP.","17439923","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C288,D288)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L288,M288)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N288,N288)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J288,J288)","v":"17196944"},"Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not.","17196944","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C289,D289)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L289,M289)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N289,N289)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J289,J289)","v":"18808450"},"Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum.","18808450","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C290,D290)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L290,M290)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N290,N290)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J290,J290)","v":"18328479"},"Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV.","18328479","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C291,D291)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L291,M291)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N291,N291)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J291,J291)","v":"17038483"},"Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).","17038483","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C292,D292)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L292,M292)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N292,N292)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J292,J292)","v":"1771272"},"Pyridine derivatives: structure-activity relationships causing parkinsonism-like symptoms.","1771272","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C293,D293)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L293,M293)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N293,N293)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J293,J293)","v":"18573265"},"A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.","18573265","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C294,D294)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L294,M294)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N294,N294)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J294,J294)","v":"23893731"},"The yeast product Milmed enhances the effect of physical exercise on motor performance and dopamine neurochemistry recovery in MPTP-lesioned mice.","23893731","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C295,D295)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L295,M295)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N295,N295)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J295,J295)","v":"24726706"},"Neuroprotective effects of the andrographolide analogue AL-1 in the MPP⁺/MPTP-induced Parkinson's disease model in vitro and in mice.","24726706","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C296,D296)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L296,M296)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N296,N296)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J296,J296)","v":"24220636"},"Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice.","24220636","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C297,D297)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L297,M297)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N297,N297)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J297,J297)","v":"23375447"},"Antiparkinsonian activity of some 9-N-, O-, S- and C-derivatives of 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol.","23375447","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C298,D298)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L298,M298)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N298,N298)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J298,J298)","v":"23959162"},"Cholinergic manipulation of motor disability and L-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosets.","23959162","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C299,D299)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L299,M299)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N299,N299)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J299,J299)","v":"25127682"},"Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine.","25127682","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C300,D300)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L300,M300)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N300,N300)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J300,J300)","v":"24744393"},"Human neural stem cells survive long term in the midbrain of dopamine-depleted monkeys after GDNF overexpression and project neurites toward an appropriate target.","24744393","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C301,D301)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L301,M301)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N301,N301)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J301,J301)","v":"23820985"},"Intranasal and subcutaneous administration of dopamine D3 receptor agonists functionally restores nigrostriatal dopamine in MPTP-treated mice.","23820985","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C302,D302)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L302,M302)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N302,N302)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J302,J302)","v":"24140863"},"The role of thioredoxin-1 in suppression of endoplasmic reticulum stress in Parkinson disease.","24140863","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C303,D303)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L303,M303)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N303,N303)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J303,J303)","v":"23670541"},"Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective.","23670541","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C304,D304)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L304,M304)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N304,N304)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J304,J304)","v":"2350702"},"MPTP-induced parkinsonism: relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeys.","2350702","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C305,D305)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L305,M305)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N305,N305)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J305,J305)","v":"25038418"},"Neuroprotection by Orexin-A via HIF-1α induction in a cellular model of Parkinson's disease.","25038418","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C306,D306)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L306,M306)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N306,N306)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J306,J306)","v":"2393218"},"Pharmacological correction of CNS functional disorders and parkinsonian syndrome in old animals.","2393218","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C307,D307)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L307,M307)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N307,N307)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J307,J307)","v":"23810671"},"Anti-inflammatory and anti-apoptotic effects of (RS)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson's disease.","23810671","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C308,D308)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L308,M308)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N308,N308)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J308,J308)","v":"24055409"},"Trasferrin receptor 2 gene regulation by microRNA 221 in SH-SY5Y cells treated with MPP⁺ as Parkinson's disease cellular model.","24055409","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C309,D309)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L309,M309)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N309,N309)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J309,J309)","v":"23876367"},"Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.","23876367","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C310,D310)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L310,M310)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N310,N310)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J310,J310)","v":"23902361"},"Dopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.","23902361","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C311,D311)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L311,M311)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N311,N311)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J311,J311)","v":"2357577"},"Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism.","2357577","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C312,D312)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L312,M312)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N312,N312)","v":"DTXSID8040933"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J312,J312)","v":"16464239"},"Pramipexole protects against MPTP toxicity in non-human primates.","16464239","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C313,D313)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L313,M313)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N313,N313)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J313,J313)","v":"1613817"},"MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.","1613817","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C314,D314)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L314,M314)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N314,N314)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J314,J314)","v":"1584431"},"Emerging perspectives in Parkinson's disease.","1584431","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C315,D315)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L315,M315)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N315,N315)","v":"DTXSID8040933"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J315,J315)","v":"15377875"},"MPTP as a mitochondrial neurotoxic model of Parkinson's disease.","15377875","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C316,D316)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L316,M316)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N316,N316)","v":"DTXSID8040933"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J316,J316)","v":"15262334"},"The strong inhibition of triosephosphate isomerase by the natural beta-carbolines may explain their neurotoxic actions.","15262334","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C317,D317)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L317,M317)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N317,N317)","v":"DTXSID8040933"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J317,J317)","v":"16336966"},"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys.","16336966","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C318,D318)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L318,M318)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N318,N318)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J318,J318)","v":"1521037"},"Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse.","1521037","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C319,D319)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L319,M319)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N319,N319)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J319,J319)","v":"1681090"},"Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-dopa in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.","1681090","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C320,D320)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L320,M320)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N320,N320)","v":"DTXSID8040933"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J320,J320)","v":"16920272"},"Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson's disease.","16920272","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C321,D321)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L321,M321)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N321,N321)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J321,J321)","v":"1637057"},"Mitochondrial mechanisms of neurotoxicity.","1637057","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C322,D322)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L322,M322)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N322,N322)","v":"DTXSID8040933"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J322,J322)","v":"16424396"},"Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice.","16424396","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C323,D323)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L323,M323)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N323,N323)","v":"DTXSID8040933"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J323,J323)","v":"16437566"},"Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.","16437566","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C324,D324)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L324,M324)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N324,N324)","v":"DTXSID8040933"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J324,J324)","v":"15490461"},"Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.","15490461","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C325,D325)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L325,M325)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N325,N325)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J325,J325)","v":"1623269"},"MPTP and other Parkinson-inducing agents.","1623269","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C326,D326)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L326,M326)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N326,N326)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J326,J326)","v":"1978517"},"Chronic administration of MPTP to marmosets.","1978517","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C327,D327)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L327,M327)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N327,N327)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J327,J327)","v":"20197696"},"Social odor recognition: a novel behavioral model for cognitive dysfunction in Parkinson's disease.","20197696","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C328,D328)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L328,M328)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N328,N328)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J328,J328)","v":"19490092"},"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.","19490092","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C329,D329)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L329,M329)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N329,N329)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J329,J329)","v":"19817968"},"Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease.","19817968","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C330,D330)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L330,M330)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N330,N330)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J330,J330)","v":"19245367"},"PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.","19245367","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C331,D331)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L331,M331)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N331,N331)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J331,J331)","v":"19551455"},"CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson's disease.","19551455","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C332,D332)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L332,M332)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N332,N332)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J332,J332)","v":"2036621"},"MPTP-induced neurotoxicity and the quest for a preventative therapy for Parkinson's disease.","2036621","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C333,D333)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L333,M333)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N333,N333)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J333,J333)","v":"1976438"},"Modulatory role for CCK-B antagonists in Parkinson's disease.","1976438","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C334,D334)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L334,M334)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N334,N334)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J334,J334)","v":"2064731"},"Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates.","2064731","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C335,D335)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L335,M335)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N335,N335)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J335,J335)","v":"19635479"},"Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model.","19635479","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C336,D336)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L336,M336)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N336,N336)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J336,J336)","v":"19070648"},"Neuroprotective effects of (+/-)-catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice.","19070648","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C337,D337)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L337,M337)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N337,N337)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J337,J337)","v":"20980117"},"Assessment of metabolic changes in the striatum of a MPTP-intoxicated canine model: in vivo ¹H-MRS study of an animal model for Parkinson's disease.","20980117","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C338,D338)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L338,M338)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N338,N338)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J338,J338)","v":"2005976"},"Parkinson's disease. Fresh factors to consider.","2005976","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C339,D339)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L339,M339)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N339,N339)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J339,J339)","v":"2233418"},"Parkinson's disease and cytochrome P450: a possible link?","2233418","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C340,D340)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L340,M340)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N340,N340)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J340,J340)","v":"21725169"},"Effect of endurance exercise training on the expression of GFAP, S100B, and NSE in the striatum of chronic/progressive mouse model of Parkinson's disease.","21725169","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C341,D341)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L341,M341)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N341,N341)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J341,J341)","v":"21322017"},"Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.","21322017","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C342,D342)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L342,M342)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N342,N342)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J342,J342)","v":"2199253"},"Biochemical aspects of drug-induced Parkinson's disease.","2199253","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C343,D343)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L343,M343)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N343,N343)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J343,J343)","v":"22546197"},"Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model.","22546197","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C344,D344)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L344,M344)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N344,N344)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J344,J344)","v":"2253695"},"Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.","2253695","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C345,D345)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L345,M345)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N345,N345)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J345,J345)","v":"21375482"},"The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.","21375482","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C346,D346)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L346,M346)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N346,N346)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J346,J346)","v":"2296259"},"Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.","2296259","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C347,D347)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L347,M347)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N347,N347)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J347,J347)","v":"22639229"},"Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice.","22639229","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C348,D348)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L348,M348)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N348,N348)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J348,J348)","v":"21798732"},"Acute toxicity of MPTP and MPP(+) in the brain of embryo and newborn mice.","21798732","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C349,D349)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L349,M349)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N349,N349)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J349,J349)","v":"21254589"},"[Effects of subchronic hemantane administration on dopamine and serotonin receptors in intact and MPP+-treated rat brain ex vivo].","21254589","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C350,D350)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L350,M350)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N350,N350)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J350,J350)","v":"22166429"},"Animal models of Parkinson's disease.","22166429","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C351,D351)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L351,M351)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N351,N351)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J351,J351)","v":"2130940"},"Studies on 4-benzyl-1-methyl-1,2,3,6-tetrahydropyridine, a nonneurotoxic analogue of the parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","2130940","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C352,D352)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L352,M352)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N352,N352)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J352,J352)","v":"2309157"},"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the rat: characterization and age-dependent effects.","2309157","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C353,D353)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L353,M353)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N353,N353)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J353,J353)","v":"21760537"},"Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease.","21760537","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C354,D354)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L354,M354)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N354,N354)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J354,J354)","v":"2204050"},"The neurotoxicity of MPTP and the relevance to Parkinson's disease.","2204050","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C355,D355)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L355,M355)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N355,N355)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J355,J355)","v":"2296255"},"Induction of chorea and dystonia in parkinsonian primates.","2296255","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C356,D356)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L356,M356)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N356,N356)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J356,J356)","v":"22669749"},"Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/probenecid model of Parkinson's disease.","22669749","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C357,D357)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L357,M357)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N357,N357)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J357,J357)","v":"22040668"},"Impact of exercise on mitochondrial transcription factor expression and damage in the striatum of a chronic mouse model of Parkinson's disease.","22040668","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C358,D358)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L358,M358)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N358,N358)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J358,J358)","v":"22356806"},"Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.","22356806","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C359,D359)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L359,M359)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N359,N359)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J359,J359)","v":"21788124"},"Neuronal or inducible nitric oxide synthase (NOS) expression level is not involved in the different susceptibility to nigro-striatal dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) between C57BL/6 and BALB/c mice.","21788124","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C360,D360)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L360,M360)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N360,N360)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J360,J360)","v":"21669281"},"Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson's disease mice.","21669281","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C361,D361)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L361,M361)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N361,N361)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J361,J361)","v":"22964486"},"Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease.","22964486","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C362,D362)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L362,M362)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N362,N362)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J362,J362)","v":"21209200"},"Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease.","21209200","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C363,D363)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L363,M363)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N363,N363)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J363,J363)","v":"2192787"},"Drug-induced parkinsonism and other movement disorders.","2192787","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C364,D364)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L364,M364)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N364,N364)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J364,J364)","v":"2123984"},"Animal models of parkinsonism.","2123984","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C365,D365)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L365,M365)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N365,N365)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J365,J365)","v":"21855308"},"Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).","21855308","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C366,D366)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L366,M366)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N366,N366)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J366,J366)","v":"22155743"},"The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.","22155743","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C367,D367)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L367,M367)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N367,N367)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J367,J367)","v":"21413090"},"The herbal preparation Padma® 28 protects against neurotoxicity in PC12 cells.","21413090","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C368,D368)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L368,M368)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N368,N368)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J368,J368)","v":"22708926"},"Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","22708926","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C369,D369)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L369,M369)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N369,N369)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J369,J369)","v":"23139861"},"ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo.","23139861","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C370,D370)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L370,M370)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N370,N370)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J370,J370)","v":"10223460"},"Reversal of experimental parkinsonism by using selective chemical ablation of the medial globus pallidus.","10223460","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C371,D371)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L371,M371)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N371,N371)","v":"DTXSID8040933"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J371,J371)","v":"10823583"},"MPTP decreases MT-I mRNA in mouse striatum.","10823583","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C372,D372)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L372,M372)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N372,N372)","v":"DTXSID8040933"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J372,J372)","v":"10817604"},"Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity.","10817604","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C373,D373)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L373,M373)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N373,N373)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J373,J373)","v":"10375668"},"Dopamine transporter loss and clinical changes in MPTP-lesioned primates.","10375668","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C374,D374)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L374,M374)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N374,N374)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J374,J374)","v":"10320728"},"Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus.","10320728","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C375,D375)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L375,M375)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N375,N375)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J375,J375)","v":"10192785"},"Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease.","10192785","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C376,D376)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L376,M376)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N376,N376)","v":"DTXSID8040933"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J376,J376)","v":"11208898"},"Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction.","11208898","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C377,D377)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L377,M377)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N377,N377)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J377,J377)","v":"10398297"},"Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease.","10398297","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C378,D378)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L378,M378)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N378,N378)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J378,J378)","v":"1362875"},"Molecular basis of discrepancies in neurotoxic properties among 1-methyl-4-aryl-1,2,3,6-tetrahydropyridines.","1362875","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C379,D379)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L379,M379)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N379,N379)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J379,J379)","v":"12900079"},"Effect of manganese exposure on MPTP neurotoxicities.","12900079","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C380,D380)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L380,M380)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N380,N380)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J380,J380)","v":"12846982"},"Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease.","12846982","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C381,D381)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L381,M381)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N381,N381)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J381,J381)","v":"12846988"},"Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder.","12846988","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C382,D382)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L382,M382)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N382,N382)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J382,J382)","v":"1287728"},"Astrocytes and Parkinson's disease.","1287728","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C383,D383)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L383,M383)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N383,N383)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J383,J383)","v":"14656072"},"MPP+ induces the endoplasmic reticulum stress response in rabbit brain involving activation of the ATF-6 and NF-kappaB signaling pathways.","14656072","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C384,D384)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L384,M384)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N384,N384)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J384,J384)","v":"1461362"},"Mitochondrial factors involved in Parkinson's disease by MPTP toxicity in Macaca fascicularis and drug effect.","1461362","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C385,D385)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L385,M385)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N385,N385)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J385,J385)","v":"1354166"},"Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys.","1354166","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C386,D386)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L386,M386)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N386,N386)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J386,J386)","v":"12805479"},"Sympathetic innervation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease.","12805479","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C387,D387)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L387,M387)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N387,N387)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J387,J387)","v":"1353337"},"Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.","1353337","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C388,D388)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L388,M388)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N388,N388)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J388,J388)","v":"12920198"},"L-DOPA treatment modulates nicotinic receptors in monkey striatum.","12920198","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C389,D389)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L389,M389)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N389,N389)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J389,J389)","v":"1353328"},"Neurotoxin-related research: from the laboratory to the clinic.","1353328","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C390,D390)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L390,M390)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N390,N390)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J390,J390)","v":"12642174"},"Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration.","12642174","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C391,D391)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L391,M391)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N391,N391)","v":"DTXSID8040933"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J391,J391)","v":"14749427"},"Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.","14749427","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C392,D392)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L392,M392)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N392,N392)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J392,J392)","v":"12871582"},"Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity.","12871582","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C393,D393)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L393,M393)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N393,N393)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J393,J393)","v":"12871570"},"Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.","12871570","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C394,D394)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L394,M394)","v":"MPTP Poisoning"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N394,N394)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J394,J394)","v":"12606067"},"Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism.","12606067","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C395,D395)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L395,M395)","v":"Multiple System Atrophy"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N395,N395)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J395,J395)","v":"21054946"},"Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism.","21054946","Basal Ganglia Diseases","D019578","Multiple System Atrophy","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C396,D396)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L396,M396)","v":"Muscle Rigidity"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N396,N396)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J396,J396)","v":"1762681"},"Influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced injury of dopaminergic nigrostriatal system on movement components of the instrumental reflex and motor thalamic neurons' reactions in the cat.","1762681","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C397,D397)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L397,M397)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N397,N397)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J397,J397)","v":"8039547"},"1-Methyl-4-phenylpyridinium has greater neurotoxic effect after selenium deficiency than after vitamin E deficiency in rat striatum.","8039547","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C398,D398)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L398,M398)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N398,N398)","v":"DTXSID8040933"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J398,J398)","v":"8534316"},"Relative resistance of rabbits to MPTP neurotoxicity.","8534316","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C399,D399)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L399,M399)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N399,N399)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J399,J399)","v":"8089930"},"A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor.","8089930","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C400,D400)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L400,M400)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N400,N400)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J400,J400)","v":"8102929"},"Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.","8102929","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C401,D401)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L401,M401)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N401,N401)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J401,J401)","v":"8487266"},"Design and synthesis of 18F-labeled neurotoxic analogs of MPTP.","8487266","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C402,D402)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L402,M402)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N402,N402)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J402,J402)","v":"8739629"},"Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.","8739629","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C403,D403)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L403,M403)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N403,N403)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J403,J403)","v":"9663939"},"Neurotoxicity risk assessment of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) as a synthetic impurity of drugs.","9663939","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C404,D404)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L404,M404)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N404,N404)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J404,J404)","v":"3878976"},"Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice.","3878976","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C405,D405)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L405,M405)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N405,N405)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J405,J405)","v":"3878793"},"Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources.","3878793","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C406,D406)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L406,M406)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N406,N406)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J406,J406)","v":"2616897"},"Maneb enhances MPTP neurotoxicity in mice.","2616897","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C407,D407)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L407,M407)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N407,N407)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J407,J407)","v":"2570859"},"A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.","2570859","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C408,D408)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L408,M408)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N408,N408)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J408,J408)","v":"3068045"},"[The bases of MPTP neurotoxicity].","3068045","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C409,D409)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L409,M409)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N409,N409)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J409,J409)","v":"3002815"},"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.","3002815","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C410,D410)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L410,M410)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N410,N410)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J410,J410)","v":"3492590"},"Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","3492590","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C411,D411)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L411,M411)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N411,N411)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J411,J411)","v":"3491762"},"Diphenylhydantoin and phenobarbital suppress the dopaminergic neurotoxicity of MPTP in mice.","3491762","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C412,D412)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L412,M412)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N412,N412)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J412,J412)","v":"2325834"},"Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke.","2325834","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C413,D413)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L413,M413)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N413,N413)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J413,J413)","v":"2323346"},"Behavioural effects and supersensitivity in the rat following intranigral MPTP and MPP+ administration.","2323346","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C414,D414)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L414,M414)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N414,N414)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J414,J414)","v":"2485822"},"The neurotoxicity of MPTP and its relationship to the pathophysiology of Parkinson's disease.","2485822","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C415,D415)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L415,M415)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N415,N415)","v":"DTXSID8040933"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J415,J415)","v":"15178694"},"SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.","15178694","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C416,D416)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L416,M416)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N416,N416)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J416,J416)","v":"1933326"},"Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood-brain barrier in vitro in five rat strains.","1933326","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C417,D417)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L417,M417)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N417,N417)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J417,J417)","v":"1974854"},"Differential recovery of dopamine synthetic enzymes following MPTP and the consequences of GM1 ganglioside treatment.","1974854","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C418,D418)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L418,M418)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N418,N418)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J418,J418)","v":"2117541"},"1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset.","2117541","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C419,D419)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L419,M419)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N419,N419)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J419,J419)","v":"10389142"},"Enzyme-catalyzed bioactivation of cyclic tertiary amines to form potential neurotoxins.","10389142","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C420,D420)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L420,M420)","v":"Nervous System Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N420,N420)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J420,J420)","v":"1364057"},"Comparative studies of the neurotoxicity of MPTP in rats of different ages.","1364057","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C421,D421)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L421,M421)","v":"Neurodegenerative Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N421,N421)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J421,J421)","v":"28363982"},"Deficiency in Neuronal TGF-β Signaling Leads to Nigrostriatal Degeneration and Activation of TGF-β Signaling Protects against MPTP Neurotoxicity in Mice.","28363982","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C422,D422)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L422,M422)","v":"Neurodegenerative Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N422,N422)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J422,J422)","v":"28442167"},"Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP.","28442167","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C423,D423)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L423,M423)","v":"Neurodegenerative Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N423,N423)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J423,J423)","v":"17985252"},"Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?","17985252","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C424,D424)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L424,M424)","v":"Neurodegenerative Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N424,N424)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J424,J424)","v":"17127354"},"Mitochondrial toxins and neurodegenerative diseases.","17127354","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C425,D425)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L425,M425)","v":"Neuromuscular Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N425,N425)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J425,J425)","v":"24103762"},"Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner.","24103762","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C426,D426)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L426,M426)","v":"Olfaction Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N426,N426)","v":"DTXSID8040933"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J426,J426)","v":"15277042"},"Olfactory impairment and Parkinson's disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","15277042","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C427,D427)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L427,M427)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N427,N427)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J427,J427)","v":"6610772"},"Leads from the MMWR. Street-drug contaminant causing parkinsonism.","6610772","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C428,D428)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L428,M428)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N428,N428)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J428,J428)","v":"6608980"},"The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.","6608980","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C429,D429)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L429,M429)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N429,N429)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J429,J429)","v":"6608943"},"Inhibition of dopamine uptake by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a cause of parkinsonism.","6608943","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C430,D430)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L430,M430)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N430,N430)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J430,J430)","v":"6335692"},"Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.","6335692","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C431,D431)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L431,M431)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N431,N431)","v":"DTXSID8040933"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J431,J431)","v":"6602228"},"Street drugs yield primate Parkinson's model.","6602228","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C432,D432)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L432,M432)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N432,N432)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J432,J432)","v":"6332378"},"Pargyline prevents MPTP-induced parkinsonism in primates.","6332378","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C433,D433)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L433,M433)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N433,N433)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J433,J433)","v":"6332988"},"Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.","6332988","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C434,D434)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L434,M434)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N434,N434)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J434,J434)","v":"6606784"},"Chronic parkinsonism secondary to intranasal administration of a product of meperidine-analogue synthesis.","6606784","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C435,D435)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L435,M435)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N435,N435)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J435,J435)","v":"6332333"},"Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey.","6332333","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C436,D436)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L436,M436)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N436,N436)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J436,J436)","v":"6333134"},"MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.","6333134","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C437,D437)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L437,M437)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N437,N437)","v":"DTXSID8040933"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J437,J437)","v":"6602944"},"Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.","6602944","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C438,D438)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L438,M438)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N438,N438)","v":"DTXSID8040933"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J438,J438)","v":"6403987"},"Monkey model of Parkinson's disease.","6403987","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C439,D439)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L439,M439)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N439,N439)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J439,J439)","v":"6433484"},"Brain enzyme is the target of drug toxin.","6433484","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C440,D440)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L440,M440)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N440,N440)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J440,J440)","v":"6442232"},"Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.","6442232","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C441,D441)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L441,M441)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N441,N441)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J441,J441)","v":"6427583"},"Street-drug contaminant causing parkinsonism.","6427583","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C442,D442)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L442,M442)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N442,N442)","v":"DTXSID8040933"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J442,J442)","v":"6437573"},"MPTP parkinsonism.","6437573","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C443,D443)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L443,M443)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N443,N443)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J443,J443)","v":"8105418"},"Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.","8105418","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C444,D444)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L444,M444)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N444,N444)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J444,J444)","v":"8243537"},"L-deprenyl confers specific protection against MPTP-induced Parkinson's disease-like movement disorder in the goldfish.","8243537","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C445,D445)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L445,M445)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N445,N445)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J445,J445)","v":"8179773"},"Long-term MPTP-treated monkeys are resistant to GM1 systemic therapy.","8179773","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C446,D446)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L446,M446)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N446,N446)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J446,J446)","v":"8177363"},"Parkinson-like disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in Macaca fascicularis: synaptosomal metabolism and action of dihydroergocriptine.","8177363","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C447,D447)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L447,M447)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N447,N447)","v":"DTXSID8040933"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J447,J447)","v":"7670030"},"[A new model of depressive syndrome in rats caused by administering 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].","7670030","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C448,D448)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L448,M448)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N448,N448)","v":"DTXSID8040933"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J448,J448)","v":"7672436"},"Might environmental factors contribute to neurodegenerative diseases?","7672436","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C449,D449)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L449,M449)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N449,N449)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J449,J449)","v":"8210225"},"MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.","8210225","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C450,D450)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L450,M450)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N450,N450)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J450,J450)","v":"8714707"},"Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.","8714707","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C451,D451)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L451,M451)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N451,N451)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J451,J451)","v":"8197222"},"[MPTP--neurotoxin and model substance in Parkinson research].","8197222","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C452,D452)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L452,M452)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N452,N452)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J452,J452)","v":"8469305"},"Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons.","8469305","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C453,D453)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L453,M453)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N453,N453)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J453,J453)","v":"7580173"},"The effects of electroconvulsive shock on dopamine-1 and dopamine-2 receptor ligand binding activity in MPTP-treated mice.","7580173","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C454,D454)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L454,M454)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N454,N454)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J454,J454)","v":"8263513"},"Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis.","8263513","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C455,D455)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L455,M455)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N455,N455)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J455,J455)","v":"8263548"},"Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.","8263548","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C456,D456)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L456,M456)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N456,N456)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J456,J456)","v":"8512193"},"The goldfish as a drug discovery vehicle for Parkinson's disease and other neurodegenerative disorders.","8512193","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C457,D457)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L457,M457)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N457,N457)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J457,J457)","v":"8684621"},"Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.","8684621","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C458,D458)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L458,M458)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N458,N458)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J458,J458)","v":"8247275"},"Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?","8247275","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C459,D459)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L459,M459)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N459,N459)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J459,J459)","v":"7688878"},"Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.","7688878","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C460,D460)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L460,M460)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N460,N460)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J460,J460)","v":"8028787"},"Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys.","8028787","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C461,D461)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L461,M461)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N461,N461)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J461,J461)","v":"8028778"},"Alteration of pallidal cholinergic activity in MPTP-treated monkeys: effect of dihydro-alpha-ergocryptine (DEK).","8028778","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C462,D462)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L462,M462)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N462,N462)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J462,J462)","v":"7838312"},"Potential parkinsonian protoxicants within and without.","7838312","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C463,D463)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L463,M463)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N463,N463)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J463,J463)","v":"7970192"},"MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.","7970192","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C464,D464)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L464,M464)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N464,N464)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J464,J464)","v":"8380528"},"Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations.","8380528","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C465,D465)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L465,M465)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N465,N465)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J465,J465)","v":"7851473"},"Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-dopa and as chronic treatment.","7851473","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C466,D466)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L466,M466)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N466,N466)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J466,J466)","v":"8380523"},"Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. New vistas.","8380523","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C467,D467)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L467,M467)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N467,N467)","v":"DTXSID8040933"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J467,J467)","v":"8544992"},"Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.","8544992","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C468,D468)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L468,M468)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N468,N468)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J468,J468)","v":"7979223"},"Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.","7979223","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C469,D469)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L469,M469)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N469,N469)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J469,J469)","v":"8615126"},"Excitatory amino acids and MPTP toxicity.","8615126","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C470,D470)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L470,M470)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N470,N470)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J470,J470)","v":"8420136"},"MPTP and aging. Studies in the C57BL/6 mouse.","8420136","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C471,D471)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L471,M471)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N471,N471)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J471,J471)","v":"8420218"},"Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism.","8420218","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C472,D472)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L472,M472)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N472,N472)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J472,J472)","v":"8618687"},"Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes.","8618687","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C473,D473)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L473,M473)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N473,N473)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J473,J473)","v":"8093421"},"Movement disorders: therapeutic role of vitamin E.","8093421","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C474,D474)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L474,M474)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N474,N474)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J474,J474)","v":"7911652"},"Glutamate and Parkinson's disease.","7911652","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C475,D475)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L475,M475)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N475,N475)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J475,J475)","v":"7925842"},"Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.","7925842","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C476,D476)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L476,M476)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N476,N476)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J476,J476)","v":"8689042"},"Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys.","8689042","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C477,D477)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L477,M477)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N477,N477)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J477,J477)","v":"8098931"},"Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys.","8098931","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C478,D478)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L478,M478)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N478,N478)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J478,J478)","v":"8289584"},"The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's disease.","8289584","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C479,D479)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L479,M479)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N479,N479)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J479,J479)","v":"8095431"},"Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.","8095431","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C480,D480)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L480,M480)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N480,N480)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J480,J480)","v":"8744121"},"[Effect of interferon on the development of Parkinson's syndrome, caused by administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57Bl/6 mice].","8744121","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C481,D481)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L481,M481)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N481,N481)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J481,J481)","v":"8094427"},"Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys.","8094427","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C482,D482)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L482,M482)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N482,N482)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J482,J482)","v":"8413979"},"Gangliosides and parkinsonism.","8413979","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C483,D483)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L483,M483)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N483,N483)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J483,J483)","v":"8064321"},"Medium latency stretch reflexes in young-onset Parkinson's disease and MPTP-induced parkinsonism.","8064321","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C484,D484)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L484,M484)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N484,N484)","v":"DTXSID8040933"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J484,J484)","v":"8588064"},"Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors.","8588064","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C485,D485)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L485,M485)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N485,N485)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J485,J485)","v":"7509198"},"6-[18F]fluoro-L-dopa and cerebral blood flow in unilaterally MPTP-treated monkeys.","7509198","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C486,D486)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L486,M486)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N486,N486)","v":"DTXSID8040933"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J486,J486)","v":"8309350"},"Development of a model for Parkinson's disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion.","8309350","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C487,D487)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L487,M487)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N487,N487)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J487,J487)","v":"9473580"},"MPTP-Parkinsonism is accompanied by persistent expression of a delta-FosB-like protein in dopaminergic pathways.","9473580","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C488,D488)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L488,M488)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N488,N488)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J488,J488)","v":"9518590"},"Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey.","9518590","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C489,D489)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L489,M489)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N489,N489)","v":"DTXSID8040933"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J489,J489)","v":"9195598"},"Species differences in the role of excitatory amino acids in experimental parkinsonism.","9195598","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C490,D490)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L490,M490)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N490,N490)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J490,J490)","v":"8819134"},"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model.","8819134","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C491,D491)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L491,M491)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N491,N491)","v":"DTXSID8040933"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J491,J491)","v":"9163560"},"Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.","9163560","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C492,D492)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L492,M492)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N492,N492)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J492,J492)","v":"9001722"},"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.","9001722","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C493,D493)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L493,M493)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N493,N493)","v":"DTXSID8040933"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J493,J493)","v":"9396088"},"Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents.","9396088","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C494,D494)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L494,M494)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N494,N494)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J494,J494)","v":"9280455"},"[The effect of liposomal form of L-Dopa on the level of dopamine, its metabolites, and phospholipid metabolism in the striatum of mice with experimental parkinsonian syndrome].","9280455","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C495,D495)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L495,M495)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N495,N495)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J495,J495)","v":"8915594"},"Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys.","8915594","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C496,D496)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L496,M496)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N496,N496)","v":"DTXSID8040933"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J496,J496)","v":"9398471"},"Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice.","9398471","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C497,D497)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L497,M497)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N497,N497)","v":"DTXSID8040933"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J497,J497)","v":"8974482"},"[Sleep disorders and impaired learning ability in rats with parkinsonian syndrome induced by MPTP].","8974482","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C498,D498)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L498,M498)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N498,N498)","v":"DTXSID8040933"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J498,J498)","v":"9126147"},"Neuroprotective therapy for Parkinson's disease.","9126147","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C499,D499)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L499,M499)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N499,N499)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J499,J499)","v":"9827593"},"The role of the thalamus and basal ganglia in parkinsonian tremor.","9827593","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C500,D500)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L500,M500)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N500,N500)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J500,J500)","v":"9756328"},"Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice.","9756328","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C501,D501)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L501,M501)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N501,N501)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J501,J501)","v":"9710520"},"MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose.","9710520","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C502,D502)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L502,M502)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N502,N502)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J502,J502)","v":"9860271"},"Efferent synaptic connections of dopaminergic neurons grafted into the caudate nucleus of experimentally induced parkinsonian monkeys are different from those of control animals.","9860271","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C503,D503)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L503,M503)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N503,N503)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J503,J503)","v":"9928895"},"Environmental MPTP as a factor in the aetiology of Parkinson's disease?","9928895","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C504,D504)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L504,M504)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N504,N504)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J504,J504)","v":"9754903"},"Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).","9754903","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C505,D505)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L505,M505)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N505,N505)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J505,J505)","v":"9613716"},"Mechanisms of MPTP toxicity.","9613716","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C506,D506)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L506,M506)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N506,N506)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J506,J506)","v":"9635986"},"N-methyl-(R)-salsolinol and Parkinson's disease.","9635986","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C507,D507)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L507,M507)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N507,N507)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J507,J507)","v":"9710523"},"Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys.","9710523","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C508,D508)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L508,M508)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N508,N508)","v":"DTXSID8040933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J508,J508)","v":"9668361"},"Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.","9668361","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C509,D509)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L509,M509)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N509,N509)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J509,J509)","v":"3878482"},"Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.","3878482","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C510,D510)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L510,M510)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N510,N510)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J510,J510)","v":"3875807"},"Intellectual changes in patients with MPTP-induced parkinsonism.","3875807","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C511,D511)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L511,M511)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N511,N511)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J511,J511)","v":"3871241"},"Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.","3871241","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C512,D512)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L512,M512)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N512,N512)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J512,J512)","v":"3876500"},"Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens.","3876500","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C513,D513)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L513,M513)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N513,N513)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J513,J513)","v":"3876510"},"Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.","3876510","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C514,D514)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L514,M514)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N514,N514)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J514,J514)","v":"3876575"},"MPTP and parkinsonism.","3876575","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C515,D515)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L515,M515)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N515,N515)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J515,J515)","v":"3876508"},"The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by MPTP.","3876508","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C516,D516)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L516,M516)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N516,N516)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J516,J516)","v":"2783550"},"Chemically induced Parkinson's disease. II: Intermediates in the oxidation and reduction reactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium ion and its deprotonated form.","2783550","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C517,D517)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L517,M517)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N517,N517)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J517,J517)","v":"28108849"},"Toll Like Receptor 4 Affects the Cerebral Biochemical Changes Induced by MPTP Treatment.","28108849","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C518,D518)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L518,M518)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N518,N518)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J518,J518)","v":"25681412"},"Reduced cortical innervation of the subthalamic nucleus in MPTP-treated parkinsonian monkeys.","25681412","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C519,D519)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L519,M519)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N519,N519)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J519,J519)","v":"26114655"},"Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse.","26114655","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C520,D520)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L520,M520)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N520,N520)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J520,J520)","v":"2688042"},"[MPTP: a new chapter in the history of Parkinson's disease].","2688042","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C521,D521)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L521,M521)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N521,N521)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J521,J521)","v":"2689379"},"Animal models of parkinsonism using selective neurotoxins: clinical and basic implications.","2689379","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C522,D522)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L522,M522)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N522,N522)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J522,J522)","v":"26431624"},"Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.","26431624","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C523,D523)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L523,M523)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N523,N523)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J523,J523)","v":"27395789"},"Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.","27395789","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C524,D524)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L524,M524)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N524,N524)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J524,J524)","v":"2687716"},"Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey.","2687716","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C525,D525)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L525,M525)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N525,N525)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J525,J525)","v":"2790469"},"Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism.","2790469","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C526,D526)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L526,M526)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N526,N526)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J526,J526)","v":"2581135"},"The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).","2581135","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C527,D527)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L527,M527)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N527,N527)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J527,J527)","v":"25839189"},"Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson's disease.","25839189","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C528,D528)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L528,M528)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N528,N528)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J528,J528)","v":"2581589"},"The influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the levels of dopamine, serotonin and their metabolites in the caudate nucleus of the rat.","2581589","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C529,D529)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L529,M529)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N529,N529)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J529,J529)","v":"2622529"},"Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions.","2622529","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C530,D530)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L530,M530)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N530,N530)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J530,J530)","v":"2686017"},"[MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and parkinsonism].","2686017","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C531,D531)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L531,M531)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N531,N531)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J531,J531)","v":"26859995"},"[Early Stages of Parkinson's Disease: Comparative Characteristics of Sleep-Wakefulness Cycle in Patients and Model Animals].","26859995","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C532,D532)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L532,M532)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N532,N532)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J532,J532)","v":"2790166"},"[Evaluation of the capability of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pyridine derivatives to evoke parkinsonism].","2790166","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C533,D533)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L533,M533)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N533,N533)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J533,J533)","v":"25631236"},"Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.","25631236","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C534,D534)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L534,M534)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N534,N534)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J534,J534)","v":"2586750"},"Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","2586750","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C535,D535)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L535,M535)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N535,N535)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J535,J535)","v":"2637935"},"MPTP-induced Parkinson-like disease in sheep: clinical and pathologic findings.","2637935","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C536,D536)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L536,M536)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N536,N536)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J536,J536)","v":"2812327"},"Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).","2812327","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C537,D537)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L537,M537)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N537,N537)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J537,J537)","v":"2669769"},"Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.","2669769","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C538,D538)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L538,M538)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N538,N538)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J538,J538)","v":"2698296"},"[Contribution of MPTP to studies on the pathogenesis of Parkinson's disease].","2698296","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C539,D539)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L539,M539)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N539,N539)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J539,J539)","v":"27694423"},"Posttransplant Lymphoproliferative Disorders in Neuronal Xenotransplanted Macaques.","27694423","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C540,D540)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L540,M540)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N540,N540)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J540,J540)","v":"26994817"},"Medicinal plant Combretum leprosum mart ameliorates motor, biochemical and molecular alterations in a Parkinson's disease model induced by MPTP.","26994817","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C541,D541)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L541,M541)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N541,N541)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J541,J541)","v":"2785665"},"Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on ultrastructure of nigral neuromelanin in Macaca fascicularis.","2785665","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C542,D542)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L542,M542)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N542,N542)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J542,J542)","v":"2614476"},"Transplantation of human sympathetic neurons and adrenal chromaffin cells into parkinsonian monkeys: no reversal of clinical symptoms.","2614476","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C543,D543)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L543,M543)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N543,N543)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J543,J543)","v":"2694734"},"MPTP-induced parkinsonism as a model for Parkinson's disease.","2694734","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C544,D544)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L544,M544)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N544,N544)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J544,J544)","v":"2597310"},"MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.","2597310","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C545,D545)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L545,M545)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N545,N545)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J545,J545)","v":"2565752"},"GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.","2565752","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C546,D546)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L546,M546)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N546,N546)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J546,J546)","v":"2786926"},"Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).","2786926","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C547,D547)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L547,M547)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N547,N547)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J547,J547)","v":"2656447"},"[Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].","2656447","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C548,D548)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L548,M548)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N548,N548)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J548,J548)","v":"2893993"},"An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.","2893993","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C549,D549)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L549,M549)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N549,N549)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J549,J549)","v":"3520683"},"[Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].","3520683","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C550,D550)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L550,M550)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N550,N550)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J550,J550)","v":"3491578"},"Saccade responses to dopamine in human MPTP-induced parkinsonism.","3491578","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C551,D551)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L551,M551)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N551,N551)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J551,J551)","v":"3126391"},"MPTP in animal models of Parkinson's disease.","3126391","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C552,D552)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L552,M552)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N552,N552)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J552,J552)","v":"28338241"},"Neuroprotective Effects of Loganin on MPTP-Induced Parkinson's Disease Mice: Neurochemistry, Glial Reaction and Autophagy Studies.","28338241","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C553,D553)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L553,M553)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N553,N553)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J553,J553)","v":"3259295"},"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?","3259295","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C554,D554)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L554,M554)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N554,N554)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J554,J554)","v":"3259617"},"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): one designer drug and serendipity.","3259617","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C555,D555)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L555,M555)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N555,N555)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J555,J555)","v":"3261249"},"Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.","3261249","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C556,D556)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L556,M556)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N556,N556)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J556,J556)","v":"3493624"},"Changes in the local cerebral metabolic rate for glucose in the MPTP primate model of Parkinson's disease.","3493624","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C557,D557)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L557,M557)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N557,N557)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J557,J557)","v":"3484707"},"Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry.","3484707","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C558,D558)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L558,M558)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N558,N558)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J558,J558)","v":"3091759"},"The MPTP story: an introduction.","3091759","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C559,D559)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L559,M559)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N559,N559)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J559,J559)","v":"3264746"},"Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology.","3264746","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C560,D560)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L560,M560)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N560,N560)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J560,J560)","v":"28552716"},"Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease.","28552716","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C561,D561)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L561,M561)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N561,N561)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J561,J561)","v":"3493621"},"Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals.","3493621","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C562,D562)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L562,M562)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N562,N562)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J562,J562)","v":"3129982"},"MPTP toxicity: implications for research in Parkinson's disease.","3129982","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C563,D563)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L563,M563)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N563,N563)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J563,J563)","v":"3103408"},"Parkinson's disease: current view.","3103408","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C564,D564)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L564,M564)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N564,N564)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J564,J564)","v":"3103386"},"Pathology of MPTP in the marmoset.","3103386","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C565,D565)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L565,M565)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N565,N565)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J565,J565)","v":"3103385"},"Determination and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by [18F]-labeled 6-fluoro-L-dopa and positron emission tomography.","3103385","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C566,D566)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L566,M566)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N566,N566)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J566,J566)","v":"3259063"},"Neuropathological study on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of the crab-eating monkey.","3259063","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C567,D567)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L567,M567)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N567,N567)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J567,J567)","v":"2881442"},"Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.","2881442","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C568,D568)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L568,M568)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N568,N568)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J568,J568)","v":"2881443"},"MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects.","2881443","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C569,D569)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L569,M569)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N569,N569)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J569,J569)","v":"3257287"},"MPTP in mice: treatment, distribution and possible source of contamination.","3257287","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C570,D570)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L570,M570)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N570,N570)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J570,J570)","v":"3258018"},"Potent neurotoxic fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs as potential probes in models of Parkinson disease.","3258018","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C571,D571)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L571,M571)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N571,N571)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J571,J571)","v":"3488406"},"Characterization of the neurotoxic potential of m-methoxy-MPTP and the use of its N-ethyl analogue as a means of avoiding exposure to a possible Parkinsonism-causing agent.","3488406","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C572,D572)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L572,M572)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N572,N572)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J572,J572)","v":"3489476"},"[Parkinsonism and MPTP (methylphenyltetrahydropyridine)].","3489476","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C573,D573)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L573,M573)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N573,N573)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J573,J573)","v":"3487056"},"Parkinson-like syndrome in nonhuman primates receiving a tetrahydropyridine derivative.","3487056","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C574,D574)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L574,M574)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N574,N574)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J574,J574)","v":"3534484"},"The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and structurally related compounds.","3534484","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C575,D575)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L575,M575)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N575,N575)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J575,J575)","v":"3487691"},"Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).","3487691","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C576,D576)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L576,M576)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N576,N576)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J576,J576)","v":"3489070"},"MPTP toxicity: clinical features.","3489070","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C577,D577)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L577,M577)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N577,N577)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J577,J577)","v":"3489069"},"MPTP and the aetiology of Parkinson's disease. Clinical implications. London, June 27, 1985.","3489069","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C578,D578)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L578,M578)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N578,N578)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J578,J578)","v":"3488798"},"Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].","3488798","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C579,D579)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L579,M579)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N579,N579)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J579,J579)","v":"3146035"},"Mechanisms of recovery in MPTP-induced parkinsonism.","3146035","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C580,D580)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L580,M580)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N580,N580)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J580,J580)","v":"3143064"},"Administration of MPTP to the common marmoset does not alter cortical cholinergic function.","3143064","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C581,D581)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L581,M581)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N581,N581)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J581,J581)","v":"3486388"},"The dopamine neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces histological lesions in the hypothalamus of the common marmoset.","3486388","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C582,D582)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L582,M582)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N582,N582)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J582,J582)","v":"3485368"},"Toxin-induced parkinsonism: recent developments.","3485368","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C583,D583)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L583,M583)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N583,N583)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J583,J583)","v":"3150735"},"Study on MPTP-induced parkinsonian animal model in rhesus monkey and the mechanism of MPTP.","3150735","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C584,D584)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L584,M584)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N584,N584)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J584,J584)","v":"3059935"},"MPTP effects on dopamine neurons.","3059935","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C585,D585)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L585,M585)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N585,N585)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J585,J585)","v":"3068045"},"[The bases of MPTP neurotoxicity].","3068045","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C586,D586)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L586,M586)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N586,N586)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J586,J586)","v":"3064783"},"[MPTP and Parkinson's disease].","3064783","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C587,D587)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L587,M587)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N587,N587)","v":"DTXSID8040933"},2018,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J587,J587)","v":"29604467"},"Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.","29604467","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C588,D588)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L588,M588)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N588,N588)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J588,J588)","v":"3498914"},"MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans.","3498914","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C589,D589)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L589,M589)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N589,N589)","v":"DTXSID8040933"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J589,J589)","v":"2857280"},"Production in nature of compound resembling methylphenyltetrahydropyridine, a possible cause of Parkinson's disease.","2857280","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C590,D590)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L590,M590)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N590,N590)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J590,J590)","v":"3072280"},"Secondary (toxic) parkinsonism as model of Parkinson's disease.","3072280","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C591,D591)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L591,M591)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N591,N591)","v":"DTXSID8040933"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J591,J591)","v":"3072279"},"MPTP-induced parkinsonism. Recent studies on the mechanism of toxicity.","3072279","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C592,D592)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L592,M592)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N592,N592)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J592,J592)","v":"3319563"},"MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease.","3319563","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C593,D593)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L593,M593)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N593,N593)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J593,J593)","v":"2884568"},"Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.","2884568","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C594,D594)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L594,M594)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N594,N594)","v":"DTXSID8040933"},2018,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J594,J594)","v":"29627306"},"Paraquat and MPTP induce alteration in the expression profile of long noncoding RNAs in the substantia nigra of mice: Role of the transcription factor Nrf2.","29627306","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C595,D595)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L595,M595)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N595,N595)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J595,J595)","v":"3493625"},"Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.","3493625","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C596,D596)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L596,M596)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N596,N596)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J596,J596)","v":"2870243"},"Parkinsonism as late toxic effect of dihydropyridines?","2870243","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C597,D597)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L597,M597)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N597,N597)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J597,J597)","v":"3080696"},"MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture.","3080696","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C598,D598)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L598,M598)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N598,N598)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J598,J598)","v":"3493894"},"Effect of increasing regimens of levodopa on chronic MPTP-induced parkinsonism in monkey; mechanographic and electromyographic data.","3493894","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C599,D599)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L599,M599)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N599,N599)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J599,J599)","v":"17359968"},"Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease.","17359968","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C600,D600)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L600,M600)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N600,N600)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J600,J600)","v":"17675560"},"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.","17675560","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C601,D601)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L601,M601)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N601,N601)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J601,J601)","v":"17985252"},"Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?","17985252","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C602,D602)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L602,M602)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N602,N602)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J602,J602)","v":"17610816"},"Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.","17610816","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C603,D603)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L603,M603)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N603,N603)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J603,J603)","v":"17127354"},"Mitochondrial toxins and neurodegenerative diseases.","17127354","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C604,D604)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L604,M604)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N604,N604)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J604,J604)","v":"18522240"},"Intraputamenal infusion of exogenous neurturin protein restores motor and dopaminergic function in the globus pallidus of MPTP-lesioned rhesus monkeys.","18522240","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C605,D605)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L605,M605)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N605,N605)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J605,J605)","v":"17855373"},"A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.","17855373","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C606,D606)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L606,M606)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N606,N606)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J606,J606)","v":"17045989"},"Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease.","17045989","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C607,D607)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L607,M607)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N607,N607)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J607,J607)","v":"17899020"},"Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic?","17899020","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C608,D608)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L608,M608)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N608,N608)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J608,J608)","v":"18440632"},"Neuroprotective effects of PACAP27 in mice model of Parkinson's disease involved in the modulation of K(ATP) subunits and D2 receptors in the striatum.","18440632","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C609,D609)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L609,M609)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N609,N609)","v":"DTXSID8040933"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J609,J609)","v":"17254792"},"Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism.","17254792","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C610,D610)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L610,M610)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N610,N610)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J610,J610)","v":"1771272"},"Pyridine derivatives: structure-activity relationships causing parkinsonism-like symptoms.","1771272","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C611,D611)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L611,M611)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N611,N611)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J611,J611)","v":"2469210"},"The role of environmental toxins in the etiology of Parkinson's disease.","2469210","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C612,D612)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L612,M612)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N612,N612)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J612,J612)","v":"24989117"},"Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?","24989117","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C613,D613)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L613,M613)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N613,N613)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J613,J613)","v":"24002224"},"Recovery of neurological functions in non-human primate model of Parkinson's disease by transplantation of encapsulated neonatal porcine choroid plexus cells.","24002224","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C614,D614)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L614,M614)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N614,N614)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J614,J614)","v":"24704796"},"Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease.","24704796","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C615,D615)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L615,M615)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N615,N615)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J615,J615)","v":"23360802"},"Modeling dyskinesia in animal models of Parkinson disease.","23360802","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C616,D616)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L616,M616)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N616,N616)","v":"DTXSID8040933"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J616,J616)","v":"2433563"},"The development of amine substituted analogues of MPTP as unique tools for the study of MPTP toxicity and Parkinson's disease.","2433563","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C617,D617)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L617,M617)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N617,N617)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J617,J617)","v":"2350702"},"MPTP-induced parkinsonism: relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeys.","2350702","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C618,D618)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L618,M618)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N618,N618)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J618,J618)","v":"2494438"},"The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","2494438","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C619,D619)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L619,M619)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N619,N619)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J619,J619)","v":"2357577"},"Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism.","2357577","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C620,D620)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L620,M620)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N620,N620)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J620,J620)","v":"23957451"},"In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment.","23957451","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C621,D621)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L621,M621)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N621,N621)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J621,J621)","v":"2427166"},"Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.","2427166","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C622,D622)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L622,M622)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N622,N622)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J622,J622)","v":"24070854"},"Modeling Parkinson's disease in monkeys for translational studies, a critical analysis.","24070854","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C623,D623)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L623,M623)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N623,N623)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J623,J623)","v":"2393218"},"Pharmacological correction of CNS functional disorders and parkinsonian syndrome in old animals.","2393218","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C624,D624)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L624,M624)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N624,N624)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J624,J624)","v":"23836409"},"Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease.","23836409","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C625,D625)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L625,M625)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N625,N625)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J625,J625)","v":"24726706"},"Neuroprotective effects of the andrographolide analogue AL-1 in the MPP⁺/MPTP-induced Parkinson's disease model in vitro and in mice.","24726706","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C626,D626)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L626,M626)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N626,N626)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J626,J626)","v":"1637057"},"Mitochondrial mechanisms of neurotoxicity.","1637057","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C627,D627)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L627,M627)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N627,N627)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J627,J627)","v":"1613817"},"MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.","1613817","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C628,D628)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L628,M628)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N628,N628)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J628,J628)","v":"1681090"},"Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-dopa in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.","1681090","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C629,D629)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L629,M629)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N629,N629)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J629,J629)","v":"1629743"},"MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.","1629743","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C630,D630)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L630,M630)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N630,N630)","v":"DTXSID8040933"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J630,J630)","v":"16337943"},"Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.","16337943","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C631,D631)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L631,M631)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N631,N631)","v":"DTXSID8040933"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J631,J631)","v":"15277042"},"Olfactory impairment and Parkinson's disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","15277042","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C632,D632)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L632,M632)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N632,N632)","v":"DTXSID8040933"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J632,J632)","v":"16049934"},"Trophic factor distribution predicts functional recovery in parkinsonian monkeys.","16049934","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C633,D633)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L633,M633)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N633,N633)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J633,J633)","v":"1521037"},"Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse.","1521037","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C634,D634)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L634,M634)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N634,N634)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J634,J634)","v":"1623269"},"MPTP and other Parkinson-inducing agents.","1623269","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C635,D635)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L635,M635)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N635,N635)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J635,J635)","v":"1584431"},"Emerging perspectives in Parkinson's disease.","1584431","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C636,D636)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L636,M636)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N636,N636)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J636,J636)","v":"1650080"},"[Parkinsonism and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (review of the literature)].","1650080","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C637,D637)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L637,M637)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N637,N637)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J637,J637)","v":"1642478"},"Lack of major olfactory dysfunction in MPTP-induced parkinsonism.","1642478","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C638,D638)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L638,M638)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N638,N638)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J638,J638)","v":"20231306"},"Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.","20231306","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C639,D639)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L639,M639)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N639,N639)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J639,J639)","v":"18991880"},"MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut.","18991880","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C640,D640)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L640,M640)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N640,N640)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J640,J640)","v":"1976438"},"Modulatory role for CCK-B antagonists in Parkinson's disease.","1976438","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C641,D641)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L641,M641)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N641,N641)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J641,J641)","v":"2005976"},"Parkinson's disease. Fresh factors to consider.","2005976","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C642,D642)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L642,M642)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N642,N642)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J642,J642)","v":"20887873"},"The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future.","20887873","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C643,D643)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L643,M643)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N643,N643)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J643,J643)","v":"20887872"},"Modeling neuroinflammatory pathogenesis of Parkinson's disease.","20887872","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C644,D644)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L644,M644)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N644,N644)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J644,J644)","v":"20887868"},"Neurotoxic in vivo models of Parkinson's disease recent advances.","20887868","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C645,D645)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L645,M645)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N645,N645)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J645,J645)","v":"20457209"},"Cassiae semen, a seed of Cassia obtusifolia, has neuroprotective effects in Parkinson's disease models.","20457209","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C646,D646)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L646,M646)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N646,N646)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J646,J646)","v":"20478277"},"Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.","20478277","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C647,D647)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L647,M647)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N647,N647)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J647,J647)","v":"19629612"},"Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.","19629612","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C648,D648)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L648,M648)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N648,N648)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J648,J648)","v":"2076347"},"[Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].","2076347","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C649,D649)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L649,M649)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N649,N649)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J649,J649)","v":"20556443"},"Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.","20556443","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C650,D650)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L650,M650)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N650,N650)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J650,J650)","v":"19490092"},"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.","19490092","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C651,D651)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L651,M651)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N651,N651)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J651,J651)","v":"2064731"},"Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates.","2064731","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C652,D652)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L652,M652)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N652,N652)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J652,J652)","v":"19401171"},"Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","19401171","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C653,D653)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L653,M653)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N653,N653)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J653,J653)","v":"19410592"},"Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.","19410592","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C654,D654)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L654,M654)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N654,N654)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J654,J654)","v":"20868359"},"Biomarkers of cell damage induced by oxidative stress in Parkinson's disease and related models.","20868359","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C655,D655)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L655,M655)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N655,N655)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J655,J655)","v":"1978517"},"Chronic administration of MPTP to marmosets.","1978517","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C656,D656)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L656,M656)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N656,N656)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J656,J656)","v":"2036621"},"MPTP-induced neurotoxicity and the quest for a preventative therapy for Parkinson's disease.","2036621","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C657,D657)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L657,M657)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N657,N657)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J657,J657)","v":"20852902"},"Running wheel activity restores MPTP-induced functional deficits.","20852902","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C658,D658)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L658,M658)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N658,N658)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J658,J658)","v":"21626392"},"In search of the causes of Parkinson's disease, seasons 1 to 4.","21626392","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C659,D659)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L659,M659)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N659,N659)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J659,J659)","v":"2233418"},"Parkinson's disease and cytochrome P450: a possible link?","2233418","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C660,D660)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L660,M660)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N660,N660)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J660,J660)","v":"2309157"},"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the rat: characterization and age-dependent effects.","2309157","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C661,D661)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L661,M661)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N661,N661)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J661,J661)","v":"2279092"},"[Clinical and biochemical parameters of parkinsonism induced by 1-methyl-4-phenyl-1,2,2,6-tetrahydropyridine and its methyl-phenyl and methoxy-phenyl derivatives in C57Bl/6 mice].","2279092","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C662,D662)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L662,M662)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N662,N662)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J662,J662)","v":"2130940"},"Studies on 4-benzyl-1-methyl-1,2,3,6-tetrahydropyridine, a nonneurotoxic analogue of the parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","2130940","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C663,D663)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L663,M663)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N663,N663)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J663,J663)","v":"22394540"},"Cranial and related sensorimotor impairments in rodent models of Parkinson's disease.","22394540","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C664,D664)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L664,M664)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N664,N664)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J664,J664)","v":"22229125"},"A guide to neurotoxic animal models of Parkinson's disease.","22229125","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C665,D665)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L665,M665)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N665,N665)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J665,J665)","v":"22227007"},"Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity.","22227007","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C666,D666)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L666,M666)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N666,N666)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J666,J666)","v":"22236386"},"Animal models of the non-motor features of Parkinson's disease.","22236386","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C667,D667)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L667,M667)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N667,N667)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J667,J667)","v":"23087045"},"Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.","23087045","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C668,D668)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L668,M668)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N668,N668)","v":"DTXSID8040933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J668,J668)","v":"21186622"},"[Effects of SV heat-resisting protein on the microglial cells in MPTP-treated mice].","21186622","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C669,D669)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L669,M669)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N669,N669)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J669,J669)","v":"2253555"},"The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism.","2253555","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C670,D670)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L670,M670)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N670,N670)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J670,J670)","v":"2253695"},"Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.","2253695","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C671,D671)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L671,M671)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N671,N671)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J671,J671)","v":"2296255"},"Induction of chorea and dystonia in parkinsonian primates.","2296255","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C672,D672)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L672,M672)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N672,N672)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J672,J672)","v":"2199253"},"Biochemical aspects of drug-induced Parkinson's disease.","2199253","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C673,D673)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L673,M673)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N673,N673)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J673,J673)","v":"2181530"},"MPTP-induced parkinsonism.","2181530","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C674,D674)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L674,M674)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N674,N674)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J674,J674)","v":"2204050"},"The neurotoxicity of MPTP and the relevance to Parkinson's disease.","2204050","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C675,D675)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L675,M675)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N675,N675)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J675,J675)","v":"2300245"},"Cognitive change following MPTP exposure.","2300245","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C676,D676)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L676,M676)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N676,N676)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J676,J676)","v":"22117806"},"Potentiation of D-serine involves degeneration of dopaminergic neurons in MPTP/p mouse model of Parkinson's disease.","22117806","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C677,D677)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L677,M677)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N677,N677)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J677,J677)","v":"21254589"},"[Effects of subchronic hemantane administration on dopamine and serotonin receptors in intact and MPP+-treated rat brain ex vivo].","21254589","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C678,D678)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L678,M678)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N678,N678)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J678,J678)","v":"2123984"},"Animal models of parkinsonism.","2123984","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C679,D679)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L679,M679)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N679,N679)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J679,J679)","v":"21074478"},"Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys.","21074478","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C680,D680)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L680,M680)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N680,N680)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J680,J680)","v":"2192210"},"[An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease].","2192210","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C681,D681)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L681,M681)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N681,N681)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J681,J681)","v":"22898818"},"Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via deacetylating forkhead box O3a (Foxo3a) and activating Bim protein.","22898818","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C682,D682)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L682,M682)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N682,N682)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J682,J682)","v":"21693708"},"Involvement of the Fc gamma receptor in a chronic N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of dopaminergic loss.","21693708","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C683,D683)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L683,M683)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N683,N683)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J683,J683)","v":"2296259"},"Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.","2296259","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C684,D684)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L684,M684)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N684,N684)","v":"DTXSID8040933"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J684,J684)","v":"2192787"},"Drug-induced parkinsonism and other movement disorders.","2192787","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C685,D685)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L685,M685)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N685,N685)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J685,J685)","v":"10543426"},"Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice.","10543426","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C686,D686)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L686,M686)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N686,N686)","v":"DTXSID8040933"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J686,J686)","v":"11775597"},"Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease. 1990.","11775597","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C687,D687)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L687,M687)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N687,N687)","v":"DTXSID8040933"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J687,J687)","v":"11768626"},"Neurochemical findings in the MPTP model of Parkinson's disease.","11768626","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C688,D688)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L688,M688)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N688,N688)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J688,J688)","v":"10078726"},"D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys.","10078726","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C689,D689)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L689,M689)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N689,N689)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J689,J689)","v":"10780829"},"The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297.","10780829","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C690,D690)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L690,M690)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N690,N690)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J690,J690)","v":"10780830"},"The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958.","10780830","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C691,D691)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L691,M691)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N691,N691)","v":"DTXSID8040933"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J691,J691)","v":"10744035"},"Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.","10744035","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C692,D692)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L692,M692)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N692,N692)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J692,J692)","v":"10577096"},"More about parkinsonism after taking ecstasy.","10577096","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C693,D693)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L693,M693)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N693,N693)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J693,J693)","v":"10320728"},"Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus.","10320728","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C694,D694)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L694,M694)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N694,N694)","v":"DTXSID8040933"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J694,J694)","v":"10683860"},"MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons.","10683860","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C695,D695)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L695,M695)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N695,N695)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J695,J695)","v":"10331698"},"Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.","10331698","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C696,D696)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L696,M696)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N696,N696)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J696,J696)","v":"10434585"},"[MPTP parkinsonism].","10434585","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C697,D697)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L697,M697)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N697,N697)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J697,J697)","v":"10375668"},"Dopamine transporter loss and clinical changes in MPTP-lesioned primates.","10375668","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C698,D698)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L698,M698)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N698,N698)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J698,J698)","v":"10398297"},"Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease.","10398297","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C699,D699)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L699,M699)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N699,N699)","v":"DTXSID8040933"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J699,J699)","v":"10971632"},"Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.","10971632","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C700,D700)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L700,M700)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N700,N700)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J700,J700)","v":"10591875"},"Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeys.","10591875","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C701,D701)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L701,M701)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N701,N701)","v":"DTXSID8040933"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J701,J701)","v":"11295768"},"Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.","11295768","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C702,D702)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L702,M702)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N702,N702)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J702,J702)","v":"10192785"},"Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease.","10192785","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C703,D703)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L703,M703)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N703,N703)","v":"DTXSID8040933"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J703,J703)","v":"10727642"},"Effects of the partial glycine agonist D-cycloserine on cognitive functioning in chronic low dose MPTP-treated monkeys.","10727642","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C704,D704)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L704,M704)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N704,N704)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J704,J704)","v":"10448434"},"Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys.","10448434","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C705,D705)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L705,M705)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N705,N705)","v":"DTXSID8040933"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J705,J705)","v":"10223460"},"Reversal of experimental parkinsonism by using selective chemical ablation of the medial globus pallidus.","10223460","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C706,D706)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L706,M706)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N706,N706)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J706,J706)","v":"12506692"},"From drugs of abuse to parkinsonism. The MPTP mouse model of Parkinson's disease.","12506692","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C707,D707)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L707,M707)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N707,N707)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J707,J707)","v":"1287728"},"Astrocytes and Parkinson's disease.","1287728","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C708,D708)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L708,M708)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N708,N708)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J708,J708)","v":"12700090"},"Rest tremor in rhesus monkeys with MPTP-induced parkinsonism.","12700090","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C709,D709)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L709,M709)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N709,N709)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J709,J709)","v":"1362875"},"Molecular basis of discrepancies in neurotoxic properties among 1-methyl-4-aryl-1,2,3,6-tetrahydropyridines.","1362875","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C710,D710)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L710,M710)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N710,N710)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J710,J710)","v":"12534964"},"The mouse MPTP model: gene expression changes in dopaminergic neurons.","12534964","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C711,D711)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L711,M711)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N711,N711)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J711,J711)","v":"1435882"},"Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","1435882","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C712,D712)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L712,M712)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N712,N712)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J712,J712)","v":"1354166"},"Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys.","1354166","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C713,D713)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L713,M713)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N713,N713)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J713,J713)","v":"1353337"},"Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.","1353337","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C714,D714)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L714,M714)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N714,N714)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J714,J714)","v":"1353328"},"Neurotoxin-related research: from the laboratory to the clinic.","1353328","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C715,D715)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L715,M715)","v":"Parkinson Disease, Secondary"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N715,N715)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J715,J715)","v":"1461362"},"Mitochondrial factors involved in Parkinson's disease by MPTP toxicity in Macaca fascicularis and drug effect.","1461362","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C716,D716)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L716,M716)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N716,N716)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J716,J716)","v":"26510314"},"Mechanism of Nanotization-Mediated Improvement in the Efficacy of Caffeine Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonism.","26510314","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C717,D717)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L717,M717)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N717,N717)","v":"DTXSID8040933"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J717,J717)","v":"26723869"},"Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.","26723869","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C718,D718)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L718,M718)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N718,N718)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J718,J718)","v":"25633843"},"Acute Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or Paraquat on Core Temperature in C57BL/6J Mice.","25633843","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C719,D719)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L719,M719)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N719,N719)","v":"DTXSID8040933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J719,J719)","v":"25944473"},"Dietary Supplementation of Walnut Partially Reverses 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Neurodegeneration in a Mouse Model of Parkinson's Disease.","25944473","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C720,D720)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L720,M720)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N720,N720)","v":"DTXSID8040933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J720,J720)","v":"28130646"},"The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset.","28130646","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C721,D721)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L721,M721)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N721,N721)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J721,J721)","v":"17985252"},"Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?","17985252","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C722,D722)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L722,M722)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N722,N722)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J722,J722)","v":"18328580"},"Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission.","18328580","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C723,D723)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L723,M723)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N723,N723)","v":"DTXSID8040933"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J723,J723)","v":"17142799"},"3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro.","17142799","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C724,D724)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L724,M724)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N724,N724)","v":"DTXSID8040933"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J724,J724)","v":"18428552"},"Preclinical models of Parkinson's disease.","18428552","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C725,D725)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L725,M725)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N725,N725)","v":"DTXSID8040933"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J725,J725)","v":"17156378"},"Neuroprotection in Parkinson models varies with toxin administration protocol.","17156378","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C726,D726)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L726,M726)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N726,N726)","v":"DTXSID8040933"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J726,J726)","v":"24351065"},"Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+.","24351065","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C727,D727)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L727,M727)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N727,N727)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J727,J727)","v":"23670541"},"Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective.","23670541","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C728,D728)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L728,M728)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N728,N728)","v":"DTXSID8040933"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J728,J728)","v":"15305030"},"Neuroprotective effects of Bak Foong Pill in 1-methyl-4-phenyl-1,2,3,6-tetrahyrdropyridine (MPTP)-induced Parkinson's disease model mice.","15305030","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C729,D729)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L729,M729)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N729,N729)","v":"DTXSID8040933"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J729,J729)","v":"15236401"},"L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.","15236401","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C730,D730)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L730,M730)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N730,N730)","v":"DTXSID8040933"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J730,J730)","v":"16457591"},"Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.","16457591","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C731,D731)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L731,M731)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N731,N731)","v":"DTXSID8040933"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J731,J731)","v":"16781689"},"Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats.","16781689","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C732,D732)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L732,M732)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N732,N732)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J732,J732)","v":"21054946"},"Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism.","21054946","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C733,D733)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L733,M733)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N733,N733)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J733,J733)","v":"20594931"},"Mesencephalic and striatal protein profiles in mice over-expressing glucose-6-phosphate dehydrogenase in dopaminergic neurons.","20594931","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C734,D734)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L734,M734)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N734,N734)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J734,J734)","v":"20347863"},"Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.","20347863","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C735,D735)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L735,M735)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N735,N735)","v":"DTXSID8040933"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J735,J735)","v":"21741988"},"Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's disease.","21741988","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C736,D736)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L736,M736)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N736,N736)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J736,J736)","v":"21951056"},"A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP.","21951056","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C737,D737)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L737,M737)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N737,N737)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J737,J737)","v":"21971013"},"Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease.","21971013","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C738,D738)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L738,M738)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N738,N738)","v":"DTXSID8040933"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J738,J738)","v":"22766071"},"NRSF/REST neuronal deficient mice are more vulnerable to the neurotoxin MPTP.","22766071","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C739,D739)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L739,M739)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N739,N739)","v":"DTXSID8040933"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J739,J739)","v":"11837540"},"Neurotoxicity of MPTP.","11837540","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C740,D740)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L740,M740)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N740,N740)","v":"DTXSID8040933"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J740,J740)","v":"10646524"},"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.","10646524","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C741,D741)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L741,M741)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N741,N741)","v":"DTXSID8040933"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J741,J741)","v":"11724929"},"Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.","11724929","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C742,D742)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L742,M742)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N742,N742)","v":"DTXSID8040933"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J742,J742)","v":"12379867"},"Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons.","12379867","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C743,D743)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L743,M743)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N743,N743)","v":"DTXSID8040933"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J743,J743)","v":"12378066"},"The role of the pedunculopontine tegmental nucleus in experimental parkinsonism in primates.","12378066","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C744,D744)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L744,M744)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N744,N744)","v":"DTXSID8040933"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J744,J744)","v":"12410250"},"Neural stem cells, scaffolds, and chaperones.","12410250","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C745,D745)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L745,M745)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N745,N745)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J745,J745)","v":"12732244"},"Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.","12732244","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C746,D746)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L746,M746)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N746,N746)","v":"DTXSID8040933"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J746,J746)","v":"14734632"},"Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.","14734632","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C747,D747)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L747,M747)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N747,N747)","v":"DTXSID8040933"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J747,J747)","v":"11996504"},"Cytochrome p450 and parkinsonism: protective role of CYP2E1.","11996504","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C748,D748)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L748,M748)","v":"Parkinsonian Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N748,N748)","v":"DTXSID8040933"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J748,J748)","v":"14639671"},"Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset.","14639671","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C749,D749)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L749,M749)","v":"Seizures"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N749,N749)","v":"DTXSID8040933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J749,J749)","v":"2598030"},"MPTP is proconvulsant acutely but has no long-term effect in rodent models of seizure and epilepsy.","2598030","Neurologic Manifestations","D012640","Seizures","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C750,D750)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L750,M750)","v":"Sleep Wake Disorders"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N750,N750)","v":"DTXSID8040933"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J750,J750)","v":"20887873"},"The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future.","20887873","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C751,D751)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L751,M751)","v":"Spinal Cord Diseases"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N751,N751)","v":"DTXSID8040933"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J751,J751)","v":"18036149"},"Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP.","18036149","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C752,D752)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L752,M752)","v":"Status Epilepticus"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N752,N752)","v":"DTXSID8040933"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J752,J752)","v":"1713316"},"The acute convulsant effect of MPTP is dependent on intracerebral MPP+.","1713316","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C753,D753)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L753,M753)","v":"Striatonigral Degeneration"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N753,N753)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J753,J753)","v":"22342763"},"Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.","22342763","Basal Ganglia Diseases","D020955","Striatonigral Degeneration","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C754,D754)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L754,M754)","v":"Striatonigral Degeneration"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N754,N754)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J754,J754)","v":"22898818"},"Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via deacetylating forkhead box O3a (Foxo3a) and activating Bim protein.","22898818","Basal Ganglia Diseases","D020955","Striatonigral Degeneration","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C755,D755)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L755,M755)","v":"Striatonigral Degeneration"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N755,N755)","v":"DTXSID8040933"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J755,J755)","v":"10683860"},"MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons.","10683860","Basal Ganglia Diseases","D020955","Striatonigral Degeneration","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C756,D756)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L756,M756)","v":"Tremor"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N756,N756)","v":"DTXSID8040933"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J756,J756)","v":"8469305"},"Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons.","8469305","Neurologic Manifestations","D014202","Tremor","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C757,D757)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L757,M757)","v":"Tremor"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N757,N757)","v":"DTXSID8040933"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J757,J757)","v":"3488798"},"Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].","3488798","Neurologic Manifestations","D014202","Tremor","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C758,D758)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L758,M758)","v":"Tremor"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N758,N758)","v":"DTXSID8040933"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J758,J758)","v":"1736174"},"Tremor in MPTP-induced parkinsonism.","1736174","Neurologic Manifestations","D014202","Tremor","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C759,D759)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L759,M759)","v":"Tremor"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N759,N759)","v":"DTXSID8040933"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J759,J759)","v":"15178694"},"SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.","15178694","Neurologic Manifestations","D014202","Tremor","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C760,D760)","v":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L760,M760)","v":"Tremor"},"D015632","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","28289-54-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N760,N760)","v":"DTXSID8040933"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J760,J760)","v":"22850123"},"The food reaching test: a sensitive test of behavioral improvements by deep brain stimulation in MPTP-treated monkey.","22850123","Neurologic Manifestations","D014202","Tremor","DTXSID8040933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C761,D761)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L761,M761)","v":"Basal Ganglia Diseases"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N761,N761)","v":"DTXSID8041826"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J761,J761)","v":"1956587"},"A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.","1956587","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C762,D762)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L762,M762)","v":"Brain Diseases"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N762,N762)","v":"DTXSID8041826"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J762,J762)","v":"8019760"},"Effect of L-arginine/nitric oxide pathway on MPP(+)-induced cell injury in the striatum of rats.","8019760","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C763,D763)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L763,M763)","v":"Brain Diseases"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N763,N763)","v":"DTXSID8041826"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J763,J763)","v":"2417166"},"The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.","2417166","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C764,D764)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L764,M764)","v":"Catalepsy"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N764,N764)","v":"DTXSID8041826"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J764,J764)","v":"1649252"},"Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.","1649252","Neurologic Manifestations","D002375","Catalepsy","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C765,D765)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L765,M765)","v":"Central Nervous System Diseases"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N765,N765)","v":"DTXSID8041826"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J765,J765)","v":"9044384"},"Less induced 1-methyl-4-phenylpyridinium ion neurotoxicity on striatal slices from guinea-pigs fed with a vitamin C-deficient diet.","9044384","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C766,D766)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L766,M766)","v":"Movement Disorders"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N766,N766)","v":"DTXSID8041826"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J766,J766)","v":"2417166"},"The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.","2417166","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C767,D767)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L767,M767)","v":"MPTP Poisoning"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N767,N767)","v":"DTXSID8041826"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J767,J767)","v":"1637057"},"Mitochondrial mechanisms of neurotoxicity.","1637057","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C768,D768)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L768,M768)","v":"MPTP Poisoning"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N768,N768)","v":"DTXSID8041826"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J768,J768)","v":"21798732"},"Acute toxicity of MPTP and MPP(+) in the brain of embryo and newborn mice.","21798732","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C769,D769)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L769,M769)","v":"MPTP Poisoning"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N769,N769)","v":"DTXSID8041826"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J769,J769)","v":"21855308"},"Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).","21855308","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C770,D770)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L770,M770)","v":"Nervous System Diseases"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N770,N770)","v":"DTXSID8041826"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J770,J770)","v":"8739616"},"MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport.","8739616","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C771,D771)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L771,M771)","v":"Nervous System Diseases"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N771,N771)","v":"DTXSID8041826"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J771,J771)","v":"9260741"},"In vivo protection of striatal dopaminergic system against 1-methyl-4-phenylpyridinium neurotoxicity by phenobarbital.","9260741","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C772,D772)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L772,M772)","v":"Nervous System Diseases"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N772,N772)","v":"DTXSID8041826"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J772,J772)","v":"2806366"},"1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.","2806366","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C773,D773)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L773,M773)","v":"Nervous System Diseases"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N773,N773)","v":"DTXSID8041826"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J773,J773)","v":"3265107"},"In vivo dopaminergic neurotoxicity of the 2-beta-methylcarbolinium ion, a potential endogenous MPP+ analog.","3265107","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C774,D774)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L774,M774)","v":"Neurodegenerative Diseases"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N774,N774)","v":"DTXSID8041826"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J774,J774)","v":"23106698"},"ω-3 fatty acid eicosapentaenoic acid attenuates MPP+-induced neurodegeneration in fully differentiated human SH-SY5Y and primary mesencephalic cells.","23106698","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C775,D775)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L775,M775)","v":"Neurodegenerative Diseases"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N775,N775)","v":"DTXSID8041826"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J775,J775)","v":"12618347"},"Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.","12618347","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C776,D776)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L776,M776)","v":"Neurodegenerative Diseases"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N776,N776)","v":"DTXSID8041826"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J776,J776)","v":"14529466"},"MPP+ analogs acting on mitochondria and inducing neuro-degeneration.","14529466","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C777,D777)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L777,M777)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N777,N777)","v":"DTXSID8041826"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J777,J777)","v":"8410185"},"Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.","8410185","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C778,D778)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L778,M778)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N778,N778)","v":"DTXSID8041826"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J778,J778)","v":"8522992"},"Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium.","8522992","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C779,D779)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L779,M779)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N779,N779)","v":"DTXSID8041826"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J779,J779)","v":"3876500"},"Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens.","3876500","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C780,D780)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L780,M780)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N780,N780)","v":"DTXSID8041826"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J780,J780)","v":"2784332"},"[Clinico-electroencephalographic indices of the parkinsonian syndrome induced by MPP+ in rats].","2784332","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C781,D781)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L781,M781)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N781,N781)","v":"DTXSID8041826"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J781,J781)","v":"26558463"},"Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.","26558463","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C782,D782)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L782,M782)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N782,N782)","v":"DTXSID8041826"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J782,J782)","v":"27309572"},"Mild MPP+ exposure impairs autophagic degradation through a novel lysosomal acidity-independent mechanism.","27309572","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C783,D783)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L783,M783)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N783,N783)","v":"DTXSID8041826"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J783,J783)","v":"3264391"},"Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.","3264391","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C784,D784)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L784,M784)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N784,N784)","v":"DTXSID8041826"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J784,J784)","v":"3264392"},"Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.","3264392","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C785,D785)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L785,M785)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N785,N785)","v":"DTXSID8041826"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J785,J785)","v":"3082673"},"N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria.","3082673","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C786,D786)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L786,M786)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N786,N786)","v":"DTXSID8041826"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J786,J786)","v":"17043098"},"Chemical genomic profiling for identifying intracellular targets of toxicants producing Parkinson's disease.","17043098","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C787,D787)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L787,M787)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N787,N787)","v":"DTXSID8041826"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J787,J787)","v":"25232110"},"MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA.","25232110","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C788,D788)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L788,M788)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N788,N788)","v":"DTXSID8041826"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J788,J788)","v":"1637057"},"Mitochondrial mechanisms of neurotoxicity.","1637057","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C789,D789)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L789,M789)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N789,N789)","v":"DTXSID8041826"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J789,J789)","v":"16098973"},"The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as a destabilising factor.","16098973","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C790,D790)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L790,M790)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N790,N790)","v":"DTXSID8041826"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J790,J790)","v":"16546169"},"Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+).","16546169","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C791,D791)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L791,M791)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N791,N791)","v":"DTXSID8041826"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J791,J791)","v":"1642464"},"Parkinsonism-inducing neurotoxin MPP+: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA.","1642464","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C792,D792)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L792,M792)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N792,N792)","v":"DTXSID8041826"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J792,J792)","v":"20868657"},"Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices.","20868657","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C793,D793)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L793,M793)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N793,N793)","v":"DTXSID8041826"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J793,J793)","v":"22437482"},"Protection against neurotoxicity by an autophagic mechanism.","22437482","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C794,D794)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L794,M794)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N794,N794)","v":"DTXSID8041826"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J794,J794)","v":"23087045"},"Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.","23087045","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C795,D795)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L795,M795)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N795,N795)","v":"DTXSID8041826"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J795,J795)","v":"11403945"},"Allopurinol suppresses para-nonylphenol and 1-methyl-4-phenylpyridinium ion (MPP(+))-induced hydroxyl radical generation in rat striatum.","11403945","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C796,D796)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L796,M796)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N796,N796)","v":"DTXSID8041826"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J796,J796)","v":"10679305"},"MPP(+)-induced mitochondrial dysfunction is potentiated by dopamine.","10679305","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C797,D797)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L797,M797)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N797,N797)","v":"DTXSID8041826"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J797,J797)","v":"10949539"},"Protective effect of melatonin against the 1-methyl-4-phenylpyridinium-induced inhibition of complex I of the mitochondrial respiratory chain.","10949539","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C798,D798)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L798,M798)","v":"Parkinson Disease, Secondary"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N798,N798)","v":"DTXSID8041826"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J798,J798)","v":"10841892"},"Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats.","10841892","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C799,D799)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L799,M799)","v":"Parkinsonian Disorders"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N799,N799)","v":"DTXSID8041826"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J799,J799)","v":"26003862"},"A quantitative approach to developing Parkinsonian monkeys (Macaca fascicularis) with intracerebroventricular 1-methyl-4-phenylpyridinium injections.","26003862","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C800,D800)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L800,M800)","v":"Parkinsonian Disorders"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N800,N800)","v":"DTXSID8041826"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J800,J800)","v":"17018646"},"Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation.","17018646","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C801,D801)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L801,M801)","v":"Parkinsonian Disorders"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N801,N801)","v":"DTXSID8041826"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J801,J801)","v":"25193392"},"Effects of the Parkinsonian toxin MPP+ on electrophysiological properties of nigral dopaminergic neurons.","25193392","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C802,D802)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L802,M802)","v":"Parkinsonian Disorders"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N802,N802)","v":"DTXSID8041826"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J802,J802)","v":"10969076"},"The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity.","10969076","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C803,D803)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L803,M803)","v":"Parkinsonian Disorders"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N803,N803)","v":"DTXSID8041826"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J803,J803)","v":"14565778"},"The parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) mediates release of l-3,4-dihydroxyphenylalanine (l-DOPA) and inhibition of l-DOPA decarboxylase in the rat striatum: a microdialysis study.","14565778","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C804,D804)","v":"1-Methyl-4-phenylpyridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L804,M804)","v":"Parkinsonian Disorders"},"D015655","1-Methyl-4-phenylpyridinium","39794-99-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N804,N804)","v":"DTXSID8041826"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J804,J804)","v":"12128007"},"Estradiol protects dopaminergic neurons in a MPP+Parkinson's disease model.","12128007","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8041826"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C805,D805)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L805,M805)","v":"Anisocoria"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N805,N805)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J805,J805)","v":"7819940"},"Anisocoria associated with selective serotonin reuptake inhibitors.","7819940","Neurologic Manifestations","D015875","Anisocoria","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C806,D806)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L806,M806)","v":"Basal Ganglia Diseases"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N806,N806)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J806,J806)","v":"8766773"},"[Extrapyramidal disorders following sertraline use; experiences with a new selective antidepressant].","8766773","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C807,D807)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L807,M807)","v":"Basal Ganglia Diseases"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N807,N807)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J807,J807)","v":"8296906"},"Sertraline and extrapyramidal side effects.","8296906","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C808,D808)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L808,M808)","v":"Basal Ganglia Diseases"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N808,N808)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J808,J808)","v":"9010129"},"Mandibular dystonia associated with the combination of sertraline and metoclopramide.","9010129","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C809,D809)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L809,M809)","v":"Brain Diseases"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N809,N809)","v":"DTXSID7020920"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J809,J809)","v":"9048728"},"Triphasic waves in serotonin syndrome.","9048728","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C810,D810)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L810,M810)","v":"Central Nervous System Diseases"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N810,N810)","v":"DTXSID7020920"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J810,J810)","v":"7476638"},"Serotonin syndrome--a potentially fatal complication of antidepressant therapy.","7476638","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C811,D811)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L811,M811)","v":"Coma"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N811,N811)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J811,J811)","v":"8198316"},"Sertraline intoxication in a child.","8198316","Neurologic Manifestations","D003128","Coma","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C812,D812)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L812,M812)","v":"Delirium"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N812,N812)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J812,J812)","v":"8659626"},"Delirium associated with a combination of sertraline, haloperidol, and benztropine.","8659626","Neurologic Manifestations","D003693","Delirium","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C813,D813)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L813,M813)","v":"Dysarthria"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N813,N813)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J813,J813)","v":"7884029"},"Sertraline and speech blockage.","7884029","Neurologic Manifestations","D004401","Dysarthria","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C814,D814)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L814,M814)","v":"Dystonia"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N814,N814)","v":"DTXSID7020920"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J814,J814)","v":"7874680"},"An alert to extrapyramidal side-effects from SSRIs.","7874680","Neurologic Manifestations","D004421","Dystonia","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C815,D815)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L815,M815)","v":"Dystonia"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N815,N815)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J815,J815)","v":"8296906"},"Sertraline and extrapyramidal side effects.","8296906","Neurologic Manifestations","D004421","Dystonia","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C816,D816)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L816,M816)","v":"Dystonia"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N816,N816)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J816,J816)","v":"9010129"},"Mandibular dystonia associated with the combination of sertraline and metoclopramide.","9010129","Neurologic Manifestations","D004421","Dystonia","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C817,D817)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L817,M817)","v":"Dystonia"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N817,N817)","v":"DTXSID7020920"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J817,J817)","v":"9004068"},"Dystonia associated with trazodone and sertraline.","9004068","Neurologic Manifestations","D004421","Dystonia","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C818,D818)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L818,M818)","v":"Hallucinations"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N818,N818)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J818,J818)","v":"8198316"},"Sertraline intoxication in a child.","8198316","Neurologic Manifestations","D006212","Hallucinations","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C819,D819)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L819,M819)","v":"Hallucinations"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N819,N819)","v":"DTXSID7020920"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J819,J819)","v":"9048728"},"Triphasic waves in serotonin syndrome.","9048728","Neurologic Manifestations","D006212","Hallucinations","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C820,D820)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L820,M820)","v":"Hyperkinesis"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N820,N820)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J820,J820)","v":"9231321"},"Sertraline-induced behavioral activation during the treatment of an adolescent with major depression.","9231321","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C821,D821)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L821,M821)","v":"Hypotension, Orthostatic"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N821,N821)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J821,J821)","v":"8840377"},"Orthostatic hypotension induced by sertraline withdrawal.","8840377","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C822,D822)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L822,M822)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N822,N822)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J822,J822)","v":"8166325"},"Association of transient SIADH with sertraline.","8166325","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C823,D823)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L823,M823)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N823,N823)","v":"DTXSID7020920"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J823,J823)","v":"8379571"},"Hyponatremia in a patient treated with sertraline.","8379571","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C824,D824)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L824,M824)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N824,N824)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J824,J824)","v":"7814351"},"Sertraline as the cause of inappropriate antidiuretic hormone secretion.","7814351","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C825,D825)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L825,M825)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N825,N825)","v":"DTXSID7020920"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J825,J825)","v":"7726326"},"SIADH associated with fluoxetine and sertraline therapy.","7726326","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C826,D826)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L826,M826)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N826,N826)","v":"DTXSID7020920"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J826,J826)","v":"7726325"},"SIADH associated with sertraline therapy.","7726325","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C827,D827)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L827,M827)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N827,N827)","v":"DTXSID7020920"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J827,J827)","v":"7574211"},"SIADH in a patient receiving sertraline.","7574211","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C828,D828)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L828,M828)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N828,N828)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J828,J828)","v":"8649298"},"Selective serotonin reuptake inhibitors and SIADH. Adverse Drug Reactions Advisory Committee.","8649298","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C829,D829)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L829,M829)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N829,N829)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J829,J829)","v":"8676965"},"Sertraline and hyponatremia.","8676965","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C830,D830)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L830,M830)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N830,N830)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J830,J830)","v":"8615425"},"Seizure and transient SIADH associated with sertraline.","8615425","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C831,D831)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L831,M831)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N831,N831)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J831,J831)","v":"8826582"},"SIADH--compulsive drinking or SSRI influence?","8826582","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C832,D832)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L832,M832)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N832,N832)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J832,J832)","v":"8840376"},"Sertraline-associated syndrome of inappropriate antidiuretic hormone: case report and review of the literature.","8840376","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C833,D833)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L833,M833)","v":"Inappropriate ADH Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N833,N833)","v":"DTXSID7020920"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J833,J833)","v":"9090354"},"Recurrent hyponatremia associated with sertraline and lofepramine.","9090354","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C834,D834)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L834,M834)","v":"Myoclonus"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N834,N834)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J834,J834)","v":"8010436"},"The serotonin syndrome in a patient receiving sertraline after an ankle block.","8010436","Neurologic Manifestations","D009207","Myoclonus","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C835,D835)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L835,M835)","v":"Myoclonus"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N835,N835)","v":"DTXSID7020920"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J835,J835)","v":"9048728"},"Triphasic waves in serotonin syndrome.","9048728","Neurologic Manifestations","D009207","Myoclonus","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C836,D836)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L836,M836)","v":"Nervous System Diseases"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N836,N836)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J836,J836)","v":"8195456"},"Sertraline and isocarboxazid cause a serotonin syndrome.","8195456","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C837,D837)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L837,M837)","v":"Nervous System Diseases"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N837,N837)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J837,J837)","v":"8968471"},"Comment: Serotonin syndrome associated with combined sertraline-amitriptyline treatment.","8968471","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C838,D838)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L838,M838)","v":"Neuromuscular Diseases"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N838,N838)","v":"DTXSID7020920"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J838,J838)","v":"7782491"},"Response to \"Sertraline and isocarboxazid cause a serotonin syndrome\".","7782491","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C839,D839)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L839,M839)","v":"Paresthesia"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N839,N839)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J839,J839)","v":"8626355"},"Fluoxetine associated paresthesias and alopecia in a woman who tolerated sertraline.","8626355","Neurologic Manifestations","D010292","Paresthesia","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C840,D840)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L840,M840)","v":"Parkinson Disease, Secondary"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N840,N840)","v":"DTXSID7020920"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J840,J840)","v":"8558984"},"[Parkinsonism secondary to the use of sertraline].","8558984","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C841,D841)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L841,M841)","v":"Parkinson Disease, Secondary"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N841,N841)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J841,J841)","v":"8659626"},"Delirium associated with a combination of sertraline, haloperidol, and benztropine.","8659626","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C842,D842)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L842,M842)","v":"Parkinson Disease, Secondary"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N842,N842)","v":"DTXSID7020920"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J842,J842)","v":"9228898"},"Reversible parkinsonism in a 90-year-old man taking sertraline.","9228898","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C843,D843)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L843,M843)","v":"Parkinson Disease, Secondary"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N843,N843)","v":"DTXSID7020920"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J843,J843)","v":"9660102"},"Sertraline induced parkinsonism. A case report and an in-vivo study of the effect of sertraline on dopamine metabolism.","9660102","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C844,D844)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L844,M844)","v":"Restless Legs Syndrome"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N844,N844)","v":"DTXSID7020920"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J844,J844)","v":"9584547"},"Restless leg syndrome exacerbated by sertraline.","9584547","Sleep Wake Disorders","D012148","Restless Legs Syndrome","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C845,D845)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L845,M845)","v":"Seizures"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N845,N845)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J845,J845)","v":"8615425"},"Seizure and transient SIADH associated with sertraline.","8615425","Neurologic Manifestations","D012640","Seizures","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C846,D846)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L846,M846)","v":"Seizures"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N846,N846)","v":"DTXSID7020920"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J846,J846)","v":"9256580"},"Medication-induced seizures.","9256580","Neurologic Manifestations","D012640","Seizures","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C847,D847)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L847,M847)","v":"Sensation Disorders"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N847,N847)","v":"DTXSID7020920"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J847,J847)","v":"7726327"},"Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.","7726327","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C848,D848)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L848,M848)","v":"Sleep Initiation and Maintenance Disorders"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N848,N848)","v":"DTXSID7020920"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J848,J848)","v":"9547132"},"A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.","9547132","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C849,D849)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L849,M849)","v":"Sleep Initiation and Maintenance Disorders"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N849,N849)","v":"DTXSID7020920"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J849,J849)","v":"9448656"},"Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.","9448656","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C850,D850)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L850,M850)","v":"Stuttering"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N850,N850)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J850,J850)","v":"8591976"},"Stuttering with sertraline.","8591976","Neurologic Manifestations","D013342","Stuttering","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C851,D851)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L851,M851)","v":"Stuttering"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N851,N851)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J851,J851)","v":"8071298"},"Sertraline-induced stuttering.","8071298","Neurologic Manifestations","D013342","Stuttering","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C852,D852)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L852,M852)","v":"Stuttering"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N852,N852)","v":"DTXSID7020920"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J852,J852)","v":"8834434"},"A case of sertraline-induced stuttering.","8834434","Neurologic Manifestations","D013342","Stuttering","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C853,D853)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L853,M853)","v":"Tinnitus"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N853,N853)","v":"DTXSID7020920"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J853,J853)","v":"8555382"},"Discontinuation reactions following sertraline.","8555382","Neurologic Manifestations","D014012","Tinnitus","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C854,D854)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L854,M854)","v":"Tremor"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N854,N854)","v":"DTXSID7020920"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J854,J854)","v":"8198316"},"Sertraline intoxication in a child.","8198316","Neurologic Manifestations","D014202","Tremor","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C855,D855)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L855,M855)","v":"Tremor"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N855,N855)","v":"DTXSID7020920"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J855,J855)","v":"8573661"},"Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.","8573661","Neurologic Manifestations","D014202","Tremor","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C856,D856)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L856,M856)","v":"Tremor"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N856,N856)","v":"DTXSID7020920"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J856,J856)","v":"1640004"},"Sertraline does not alter steady-state concentrations or renal clearance of lithium in healthy volunteers.","1640004","Neurologic Manifestations","D014202","Tremor","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C857,D857)","v":"1-Naphthylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L857,M857)","v":"Vertigo"},"D015057","1-Naphthylamine","134-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N857,N857)","v":"DTXSID7020920"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J857,J857)","v":"8555382"},"Discontinuation reactions following sertraline.","8555382","Neurologic Manifestations","D014717","Vertigo","DTXSID7020920"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C858,D858)","v":"1-pentyl-3-(1-naphthoyl)indole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L858,M858)","v":"Brain Ischemia"},"C552597","1-pentyl-3-(1-naphthoyl)indole","209414-07-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N858,N858)","v":"DTXSID10175117"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J858,J858)","v":"24212392"},"Spice, pot, and stroke.","24212392","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID10175117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C859,D859)","v":"1-pentyl-3-(1-naphthoyl)indole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L859,M859)","v":"Brain Ischemia"},"C552597","1-pentyl-3-(1-naphthoyl)indole","209414-07-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N859,N859)","v":"DTXSID10175117"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J859,J859)","v":"24212384"},"Ischemic stroke after use of the synthetic marijuana \"spice\".","24212384","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID10175117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C860,D860)","v":"1-pentyl-3-(1-naphthoyl)indole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L860,M860)","v":"Catalepsy"},"C552597","1-pentyl-3-(1-naphthoyl)indole","209414-07-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N860,N860)","v":"DTXSID10175117"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J860,J860)","v":"25769232"},"Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.","25769232","Neurologic Manifestations","D002375","Catalepsy","DTXSID10175117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C861,D861)","v":"1-pentyl-3-(1-naphthoyl)indole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L861,M861)","v":"Epilepsy, Tonic-Clonic"},"C552597","1-pentyl-3-(1-naphthoyl)indole","209414-07-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N861,N861)","v":"DTXSID10175117"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J861,J861)","v":"22824736"},"Internet highs--seizures after consumption of synthetic cannabinoids purchased online.","22824736","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID10175117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C862,D862)","v":"1-pentyl-3-(1-naphthoyl)indole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L862,M862)","v":"Seizures"},"C552597","1-pentyl-3-(1-naphthoyl)indole","209414-07-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N862,N862)","v":"DTXSID10175117"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J862,J862)","v":"25769232"},"Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.","25769232","Neurologic Manifestations","D012640","Seizures","DTXSID10175117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C863,D863)","v":"1-pentyl-3-(1-naphthoyl)indole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L863,M863)","v":"Seizures"},"C552597","1-pentyl-3-(1-naphthoyl)indole","209414-07-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N863,N863)","v":"DTXSID10175117"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J863,J863)","v":"27753006"},"Tripping with Synthetic Cannabinoids (\"Spice\"): Anecdotal and Experimental Observations in Animals and Man.","27753006","Neurologic Manifestations","D012640","Seizures","DTXSID10175117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C864,D864)","v":"1-pentyl-3-(1-naphthoyl)indole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L864,M864)","v":"Seizures"},"C552597","1-pentyl-3-(1-naphthoyl)indole","209414-07-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N864,N864)","v":"DTXSID10175117"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J864,J864)","v":"22627260"},"Spicy seizure.","22627260","Neurologic Manifestations","D012640","Seizures","DTXSID10175117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C865,D865)","v":"1-pentyl-3-(1-naphthoyl)indole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L865,M865)","v":"Seizures"},"C552597","1-pentyl-3-(1-naphthoyl)indole","209414-07-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N865,N865)","v":"DTXSID10175117"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J865,J865)","v":"21970775"},"Severe toxicity following synthetic cannabinoid ingestion.","21970775","Neurologic Manifestations","D012640","Seizures","DTXSID10175117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C866,D866)","v":"1-pentyl-3-(1-naphthoyl)indole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L866,M866)","v":"Stroke"},"C552597","1-pentyl-3-(1-naphthoyl)indole","209414-07-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N866,N866)","v":"DTXSID10175117"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J866,J866)","v":"24212392"},"Spice, pot, and stroke.","24212392","Central Nervous System Diseases","D020521","Stroke","DTXSID10175117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C867,D867)","v":"1-pentyl-3-(1-naphthoyl)indole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L867,M867)","v":"Stroke"},"C552597","1-pentyl-3-(1-naphthoyl)indole","209414-07-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N867,N867)","v":"DTXSID10175117"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J867,J867)","v":"24212384"},"Ischemic stroke after use of the synthetic marijuana \"spice\".","24212384","Central Nervous System Diseases","D020521","Stroke","DTXSID10175117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C868,D868)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L868,M868)","v":"Blindness"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N868,N868)","v":"DTXSID2021739"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J868,J868)","v":"2870460"},"The alcohols: ethanol, methanol, isopropanol, ethylene glycol.","2870460","Neurologic Manifestations","D001766","Blindness","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C869,D869)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L869,M869)","v":"Brain Diseases"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N869,N869)","v":"DTXSID2021739"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J869,J869)","v":"4169788"},"Encephalopathy and visceral fatty infiltration of probable toxic aetiology.","4169788","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C870,D870)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L870,M870)","v":"Brain Diseases"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N870,N870)","v":"DTXSID2021739"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J870,J870)","v":"2178594"},"Isopropyl alcohol intoxication.","2178594","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C871,D871)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L871,M871)","v":"Coma"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N871,N871)","v":"DTXSID2021739"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J871,J871)","v":"3930536"},"Isopropanol intoxication: managing the coma.","3930536","Neurologic Manifestations","D003128","Coma","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C872,D872)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L872,M872)","v":"Coma"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N872,N872)","v":"DTXSID2021739"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J872,J872)","v":"4064721"},"Diagnostic clinical osmometry in the unconscious infant.","4064721","Neurologic Manifestations","D003128","Coma","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C873,D873)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L873,M873)","v":"Coma"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N873,N873)","v":"DTXSID2021739"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J873,J873)","v":"3812394"},"Coma following use of rubbing alcohol for fever control.","3812394","Neurologic Manifestations","D003128","Coma","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C874,D874)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L874,M874)","v":"Coma"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N874,N874)","v":"DTXSID2021739"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J874,J874)","v":"2712894"},"Isopropanol ingestion: case report with pharmacokinetic analysis.","2712894","Neurologic Manifestations","D003128","Coma","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C875,D875)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L875,M875)","v":"Coma"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N875,N875)","v":"DTXSID2021739"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J875,J875)","v":"5696096"},"Suicide attempted by rectal administration of drug.","5696096","Neurologic Manifestations","D003128","Coma","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C876,D876)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L876,M876)","v":"Coma"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N876,N876)","v":"DTXSID2021739"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J876,J876)","v":"5777081"},"Coma produced by topical application of isopropanol.","5777081","Neurologic Manifestations","D003128","Coma","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C877,D877)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L877,M877)","v":"Coma"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N877,N877)","v":"DTXSID2021739"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J877,J877)","v":"2178594"},"Isopropyl alcohol intoxication.","2178594","Neurologic Manifestations","D003128","Coma","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C878,D878)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L878,M878)","v":"Eye Burns"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N878,N878)","v":"DTXSID2021739"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J878,J878)","v":"1477882"},"Tonometer-induced corneal injury: a report of two cases.","1477882","Trauma, Nervous System","D005126","Eye Burns","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C879,D879)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L879,M879)","v":"Muscle Hypotonia"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N879,N879)","v":"DTXSID2021739"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J879,J879)","v":"8346086"},"Two-week-old infant with isopropanol intoxication.","8346086","Neurologic Manifestations","D009123","Muscle Hypotonia","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C880,D880)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L880,M880)","v":"Muscular Diseases"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N880,N880)","v":"DTXSID2021739"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J880,J880)","v":"5694722"},"Isopropyl alcohol intoxication. Report of a case associated with myopathy renal failure, and hemolytic anemia.","5694722","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C881,D881)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L881,M881)","v":"Nystagmus, Pathologic"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N881,N881)","v":"DTXSID2021739"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J881,J881)","v":"5963137"},"Effect of congeners in alcoholic beverages on the incidence of nystagmus.","5963137","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C882,D882)","v":"1-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L882,M882)","v":"Vision Disorders"},"D000433","1-Propanol","71-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N882,N882)","v":"DTXSID2021739"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J882,J882)","v":"7432265"},"Outbreak of methanol and isopropanol poisoning in New Britain, Papua New Guinea.","7432265","Neurologic Manifestations","D014786","Vision Disorders","DTXSID2021739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C883,D883)","v":"2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L883,M883)","v":"Fasciculation"},"C000516","2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N883,N883)","v":"DTXSID00924111"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J883,J883)","v":"10076534"},"Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.","10076534","Neurologic Manifestations","D005207","Fasciculation","DTXSID00924111"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C884,D884)","v":"2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L884,M884)","v":"Nervous System Diseases"},"C000516","2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N884,N884)","v":"DTXSID00924111"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J884,J884)","v":"2593176"},"Effect of beta-naphthoflavone on o-tolyl saligenin phosphate-induced delayed neuropathy in two lines of chickens.","2593176","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID00924111"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C885,D885)","v":"2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L885,M885)","v":"Nervous System Diseases"},"C000516","2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N885,N885)","v":"DTXSID00924111"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J885,J885)","v":"1994513"},"Murine susceptibility to organophosphorus-induced delayed neuropathy (OPIDN).","1994513","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID00924111"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C886,D886)","v":"2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L886,M886)","v":"Peripheral Nervous System Diseases"},"C000516","2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N886,N886)","v":"DTXSID00924111"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J886,J886)","v":"21438623"},"Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.","21438623","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID00924111"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C887,D887)","v":"2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L887,M887)","v":"Seizures"},"C000516","2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N887,N887)","v":"DTXSID00924111"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J887,J887)","v":"10076534"},"Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.","10076534","Neurologic Manifestations","D012640","Seizures","DTXSID00924111"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C888,D888)","v":"2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L888,M888)","v":"Tremor"},"C000516","2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N888,N888)","v":"DTXSID00924111"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J888,J888)","v":"10076534"},"Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.","10076534","Neurologic Manifestations","D014202","Tremor","DTXSID00924111"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C889,D889)","v":"2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L889,M889)","v":"Cerebellar Ataxia"},"C569113","2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N889,N889)","v":"DTXSID301009327"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J889,J889)","v":"22578175"},"Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation.","22578175","Central Nervous System Diseases","D002524","Cerebellar Ataxia","DTXSID301009327"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C890,D890)","v":"2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L890,M890)","v":"Confusion"},"C569113","2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N890,N890)","v":"DTXSID301009327"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J890,J890)","v":"22237166"},"Ketamine-like effects after recreational use of methoxetamine.","22237166","Neurologic Manifestations","D003221","Confusion","DTXSID301009327"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C891,D891)","v":"2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L891,M891)","v":"Consciousness Disorders"},"C569113","2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N891,N891)","v":"DTXSID301009327"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J891,J891)","v":"22578175"},"Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation.","22578175","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID301009327"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C892,D892)","v":"2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L892,M892)","v":"Nystagmus, Pathologic"},"C569113","2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N892,N892)","v":"DTXSID301009327"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J892,J892)","v":"22237166"},"Ketamine-like effects after recreational use of methoxetamine.","22237166","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID301009327"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C893,D893)","v":"2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L893,M893)","v":"Seizures"},"C569113","2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N893,N893)","v":"DTXSID301009327"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J893,J893)","v":"25817453"},"[Methoxetamine-associated emergencies. First Spanish descriptions of this new drug].","25817453","Neurologic Manifestations","D012640","Seizures","DTXSID301009327"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C894,D894)","v":"2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L894,M894)","v":"Seizures"},"C569113","2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N894,N894)","v":"DTXSID301009327"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J894,J894)","v":"24904014"},"Analytical findings of an acute intoxication after inhalation of methoxetamine.","24904014","Neurologic Manifestations","D012640","Seizures","DTXSID301009327"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C895,D895)","v":"2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L895,M895)","v":"Seizures"},"C569113","2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N895,N895)","v":"DTXSID301009327"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J895,J895)","v":"25060403"},"Acute methoxetamine and amphetamine poisoning with fatal outcome: a case report.","25060403","Neurologic Manifestations","D012640","Seizures","DTXSID301009327"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C896,D896)","v":"2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L896,M896)","v":"Speech Disorders"},"C569113","2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N896,N896)","v":"DTXSID301009327"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J896,J896)","v":"22578175"},"Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation.","22578175","Neurologic Manifestations","D013064","Speech Disorders","DTXSID301009327"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C897,D897)","v":"2,4,5-Trichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L897,M897)","v":"Cerebrovascular Disorders"},"D015085","2,4,5-Trichlorophenoxyacetic Acid","93-76-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N897,N897)","v":"DTXSID5021388"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J897,J897)","v":"2904874"},"Comparative study on cerebrovascular injuries by three chlorophenoxyacetic acids (2,4-D, 2,4,5-T and MCPA).","2904874","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID5021388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C898,D898)","v":"2,4,5-Trichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L898,M898)","v":"Nervous System Diseases"},"D015085","2,4,5-Trichlorophenoxyacetic Acid","93-76-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N898,N898)","v":"DTXSID5021388"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J898,J898)","v":"6957189"},"Neuropsychiatric effects of herbicides.","6957189","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5021388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C899,D899)","v":"2,4,5-Trichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L899,M899)","v":"Nervous System Diseases"},"D015085","2,4,5-Trichlorophenoxyacetic Acid","93-76-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N899,N899)","v":"DTXSID5021388"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J899,J899)","v":"8190278"},"Neurologic health outcomes and Agent Orange: Institute of Medicine report.","8190278","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5021388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C900,D900)","v":"2,4,5-Trichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L900,M900)","v":"Neuromuscular Diseases"},"D015085","2,4,5-Trichlorophenoxyacetic Acid","93-76-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N900,N900)","v":"DTXSID5021388"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J900,J900)","v":"2593947"},"The boring story of Agent Orange already is outdated.","2593947","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID5021388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C901,D901)","v":"2,4,5-Trichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L901,M901)","v":"Peripheral Nervous System Diseases"},"D015085","2,4,5-Trichlorophenoxyacetic Acid","93-76-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N901,N901)","v":"DTXSID5021388"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J901,J901)","v":"8190278"},"Neurologic health outcomes and Agent Orange: Institute of Medicine report.","8190278","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5021388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C902,D902)","v":"2,4,5-Trichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L902,M902)","v":"Peripheral Nervous System Diseases"},"D015085","2,4,5-Trichlorophenoxyacetic Acid","93-76-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N902,N902)","v":"DTXSID5021388"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J902,J902)","v":"2983263"},"An agent orange: case history.","2983263","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5021388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C903,D903)","v":"2,4,5-Trichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L903,M903)","v":"Radiculopathy"},"D015085","2,4,5-Trichlorophenoxyacetic Acid","93-76-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N903,N903)","v":"DTXSID5021388"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J903,J903)","v":"12916744"},"Impact of Agent Orange exposure among Korean Vietnam veterans.","12916744","Neuromuscular Diseases","D011843","Radiculopathy","DTXSID5021388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C904,D904)","v":"2,4,5-Trichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L904,M904)","v":"Spinal Dysraphism"},"D015085","2,4,5-Trichlorophenoxyacetic Acid","93-76-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N904,N904)","v":"DTXSID5021388"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J904,J904)","v":"19894129"},"Paternal exposure to Agent Orange and spina bifida: a meta-analysis.","19894129","Nervous System Malformations","D016135","Spinal Dysraphism","DTXSID5021388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C905,D905)","v":"2,4,5-Trichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L905,M905)","v":"Spinal Dysraphism"},"D015085","2,4,5-Trichlorophenoxyacetic Acid","93-76-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N905,N905)","v":"DTXSID5021388"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J905,J905)","v":"21275190"},"Herbicide exposure and veterans with covered service in Korea. Final rule.","21275190","Nervous System Malformations","D016135","Spinal Dysraphism","DTXSID5021388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C906,D906)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L906,M906)","v":"Amyotrophic Lateral Sclerosis"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N906,N906)","v":"DTXSID2058336"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J906,J906)","v":"11529236"},"Amyotrophic lateral sclerosis and occupational exposure to 2,4-dichlorophenoxyacetic acid.","11529236","Central Nervous System Diseases","D000690","Amyotrophic Lateral Sclerosis","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C907,D907)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L907,M907)","v":"Ataxia"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N907,N907)","v":"DTXSID2058336"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J907,J907)","v":"3352573"},"2,4-D-n-butyl ester (2,4-D ester) induced ataxia in rats: role for n-butanol formation.","3352573","Neurologic Manifestations","D001259","Ataxia","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C908,D908)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L908,M908)","v":"Ataxia"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N908,N908)","v":"DTXSID2058336"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J908,J908)","v":"11222879"},"Developmental toxicity studies in rats and rabbits on 2,4-dichlorophenoxyacetic acid and its forms.","11222879","Neurologic Manifestations","D001259","Ataxia","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C909,D909)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L909,M909)","v":"Brain Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N909,N909)","v":"DTXSID2058336"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J909,J909)","v":"700421"},"[Case of acute 2,4-D herbicide poisoning (late sequelae)].","700421","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C910,D910)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L910,M910)","v":"Brain Neoplasms"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N910,N910)","v":"DTXSID2058336"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J910,J910)","v":"3342201"},"Cause specific mortality among employees engaged in the manufacture, formulation, or packaging of 2,4-dichlorophenoxyacetic acid and related salts.","3342201","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C911,D911)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L911,M911)","v":"Central Nervous System Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N911,N911)","v":"DTXSID2058336"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J911,J911)","v":"538756"},"Distribution of 2-methyl-4-chlorophenoxyacetic acid and 2,4-dichlorophenoxyacetic acid in male rats: evidence for the involvement of the central nervous system in their toxicity.","538756","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C912,D912)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L912,M912)","v":"Cerebrovascular Disorders"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N912,N912)","v":"DTXSID2058336"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J912,J912)","v":"2904874"},"Comparative study on cerebrovascular injuries by three chlorophenoxyacetic acids (2,4-D, 2,4,5-T and MCPA).","2904874","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C913,D913)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L913,M913)","v":"Coma"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N913,N913)","v":"DTXSID2058336"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J913,J913)","v":"3223824"},"[2,4-dichlorophenoxyacetic acid poisoning with a coma state in an elderly patient].","3223824","Neurologic Manifestations","D003128","Coma","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C914,D914)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L914,M914)","v":"Demyelinating Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N914,N914)","v":"DTXSID2058336"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J914,J914)","v":"18460445"},"Neonatal hypomyelination by the herbicide 2,4-dichlorophenoxyacetic acid. Chemical and ultrastructural studies in rats.","18460445","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C915,D915)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L915,M915)","v":"Intellectual Disability"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N915,N915)","v":"DTXSID2058336"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J915,J915)","v":"6694032"},"Severe mental retardation and multiple congenital anomalies of uncertain cause after extreme parental exposure to 2,4-D.","6694032","Neurologic Manifestations","D008607","Intellectual Disability","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C916,D916)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L916,M916)","v":"Myotonia"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N916,N916)","v":"DTXSID2058336"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J916,J916)","v":"6277592"},"[The influence of several membrane stabilizing drugs on the induced hereditary myotonia--a methodic way to test the effectiveness of drugs on myotonia (author's transl)].","6277592","Neurologic Manifestations","D009222","Myotonia","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C917,D917)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L917,M917)","v":"Myotonia"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N917,N917)","v":"DTXSID2058336"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J917,J917)","v":"1746132"},"2,4-D toxicosis. I: A pilot study of 2,4-dichlorophenoxyacetic acid- and dicamba-induced myotonia in experimental dogs.","1746132","Neurologic Manifestations","D009222","Myotonia","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C918,D918)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L918,M918)","v":"Myotonia"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N918,N918)","v":"DTXSID2058336"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J918,J918)","v":"20045836"},"Confirmed 2,4-dichlorophenoxyacetic acid toxicosis in a dog.","20045836","Neurologic Manifestations","D009222","Myotonia","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C919,D919)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L919,M919)","v":"Myotonia"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N919,N919)","v":"DTXSID2058336"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J919,J919)","v":"11192461"},"Clinical effects and plasma concentration determination after 2,4-dichlorophenoxyacetic acid 200 mg/kg administration in the dog.","11192461","Neurologic Manifestations","D009222","Myotonia","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C920,D920)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L920,M920)","v":"Nervous System Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N920,N920)","v":"DTXSID2058336"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J920,J920)","v":"6957189"},"Neuropsychiatric effects of herbicides.","6957189","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C921,D921)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L921,M921)","v":"Nervous System Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N921,N921)","v":"DTXSID2058336"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J921,J921)","v":"8190278"},"Neurologic health outcomes and Agent Orange: Institute of Medicine report.","8190278","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C922,D922)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L922,M922)","v":"Nervous System Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N922,N922)","v":"DTXSID2058336"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J922,J922)","v":"8479604"},"Neurotoxicity of 2,4-dichlorophenoxyacetic butyl ester in chick embryos.","8479604","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C923,D923)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L923,M923)","v":"Nervous System Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N923,N923)","v":"DTXSID2058336"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J923,J923)","v":"9398493"},"Single-dose and chronic dietary neurotoxicity screening studies on 2,4-dichlorophenoxyacetic acid in rats.","9398493","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C924,D924)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L924,M924)","v":"Nervous System Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N924,N924)","v":"DTXSID2058336"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J924,J924)","v":"3371581"},"Neurobehavioral toxicity and tolerance to the herbicide 2,4-dichlorophenoxyacetic acid-n-butyl ester (2,4-D ester).","3371581","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C925,D925)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L925,M925)","v":"Nervous System Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N925,N925)","v":"DTXSID2058336"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J925,J925)","v":"12184504"},"Review of 2,4-dichlorophenoxyacetic acid (2,4-D) epidemiology and toxicology.","12184504","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C926,D926)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L926,M926)","v":"Neuromuscular Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N926,N926)","v":"DTXSID2058336"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J926,J926)","v":"2593947"},"The boring story of Agent Orange already is outdated.","2593947","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C927,D927)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L927,M927)","v":"Neuromuscular Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N927,N927)","v":"DTXSID2058336"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J927,J927)","v":"3585404"},"Neuromuscular effects of acute 2,4-dichlorophenoxyacetic acid (2,4-D) exposure in dogs.","3585404","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C928,D928)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L928,M928)","v":"Neuromuscular Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N928,N928)","v":"DTXSID2058336"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J928,J928)","v":"2158793"},"The improbable association between the herbicide 2,4-D and polyneuropathy.","2158793","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C929,D929)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L929,M929)","v":"Peripheral Nervous System Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N929,N929)","v":"DTXSID2058336"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J929,J929)","v":"8190278"},"Neurologic health outcomes and Agent Orange: Institute of Medicine report.","8190278","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C930,D930)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L930,M930)","v":"Peripheral Nervous System Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N930,N930)","v":"DTXSID2058336"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J930,J930)","v":"2983263"},"An agent orange: case history.","2983263","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C931,D931)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L931,M931)","v":"Peripheral Nervous System Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N931,N931)","v":"DTXSID2058336"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J931,J931)","v":"2997403"},"2,4-Dichlorophenoxyacetic acid (2,4-D) does not cause polyneuropathy in the rat.","2997403","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C932,D932)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L932,M932)","v":"Peripheral Nervous System Diseases"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N932,N932)","v":"DTXSID2058336"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J932,J932)","v":"2158793"},"The improbable association between the herbicide 2,4-D and polyneuropathy.","2158793","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C933,D933)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L933,M933)","v":"Radiculopathy"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N933,N933)","v":"DTXSID2058336"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J933,J933)","v":"12916744"},"Impact of Agent Orange exposure among Korean Vietnam veterans.","12916744","Neuromuscular Diseases","D011843","Radiculopathy","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C934,D934)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L934,M934)","v":"Spinal Dysraphism"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N934,N934)","v":"DTXSID2058336"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J934,J934)","v":"19894129"},"Paternal exposure to Agent Orange and spina bifida: a meta-analysis.","19894129","Nervous System Malformations","D016135","Spinal Dysraphism","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C935,D935)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L935,M935)","v":"Spinal Dysraphism"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N935,N935)","v":"DTXSID2058336"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J935,J935)","v":"21275190"},"Herbicide exposure and veterans with covered service in Korea. Final rule.","21275190","Nervous System Malformations","D016135","Spinal Dysraphism","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C936,D936)","v":"2,4-Dichlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L936,M936)","v":"Vertigo"},"D015084","2,4-Dichlorophenoxyacetic Acid","2307-55-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N936,N936)","v":"DTXSID2058336"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J936,J936)","v":"642801"},"[2,4-D poisoning].","642801","Neurologic Manifestations","D014717","Vertigo","DTXSID2058336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C937,D937)","v":"2,4-Dinitrophenol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L937,M937)","v":"Muscular Diseases"},"D019297","2,4-Dinitrophenol","51-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N937,N937)","v":"DTXSID0020523"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J937,J937)","v":"1913585"},"Scanning electron microscopic observations on muscle cells of experimental mitochondrial myopathy produced by 2, 4-dinitrophenol.","1913585","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID0020523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C938,D938)","v":"2,4-Dinitrophenol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L938,M938)","v":"Peripheral Nervous System Diseases"},"D019297","2,4-Dinitrophenol","51-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N938,N938)","v":"DTXSID0020523"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J938,J938)","v":"28966228"},"Sensory axonal polyneuropathy due to 2,4-dinitrophenol.","28966228","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0020523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C939,D939)","v":"2,4-Dinitrophenol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L939,M939)","v":"Peripheral Nervous System Diseases"},"D019297","2,4-Dinitrophenol","51-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N939,N939)","v":"DTXSID0020523"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J939,J939)","v":"23365059"},"Peripheral neuropathy due to dinitrophenol used for weight loss: something old, something new.","23365059","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0020523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C940,D940)","v":"2,4-Dinitrophenol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L940,M940)","v":"Polyneuropathies"},"D019297","2,4-Dinitrophenol","51-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N940,N940)","v":"DTXSID0020523"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J940,J940)","v":"28966228"},"Sensory axonal polyneuropathy due to 2,4-dinitrophenol.","28966228","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID0020523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C941,D941)","v":"2,4-Dinitrophenol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L941,M941)","v":"Seizures"},"D019297","2,4-Dinitrophenol","51-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N941,N941)","v":"DTXSID0020523"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J941,J941)","v":"21739343"},"2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death.","21739343","Neurologic Manifestations","D012640","Seizures","DTXSID0020523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C942,D942)","v":"2,4-Dinitrophenol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L942,M942)","v":"Somatosensory Disorders"},"D019297","2,4-Dinitrophenol","51-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N942,N942)","v":"DTXSID0020523"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J942,J942)","v":"28966228"},"Sensory axonal polyneuropathy due to 2,4-dinitrophenol.","28966228","Neurologic Manifestations","D020886","Somatosensory Disorders","DTXSID0020523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C943,D943)","v":"2,4-dithiobiuret"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L943,M943)","v":"Muscle Weakness"},"C007540","2,4-dithiobiuret","541-53-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N943,N943)","v":"DTXSID2034968"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J943,J943)","v":"15081273"},"Morphometric characterization of the neuromuscular junction of rodents intoxicated with 2,4-dithiobiuret: evidence that nerve terminal recycling processes contribute to muscle weakness.","15081273","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID2034968"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C944,D944)","v":"2,4-dithiobiuret"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L944,M944)","v":"Nervous System Diseases"},"C007540","2,4-dithiobiuret","541-53-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N944,N944)","v":"DTXSID2034968"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J944,J944)","v":"2127981"},"Distal terminal axonopathy produced by 2,4-dithiobiuret: effects of long-term intoxication in rats.","2127981","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2034968"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C945,D945)","v":"2,4-dithiobiuret"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L945,M945)","v":"Neuromuscular Diseases"},"C007540","2,4-dithiobiuret","541-53-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N945,N945)","v":"DTXSID2034968"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J945,J945)","v":"6438566"},"Glucose-dependent lactate production by homogenates of neuronal tissues prepared from rats treated with 2,4-dithiobiuret, acrylamide, p-bromophenylacetylurea and 2,5-hexanedione.","6438566","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID2034968"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C946,D946)","v":"2,4-dithiobiuret"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L946,M946)","v":"Neuromuscular Diseases"},"C007540","2,4-dithiobiuret","541-53-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N946,N946)","v":"DTXSID2034968"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J946,J946)","v":"6440404"},"Effects of dithiobiuret intoxication on motor end plates in sternocostalis and hindlimb muscles of female rats.","6440404","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID2034968"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C947,D947)","v":"2,4-dithiobiuret"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L947,M947)","v":"Neuromuscular Diseases"},"C007540","2,4-dithiobiuret","541-53-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N947,N947)","v":"DTXSID2034968"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J947,J947)","v":"6782707"},"Potential neuromuscular toxicity of 2,4-dithiobiuret in the rat.","6782707","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID2034968"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C948,D948)","v":"2,4-dithiobiuret"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L948,M948)","v":"Neuromuscular Diseases"},"C007540","2,4-dithiobiuret","541-53-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N948,N948)","v":"DTXSID2034968"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J948,J948)","v":"6428932"},"Excretion of porphyrins and porphyrin precursors during neuromuscular paralysis produced by dithiobiuret.","6428932","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID2034968"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C949,D949)","v":"2,4-dithiobiuret"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L949,M949)","v":"Paralysis"},"C007540","2,4-dithiobiuret","541-53-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N949,N949)","v":"DTXSID2034968"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J949,J949)","v":"6428932"},"Excretion of porphyrins and porphyrin precursors during neuromuscular paralysis produced by dithiobiuret.","6428932","Neurologic Manifestations","D010243","Paralysis","DTXSID2034968"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C950,D950)","v":"2,4-dithiobiuret"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L950,M950)","v":"Paralysis"},"C007540","2,4-dithiobiuret","541-53-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N950,N950)","v":"DTXSID2034968"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J950,J950)","v":"9215993"},"Effects of the paralytic agent 2,4-dithiobiuret on viability and morphology of rat pheochromocytoma (PC12) cells.","9215993","Neurologic Manifestations","D010243","Paralysis","DTXSID2034968"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C951,D951)","v":"2,4-dithiobiuret"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L951,M951)","v":"Paralysis"},"C007540","2,4-dithiobiuret","541-53-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N951,N951)","v":"DTXSID2034968"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J951,J951)","v":"2499675"},"Alterations of spontaneous and evoked release of acetylcholine during dithiobiuret-induced neuromuscular weakness.","2499675","Neurologic Manifestations","D010243","Paralysis","DTXSID2034968"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C952,D952)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L952,M952)","v":"Ataxia"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N952,N952)","v":"DTXSID8030138"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J952,J952)","v":"8345530"},"Comparison of toxicities of acrylamide and 2,5-hexanedione in hens and rats on 3-week dosing regimens.","8345530","Neurologic Manifestations","D001259","Ataxia","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C953,D953)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L953,M953)","v":"Ataxia"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N953,N953)","v":"DTXSID8030138"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J953,J953)","v":"4068058"},"Pattern of neurotoxicity of n-hexane, methyl n-butyl ketone, 2,5-hexanediol, and 2,5-hexanedione alone and in combination with O-ethyl O-4-nitrophenyl phenylphosphonothioate in hens.","4068058","Neurologic Manifestations","D001259","Ataxia","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C954,D954)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L954,M954)","v":"Ataxia"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N954,N954)","v":"DTXSID8030138"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J954,J954)","v":"3341029"},"Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat.","3341029","Neurologic Manifestations","D001259","Ataxia","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C955,D955)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L955,M955)","v":"Ataxia"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N955,N955)","v":"DTXSID8030138"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J955,J955)","v":"10356712"},"Neurotoxic effects of 2,5-hexanedione on normal and neurofilament-deficient quail.","10356712","Neurologic Manifestations","D001259","Ataxia","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C956,D956)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L956,M956)","v":"Brain Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N956,N956)","v":"DTXSID8030138"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J956,J956)","v":"10356712"},"Neurotoxic effects of 2,5-hexanedione on normal and neurofilament-deficient quail.","10356712","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C957,D957)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L957,M957)","v":"Brain Edema"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N957,N957)","v":"DTXSID8030138"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J957,J957)","v":"1921920"},"Effects of 2,5-hexanedione alone and in combination with acetone on radial arm maze behavior, the \"brain-swelling\" reaction and synaptosomal functions.","1921920","Central Nervous System Diseases","D001929","Brain Edema","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C958,D958)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L958,M958)","v":"Central Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N958,N958)","v":"DTXSID8030138"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J958,J958)","v":"25218479"},"Toxic neuropathies: Mechanistic insights based on a chemical perspective.","25218479","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C959,D959)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L959,M959)","v":"Gait Disorders, Neurologic"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N959,N959)","v":"DTXSID8030138"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J959,J959)","v":"18582483"},"2,5-hexanedione (HD) treatment alters calmodulin, Ca2+/calmodulin-dependent protein kinase II, and protein kinase C in rats' nerve tissues.","18582483","Neurologic Manifestations","D020233","Gait Disorders, Neurologic","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C960,D960)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L960,M960)","v":"Memory Disorders"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N960,N960)","v":"DTXSID8030138"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J960,J960)","v":"11869822"},"Early spatial memory deficit induced by 2,5-hexanedione in the rat.","11869822","Neurologic Manifestations","D008569","Memory Disorders","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C961,D961)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L961,M961)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N961,N961)","v":"DTXSID8030138"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J961,J961)","v":"7044283"},"Toxicity and metabolism of the neurotoxic hexacarbons n-hexane, 2-hexanone, and 2,5-hexanedione.","7044283","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C962,D962)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L962,M962)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N962,N962)","v":"DTXSID8030138"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J962,J962)","v":"6501003"},"Molecular mechanism of hexane neuropathy: significant differences in pharmacokinetics between 2.3-, 2.4-, and 2.5-hexanedione.","6501003","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C963,D963)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L963,M963)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N963,N963)","v":"DTXSID8030138"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J963,J963)","v":"7192310"},"Ultrastructural studies of the dying-back process. V. Axonal neurofilaments accumulate at sites of 2,5-hexanedione application: evidence for nerve fibre dysfunction in experimental hexacarbon neuropathy.","7192310","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C964,D964)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L964,M964)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N964,N964)","v":"DTXSID8030138"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J964,J964)","v":"6686866"},"Interaction between neurotoxicities induced by organophosphorus and long-chain hexacarbon compounds.","6686866","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C965,D965)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L965,M965)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N965,N965)","v":"DTXSID8030138"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J965,J965)","v":"3806106"},"Uncoupling of cerebral glucose supply and utilization after hexane-2,5-dione intoxication in the rat.","3806106","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C966,D966)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L966,M966)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N966,N966)","v":"DTXSID8030138"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J966,J966)","v":"3937075"},"Covalent crosslinking of neurofilaments in the pathogenesis of n-hexane neuropathy.","3937075","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C967,D967)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L967,M967)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N967,N967)","v":"DTXSID8030138"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J967,J967)","v":"2616066"},"Effects of acrylamide and 2,5-hexanedione on brain mitochondrial respiration.","2616066","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C968,D968)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L968,M968)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N968,N968)","v":"DTXSID8030138"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J968,J968)","v":"2562540"},"Neurofilament protein crosslinking in gamma-diketone neuropathy: in vitro and in vivo studies using the seaworm myxicola infundibulum.","2562540","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C969,D969)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L969,M969)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N969,N969)","v":"DTXSID8030138"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J969,J969)","v":"17447142"},"Time-dependent alteration of cytoskeletal proteins in cerebral cortex of rat during 2,5-hexanedione-induced neuropathy.","17447142","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C970,D970)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L970,M970)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N970,N970)","v":"DTXSID8030138"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J970,J970)","v":"2141734"},"Lack of evidence for the size principle of selective vulnerability of axons in toxic neuropathies. I. The effects of subcutaneous injections of 2,5-hexanedione on behavior and muscle spindle function.","2141734","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C971,D971)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L971,M971)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N971,N971)","v":"DTXSID8030138"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J971,J971)","v":"11275420"},"Interaction of zinc on biomarker responses in rats exposed to 2,5-hexanedione by two routes of exposure.","11275420","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C972,D972)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L972,M972)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N972,N972)","v":"DTXSID8030138"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J972,J972)","v":"12164553"},"Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione.","12164553","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C973,D973)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L973,M973)","v":"Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N973,N973)","v":"DTXSID8030138"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J973,J973)","v":"1455423"},"Effects of 2,5-hexanedione on the ovary and fertility. An experimental study in mice.","1455423","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C974,D974)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L974,M974)","v":"Neurodegenerative Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N974,N974)","v":"DTXSID8030138"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J974,J974)","v":"17492505"},"Expression of Bcl-2, Bax and Caspase-3 in nerve tissues of rats chronically exposed to 2,5-hexanedione.","17492505","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C975,D975)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L975,M975)","v":"Neuromuscular Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N975,N975)","v":"DTXSID8030138"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J975,J975)","v":"6857666"},"Neurotoxicity and protein binding of 2,5-hexanedione in the hen.","6857666","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C976,D976)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L976,M976)","v":"Paralysis"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N976,N976)","v":"DTXSID8030138"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J976,J976)","v":"8685898"},"The effects of 2,5-hexanedione and acrylamide on myosin heavy chain isoforms of slow and fast skeletal muscles of the rat.","8685898","Neurologic Manifestations","D010243","Paralysis","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C977,D977)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L977,M977)","v":"Paralysis"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N977,N977)","v":"DTXSID8030138"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J977,J977)","v":"3824391"},"Hyperbaric oxygen accelerates the neurotoxicity of 2,5-hexanedione.","3824391","Neurologic Manifestations","D010243","Paralysis","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C978,D978)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L978,M978)","v":"Paraplegia"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N978,N978)","v":"DTXSID8030138"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J978,J978)","v":"10356712"},"Neurotoxic effects of 2,5-hexanedione on normal and neurofilament-deficient quail.","10356712","Neurologic Manifestations","D010264","Paraplegia","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C979,D979)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L979,M979)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N979,N979)","v":"DTXSID8030138"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J979,J979)","v":"6252662"},"Inhibition of sciatic nerve sterologenesis in hexacarbon-induced distal axonopathy in the rat.","6252662","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C980,D980)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L980,M980)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N980,N980)","v":"DTXSID8030138"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J980,J980)","v":"6252661"},"Effect of 2,5-Hexanedione on lipid biosynthesis in sciatic nerve and brain of the rat.","6252661","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C981,D981)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L981,M981)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N981,N981)","v":"DTXSID8030138"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J981,J981)","v":"6266077"},"Altered lipid metabolism in 2,5-hexanedione-induced testicular atrophy and peripheral neuropathy in the rat.","6266077","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C982,D982)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L982,M982)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N982,N982)","v":"DTXSID8030138"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J982,J982)","v":"6266076"},"Inhibition of sterologenesis but not glycolysis in 2,5-hexanedione-induced distal axonopathy in the rat.","6266076","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C983,D983)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L983,M983)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N983,N983)","v":"DTXSID8030138"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J983,J983)","v":"6308313"},"[An experimental study on electrophysiological and histopathological changes in 2,5-hexanedione-intoxicated rats].","6308313","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C984,D984)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L984,M984)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N984,N984)","v":"DTXSID8030138"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J984,J984)","v":"7482540"},"Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy.","7482540","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C985,D985)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L985,M985)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N985,N985)","v":"DTXSID8030138"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J985,J985)","v":"8090702"},"Acetone potentiation and influence on the reversibility of 2,5-hexanedione-induced neurotoxicity studied with behavioural and morphometric methods in rats.","8090702","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C986,D986)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L986,M986)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N986,N986)","v":"DTXSID8030138"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J986,J986)","v":"8243422"},"Neurotoxic effects of 2,5-hexanedione on rapidly growing unmyelinated peripheral nerve axons of a rat fetus: dose-effect relationship.","8243422","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C987,D987)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L987,M987)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N987,N987)","v":"DTXSID8030138"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J987,J987)","v":"9021758"},"Different administration schedules of the same dose of 2,5-hexanedione influence the development of neuropathy and the toxicokinetics.","9021758","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C988,D988)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L988,M988)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N988,N988)","v":"DTXSID8030138"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J988,J988)","v":"3003628"},"Hexacarbon neuropathy: tracking a toxin.","3003628","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C989,D989)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L989,M989)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N989,N989)","v":"DTXSID8030138"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J989,J989)","v":"2983642"},"Effects of vitamin B12 and B6 on 2,5-hexanedione-induced neuropathy.","2983642","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C990,D990)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L990,M990)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N990,N990)","v":"DTXSID8030138"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J990,J990)","v":"25218479"},"Toxic neuropathies: Mechanistic insights based on a chemical perspective.","25218479","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C991,D991)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L991,M991)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N991,N991)","v":"DTXSID8030138"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J991,J991)","v":"1648869"},"Molecular mechanisms of gamma-diketone neuropathy.","1648869","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C992,D992)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L992,M992)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N992,N992)","v":"DTXSID8030138"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J992,J992)","v":"15622721"},"Neurotoxic effects of 2,5-hexanedione in rats: early morphological and functional changes in nerve fibres and neuromuscular junctions.","15622721","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C993,D993)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L993,M993)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N993,N993)","v":"DTXSID8030138"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J993,J993)","v":"20051453"},"The effect of 2,5-hexanedione on permeability of blood-nerve barrier in rats.","20051453","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C994,D994)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L994,M994)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N994,N994)","v":"DTXSID8030138"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J994,J994)","v":"20568451"},"[Effect of 2,5-hexanedione on myelin protein zero in sciatic nerve and its antibody in serum of rats at different time points].","20568451","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C995,D995)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L995,M995)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N995,N995)","v":"DTXSID8030138"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J995,J995)","v":"10828208"},"gamma-diketone peripheral neuropathy. I. Quality morphometric analyses of axonal atrophy and swelling.","10828208","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C996,D996)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L996,M996)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N996,N996)","v":"DTXSID8030138"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J996,J996)","v":"10828209"},"gamma-diketone peripheral neuropathy. II. Neurofilament subunit content.","10828209","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C997,D997)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L997,M997)","v":"Peripheral Nervous System Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N997,N997)","v":"DTXSID8030138"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J997,J997)","v":"11405253"},"Gamma-diketone peripheral neuropathy III. Neurofilament gene expression.","11405253","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C998,D998)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L998,M998)","v":"Polyneuropathies"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N998,N998)","v":"DTXSID8030138"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J998,J998)","v":"10720709"},"Redefining toxic distal axonopathies.","10720709","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C999,D999)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L999,M999)","v":"Quadriplegia"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N999,N999)","v":"DTXSID8030138"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J999,J999)","v":"15941647"},"Are sperm parameters the best indicator of 2,5-hexanedione reproductive toxicity in male rats?","15941647","Neurologic Manifestations","D011782","Quadriplegia","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1000,D1000)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1000,M1000)","v":"Seizures"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1000,N1000)","v":"DTXSID8030138"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1000,J1000)","v":"10356712"},"Neurotoxic effects of 2,5-hexanedione on normal and neurofilament-deficient quail.","10356712","Neurologic Manifestations","D012640","Seizures","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1001,D1001)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1001,M1001)","v":"Spinal Cord Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1001,N1001)","v":"DTXSID8030138"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1001,J1001)","v":"15207649"},"2,5-Hexanedione-induced changes in the monomeric neurofilament protein content of rat spinal cord fractions.","15207649","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1002,D1002)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1002,M1002)","v":"Spinal Cord Diseases"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1002,N1002)","v":"DTXSID8030138"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1002,J1002)","v":"14613714"},"gamma-diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots.","14613714","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1003,D1003)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1003,M1003)","v":"Spinal Cord Injuries"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1003,N1003)","v":"DTXSID8030138"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1003,J1003)","v":"27703213"},"Bone marrow mesenchymal stem cells attenuate 2,5-hexanedione-induced neuronal apoptosis through a NGF/AKT-dependent pathway.","27703213","Trauma, Nervous System","D013119","Spinal Cord Injuries","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1004,D1004)","v":"2,5-hexanedione"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1004,M1004)","v":"Vision, Low"},"C011269","2,5-hexanedione","110-13-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1004,N1004)","v":"DTXSID8030138"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1004,J1004)","v":"2784598"},"Subchronic dosing of macaques with 2,5-hexanedione causes long-lasting motor dysfunction but reversible visual loss.","2784598","Neurologic Manifestations","D015354","Vision, Low","DTXSID8030138"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1005,D1005)","v":"2-chloropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1005,M1005)","v":"Brain Edema"},"C021974","2-chloropropionic acid","598-78-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1005,N1005)","v":"DTXSID0021545"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1005,J1005)","v":"8560467"},"L-2-chloropropionic acid-induced neurotoxicity is prevented by MK-801: possible role of NMDA receptors in the neuropathology.","8560467","Central Nervous System Diseases","D001929","Brain Edema","DTXSID0021545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1006,D1006)","v":"2-chloropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1006,M1006)","v":"Brain Edema"},"C021974","2-chloropropionic acid","598-78-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1006,N1006)","v":"DTXSID0021545"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1006,J1006)","v":"15158016"},"Putrescine as a marker of the effects of 2-chloropropionic acid in the rat brain.","15158016","Central Nervous System Diseases","D001929","Brain Edema","DTXSID0021545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1007,D1007)","v":"2-chloropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1007,M1007)","v":"Brain Edema"},"C021974","2-chloropropionic acid","598-78-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1007,N1007)","v":"DTXSID0021545"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1007,J1007)","v":"11358650"},"MRI studies of the neurotoxic effects of L-2-chloropropionic acid on rat brain.","11358650","Central Nervous System Diseases","D001929","Brain Edema","DTXSID0021545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1008,D1008)","v":"2-chloropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1008,M1008)","v":"Cerebellar Diseases"},"C021974","2-chloropropionic acid","598-78-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1008,N1008)","v":"DTXSID0021545"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1008,J1008)","v":"9363839"},"L-2-Chloropropionic acid metabolism and disposition in male rats: relevance to cerebellar injury.","9363839","Central Nervous System Diseases","D002526","Cerebellar Diseases","DTXSID0021545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1009,D1009)","v":"2-chloropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1009,M1009)","v":"Cerebellar Diseases"},"C021974","2-chloropropionic acid","598-78-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1009,N1009)","v":"DTXSID0021545"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1009,J1009)","v":"9388008"},"L-2-chloropropionic acid-induced cerebellar granule cell necrosis is potentiated by L-type calcium channel antagonists.","9388008","Central Nervous System Diseases","D002526","Cerebellar Diseases","DTXSID0021545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1010,D1010)","v":"2-chloropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1010,M1010)","v":"Cerebellar Diseases"},"C021974","2-chloropropionic acid","598-78-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1010,N1010)","v":"DTXSID0021545"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1010,J1010)","v":"8886423"},"Evidence for mediation of L-2-chloropropionic acid-induced delayed neuronal cell death by activation of a constitutive nitric oxide synthase.","8886423","Central Nervous System Diseases","D002526","Cerebellar Diseases","DTXSID0021545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1011,D1011)","v":"2-chloropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1011,M1011)","v":"Muscle Weakness"},"C021974","2-chloropropionic acid","598-78-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1011,N1011)","v":"DTXSID0021545"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1011,J1011)","v":"11305781"},"The effect of postnatal age on L-2-chloropropionic acid-induced cerebellar granule cell necrosis in the rat.","11305781","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID0021545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1012,D1012)","v":"2-chloropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1012,M1012)","v":"Nervous System Diseases"},"C021974","2-chloropropionic acid","598-78-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1012,N1012)","v":"DTXSID0021545"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1012,J1012)","v":"9070346"},"Calpain activation and not oxidative damage mediates L-2-chloropropionic acid-induced cerebellar granule cell necrosis.","9070346","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0021545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1013,D1013)","v":"2-chloropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1013,M1013)","v":"Spinocerebellar Degenerations"},"C021974","2-chloropropionic acid","598-78-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1013,N1013)","v":"DTXSID0021545"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1013,J1013)","v":"11358650"},"MRI studies of the neurotoxic effects of L-2-chloropropionic acid on rat brain.","11358650","Neurodegenerative Diseases","D013132","Spinocerebellar Degenerations","DTXSID0021545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1014,D1014)","v":"2-Hydroxypropyl-beta-cyclodextrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1014,M1014)","v":"Ataxia"},"D000073738","2-Hydroxypropyl-beta-cyclodextrin","128446-35-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1014,N1014)","v":"DTXSID20894281"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1014,J1014)","v":"11015689"},"Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.","11015689","Neurologic Manifestations","D001259","Ataxia","DTXSID20894281"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1015,D1015)","v":"2-Hydroxypropyl-beta-cyclodextrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1015,M1015)","v":"Catalepsy"},"D000073738","2-Hydroxypropyl-beta-cyclodextrin","128446-35-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1015,N1015)","v":"DTXSID20894281"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1015,J1015)","v":"1349642"},"Use of 2-hydroxypropyl-beta-cyclodextrin as an intrathecal drug vehicle with opioids.","1349642","Neurologic Manifestations","D002375","Catalepsy","DTXSID20894281"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1016,D1016)","v":"2-Hydroxypropyl-beta-cyclodextrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1016,M1016)","v":"Eye Burns"},"D000073738","2-Hydroxypropyl-beta-cyclodextrin","128446-35-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1016,N1016)","v":"DTXSID20894281"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1016,J1016)","v":"21275515"},"Formulation of indomethacin eye drops via complexation with cyclodextrins.","21275515","Trauma, Nervous System","D005126","Eye Burns","DTXSID20894281"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1017,D1017)","v":"2-Hydroxypropyl-beta-cyclodextrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1017,M1017)","v":"Hearing Loss"},"D000073738","2-Hydroxypropyl-beta-cyclodextrin","128446-35-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1017,N1017)","v":"DTXSID20894281"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1017,J1017)","v":"26055150"},"Hearing Loss and Otopathology Following Systemic and Intracerebroventricular Delivery of 2-Hydroxypropyl-Beta-Cyclodextrin.","26055150","Neurologic Manifestations","D034381","Hearing Loss","DTXSID20894281"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1018,D1018)","v":"2-Hydroxypropyl-beta-cyclodextrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1018,M1018)","v":"Hearing Loss"},"D000073738","2-Hydroxypropyl-beta-cyclodextrin","128446-35-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1018,N1018)","v":"DTXSID20894281"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1018,J1018)","v":"23285273"},"Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-β-cyclodextrin.","23285273","Neurologic Manifestations","D034381","Hearing Loss","DTXSID20894281"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1019,D1019)","v":"2-Hydroxypropyl-beta-cyclodextrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1019,M1019)","v":"Hearing Loss, Sensorineural"},"D000073738","2-Hydroxypropyl-beta-cyclodextrin","128446-35-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1019,N1019)","v":"DTXSID20894281"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1019,J1019)","v":"26903308"},"Susceptibility of outer hair cells to cholesterol chelator 2-hydroxypropyl-β-cyclodextrine is prestin-dependent.","26903308","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID20894281"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1020,D1020)","v":"2-Hydroxypropyl-beta-cyclodextrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1020,M1020)","v":"Paralysis"},"D000073738","2-Hydroxypropyl-beta-cyclodextrin","128446-35-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1020,N1020)","v":"DTXSID20894281"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1020,J1020)","v":"15212188"},"Effects and toxicity of new fomocaine derivatives and of 2-hydroxypropyl-beta-cyclodextrin inclusion compounds in rats.","15212188","Neurologic Manifestations","D010243","Paralysis","DTXSID20894281"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1021,D1021)","v":"2-Methyl-4-chlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1021,M1021)","v":"Central Nervous System Diseases"},"D008456","2-Methyl-4-chlorophenoxyacetic Acid","94-74-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1021,N1021)","v":"DTXSID4024195"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1021,J1021)","v":"538756"},"Distribution of 2-methyl-4-chlorophenoxyacetic acid and 2,4-dichlorophenoxyacetic acid in male rats: evidence for the involvement of the central nervous system in their toxicity.","538756","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID4024195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1022,D1022)","v":"2-Methyl-4-chlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1022,M1022)","v":"Cerebrovascular Disorders"},"D008456","2-Methyl-4-chlorophenoxyacetic Acid","94-74-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1022,N1022)","v":"DTXSID4024195"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1022,J1022)","v":"2904874"},"Comparative study on cerebrovascular injuries by three chlorophenoxyacetic acids (2,4-D, 2,4,5-T and MCPA).","2904874","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID4024195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1023,D1023)","v":"2-Methyl-4-chlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1023,M1023)","v":"Coma"},"D008456","2-Methyl-4-chlorophenoxyacetic Acid","94-74-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1023,N1023)","v":"DTXSID4024195"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1023,J1023)","v":"3391629"},"Acute MCPP intoxication: report of two cases.","3391629","Neurologic Manifestations","D003128","Coma","DTXSID4024195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1024,D1024)","v":"2-Methyl-4-chlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1024,M1024)","v":"Muscle Cramp"},"D008456","2-Methyl-4-chlorophenoxyacetic Acid","94-74-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1024,N1024)","v":"DTXSID4024195"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1024,J1024)","v":"3391629"},"Acute MCPP intoxication: report of two cases.","3391629","Neurologic Manifestations","D009120","Muscle Cramp","DTXSID4024195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1025,D1025)","v":"2-Methyl-4-chlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1025,M1025)","v":"Myotonia"},"D008456","2-Methyl-4-chlorophenoxyacetic Acid","94-74-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1025,N1025)","v":"DTXSID4024195"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1025,J1025)","v":"8960192"},"Suspected herbicide toxicosis in a dog.","8960192","Neurologic Manifestations","D009222","Myotonia","DTXSID4024195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1026,D1026)","v":"2-Methyl-4-chlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1026,M1026)","v":"Nervous System Diseases"},"D008456","2-Methyl-4-chlorophenoxyacetic Acid","94-74-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1026,N1026)","v":"DTXSID4024195"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1026,J1026)","v":"9478100"},"Severe polyneuropathy in a 3-year-old child after dichlorophenoxyacetic herbicide--chwastox intoxication, treated successfully with plasmapheresis (PF).","9478100","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID4024195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1027,D1027)","v":"2-Methyl-4-chlorophenoxyacetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1027,M1027)","v":"Unconsciousness"},"D008456","2-Methyl-4-chlorophenoxyacetic Acid","94-74-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1027,N1027)","v":"DTXSID4024195"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1027,J1027)","v":"3391629"},"Acute MCPP intoxication: report of two cases.","3391629","Neurologic Manifestations","D014474","Unconsciousness","DTXSID4024195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1028,D1028)","v":"2-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1028,M1028)","v":"Coma"},"D019840","2-Propanol","67-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1028,N1028)","v":"DTXSID7020762"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1028,J1028)","v":"11451852"},"Gait disturbance, confusion, and coma in a 93-year-old blind woman.","11451852","Neurologic Manifestations","D003128","Coma","DTXSID7020762"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1029,D1029)","v":"2-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1029,M1029)","v":"Confusion"},"D019840","2-Propanol","67-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1029,N1029)","v":"DTXSID7020762"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1029,J1029)","v":"11451852"},"Gait disturbance, confusion, and coma in a 93-year-old blind woman.","11451852","Neurologic Manifestations","D003221","Confusion","DTXSID7020762"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1030,D1030)","v":"2-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1030,M1030)","v":"Intracranial Thrombosis"},"D019840","2-Propanol","67-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1030,N1030)","v":"DTXSID7020762"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1030,J1030)","v":"19258296"},"Cerebral sinovenous thrombosis associated with isopropanol ingestion in an infant.","19258296","Central Nervous System Diseases","D020767","Intracranial Thrombosis","DTXSID7020762"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1031,D1031)","v":"2-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1031,M1031)","v":"Nervous System Diseases"},"D019840","2-Propanol","67-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1031,N1031)","v":"DTXSID7020762"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1031,J1031)","v":"10670080"},"Topical absorption of isopropyl alcohol induced cardiac and neurologic deficits in an adult female with intact skin.","10670080","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7020762"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1032,D1032)","v":"2-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1032,M1032)","v":"Olfaction Disorders"},"D019840","2-Propanol","67-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1032,N1032)","v":"DTXSID7020762"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1032,J1032)","v":"18409971"},"[Dysphonia and cacosmia in a worker in sterilized rooms].","18409971","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID7020762"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1033,D1033)","v":"2-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1033,M1033)","v":"Peripheral Nervous System Diseases"},"D019840","2-Propanol","67-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1033,N1033)","v":"DTXSID7020762"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1033,J1033)","v":"14748412"},"Acute neuropathy and erythromelalgia following topical exposure to isopropanol.","14748412","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7020762"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1034,D1034)","v":"2-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1034,M1034)","v":"Sinus Thrombosis, Intracranial"},"D019840","2-Propanol","67-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1034,N1034)","v":"DTXSID7020762"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1034,J1034)","v":"19258296"},"Cerebral sinovenous thrombosis associated with isopropanol ingestion in an infant.","19258296","Central Nervous System Diseases","D012851","Sinus Thrombosis, Intracranial","DTXSID7020762"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1035,D1035)","v":"2-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1035,M1035)","v":"Syncope"},"D019840","2-Propanol","67-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1035,N1035)","v":"DTXSID7020762"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1035,J1035)","v":"10670080"},"Topical absorption of isopropyl alcohol induced cardiac and neurologic deficits in an adult female with intact skin.","10670080","Neurologic Manifestations","D013575","Syncope","DTXSID7020762"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1036,D1036)","v":"2-Propanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1036,M1036)","v":"Voice Disorders"},"D019840","2-Propanol","67-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1036,N1036)","v":"DTXSID7020762"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1036,J1036)","v":"18409971"},"[Dysphonia and cacosmia in a worker in sterilized rooms].","18409971","Neurologic Manifestations","D014832","Voice Disorders","DTXSID7020762"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1037,D1037)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1037,M1037)","v":"Amyotrophic Lateral Sclerosis"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1037,N1037)","v":"DTXSID50333956"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1037,J1037)","v":"8203467"},"Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis (ALS). Clinical studies in ALS of Guam and experimental studies in deafferented neurons and in beta,beta'-iminodipropionitrile axonopathy.","8203467","Central Nervous System Diseases","D000690","Amyotrophic Lateral Sclerosis","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1038,D1038)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1038,M1038)","v":"Amyotrophic Lateral Sclerosis"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1038,N1038)","v":"DTXSID50333956"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1038,J1038)","v":"23331301"},"Toxic neurofilamentous axonopathies -- accumulation of neurofilaments and axonal degeneration.","23331301","Central Nervous System Diseases","D000690","Amyotrophic Lateral Sclerosis","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1039,D1039)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1039,M1039)","v":"Bilateral Vestibulopathy"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1039,N1039)","v":"DTXSID50333956"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1039,J1039)","v":"28013217"},"Strain and Sex Differences in the Vestibular and Systemic Toxicity of 3,3'-Iminodipropionitrile in Mice.","28013217","Neurologic Manifestations","D000071699","Bilateral Vestibulopathy","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1040,D1040)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1040,M1040)","v":"Brain Neoplasms"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1040,N1040)","v":"DTXSID50333956"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1040,J1040)","v":"8590023"},"Distribution of microsomal epoxide hydrolase and glutathione S-transferase in the rat olfactory mucosa: relevance to distribution of lesions caused by systemically-administered olfactory toxicants.","8590023","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1041,D1041)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1041,M1041)","v":"Central Nervous System Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1041,N1041)","v":"DTXSID50333956"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1041,J1041)","v":"6085407"},"[Neurotoxicology: effects of lead and beta,beta'-iminodipropionitrile on the nervous system].","6085407","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1042,D1042)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1042,M1042)","v":"Chorea"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1042,N1042)","v":"DTXSID50333956"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1042,J1042)","v":"19244277"},"Neurovestibular toxicities of acrylonitrile and iminodipropionitrile in rats: a comparative evaluation of putative mechanisms and target sites.","19244277","Central Nervous System Diseases","D002819","Chorea","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1043,D1043)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1043,M1043)","v":"Demyelinating Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1043,N1043)","v":"DTXSID50333956"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1043,J1043)","v":"3942872"},"Structural correlates of physiological abnormalities in beta, beta'-iminodipropionitrile.","3942872","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1044,D1044)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1044,M1044)","v":"Demyelinating Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1044,N1044)","v":"DTXSID50333956"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1044,J1044)","v":"6174920"},"[Neurotoxic substances as a tool to understand some mechanisms of peripheral neuropathies (author's transl)].","6174920","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1045,D1045)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1045,M1045)","v":"Hearing Disorders"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1045,N1045)","v":"DTXSID50333956"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1045,J1045)","v":"1779945"},"Auditory deficits and motor dysfunction following iminodipropionitrile administration in the rat.","1779945","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1046,D1046)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1046,M1046)","v":"Hearing Loss"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1046,N1046)","v":"DTXSID50333956"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1046,J1046)","v":"8226343"},"The sensitivity to 3,3'-iminodipropionitrile differs for high- and midfrequency hearing loss in the developing rat.","8226343","Neurologic Manifestations","D034381","Hearing Loss","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1047,D1047)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1047,M1047)","v":"Hearing Loss, High-Frequency"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1047,N1047)","v":"DTXSID50333956"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1047,J1047)","v":"7896571"},"The ototoxicity of 3,3'-iminodipropionitrile: functional and morphological evidence of cochlear damage.","7896571","Neurologic Manifestations","D006316","Hearing Loss, High-Frequency","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1048,D1048)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1048,M1048)","v":"Hearing Loss, High-Frequency"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1048,N1048)","v":"DTXSID50333956"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1048,J1048)","v":"8226343"},"The sensitivity to 3,3'-iminodipropionitrile differs for high- and midfrequency hearing loss in the developing rat.","8226343","Neurologic Manifestations","D006316","Hearing Loss, High-Frequency","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1049,D1049)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1049,M1049)","v":"Hydrocephalus"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1049,N1049)","v":"DTXSID50333956"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1049,J1049)","v":"3976358"},"Communicating hydrocephalus in rodents treated with beta,beta'-iminodipropionitrile (IDPN).","3976358","Central Nervous System Diseases","D006849","Hydrocephalus","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1050,D1050)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1050,M1050)","v":"Memory Disorders"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1050,N1050)","v":"DTXSID50333956"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1050,J1050)","v":"25817367"},"Ameliorative effect of gastrodin on 3,3'-iminodipropionitrile-induced memory impairment in rats.","25817367","Neurologic Manifestations","D008569","Memory Disorders","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1051,D1051)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1051,M1051)","v":"Memory Disorders"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1051,N1051)","v":"DTXSID50333956"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1051,J1051)","v":"24842556"},"Gastrodin ameliorates memory deficits in 3,3'-iminodipropionitrile-induced rats: possible involvement of dopaminergic system.","24842556","Neurologic Manifestations","D008569","Memory Disorders","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1052,D1052)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1052,M1052)","v":"Movement Disorders"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1052,N1052)","v":"DTXSID50333956"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1052,J1052)","v":"7456507"},"[On age-dependent effects of IDPN in the rat (author's transl)].","7456507","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1053,D1053)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1053,M1053)","v":"Nervous System Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1053,N1053)","v":"DTXSID50333956"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1053,J1053)","v":"4088540"},"Electrophysiological investigation of IDPN neuropathy--initial studies.","4088540","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1054,D1054)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1054,M1054)","v":"Nervous System Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1054,N1054)","v":"DTXSID50333956"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1054,J1054)","v":"3942872"},"Structural correlates of physiological abnormalities in beta, beta'-iminodipropionitrile.","3942872","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1055,D1055)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1055,M1055)","v":"Nervous System Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1055,N1055)","v":"DTXSID50333956"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1055,J1055)","v":"3629601"},"Cross talk between intraspinal elements during progression of IDPN neuropathy.","3629601","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1056,D1056)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1056,M1056)","v":"Nervous System Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1056,N1056)","v":"DTXSID50333956"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1056,J1056)","v":"1842897"},"A neurotoxicity screening battery for use in safety evaluation: effects of acrylamide and 3',3'-iminodipropionitrile.","1842897","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1057,D1057)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1057,M1057)","v":"Nervous System Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1057,N1057)","v":"DTXSID50333956"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1057,J1057)","v":"2418391"},"Axonal transport of neurofilament proteins in IDPN neurotoxicity.","2418391","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1058,D1058)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1058,M1058)","v":"Nervous System Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1058,N1058)","v":"DTXSID50333956"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1058,J1058)","v":"19403855"},"Nervous and vestibular toxicities of acrylonitrile and iminodipropionitrile.","19403855","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1059,D1059)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1059,M1059)","v":"Nervous System Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1059,N1059)","v":"DTXSID50333956"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1059,J1059)","v":"10761986"},"IDPN-induced monoamine and hydroxyl radical changes in the rat brain.","10761986","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1060,D1060)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1060,M1060)","v":"Olfaction Disorders"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1060,N1060)","v":"DTXSID50333956"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1060,J1060)","v":"8838641"},"Characterization of olfactory deficits in the rat following administration of 2,6-dichlorobenzonitrile (dichlobenil), 3,3'-iminodipropionitrile, or methimazole.","8838641","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1061,D1061)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1061,M1061)","v":"Peripheral Nervous System Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1061,N1061)","v":"DTXSID50333956"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1061,J1061)","v":"6174920"},"[Neurotoxic substances as a tool to understand some mechanisms of peripheral neuropathies (author's transl)].","6174920","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1062,D1062)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1062,M1062)","v":"Peripheral Nervous System Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1062,N1062)","v":"DTXSID50333956"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1062,J1062)","v":"6095141"},"Electrophysiological investigation of beta, beta'-iminodipropionitrile neurotoxicity: monosynaptic reflexes and recurrent inhibition.","6095141","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1063,D1063)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1063,M1063)","v":"Reflex, Abnormal"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1063,N1063)","v":"DTXSID50333956"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1063,J1063)","v":"4088540"},"Electrophysiological investigation of IDPN neuropathy--initial studies.","4088540","Neurologic Manifestations","D012021","Reflex, Abnormal","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1064,D1064)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1064,M1064)","v":"Reflex, Abnormal"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1064,N1064)","v":"DTXSID50333956"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1064,J1064)","v":"6095141"},"Electrophysiological investigation of beta, beta'-iminodipropionitrile neurotoxicity: monosynaptic reflexes and recurrent inhibition.","6095141","Neurologic Manifestations","D012021","Reflex, Abnormal","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1065,D1065)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1065,M1065)","v":"Seizures"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1065,N1065)","v":"DTXSID50333956"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1065,J1065)","v":"8413078"},"Delay in the development of amygdala kindling following treatment with 3,3'-iminodipropionitrile.","8413078","Neurologic Manifestations","D012640","Seizures","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1066,D1066)","v":"3,3'-iminodipropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1066,M1066)","v":"Spinal Cord Diseases"},"C008110","3,3'-iminodipropionitrile","16688-98-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1066,N1066)","v":"DTXSID50333956"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1066,J1066)","v":"6095141"},"Electrophysiological investigation of beta, beta'-iminodipropionitrile neurotoxicity: monosynaptic reflexes and recurrent inhibition.","6095141","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID50333956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1067,D1067)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1067,M1067)","v":"Brain Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1067,N1067)","v":"DTXSID1049017"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1067,J1067)","v":"7792039"},"Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy').","7792039","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1068,D1068)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1068,M1068)","v":"Brain Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1068,N1068)","v":"DTXSID1049017"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1068,J1068)","v":"8761239"},"Ecstasy and neurodegeneration. No evidence of neurotoxicity exists.","8761239","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1069,D1069)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1069,M1069)","v":"Brain Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1069,N1069)","v":"DTXSID1049017"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1069,J1069)","v":"10580546"},"The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture.","10580546","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1070,D1070)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1070,M1070)","v":"Brain Ischemia"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1070,N1070)","v":"DTXSID1049017"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1070,J1070)","v":"1348879"},"Ecstasy--a dangerous drug.","1348879","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1071,D1071)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1071,M1071)","v":"Catatonia"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1071,N1071)","v":"DTXSID1049017"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1071,J1071)","v":"7903884"},"Hyponatraemia and catatonic stupor after taking \"ecstasy\".","7903884","Neurologic Manifestations","D002389","Catatonia","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1072,D1072)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1072,M1072)","v":"Catatonia"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1072,N1072)","v":"DTXSID1049017"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1072,J1072)","v":"7908237"},"Catatonic stupor after \"ecstasy\".","7908237","Neurologic Manifestations","D002389","Catatonia","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1073,D1073)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1073,M1073)","v":"Cerebral Hemorrhage"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1073,N1073)","v":"DTXSID1049017"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1073,J1073)","v":"7906517"},"Intracranial haemorrhage associated with ingestion of 'ecstasy'.","7906517","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1074,D1074)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1074,M1074)","v":"Cerebrovascular Disorders"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1074,N1074)","v":"DTXSID1049017"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1074,J1074)","v":"1356545"},"Misuse of ecstasy.","1356545","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1075,D1075)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1075,M1075)","v":"Coma"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1075,N1075)","v":"DTXSID1049017"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1075,J1075)","v":"8606600"},"Near-fatal hyponatraemic coma due to vasopressin over-secretion after \"ecstasy\" (3,4-MDMA)","8606600","Neurologic Manifestations","D003128","Coma","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1076,D1076)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1076,M1076)","v":"Confusion"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1076,N1076)","v":"DTXSID1049017"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1076,J1076)","v":"8796401"},"Acute poisoning with amphetamines (MDEA) and heroin: antagonistic effects between the two drugs.","8796401","Neurologic Manifestations","D003221","Confusion","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1077,D1077)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1077,M1077)","v":"Hallucinations"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1077,N1077)","v":"DTXSID1049017"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1077,J1077)","v":"8103042"},"Ecstasy abuse in Ireland.","8103042","Neurologic Manifestations","D006212","Hallucinations","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1078,D1078)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1078,M1078)","v":"Hallucinations"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1078,N1078)","v":"DTXSID1049017"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1078,J1078)","v":"2886672"},"Multiple severe complications from recreational ingestion of MDMA ('Ecstasy')","2886672","Neurologic Manifestations","D006212","Hallucinations","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1079,D1079)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1079,M1079)","v":"Hallucinations"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1079,N1079)","v":"DTXSID1049017"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1079,J1079)","v":"1347241"},"Flashbacks following MDMA.","1347241","Neurologic Manifestations","D006212","Hallucinations","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1080,D1080)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1080,M1080)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1080,N1080)","v":"DTXSID1049017"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1080,J1080)","v":"8101380"},"Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.","8101380","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1081,D1081)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1081,M1081)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1081,N1081)","v":"DTXSID1049017"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1081,J1081)","v":"8761240"},"Ecstasy and neurodegeneration. Tablets often contain substances in addition to, or instead of, ecstasy...","8761240","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1082,D1082)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1082,M1082)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1082,N1082)","v":"DTXSID1049017"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1082,J1082)","v":"8761239"},"Ecstasy and neurodegeneration. No evidence of neurotoxicity exists.","8761239","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1083,D1083)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1083,M1083)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1083,N1083)","v":"DTXSID1049017"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1083,J1083)","v":"8761238"},"Ecstasy and neurodegeneration. Advice is that \"less is more\".","8761238","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1084,D1084)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1084,M1084)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1084,N1084)","v":"DTXSID1049017"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1084,J1084)","v":"2573011"},"Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.","2573011","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1085,D1085)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1085,M1085)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1085,N1085)","v":"DTXSID1049017"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1085,J1085)","v":"2575224"},"Acute and long-term neurochemical effects of methylenedioxymethamphetamine in the rat.","2575224","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1086,D1086)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1086,M1086)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1086,N1086)","v":"DTXSID1049017"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1086,J1086)","v":"2575227"},"Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans.","2575227","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1087,D1087)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1087,M1087)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1087,N1087)","v":"DTXSID1049017"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1087,J1087)","v":"2563326"},"'Ecstasy': a human neurotoxin?","2563326","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1088,D1088)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1088,M1088)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1088,N1088)","v":"DTXSID1049017"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1088,J1088)","v":"2893452"},"New data intensify the agony over ecstasy.","2893452","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1089,D1089)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1089,M1089)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1089,N1089)","v":"DTXSID1049017"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1089,J1089)","v":"2906000"},"Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.","2906000","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1090,D1090)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1090,M1090)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1090,N1090)","v":"DTXSID1049017"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1090,J1090)","v":"1715034"},"Lack of neurotoxicity after intra-raphe micro-injections of MDMA (\"ecstasy\").","1715034","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1091,D1091)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1091,M1091)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1091,N1091)","v":"DTXSID1049017"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1091,J1091)","v":"1784586"},"3,4-Methylenedioxyamphetamine (MDA) self-administration and neurotoxicity.","1784586","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1092,D1092)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1092,M1092)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1092,N1092)","v":"DTXSID1049017"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1092,J1092)","v":"2470597"},"Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity.","2470597","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1093,D1093)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1093,M1093)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1093,N1093)","v":"DTXSID1049017"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1093,J1093)","v":"2476831"},"Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.","2476831","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1094,D1094)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1094,M1094)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1094,N1094)","v":"DTXSID1049017"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1094,J1094)","v":"1676172"},"Assessment of the role of alpha-methylepinine in the neurotoxicity of MDMA.","1676172","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1095,D1095)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1095,M1095)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1095,N1095)","v":"DTXSID1049017"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1095,J1095)","v":"15179441"},"The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA).","15179441","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1096,D1096)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1096,M1096)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1096,N1096)","v":"DTXSID1049017"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1096,J1096)","v":"1968330"},"Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.","1968330","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1097,D1097)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1097,M1097)","v":"Nervous System Diseases"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1097,N1097)","v":"DTXSID1049017"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1097,J1097)","v":"1350614"},"The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs.","1350614","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1098,D1098)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1098,M1098)","v":"Seizures"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1098,N1098)","v":"DTXSID1049017"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1098,J1098)","v":"9889612"},"[Ecstasy--cool dope with long-lasting effects?].","9889612","Neurologic Manifestations","D012640","Seizures","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1099,D1099)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1099,M1099)","v":"Seizures"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1099,N1099)","v":"DTXSID1049017"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1099,J1099)","v":"16188283"},"Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA (\"Ecstasy\") and MDA (\"Love\").","16188283","Neurologic Manifestations","D012640","Seizures","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1100,D1100)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1100,M1100)","v":"Seizures"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1100,N1100)","v":"DTXSID1049017"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1100,J1100)","v":"1356546"},"Misuse of ecstasy.","1356546","Neurologic Manifestations","D012640","Seizures","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1101,D1101)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1101,M1101)","v":"Seizures"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1101,N1101)","v":"DTXSID1049017"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1101,J1101)","v":"1358033"},"Accidental ingestion of 'Ecstasy' (3,4-methylenedioxymethylamphetamine).","1358033","Neurologic Manifestations","D012640","Seizures","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1102,D1102)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1102,M1102)","v":"Sinus Thrombosis, Intracranial"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1102,N1102)","v":"DTXSID1049017"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1102,J1102)","v":"8105031"},"Cerebral venous sinus thrombosis induced by 'ecstasy'.","8105031","Central Nervous System Diseases","D012851","Sinus Thrombosis, Intracranial","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1103,D1103)","v":"3,4-Methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1103,M1103)","v":"Unconsciousness"},"D015104","3,4-Methylenedioxyamphetamine","6292-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1103,N1103)","v":"DTXSID1049017"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1103,J1103)","v":"7903884"},"Hyponatraemia and catatonic stupor after taking \"ecstasy\".","7903884","Neurologic Manifestations","D014474","Unconsciousness","DTXSID1049017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1104,D1104)","v":"3,4-methylenedioxyethamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1104,M1104)","v":"Brain Diseases"},"C051800","3,4-methylenedioxyethamphetamine","74341-78-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1104,N1104)","v":"DTXSID0048892"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1104,J1104)","v":"8761239"},"Ecstasy and neurodegeneration. No evidence of neurotoxicity exists.","8761239","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID0048892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1105,D1105)","v":"3,4-methylenedioxyethamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1105,M1105)","v":"Confusion"},"C051800","3,4-methylenedioxyethamphetamine","74341-78-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1105,N1105)","v":"DTXSID0048892"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1105,J1105)","v":"8796401"},"Acute poisoning with amphetamines (MDEA) and heroin: antagonistic effects between the two drugs.","8796401","Neurologic Manifestations","D003221","Confusion","DTXSID0048892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1106,D1106)","v":"3,4-methylenedioxyethamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1106,M1106)","v":"Nervous System Diseases"},"C051800","3,4-methylenedioxyethamphetamine","74341-78-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1106,N1106)","v":"DTXSID0048892"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1106,J1106)","v":"8761240"},"Ecstasy and neurodegeneration. Tablets often contain substances in addition to, or instead of, ecstasy...","8761240","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0048892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1107,D1107)","v":"3,4-methylenedioxyethamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1107,M1107)","v":"Nervous System Diseases"},"C051800","3,4-methylenedioxyethamphetamine","74341-78-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1107,N1107)","v":"DTXSID0048892"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1107,J1107)","v":"8761239"},"Ecstasy and neurodegeneration. No evidence of neurotoxicity exists.","8761239","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0048892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1108,D1108)","v":"3,4-methylenedioxyethamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1108,M1108)","v":"Nervous System Diseases"},"C051800","3,4-methylenedioxyethamphetamine","74341-78-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1108,N1108)","v":"DTXSID0048892"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1108,J1108)","v":"8761238"},"Ecstasy and neurodegeneration. Advice is that \"less is more\".","8761238","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0048892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1109,D1109)","v":"3,4-methylenedioxyethamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1109,M1109)","v":"Nervous System Diseases"},"C051800","3,4-methylenedioxyethamphetamine","74341-78-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1109,N1109)","v":"DTXSID0048892"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1109,J1109)","v":"2906000"},"Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.","2906000","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0048892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1110,D1110)","v":"3,4-methylenedioxyethamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1110,M1110)","v":"Nervous System Diseases"},"C051800","3,4-methylenedioxyethamphetamine","74341-78-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1110,N1110)","v":"DTXSID0048892"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1110,J1110)","v":"15179441"},"The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA).","15179441","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0048892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1111,D1111)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1111,M1111)","v":"Athetosis"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1111,N1111)","v":"DTXSID90897461"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1111,J1111)","v":"24356039"},"Sympathomimetic syndrome, choreoathetosis, and acute kidney injury following \"bath salts\" injection.","24356039","Neurologic Manifestations","D001264","Athetosis","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1112,D1112)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1112,M1112)","v":"Brain Ischemia"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1112,N1112)","v":"DTXSID90897461"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1112,J1112)","v":"22539576"},"A young man with hemiplegia after inhaling the bath salt \"Ivory wave\".","22539576","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1113,D1113)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1113,M1113)","v":"Chorea"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1113,N1113)","v":"DTXSID90897461"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1113,J1113)","v":"24356039"},"Sympathomimetic syndrome, choreoathetosis, and acute kidney injury following \"bath salts\" injection.","24356039","Central Nervous System Diseases","D002819","Chorea","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1114,D1114)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1114,M1114)","v":"Confusion"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1114,N1114)","v":"DTXSID90897461"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1114,J1114)","v":"29275216"},"MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations.","29275216","Neurologic Manifestations","D003221","Confusion","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1115,D1115)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1115,M1115)","v":"Delirium"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1115,N1115)","v":"DTXSID90897461"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1115,J1115)","v":"28668987"},"A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature.","28668987","Neurologic Manifestations","D003693","Delirium","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1116,D1116)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1116,M1116)","v":"Delirium"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1116,N1116)","v":"DTXSID90897461"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1116,J1116)","v":"23822613"},"Methylenedioxypyrovalerone (\"bath salts\"), related death: case report and review of the literature.","23822613","Neurologic Manifestations","D003693","Delirium","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1117,D1117)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1117,M1117)","v":"Delirium"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1117,N1117)","v":"DTXSID90897461"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1117,J1117)","v":"24749855"},"Letter to the Editor--Methylenedioxypyrovalerone as a cause of excited delirium.","24749855","Neurologic Manifestations","D003693","Delirium","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1118,D1118)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1118,M1118)","v":"Delirium"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1118,N1118)","v":"DTXSID90897461"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1118,J1118)","v":"21762997"},"Hallucinatory delirium following use of MDPV: \"Bath Salts\".","21762997","Neurologic Manifestations","D003693","Delirium","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1119,D1119)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1119,M1119)","v":"Delirium"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1119,N1119)","v":"DTXSID90897461"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1119,J1119)","v":"22867829"},"Two cases of disseminated intravascular coagulation due to \"bath salts\" resulting in fatalities, with laboratory confirmation.","22867829","Neurologic Manifestations","D003693","Delirium","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1120,D1120)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1120,M1120)","v":"Delirium"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1120,N1120)","v":"DTXSID90897461"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1120,J1120)","v":"22898445"},"Excited delirium following use of synthetic cathinones (bath salts).","22898445","Neurologic Manifestations","D003693","Delirium","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1121,D1121)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1121,M1121)","v":"Hallucinations"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1121,N1121)","v":"DTXSID90897461"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1121,J1121)","v":"29275216"},"MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations.","29275216","Neurologic Manifestations","D006212","Hallucinations","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1122,D1122)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1122,M1122)","v":"Hallucinations"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1122,N1122)","v":"DTXSID90897461"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1122,J1122)","v":"23609518"},"Electroconvulsive therapy improves persistent psychosis after repeated use of methylenedioxypyrovalerone (\"bath salts\").","23609518","Neurologic Manifestations","D006212","Hallucinations","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1123,D1123)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1123,M1123)","v":"Hallucinations"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1123,N1123)","v":"DTXSID90897461"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1123,J1123)","v":"21762997"},"Hallucinatory delirium following use of MDPV: \"Bath Salts\".","21762997","Neurologic Manifestations","D006212","Hallucinations","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1124,D1124)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1124,M1124)","v":"Hallucinations"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1124,N1124)","v":"DTXSID90897461"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1124,J1124)","v":"21597456"},"Emergency department visits after use of a drug sold as \"bath salts\"--Michigan, November 13, 2010-March 31, 2011.","21597456","Neurologic Manifestations","D006212","Hallucinations","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1125,D1125)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1125,M1125)","v":"Hallucinations"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1125,N1125)","v":"DTXSID90897461"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1125,J1125)","v":"22329114"},"Illicit bath salts: not for bathing.","22329114","Neurologic Manifestations","D006212","Hallucinations","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1126,D1126)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1126,M1126)","v":"Hallucinations"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1126,N1126)","v":"DTXSID90897461"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1126,J1126)","v":"22682791"},"Psychoactive \"bath salts\" intoxication with methylenedioxypyrovalerone.","22682791","Neurologic Manifestations","D006212","Hallucinations","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1127,D1127)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1127,M1127)","v":"Hemiplegia"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1127,N1127)","v":"DTXSID90897461"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1127,J1127)","v":"22539576"},"A young man with hemiplegia after inhaling the bath salt \"Ivory wave\".","22539576","Neurologic Manifestations","D006429","Hemiplegia","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1128,D1128)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1128,M1128)","v":"Intracranial Hemorrhages"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1128,N1128)","v":"DTXSID90897461"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1128,J1128)","v":"22539576"},"A young man with hemiplegia after inhaling the bath salt \"Ivory wave\".","22539576","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1129,D1129)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1129,M1129)","v":"Leukoencephalopathies"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1129,N1129)","v":"DTXSID90897461"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1129,J1129)","v":"26666544"},"Devastating Delayed Leukoencephalopathy Associated with Bath Salt Inhalation.","26666544","Central Nervous System Diseases","D056784","Leukoencephalopathies","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1130,D1130)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1130,M1130)","v":"Persistent Vegetative State"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1130,N1130)","v":"DTXSID90897461"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1130,J1130)","v":"26666544"},"Devastating Delayed Leukoencephalopathy Associated with Bath Salt Inhalation.","26666544","Central Nervous System Diseases","D018458","Persistent Vegetative State","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1131,D1131)","v":"3,4-methylenedioxypyrovalerone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1131,M1131)","v":"Stroke"},"C554666","3,4-methylenedioxypyrovalerone","687603-66-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1131,N1131)","v":"DTXSID90897461"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1131,J1131)","v":"22539576"},"A young man with hemiplegia after inhaling the bath salt \"Ivory wave\".","22539576","Central Nervous System Diseases","D020521","Stroke","DTXSID90897461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1132,D1132)","v":"3-dinitrobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1132,M1132)","v":"Ataxia"},"C017906","3-dinitrobenzene","99-65-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1132,N1132)","v":"DTXSID9024065"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1132,J1132)","v":"3660433"},"Preliminary investigations into the involvement of the intestinal microflora in CNS toxicity induced by 1,3-dinitrobenzene in male F-344 rats.","3660433","Neurologic Manifestations","D001259","Ataxia","DTXSID9024065"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1133,D1133)","v":"3-dinitrobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1133,M1133)","v":"Ataxia"},"C017906","3-dinitrobenzene","99-65-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1133,N1133)","v":"DTXSID9024065"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1133,J1133)","v":"10091861"},"Glutathione depletion increases brain susceptibility to m-dinitrobenzene neurotoxicity.","10091861","Neurologic Manifestations","D001259","Ataxia","DTXSID9024065"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1134,D1134)","v":"3-dinitrobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1134,M1134)","v":"Brain Diseases"},"C017906","3-dinitrobenzene","99-65-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1134,N1134)","v":"DTXSID9024065"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1134,J1134)","v":"7744316"},"Early metabolic changes during m-Dinitrobenzene neurotoxicity and the possible role of oxidative stress.","7744316","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID9024065"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1135,D1135)","v":"3-dinitrobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1135,M1135)","v":"Brain Diseases"},"C017906","3-dinitrobenzene","99-65-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1135,N1135)","v":"DTXSID9024065"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1135,J1135)","v":"3683748"},"1,3-Dinitrobenzene-induced encephalopathy in rats.","3683748","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID9024065"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1136,D1136)","v":"3-dinitrobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1136,M1136)","v":"Brain Diseases"},"C017906","3-dinitrobenzene","99-65-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1136,N1136)","v":"DTXSID9024065"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1136,J1136)","v":"1800913"},"Vascular factors in the neurotoxic damage caused by 1,3-dinitrobenzene in the rat.","1800913","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID9024065"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1137,D1137)","v":"3-dinitrobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1137,M1137)","v":"Nervous System Diseases"},"C017906","3-dinitrobenzene","99-65-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1137,N1137)","v":"DTXSID9024065"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1137,J1137)","v":"10620484"},"Pharmacokinetic factors and concentration-time threshold in m-dinitrobenzene-induced neurotoxicity.","10620484","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID9024065"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1138,D1138)","v":"3-dinitrobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1138,M1138)","v":"Nervous System Diseases"},"C017906","3-dinitrobenzene","99-65-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1138,N1138)","v":"DTXSID9024065"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1138,J1138)","v":"10091861"},"Glutathione depletion increases brain susceptibility to m-dinitrobenzene neurotoxicity.","10091861","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID9024065"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1139,D1139)","v":"3-dinitrobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1139,M1139)","v":"Tremor"},"C017906","3-dinitrobenzene","99-65-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1139,N1139)","v":"DTXSID9024065"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1139,J1139)","v":"8678789"},"The glio-vascular toxicity of m-dinitrobenzene and related agents: modulation of toxicity by neuronal activation.","8678789","Neurologic Manifestations","D014202","Tremor","DTXSID9024065"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1140,D1140)","v":"3-dinitrobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1140,M1140)","v":"Tremor"},"C017906","3-dinitrobenzene","99-65-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1140,N1140)","v":"DTXSID9024065"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1140,J1140)","v":"9039463"},"Increasing or decreasing nervous activity modulates the severity of the glio-vascular lesions of 1,3-dinitrobenzene in the rat: effects of the tremorgenic pyrethroid, Bifenthrin, and of anaesthesia.","9039463","Neurologic Manifestations","D014202","Tremor","DTXSID9024065"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1141,D1141)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1141,M1141)","v":"Amyotrophic Lateral Sclerosis"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1141,N1141)","v":"DTXSID1020982"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1141,J1141)","v":"19852992"},"Promethazine protects against 3-nitropropionic acid-induced neurotoxicity.","19852992","Central Nervous System Diseases","D000690","Amyotrophic Lateral Sclerosis","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1142,D1142)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1142,M1142)","v":"Basal Ganglia Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1142,N1142)","v":"DTXSID1020982"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1142,J1142)","v":"19799953"},"Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats.","19799953","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1143,D1143)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1143,M1143)","v":"Basal Ganglia Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1143,N1143)","v":"DTXSID1020982"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1143,J1143)","v":"12379255"},"Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation.","12379255","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1144,D1144)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1144,M1144)","v":"Brain Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1144,N1144)","v":"DTXSID1020982"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1144,J1144)","v":"7623740"},"3-Nitropropionic acid produces indirect excitotoxic damage to rat striatum.","7623740","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1145,D1145)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1145,M1145)","v":"Brain Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1145,N1145)","v":"DTXSID1020982"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1145,J1145)","v":"7777187"},"Chronically administered 3-nitropropionic acid induces striatal lesions attributed to dysfunction of the blood-brain barrier.","7777187","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1146,D1146)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1146,M1146)","v":"Brain Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1146,N1146)","v":"DTXSID1020982"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1146,J1146)","v":"27289244"},"Lithium chloride could aggravate brain injury caused by 3-nitropropionic acid.","27289244","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1147,D1147)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1147,M1147)","v":"Brain Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1147,N1147)","v":"DTXSID1020982"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1147,J1147)","v":"16681260"},"[The research of the pathogen responsible for Pleurocybella porrigens related encephalopathy: investigation of 3-nitropropionic acid hypothesis].","16681260","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1148,D1148)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1148,M1148)","v":"Brain Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1148,N1148)","v":"DTXSID1020982"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1148,J1148)","v":"11172780"},"White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat.","11172780","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1149,D1149)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1149,M1149)","v":"Brain Ischemia"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1149,N1149)","v":"DTXSID1020982"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1149,J1149)","v":"9369983"},"Compensatory long-term effect of perinatal hypoxia-ischemia. A possible mechanism for neuroprotection?","9369983","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1150,D1150)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1150,M1150)","v":"Brain Ischemia"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1150,N1150)","v":"DTXSID1020982"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1150,J1150)","v":"19852992"},"Promethazine protects against 3-nitropropionic acid-induced neurotoxicity.","19852992","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1151,D1151)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1151,M1151)","v":"Central Nervous System Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1151,N1151)","v":"DTXSID1020982"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1151,J1151)","v":"6817156"},"Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropanoic acid.","6817156","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1152,D1152)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1152,M1152)","v":"Dystonia"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1152,N1152)","v":"DTXSID1020982"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1152,J1152)","v":"8848189"},"Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid).","8848189","Neurologic Manifestations","D004421","Dystonia","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1153,D1153)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1153,M1153)","v":"Dystonia"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1153,N1153)","v":"DTXSID1020982"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1153,J1153)","v":"12379255"},"Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation.","12379255","Neurologic Manifestations","D004421","Dystonia","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1154,D1154)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1154,M1154)","v":"Dystonic Disorders"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1154,N1154)","v":"DTXSID1020982"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1154,J1154)","v":"24194961"},"A rat model of hemidystonia induced by 3-nitropropionic acid.","24194961","Central Nervous System Diseases","D020821","Dystonic Disorders","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1155,D1155)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1155,M1155)","v":"Encephalitis"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1155,N1155)","v":"DTXSID1020982"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1155,J1155)","v":"16857175"},"Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats.","16857175","Central Nervous System Diseases","D004660","Encephalitis","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1156,D1156)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1156,M1156)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1156,N1156)","v":"DTXSID1020982"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1156,J1156)","v":"9178864"},"Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.","9178864","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1157,D1157)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1157,M1157)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1157,N1157)","v":"DTXSID1020982"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1157,J1157)","v":"9237266"},"Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation.","9237266","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1158,D1158)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1158,M1158)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1158,N1158)","v":"DTXSID1020982"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1158,J1158)","v":"9225755"},"3-Nitropropionic acid neurotoxicity: visualization by silver staining and implications for use as an animal model of Huntington's disease.","9225755","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1159,D1159)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1159,M1159)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1159,N1159)","v":"DTXSID1020982"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1159,J1159)","v":"9829299"},"Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.","9829299","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1160,D1160)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1160,M1160)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1160,N1160)","v":"DTXSID1020982"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1160,J1160)","v":"27928694"},"Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.","27928694","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1161,D1161)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1161,M1161)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1161,N1161)","v":"DTXSID1020982"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1161,J1161)","v":"27939523"},"Effect of Praeruptorin C on 3-nitropropionic acid induced Huntington's disease-like symptoms in mice.","27939523","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1162,D1162)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1162,M1162)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1162,N1162)","v":"DTXSID1020982"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1162,J1162)","v":"28391182"},"Tert-buthylhydroquinone pre-conditioning exerts dual effects in old female rats exposed to 3-nitropropionic acid.","28391182","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1163,D1163)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1163,M1163)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1163,N1163)","v":"DTXSID1020982"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1163,J1163)","v":"28624355"},"3-NP-induced Huntington's-like disease impairs Nrf2 activation without loss of cardiac function in aged rats.","28624355","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1164,D1164)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1164,M1164)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1164,N1164)","v":"DTXSID1020982"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1164,J1164)","v":"16940769"},"Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms.","16940769","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1165,D1165)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1165,M1165)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1165,N1165)","v":"DTXSID1020982"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1165,J1165)","v":"17418947"},"Mutant SOD1G93A in bone marrow-derived cells exacerbates 3-nitropropionic acid induced striatal damage in mice.","17418947","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1166,D1166)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1166,M1166)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1166,N1166)","v":"DTXSID1020982"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1166,J1166)","v":"17127354"},"Mitochondrial toxins and neurodegenerative diseases.","17127354","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1167,D1167)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1167,M1167)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1167,N1167)","v":"DTXSID1020982"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1167,J1167)","v":"24690258"},"Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntington׳s disease.","24690258","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1168,D1168)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1168,M1168)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1168,N1168)","v":"DTXSID1020982"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1168,J1168)","v":"23590827"},"Protective effect of Calendula officinalis Linn. flowers against 3-nitropropionic acid induced experimental Huntington's disease in rats.","23590827","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1169,D1169)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1169,M1169)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1169,N1169)","v":"DTXSID1020982"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1169,J1169)","v":"24138168"},"Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations.","24138168","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1170,D1170)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1170,M1170)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1170,N1170)","v":"DTXSID1020982"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1170,J1170)","v":"25445565"},"Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.","25445565","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1171,D1171)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1171,M1171)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1171,N1171)","v":"DTXSID1020982"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1171,J1171)","v":"24723322"},"The 3-NP Model of Striatal Neurodegeneration.","24723322","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1172,D1172)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1172,M1172)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1172,N1172)","v":"DTXSID1020982"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1172,J1172)","v":"23447628"},"Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease.","23447628","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1173,D1173)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1173,M1173)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1173,N1173)","v":"DTXSID1020982"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1173,J1173)","v":"16337998"},"Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.","16337998","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1174,D1174)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1174,M1174)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1174,N1174)","v":"DTXSID1020982"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1174,J1174)","v":"15454669"},"3-nitropropionic acid model of metabolic stress: assessment by magnetic resonance imaging.","15454669","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1175,D1175)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1175,M1175)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1175,N1175)","v":"DTXSID1020982"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1175,J1175)","v":"20305041"},"Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study.","20305041","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1176,D1176)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1176,M1176)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1176,N1176)","v":"DTXSID1020982"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1176,J1176)","v":"19026682"},"Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid.","19026682","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1177,D1177)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1177,M1177)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1177,N1177)","v":"DTXSID1020982"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1177,J1177)","v":"19852992"},"Promethazine protects against 3-nitropropionic acid-induced neurotoxicity.","19852992","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1178,D1178)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1178,M1178)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1178,N1178)","v":"DTXSID1020982"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1178,J1178)","v":"19340784"},"[Model of Huntington's disease induced with 3-nitropropionic acid].","19340784","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1179,D1179)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1179,M1179)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1179,N1179)","v":"DTXSID1020982"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1179,J1179)","v":"20448265"},"Cyclosporine A attenuates 3-nitropropionic acid-induced Huntington-like symptoms in rats: possible nitric oxide mechanism.","20448265","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1180,D1180)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1180,M1180)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1180,N1180)","v":"DTXSID1020982"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1180,J1180)","v":"19822156"},"Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity.","19822156","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1181,D1181)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1181,M1181)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1181,N1181)","v":"DTXSID1020982"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1181,J1181)","v":"22327485"},"N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease.","22327485","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1182,D1182)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1182,M1182)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1182,N1182)","v":"DTXSID1020982"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1182,J1182)","v":"21355552"},"Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.","21355552","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1183,D1183)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1183,M1183)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1183,N1183)","v":"DTXSID1020982"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1183,J1183)","v":"21756531"},"Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced Huntington's disease-like rat model.","21756531","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1184,D1184)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1184,M1184)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1184,N1184)","v":"DTXSID1020982"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1184,J1184)","v":"21827809"},"The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats.","21827809","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1185,D1185)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1185,M1185)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1185,N1185)","v":"DTXSID1020982"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1185,J1185)","v":"21070819"},"Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.","21070819","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1186,D1186)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1186,M1186)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1186,N1186)","v":"DTXSID1020982"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1186,J1186)","v":"10632901"},"3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.","10632901","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1187,D1187)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1187,M1187)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1187,N1187)","v":"DTXSID1020982"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1187,J1187)","v":"11299004"},"The mitochondrial toxin 3-nitropropionic acid induces differential expression patterns of apoptosis-related markers in rat striatum.","11299004","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1188,D1188)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1188,M1188)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1188,N1188)","v":"DTXSID1020982"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1188,J1188)","v":"11681849"},"Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid.","11681849","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1189,D1189)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1189,M1189)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1189,N1189)","v":"DTXSID1020982"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1189,J1189)","v":"10828534"},"Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.","10828534","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1190,D1190)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1190,M1190)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1190,N1190)","v":"DTXSID1020982"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1190,J1190)","v":"11896157"},"The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module.","11896157","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1191,D1191)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1191,M1191)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1191,N1191)","v":"DTXSID1020982"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1191,J1191)","v":"11844244"},"Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease.","11844244","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1192,D1192)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1192,M1192)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1192,N1192)","v":"DTXSID1020982"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1192,J1192)","v":"15063527"},"Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease.","15063527","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1193,D1193)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1193,M1193)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1193,N1193)","v":"DTXSID1020982"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1193,J1193)","v":"14715448"},"Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study.","14715448","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1194,D1194)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1194,M1194)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1194,N1194)","v":"DTXSID1020982"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1194,J1194)","v":"14642447"},"Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease.","14642447","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1195,D1195)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1195,M1195)","v":"Huntington Disease"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1195,N1195)","v":"DTXSID1020982"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1195,J1195)","v":"12270701"},"Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease.","12270701","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1196,D1196)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1196,M1196)","v":"Hypoxia, Brain"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1196,N1196)","v":"DTXSID1020982"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1196,J1196)","v":"9369983"},"Compensatory long-term effect of perinatal hypoxia-ischemia. A possible mechanism for neuroprotection?","9369983","Central Nervous System Diseases","D002534","Hypoxia, Brain","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1197,D1197)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1197,M1197)","v":"Hypoxia, Brain"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1197,N1197)","v":"DTXSID1020982"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1197,J1197)","v":"22515819"},"Optimal dosages of fluoxetine in the treatment of hypoxic brain injury induced by 3-nitropropionic acid: implications for the adjunctive treatment of patients after acute ischemic stroke.","22515819","Central Nervous System Diseases","D002534","Hypoxia, Brain","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1198,D1198)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1198,M1198)","v":"Memory Disorders"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1198,N1198)","v":"DTXSID1020982"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1198,J1198)","v":"25675218"},"Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties.","25675218","Neurologic Manifestations","D008569","Memory Disorders","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1199,D1199)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1199,M1199)","v":"Memory Disorders"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1199,N1199)","v":"DTXSID1020982"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1199,J1199)","v":"27928694"},"Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.","27928694","Neurologic Manifestations","D008569","Memory Disorders","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1200,D1200)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1200,M1200)","v":"MPTP Poisoning"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1200,N1200)","v":"DTXSID1020982"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1200,J1200)","v":"17127354"},"Mitochondrial toxins and neurodegenerative diseases.","17127354","Neurotoxicity Syndromes","D020267","MPTP Poisoning","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1201,D1201)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1201,M1201)","v":"Nervous System Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1201,N1201)","v":"DTXSID1020982"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1201,J1201)","v":"8837046"},"Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity.","8837046","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1202,D1202)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1202,M1202)","v":"Nervous System Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1202,N1202)","v":"DTXSID1020982"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1202,J1202)","v":"10629758"},"3-Nitropropionic acid: an astrocyte-sparing neurotoxin in vitro.","10629758","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1203,D1203)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1203,M1203)","v":"Neurodegenerative Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1203,N1203)","v":"DTXSID1020982"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1203,J1203)","v":"17127354"},"Mitochondrial toxins and neurodegenerative diseases.","17127354","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1204,D1204)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1204,M1204)","v":"Neurodegenerative Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1204,N1204)","v":"DTXSID1020982"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1204,J1204)","v":"24723322"},"The 3-NP Model of Striatal Neurodegeneration.","24723322","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1205,D1205)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1205,M1205)","v":"Neurodegenerative Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1205,N1205)","v":"DTXSID1020982"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1205,J1205)","v":"19714564"},"Regulation of GSK-3beta by calpain in the 3-nitropropionic acid model.","19714564","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1206,D1206)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1206,M1206)","v":"Neurodegenerative Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1206,N1206)","v":"DTXSID1020982"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1206,J1206)","v":"10830405"},"Limited-time exposure to mitochondrial toxins may lead to chronic progressive neurodegenerative diseases.","10830405","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1207,D1207)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1207,M1207)","v":"Neurodegenerative Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1207,N1207)","v":"DTXSID1020982"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1207,J1207)","v":"10826529"},"Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid.","10826529","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1208,D1208)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1208,M1208)","v":"Parkinson Disease, Secondary"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1208,N1208)","v":"DTXSID1020982"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1208,J1208)","v":"17127354"},"Mitochondrial toxins and neurodegenerative diseases.","17127354","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1209,D1209)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1209,M1209)","v":"Peripheral Nervous System Diseases"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1209,N1209)","v":"DTXSID1020982"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1209,J1209)","v":"20542088"},"Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol.","20542088","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1210,D1210)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1210,M1210)","v":"Seizures"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1210,N1210)","v":"DTXSID1020982"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1210,J1210)","v":"15572277"},"Adenosine A1 receptors and the anticonvulsant potential of drugs effective in the model of 3-nitropropionic acid-induced seizures in mice.","15572277","Neurologic Manifestations","D012640","Seizures","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1211,D1211)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1211,M1211)","v":"Seizures"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1211,N1211)","v":"DTXSID1020982"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1211,J1211)","v":"10949122"},"Seizures evoked by mitochondrial toxin, 3-nitropropionic acid: new mechanism of epileptogenesis?","10949122","Neurologic Manifestations","D012640","Seizures","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1212,D1212)","v":"3-nitropropionic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1212,M1212)","v":"Striatonigral Degeneration"},"C015392","3-nitropropionic acid","504-88-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1212,N1212)","v":"DTXSID1020982"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1212,J1212)","v":"15640759"},"Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.","15640759","Basal Ganglia Diseases","D020955","Striatonigral Degeneration","DTXSID1020982"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1213,D1213)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1213,M1213)","v":"Cerebral Hemorrhage"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1213,N1213)","v":"DTXSID0023870"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1213,J1213)","v":"19443164"},"Severe accidental overdose of 4-aminopyridine due to a compounding pharmacy error.","19443164","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1214,D1214)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1214,M1214)","v":"Confusion"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1214,N1214)","v":"DTXSID0023870"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1214,J1214)","v":"21425264"},"Multiple sclerosis therapeutic pipeline: opportunities and challenges.","21425264","Neurologic Manifestations","D003221","Confusion","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1215,D1215)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1215,M1215)","v":"Dystonia"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1215,N1215)","v":"DTXSID0023870"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1215,J1215)","v":"8599505"},"Atypical presentation of 4-aminopyridine overdose.","8599505","Neurologic Manifestations","D004421","Dystonia","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1216,D1216)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1216,M1216)","v":"Epilepsy"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1216,N1216)","v":"DTXSID0023870"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1216,J1216)","v":"20955719"},"The 4-aminopyridine in vitro epilepsy model analyzed with a perforated multi-electrode array.","20955719","Central Nervous System Diseases","D004827","Epilepsy","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1217,D1217)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1217,M1217)","v":"Epilepsy"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1217,N1217)","v":"DTXSID0023870"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1217,J1217)","v":"22931236"},"Rapid compensatory changes in the expression of EAAT-3 and GAT-1 transporters during seizures in cells of the CA1 and dentate gyrus.","22931236","Central Nervous System Diseases","D004827","Epilepsy","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1218,D1218)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1218,M1218)","v":"Epilepsy"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1218,N1218)","v":"DTXSID0023870"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1218,J1218)","v":"12948618"},"Effects of neurosteroids on epileptiform activity induced by picrotoxin and 4-aminopyridine in the rat hippocampal slice.","12948618","Central Nervous System Diseases","D004827","Epilepsy","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1219,D1219)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1219,M1219)","v":"Epilepsy"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1219,N1219)","v":"DTXSID0023870"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1219,J1219)","v":"1309571"},"4-aminopyridine-induced epileptiform activity and a GABA-mediated long-lasting depolarization in the rat hippocampus.","1309571","Central Nervous System Diseases","D004827","Epilepsy","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1220,D1220)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1220,M1220)","v":"Epilepsy, Tonic-Clonic"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1220,N1220)","v":"DTXSID0023870"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1220,J1220)","v":"19402572"},"An unusual case of 4-aminopyridine toxicity in a multiple sclerosis patient: epileptic disorder or toxic encephalopathy?","19402572","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1221,D1221)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1221,M1221)","v":"Memory Disorders"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1221,N1221)","v":"DTXSID0023870"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1221,J1221)","v":"19307545"},"4-Aminopyridine toxicity mimics autoimmune-mediated limbic encephalitis.","19307545","Neurologic Manifestations","D008569","Memory Disorders","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1222,D1222)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1222,M1222)","v":"Nystagmus, Pathologic"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1222,N1222)","v":"DTXSID0023870"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1222,J1222)","v":"12509600"},"Opisthotonic posturing with neuromuscular irritability attributable to 4-aminopyridine ingestion by a healthy pediatric patient.","12509600","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1223,D1223)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1223,M1223)","v":"Paresthesia"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1223,N1223)","v":"DTXSID0023870"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1223,J1223)","v":"2985185"},"4-Aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve.","2985185","Neurologic Manifestations","D010292","Paresthesia","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1224,D1224)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1224,M1224)","v":"Paresthesia"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1224,N1224)","v":"DTXSID0023870"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1224,J1224)","v":"1303573"},"[Long-term treatment of Lambert-Eaton syndrome by 3, 4 diaminopyridine].","1303573","Neurologic Manifestations","D010292","Paresthesia","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1225,D1225)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1225,M1225)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1225,N1225)","v":"DTXSID0023870"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1225,J1225)","v":"7299851"},"Effect of taurine on seizures induced by 4-aminopyridine.","7299851","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1226,D1226)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1226,M1226)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1226,N1226)","v":"DTXSID0023870"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1226,J1226)","v":"8813536"},"Protection by NMDA receptor antagonists against seizures induced by intracerebral administration of 4-aminopyridine.","8813536","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1227,D1227)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1227,M1227)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1227,N1227)","v":"DTXSID0023870"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1227,J1227)","v":"25576253"},"Repeated application of 4-aminopyridine provoke an increase in entorhinal cortex excitability and rearrange AMPA and kainate receptors.","25576253","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1228,D1228)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1228,M1228)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1228,N1228)","v":"DTXSID0023870"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1228,J1228)","v":"26268619"},"Analysis of connexin expression during seizures induced by 4-aminopyridine in the rat hippocampus.","26268619","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1229,D1229)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1229,M1229)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1229,N1229)","v":"DTXSID0023870"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1229,J1229)","v":"25682917"},"Treatment with direct-current stimulation against cingulate seizure-like activity induced by 4-aminopyridine and bicuculline in an in vitro mouse model.","25682917","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1230,D1230)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1230,M1230)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1230,N1230)","v":"DTXSID0023870"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1230,J1230)","v":"26830290"},"Effect of the Anti-depressant Sertraline, the Novel Anti-seizure Drug Vinpocetine and Several Conventional Antiepileptic Drugs on the Epileptiform EEG Activity Induced by 4-Aminopyridine.","26830290","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1231,D1231)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1231,M1231)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1231,N1231)","v":"DTXSID0023870"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1231,J1231)","v":"2830554"},"Higher susceptibility of taurine-deficient rats to seizures induced by 4-aminopyridine.","2830554","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1232,D1232)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1232,M1232)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1232,N1232)","v":"DTXSID0023870"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1232,J1232)","v":"2848207"},"Effects of 4-aminopyridine in experimental CNS demyelination.","2848207","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1233,D1233)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1233,M1233)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1233,N1233)","v":"DTXSID0023870"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1233,J1233)","v":"17007911"},"Alterations of seizure-induced c-fos immunolabelling and gene expression in the rat cerebral cortex following dexamethasone treatment.","17007911","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1234,D1234)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1234,M1234)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1234,N1234)","v":"DTXSID0023870"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1234,J1234)","v":"18497363"},"Layer-specific generation and propagation of seizures in slices of developing neocortex: role of excitatory GABAergic synapses.","18497363","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1235,D1235)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1235,M1235)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1235,N1235)","v":"DTXSID0023870"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1235,J1235)","v":"18602900"},"Generalization of seizures parallels the formation of \"dark\" neurons in the hippocampus and pontine reticular formation after focal-cortical application of 4-aminopyridine (4-AP) in the rat.","18602900","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1236,D1236)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1236,M1236)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1236,N1236)","v":"DTXSID0023870"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1236,J1236)","v":"23383704"},"Dalfampridine prior authorization program: a cohort study.","23383704","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1237,D1237)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1237,M1237)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1237,N1237)","v":"DTXSID0023870"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1237,J1237)","v":"25466986"},"Immunohistochemistry of cerebellar seizures: mossy fiber afferents play an important role in seizure spread and initiation in the rat.","25466986","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1238,D1238)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1238,M1238)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1238,N1238)","v":"DTXSID0023870"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1238,J1238)","v":"24359689"},"Isovaline attenuates epileptiform activity and seizure behavior in 4-aminopyridine treated rats.","24359689","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1239,D1239)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1239,M1239)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1239,N1239)","v":"DTXSID0023870"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1239,J1239)","v":"19238257"},"Diphenyl diselenide and diphenyl ditelluride increase the latency for 4-aminopyridine-induced chemical seizure and prevent death in mice.","19238257","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1240,D1240)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1240,M1240)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1240,N1240)","v":"DTXSID0023870"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1240,J1240)","v":"23123001"},"Clinical overview of dalfampridine: an agent with a novel mechanism of action to help with gait disturbances.","23123001","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1241,D1241)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1241,M1241)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1241,N1241)","v":"DTXSID0023870"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1241,J1241)","v":"23051757"},"Dalfampridine: is the seizure risk greater than previously thought?","23051757","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1242,D1242)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1242,M1242)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1242,N1242)","v":"DTXSID0023870"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1242,J1242)","v":"22931236"},"Rapid compensatory changes in the expression of EAAT-3 and GAT-1 transporters during seizures in cells of the CA1 and dentate gyrus.","22931236","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1243,D1243)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1243,M1243)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1243,N1243)","v":"DTXSID0023870"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1243,J1243)","v":"22081320"},"Allopregnanolone potentiates the glutamate-mediated seizures induced by 4-aminopyridine in rat hippocampus in vivo.","22081320","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1244,D1244)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1244,M1244)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1244,N1244)","v":"DTXSID0023870"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1244,J1244)","v":"22703551"},"Clinical overview of the seizure risk of  dalfampridine.","22703551","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1245,D1245)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1245,M1245)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1245,N1245)","v":"DTXSID0023870"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1245,J1245)","v":"11757995"},"4-aminopyridine poisoning of crows in the Chicago area.","11757995","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1246,D1246)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1246,M1246)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1246,N1246)","v":"DTXSID0023870"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1246,J1246)","v":"11032047"},"Acute 4-aminopyridine seizures increase the regional cerebral blood flow in the thalamus and neocortex, but not in the entire allocortex of the mouse brain.","11032047","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1247,D1247)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1247,M1247)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1247,N1247)","v":"DTXSID0023870"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1247,J1247)","v":"11113304"},"Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels.","11113304","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1248,D1248)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1248,M1248)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1248,N1248)","v":"DTXSID0023870"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1248,J1248)","v":"11864638"},"Nitric oxide and convulsions in 4-aminopyridine-treated mice.","11864638","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1249,D1249)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1249,M1249)","v":"Seizures"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1249,N1249)","v":"DTXSID0023870"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1249,J1249)","v":"12948621"},"Seizure, neurotransmitter release, and gene expression are closely related in the striatum of 4-aminopyridine-treated rats.","12948621","Neurologic Manifestations","D012640","Seizures","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1250,D1250)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1250,M1250)","v":"Spasm"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1250,N1250)","v":"DTXSID0023870"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1250,J1250)","v":"12509600"},"Opisthotonic posturing with neuromuscular irritability attributable to 4-aminopyridine ingestion by a healthy pediatric patient.","12509600","Neurologic Manifestations","D013035","Spasm","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1251,D1251)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1251,M1251)","v":"Status Epilepticus"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1251,N1251)","v":"DTXSID0023870"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1251,J1251)","v":"17942314"},"Reduced ictogenic potential of 4-aminopyridine in the perirhinal and entorhinal cortex of kainate-treated chronic epileptic rats.","17942314","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1252,D1252)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1252,M1252)","v":"Status Epilepticus"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1252,N1252)","v":"DTXSID0023870"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1252,J1252)","v":"23224484"},"Status epilepticus associated with dalfampridine in a patient with multiple sclerosis.","23224484","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1253,D1253)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1253,M1253)","v":"Status Epilepticus"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1253,N1253)","v":"DTXSID0023870"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1253,J1253)","v":"19029525"},"4-aminopyridine toxicity with unintentional overdose in four patients with multiple sclerosis.","19029525","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1254,D1254)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1254,M1254)","v":"Trigeminal Neuralgia"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1254,N1254)","v":"DTXSID0023870"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1254,J1254)","v":"25555847"},"[Recurrence and de novo trigeminal neuralgia induced by fampridine].","25555847","Cranial Nerve Diseases","D014277","Trigeminal Neuralgia","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1255,D1255)","v":"4-Aminopyridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1255,M1255)","v":"Trigeminal Neuralgia"},"D015761","4-Aminopyridine","504-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1255,N1255)","v":"DTXSID0023870"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1255,J1255)","v":"25261505"},"Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.","25261505","Cranial Nerve Diseases","D014277","Trigeminal Neuralgia","DTXSID0023870"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1256,D1256)","v":"4-bromophenylacetylurea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1256,M1256)","v":"Ataxia"},"C004506","4-bromophenylacetylurea","30241-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1256,N1256)","v":"DTXSID40184338"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1256,J1256)","v":"10373406"},"Neurotoxic potentiation is related to a metabolic interaction between p-bromophenylacetylurea and phenylmethanesulfonyl fluoride.","10373406","Neurologic Manifestations","D001259","Ataxia","DTXSID40184338"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1257,D1257)","v":"4-bromophenylacetylurea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1257,M1257)","v":"Brain Edema"},"C004506","4-bromophenylacetylurea","30241-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1257,N1257)","v":"DTXSID40184338"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1257,J1257)","v":"20188121"},"Organophosphates induce distal axonal damage, but not brain oedema, by inactivating neuropathy target esterase.","20188121","Central Nervous System Diseases","D001929","Brain Edema","DTXSID40184338"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1258,D1258)","v":"4-bromophenylacetylurea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1258,M1258)","v":"Nervous System Diseases"},"C004506","4-bromophenylacetylurea","30241-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1258,N1258)","v":"DTXSID40184338"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1258,J1258)","v":"2445441"},"Slow axonal transport in experimental hypoxia and in neuropathy induced by p-bromophenylacetylurea.","2445441","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID40184338"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1259,D1259)","v":"4-bromophenylacetylurea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1259,M1259)","v":"Paralysis"},"C004506","4-bromophenylacetylurea","30241-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1259,N1259)","v":"DTXSID40184338"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1259,J1259)","v":"3873034"},"Long lasting behavioral effects of dimethyl sulfoxide and the \"peripheral\" toxicant p-bromophenylacetylurea.","3873034","Neurologic Manifestations","D010243","Paralysis","DTXSID40184338"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1260,D1260)","v":"4-bromophenylacetylurea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1260,M1260)","v":"Peripheral Nervous System Diseases"},"C004506","4-bromophenylacetylurea","30241-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1260,N1260)","v":"DTXSID40184338"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1260,J1260)","v":"6302488"},"Analogs of p-bromophenylacetylurea: a structure activity study of their neurotoxicity in rats.","6302488","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID40184338"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1261,D1261)","v":"4-bromophenylacetylurea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1261,M1261)","v":"Peripheral Nervous System Diseases"},"C004506","4-bromophenylacetylurea","30241-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1261,N1261)","v":"DTXSID40184338"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1261,J1261)","v":"6100457"},"Unimpaired energy metabolism in experimental neuropathy induced by p-bromophenylacetylurea.","6100457","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID40184338"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1262,D1262)","v":"4-bromophenylacetylurea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1262,M1262)","v":"Peripheral Nervous System Diseases"},"C004506","4-bromophenylacetylurea","30241-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1262,N1262)","v":"DTXSID40184338"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1262,J1262)","v":"1372380"},"Tubulomembranous lesions in p-bromophenylacetylurea neuropathy reflect local stasis of fast axonal transport: evidence from electron microscopic autoradiography.","1372380","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID40184338"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1263,D1263)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1263,M1263)","v":"Amnesia, Retrograde"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1263,N1263)","v":"DTXSID6020224"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1263,J1263)","v":"23243924"},"[Gamma-hydroxybutyrate (GHB) and its lactone (GBL) as psychoactive substances].","23243924","Neurologic Manifestations","D000648","Amnesia, Retrograde","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1264,D1264)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1264,M1264)","v":"Autonomic Nervous System Diseases"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1264,N1264)","v":"DTXSID6020224"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1264,J1264)","v":"11719746"},"Pentobarbital for severe gamma-butyrolactone withdrawal.","11719746","Autonomic Nervous System Diseases","D001342","Autonomic Nervous System Diseases","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1265,D1265)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1265,M1265)","v":"Catalepsy"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1265,N1265)","v":"DTXSID6020224"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1265,J1265)","v":"23104245"},"Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration.","23104245","Neurologic Manifestations","D002375","Catalepsy","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1266,D1266)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1266,M1266)","v":"Coma"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1266,N1266)","v":"DTXSID6020224"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1266,J1266)","v":"8842916"},"Coma and respiratory arrest after exposure to butyrolactone.","8842916","Neurologic Manifestations","D003128","Coma","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1267,D1267)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1267,M1267)","v":"Coma"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1267,N1267)","v":"DTXSID6020224"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1267,J1267)","v":"17376952"},"Acetone-free nail polish remover pads: toxicity in a 9-month old.","17376952","Neurologic Manifestations","D003128","Coma","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1268,D1268)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1268,M1268)","v":"Coma"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1268,N1268)","v":"DTXSID6020224"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1268,J1268)","v":"16143455"},"Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.","16143455","Neurologic Manifestations","D003128","Coma","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1269,D1269)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1269,M1269)","v":"Coma"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1269,N1269)","v":"DTXSID6020224"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1269,J1269)","v":"22010460"},"[Acute gamma-butyrolactone poisoning with withdrawal syndrome].","22010460","Neurologic Manifestations","D003128","Coma","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1270,D1270)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1270,M1270)","v":"Coma"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1270,N1270)","v":"DTXSID6020224"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1270,J1270)","v":"10026060"},"Central nervous system depression after ingestion of RenewTrient.","10026060","Neurologic Manifestations","D003128","Coma","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1271,D1271)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1271,M1271)","v":"Coma"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1271,N1271)","v":"DTXSID6020224"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1271,J1271)","v":"11493842"},"Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol.","11493842","Neurologic Manifestations","D003128","Coma","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1272,D1272)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1272,M1272)","v":"Coma"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1272,N1272)","v":"DTXSID6020224"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1272,J1272)","v":"11339620"},"Near-fatal gamma-butyrolactone intoxication--first report in the UK.","11339620","Neurologic Manifestations","D003128","Coma","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1273,D1273)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1273,M1273)","v":"Coma"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1273,N1273)","v":"DTXSID6020224"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1273,J1273)","v":"10830711"},"Revivarant (gamma-butyrolactone) poisoning.","10830711","Neurologic Manifestations","D003128","Coma","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1274,D1274)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1274,M1274)","v":"Coma"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1274,N1274)","v":"DTXSID6020224"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1274,J1274)","v":"11919114"},"Pulmonary oedema caused by \"liquid ecstasy\" ingestion.","11919114","Neurologic Manifestations","D003128","Coma","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1275,D1275)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1275,M1275)","v":"Confusion"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1275,N1275)","v":"DTXSID6020224"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1275,J1275)","v":"22285498"},"[Withdrawal syndrome from abusive consumption of liquid ecstasy precursors].","22285498","Neurologic Manifestations","D003221","Confusion","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1276,D1276)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1276,M1276)","v":"Consciousness Disorders"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1276,N1276)","v":"DTXSID6020224"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1276,J1276)","v":"22111167"},"[\"Harmless\" drug from the hardware store].","22111167","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1277,D1277)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1277,M1277)","v":"Consciousness Disorders"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1277,N1277)","v":"DTXSID6020224"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1277,J1277)","v":"11015059"},"Dietary supplement or dangerous drug? Two case reports of gamma-butyrolactone toxicity.","11015059","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1278,D1278)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1278,M1278)","v":"Delirium"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1278,N1278)","v":"DTXSID6020224"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1278,J1278)","v":"20925687"},"Gamma-butyrolactone (GBL) dependence and withdrawal.","20925687","Neurologic Manifestations","D003693","Delirium","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1279,D1279)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1279,M1279)","v":"Delirium"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1279,N1279)","v":"DTXSID6020224"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1279,J1279)","v":"20340076"},"F. D. Zepf et al.: a 16-year-old boy with severe Gamma-Butyrolactone (GBL) withdrawal delirium. Pharmacopsychiatry 2009; 42: 202-203.","20340076","Neurologic Manifestations","D003693","Delirium","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1280,D1280)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1280,M1280)","v":"Delirium"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1280,N1280)","v":"DTXSID6020224"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1280,J1280)","v":"19724983"},"A 16-year-old boy with severe gamma-butyrolactone (GBL) withdrawal delirium.","19724983","Neurologic Manifestations","D003693","Delirium","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1281,D1281)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1281,M1281)","v":"Delirium"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1281,N1281)","v":"DTXSID6020224"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1281,J1281)","v":"21894099"},"Unusual presentation of a patient with GBL withdrawal: a case report.","21894099","Neurologic Manifestations","D003693","Delirium","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1282,D1282)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1282,M1282)","v":"Delirium"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1282,N1282)","v":"DTXSID6020224"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1282,J1282)","v":"21454980"},"A case of γ-butyrolactone associated with severe withdrawal delirium and acute renal failure.","21454980","Neurologic Manifestations","D003693","Delirium","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1283,D1283)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1283,M1283)","v":"Epilepsy"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1283,N1283)","v":"DTXSID6020224"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1283,J1283)","v":"2507307"},"Comparison of the anticonvulsant activities of ethosuximide, valproate, and a new anticonvulsant, thiobutyrolactone.","2507307","Central Nervous System Diseases","D004827","Epilepsy","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1284,D1284)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1284,M1284)","v":"Hallucinations"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1284,N1284)","v":"DTXSID6020224"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1284,J1284)","v":"21894099"},"Unusual presentation of a patient with GBL withdrawal: a case report.","21894099","Neurologic Manifestations","D006212","Hallucinations","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1285,D1285)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1285,M1285)","v":"Hallucinations"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1285,N1285)","v":"DTXSID6020224"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1285,J1285)","v":"21817917"},"Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.","21817917","Neurologic Manifestations","D006212","Hallucinations","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1286,D1286)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1286,M1286)","v":"Hallucinations"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1286,N1286)","v":"DTXSID6020224"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1286,J1286)","v":"11161128"},"Gamma butyrolactone (GBL) withdrawal syndromes.","11161128","Neurologic Manifestations","D006212","Hallucinations","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1287,D1287)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1287,M1287)","v":"Myoclonus"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1287,N1287)","v":"DTXSID6020224"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1287,J1287)","v":"19384813"},"[\"Liquid ecstasy\": gamma-butyrolactone withdrawal delirium with rhabdomyolysis and dialysis dependent renal failure].","19384813","Neurologic Manifestations","D009207","Myoclonus","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1288,D1288)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1288,M1288)","v":"Pituitary Neoplasms"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1288,N1288)","v":"DTXSID6020224"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1288,J1288)","v":"791821"},"gamma-Butyrolactone.","791821","Central Nervous System Diseases","D010911","Pituitary Neoplasms","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1289,D1289)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1289,M1289)","v":"Seizures"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1289,N1289)","v":"DTXSID6020224"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1289,J1289)","v":"18226321"},"Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.","18226321","Neurologic Manifestations","D012640","Seizures","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1290,D1290)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1290,M1290)","v":"Seizures"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1290,N1290)","v":"DTXSID6020224"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1290,J1290)","v":"15298490"},"Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.","15298490","Neurologic Manifestations","D012640","Seizures","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1291,D1291)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1291,M1291)","v":"Seizures"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1291,N1291)","v":"DTXSID6020224"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1291,J1291)","v":"11138892"},"Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature.","11138892","Neurologic Manifestations","D012640","Seizures","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1292,D1292)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1292,M1292)","v":"Seizures"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1292,N1292)","v":"DTXSID6020224"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1292,J1292)","v":"11493842"},"Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol.","11493842","Neurologic Manifestations","D012640","Seizures","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1293,D1293)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1293,M1293)","v":"Sleep Initiation and Maintenance Disorders"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1293,N1293)","v":"DTXSID6020224"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1293,J1293)","v":"11161128"},"Gamma butyrolactone (GBL) withdrawal syndromes.","11161128","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1294,D1294)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1294,M1294)","v":"Sleep Initiation and Maintenance Disorders"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1294,N1294)","v":"DTXSID6020224"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1294,J1294)","v":"11476261"},"Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.","11476261","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1295,D1295)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1295,M1295)","v":"Tremor"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1295,N1295)","v":"DTXSID6020224"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1295,J1295)","v":"11476261"},"Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.","11476261","Neurologic Manifestations","D014202","Tremor","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1296,D1296)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1296,M1296)","v":"Unconsciousness"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1296,N1296)","v":"DTXSID6020224"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1296,J1296)","v":"23397667"},"Two cases of near-fatal gamma-butyrolactone (GBL) ingestion and intoxication.","23397667","Neurologic Manifestations","D014474","Unconsciousness","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1297,D1297)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1297,M1297)","v":"Unconsciousness"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1297,N1297)","v":"DTXSID6020224"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1297,J1297)","v":"19376455"},"Fast-in, fast-out.","19376455","Neurologic Manifestations","D014474","Unconsciousness","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1298,D1298)","v":"4-Butyrolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1298,M1298)","v":"Unconsciousness"},"D015107","4-Butyrolactone","96-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1298,N1298)","v":"DTXSID6020224"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1298,J1298)","v":"1462403"},"[Unconsciousness after ingestion of nail varnish].","1462403","Neurologic Manifestations","D014474","Unconsciousness","DTXSID6020224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1299,D1299)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1299,M1299)","v":"Brain Diseases"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1299,N1299)","v":"DTXSID1020431"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1299,J1299)","v":"1295976"},"[Encephalopathy due to repeated voluntary inhalation of paradichlorobenzene].","1295976","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1300,D1300)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1300,M1300)","v":"Cerebellar Ataxia"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1300,N1300)","v":"DTXSID1020431"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1300,J1300)","v":"3361344"},"Reversible ataxia following chronic exposure to paradichlorobenzene.","3361344","Central Nervous System Diseases","D002524","Cerebellar Ataxia","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1301,D1301)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1301,M1301)","v":"Cerebellar Ataxia"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1301,N1301)","v":"DTXSID1020431"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1301,J1301)","v":"1532642"},"[Encephalopathy caused by repeated voluntary inhalation of paradichlorobenzene].","1532642","Central Nervous System Diseases","D002524","Cerebellar Ataxia","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1302,D1302)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1302,M1302)","v":"Dementia"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1302,N1302)","v":"DTXSID1020431"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1302,J1302)","v":"22314767"},"[Dementia associated to paradichlorobenzene poisoning].","22314767","Central Nervous System Diseases","D003704","Dementia","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1303,D1303)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1303,M1303)","v":"Dementia"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1303,N1303)","v":"DTXSID1020431"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1303,J1303)","v":"21565601"},"Partially reversible dementia associated with the use of para-dichlorobenzene in the case of pica.","21565601","Central Nervous System Diseases","D003704","Dementia","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1304,D1304)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1304,M1304)","v":"Dysarthria"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1304,N1304)","v":"DTXSID1020431"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1304,J1304)","v":"16364591"},"Mothballs and obstetric anesthesia.","16364591","Neurologic Manifestations","D004401","Dysarthria","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1305,D1305)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1305,M1305)","v":"Encephalitis"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1305,N1305)","v":"DTXSID1020431"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1305,J1305)","v":"20430245"},"Mothball induced encephalopathy presenting as depression: it's all in the history.","20430245","Central Nervous System Diseases","D004660","Encephalitis","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1306,D1306)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1306,M1306)","v":"Gait Ataxia"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1306,N1306)","v":"DTXSID1020431"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1306,J1306)","v":"17347127"},"Mothball withdrawal encephalopathy: case report and review of paradichlorobenzene neurotoxicity.","17347127","Neurologic Manifestations","D020234","Gait Ataxia","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1307,D1307)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1307,M1307)","v":"Leukoencephalopathies"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1307,N1307)","v":"DTXSID1020431"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1307,J1307)","v":"23608871"},"Paradichlorobenzene (toxin)-induced leucoencephalopathy.","23608871","Central Nervous System Diseases","D056784","Leukoencephalopathies","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1308,D1308)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1308,M1308)","v":"Leukoencephalopathies"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1308,N1308)","v":"DTXSID1020431"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1308,J1308)","v":"20373064"},"Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy.","20373064","Central Nervous System Diseases","D056784","Leukoencephalopathies","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1309,D1309)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1309,M1309)","v":"Leukoencephalopathies"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1309,N1309)","v":"DTXSID1020431"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1309,J1309)","v":"22431793"},"A fatal case of mothball intoxication presenting with refractory pruritus and ichthyosis.","22431793","Central Nervous System Diseases","D056784","Leukoencephalopathies","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1310,D1310)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1310,M1310)","v":"Multiple Sclerosis, Relapsing-Remitting"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1310,N1310)","v":"DTXSID1020431"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1310,J1310)","v":"24343157"},"Multiple sclerosis disease progression and paradichlorobenzene: a tale of mothballs and toilet cleaner.","24343157","Autoimmune Diseases of the Nervous System","D020529","Multiple Sclerosis, Relapsing-Remitting","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1311,D1311)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1311,M1311)","v":"Mutism"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1311,N1311)","v":"DTXSID1020431"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1311,J1311)","v":"17347127"},"Mothball withdrawal encephalopathy: case report and review of paradichlorobenzene neurotoxicity.","17347127","Neurologic Manifestations","D009155","Mutism","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1312,D1312)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1312,M1312)","v":"Nervous System Diseases"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1312,N1312)","v":"DTXSID1020431"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1312,J1312)","v":"1532642"},"[Encephalopathy caused by repeated voluntary inhalation of paradichlorobenzene].","1532642","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1313,D1313)","v":"4-dichlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1313,M1313)","v":"Neuromuscular Diseases"},"C018511","4-dichlorobenzene","106-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1313,N1313)","v":"DTXSID1020431"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1313,J1313)","v":"17347127"},"Mothball withdrawal encephalopathy: case report and review of paradichlorobenzene neurotoxicity.","17347127","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID1020431"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1314,D1314)","v":"4-hydroxybutyric acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1314,M1314)","v":"Catatonia"},"C111420","4-hydroxybutyric acid","591-81-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1314,N1314)","v":"DTXSID2074740"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1314,J1314)","v":"25377371"},"Catatonic stupor secondary to gamma-hydroxy-butyric acid (GHB)-dependence and -withdrawal syndrome.","25377371","Neurologic Manifestations","D002389","Catatonia","DTXSID2074740"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1315,D1315)","v":"4-hydroxybutyric acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1315,M1315)","v":"Coma"},"C111420","4-hydroxybutyric acid","591-81-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1315,N1315)","v":"DTXSID2074740"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1315,J1315)","v":"23250641"},"[Cognitive impairment due to intensive use and overdoses of gammahydroxybutyric acid (GHB)].","23250641","Neurologic Manifestations","D003128","Coma","DTXSID2074740"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1316,D1316)","v":"4-hydroxybutyric acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1316,M1316)","v":"Coma"},"C111420","4-hydroxybutyric acid","591-81-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1316,N1316)","v":"DTXSID2074740"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1316,J1316)","v":"12674741"},"[Coma in a 21-year-old party attendant].","12674741","Neurologic Manifestations","D003128","Coma","DTXSID2074740"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1317,D1317)","v":"4-hydroxybutyric acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1317,M1317)","v":"Consciousness Disorders"},"C111420","4-hydroxybutyric acid","591-81-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1317,N1317)","v":"DTXSID2074740"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1317,J1317)","v":"15243989"},"Sedation with 4-hydroxybutyric acid: a potential pitfall in the diagnosis of SSADH deficiency.","15243989","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID2074740"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1318,D1318)","v":"4-hydroxybutyric acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1318,M1318)","v":"Epilepsy, Absence"},"C111420","4-hydroxybutyric acid","591-81-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1318,N1318)","v":"DTXSID2074740"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1318,J1318)","v":"14673012"},"Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures.","14673012","Central Nervous System Diseases","D004832","Epilepsy, Absence","DTXSID2074740"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1319,D1319)","v":"4-hydroxybutyric acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1319,M1319)","v":"Exotropia"},"C111420","4-hydroxybutyric acid","591-81-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1319,N1319)","v":"DTXSID2074740"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1319,J1319)","v":"18004131"},"Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.","18004131","Cranial Nerve Diseases","D005099","Exotropia","DTXSID2074740"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1320,D1320)","v":"4-hydroxybutyric acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1320,M1320)","v":"Hallucinations"},"C111420","4-hydroxybutyric acid","591-81-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1320,N1320)","v":"DTXSID2074740"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1320,J1320)","v":"11739915"},"Prolonged withdrawal from extreme gamma-hydroxybutyrate (GHB) abuse.","11739915","Neurologic Manifestations","D006212","Hallucinations","DTXSID2074740"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1321,D1321)","v":"4-hydroxybutyric acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1321,M1321)","v":"Miosis"},"C111420","4-hydroxybutyric acid","591-81-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1321,N1321)","v":"DTXSID2074740"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1321,J1321)","v":"18004131"},"Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.","18004131","Neurologic Manifestations","D015877","Miosis","DTXSID2074740"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1322,D1322)","v":"4-hydroxybutyric acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1322,M1322)","v":"Seizures"},"C111420","4-hydroxybutyric acid","591-81-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1322,N1322)","v":"DTXSID2074740"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1322,J1322)","v":"21530412"},"γ-Hydroxybutyric acid-induced psychosis and seizures.","21530412","Neurologic Manifestations","D012640","Seizures","DTXSID2074740"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1323,D1323)","v":"4-hydroxybutyric acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1323,M1323)","v":"Stupor"},"C111420","4-hydroxybutyric acid","591-81-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1323,N1323)","v":"DTXSID2074740"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1323,J1323)","v":"25377371"},"Catatonic stupor secondary to gamma-hydroxy-butyric acid (GHB)-dependence and -withdrawal syndrome.","25377371","Neurologic Manifestations","D053608","Stupor","DTXSID2074740"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1324,D1324)","v":"4-methylimidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1324,M1324)","v":"Ataxia"},"C023439","4-methylimidazole","822-36-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1324,N1324)","v":"DTXSID9025617"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1324,J1324)","v":"3603554"},"The relationship between uncoupling of oxidative phosphorylation and neuronal necrosis within the CNS in rats dosed with trihalogenated imidazoles.","3603554","Neurologic Manifestations","D001259","Ataxia","DTXSID9025617"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1325,D1325)","v":"4-methylimidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1325,M1325)","v":"Nervous System Diseases"},"C023439","4-methylimidazole","822-36-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1325,N1325)","v":"DTXSID9025617"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1325,J1325)","v":"17619857"},"Toxicity and carcinogenicity studies of 4-methylimidazole in F344/N rats and B6C3F1 mice.","17619857","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID9025617"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1326,D1326)","v":"4-methylimidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1326,M1326)","v":"Seizures"},"C023439","4-methylimidazole","822-36-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1326,N1326)","v":"DTXSID9025617"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1326,J1326)","v":"3727358"},"Pilot studies in cattle and mice to determine the presence of 4-methylimidazole in milk after oral ingestion.","3727358","Neurologic Manifestations","D012640","Seizures","DTXSID9025617"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1327,D1327)","v":"4-methylimidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1327,M1327)","v":"Seizures"},"C023439","4-methylimidazole","822-36-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1327,N1327)","v":"DTXSID9025617"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1327,J1327)","v":"17619857"},"Toxicity and carcinogenicity studies of 4-methylimidazole in F344/N rats and B6C3F1 mice.","17619857","Neurologic Manifestations","D012640","Seizures","DTXSID9025617"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1328,D1328)","v":"4-methylimidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1328,M1328)","v":"Tremor"},"C023439","4-methylimidazole","822-36-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1328,N1328)","v":"DTXSID9025617"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1328,J1328)","v":"3727358"},"Pilot studies in cattle and mice to determine the presence of 4-methylimidazole in milk after oral ingestion.","3727358","Neurologic Manifestations","D014202","Tremor","DTXSID9025617"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1329,D1329)","v":"4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1329,M1329)","v":"Brain Ischemia"},"C498826","4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide","641571-10-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1329,N1329)","v":"DTXSID5042663"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1329,J1329)","v":"24659599"},"Cerebrovascular events during nilotinib treatment.","24659599","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID5042663"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1330,D1330)","v":"4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1330,M1330)","v":"Carotid Stenosis"},"C498826","4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide","641571-10-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1330,N1330)","v":"DTXSID5042663"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1330,J1330)","v":"28583043"},"Intracranial stenting for nilotinib treatment-associated cerebrovascular stenosis in chronic myeloid leukemia.","28583043","Central Nervous System Diseases","D016893","Carotid Stenosis","DTXSID5042663"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1331,D1331)","v":"4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1331,M1331)","v":"Cerebrovascular Disorders"},"C498826","4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide","641571-10-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1331,N1331)","v":"DTXSID5042663"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1331,J1331)","v":"23526495"},"Nilotinib treatment-associated cerebrovascular disease and stroke.","23526495","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID5042663"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1332,D1332)","v":"4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1332,M1332)","v":"Muscular Diseases"},"C498826","4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide","641571-10-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1332,N1332)","v":"DTXSID5042663"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1332,J1332)","v":"22742815"},"Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib.","22742815","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID5042663"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1333,D1333)","v":"4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1333,M1333)","v":"Spasm"},"C498826","4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide","641571-10-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1333,N1333)","v":"DTXSID5042663"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1333,J1333)","v":"22742815"},"Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib.","22742815","Neurologic Manifestations","D013035","Spasm","DTXSID5042663"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1334,D1334)","v":"4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1334,M1334)","v":"Stroke"},"C498826","4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide","641571-10-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1334,N1334)","v":"DTXSID5042663"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1334,J1334)","v":"23526495"},"Nilotinib treatment-associated cerebrovascular disease and stroke.","23526495","Central Nervous System Diseases","D020521","Stroke","DTXSID5042663"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1335,D1335)","v":"4-phenylenediamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1335,M1335)","v":"Brain Diseases"},"C029728","4-phenylenediamine","16245-77-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1335,N1335)","v":"DTXSID6066028"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1335,J1335)","v":"25666242"},"Characteristic autopsy findings in hair dye poisoning.","25666242","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID6066028"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1336,D1336)","v":"4-phenylenediamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1336,M1336)","v":"Muscular Diseases"},"C029728","4-phenylenediamine","16245-77-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1336,N1336)","v":"DTXSID6066028"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1336,J1336)","v":"25666242"},"Characteristic autopsy findings in hair dye poisoning.","25666242","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID6066028"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1337,D1337)","v":"4-phenylenediamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1337,M1337)","v":"Optic Atrophy"},"C029728","4-phenylenediamine","16245-77-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1337,N1337)","v":"DTXSID6066028"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1337,J1337)","v":"8863054"},"Paraphenylenediamine induced optic atrophy following hair dye poisoning.","8863054","Cranial Nerve Diseases","D009896","Optic Atrophy","DTXSID6066028"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1338,D1338)","v":"4-phenylenediamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1338,M1338)","v":"Paralysis"},"C029728","4-phenylenediamine","16245-77-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1338,N1338)","v":"DTXSID6066028"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1338,J1338)","v":"8773104"},"Hair dye poisoning.","8773104","Neurologic Manifestations","D010243","Paralysis","DTXSID6066028"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1339,D1339)","v":"4-phenylenediamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1339,M1339)","v":"Paresthesia"},"C029728","4-phenylenediamine","16245-77-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1339,N1339)","v":"DTXSID6066028"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1339,J1339)","v":"8773104"},"Hair dye poisoning.","8773104","Neurologic Manifestations","D010292","Paresthesia","DTXSID6066028"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1340,D1340)","v":"4-phenylenediamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1340,M1340)","v":"Trismus"},"C029728","4-phenylenediamine","16245-77-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1340,N1340)","v":"DTXSID6066028"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1340,J1340)","v":"18405138"},"Hair dye poisoning.","18405138","Neurologic Manifestations","D014313","Trismus","DTXSID6066028"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1341,D1341)","v":"5,7-Dihydroxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1341,M1341)","v":"Ataxia"},"D015116","5,7-Dihydroxytryptamine","31363-74-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1341,N1341)","v":"DTXSID00185285"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1341,J1341)","v":"10640305"},"Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agents.","10640305","Neurologic Manifestations","D001259","Ataxia","DTXSID00185285"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1342,D1342)","v":"5,7-Dihydroxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1342,M1342)","v":"Brain Diseases"},"D015116","5,7-Dihydroxytryptamine","31363-74-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1342,N1342)","v":"DTXSID00185285"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1342,J1342)","v":"12062580"},"Combined 192 IgG-saporin and 5,7-dihydroxytryptamine lesions in the male rat brain: a neurochemical and behavioral study.","12062580","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID00185285"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1343,D1343)","v":"5,7-Dihydroxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1343,M1343)","v":"Brain Neoplasms"},"D015116","5,7-Dihydroxytryptamine","31363-74-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1343,N1343)","v":"DTXSID00185285"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1343,J1343)","v":"8243108"},"High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.","8243108","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID00185285"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1344,D1344)","v":"5,7-Dihydroxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1344,M1344)","v":"Epilepsies, Partial"},"D015116","5,7-Dihydroxytryptamine","31363-74-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1344,N1344)","v":"DTXSID00185285"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1344,J1344)","v":"18845420"},"Serotonin depletion effects on the pilocarpine model of epilepsy.","18845420","Central Nervous System Diseases","D004828","Epilepsies, Partial","DTXSID00185285"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1345,D1345)","v":"5,7-Dihydroxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1345,M1345)","v":"Epilepsy"},"D015116","5,7-Dihydroxytryptamine","31363-74-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1345,N1345)","v":"DTXSID00185285"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1345,J1345)","v":"22860417"},"[Effect of serotonin depletion on seizures learning-memory in pilocarpine-induced epileptic rats].","22860417","Central Nervous System Diseases","D004827","Epilepsy","DTXSID00185285"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1346,D1346)","v":"5,7-Dihydroxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1346,M1346)","v":"Nervous System Diseases"},"D015116","5,7-Dihydroxytryptamine","31363-74-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1346,N1346)","v":"DTXSID00185285"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1346,J1346)","v":"7391271"},"Effects of indolic neurotoxins on enteric serotonergic neurons.","7391271","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID00185285"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1347,D1347)","v":"5,7-Dihydroxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1347,M1347)","v":"Seizures"},"D015116","5,7-Dihydroxytryptamine","31363-74-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1347,N1347)","v":"DTXSID00185285"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1347,J1347)","v":"15246707"},"Neural and hormonal consequences of neonatal 5,7-dihydroxytryptamine may not be associated with serotonin depletion.","15246707","Neurologic Manifestations","D012640","Seizures","DTXSID00185285"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1348,D1348)","v":"5,7-Dihydroxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1348,M1348)","v":"Spinal Cord Diseases"},"D015116","5,7-Dihydroxytryptamine","31363-74-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1348,N1348)","v":"DTXSID00185285"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1348,J1348)","v":"1762682"},"Immunoelectron microscopic analysis of the synaptic connectivity of serotoninergic neurons grafted to the 5,7-dihydroxytryptamine-lesioned rat spinal cord.","1762682","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID00185285"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1349,D1349)","v":"5,7-Dihydroxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1349,M1349)","v":"Status Epilepticus"},"D015116","5,7-Dihydroxytryptamine","31363-74-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1349,N1349)","v":"DTXSID00185285"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1349,J1349)","v":"18845420"},"Serotonin depletion effects on the pilocarpine model of epilepsy.","18845420","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID00185285"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1350,D1350)","v":"5-methoxy-N,N-diisopropyltryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1350,M1350)","v":"Catalepsy"},"C033696","5-methoxy-N,N-diisopropyltryptamine","4021-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1350,N1350)","v":"DTXSID00193209"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1350,J1350)","v":"18072099"},"Foxy methoxy: a new drug of abuse.","18072099","Neurologic Manifestations","D002375","Catalepsy","DTXSID00193209"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1351,D1351)","v":"5-methoxy-N,N-diisopropyltryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1351,M1351)","v":"Dementia"},"C033696","5-methoxy-N,N-diisopropyltryptamine","4021-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1351,N1351)","v":"DTXSID00193209"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1351,J1351)","v":"16280455"},"Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.","16280455","Central Nervous System Diseases","D003704","Dementia","DTXSID00193209"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1352,D1352)","v":"5-methoxy-N,N-diisopropyltryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1352,M1352)","v":"Hallucinations"},"C033696","5-methoxy-N,N-diisopropyltryptamine","4021-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1352,N1352)","v":"DTXSID00193209"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1352,J1352)","v":"18072099"},"Foxy methoxy: a new drug of abuse.","18072099","Neurologic Manifestations","D006212","Hallucinations","DTXSID00193209"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1353,D1353)","v":"5-methoxy-N,N-diisopropyltryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1353,M1353)","v":"Paresthesia"},"C033696","5-methoxy-N,N-diisopropyltryptamine","4021-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1353,N1353)","v":"DTXSID00193209"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1353,J1353)","v":"15607587"},"A foxy intoxication.","15607587","Neurologic Manifestations","D010292","Paresthesia","DTXSID00193209"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1354,D1354)","v":"5-methoxy-N,N-diisopropyltryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1354,M1354)","v":"Perceptual Disorders"},"C033696","5-methoxy-N,N-diisopropyltryptamine","4021-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1354,N1354)","v":"DTXSID00193209"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1354,J1354)","v":"16933659"},"An examination of the effects of 5-Methoxy-n, n-di(ISO)propyltryptamine hydrochloride (Foxy) on cognitive development in rats.","16933659","Neurologic Manifestations","D010468","Perceptual Disorders","DTXSID00193209"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1355,D1355)","v":"5-Methoxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1355,M1355)","v":"Catalepsy"},"D008735","5-Methoxytryptamine","608-07-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1355,N1355)","v":"DTXSID60209638"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1355,J1355)","v":"18072099"},"Foxy methoxy: a new drug of abuse.","18072099","Neurologic Manifestations","D002375","Catalepsy","DTXSID60209638"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1356,D1356)","v":"5-Methoxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1356,M1356)","v":"Dementia"},"D008735","5-Methoxytryptamine","608-07-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1356,N1356)","v":"DTXSID60209638"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1356,J1356)","v":"16280455"},"Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.","16280455","Central Nervous System Diseases","D003704","Dementia","DTXSID60209638"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1357,D1357)","v":"5-Methoxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1357,M1357)","v":"Hallucinations"},"D008735","5-Methoxytryptamine","608-07-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1357,N1357)","v":"DTXSID60209638"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1357,J1357)","v":"18072099"},"Foxy methoxy: a new drug of abuse.","18072099","Neurologic Manifestations","D006212","Hallucinations","DTXSID60209638"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1358,D1358)","v":"5-Methoxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1358,M1358)","v":"Paresthesia"},"D008735","5-Methoxytryptamine","608-07-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1358,N1358)","v":"DTXSID60209638"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1358,J1358)","v":"15607587"},"A foxy intoxication.","15607587","Neurologic Manifestations","D010292","Paresthesia","DTXSID60209638"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1359,D1359)","v":"5-Methoxytryptamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1359,M1359)","v":"Perceptual Disorders"},"D008735","5-Methoxytryptamine","608-07-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1359,N1359)","v":"DTXSID60209638"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1359,J1359)","v":"16933659"},"An examination of the effects of 5-Methoxy-n, n-di(ISO)propyltryptamine hydrochloride (Foxy) on cognitive development in rats.","16933659","Neurologic Manifestations","D010468","Perceptual Disorders","DTXSID60209638"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1360,D1360)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1360,M1360)","v":"Brain Edema"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1360,N1360)","v":"DTXSID5051446"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1360,J1360)","v":"6216837"},"Brain edema and gliopathy induced by 6-aminonicotinamide intoxication in the central nervous system of rats.","6216837","Central Nervous System Diseases","D001929","Brain Edema","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1361,D1361)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1361,M1361)","v":"Brain Edema"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1361,N1361)","v":"DTXSID5051446"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1361,J1361)","v":"212697"},"Cytotoxic edema produced by 6-aminonicotinamide and its response to therapy.","212697","Central Nervous System Diseases","D001929","Brain Edema","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1362,D1362)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1362,M1362)","v":"Central Nervous System Diseases"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1362,N1362)","v":"DTXSID5051446"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1362,J1362)","v":"39569"},"Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.","39569","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1363,D1363)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1363,M1363)","v":"Central Nervous System Diseases"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1363,N1363)","v":"DTXSID5051446"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1363,J1363)","v":"147938"},"Repression of glial RNA transcription during the development of 6-aminonic-otinamide (6-AN)-induced acute gliopathy.","147938","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1364,D1364)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1364,M1364)","v":"Encephalitis"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1364,N1364)","v":"DTXSID5051446"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1364,J1364)","v":"12359172"},"M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment.","12359172","Central Nervous System Diseases","D004660","Encephalitis","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1365,D1365)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1365,M1365)","v":"Hydrocephalus"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1365,N1365)","v":"DTXSID5051446"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1365,J1365)","v":"2948367"},"Aqueductal lesions in 6-aminonicotinamide-treated suckling mice.","2948367","Central Nervous System Diseases","D006849","Hydrocephalus","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1366,D1366)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1366,M1366)","v":"Hydrocephalus"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1366,N1366)","v":"DTXSID5051446"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1366,J1366)","v":"2932200"},"Aqueduct stenosis induced by a single injection of antivitamin.","2932200","Central Nervous System Diseases","D006849","Hydrocephalus","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1367,D1367)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1367,M1367)","v":"Hydrocephalus"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1367,N1367)","v":"DTXSID5051446"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1367,J1367)","v":"2933377"},"An electron microscopical study of epiplexus and supraependymal cells in the prenatal rat brain following a maternal injection of 6-aminonicotinamide.","2933377","Central Nervous System Diseases","D006849","Hydrocephalus","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1368,D1368)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1368,M1368)","v":"Hydrocephalus"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1368,N1368)","v":"DTXSID5051446"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1368,J1368)","v":"1724296"},"Congenital hydrocephalus mimicking Dandy-Walker syndrome induced by 6-aminonicotinamide injection in pregnant rat.","1724296","Central Nervous System Diseases","D006849","Hydrocephalus","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1369,D1369)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1369,M1369)","v":"Neural Tube Defects"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1369,N1369)","v":"DTXSID5051446"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1369,J1369)","v":"6454986"},"The effect of 6-aminonicotinamide on energy metabolism in rat embryo neural tube.","6454986","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1370,D1370)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1370,M1370)","v":"Neurodegenerative Diseases"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1370,N1370)","v":"DTXSID5051446"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1370,J1370)","v":"9783999"},"Spongiform neuropathy induced in dogs by prolonged, low-level administration of 6-aminonicotinamide (6-ANA).","9783999","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1371,D1371)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1371,M1371)","v":"Paraplegia"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1371,N1371)","v":"DTXSID5051446"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1371,J1371)","v":"6156230"},"Axonal transport in rats rendered paraplegic following a single subarachnoid injection of either batrachotoxin or 6-aminonicotinamide into the spinal cord.","6156230","Neurologic Manifestations","D010264","Paraplegia","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1372,D1372)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1372,M1372)","v":"Paraplegia"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1372,N1372)","v":"DTXSID5051446"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1372,J1372)","v":"146536"},"Physiological, biochemical and histological changes in skeletal muscle, neuromuscular junction and spinal cord of rats rendered paraplegic by subarachnoidal administration of 6-aminonicotinamide.","146536","Neurologic Manifestations","D010264","Paraplegia","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1373,D1373)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1373,M1373)","v":"Parkinson Disease, Secondary"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1373,N1373)","v":"DTXSID5051446"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1373,J1373)","v":"39569"},"Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.","39569","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1374,D1374)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1374,M1374)","v":"Peripheral Nervous System Diseases"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1374,N1374)","v":"DTXSID5051446"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1374,J1374)","v":"204752"},"How do axons control myelin formation? The model of 6-aminonicotinamide neuropathy.","204752","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1375,D1375)","v":"6-Aminonicotinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1375,M1375)","v":"Tinnitus"},"D015120","6-Aminonicotinamide","329-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1375,N1375)","v":"DTXSID5051446"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1375,J1375)","v":"152612"},"Topical 6-aminonicotinamide plus oral niacinamide therapy for psoriasis.","152612","Neurologic Manifestations","D014012","Tinnitus","DTXSID5051446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1376,D1376)","v":"9,10-Dimethyl-1,2-benzanthracene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1376,M1376)","v":"Brain Neoplasms"},"D015127","9,10-Dimethyl-1,2-benzanthracene","57-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1376,N1376)","v":"DTXSID1020510"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1376,J1376)","v":"105473"},"[Blastomogenesis in repeated administration of DMBA in rats during different life periods].","105473","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID1020510"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1377,D1377)","v":"9,10-Dimethyl-1,2-benzanthracene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1377,M1377)","v":"Brain Neoplasms"},"D015127","9,10-Dimethyl-1,2-benzanthracene","57-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1377,N1377)","v":"DTXSID1020510"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1377,J1377)","v":"101257"},"[Transplacental penetration of 7,12-dimethylbenz(a)anthracene and its distribution in the organs of rat fetuses].","101257","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID1020510"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1378,D1378)","v":"9,10-Dimethyl-1,2-benzanthracene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1378,M1378)","v":"Chronobiology Disorders"},"D015127","9,10-Dimethyl-1,2-benzanthracene","57-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1378,N1378)","v":"DTXSID1020510"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1378,J1378)","v":"15980990"},"Long-term dysregulation of circadian and 17-beta estradiol-induced LH, prolactin and corticosterone secretion after dimethylbenz (a) anthracene administration in the Sprague-Dawley female rat.","15980990","Chronobiology Disorders","D021081","Chronobiology Disorders","DTXSID1020510"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1379,D1379)","v":"9,10-Dimethyl-1,2-benzanthracene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1379,M1379)","v":"Hyperprolactinemia"},"D015127","9,10-Dimethyl-1,2-benzanthracene","57-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1379,N1379)","v":"DTXSID1020510"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1379,J1379)","v":"9131265"},"Effects of dehydroepiandrosterone and other sex steroid hormones on mammary carcinogenesis by direct injection of 7,12-dimethylbenz(a) anthracene (DMBA) in hyperprolactinemic female rats.","9131265","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID1020510"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1380,D1380)","v":"9,10-Dimethyl-1,2-benzanthracene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1380,M1380)","v":"Peripheral Nervous System Neoplasms"},"D015127","9,10-Dimethyl-1,2-benzanthracene","57-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1380,N1380)","v":"DTXSID1020510"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1380,J1380)","v":"101257"},"[Transplacental penetration of 7,12-dimethylbenz(a)anthracene and its distribution in the organs of rat fetuses].","101257","Neuromuscular Diseases","D010524","Peripheral Nervous System Neoplasms","DTXSID1020510"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1381,D1381)","v":"9,10-Dimethyl-1,2-benzanthracene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1381,M1381)","v":"Spinal Cord Neoplasms"},"D015127","9,10-Dimethyl-1,2-benzanthracene","57-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1381,N1381)","v":"DTXSID1020510"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1381,J1381)","v":"105473"},"[Blastomogenesis in repeated administration of DMBA in rats during different life periods].","105473","Nervous System Neoplasms","D013120","Spinal Cord Neoplasms","DTXSID1020510"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1382,D1382)","v":"9-fluoroprednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1382,M1382)","v":"Muscle Hypotonia"},"C010958","9-fluoroprednisolone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1382,N1382)","v":"DTXSID101009333"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1382,J1382)","v":"6856155"},"[Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases].","6856155","Neurologic Manifestations","D009123","Muscle Hypotonia","DTXSID101009333"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1383,D1383)","v":"9-fluoroprednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1383,M1383)","v":"Muscular Diseases"},"C010958","9-fluoroprednisolone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1383,N1383)","v":"DTXSID101009333"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1383,J1383)","v":"3720236"},"[Hypokalemic myopathy, high levels of muscle enzymes and myocardial ischemia secondary to the topical administration of 9-alpha-fluoro-prednisolone].","3720236","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID101009333"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1384,D1384)","v":"9-fluoroprednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1384,M1384)","v":"Muscular Diseases"},"C010958","9-fluoroprednisolone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1384,N1384)","v":"DTXSID101009333"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1384,J1384)","v":"3594977"},"Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray.","3594977","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID101009333"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1385,D1385)","v":"9-fluoroprednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1385,M1385)","v":"Muscular Diseases"},"C010958","9-fluoroprednisolone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1385,N1385)","v":"DTXSID101009333"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1385,J1385)","v":"3274232"},"[Hypopotassemic myopathy caused by topical administration of 9 alpha fluoroprednisolone].","3274232","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID101009333"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1386,D1386)","v":"9-fluoroprednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1386,M1386)","v":"Paralysis"},"C010958","9-fluoroprednisolone",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1386,N1386)","v":"DTXSID101009333"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1386,J1386)","v":"2762657"},"[Severe hypopotassemia and rhabdomyolysis in a normotensive subject after use of a nasal spray containing 9-alpha-fluoroprednisolone].","2762657","Neurologic Manifestations","D010243","Paralysis","DTXSID101009333"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1387,D1387)","v":"abacavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1387,M1387)","v":"Hallucinations"},"C106538","abacavir","136470-78-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1387,N1387)","v":"DTXSID4046444"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1387,J1387)","v":"12459415"},"Neuropsychiatric reaction induced by abacavir.","12459415","Neurologic Manifestations","D006212","Hallucinations","DTXSID4046444"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1388,D1388)","v":"abacavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1388,M1388)","v":"Ischemic Attack, Transient"},"C106538","abacavir","136470-78-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1388,N1388)","v":"DTXSID4046444"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1388,J1388)","v":"21653308"},"Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.","21653308","Central Nervous System Diseases","D002546","Ischemic Attack, Transient","DTXSID4046444"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1389,D1389)","v":"abacavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1389,M1389)","v":"Migraine Disorders"},"C106538","abacavir","136470-78-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1389,N1389)","v":"DTXSID4046444"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1389,J1389)","v":"12459415"},"Neuropsychiatric reaction induced by abacavir.","12459415","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID4046444"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1390,D1390)","v":"abacavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1390,M1390)","v":"Mitochondrial Myopathies"},"C106538","abacavir","136470-78-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1390,N1390)","v":"DTXSID4046444"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1390,J1390)","v":"16759591"},"[Antiretroviral treatment associated life-threatening adverse events].","16759591","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID4046444"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1391,D1391)","v":"abacavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1391,M1391)","v":"Nervous System Diseases"},"C106538","abacavir","136470-78-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1391,N1391)","v":"DTXSID4046444"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1391,J1391)","v":"14502007"},"Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.","14502007","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID4046444"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1392,D1392)","v":"abacavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1392,M1392)","v":"Night Terrors"},"C106538","abacavir","136470-78-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1392,N1392)","v":"DTXSID4046444"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1392,J1392)","v":"15622330"},"More on abacavir-induced neuropsychiatric reactions.","15622330","Sleep Wake Disorders","D020184","Night Terrors","DTXSID4046444"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1393,D1393)","v":"abacavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1393,M1393)","v":"Sleep Wake Disorders"},"C106538","abacavir","136470-78-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1393,N1393)","v":"DTXSID4046444"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1393,J1393)","v":"16568000"},"Neuropsychiatric reaction induced by abacavir in a pediatric human immunodeficiency virus-infected patient.","16568000","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID4046444"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1394,D1394)","v":"abacavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1394,M1394)","v":"Sleep Wake Disorders"},"C106538","abacavir","136470-78-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1394,N1394)","v":"DTXSID4046444"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1394,J1394)","v":"12459415"},"Neuropsychiatric reaction induced by abacavir.","12459415","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID4046444"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1395,D1395)","v":"abacavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1395,M1395)","v":"Stroke"},"C106538","abacavir","136470-78-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1395,N1395)","v":"DTXSID4046444"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1395,J1395)","v":"21653308"},"Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.","21653308","Central Nervous System Diseases","D020521","Stroke","DTXSID4046444"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1396,D1396)","v":"abacavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1396,M1396)","v":"Vertigo"},"C106538","abacavir","136470-78-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1396,N1396)","v":"DTXSID4046444"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1396,J1396)","v":"11839213"},"Vertigo and abacavir.","11839213","Neurologic Manifestations","D014717","Vertigo","DTXSID4046444"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1397,D1397)","v":"abamectin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1397,M1397)","v":"Ataxia"},"C048324","abamectin","71751-41-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1397,N1397)","v":"DTXSID8023892"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1397,J1397)","v":"23086031"},"Partial ptosis, dilated pupils and ataxia following abamectin poisoning.","23086031","Neurologic Manifestations","D001259","Ataxia","DTXSID8023892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1398,D1398)","v":"abamectin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1398,M1398)","v":"Coma"},"C048324","abamectin","71751-41-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1398,N1398)","v":"DTXSID8023892"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1398,J1398)","v":"17453886"},"Abamectin intoxication with coma and hypotension.","17453886","Neurologic Manifestations","D003128","Coma","DTXSID8023892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1399,D1399)","v":"abamectin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1399,M1399)","v":"Coma"},"C048324","abamectin","71751-41-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1399,N1399)","v":"DTXSID8023892"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1399,J1399)","v":"10381994"},"Agricultural avermectins: an uncommon but potentially fatal cause of pesticide poisoning.","10381994","Neurologic Manifestations","D003128","Coma","DTXSID8023892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1400,D1400)","v":"abamectin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1400,M1400)","v":"Confusion"},"C048324","abamectin","71751-41-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1400,N1400)","v":"DTXSID8023892"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1400,J1400)","v":"23086031"},"Partial ptosis, dilated pupils and ataxia following abamectin poisoning.","23086031","Neurologic Manifestations","D003221","Confusion","DTXSID8023892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1401,D1401)","v":"abamectin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1401,M1401)","v":"Nervous System Diseases"},"C048324","abamectin","71751-41-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1401,N1401)","v":"DTXSID8023892"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1401,J1401)","v":"9144452"},"P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity.","9144452","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8023892"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1402,D1402)","v":"Acebutolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1402,M1402)","v":"Cerebrovascular Disorders"},"D000070","Acebutolol","37517-30-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1402,N1402)","v":"DTXSID2048539"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1402,J1402)","v":"3099718"},"[Acebutolol and cerebral blood flow of the moderately hypertensive aged subject].","3099718","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID2048539"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1403,D1403)","v":"Acebutolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1403,M1403)","v":"Hypotension, Orthostatic"},"D000070","Acebutolol","37517-30-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1403,N1403)","v":"DTXSID2048539"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1403,J1403)","v":"6646473"},"[Treatment of essential arterial hypertension with a single daily dose of acebutolol].","6646473","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID2048539"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1404,D1404)","v":"Acebutolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1404,M1404)","v":"Myasthenia Gravis"},"D000070","Acebutolol","37517-30-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1404,N1404)","v":"DTXSID2048539"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1404,J1404)","v":"2269319"},"Fulminant myasthenia gravis soon after initiation of acebutolol therapy.","2269319","Autoimmune Diseases of the Nervous System","D009157","Myasthenia Gravis","DTXSID2048539"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1405,D1405)","v":"Acebutolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1405,M1405)","v":"Paresthesia"},"D000070","Acebutolol","37517-30-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1405,N1405)","v":"DTXSID2048539"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1405,J1405)","v":"277805"},"Subjective anaesthesia with acebutalol.","277805","Neurologic Manifestations","D010292","Paresthesia","DTXSID2048539"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1406,D1406)","v":"Acebutolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1406,M1406)","v":"Sleep Initiation and Maintenance Disorders"},"D000070","Acebutolol","37517-30-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1406,N1406)","v":"DTXSID2048539"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1406,J1406)","v":"6646473"},"[Treatment of essential arterial hypertension with a single daily dose of acebutolol].","6646473","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID2048539"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1407,D1407)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1407,M1407)","v":"Brain Diseases"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1407,N1407)","v":"DTXSID2022541"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1407,J1407)","v":"11408097"},"Neurological outcome in school-age children after in utero exposure to coumarins.","11408097","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1408,D1408)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1408,M1408)","v":"Causalgia"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1408,N1408)","v":"DTXSID2022541"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1408,J1408)","v":"2709909"},"[Causalgia in patients treated with anticoagulants].","2709909","Autonomic Nervous System Diseases","D002422","Causalgia","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1409,D1409)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1409,M1409)","v":"Cerebral Hemorrhage"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1409,N1409)","v":"DTXSID2022541"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1409,J1409)","v":"6442071"},"[Long-term treatment with coumarin preparations in advanced age].","6442071","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1410,D1410)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1410,M1410)","v":"Cerebral Hemorrhage"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1410,N1410)","v":"DTXSID2022541"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1410,J1410)","v":"4024857"},"Anticoagulant-induced intracerebral bleeding in brain ischemia. Evaluation in 200 patients with TIAs, emboli from the heart, and progressing stroke.","4024857","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1411,D1411)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1411,M1411)","v":"Cerebral Hemorrhage"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1411,N1411)","v":"DTXSID2022541"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1411,J1411)","v":"18690570"},"[Hemorrhagic stroke in a patient requiring long-term anticoagulant treatment: how to solve a dilemma].","18690570","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1412,D1412)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1412,M1412)","v":"Cerebral Hemorrhage"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1412,N1412)","v":"DTXSID2022541"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1412,J1412)","v":"2329852"},"[Intracranial hemorrhage in patients undergoing anticoagulant treatment with acenocoumarol].","2329852","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1413,D1413)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1413,M1413)","v":"Cerebral Hemorrhage"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1413,N1413)","v":"DTXSID2022541"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1413,J1413)","v":"15826524"},"[Serious haemorrhages linked to acenocoumarol in a rural area].","15826524","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1414,D1414)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1414,M1414)","v":"Cerebral Hemorrhage"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1414,N1414)","v":"DTXSID2022541"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1414,J1414)","v":"1343069"},"[Risk of chronic oral anticoagulant treatment in elderly patients].","1343069","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1415,D1415)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1415,M1415)","v":"Cerebral Infarction"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1415,N1415)","v":"DTXSID2022541"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1415,J1415)","v":"1682588"},"Strokes soon after oral anticoagulant therapy in patients with atrial fibrillation.","1682588","Central Nervous System Diseases","D002544","Cerebral Infarction","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1416,D1416)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1416,M1416)","v":"Hematoma, Epidural, Cranial"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1416,N1416)","v":"DTXSID2022541"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1416,J1416)","v":"175496"},"[Brown-Sequard syndrome and extradural spinal cord hematoma in a patient taking antivitamin K].","175496","Trauma, Nervous System","D006407","Hematoma, Epidural, Cranial","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1417,D1417)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1417,M1417)","v":"Hematoma, Epidural, Cranial"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1417,N1417)","v":"DTXSID2022541"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1417,J1417)","v":"5041385"},"[Spontaneous spinal epidural hematoma, unusual complication of anticoagulant treatment].","5041385","Trauma, Nervous System","D006407","Hematoma, Epidural, Cranial","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1418,D1418)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1418,M1418)","v":"Hematoma, Epidural, Cranial"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1418,N1418)","v":"DTXSID2022541"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1418,J1418)","v":"12944455"},"Spontaneous spinal hemorrhage complicating anticoagulant therapy.","12944455","Trauma, Nervous System","D006407","Hematoma, Epidural, Cranial","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1419,D1419)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1419,M1419)","v":"Hematoma, Subdural"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1419,N1419)","v":"DTXSID2022541"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1419,J1419)","v":"5751919"},"Subdural hematoma of the posterior fossa as a complication of anticoagulant therapy. Presentation of a case.","5751919","Central Nervous System Diseases","D006408","Hematoma, Subdural","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1420,D1420)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1420,M1420)","v":"Intracranial Embolism and Thrombosis"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1420,N1420)","v":"DTXSID2022541"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1420,J1420)","v":"1343069"},"[Risk of chronic oral anticoagulant treatment in elderly patients].","1343069","Central Nervous System Diseases","D002542","Intracranial Embolism and Thrombosis","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1421,D1421)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1421,M1421)","v":"Intracranial Hemorrhages"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1421,N1421)","v":"DTXSID2022541"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1421,J1421)","v":"10878885"},"[Intracranial hemorrhages in patients being treatment with anticoagulants].","10878885","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1422,D1422)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1422,M1422)","v":"Intracranial Hemorrhages"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1422,N1422)","v":"DTXSID2022541"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1422,J1422)","v":"11531623"},"Intracranial bleed in a pregnant patient on oral anticoagulants for prosthetic heart valve.","11531623","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1423,D1423)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1423,M1423)","v":"Muscular Diseases"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1423,N1423)","v":"DTXSID2022541"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1423,J1423)","v":"1867514"},"[Hematoma of the iliac psoas secondary to anticoagulant treatment. Urological implications].","1867514","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1424,D1424)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1424,M1424)","v":"Neuralgia"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1424,N1424)","v":"DTXSID2022541"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1424,J1424)","v":"2709909"},"[Causalgia in patients treated with anticoagulants].","2709909","Neuromuscular Diseases","D009437","Neuralgia","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1425,D1425)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1425,M1425)","v":"Paraplegia"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1425,N1425)","v":"DTXSID2022541"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1425,J1425)","v":"20570088"},"[Flaccid spontaneous paraplegia related to vitamin K antagonist].","20570088","Neurologic Manifestations","D010264","Paraplegia","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1426,D1426)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1426,M1426)","v":"Spinal Cord Diseases"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1426,N1426)","v":"DTXSID2022541"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1426,J1426)","v":"175496"},"[Brown-Sequard syndrome and extradural spinal cord hematoma in a patient taking antivitamin K].","175496","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1427,D1427)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1427,M1427)","v":"Spinal Cord Diseases"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1427,N1427)","v":"DTXSID2022541"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1427,J1427)","v":"5041385"},"[Spontaneous spinal epidural hematoma, unusual complication of anticoagulant treatment].","5041385","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1428,D1428)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1428,M1428)","v":"Spinal Cord Injuries"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1428,N1428)","v":"DTXSID2022541"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1428,J1428)","v":"12944455"},"Spontaneous spinal hemorrhage complicating anticoagulant therapy.","12944455","Trauma, Nervous System","D013119","Spinal Cord Injuries","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1429,D1429)","v":"Acenocoumarol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1429,M1429)","v":"Stroke"},"D000074","Acenocoumarol","152-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1429,N1429)","v":"DTXSID2022541"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1429,J1429)","v":"18690570"},"[Hemorrhagic stroke in a patient requiring long-term anticoagulant treatment: how to solve a dilemma].","18690570","Central Nervous System Diseases","D020521","Stroke","DTXSID2022541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1430,D1430)","v":"Acepromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1430,M1430)","v":"Brain Damage, Chronic"},"D000075","Acepromazine","3598-37-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1430,N1430)","v":"DTXSID6047783"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1430,J1430)","v":"12509193"},"The brain matrix and multifocal brain damage following a single injection of ketamine in young adult rats: conspicuous changes in old age.","12509193","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID6047783"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1431,D1431)","v":"Acepromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1431,M1431)","v":"Coma"},"D000075","Acepromazine","3598-37-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1431,N1431)","v":"DTXSID6047783"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1431,J1431)","v":"8116589"},"A fatality involving two unusual compounds--zolpidem and acepromazine.","8116589","Neurologic Manifestations","D003128","Coma","DTXSID6047783"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1432,D1432)","v":"Acepromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1432,M1432)","v":"Seizures"},"D000075","Acepromazine","3598-37-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1432,N1432)","v":"DTXSID6047783"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1432,J1432)","v":"22487256"},"Incidence of seizures associated with the use of acepromazine in dogs undergoing myelography.","22487256","Neurologic Manifestations","D012640","Seizures","DTXSID6047783"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1433,D1433)","v":"Acepromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1433,M1433)","v":"Seizures"},"D000075","Acepromazine","3598-37-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1433,N1433)","v":"DTXSID6047783"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1433,J1433)","v":"12509193"},"The brain matrix and multifocal brain damage following a single injection of ketamine in young adult rats: conspicuous changes in old age.","12509193","Neurologic Manifestations","D012640","Seizures","DTXSID6047783"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1434,D1434)","v":"Acepromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1434,M1434)","v":"Syncope"},"D000075","Acepromazine","3598-37-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1434,N1434)","v":"DTXSID6047783"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1434,J1434)","v":"982757"},"Overdosage with nalorphine hydrobromide following self-inflicted injury with Immobilon.","982757","Neurologic Manifestations","D013575","Syncope","DTXSID6047783"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1435,D1435)","v":"Acepromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1435,M1435)","v":"Vertigo"},"D000075","Acepromazine","3598-37-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1435,N1435)","v":"DTXSID6047783"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1435,J1435)","v":"982757"},"Overdosage with nalorphine hydrobromide following self-inflicted injury with Immobilon.","982757","Neurologic Manifestations","D014717","Vertigo","DTXSID6047783"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1436,D1436)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1436,M1436)","v":"Ataxia"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1436,N1436)","v":"DTXSID5039224"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1436,J1436)","v":"473559"},"Metaldehyde poisoning in a dairy herd.","473559","Neurologic Manifestations","D001259","Ataxia","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1437,D1437)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1437,M1437)","v":"Ataxia"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1437,N1437)","v":"DTXSID5039224"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1437,J1437)","v":"3084327"},"An investigation of metaldehyde and acetaldehyde toxicities in dogs.","3084327","Neurologic Manifestations","D001259","Ataxia","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1438,D1438)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1438,M1438)","v":"Blindness"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1438,N1438)","v":"DTXSID5039224"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1438,J1438)","v":"936434"},"Three cases of metaldehyde poisoning in cattle.","936434","Neurologic Manifestations","D001766","Blindness","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1439,D1439)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1439,M1439)","v":"Blindness"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1439,N1439)","v":"DTXSID5039224"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1439,J1439)","v":"1136109"},"Letter: Blindness associated with metaldehyde poisoning.","1136109","Neurologic Manifestations","D001766","Blindness","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1440,D1440)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1440,M1440)","v":"Brain Diseases"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1440,N1440)","v":"DTXSID5039224"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1440,J1440)","v":"15611524"},"Cardiotoxicity and neurotoxicity of high-dose continuous fluorouracil as a result of degradation compounds in the drug vials.","15611524","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1441,D1441)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1441,M1441)","v":"Coma"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1441,N1441)","v":"DTXSID5039224"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1441,J1441)","v":"5587253"},"[Acute poisonings and convulsive crises. Electroencephalographic study of 3 very different products: Rimifon, chloralose, metaldehyde].","5587253","Neurologic Manifestations","D003128","Coma","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1442,D1442)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1442,M1442)","v":"Memory Disorders"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1442,N1442)","v":"DTXSID5039224"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1442,J1442)","v":"7135949"},"Metaldehyde poisoning from slug bait ingestion.","7135949","Neurologic Manifestations","D008569","Memory Disorders","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1443,D1443)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1443,M1443)","v":"Movement Disorders"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1443,N1443)","v":"DTXSID5039224"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1443,J1443)","v":"936434"},"Three cases of metaldehyde poisoning in cattle.","936434","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1444,D1444)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1444,M1444)","v":"Muscular Diseases"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1444,N1444)","v":"DTXSID5039224"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1444,J1444)","v":"2247021"},"Comparative effects of ethanol, acetaldehyde and acetate on arterioles and venules in skeletal muscle: direct in situ studies on the microcirculation and their possible relationship to alcoholic myopathy.","2247021","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1445,D1445)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1445,M1445)","v":"Muscular Diseases"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1445,N1445)","v":"DTXSID5039224"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1445,J1445)","v":"2178074"},"Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome--United States.","2178074","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1446,D1446)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1446,M1446)","v":"Nervous System Diseases"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1446,N1446)","v":"DTXSID5039224"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1446,J1446)","v":"8408098"},"Neurotoxicity and induction of fibroblast proliferation by acetaldehyde in the rabbit liver.","8408098","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1447,D1447)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1447,M1447)","v":"Nervous System Diseases"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1447,N1447)","v":"DTXSID5039224"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1447,J1447)","v":"5145230"},"[Toxicological characteristics of the products of the thermal destruction of polyethylene-terephthalate].","5145230","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1448,D1448)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1448,M1448)","v":"Neuromuscular Diseases"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1448,N1448)","v":"DTXSID5039224"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1448,J1448)","v":"5058642"},"Toxicity profile of chloroacetaldehyde.","5058642","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1449,D1449)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1449,M1449)","v":"Neuromuscular Diseases"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1449,N1449)","v":"DTXSID5039224"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1449,J1449)","v":"5145230"},"[Toxicological characteristics of the products of the thermal destruction of polyethylene-terephthalate].","5145230","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1450,D1450)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1450,M1450)","v":"Nystagmus, Pathologic"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1450,N1450)","v":"DTXSID5039224"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1450,J1450)","v":"5963137"},"Effect of congeners in alcoholic beverages on the incidence of nystagmus.","5963137","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1451,D1451)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1451,M1451)","v":"Seizures"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1451,N1451)","v":"DTXSID5039224"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1451,J1451)","v":"7143555"},"Anti-convulsant activity of diazepam and clonidine on metaldehyde-induced seizures in mice: effects on brain gamma-amino butyric acid concentrations and monoamine oxidase activity.","7143555","Neurologic Manifestations","D012640","Seizures","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1452,D1452)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1452,M1452)","v":"Seizures"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1452,N1452)","v":"DTXSID5039224"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1452,J1452)","v":"7135949"},"Metaldehyde poisoning from slug bait ingestion.","7135949","Neurologic Manifestations","D012640","Seizures","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1453,D1453)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1453,M1453)","v":"Seizures"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1453,N1453)","v":"DTXSID5039224"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1453,J1453)","v":"936434"},"Three cases of metaldehyde poisoning in cattle.","936434","Neurologic Manifestations","D012640","Seizures","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1454,D1454)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1454,M1454)","v":"Seizures"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1454,N1454)","v":"DTXSID5039224"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1454,J1454)","v":"473559"},"Metaldehyde poisoning in a dairy herd.","473559","Neurologic Manifestations","D012640","Seizures","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1455,D1455)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1455,M1455)","v":"Seizures"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1455,N1455)","v":"DTXSID5039224"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1455,J1455)","v":"3811156"},"Anaesthetic control for metaldehyde poisoning.","3811156","Neurologic Manifestations","D012640","Seizures","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1456,D1456)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1456,M1456)","v":"Seizures"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1456,N1456)","v":"DTXSID5039224"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1456,J1456)","v":"570515"},"[Effect of piracetam on some manifestations of the effects of ethanol and acetaldehyde].","570515","Neurologic Manifestations","D012640","Seizures","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1457,D1457)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1457,M1457)","v":"Seizures"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1457,N1457)","v":"DTXSID5039224"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1457,J1457)","v":"6178838"},"Pharmacological aspects of metaldehyde poisoning in mice.","6178838","Neurologic Manifestations","D012640","Seizures","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1458,D1458)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1458,M1458)","v":"Seizures"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1458,N1458)","v":"DTXSID5039224"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1458,J1458)","v":"5587253"},"[Acute poisonings and convulsive crises. Electroencephalographic study of 3 very different products: Rimifon, chloralose, metaldehyde].","5587253","Neurologic Manifestations","D012640","Seizures","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1459,D1459)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1459,M1459)","v":"Seizures"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1459,N1459)","v":"DTXSID5039224"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1459,J1459)","v":"2033513"},"Acute dependence on depressant drugs is determined by common genes in mice.","2033513","Neurologic Manifestations","D012640","Seizures","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1460,D1460)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1460,M1460)","v":"Seizures"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1460,N1460)","v":"DTXSID5039224"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1460,J1460)","v":"21852306"},"Effect of prolonged status epilepticus as a result of intoxication on epileptogenesis in a UK canine population.","21852306","Neurologic Manifestations","D012640","Seizures","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1461,D1461)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1461,M1461)","v":"Seizures"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1461,N1461)","v":"DTXSID5039224"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1461,J1461)","v":"1134493"},"Metaldehyde poisoning in three horses.","1134493","Neurologic Manifestations","D012640","Seizures","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1462,D1462)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1462,M1462)","v":"Spasm"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1462,N1462)","v":"DTXSID5039224"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1462,J1462)","v":"7135949"},"Metaldehyde poisoning from slug bait ingestion.","7135949","Neurologic Manifestations","D013035","Spasm","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1463,D1463)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1463,M1463)","v":"Status Epilepticus"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1463,N1463)","v":"DTXSID5039224"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1463,J1463)","v":"21852306"},"Effect of prolonged status epilepticus as a result of intoxication on epileptogenesis in a UK canine population.","21852306","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1464,D1464)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1464,M1464)","v":"Tremor"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1464,N1464)","v":"DTXSID5039224"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1464,J1464)","v":"473559"},"Metaldehyde poisoning in a dairy herd.","473559","Neurologic Manifestations","D014202","Tremor","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1465,D1465)","v":"Acetaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1465,M1465)","v":"Tremor"},"D000079","Acetaldehyde","75-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1465,N1465)","v":"DTXSID5039224"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1465,J1465)","v":"3084327"},"An investigation of metaldehyde and acetaldehyde toxicities in dogs.","3084327","Neurologic Manifestations","D014202","Tremor","DTXSID5039224"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1466,D1466)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1466,M1466)","v":"Alzheimer Disease"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1466,N1466)","v":"DTXSID2020006"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1466,J1466)","v":"11133268"},"Causes of Alzheimer's disease: paracetamol (acetaminophen) today? Amphetamines tomorrow?","11133268","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1467,D1467)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1467,M1467)","v":"Ataxia"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1467,N1467)","v":"DTXSID2020006"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1467,J1467)","v":"3984202"},"Paracetamol poisoning in a cat.","3984202","Neurologic Manifestations","D001259","Ataxia","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1468,D1468)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1468,M1468)","v":"Blindness"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1468,N1468)","v":"DTXSID2020006"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1468,J1468)","v":"8960081"},"Status epilepticus following intravenous N-acetylcysteine therapy.","8960081","Neurologic Manifestations","D001766","Blindness","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1469,D1469)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1469,M1469)","v":"Brain Damage, Chronic"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1469,N1469)","v":"DTXSID2020006"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1469,J1469)","v":"421108"},"Acute poisoning with Distalgesic.","421108","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1470,D1470)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1470,M1470)","v":"Brain Damage, Chronic"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1470,N1470)","v":"DTXSID2020006"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1470,J1470)","v":"10728216"},"Arthrogryposis multiplex congenita and bilateral mid-brain infarction following maternal overdose of co-proxamol.","10728216","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1471,D1471)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1471,M1471)","v":"Brain Diseases"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1471,N1471)","v":"DTXSID2020006"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1471,J1471)","v":"839360"},"Acetaminophen and encephalopathy.","839360","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1472,D1472)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1472,M1472)","v":"Brain Diseases"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1472,N1472)","v":"DTXSID2020006"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1472,J1472)","v":"23984368"},"Effects of an Agaricus blazei aqueous extract pretreatment on paracetamol-induced brain and liver injury in rats.","23984368","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1473,D1473)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1473,M1473)","v":"Brain Edema"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1473,N1473)","v":"DTXSID2020006"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1473,J1473)","v":"7498656"},"A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993).","7498656","Central Nervous System Diseases","D001929","Brain Edema","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1474,D1474)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1474,M1474)","v":"Brain Edema"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1474,N1474)","v":"DTXSID2020006"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1474,J1474)","v":"4175743"},"Treatment of acute paracetamol poisoning.","4175743","Central Nervous System Diseases","D001929","Brain Edema","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1475,D1475)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1475,M1475)","v":"Brain Edema"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1475,N1475)","v":"DTXSID2020006"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1475,J1475)","v":"3122934"},"Toxic myocarditis in paracetamol poisoning.","3122934","Central Nervous System Diseases","D001929","Brain Edema","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1476,D1476)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1476,M1476)","v":"Brain Edema"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1476,N1476)","v":"DTXSID2020006"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1476,J1476)","v":"1687856"},"The effect of chronic alcohol intake on prognosis and outcome in paracetamol overdose.","1687856","Central Nervous System Diseases","D001929","Brain Edema","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1477,D1477)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1477,M1477)","v":"Brain Edema"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1477,N1477)","v":"DTXSID2020006"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1477,J1477)","v":"19728177"},"Prolonged hypothermia as a bridge to recovery for cerebral edema and intracranial hypertension associated with fulminant hepatic failure.","19728177","Central Nervous System Diseases","D001929","Brain Edema","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1478,D1478)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1478,M1478)","v":"Brain Edema"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1478,N1478)","v":"DTXSID2020006"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1478,J1478)","v":"21593677"},"Tumor necrosis factor-α affects blood-brain barrier permeability in acetaminophen-induced acute liver failure.","21593677","Central Nervous System Diseases","D001929","Brain Edema","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1479,D1479)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1479,M1479)","v":"Brain Edema"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1479,N1479)","v":"DTXSID2020006"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1479,J1479)","v":"12971964"},"Early death from paracetamol (acetaminophen) induced fulminant hepatic failure without cerebral oedema.","12971964","Central Nervous System Diseases","D001929","Brain Edema","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1480,D1480)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1480,M1480)","v":"Brain Ischemia"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1480,N1480)","v":"DTXSID2020006"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1480,J1480)","v":"25611553"},"Risk of ischemic stroke associated with non-steroidal anti-inflammatory drugs and paracetamol: a population-based case-control study.","25611553","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1481,D1481)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1481,M1481)","v":"Central Nervous System Diseases"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1481,N1481)","v":"DTXSID2020006"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1481,J1481)","v":"20877175"},"Clinical cases in acute intoxication.","20877175","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1482,D1482)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1482,M1482)","v":"Cerebral Hemorrhage"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1482,N1482)","v":"DTXSID2020006"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1482,J1482)","v":"26058438"},"[Fatal intracerebral haemorrhage possibly caused by interaction between paracetamol and warfarin].","26058438","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1483,D1483)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1483,M1483)","v":"Cerebral Hemorrhage"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1483,N1483)","v":"DTXSID2020006"},2018,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1483,J1483)","v":"29642171"},"Over-the-counter analgesic powder use in patients presenting with intracerebral hemorrhage: A case series.","29642171","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1484,D1484)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1484,M1484)","v":"Cerebral Hemorrhage"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1484,N1484)","v":"DTXSID2020006"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1484,J1484)","v":"2382159"},"Can acetaminophen excess result in maternal and fetal toxicity?","2382159","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1485,D1485)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1485,M1485)","v":"Cerebral Hemorrhage"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1485,N1485)","v":"DTXSID2020006"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1485,J1485)","v":"19782324"},"Life threatening intracerebral hemorrhage with isometheptene mucate, dichlorophenazine and acetaminophen combination therapy.","19782324","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1486,D1486)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1486,M1486)","v":"Cerebral Hemorrhage"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1486,N1486)","v":"DTXSID2020006"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1486,J1486)","v":"21075510"},"Spontaneous intracerebral hemorrhage associated with ingestion of isometheptine containing anti-migraine medication.","21075510","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1487,D1487)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1487,M1487)","v":"Cerebral Infarction"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1487,N1487)","v":"DTXSID2020006"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1487,J1487)","v":"9605729"},"Reversible segmental cerebral arterial vasospasm and cerebral infarction: possible association with excessive use of sumatriptan and Midrin.","9605729","Central Nervous System Diseases","D002544","Cerebral Infarction","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1488,D1488)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1488,M1488)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1488,N1488)","v":"DTXSID2020006"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1488,J1488)","v":"7109008"},"Impaired metabolism of methylphenobarbital after a combined drug overdose: treatment by resin hemoperfusion.","7109008","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1489,D1489)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1489,M1489)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1489,N1489)","v":"DTXSID2020006"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1489,J1489)","v":"9140331"},"Heart donation after fatal acetaminophen poisoning.","9140331","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1490,D1490)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1490,M1490)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1490,N1490)","v":"DTXSID2020006"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1490,J1490)","v":"26153488"},"Case Files from the University of California San Diego Health System Fellowship Coma and Severe Acidosis: Remember to Consider Acetaminophen.","26153488","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1491,D1491)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1491,M1491)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1491,N1491)","v":"DTXSID2020006"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1491,J1491)","v":"27118496"},"Massive acetaminophen overdose: effect of hemodialysis on acetaminophen and acetylcysteine kinetics.","27118496","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1492,D1492)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1492,M1492)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1492,N1492)","v":"DTXSID2020006"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1492,J1492)","v":"3403780"},"Paracetamol-associated coma, metabolic acidosis, renal and hepatic failure.","3403780","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1493,D1493)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1493,M1493)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1493,N1493)","v":"DTXSID2020006"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1493,J1493)","v":"3710495"},"Coma and metabolic acidosis early in severe acute paracetamol poisoning.","3710495","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1494,D1494)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1494,M1494)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1494,N1494)","v":"DTXSID2020006"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1494,J1494)","v":"17052573"},"Coma, metabolic acidosis and normal liver function in a child with a large serum acetaminophen level.","17052573","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1495,D1495)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1495,M1495)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1495,N1495)","v":"DTXSID2020006"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1495,J1495)","v":"17952753"},"Coma blisters.","17952753","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1496,D1496)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1496,M1496)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1496,N1496)","v":"DTXSID2020006"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1496,J1496)","v":"4829646"},"Abnormal drug metabolism following barbiturate and paracetamol overdosage.","4829646","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1497,D1497)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1497,M1497)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1497,N1497)","v":"DTXSID2020006"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1497,J1497)","v":"24077426"},"Coma, metabolic acidosis, and methemoglobinemia in a patient with acetaminophen toxicity.","24077426","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1498,D1498)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1498,M1498)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1498,N1498)","v":"DTXSID2020006"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1498,J1498)","v":"15628737"},"Recognition of nonhepatic coma in the setting of acetaminophen overdose.","15628737","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1499,D1499)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1499,M1499)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1499,N1499)","v":"DTXSID2020006"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1499,J1499)","v":"20199132"},"Massive acetaminophen ingestion with early metabolic acidosis and coma: treatment with IV NAC and continuous venovenous hemodiafiltration.","20199132","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1500,D1500)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1500,M1500)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1500,N1500)","v":"DTXSID2020006"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1500,J1500)","v":"21171858"},"\"Massive acetaminophen ingestion with early metabolic acidosis and coma: treatment with iv nac and continuous venovenous hemodiafiltration\" by Wiegand et al., Clin Toxicol (Phila) 48:156-159.","21171858","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1501,D1501)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1501,M1501)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1501,N1501)","v":"DTXSID2020006"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1501,J1501)","v":"22265882"},"[Early coma and metabolic acidosis after massive paracetamol self poisoning].","22265882","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1502,D1502)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1502,M1502)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1502,N1502)","v":"DTXSID2020006"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1502,J1502)","v":"10092726"},"Early metabolic acidosis and coma after acetaminophen ingestion.","10092726","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1503,D1503)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1503,M1503)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1503,N1503)","v":"DTXSID2020006"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1503,J1503)","v":"10577289"},"Metabolic acidosis and coma after acetaminophen ingestion.","10577289","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1504,D1504)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1504,M1504)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1504,N1504)","v":"DTXSID2020006"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1504,J1504)","v":"10573319"},"Metabolic acidosis and coma following a severe acetaminophen overdose.","10573319","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1505,D1505)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1505,M1505)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1505,N1505)","v":"DTXSID2020006"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1505,J1505)","v":"11757993"},"Pancytopenia, hyperglycemia, shock, coma, rhabdomyolysis, and pancreatitis associated with acetaminophen poisoning.","11757993","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1506,D1506)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1506,M1506)","v":"Coma"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1506,N1506)","v":"DTXSID2020006"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1506,J1506)","v":"15024447"},"Metabolic acidosis and coma in a child with acetaminophen toxicity.","15024447","Neurologic Manifestations","D003128","Coma","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1507,D1507)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1507,M1507)","v":"Confusion"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1507,N1507)","v":"DTXSID2020006"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1507,J1507)","v":"9767979"},"[The elderly in need].","9767979","Neurologic Manifestations","D003221","Confusion","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1508,D1508)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1508,M1508)","v":"Confusion"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1508,N1508)","v":"DTXSID2020006"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1508,J1508)","v":"20837257"},"Early anion gap metabolic acidosis in acetaminophen overdose.","20837257","Neurologic Manifestations","D003221","Confusion","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1509,D1509)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1509,M1509)","v":"Confusion"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1509,N1509)","v":"DTXSID2020006"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1509,J1509)","v":"10761163"},"Acetaminophen controlled-release sprinkles versus acetaminophen immediate-release elixir in febrile children.","10761163","Neurologic Manifestations","D003221","Confusion","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1510,D1510)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1510,M1510)","v":"Deafness"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1510,N1510)","v":"DTXSID2020006"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1510,J1510)","v":"19128584"},"Deafness associated with acetaminophen and codeine abuse.","19128584","Neurologic Manifestations","D003638","Deafness","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1511,D1511)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1511,M1511)","v":"Delirium"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1511,N1511)","v":"DTXSID2020006"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1511,J1511)","v":"24247880"},"Late-onset delirium after an overdose of acetaminophen in a case of benzodiazepine dependence.","24247880","Neurologic Manifestations","D003693","Delirium","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1512,D1512)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1512,M1512)","v":"Epilepsy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1512,N1512)","v":"DTXSID2020006"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1512,J1512)","v":"2387168"},"[Paracetamol, a good analgesic? Yes, but ...].","2387168","Central Nervous System Diseases","D004827","Epilepsy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1513,D1513)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1513,M1513)","v":"Epilepsy, Tonic-Clonic"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1513,N1513)","v":"DTXSID2020006"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1513,J1513)","v":"25631537"},"N-Acetylcysteine (NAC)-Induced Hyponatremia Caused by an Electronic Medical Record (EMR) Order Error.","25631537","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1514,D1514)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1514,M1514)","v":"Hallucinations"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1514,N1514)","v":"DTXSID2020006"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1514,J1514)","v":"26222326"},"Visual Hallucinations with Methylphenidate and Acetaminophen in Combination.","26222326","Neurologic Manifestations","D006212","Hallucinations","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1515,D1515)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1515,M1515)","v":"Hallucinations"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1515,N1515)","v":"DTXSID2020006"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1515,J1515)","v":"3343203"},"Drug-induced hallucinations.","3343203","Neurologic Manifestations","D006212","Hallucinations","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1516,D1516)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1516,M1516)","v":"Hallucinations"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1516,N1516)","v":"DTXSID2020006"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1516,J1516)","v":"21146371"},"Examining the association between maternal analgesic use during pregnancy and risk of psychotic symptoms during adolescence.","21146371","Neurologic Manifestations","D006212","Hallucinations","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1517,D1517)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1517,M1517)","v":"Headache Disorders"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1517,N1517)","v":"DTXSID2020006"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1517,J1517)","v":"19706739"},"Resolution of chronic daily headache after acetaminophen discontinuation.","19706739","Central Nervous System Diseases","D020773","Headache Disorders","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1518,D1518)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1518,M1518)","v":"Hearing Disorders"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1518,N1518)","v":"DTXSID2020006"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1518,J1518)","v":"6354448"},"Nonprescription analgesics.","6354448","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1519,D1519)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1519,M1519)","v":"Hearing Loss"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1519,N1519)","v":"DTXSID2020006"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1519,J1519)","v":"27974293"},"Duration of Analgesic Use and Risk of Hearing Loss in Women.","27974293","Neurologic Manifestations","D034381","Hearing Loss","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1520,D1520)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1520,M1520)","v":"Hearing Loss"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1520,N1520)","v":"DTXSID2020006"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1520,J1520)","v":"28333727"},"Long-Term NSAIDs and Acetaminophen Linked to Hearing Loss in Women.","28333727","Neurologic Manifestations","D034381","Hearing Loss","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1521,D1521)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1521,M1521)","v":"Hearing Loss"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1521,N1521)","v":"DTXSID2020006"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1521,J1521)","v":"25412514"},"Over-the-counter painkillers linked to hearing loss.  The three most commonly used medications in the U.S. have a significant, and little known, side effect.","25412514","Neurologic Manifestations","D034381","Hearing Loss","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1522,D1522)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1522,M1522)","v":"Hearing Loss"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1522,N1522)","v":"DTXSID2020006"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1522,J1522)","v":"22933387"},"Analgesic use and the risk of hearing loss in women.","22933387","Neurologic Manifestations","D034381","Hearing Loss","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1523,D1523)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1523,M1523)","v":"Hearing Loss, Sensorineural"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1523,N1523)","v":"DTXSID2020006"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1523,J1523)","v":"25560405"},"Impact of nonaspirin nonsteroidal anti-inflammatory agents and acetaminophen on sensorineural hearing loss: a systematic review.","25560405","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1524,D1524)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1524,M1524)","v":"Hearing Loss, Sensorineural"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1524,N1524)","v":"DTXSID2020006"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1524,J1524)","v":"10733182"},"Profound hearing loss associated with hydrocodone/acetaminophen abuse.","10733182","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1525,D1525)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1525,M1525)","v":"Hearing Loss, Sensorineural"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1525,N1525)","v":"DTXSID2020006"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1525,J1525)","v":"10881270"},"Deafness associated with abuse of hydrocodone/acetaminophen.","10881270","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1526,D1526)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1526,M1526)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1526,N1526)","v":"DTXSID2020006"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1526,J1526)","v":"6985598"},"Acetaminophen hepatotoxicity.","6985598","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1527,D1527)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1527,M1527)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1527,N1527)","v":"DTXSID2020006"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1527,J1527)","v":"6779949"},"Factors contributing to mortality in paracetamol-induced hepatic failure.","6779949","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1528,D1528)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1528,M1528)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1528,N1528)","v":"DTXSID2020006"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1528,J1528)","v":"6637917"},"Acute liver failure and encephalopathy in a 15-month-old infant.","6637917","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1529,D1529)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1529,M1529)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1529,N1529)","v":"DTXSID2020006"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1529,J1529)","v":"7163155"},"A look at \"Tylenol\" poisoning.","7163155","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1530,D1530)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1530,M1530)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1530,N1530)","v":"DTXSID2020006"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1530,J1530)","v":"7364136"},"Acetaminophen overdosage: a case presentation and review of current therapy.","7364136","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1531,D1531)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1531,M1531)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1531,N1531)","v":"DTXSID2020006"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1531,J1531)","v":"628952"},"[Paracetamol poisoning].","628952","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1532,D1532)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1532,M1532)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1532,N1532)","v":"DTXSID2020006"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1532,J1532)","v":"8209319"},"[Treatment of paracetamol poisoning. An indication for liver transplantation?].","8209319","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1533,D1533)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1533,M1533)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1533,N1533)","v":"DTXSID2020006"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1533,J1533)","v":"8214766"},"Vicodin-induced fulminant hepatic failure.","8214766","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1534,D1534)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1534,M1534)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1534,N1534)","v":"DTXSID2020006"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1534,J1534)","v":"7492887"},"Paracetamol poisoning: a case study.","7492887","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1535,D1535)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1535,M1535)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1535,N1535)","v":"DTXSID2020006"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1535,J1535)","v":"7498656"},"A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993).","7498656","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1536,D1536)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1536,M1536)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1536,N1536)","v":"DTXSID2020006"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1536,J1536)","v":"7470213"},"The laboratory in the diagnosis and management of acetaminophen and salicylate intoxications.","7470213","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1537,D1537)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1537,M1537)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1537,N1537)","v":"DTXSID2020006"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1537,J1537)","v":"7785015"},"Acute lung injury in fulminant hepatic failure following paracetamol poisoning.","7785015","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1538,D1538)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1538,M1538)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1538,N1538)","v":"DTXSID2020006"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1538,J1538)","v":"7701647"},"[Paracetamol poisoning at a department of hepatology].","7701647","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1539,D1539)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1539,M1539)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1539,N1539)","v":"DTXSID2020006"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1539,J1539)","v":"7651041"},"Factor V and factor VIII:V ratio as prognostic indicators in paracetamol poisoning.","7651041","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1540,D1540)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1540,M1540)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1540,N1540)","v":"DTXSID2020006"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1540,J1540)","v":"8020810"},"Serious paracetamol poisoning and the results of liver transplantation.","8020810","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1541,D1541)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1541,M1541)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1541,N1541)","v":"DTXSID2020006"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1541,J1541)","v":"8540079"},"The Danish liver transplantation program and patients with serious acetaminophen intoxication.","8540079","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1542,D1542)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1542,M1542)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1542,N1542)","v":"DTXSID2020006"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1542,J1542)","v":"8440601"},"Paracetamol hepatotoxicity.","8440601","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1543,D1543)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1543,M1543)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1543,N1543)","v":"DTXSID2020006"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1543,J1543)","v":"847823"},"[Liver damage after paracetamol].","847823","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1544,D1544)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1544,M1544)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1544,N1544)","v":"DTXSID2020006"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1544,J1544)","v":"8590158"},"Serial measurements of serum Gc-globulin in acetaminophen intoxication.","8590158","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1545,D1545)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1545,M1545)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1545,N1545)","v":"DTXSID2020006"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1545,J1545)","v":"9633343"},"Fulminant hepatic failure in acute acetaminophen overdose.","9633343","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1546,D1546)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1546,M1546)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1546,N1546)","v":"DTXSID2020006"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1546,J1546)","v":"8966827"},"[Gc-globulin in paracetamol poisoning].","8966827","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1547,D1547)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1547,M1547)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1547,N1547)","v":"DTXSID2020006"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1547,J1547)","v":"9085330"},"Acetaminophen-related acute renal failure without fulminant liver failure.","9085330","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1548,D1548)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1548,M1548)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1548,N1548)","v":"DTXSID2020006"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1548,J1548)","v":"9123096"},"Treatment of acetaminophen-induced fulminant hepatic failure with a bioartificial liver.","9123096","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1549,D1549)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1549,M1549)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1549,N1549)","v":"DTXSID2020006"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1549,J1549)","v":"9057756"},"Transplantation in patients with paracetamol-induced fulminant hepatic failure.","9057756","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1550,D1550)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1550,M1550)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1550,N1550)","v":"DTXSID2020006"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1550,J1550)","v":"4118649"},"Hepatic damage and death from overdose of paracetamol.","4118649","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1551,D1551)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1551,M1551)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1551,N1551)","v":"DTXSID2020006"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1551,J1551)","v":"4758975"},"Disorderd hemostasis in liver damage from paracetamol overdose.","4758975","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1552,D1552)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1552,M1552)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1552,N1552)","v":"DTXSID2020006"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1552,J1552)","v":"4586647"},"How safe is acetaminophen? Some practical cautions with this widely used agent.","4586647","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1553,D1553)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1553,M1553)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1553,N1553)","v":"DTXSID2020006"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1553,J1553)","v":"2570295"},"Hypophosphataemia and phosphaturia in paracetamol poisoning.","2570295","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1554,D1554)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1554,M1554)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1554,N1554)","v":"DTXSID2020006"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1554,J1554)","v":"25689020"},"Acute Liver Failure and Hepatic Encephalopathy After Cleft Palate Repair.","25689020","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1555,D1555)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1555,M1555)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1555,N1555)","v":"DTXSID2020006"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1555,J1555)","v":"3364415"},"Long-term sequellae of acetaminophen-associated fulminant hepatic failure: relevance of early histology.","3364415","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1556,D1556)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1556,M1556)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1556,N1556)","v":"DTXSID2020006"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1556,J1556)","v":"347920"},"Death in an adolescent following an overdose of acetaminophen and phenobarbital.","347920","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1557,D1557)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1557,M1557)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1557,N1557)","v":"DTXSID2020006"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1557,J1557)","v":"3173602"},"Paracetamol (acetaminophen) poisoning resulting in acute renal failure without hepatic coma.","3173602","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1558,D1558)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1558,M1558)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1558,N1558)","v":"DTXSID2020006"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1558,J1558)","v":"3231191"},"[Hepatic injury and death of a 3-year-old girl due to paracetamol poisoning].","3231191","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1559,D1559)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1559,M1559)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1559,N1559)","v":"DTXSID2020006"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1559,J1559)","v":"3710497"},"Analysis of factors responsible for continuing mortality after paracetamol overdose.","3710497","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1560,D1560)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1560,M1560)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1560,N1560)","v":"DTXSID2020006"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1560,J1560)","v":"1783517"},"[Hepatic coma of unknown origin in an 18-year-old patient].","1783517","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1561,D1561)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1561,M1561)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1561,N1561)","v":"DTXSID2020006"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1561,J1561)","v":"1740285"},"Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.","1740285","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1562,D1562)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1562,M1562)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1562,N1562)","v":"DTXSID2020006"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1562,J1562)","v":"17326205"},"MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury.","17326205","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1563,D1563)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1563,M1563)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1563,N1563)","v":"DTXSID2020006"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1563,J1563)","v":"17910762"},"Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data.","17910762","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1564,D1564)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1564,M1564)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1564,N1564)","v":"DTXSID2020006"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1564,J1564)","v":"1825077"},"Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure.","1825077","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1565,D1565)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1565,M1565)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1565,N1565)","v":"DTXSID2020006"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1565,J1565)","v":"53523"},"Letter: Risk of hepatic coma in paracetamol poisoning.","53523","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1566,D1566)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1566,M1566)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1566,N1566)","v":"DTXSID2020006"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1566,J1566)","v":"24893242"},"Liver transplant for intentional acetaminophen overdose and hepatic encephalopathy: a conflict between beneficence and justice.","24893242","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1567,D1567)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1567,M1567)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1567,N1567)","v":"DTXSID2020006"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1567,J1567)","v":"252126"},"Acetaminophen overdose: a new--and treacherous--care problem.","252126","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1568,D1568)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1568,M1568)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1568,N1568)","v":"DTXSID2020006"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1568,J1568)","v":"25045842"},"An elevated neutrophil-lymphocyte ratio is associated with adverse outcomes following single time-point paracetamol (acetaminophen) overdose: a time-course analysis.","25045842","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1569,D1569)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1569,M1569)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1569,N1569)","v":"DTXSID2020006"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1569,J1569)","v":"1602296"},"Hepatotoxicity due to repeated intake of low doses of paracetamol.","1602296","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1570,D1570)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1570,M1570)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1570,N1570)","v":"DTXSID2020006"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1570,J1570)","v":"15344957"},"Renal transplants from non-heart beating paracetamol overdose donors.","15344957","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1571,D1571)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1571,M1571)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1571,N1571)","v":"DTXSID2020006"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1571,J1571)","v":"15521608"},"[Liver albumin dialysis--application in acetaminophen poisoning].","15521608","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1572,D1572)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1572,M1572)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1572,N1572)","v":"DTXSID2020006"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1572,J1572)","v":"20436226"},"High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736).","20436226","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1573,D1573)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1573,M1573)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1573,N1573)","v":"DTXSID2020006"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1573,J1573)","v":"1972496"},"Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine.","1972496","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1574,D1574)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1574,M1574)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1574,N1574)","v":"DTXSID2020006"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1574,J1574)","v":"1954453"},"Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial.","1954453","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1575,D1575)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1575,M1575)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1575,N1575)","v":"DTXSID2020006"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1575,J1575)","v":"1976966"},"Acetylcysteine in paracetamol poisoning.","1976966","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1576,D1576)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1576,M1576)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1576,N1576)","v":"DTXSID2020006"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1576,J1576)","v":"19021948"},"Acute hepatic failure in an infant caused by acetaminophen (paracetamol) toxicity.","19021948","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1577,D1577)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1577,M1577)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1577,N1577)","v":"DTXSID2020006"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1577,J1577)","v":"22260637"},"The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose.","22260637","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1578,D1578)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1578,M1578)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1578,N1578)","v":"DTXSID2020006"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1578,J1578)","v":"21402629"},"Hepatic failure despite early acetylcysteine following large acetaminophen-diphenhydramine overdose.","21402629","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1579,D1579)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1579,M1579)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1579,N1579)","v":"DTXSID2020006"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1579,J1579)","v":"2302954"},"Effect of posture on intracranial pressure and cerebral perfusion pressure in patients with fulminant hepatic and renal failure after acetaminophen self-poisoning.","2302954","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1580,D1580)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1580,M1580)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1580,N1580)","v":"DTXSID2020006"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1580,J1580)","v":"10368999"},"[A case of drug-induced fulminant hepatic failure accompanied with marked increase of pancreatic enzymes].","10368999","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1581,D1581)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1581,M1581)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1581,N1581)","v":"DTXSID2020006"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1581,J1581)","v":"10447915"},"Paracetamol-induced fulminant hepatic failure in a child after 5 days of therapeutic doses.","10447915","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1582,D1582)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1582,M1582)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1582,N1582)","v":"DTXSID2020006"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1582,J1582)","v":"11316203"},"Hepatic failure and encephalopathy attributed to an interaction between acetaminophen and rifampicin.","11316203","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1583,D1583)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1583,M1583)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1583,N1583)","v":"DTXSID2020006"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1583,J1583)","v":"10447373"},"Case presentation: fulminant hepatic failure.","10447373","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1584,D1584)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1584,M1584)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1584,N1584)","v":"DTXSID2020006"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1584,J1584)","v":"11267347"},"Auxiliary orthotopic liver transplantation: new technique and results in toxic liver injury.","11267347","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1585,D1585)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1585,M1585)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1585,N1585)","v":"DTXSID2020006"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1585,J1585)","v":"10466885"},"Prediction of hepatic encephalopathy in paracetamol overdose: a prospective and validated study.","10466885","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1586,D1586)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1586,M1586)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1586,N1586)","v":"DTXSID2020006"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1586,J1586)","v":"10752809"},"Energy expenditure in acetaminophen-induced fulminant hepatic failure.","10752809","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1587,D1587)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1587,M1587)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1587,N1587)","v":"DTXSID2020006"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1587,J1587)","v":"11510020"},"Temporal profile of total, bound, and free Gc-globulin after acetaminophen overdose.","11510020","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1588,D1588)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1588,M1588)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1588,N1588)","v":"DTXSID2020006"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1588,J1588)","v":"10801061"},"Long-chain hydroxydicarboxylic aciduria, carnitine depletion and acetaminophen exposure.","10801061","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1589,D1589)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1589,M1589)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1589,N1589)","v":"DTXSID2020006"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1589,J1589)","v":"1455612"},"Orthotopic liver transplants necessitated by acetaminophen-induced hepatotoxicity.","1455612","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1590,D1590)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1590,M1590)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1590,N1590)","v":"DTXSID2020006"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1590,J1590)","v":"1435126"},"The fatal paracetamol dosage--how low can you go?","1435126","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1591,D1591)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1591,M1591)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1591,N1591)","v":"DTXSID2020006"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1591,J1591)","v":"1354974"},"Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure.","1354974","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1592,D1592)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1592,M1592)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1592,N1592)","v":"DTXSID2020006"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1592,J1592)","v":"1278635"},"An animal model of fulminant hepatic failure: a feasibility study.","1278635","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1593,D1593)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1593,M1593)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1593,N1593)","v":"DTXSID2020006"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1593,J1593)","v":"12610854"},"The critically ill liver patient: fulminant hepatic failure.","12610854","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1594,D1594)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1594,M1594)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1594,N1594)","v":"DTXSID2020006"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1594,J1594)","v":"11956504"},"The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage.","11956504","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1595,D1595)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1595,M1595)","v":"Hepatic Encephalopathy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1595,N1595)","v":"DTXSID2020006"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1595,J1595)","v":"11929388"},"Influence of acute and chronic alcohol intake on the clinical course and outcome in acetaminophen overdose.","11929388","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1596,D1596)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1596,M1596)","v":"Hyperalgesia"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1596,N1596)","v":"DTXSID2020006"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1596,J1596)","v":"25054394"},"Increased thermal pain sensitivity in animals exposed to chronic high dose Vicodin but not pure hydrocodone.","25054394","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1597,D1597)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1597,M1597)","v":"Hyperalgesia"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1597,N1597)","v":"DTXSID2020006"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1597,J1597)","v":"21054454"},"What do we (not) know about how paracetamol (acetaminophen) works?","21054454","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1598,D1598)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1598,M1598)","v":"Hyperalgesia"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1598,N1598)","v":"DTXSID2020006"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1598,J1598)","v":"22809664"},"Rectal paracetamol in newborn infants after assisted vaginal delivery may increase pain response.","22809664","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1599,D1599)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1599,M1599)","v":"Hyperkinesis"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1599,N1599)","v":"DTXSID2020006"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1599,J1599)","v":"27533796"},"Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding.","27533796","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1600,D1600)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1600,M1600)","v":"Hyperkinesis"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1600,N1600)","v":"DTXSID2020006"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1600,J1600)","v":"26460389"},"Acetaminophen In Pregnancy May Not Be As Safe As Previously Thought.","26460389","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1601,D1601)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1601,M1601)","v":"Hyperkinesis"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1601,N1601)","v":"DTXSID2020006"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1601,J1601)","v":"25179025"},"Characteristics of acetaminophen users compared with nonusers during pregnancy, behavioral problems, and hyperkinetic disorders--reply.","25179025","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1602,D1602)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1602,M1602)","v":"Hyperkinesis"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1602,N1602)","v":"DTXSID2020006"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1602,J1602)","v":"25179024"},"Characteristics of acetaminophen users compared with nonusers during pregnancy, behavioral problems, and hyperkinetic disorders.","25179024","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1603,D1603)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1603,M1603)","v":"Hyperkinesis"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1603,N1603)","v":"DTXSID2020006"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1603,J1603)","v":"24566677"},"Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders.","24566677","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1604,D1604)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1604,M1604)","v":"Hyperkinesis"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1604,N1604)","v":"DTXSID2020006"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1604,J1604)","v":"24566519"},"Antenatal acetaminophen use and attention-deficit/hyperactivity disorder: an interesting observed association but too early to infer causality.","24566519","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1605,D1605)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1605,M1605)","v":"Hypoxia, Brain"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1605,N1605)","v":"DTXSID2020006"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1605,J1605)","v":"12421803"},"Fatal anaphylactoid reaction to N-acetylcysteine: caution in patients with asthma.","12421803","Central Nervous System Diseases","D002534","Hypoxia, Brain","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1606,D1606)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1606,M1606)","v":"Intellectual Disability"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1606,N1606)","v":"DTXSID2020006"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1606,J1606)","v":"27479646"},"Prenatal Use of Acetaminophen and Child IQ: A Danish Cohort Study.","27479646","Neurologic Manifestations","D008607","Intellectual Disability","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1607,D1607)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1607,M1607)","v":"Ischemic Attack, Transient"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1607,N1607)","v":"DTXSID2020006"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1607,J1607)","v":"9605729"},"Reversible segmental cerebral arterial vasospasm and cerebral infarction: possible association with excessive use of sumatriptan and Midrin.","9605729","Central Nervous System Diseases","D002546","Ischemic Attack, Transient","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1608,D1608)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1608,M1608)","v":"Lethargy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1608,N1608)","v":"DTXSID2020006"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1608,J1608)","v":"20837257"},"Early anion gap metabolic acidosis in acetaminophen overdose.","20837257","Neurologic Manifestations","D053609","Lethargy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1609,D1609)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1609,M1609)","v":"Lethargy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1609,N1609)","v":"DTXSID2020006"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1609,J1609)","v":"21880331"},"Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia.","21880331","Neurologic Manifestations","D053609","Lethargy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1610,D1610)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1610,M1610)","v":"Lethargy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1610,N1610)","v":"DTXSID2020006"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1610,J1610)","v":"21996159"},"Is it safe to use opioids for obstetric pain while breastfeeding?","21996159","Neurologic Manifestations","D053609","Lethargy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1611,D1611)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1611,M1611)","v":"Lethargy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1611,N1611)","v":"DTXSID2020006"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1611,J1611)","v":"22575254"},"Breastfeeding and oxycodone.","22575254","Neurologic Manifestations","D053609","Lethargy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1612,D1612)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1612,M1612)","v":"Migraine Disorders"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1612,N1612)","v":"DTXSID2020006"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1612,J1612)","v":"11279966"},"Warning: the excedrin migraine warning label is inadequate to warn consumers of the risk of medication rebound headache.","11279966","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1613,D1613)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1613,M1613)","v":"Miosis"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1613,N1613)","v":"DTXSID2020006"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1613,J1613)","v":"15744203"},"A toddler with obtundation and miosis.","15744203","Neurologic Manifestations","D015877","Miosis","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1614,D1614)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1614,M1614)","v":"Muscular Atrophy"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1614,N1614)","v":"DTXSID2020006"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1614,J1614)","v":"25371521"},"Skeletal muscle wasting occurs in adult rats under chronic treatment with paracetamol when glutathione-dependent detoxification is highly activated.","25371521","Neurologic Manifestations","D009133","Muscular Atrophy","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1615,D1615)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1615,M1615)","v":"Muscular Diseases"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1615,N1615)","v":"DTXSID2020006"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1615,J1615)","v":"452940"},"Hyperthermia and rhabdomyolysis in self-poisoning with paracetamol and salicylates. Report of a case.","452940","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1616,D1616)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1616,M1616)","v":"Myoclonus"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1616,N1616)","v":"DTXSID2020006"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1616,J1616)","v":"7945606"},"The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease.","7945606","Neurologic Manifestations","D009207","Myoclonus","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1617,D1617)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1617,M1617)","v":"Myoclonus"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1617,N1617)","v":"DTXSID2020006"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1617,J1617)","v":"15303796"},"Acute onset of bilateral myoclonus in a 16-year-old female.","15303796","Neurologic Manifestations","D009207","Myoclonus","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1618,D1618)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1618,M1618)","v":"Neural Tube Defects"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1618,N1618)","v":"DTXSID2020006"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1618,J1618)","v":"2603160"},"Abnormal neurulation induced by 7-hydroxy-2-acetylaminofluorene and acetaminophen: evidence for catechol metabolites as proximate dysmorphogens.","2603160","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1619,D1619)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1619,M1619)","v":"Neural Tube Defects"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1619,N1619)","v":"DTXSID2020006"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1619,J1619)","v":"2609350"},"Modulation of the embryotoxicity and cytotoxicity elicited by 7-hydroxy-2-acetylaminofluorene and acetaminophen via deacetylation.","2609350","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1620,D1620)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1620,M1620)","v":"Neural Tube Defects"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1620,N1620)","v":"DTXSID2020006"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1620,J1620)","v":"2213573"},"Dysmorphogenesis elicited by microinjected acetaminophen analogs and metabolites in rat embryos cultured in vitro.","2213573","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1621,D1621)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1621,M1621)","v":"Neurodegenerative Diseases"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1621,N1621)","v":"DTXSID2020006"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1621,J1621)","v":"19815348"},"Acetaminophen and neural degeneration: is there a possible link?","19815348","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1622,D1622)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1622,M1622)","v":"Paralysis"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1622,N1622)","v":"DTXSID2020006"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1622,J1622)","v":"16109766"},"Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity.","16109766","Neurologic Manifestations","D010243","Paralysis","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1623,D1623)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1623,M1623)","v":"Psychomotor Disorders"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1623,N1623)","v":"DTXSID2020006"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1623,J1623)","v":"18489634"},"Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products.","18489634","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1624,D1624)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1624,M1624)","v":"Reflex, Abnormal"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1624,N1624)","v":"DTXSID2020006"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1624,J1624)","v":"4038034"},"Autonomic dysreflexia due to medication: misadventure in the use of an isometheptene combination to treat migraine.","4038034","Neurologic Manifestations","D012021","Reflex, Abnormal","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1625,D1625)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1625,M1625)","v":"Reye Syndrome"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1625,N1625)","v":"DTXSID2020006"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1625,J1625)","v":"4033715"},"Public Health Service study on Reye's syndrome and medications. Report of the pilot phase.","4033715","Central Nervous System Diseases","D012202","Reye Syndrome","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1626,D1626)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1626,M1626)","v":"Reye Syndrome"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1626,N1626)","v":"DTXSID2020006"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1626,J1626)","v":"21294782"},"Have the efforts to prevent aspirin-related Reye's syndrome fuelled an increase in asthma?","21294782","Central Nervous System Diseases","D012202","Reye Syndrome","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1627,D1627)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1627,M1627)","v":"Reye Syndrome"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1627,N1627)","v":"DTXSID2020006"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1627,J1627)","v":"22923226"},"The social and economic influences on medication use and misuse.","22923226","Central Nervous System Diseases","D012202","Reye Syndrome","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1628,D1628)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1628,M1628)","v":"Reye Syndrome"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1628,N1628)","v":"DTXSID2020006"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1628,J1628)","v":"12167070"},"Aspirin and Reye's syndrome: discovery of aspirin and paracetamol.","12167070","Central Nervous System Diseases","D012202","Reye Syndrome","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1629,D1629)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1629,M1629)","v":"Sarcopenia"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1629,N1629)","v":"DTXSID2020006"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1629,J1629)","v":"28011956"},"Repeated cures with paracetamol worsen sarcopenia in old rats with suboptimal food intake.","28011956","Neurologic Manifestations","D055948","Sarcopenia","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1630,D1630)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1630,M1630)","v":"Seizures"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1630,N1630)","v":"DTXSID2020006"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1630,J1630)","v":"9142563"},"Interaction of ciprofloxacin with diclofenac and paracetamol in relation to it's epileptogenic effect.","9142563","Neurologic Manifestations","D012640","Seizures","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1631,D1631)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1631,M1631)","v":"Seizures"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1631,N1631)","v":"DTXSID2020006"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1631,J1631)","v":"20436226"},"High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736).","20436226","Neurologic Manifestations","D012640","Seizures","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1632,D1632)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1632,M1632)","v":"Seizures"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1632,N1632)","v":"DTXSID2020006"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1632,J1632)","v":"10394266"},"[Dextropropoxyphene-paracetamol and general convulsive crisis: case report].","10394266","Neurologic Manifestations","D012640","Seizures","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1633,D1633)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1633,M1633)","v":"Seizures"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1633,N1633)","v":"DTXSID2020006"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1633,J1633)","v":"12831423"},"Warning note on a blood gas report leading to diagnosis of acetaminophen overdose.","12831423","Neurologic Manifestations","D012640","Seizures","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1634,D1634)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1634,M1634)","v":"Sleep Apnea Syndromes"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1634,N1634)","v":"DTXSID2020006"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1634,J1634)","v":"6476315"},"Idiopathic alveolar hypoventilation in Leber's disease. Unusual sensitivity to mild analgesics and diazepam.","6476315","Sleep Wake Disorders","D012891","Sleep Apnea Syndromes","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1635,D1635)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1635,M1635)","v":"Spasm"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1635,N1635)","v":"DTXSID2020006"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1635,J1635)","v":"19829093"},"Sudden severe abdominal pain after a single low dose of paracetamol/codein in a cholecystectomized patient: learning from a case report.","19829093","Neurologic Manifestations","D013035","Spasm","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1636,D1636)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1636,M1636)","v":"Spasm"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1636,N1636)","v":"DTXSID2020006"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1636,J1636)","v":"23138573"},"Is previous cholecystectomy a contraindication to paracetamol/codeine premedication?","23138573","Neurologic Manifestations","D013035","Spasm","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1637,D1637)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1637,M1637)","v":"Speech Disorders"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1637,N1637)","v":"DTXSID2020006"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1637,J1637)","v":"19481406"},"A 46-year-old woman with altered mental status and garbled speech.","19481406","Neurologic Manifestations","D013064","Speech Disorders","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1638,D1638)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1638,M1638)","v":"Status Epilepticus"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1638,N1638)","v":"DTXSID2020006"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1638,J1638)","v":"8960081"},"Status epilepticus following intravenous N-acetylcysteine therapy.","8960081","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1639,D1639)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1639,M1639)","v":"Stroke"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1639,N1639)","v":"DTXSID2020006"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1639,J1639)","v":"25801870"},"Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort.","25801870","Central Nervous System Diseases","D020521","Stroke","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1640,D1640)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1640,M1640)","v":"Stroke"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1640,N1640)","v":"DTXSID2020006"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1640,J1640)","v":"25611553"},"Risk of ischemic stroke associated with non-steroidal anti-inflammatory drugs and paracetamol: a population-based case-control study.","25611553","Central Nervous System Diseases","D020521","Stroke","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1641,D1641)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1641,M1641)","v":"Stroke"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1641,N1641)","v":"DTXSID2020006"},2018,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1641,J1641)","v":"29642171"},"Over-the-counter analgesic powder use in patients presenting with intracerebral hemorrhage: A case series.","29642171","Central Nervous System Diseases","D020521","Stroke","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1642,D1642)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1642,M1642)","v":"Tremor"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1642,N1642)","v":"DTXSID2020006"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1642,J1642)","v":"10999588"},"Tremor after ingestion of Tazist-D and Tylenol 3.","10999588","Neurologic Manifestations","D014202","Tremor","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1643,D1643)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1643,M1643)","v":"Unconsciousness"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1643,N1643)","v":"DTXSID2020006"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1643,J1643)","v":"15744203"},"A toddler with obtundation and miosis.","15744203","Neurologic Manifestations","D014474","Unconsciousness","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1644,D1644)","v":"Acetaminophen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1644,M1644)","v":"Unconsciousness"},"D000082","Acetaminophen","103-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1644,N1644)","v":"DTXSID2020006"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1644,J1644)","v":"20187553"},"Pattern of acute poisoning in Al-Qassim region: a surveillance report from Saudi Arabia, 1999-2003.","20187553","Neurologic Manifestations","D014474","Unconsciousness","DTXSID2020006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1645,D1645)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1645,M1645)","v":"Ataxia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1645,N1645)","v":"DTXSID00162031"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1645,J1645)","v":"17575025"},"Aggravation of ataxia due to acetazolamide induced hyperammonaemia in episodic ataxia.","17575025","Neurologic Manifestations","D001259","Ataxia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1646,D1646)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1646,M1646)","v":"Brain Ischemia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1646,N1646)","v":"DTXSID00162031"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1646,J1646)","v":"9367331"},"Reversible pontine ischemia caused by acetazolamide challenge.","9367331","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1647,D1647)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1647,M1647)","v":"Cerebellar Ataxia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1647,N1647)","v":"DTXSID00162031"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1647,J1647)","v":"10221197"},"[Salicylism and glaucoma: reciprocal augmentation of the toxicity of acetazolamide and acetylsalicylic acid].","10221197","Central Nervous System Diseases","D002524","Cerebellar Ataxia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1648,D1648)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1648,M1648)","v":"Coma"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1648,N1648)","v":"DTXSID00162031"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1648,J1648)","v":"6065848"},"A case of acetazolamide induced (Diamox) acidotic coma in polycystic renal disease.","6065848","Neurologic Manifestations","D003128","Coma","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1649,D1649)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1649,M1649)","v":"Confusion"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1649,N1649)","v":"DTXSID00162031"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1649,J1649)","v":"8340566"},"Acetazolamide and salicylate interaction in the elderly: a case report.","8340566","Neurologic Manifestations","D003221","Confusion","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1650,D1650)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1650,M1650)","v":"Confusion"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1650,N1650)","v":"DTXSID00162031"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1650,J1650)","v":"10221197"},"[Salicylism and glaucoma: reciprocal augmentation of the toxicity of acetazolamide and acetylsalicylic acid].","10221197","Neurologic Manifestations","D003221","Confusion","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1651,D1651)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1651,M1651)","v":"Confusion"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1651,N1651)","v":"DTXSID00162031"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1651,J1651)","v":"1462998"},"Acetazolamide in hemodialysis patients: a rational use after ocular surgery.","1462998","Neurologic Manifestations","D003221","Confusion","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1652,D1652)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1652,M1652)","v":"Delirium"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1652,N1652)","v":"DTXSID00162031"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1652,J1652)","v":"848601"},"Acetazolamide delirium.","848601","Neurologic Manifestations","D003693","Delirium","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1653,D1653)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1653,M1653)","v":"Dysgeusia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1653,N1653)","v":"DTXSID00162031"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1653,J1653)","v":"2380683"},"Altered taste secondary to acetazolamide therapy.","2380683","Neurologic Manifestations","D004408","Dysgeusia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1654,D1654)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1654,M1654)","v":"Dysgeusia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1654,N1654)","v":"DTXSID00162031"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1654,J1654)","v":"19689182"},"Taste disturbances related to medication use.","19689182","Neurologic Manifestations","D004408","Dysgeusia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1655,D1655)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1655,M1655)","v":"Gerstmann Syndrome"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1655,N1655)","v":"DTXSID00162031"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1655,J1655)","v":"10692744"},"Acetazolamide-induced Gerstmann syndrome.","10692744","Neurologic Manifestations","D005862","Gerstmann Syndrome","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1656,D1656)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1656,M1656)","v":"Hallucinations"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1656,N1656)","v":"DTXSID00162031"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1656,J1656)","v":"1462998"},"Acetazolamide in hemodialysis patients: a rational use after ocular surgery.","1462998","Neurologic Manifestations","D006212","Hallucinations","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1657,D1657)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1657,M1657)","v":"Hepatic Encephalopathy"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1657,N1657)","v":"DTXSID00162031"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1657,J1657)","v":"3777099"},"Acetazolamide and advanced liver disease.","3777099","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1658,D1658)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1658,M1658)","v":"Hepatic Encephalopathy"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1658,N1658)","v":"DTXSID00162031"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1658,J1658)","v":"4895969"},"[Importance of hyperammoniemia of the renal origin in the pathogenesis of hepatic coma released in cirrhotic patients by diuretics generating hypokaliemia].","4895969","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1659,D1659)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1659,M1659)","v":"Hyperalgesia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1659,N1659)","v":"DTXSID00162031"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1659,J1659)","v":"15743922"},"Acetazolamide, a carbonic anhydrase inhibitor, reverses inflammation-induced thermal hyperalgesia in rats.","15743922","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1660,D1660)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1660,M1660)","v":"Hypesthesia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1660,N1660)","v":"DTXSID00162031"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1660,J1660)","v":"15772552"},"Transient neurologic deficit after acetazolamide challenge for computed tomography perfusion imaging.","15772552","Neurologic Manifestations","D006987","Hypesthesia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1661,D1661)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1661,M1661)","v":"Ischemic Attack, Transient"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1661,N1661)","v":"DTXSID00162031"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1661,J1661)","v":"15772552"},"Transient neurologic deficit after acetazolamide challenge for computed tomography perfusion imaging.","15772552","Central Nervous System Diseases","D002546","Ischemic Attack, Transient","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1662,D1662)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1662,M1662)","v":"Memory Disorders"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1662,N1662)","v":"DTXSID00162031"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1662,J1662)","v":"11985388"},"Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial.","11985388","Neurologic Manifestations","D008569","Memory Disorders","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1663,D1663)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1663,M1663)","v":"Migraine without Aura"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1663,N1663)","v":"DTXSID00162031"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1663,J1663)","v":"19438913"},"Delayed migraine-like headache in healthy volunteers after a combination of acetazolamide and glyceryl trinitrate.","19438913","Central Nervous System Diseases","D020326","Migraine without Aura","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1664,D1664)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1664,M1664)","v":"Muscle Hypotonia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1664,N1664)","v":"DTXSID00162031"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1664,J1664)","v":"835937"},"Acetazolamide-induced weakness in paramyotonia congenita.","835937","Neurologic Manifestations","D009123","Muscle Hypotonia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1665,D1665)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1665,M1665)","v":"Muscle Weakness"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1665,N1665)","v":"DTXSID00162031"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1665,J1665)","v":"12322805"},"Acetazolamide-induced muscle weakness in hypokalemic periodic paralysis.","12322805","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1666,D1666)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1666,M1666)","v":"Myokymia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1666,N1666)","v":"DTXSID00162031"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1666,J1666)","v":"25715652"},"Acetazolamide-induced myokymia.","25715652","Neurologic Manifestations","D020385","Myokymia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1667,D1667)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1667,M1667)","v":"Ocular Motility Disorders"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1667,N1667)","v":"DTXSID00162031"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1667,J1667)","v":"19557026"},"Management of inadvertent peribulbar injection of acetazolamide: a case report.","19557026","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1668,D1668)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1668,M1668)","v":"Paralyses, Familial Periodic"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1668,N1668)","v":"DTXSID00162031"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1668,J1668)","v":"7031501"},"Hypokalemic periodic paralysis exacerbated by acetazolamide.","7031501","Neuromuscular Diseases","D010245","Paralyses, Familial Periodic","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1669,D1669)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1669,M1669)","v":"Paralysis"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1669,N1669)","v":"DTXSID00162031"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1669,J1669)","v":"25284084"},"A case of Andersen-Tawil syndrome presenting periodic paralysis exacerbated by acetazolamide.","25284084","Neurologic Manifestations","D010243","Paralysis","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1670,D1670)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1670,M1670)","v":"Paresthesia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1670,N1670)","v":"DTXSID00162031"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1670,J1670)","v":"6391074"},"Zinc therapy of acetazolamide-induced side-effects.","6391074","Neurologic Manifestations","D010292","Paresthesia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1671,D1671)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1671,M1671)","v":"Paresthesia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1671,N1671)","v":"DTXSID00162031"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1671,J1671)","v":"6349608"},"Methazolamide and acetazolamide in acute mountain sickness.","6349608","Neurologic Manifestations","D010292","Paresthesia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1672,D1672)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1672,M1672)","v":"Paresthesia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1672,N1672)","v":"DTXSID00162031"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1672,J1672)","v":"28653390"},"Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.","28653390","Neurologic Manifestations","D010292","Paresthesia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1673,D1673)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1673,M1673)","v":"Paresthesia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1673,N1673)","v":"DTXSID00162031"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1673,J1673)","v":"5246014"},"[Side-effects with the Diamox therapy of glaucoma].","5246014","Neurologic Manifestations","D010292","Paresthesia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1674,D1674)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1674,M1674)","v":"Paresthesia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1674,N1674)","v":"DTXSID00162031"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1674,J1674)","v":"4972733"},"[Diamox and manifestation of diabetes mellitus].","4972733","Neurologic Manifestations","D010292","Paresthesia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1675,D1675)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1675,M1675)","v":"Paresthesia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1675,N1675)","v":"DTXSID00162031"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1675,J1675)","v":"1999898"},"Paresthesia and numbness due to drugs: the special case of the blind.","1999898","Neurologic Manifestations","D010292","Paresthesia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1676,D1676)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1676,M1676)","v":"Paresthesia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1676,N1676)","v":"DTXSID00162031"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1676,J1676)","v":"2109942"},"Cerebral blood flow and end-tidal PCO2 during prolonged acetazolamide treatment in humans.","2109942","Neurologic Manifestations","D010292","Paresthesia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1677,D1677)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1677,M1677)","v":"Paresthesia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1677,N1677)","v":"DTXSID00162031"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1677,J1677)","v":"22724610"},"Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis.","22724610","Neurologic Manifestations","D010292","Paresthesia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1678,D1678)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1678,M1678)","v":"Paresthesia"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1678,N1678)","v":"DTXSID00162031"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1678,J1678)","v":"11985388"},"Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial.","11985388","Neurologic Manifestations","D010292","Paresthesia","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1679,D1679)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1679,M1679)","v":"Pseudotumor Cerebri"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1679,N1679)","v":"DTXSID00162031"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1679,J1679)","v":"2320196"},"[The effect of acetazolamide-induced, endogenous volume stress of the cerebrospinal system on intracranial pressure. Diamox--effect on intracranial pressure].","2320196","Central Nervous System Diseases","D011559","Pseudotumor Cerebri","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1680,D1680)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1680,M1680)","v":"Seizures"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1680,N1680)","v":"DTXSID00162031"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1680,J1680)","v":"4308261"},"Relation of laboratory evaluation to clinical effectiveness of antiepileptic drugs.","4308261","Neurologic Manifestations","D012640","Seizures","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1681,D1681)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1681,M1681)","v":"Sleep Apnea Syndromes"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1681,N1681)","v":"DTXSID00162031"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1681,J1681)","v":"2712085"},"'Ondine's curse': side effect of acetazolamide?","2712085","Sleep Wake Disorders","D012891","Sleep Apnea Syndromes","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1682,D1682)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1682,M1682)","v":"Sleep Apnea, Central"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1682,N1682)","v":"DTXSID00162031"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1682,J1682)","v":"19317383"},"Acetazolamide as an adjunct to CPAP treatment: a case of complex sleep apnea in a patient on long-acting opioid therapy.","19317383","Sleep Wake Disorders","D020182","Sleep Apnea, Central","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1683,D1683)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1683,M1683)","v":"Sleep Apnea, Obstructive"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1683,N1683)","v":"DTXSID00162031"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1683,J1683)","v":"19317383"},"Acetazolamide as an adjunct to CPAP treatment: a case of complex sleep apnea in a patient on long-acting opioid therapy.","19317383","Sleep Wake Disorders","D020181","Sleep Apnea, Obstructive","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1684,D1684)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1684,M1684)","v":"Taste Disorders"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1684,N1684)","v":"DTXSID00162031"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1684,J1684)","v":"6391074"},"Zinc therapy of acetazolamide-induced side-effects.","6391074","Neurologic Manifestations","D013651","Taste Disorders","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1685,D1685)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1685,M1685)","v":"Taste Disorders"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1685,N1685)","v":"DTXSID00162031"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1685,J1685)","v":"9066952"},"Taste disturbance with acetazolamide.","9066952","Neurologic Manifestations","D013651","Taste Disorders","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1686,D1686)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1686,M1686)","v":"Taste Disorders"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1686,N1686)","v":"DTXSID00162031"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1686,J1686)","v":"2380683"},"Altered taste secondary to acetazolamide therapy.","2380683","Neurologic Manifestations","D013651","Taste Disorders","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1687,D1687)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1687,M1687)","v":"Taste Disorders"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1687,N1687)","v":"DTXSID00162031"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1687,J1687)","v":"1978045"},"Taste disturbance with acetazolamide.","1978045","Neurologic Manifestations","D013651","Taste Disorders","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1688,D1688)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1688,M1688)","v":"Taste Disorders"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1688,N1688)","v":"DTXSID00162031"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1688,J1688)","v":"1978900"},"Taste disturbance with acetazolamide.","1978900","Neurologic Manifestations","D013651","Taste Disorders","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1689,D1689)","v":"Acetazolamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1689,M1689)","v":"Taste Disorders"},"D000086","Acetazolamide","1424-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1689,N1689)","v":"DTXSID00162031"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1689,J1689)","v":"22724610"},"Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis.","22724610","Neurologic Manifestations","D013651","Taste Disorders","DTXSID00162031"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1690,D1690)","v":"Acetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1690,M1690)","v":"Basal Ganglia Diseases"},"D019342","Acetic Acid","64-19-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1690,N1690)","v":"DTXSID5024394"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1690,J1690)","v":"3658187"},"[GABA synthesis in the central nervous system of rats with extrapyramidal syndrome after acute cobalt acetate poisoning in cerebral ischemia].","3658187","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID5024394"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1691,D1691)","v":"Acetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1691,M1691)","v":"Facial Injuries"},"D019342","Acetic Acid","64-19-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1691,N1691)","v":"DTXSID5024394"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1691,J1691)","v":"20708991"},"A case report of a chemical burn due to the misuse of glacial acetic acid.","20708991","Trauma, Nervous System","D005151","Facial Injuries","DTXSID5024394"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1692,D1692)","v":"Acetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1692,M1692)","v":"Hyperalgesia"},"D019342","Acetic Acid","64-19-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1692,N1692)","v":"DTXSID5024394"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1692,J1692)","v":"28855444"},"A rat model for studying electroacupuncture analgesia on acute visceral hyperalgesia.","28855444","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID5024394"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1693,D1693)","v":"Acetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1693,M1693)","v":"Muscle Hypertonia"},"D019342","Acetic Acid","64-19-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1693,N1693)","v":"DTXSID5024394"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1693,J1693)","v":"15371885"},"Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats.","15371885","Neurologic Manifestations","D009122","Muscle Hypertonia","DTXSID5024394"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1694,D1694)","v":"Acetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1694,M1694)","v":"Pituitary Neoplasms"},"D019342","Acetic Acid","64-19-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1694,N1694)","v":"DTXSID5024394"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1694,J1694)","v":"1499087"},"Transplacental carcinogenic effects of nickel(II) acetate in the renal cortex, renal pelvis and adenohypophysis in F344/NCr rats.","1499087","Central Nervous System Diseases","D010911","Pituitary Neoplasms","DTXSID5024394"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1695,D1695)","v":"Acetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1695,M1695)","v":"Syncope, Vasovagal"},"D019342","Acetic Acid","64-19-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1695,N1695)","v":"DTXSID5024394"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1695,J1695)","v":"16431236"},"The perils of vinegar and the Heimlich maneuver.","16431236","Autonomic Nervous System Diseases","D019462","Syncope, Vasovagal","DTXSID5024394"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1696,D1696)","v":"Acetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1696,M1696)","v":"Tremor"},"D019342","Acetic Acid","64-19-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1696,N1696)","v":"DTXSID5024394"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1696,J1696)","v":"3437779"},"Histofluorescence studies of monoamine neurons in the rat brain after cobaltous acetate intoxication.","3437779","Neurologic Manifestations","D014202","Tremor","DTXSID5024394"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1697,D1697)","v":"Acetone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1697,M1697)","v":"Anencephaly"},"D000096","Acetone","67-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1697,N1697)","v":"DTXSID8021482"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1697,J1697)","v":"594728"},"Central nervous defects in two children of mothers exposed to chemicals in the reinforced plastics industry. Chance or a causal relation?","594728","Nervous System Malformations","D000757","Anencephaly","DTXSID8021482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1698,D1698)","v":"Acetone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1698,M1698)","v":"Brain Edema"},"D000096","Acetone","67-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1698,N1698)","v":"DTXSID8021482"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1698,J1698)","v":"18202235"},"MR imaging-based evidence of vasogenic brain edema in a case of acute acetone intoxication.","18202235","Central Nervous System Diseases","D001929","Brain Edema","DTXSID8021482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1699,D1699)","v":"Acetone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1699,M1699)","v":"Coma"},"D000096","Acetone","67-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1699,N1699)","v":"DTXSID8021482"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1699,J1699)","v":"7774229"},"Coma and metabolic acidosis related to the use of muscle liniment.","7774229","Neurologic Manifestations","D003128","Coma","DTXSID8021482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1700,D1700)","v":"Acetone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1700,M1700)","v":"Coma"},"D000096","Acetone","67-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1700,N1700)","v":"DTXSID8021482"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1700,J1700)","v":"5924615"},"Coma and hyperglycemia following drinking of acetone.","5924615","Neurologic Manifestations","D003128","Coma","DTXSID8021482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1701,D1701)","v":"Acetone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1701,M1701)","v":"Eye Burns"},"D000096","Acetone","67-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1701,N1701)","v":"DTXSID8021482"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1701,J1701)","v":"6862191"},"Changes in alkaline and acid phosphatases of the rabbit cornea following experimental exposure to ethanol and acetone: a biochemical and histochemical study.","6862191","Trauma, Nervous System","D005126","Eye Burns","DTXSID8021482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1702,D1702)","v":"Acetone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1702,M1702)","v":"Guillain-Barre Syndrome"},"D000096","Acetone","67-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1702,N1702)","v":"DTXSID8021482"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1702,J1702)","v":"12381959"},"Guillain-Barré syndrome associated with minimal change glomerulopathy and tubular dysfunction - related to acetone-based organic solvent?","12381959","Neuromuscular Diseases","D020275","Guillain-Barre Syndrome","DTXSID8021482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1703,D1703)","v":"Acetone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1703,M1703)","v":"Hydrocephalus"},"D000096","Acetone","67-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1703,N1703)","v":"DTXSID8021482"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1703,J1703)","v":"594728"},"Central nervous defects in two children of mothers exposed to chemicals in the reinforced plastics industry. Chance or a causal relation?","594728","Central Nervous System Diseases","D006849","Hydrocephalus","DTXSID8021482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1704,D1704)","v":"Acetone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1704,M1704)","v":"Nervous System Diseases"},"D000096","Acetone","67-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1704,N1704)","v":"DTXSID8021482"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1704,J1704)","v":"1508428"},"Correlations between subjective disturbances due to acute exposure to organic solvents and internal dose.","1508428","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8021482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1705,D1705)","v":"Acetone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1705,M1705)","v":"Seizures"},"D000096","Acetone","67-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1705,N1705)","v":"DTXSID8021482"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1705,J1705)","v":"8997530"},"Pattern of inhalation exposure: blood levels and acute subnarcotic effects of toluene and acetone in rats.","8997530","Neurologic Manifestations","D012640","Seizures","DTXSID8021482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1706,D1706)","v":"Acetone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1706,M1706)","v":"Seizures"},"D000096","Acetone","67-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1706,N1706)","v":"DTXSID8021482"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1706,J1706)","v":"4046068"},"Acetone potentiation of acute acetonitrile toxicity in rats.","4046068","Neurologic Manifestations","D012640","Seizures","DTXSID8021482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1707,D1707)","v":"Acetone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1707,M1707)","v":"Tremor"},"D000096","Acetone","67-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1707,N1707)","v":"DTXSID8021482"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1707,J1707)","v":"4046068"},"Acetone potentiation of acute acetonitrile toxicity in rats.","4046068","Neurologic Manifestations","D014202","Tremor","DTXSID8021482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1708,D1708)","v":"Acetylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1708,M1708)","v":"Blindness"},"D000114","Acetylene","74-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1708,N1708)","v":"DTXSID6026379"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1708,J1708)","v":"24172562"},"Calcium carbide related ocular burn injuries during mango ripening season of West Bengal, eastern India.","24172562","Neurologic Manifestations","D001766","Blindness","DTXSID6026379"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1709,D1709)","v":"Acetylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1709,M1709)","v":"Catalepsy"},"D000114","Acetylene","74-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1709,N1709)","v":"DTXSID6026379"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1709,J1709)","v":"10834089"},"[The evaluation of the specific activity and side effects of the m-cholinergic blocker pentifin compared to other antiparkinson agents].","10834089","Neurologic Manifestations","D002375","Catalepsy","DTXSID6026379"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1710,D1710)","v":"Acetylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1710,M1710)","v":"Coma"},"D000114","Acetylene","74-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1710,N1710)","v":"DTXSID6026379"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1710,J1710)","v":"17307629"},"Calcium carbide poisoning via food in childhood.","17307629","Neurologic Manifestations","D003128","Coma","DTXSID6026379"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1711,D1711)","v":"Acetylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1711,M1711)","v":"Delirium"},"D000114","Acetylene","74-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1711,N1711)","v":"DTXSID6026379"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1711,J1711)","v":"17307629"},"Calcium carbide poisoning via food in childhood.","17307629","Neurologic Manifestations","D003693","Delirium","DTXSID6026379"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1712,D1712)","v":"Acetylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1712,M1712)","v":"Eye Burns"},"D000114","Acetylene","74-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1712,N1712)","v":"DTXSID6026379"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1712,J1712)","v":"11941258"},"[Severe ocular burns by calcium carbide in a speleologist: a case report].","11941258","Trauma, Nervous System","D005126","Eye Burns","DTXSID6026379"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1713,D1713)","v":"Acetylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1713,M1713)","v":"Polyneuropathies"},"D000114","Acetylene","74-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1713,N1713)","v":"DTXSID6026379"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1713,J1713)","v":"5412237"},"[\"Polyneuritis cranialis\" following poisoning with chlorinated acetylenes in connection with vinylidene copolymers].","5412237","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID6026379"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1714,D1714)","v":"Acetylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1714,M1714)","v":"Seizures"},"D000114","Acetylene","74-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1714,N1714)","v":"DTXSID6026379"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1714,J1714)","v":"17307629"},"Calcium carbide poisoning via food in childhood.","17307629","Neurologic Manifestations","D012640","Seizures","DTXSID6026379"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1715,D1715)","v":"Acetylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1715,M1715)","v":"Seizures"},"D000114","Acetylene","74-86-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1715,N1715)","v":"DTXSID6026379"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1715,J1715)","v":"10834089"},"[The evaluation of the specific activity and side effects of the m-cholinergic blocker pentifin compared to other antiparkinson agents].","10834089","Neurologic Manifestations","D012640","Seizures","DTXSID6026379"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1716,D1716)","v":"acivicin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1716,M1716)","v":"Brain Diseases"},"C006303","acivicin","42228-92-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1716,N1716)","v":"DTXSID0046010"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1716,J1716)","v":"3530455"},"Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.","3530455","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID0046010"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1717,D1717)","v":"acivicin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1717,M1717)","v":"Central Nervous System Diseases"},"C006303","acivicin","42228-92-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1717,N1717)","v":"DTXSID0046010"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1717,J1717)","v":"6478451"},"Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.","6478451","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID0046010"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1718,D1718)","v":"acivicin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1718,M1718)","v":"Central Nervous System Diseases"},"C006303","acivicin","42228-92-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1718,N1718)","v":"DTXSID0046010"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1718,J1718)","v":"3530452"},"Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.","3530452","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID0046010"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1719,D1719)","v":"acivicin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1719,M1719)","v":"Central Nervous System Diseases"},"C006303","acivicin","42228-92-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1719,N1719)","v":"DTXSID0046010"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1719,J1719)","v":"3524833"},"Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.","3524833","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID0046010"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1720,D1720)","v":"acivicin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1720,M1720)","v":"Hearing Disorders"},"C006303","acivicin","42228-92-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1720,N1720)","v":"DTXSID0046010"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1720,J1720)","v":"18420380"},"Toluene-induced hearing loss in acivicin-treated rats.","18420380","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID0046010"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1721,D1721)","v":"acivicin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1721,M1721)","v":"Nervous System Diseases"},"C006303","acivicin","42228-92-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1721,N1721)","v":"DTXSID0046010"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1721,J1721)","v":"3700040"},"Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.","3700040","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0046010"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1722,D1722)","v":"Aconitine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1722,M1722)","v":"Demyelinating Diseases"},"D000157","Aconitine","302-27-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1722,N1722)","v":"DTXSID4046319"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1722,J1722)","v":"1668243"},"Myelo-optic neuropathy caused by aconitine in rabbit model.","1668243","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID4046319"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1723,D1723)","v":"Aconitine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1723,M1723)","v":"Diplopia"},"D000157","Aconitine","302-27-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1723,N1723)","v":"DTXSID4046319"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1723,J1723)","v":"2478747"},"[Pharmacodynamics of allapinin and its possible adverse effects].","2478747","Neurologic Manifestations","D004172","Diplopia","DTXSID4046319"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1724,D1724)","v":"Aconitine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1724,M1724)","v":"Hyperalgesia"},"D000157","Aconitine","302-27-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1724,N1724)","v":"DTXSID4046319"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1724,J1724)","v":"9459571"},"Mode of antinociceptive and toxic action of alkaloids of Aconitum spec..","9459571","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID4046319"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1725,D1725)","v":"Aconitine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1725,M1725)","v":"Optic Nerve Diseases"},"D000157","Aconitine","302-27-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1725,N1725)","v":"DTXSID4046319"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1725,J1725)","v":"1668243"},"Myelo-optic neuropathy caused by aconitine in rabbit model.","1668243","Cranial Nerve Diseases","D009901","Optic Nerve Diseases","DTXSID4046319"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1726,D1726)","v":"Aconitine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1726,M1726)","v":"Peripheral Nervous System Diseases"},"D000157","Aconitine","302-27-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1726,N1726)","v":"DTXSID4046319"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1726,J1726)","v":"1668243"},"Myelo-optic neuropathy caused by aconitine in rabbit model.","1668243","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4046319"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1727,D1727)","v":"Aconitine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1727,M1727)","v":"Quadriplegia"},"D000157","Aconitine","302-27-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1727,N1727)","v":"DTXSID4046319"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1727,J1727)","v":"8197713"},"Herb-induced aconitine poisoning presenting as tetraplegia.","8197713","Neurologic Manifestations","D011782","Quadriplegia","DTXSID4046319"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1728,D1728)","v":"Aconitine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1728,M1728)","v":"Quadriplegia"},"D000157","Aconitine","302-27-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1728,N1728)","v":"DTXSID4046319"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1728,J1728)","v":"10962666"},"A woman with tetraparesis and missed beats.","10962666","Neurologic Manifestations","D011782","Quadriplegia","DTXSID4046319"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1729,D1729)","v":"Aconitine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1729,M1729)","v":"Seizures"},"D000157","Aconitine","302-27-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1729,N1729)","v":"DTXSID4046319"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1729,J1729)","v":"18329015"},"Aconitine induces prolonged seizure-like events in rat neocortical brain slices.","18329015","Neurologic Manifestations","D012640","Seizures","DTXSID4046319"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1730,D1730)","v":"Aconitine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1730,M1730)","v":"Spinal Cord Diseases"},"D000157","Aconitine","302-27-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1730,N1730)","v":"DTXSID4046319"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1730,J1730)","v":"1668243"},"Myelo-optic neuropathy caused by aconitine in rabbit model.","1668243","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID4046319"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1731,D1731)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1731,M1731)","v":"Alzheimer Disease"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1731,N1731)","v":"DTXSID5020023"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1731,J1731)","v":"18473924"},"Carbonyl-scavenging drugs &amp; protection against carbonyl stress-associated cell injury.","18473924","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1732,D1732)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1732,M1732)","v":"Alzheimer Disease"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1732,N1732)","v":"DTXSID5020023"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1732,J1732)","v":"23296102"},"Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo.","23296102","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1733,D1733)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1733,M1733)","v":"Eye Injuries"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1733,N1733)","v":"DTXSID5020023"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1733,J1733)","v":"25694172"},"Acute and long-term ocular effects of acrolein vapor on the eyes and potential therapies.","25694172","Trauma, Nervous System","D005131","Eye Injuries","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1734,D1734)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1734,M1734)","v":"Eye Injuries"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1734,N1734)","v":"DTXSID5020023"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1734,J1734)","v":"25363068"},"Acute and long-term ocular effects of acrolein vapor on the eyes and potential therapies.","25363068","Trauma, Nervous System","D005131","Eye Injuries","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1735,D1735)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1735,M1735)","v":"Hyperalgesia"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1735,N1735)","v":"DTXSID5020023"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1735,J1735)","v":"28716263"},"Exogenous Acrolein intensifies sensory hypersensitivity after spinal cord injury in rat.","28716263","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1736,D1736)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1736,M1736)","v":"Lateral Medullary Syndrome"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1736,N1736)","v":"DTXSID5020023"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1736,J1736)","v":"23615676"},"Notes from the field: Acute pesticide-related illness resulting from occupational exposure to acrolein - Washington and California, 1993-2009.","23615676","Central Nervous System Diseases","D014854","Lateral Medullary Syndrome","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1737,D1737)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1737,M1737)","v":"Nervous System Diseases"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1737,N1737)","v":"DTXSID5020023"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1737,J1737)","v":"21285012"},"Acrolein and neuro disorders.","21285012","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1738,D1738)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1738,M1738)","v":"Neuralgia"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1738,N1738)","v":"DTXSID5020023"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1738,J1738)","v":"28716263"},"Exogenous Acrolein intensifies sensory hypersensitivity after spinal cord injury in rat.","28716263","Neuromuscular Diseases","D009437","Neuralgia","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1739,D1739)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1739,M1739)","v":"Spinal Cord Injuries"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1739,N1739)","v":"DTXSID5020023"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1739,J1739)","v":"27058147"},"Unilateral microinjection of acrolein into thoracic spinal cord produces acute and chronic injury and functional deficits.","27058147","Trauma, Nervous System","D013119","Spinal Cord Injuries","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1740,D1740)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1740,M1740)","v":"Spinal Cord Injuries"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1740,N1740)","v":"DTXSID5020023"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1740,J1740)","v":"28301040"},"Dimercaprol is an acrolein scavenger that mitigates acrolein-mediated PC-12 cells toxicity and reduces acrolein in rat following spinal cord injury.","28301040","Trauma, Nervous System","D013119","Spinal Cord Injuries","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1741,D1741)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1741,M1741)","v":"Spinal Cord Injuries"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1741,N1741)","v":"DTXSID5020023"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1741,J1741)","v":"18473924"},"Carbonyl-scavenging drugs &amp; protection against carbonyl stress-associated cell injury.","18473924","Trauma, Nervous System","D013119","Spinal Cord Injuries","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1742,D1742)","v":"Acrolein"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1742,M1742)","v":"Spinal Cord Injuries"},"D000171","Acrolein","107-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1742,N1742)","v":"DTXSID5020023"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1742,J1742)","v":"17995940"},"Hydralazine inhibits compression and acrolein-mediated injuries in ex vivo spinal cord.","17995940","Trauma, Nervous System","D013119","Spinal Cord Injuries","DTXSID5020023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1743,D1743)","v":"acromelic acid A"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1743,M1743)","v":"Hyperalgesia"},"C051743","acromelic acid A","86630-09-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1743,N1743)","v":"DTXSID70897146"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1743,J1743)","v":"25861935"},"Comparison of mechanisms of allodynia induced by acromelic acid A between early and late phases.","25861935","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID70897146"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1744,D1744)","v":"acromelic acid A"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1744,M1744)","v":"Muscle Spasticity"},"C051743","acromelic acid A","86630-09-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1744,N1744)","v":"DTXSID70897146"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1744,J1744)","v":"1890926"},"Systemic administration of acromelic acid induces selective neuron damage in the rat spinal cord.","1890926","Neurologic Manifestations","D009128","Muscle Spasticity","DTXSID70897146"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1745,D1745)","v":"acromelic acid A"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1745,M1745)","v":"Neuromuscular Diseases"},"C051743","acromelic acid A","86630-09-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1745,N1745)","v":"DTXSID70897146"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1745,J1745)","v":"7821331"},"Neuron damage induced by some potent kainoids and neuroprotective action of new agonists for metabotropic glutamate receptors.","7821331","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID70897146"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1746,D1746)","v":"acromelic acid A"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1746,M1746)","v":"Paralysis"},"C051743","acromelic acid A","86630-09-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1746,N1746)","v":"DTXSID70897146"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1746,J1746)","v":"1890926"},"Systemic administration of acromelic acid induces selective neuron damage in the rat spinal cord.","1890926","Neurologic Manifestations","D010243","Paralysis","DTXSID70897146"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1747,D1747)","v":"acromelic acid A"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1747,M1747)","v":"Paraparesis, Tropical Spastic"},"C051743","acromelic acid A","86630-09-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1747,N1747)","v":"DTXSID70897146"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1747,J1747)","v":"1817797"},"[Neuron damage in the rat spinal cord induced by acromelic acid].","1817797","Central Nervous System Diseases","D015493","Paraparesis, Tropical Spastic","DTXSID70897146"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1748,D1748)","v":"acromelic acid A"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1748,M1748)","v":"Seizures"},"C051743","acromelic acid A","86630-09-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1748,N1748)","v":"DTXSID70897146"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1748,J1748)","v":"2557968"},"Specific lesions of rat spinal interneurons induced by systemic administration of acromelic acid, a new potent kainate analogue.","2557968","Neurologic Manifestations","D012640","Seizures","DTXSID70897146"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1749,D1749)","v":"acromelic acid A"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1749,M1749)","v":"Seizures"},"C051743","acromelic acid A","86630-09-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1749,N1749)","v":"DTXSID70897146"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1749,J1749)","v":"1890926"},"Systemic administration of acromelic acid induces selective neuron damage in the rat spinal cord.","1890926","Neurologic Manifestations","D012640","Seizures","DTXSID70897146"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1750,D1750)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1750,M1750)","v":"Alzheimer Disease"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1750,N1750)","v":"DTXSID5020027"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1750,J1750)","v":"18624437"},"Acrylamide-induced nerve terminal damage: relevance to neurotoxic and neurodegenerative mechanisms.","18624437","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1751,D1751)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1751,M1751)","v":"Ataxia"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1751,N1751)","v":"DTXSID5020027"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1751,J1751)","v":"8345530"},"Comparison of toxicities of acrylamide and 2,5-hexanedione in hens and rats on 3-week dosing regimens.","8345530","Neurologic Manifestations","D001259","Ataxia","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1752,D1752)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1752,M1752)","v":"Ataxia"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1752,N1752)","v":"DTXSID5020027"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1752,J1752)","v":"2996174"},"Acrylamide neurotoxicity: altered spinal monosynaptic responses to quipazine, a serotonin agonist, in cats.","2996174","Neurologic Manifestations","D001259","Ataxia","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1753,D1753)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1753,M1753)","v":"Ataxia"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1753,N1753)","v":"DTXSID5020027"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1753,J1753)","v":"21444355"},"Effect of sub-acute exposure to acrylamide on GABAergic neurons and astrocytes in weaning rat cerebellum.","21444355","Neurologic Manifestations","D001259","Ataxia","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1754,D1754)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1754,M1754)","v":"Ataxia"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1754,N1754)","v":"DTXSID5020027"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1754,J1754)","v":"12510666"},"Acrylamide and N-methylolacrylamide poisoning in a herd of Charolais crossbreed cattle.","12510666","Neurologic Manifestations","D001259","Ataxia","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1755,D1755)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1755,M1755)","v":"Brain Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1755,N1755)","v":"DTXSID5020027"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1755,J1755)","v":"6508899"},"Neurotoxic effects of acrylamide on rat retinogeniculate fibres.","6508899","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1756,D1756)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1756,M1756)","v":"Brain Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1756,N1756)","v":"DTXSID5020027"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1756,J1756)","v":"1324327"},"Protein malnourishment: a predisposing factor in acrylamide toxicity in pregnant rats.","1324327","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1757,D1757)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1757,M1757)","v":"Brain Neoplasms"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1757,N1757)","v":"DTXSID5020027"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1757,J1757)","v":"3764902"},"Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats.","3764902","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1758,D1758)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1758,M1758)","v":"Brain Neoplasms"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1758,N1758)","v":"DTXSID5020027"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1758,J1758)","v":"18624430"},"Acrylamide carcinogenicity.","18624430","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1759,D1759)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1759,M1759)","v":"Brain Neoplasms"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1759,N1759)","v":"DTXSID5020027"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1759,J1759)","v":"19383886"},"Dietary acrylamide intake and brain cancer risk.","19383886","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1760,D1760)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1760,M1760)","v":"Central Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1760,N1760)","v":"DTXSID5020027"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1760,J1760)","v":"8176411"},"Acrylamide-induced neurotoxicity in the central nervous system of Japanese quails. Comparative studies of normal and neurofilament-deficient quails.","8176411","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1761,D1761)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1761,M1761)","v":"Diabetic Neuropathies"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1761,N1761)","v":"DTXSID5020027"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1761,J1761)","v":"8740660"},"Acrylamide-induced neuropathic changes in rat enteric nerves: similarities with effects of streptozotocin-diabetes.","8740660","Neuromuscular Diseases","D003929","Diabetic Neuropathies","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1762,D1762)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1762,M1762)","v":"Gait Ataxia"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1762,N1762)","v":"DTXSID5020027"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1762,J1762)","v":"24331539"},"Acrylamide alters cytoskeletal protein level in rat serum.","24331539","Neurologic Manifestations","D020234","Gait Ataxia","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1763,D1763)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1763,M1763)","v":"Gait Disorders, Neurologic"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1763,N1763)","v":"DTXSID5020027"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1763,J1763)","v":"26423962"},"Neuroprotective Effect of Calpeptin on Acrylamide-Induced Neuropathy in Rats.","26423962","Neurologic Manifestations","D020233","Gait Disorders, Neurologic","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1764,D1764)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1764,M1764)","v":"Gait Disorders, Neurologic"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1764,N1764)","v":"DTXSID5020027"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1764,J1764)","v":"16242231"},"Effect of subchronic exposure to acrylamide induced on the expression of bcl-2, bax and caspase-3 in the rat nervous system.","16242231","Neurologic Manifestations","D020233","Gait Disorders, Neurologic","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1765,D1765)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1765,M1765)","v":"Learning Disorders"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1765,N1765)","v":"DTXSID5020027"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1765,J1765)","v":"19846048"},"Effects of chronic oral acrylamide exposure on incremental repeated acquisition (learning) task performance in Fischer 344 rats.","19846048","Neurologic Manifestations","D007859","Learning Disorders","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1766,D1766)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1766,M1766)","v":"Muscle Hypotonia"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1766,N1766)","v":"DTXSID5020027"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1766,J1766)","v":"2283066"},"[Toxic properties of acrylamide (review of the literature)].","2283066","Neurologic Manifestations","D009123","Muscle Hypotonia","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1767,D1767)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1767,M1767)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1767,N1767)","v":"DTXSID5020027"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1767,J1767)","v":"6539742"},"Acrylamide neurotoxicity.","6539742","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1768,D1768)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1768,M1768)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1768,N1768)","v":"DTXSID5020027"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1768,J1768)","v":"7202150"},"Acrylamide induces early morphologic reorganization of the neuronal cell body.","7202150","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1769,D1769)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1769,M1769)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1769,N1769)","v":"DTXSID5020027"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1769,J1769)","v":"6684458"},"Effect of oral CDP-choline on acrylamide-induced lesion.","6684458","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1770,D1770)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1770,M1770)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1770,N1770)","v":"DTXSID5020027"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1770,J1770)","v":"7994194"},"Acrylamide increases in vitro calcium and calmodulin-dependent kinase-mediated phosphorylation of rat brain and spinal cord neurofilament proteins.","7994194","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1771,D1771)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1771,M1771)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1771,N1771)","v":"DTXSID5020027"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1771,J1771)","v":"4088541"},"Studies of the primate somatosensory system in experimental acrylamide intoxication.","4088541","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1772,D1772)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1772,M1772)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1772,N1772)","v":"DTXSID5020027"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1772,J1772)","v":"4088539"},"Clinical and morphological findings in acrylamide toxicity.","4088539","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1773,D1773)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1773,M1773)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1773,N1773)","v":"DTXSID5020027"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1773,J1773)","v":"2616066"},"Effects of acrylamide and 2,5-hexanedione on brain mitochondrial respiration.","2616066","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1774,D1774)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1774,M1774)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1774,N1774)","v":"DTXSID5020027"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1774,J1774)","v":"2706498"},"Effect of exogenous pyruvate on acrylamide neuropathy in rats.","2706498","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1775,D1775)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1775,M1775)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1775,N1775)","v":"DTXSID5020027"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1775,J1775)","v":"2935750"},"Biochemical studies of acrylamide neuropathy.","2935750","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1776,D1776)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1776,M1776)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1776,N1776)","v":"DTXSID5020027"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1776,J1776)","v":"2979596"},"Metabolic interaction and neurological effect of combined exposure to acrylamide and ethanol.","2979596","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1777,D1777)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1777,M1777)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1777,N1777)","v":"DTXSID5020027"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1777,J1777)","v":"18624437"},"Acrylamide-induced nerve terminal damage: relevance to neurotoxic and neurodegenerative mechanisms.","18624437","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1778,D1778)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1778,M1778)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1778,N1778)","v":"DTXSID5020027"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1778,J1778)","v":"17391825"},"Lack of preventive effects of dietary fibers or chlorophyllin against acrylamide toxicity in rats.","17391825","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1779,D1779)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1779,M1779)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1779,N1779)","v":"DTXSID5020027"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1779,J1779)","v":"1842897"},"A neurotoxicity screening battery for use in safety evaluation: effects of acrylamide and 3',3'-iminodipropionitrile.","1842897","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1780,D1780)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1780,M1780)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1780,N1780)","v":"DTXSID5020027"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1780,J1780)","v":"18312701"},"A message in a bottle: a case report.","18312701","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1781,D1781)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1781,M1781)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1781,N1781)","v":"DTXSID5020027"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1781,J1781)","v":"6086944"},"The influence of systemic factors on acrylamide-induced changes in brain, nerve, and other tissues.","6086944","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1782,D1782)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1782,M1782)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1782,N1782)","v":"DTXSID5020027"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1782,J1782)","v":"2528204"},"Neurological and electroneuromyographic assessment of the adverse effects of acrylamide on occupationally exposed workers.","2528204","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1783,D1783)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1783,M1783)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1783,N1783)","v":"DTXSID5020027"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1783,J1783)","v":"2433402"},"Acrylamide neuropathy: changes in the composition of proteins of fast axonal transport resemble those observed in regenerating axons.","2433402","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1784,D1784)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1784,M1784)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1784,N1784)","v":"DTXSID5020027"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1784,J1784)","v":"23541332"},"Acrylamide neurotoxicity.","23541332","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1785,D1785)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1785,M1785)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1785,N1785)","v":"DTXSID5020027"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1785,J1785)","v":"15864552"},"Chemoprevention of acrylamide toxicity by antioxidative agents in rats--effective suppression of testicular toxicity by phenylethyl isothiocyanate.","15864552","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1786,D1786)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1786,M1786)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1786,N1786)","v":"DTXSID5020027"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1786,J1786)","v":"1580795"},"Somatofugal axonal atrophy precedes development of axonal degeneration in acrylamide neuropathy.","1580795","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1787,D1787)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1787,M1787)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1787,N1787)","v":"DTXSID5020027"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1787,J1787)","v":"1597260"},"Comparison of subchronic neurotoxicity of 2-hydroxyethyl acrylate and acrylamide in rats.","1597260","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1788,D1788)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1788,M1788)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1788,N1788)","v":"DTXSID5020027"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1788,J1788)","v":"20870314"},"Potent neuroprotective role of novel melatonin derivatives for management of central neuropathy induced by acrylamide in rats.","20870314","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1789,D1789)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1789,M1789)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1789,N1789)","v":"DTXSID5020027"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1789,J1789)","v":"2234542"},"Analysis of dose/time/response relationships for chronic toxic effects: the case of acrylamide.","2234542","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1790,D1790)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1790,M1790)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1790,N1790)","v":"DTXSID5020027"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1790,J1790)","v":"21511896"},"Elaidic acid enhanced the simultaneous neurotoxicity attributable to the cerebral pathological lesion resulted from oxidative damages induced by acrylamide and benzo(a)pyrene.","21511896","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1791,D1791)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1791,M1791)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1791,N1791)","v":"DTXSID5020027"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1791,J1791)","v":"10825678"},"Relationship between acrylamide reproductive and neurotoxicity in male rats.","10825678","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1792,D1792)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1792,M1792)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1792,N1792)","v":"DTXSID5020027"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1792,J1792)","v":"12387366"},"Acrylamide neuropathy. I. Spatiotemporal characteristics of nerve cell damage in rat cerebellum.","12387366","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1793,D1793)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1793,M1793)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1793,N1793)","v":"DTXSID5020027"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1793,J1793)","v":"12387367"},"Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in brainstem and spinal cord.","12387367","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1794,D1794)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1794,M1794)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1794,N1794)","v":"DTXSID5020027"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1794,J1794)","v":"12507653"},"Effects of acrylamide on rodent reproductive performance.","12507653","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1795,D1795)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1795,M1795)","v":"Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1795,N1795)","v":"DTXSID5020027"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1795,J1795)","v":"12164553"},"Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione.","12164553","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1796,D1796)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1796,M1796)","v":"Neuralgia"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1796,N1796)","v":"DTXSID5020027"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1796,J1796)","v":"25853975"},"The effect of lipoic acid on acrylamide-induced neuropathy in rats with reference to biochemical, hematological, and behavioral alterations.","25853975","Neuromuscular Diseases","D009437","Neuralgia","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1797,D1797)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1797,M1797)","v":"Neuralgia"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1797,N1797)","v":"DTXSID5020027"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1797,J1797)","v":"23161090"},"Neuroprotective efficacy of eugenol and isoeugenol in acrylamide-induced neuropathy in rats: behavioral and biochemical evidence.","23161090","Neuromuscular Diseases","D009437","Neuralgia","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1798,D1798)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1798,M1798)","v":"Neurodegenerative Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1798,N1798)","v":"DTXSID5020027"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1798,J1798)","v":"26341906"},"Farnesol quells oxidative stress, reactive gliosis and inflammation during acrylamide-induced neurotoxicity: Behavioral and biochemical evidence.","26341906","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1799,D1799)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1799,M1799)","v":"Neurodegenerative Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1799,N1799)","v":"DTXSID5020027"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1799,J1799)","v":"18624437"},"Acrylamide-induced nerve terminal damage: relevance to neurotoxic and neurodegenerative mechanisms.","18624437","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1800,D1800)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1800,M1800)","v":"Neurodegenerative Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1800,N1800)","v":"DTXSID5020027"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1800,J1800)","v":"23541332"},"Acrylamide neurotoxicity.","23541332","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1801,D1801)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1801,M1801)","v":"Optic Nerve Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1801,N1801)","v":"DTXSID5020027"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1801,J1801)","v":"3972512"},"Acrylamide effects on the macaque visual system. II. Retinogeniculate morphology.","3972512","Cranial Nerve Diseases","D009901","Optic Nerve Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1802,D1802)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1802,M1802)","v":"Optic Nerve Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1802,N1802)","v":"DTXSID5020027"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1802,J1802)","v":"3972511"},"Acrylamide effects on the macaque visual system. I. Psychophysics and electrophysiology.","3972511","Cranial Nerve Diseases","D009901","Optic Nerve Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1803,D1803)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1803,M1803)","v":"Optic Neuritis"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1803,N1803)","v":"DTXSID5020027"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1803,J1803)","v":"6508899"},"Neurotoxic effects of acrylamide on rat retinogeniculate fibres.","6508899","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1804,D1804)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1804,M1804)","v":"Paralysis"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1804,N1804)","v":"DTXSID5020027"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1804,J1804)","v":"8685898"},"The effects of 2,5-hexanedione and acrylamide on myosin heavy chain isoforms of slow and fast skeletal muscles of the rat.","8685898","Neurologic Manifestations","D010243","Paralysis","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1805,D1805)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1805,M1805)","v":"Paralysis"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1805,N1805)","v":"DTXSID5020027"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1805,J1805)","v":"3985992"},"Effects of mixed-function oxidase modifiers on neurotoxicity of acrylamide in rats.","3985992","Neurologic Manifestations","D010243","Paralysis","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1806,D1806)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1806,M1806)","v":"Paresthesia"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1806,N1806)","v":"DTXSID5020027"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1806,J1806)","v":"15018025"},"Effects on the peripheral nervous system of tunnel workers exposed to acrylamide and N-methylolacrylamide.","15018025","Neurologic Manifestations","D010292","Paresthesia","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1807,D1807)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1807,M1807)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1807,N1807)","v":"DTXSID5020027"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1807,J1807)","v":"6318389"},"Relative refractory period as a measure of peripheral nerve neurotoxicity.","6318389","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1808,D1808)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1808,M1808)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1808,N1808)","v":"DTXSID5020027"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1808,J1808)","v":"8209389"},"Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide.","8209389","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1809,D1809)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1809,M1809)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1809,N1809)","v":"DTXSID5020027"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1809,J1809)","v":"8394840"},"Quantitative measurements of vibration threshold in healthy adults and acrylamide workers.","8394840","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1810,D1810)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1810,M1810)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1810,N1810)","v":"DTXSID5020027"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1810,J1810)","v":"8021696"},"Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy.","8021696","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1811,D1811)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1811,M1811)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1811,N1811)","v":"DTXSID5020027"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1811,J1811)","v":"9707497"},"Biochemical and morphologic characterization of acrylamide peripheral neuropathy.","9707497","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1812,D1812)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1812,M1812)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1812,N1812)","v":"DTXSID5020027"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1812,J1812)","v":"2557793"},"Abnormal cough reflex in canine acrylamide neuropathy.","2557793","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1813,D1813)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1813,M1813)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1813,N1813)","v":"DTXSID5020027"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1813,J1813)","v":"26177905"},"The Role of NF mRNA and Calpain in NF Reduction of Acrylamide Neuropathy.","26177905","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1814,D1814)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1814,M1814)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1814,N1814)","v":"DTXSID5020027"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1814,J1814)","v":"28436077"},"Neuroprotective effect of epidermal growth factor in experimental acrylamide neuropathy: an electrophysiological approach.","28436077","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1815,D1815)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1815,M1815)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1815,N1815)","v":"DTXSID5020027"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1815,J1815)","v":"3031847"},"Primary afferent terminal function following acrylamide: alterations in the dorsal root potential and reflex.","3031847","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1816,D1816)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1816,M1816)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1816,N1816)","v":"DTXSID5020027"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1816,J1816)","v":"2981375"},"Acrylamide neuropathy in the rat: effects on energy metabolism in sciatic nerve.","2981375","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1817,D1817)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1817,M1817)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1817,N1817)","v":"DTXSID5020027"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1817,J1817)","v":"18383339"},"Further evidence for a crucial role of resident endoneurial macrophages in peripheral nerve disorders: lessons from acrylamide-induced neuropathy.","18383339","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1818,D1818)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1818,M1818)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1818,N1818)","v":"DTXSID5020027"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1818,J1818)","v":"18353610"},"Nerve conduction, visual evoked responses and electroretinography in tunnel workers previously exposed to acrylamide and N-methylolacrylamide containing grouting agents.","18353610","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1819,D1819)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1819,M1819)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1819,N1819)","v":"DTXSID5020027"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1819,J1819)","v":"6093740"},"Peripheral nerve phospholipids in acrylamide neuropathy.","6093740","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1820,D1820)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1820,M1820)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1820,N1820)","v":"DTXSID5020027"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1820,J1820)","v":"6095142"},"A simple, sensitive method for detecting early peripheral nerve dysfunction in the rat following acrylamide treatment.","6095142","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1821,D1821)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1821,M1821)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1821,N1821)","v":"DTXSID5020027"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1821,J1821)","v":"2410575"},"Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration.","2410575","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1822,D1822)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1822,M1822)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1822,N1822)","v":"DTXSID5020027"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1822,J1822)","v":"1647505"},"Acrylamide-induced visceral neuropathy: evidence for the involvement of capsaicin-sensitive nerves of the rat urinary bladder.","1647505","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1823,D1823)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1823,M1823)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1823,N1823)","v":"DTXSID5020027"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1823,J1823)","v":"1658984"},"Peripheral pain fiber function is relatively insensitive to the neurotoxic actions of acrylamide in the rat.","1658984","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1824,D1824)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1824,M1824)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1824,N1824)","v":"DTXSID5020027"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1824,J1824)","v":"20568453"},"[General survey of mechanisms of acrylamide neurotoxicity].","20568453","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1825,D1825)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1825,M1825)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1825,N1825)","v":"DTXSID5020027"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1825,J1825)","v":"11510240"},"[Severe chronic acrylamide intoxication].","11510240","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1826,D1826)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1826,M1826)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1826,N1826)","v":"DTXSID5020027"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1826,J1826)","v":"12460555"},"Neuropathology of skin denervation in acrylamide-induced neuropathy.","12460555","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1827,D1827)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1827,M1827)","v":"Peripheral Nervous System Diseases"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1827,N1827)","v":"DTXSID5020027"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1827,J1827)","v":"12510666"},"Acrylamide and N-methylolacrylamide poisoning in a herd of Charolais crossbreed cattle.","12510666","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1828,D1828)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1828,M1828)","v":"Polyneuropathies"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1828,N1828)","v":"DTXSID5020027"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1828,J1828)","v":"10720709"},"Redefining toxic distal axonopathies.","10720709","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1829,D1829)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1829,M1829)","v":"Reflex, Abnormal"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1829,N1829)","v":"DTXSID5020027"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1829,J1829)","v":"3031847"},"Primary afferent terminal function following acrylamide: alterations in the dorsal root potential and reflex.","3031847","Neurologic Manifestations","D012021","Reflex, Abnormal","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1830,D1830)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1830,M1830)","v":"Sciatic Neuropathy"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1830,N1830)","v":"DTXSID5020027"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1830,J1830)","v":"18383339"},"Further evidence for a crucial role of resident endoneurial macrophages in peripheral nerve disorders: lessons from acrylamide-induced neuropathy.","18383339","Neuromuscular Diseases","D020426","Sciatic Neuropathy","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1831,D1831)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1831,M1831)","v":"Spinal Cord Injuries"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1831,N1831)","v":"DTXSID5020027"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1831,J1831)","v":"28771761"},"Metformin Protects against Experimental Acrylamide Neuropathy in Rats.","28771761","Trauma, Nervous System","D013119","Spinal Cord Injuries","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1832,D1832)","v":"Acrylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1832,M1832)","v":"Vision Disorders"},"D020106","Acrylamide","79-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1832,N1832)","v":"DTXSID5020027"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1832,J1832)","v":"3972511"},"Acrylamide effects on the macaque visual system. I. Psychophysics and electrophysiology.","3972511","Neurologic Manifestations","D014786","Vision Disorders","DTXSID5020027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1833,D1833)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1833,M1833)","v":"Brain Neoplasms"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1833,N1833)","v":"DTXSID5020029"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1833,J1833)","v":"8278643"},"Comparison of cancer risks projected from animal bioassays to epidemiologic studies of acrylonitrile-exposed workers.","8278643","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1834,D1834)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1834,M1834)","v":"Brain Neoplasms"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1834,N1834)","v":"DTXSID5020029"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1834,J1834)","v":"9693074"},"Evaluation of possible genotoxic mechanisms for acrylonitrile tumorigenicity.","9693074","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1835,D1835)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1835,M1835)","v":"Brain Neoplasms"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1835,N1835)","v":"DTXSID5020029"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1835,J1835)","v":"9714515"},"Review and meta-analysis of studies of acrylonitrile workers.","9714515","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1836,D1836)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1836,M1836)","v":"Brain Neoplasms"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1836,N1836)","v":"DTXSID5020029"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1836,J1836)","v":"16099568"},"Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.","16099568","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1837,D1837)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1837,M1837)","v":"Brain Neoplasms"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1837,N1837)","v":"DTXSID5020029"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1837,J1837)","v":"22821367"},"Immunohistochemical characterization of spontaneous and acrylonitrile-induced brain tumors in the rat.","22821367","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1838,D1838)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1838,M1838)","v":"Brain Neoplasms"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1838,N1838)","v":"DTXSID5020029"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1838,J1838)","v":"11550315"},"CNS tumors and exposure to acrylonitrile: inconsistency between experimental and epidemiology studies.","11550315","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1839,D1839)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1839,M1839)","v":"Central Nervous System Diseases"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1839,N1839)","v":"DTXSID5020029"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1839,J1839)","v":"2906638"},"Biochemical and developmental effects in rats following in utero exposure to acrylonitrile: a preliminary report.","2906638","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1840,D1840)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1840,M1840)","v":"Central Nervous System Diseases"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1840,N1840)","v":"DTXSID5020029"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1840,J1840)","v":"19108508"},"[Nervous system disorders in workers engaged into acrylonitrile production].","19108508","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1841,D1841)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1841,M1841)","v":"Central Nervous System Neoplasms"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1841,N1841)","v":"DTXSID5020029"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1841,J1841)","v":"11266142"},"Reconciling animal and human data in a cancer risk assessment of acrylonitrile.","11266142","Nervous System Neoplasms","D016543","Central Nervous System Neoplasms","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1842,D1842)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1842,M1842)","v":"Central Nervous System Neoplasms"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1842,N1842)","v":"DTXSID5020029"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1842,J1842)","v":"11266147"},"Reevaluation of lung cancer risk in the acrylonitrile cohort study of the National Cancer Institute and the National Institute for Occupational Safety and Health.","11266147","Nervous System Neoplasms","D016543","Central Nervous System Neoplasms","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1843,D1843)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1843,M1843)","v":"Cerebrovascular Disorders"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1843,N1843)","v":"DTXSID5020029"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1843,J1843)","v":"3265952"},"Mortality study of workers exposed to dimethylformamide and/or acrylonitrile.","3265952","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1844,D1844)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1844,M1844)","v":"Chorea"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1844,N1844)","v":"DTXSID5020029"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1844,J1844)","v":"19244277"},"Neurovestibular toxicities of acrylonitrile and iminodipropionitrile in rats: a comparative evaluation of putative mechanisms and target sites.","19244277","Central Nervous System Diseases","D002819","Chorea","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1845,D1845)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1845,M1845)","v":"Nervous System Diseases"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1845,N1845)","v":"DTXSID5020029"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1845,J1845)","v":"19403855"},"Nervous and vestibular toxicities of acrylonitrile and iminodipropionitrile.","19403855","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1846,D1846)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1846,M1846)","v":"Paresthesia"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1846,N1846)","v":"DTXSID5020029"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1846,J1846)","v":"1828409"},"Occupational contact dermatitis due to acrylonitrile.","1828409","Neurologic Manifestations","D010292","Paresthesia","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1847,D1847)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1847,M1847)","v":"Parkinsonian Disorders"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1847,N1847)","v":"DTXSID5020029"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1847,J1847)","v":"16737605"},"[Parkinson's syndrome after acute severe acrylonitrile poisoning in one patient].","16737605","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1848,D1848)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1848,M1848)","v":"Seizures"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1848,N1848)","v":"DTXSID5020029"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1848,J1848)","v":"2986062"},"Effect of acute acrylonitrile exposure on metrazol induced seizures in the rat.","2986062","Neurologic Manifestations","D012640","Seizures","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1849,D1849)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1849,M1849)","v":"Seizures"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1849,N1849)","v":"DTXSID5020029"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1849,J1849)","v":"15864551"},"Effect of cytochrome P450 inhibitors and anticonvulsants on the acute toxicity of acrylonitrile.","15864551","Neurologic Manifestations","D012640","Seizures","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1850,D1850)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1850,M1850)","v":"Seizures"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1850,N1850)","v":"DTXSID5020029"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1850,J1850)","v":"20127315"},"Induction or inhibition of cytochrome P450 2E1 modifies the acute toxicity of acrylonitrile in rats: biochemical evidence.","20127315","Neurologic Manifestations","D012640","Seizures","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1851,D1851)","v":"Acrylonitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1851,M1851)","v":"Tremor"},"D000181","Acrylonitrile","107-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1851,N1851)","v":"DTXSID5020029"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1851,J1851)","v":"27085497"},"Short-term health effects in the general population following a major train accident with acrylonitrile in Belgium.","27085497","Neurologic Manifestations","D014202","Tremor","DTXSID5020029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1852,D1852)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1852,M1852)","v":"Ataxia"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1852,N1852)","v":"DTXSID1022556"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1852,J1852)","v":"7571352"},"Hemodialysis removal of acyclovir.","7571352","Neurologic Manifestations","D001259","Ataxia","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1853,D1853)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1853,M1853)","v":"Ataxia"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1853,N1853)","v":"DTXSID1022556"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1853,J1853)","v":"19926428"},"Altered mental status from acyclovir.","19926428","Neurologic Manifestations","D001259","Ataxia","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1854,D1854)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1854,M1854)","v":"Basal Ganglia Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1854,N1854)","v":"DTXSID1022556"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1854,J1854)","v":"11960170"},"Acyclovir induced extrapyramidal symptoms : letter to editor.","11960170","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1855,D1855)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1855,M1855)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1855,N1855)","v":"DTXSID1022556"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1855,J1855)","v":"8228796"},"Distinguishing acyclovir neurotoxicity from encephalomyelitis.","8228796","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1856,D1856)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1856,M1856)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1856,N1856)","v":"DTXSID1022556"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1856,J1856)","v":"8559507"},"Acyclovir-associated encephalopathy, lack of relationship between acyclovir levels and symptoms.","8559507","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1857,D1857)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1857,M1857)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1857,N1857)","v":"DTXSID1022556"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1857,J1857)","v":"8671884"},"Acyclovir-associated encephalopathy in haemodialysis.","8671884","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1858,D1858)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1858,M1858)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1858,N1858)","v":"DTXSID1022556"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1858,J1858)","v":"9515114"},"[Acyclovir overdose in patients with renal failure: neuro and nephrotoxicity].","9515114","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1859,D1859)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1859,M1859)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1859,N1859)","v":"DTXSID1022556"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1859,J1859)","v":"27356736"},"Periodic synchronous discharge occurred in an elderly with acute valacyclovir-associated encephalopathy.","27356736","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1860,D1860)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1860,M1860)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1860,N1860)","v":"DTXSID1022556"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1860,J1860)","v":"26589129"},"Neurotoxicity induced by the recommended acyclovir dosing in a dialysis patient with herpes zoster: A case letter.","26589129","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1861,D1861)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1861,M1861)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1861,N1861)","v":"DTXSID1022556"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1861,J1861)","v":"1766532"},"[Neurotoxicity of acyclovir in peritoneal dialysis apropos of 1 case].","1766532","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1862,D1862)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1862,M1862)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1862,N1862)","v":"DTXSID1022556"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1862,J1862)","v":"16107379"},"Aciclovir induced posterior leucoencephalopathy.","16107379","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1863,D1863)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1863,M1863)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1863,N1863)","v":"DTXSID1022556"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1863,J1863)","v":"16857003"},"Neurological toxicity of acyclovir: report of a case in a six-month-old liver transplant recipient.","16857003","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1864,D1864)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1864,M1864)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1864,N1864)","v":"DTXSID1022556"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1864,J1864)","v":"10615548"},"[Cerebral and renal toxicity of acyclovir in a patient treated for meningoencephalitis].","10615548","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1865,D1865)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1865,M1865)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1865,N1865)","v":"DTXSID1022556"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1865,J1865)","v":"12799156"},"Encephalopathy induced by oral acyclovir in a patient with normal renal function.","12799156","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1866,D1866)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1866,M1866)","v":"Brain Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1866,N1866)","v":"DTXSID1022556"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1866,J1866)","v":"14658398"},"[A young patient of acute encephalitis complicated with acyclovir encephalopathy without renal dysfunction].","14658398","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1867,D1867)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1867,M1867)","v":"Central Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1867,N1867)","v":"DTXSID1022556"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1867,J1867)","v":"6721312"},"Severe but reversible neurotoxicity from acyclovir.","6721312","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1868,D1868)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1868,M1868)","v":"Central Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1868,N1868)","v":"DTXSID1022556"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1868,J1868)","v":"8322628"},"[Severe central nervous system symptoms following oral administration of acyclovir in a patient with chronic renal failure: a case report].","8322628","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1869,D1869)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1869,M1869)","v":"Central Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1869,N1869)","v":"DTXSID1022556"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1869,J1869)","v":"7973922"},"Acyclovir neurotoxicity: clinical experience and review of the literature.","7973922","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1870,D1870)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1870,M1870)","v":"Central Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1870,N1870)","v":"DTXSID1022556"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1870,J1870)","v":"9475829"},"Acyclovir- and ganciclovir-induced neurotoxicity.","9475829","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1871,D1871)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1871,M1871)","v":"Chorea"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1871,N1871)","v":"DTXSID1022556"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1871,J1871)","v":"2843139"},"[Neurologic effects of acyclovir after an allogenic marrow graft].","2843139","Central Nervous System Diseases","D002819","Chorea","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1872,D1872)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1872,M1872)","v":"Chorea"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1872,N1872)","v":"DTXSID1022556"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1872,J1872)","v":"11440337"},"Choreiform movements in dialysis patient taking valacyclovir and famciclovir.","11440337","Central Nervous System Diseases","D002819","Chorea","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1873,D1873)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1873,M1873)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1873,N1873)","v":"DTXSID1022556"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1873,J1873)","v":"8562758"},"Delirium associated with acyclovir treatment in a patient with renal failure.","8562758","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1874,D1874)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1874,M1874)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1874,N1874)","v":"DTXSID1022556"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1874,J1874)","v":"7949522"},"Oral acyclovir and neurologic adverse effects in endstage renal disease.","7949522","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1875,D1875)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1875,M1875)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1875,N1875)","v":"DTXSID1022556"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1875,J1875)","v":"9266897"},"Progressive somnolence leading to coma in a 68-year-old man.","9266897","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1876,D1876)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1876,M1876)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1876,N1876)","v":"DTXSID1022556"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1876,J1876)","v":"9246117"},"[Coma induced by intravenous acyclovir in a hemodialyzed patient].","9246117","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1877,D1877)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1877,M1877)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1877,N1877)","v":"DTXSID1022556"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1877,J1877)","v":"3951115"},"Acute renal failure and coma secondary to acyclovir therapy.","3951115","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1878,D1878)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1878,M1878)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1878,N1878)","v":"DTXSID1022556"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1878,J1878)","v":"2843139"},"[Neurologic effects of acyclovir after an allogenic marrow graft].","2843139","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1879,D1879)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1879,M1879)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1879,N1879)","v":"DTXSID1022556"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1879,J1879)","v":"1891032"},"Acute renal failure and coma after a high dose of oral acyclovir.","1891032","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1880,D1880)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1880,M1880)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1880,N1880)","v":"DTXSID1022556"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1880,J1880)","v":"16172845"},"Acute renal failure and severe neurotoxicity following valacyclovir.","16172845","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1881,D1881)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1881,M1881)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1881,N1881)","v":"DTXSID1022556"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1881,J1881)","v":"10416924"},"Acute reversible neurological and renal failure following acyclovir treatment.","10416924","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1882,D1882)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1882,M1882)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1882,N1882)","v":"DTXSID1022556"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1882,J1882)","v":"11440418"},"Coma secondary to aciclovir neurotoxicity.","11440418","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1883,D1883)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1883,M1883)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1883,N1883)","v":"DTXSID1022556"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1883,J1883)","v":"10853214"},"Acyclovir induced coma in the intensive care unit.","10853214","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1884,D1884)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1884,M1884)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1884,N1884)","v":"DTXSID1022556"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1884,J1884)","v":"12029420"},"Acyclovir-induced coma in a young patient without preexisting renal impairment.","12029420","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1885,D1885)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1885,M1885)","v":"Coma"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1885,N1885)","v":"DTXSID1022556"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1885,J1885)","v":"1460955"},"[Neurotoxicity and acyclovir].","1460955","Neurologic Manifestations","D003128","Coma","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1886,D1886)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1886,M1886)","v":"Confusion"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1886,N1886)","v":"DTXSID1022556"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1886,J1886)","v":"6625395"},"Intravenous acyclovir and neurologic effects.","6625395","Neurologic Manifestations","D003221","Confusion","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1887,D1887)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1887,M1887)","v":"Confusion"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1887,N1887)","v":"DTXSID1022556"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1887,J1887)","v":"8038467"},"Acute renal failure and neurotoxicity following oral acyclovir.","8038467","Neurologic Manifestations","D003221","Confusion","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1888,D1888)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1888,M1888)","v":"Confusion"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1888,N1888)","v":"DTXSID1022556"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1888,J1888)","v":"9197149"},"[Neurotoxicity of acyclovir].","9197149","Neurologic Manifestations","D003221","Confusion","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1889,D1889)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1889,M1889)","v":"Confusion"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1889,N1889)","v":"DTXSID1022556"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1889,J1889)","v":"17674672"},"[Risk of CNS adverse effects of aciclovir and valaciclovir. Watch the renal function in treatment of herpes simplex and herpes zoster].","17674672","Neurologic Manifestations","D003221","Confusion","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1890,D1890)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1890,M1890)","v":"Confusion"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1890,N1890)","v":"DTXSID1022556"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1890,J1890)","v":"16172845"},"Acute renal failure and severe neurotoxicity following valacyclovir.","16172845","Neurologic Manifestations","D003221","Confusion","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1891,D1891)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1891,M1891)","v":"Confusion"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1891,N1891)","v":"DTXSID1022556"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1891,J1891)","v":"20656442"},"Acute confusion in dialysis patients.","20656442","Neurologic Manifestations","D003221","Confusion","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1892,D1892)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1892,M1892)","v":"Confusion"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1892,N1892)","v":"DTXSID1022556"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1892,J1892)","v":"19926428"},"Altered mental status from acyclovir.","19926428","Neurologic Manifestations","D003221","Confusion","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1893,D1893)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1893,M1893)","v":"Confusion"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1893,N1893)","v":"DTXSID1022556"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1893,J1893)","v":"11908272"},"Acute confusional state developing in a patient taking acyclovir: from the frying pan into the fire.","11908272","Neurologic Manifestations","D003221","Confusion","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1894,D1894)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1894,M1894)","v":"Confusion"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1894,N1894)","v":"DTXSID1022556"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1894,J1894)","v":"12799156"},"Encephalopathy induced by oral acyclovir in a patient with normal renal function.","12799156","Neurologic Manifestations","D003221","Confusion","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1895,D1895)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1895,M1895)","v":"Consciousness Disorders"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1895,N1895)","v":"DTXSID1022556"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1895,J1895)","v":"8810856"},"[A patient with thyroid carcinoma who developed consciousness disturbance during acyclovir administration for herpes zoster].","8810856","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1896,D1896)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1896,M1896)","v":"Consciousness Disorders"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1896,N1896)","v":"DTXSID1022556"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1896,J1896)","v":"25749332"},"[Acyclovir-induced neurotoxicity and acute kidney injury in an elderly diabetic patient treated with valacyclovir: report of a case].","25749332","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1897,D1897)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1897,M1897)","v":"Consciousness Disorders"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1897,N1897)","v":"DTXSID1022556"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1897,J1897)","v":"19187258"},"Valacyclovir neurotoxicity: clinical experience and review of the literature.","19187258","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1898,D1898)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1898,M1898)","v":"Delirium"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1898,N1898)","v":"DTXSID1022556"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1898,J1898)","v":"8562758"},"Delirium associated with acyclovir treatment in a patient with renal failure.","8562758","Neurologic Manifestations","D003693","Delirium","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1899,D1899)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1899,M1899)","v":"Delirium"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1899,N1899)","v":"DTXSID1022556"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1899,J1899)","v":"9859124"},"[Delirium during oral therapy of herpes zoster with acyclovir. Case report and brief review of central nervous system side-effects of acyclovir].","9859124","Neurologic Manifestations","D003693","Delirium","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1900,D1900)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1900,M1900)","v":"Delirium"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1900,N1900)","v":"DTXSID1022556"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1900,J1900)","v":"17651180"},"Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient.","17651180","Neurologic Manifestations","D003693","Delirium","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1901,D1901)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1901,M1901)","v":"Dysarthria"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1901,N1901)","v":"DTXSID1022556"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1901,J1901)","v":"14658398"},"[A young patient of acute encephalitis complicated with acyclovir encephalopathy without renal dysfunction].","14658398","Neurologic Manifestations","D004401","Dysarthria","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1902,D1902)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1902,M1902)","v":"Epilepsy, Generalized"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1902,N1902)","v":"DTXSID1022556"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1902,J1902)","v":"14658398"},"[A young patient of acute encephalitis complicated with acyclovir encephalopathy without renal dysfunction].","14658398","Central Nervous System Diseases","D004829","Epilepsy, Generalized","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1903,D1903)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1903,M1903)","v":"Epilepsy, Tonic-Clonic"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1903,N1903)","v":"DTXSID1022556"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1903,J1903)","v":"20857135"},"Tonic-clonic seizure following combined treatment of mycophenolate mofetil and acyclovir.","20857135","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1904,D1904)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1904,M1904)","v":"Hallucinations"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1904,N1904)","v":"DTXSID1022556"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1904,J1904)","v":"7571352"},"Hemodialysis removal of acyclovir.","7571352","Neurologic Manifestations","D006212","Hallucinations","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1905,D1905)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1905,M1905)","v":"Hallucinations"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1905,N1905)","v":"DTXSID1022556"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1905,J1905)","v":"7949522"},"Oral acyclovir and neurologic adverse effects in endstage renal disease.","7949522","Neurologic Manifestations","D006212","Hallucinations","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1906,D1906)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1906,M1906)","v":"Hallucinations"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1906,N1906)","v":"DTXSID1022556"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1906,J1906)","v":"9197149"},"[Neurotoxicity of acyclovir].","9197149","Neurologic Manifestations","D006212","Hallucinations","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1907,D1907)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1907,M1907)","v":"Hallucinations"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1907,N1907)","v":"DTXSID1022556"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1907,J1907)","v":"17651180"},"Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient.","17651180","Neurologic Manifestations","D006212","Hallucinations","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1908,D1908)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1908,M1908)","v":"Hallucinations"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1908,N1908)","v":"DTXSID1022556"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1908,J1908)","v":"17674672"},"[Risk of CNS adverse effects of aciclovir and valaciclovir. Watch the renal function in treatment of herpes simplex and herpes zoster].","17674672","Neurologic Manifestations","D006212","Hallucinations","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1909,D1909)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1909,M1909)","v":"Hallucinations"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1909,N1909)","v":"DTXSID1022556"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1909,J1909)","v":"24777077"},"Herpes zoster encephalopathy or acyclovir neurotoxicity: a management dilemma.","24777077","Neurologic Manifestations","D006212","Hallucinations","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1910,D1910)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1910,M1910)","v":"Hallucinations"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1910,N1910)","v":"DTXSID1022556"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1910,J1910)","v":"19187258"},"Valacyclovir neurotoxicity: clinical experience and review of the literature.","19187258","Neurologic Manifestations","D006212","Hallucinations","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1911,D1911)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1911,M1911)","v":"Hallucinations"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1911,N1911)","v":"DTXSID1022556"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1911,J1911)","v":"11359026"},"Neurotoxicity of valacyclovir in peritoneal dialysis: a pharmacokinetic study.","11359026","Neurologic Manifestations","D006212","Hallucinations","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1912,D1912)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1912,M1912)","v":"Hallucinations"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1912,N1912)","v":"DTXSID1022556"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1912,J1912)","v":"14658398"},"[A young patient of acute encephalitis complicated with acyclovir encephalopathy without renal dysfunction].","14658398","Neurologic Manifestations","D006212","Hallucinations","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1913,D1913)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1913,M1913)","v":"Hearing Loss, Sensorineural"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1913,N1913)","v":"DTXSID1022556"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1913,J1913)","v":"18429879"},"Re: Sudden hearing loss.","18429879","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1914,D1914)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1914,M1914)","v":"Hearing Loss, Sudden"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1914,N1914)","v":"DTXSID1022556"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1914,J1914)","v":"18429879"},"Re: Sudden hearing loss.","18429879","Neurologic Manifestations","D003639","Hearing Loss, Sudden","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1915,D1915)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1915,M1915)","v":"Meningitis"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1915,N1915)","v":"DTXSID1022556"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1915,J1915)","v":"9515106"},"[Neurologic toxicity of aciclovir apropos of a nw observation].","9515106","Central Nervous System Diseases","D008581","Meningitis","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1916,D1916)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1916,M1916)","v":"Meningitis, Aseptic"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1916,N1916)","v":"DTXSID1022556"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1916,J1916)","v":"11197578"},"Aseptic meningitis related to valacyclovir.","11197578","Central Nervous System Diseases","D008582","Meningitis, Aseptic","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1917,D1917)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1917,M1917)","v":"Meningitis, Aseptic"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1917,N1917)","v":"DTXSID1022556"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1917,J1917)","v":"14632597"},"Possible valacyclovir-related neurotoxicity and aseptic meningitis.","14632597","Central Nervous System Diseases","D008582","Meningitis, Aseptic","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1918,D1918)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1918,M1918)","v":"Meningoencephalitis"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1918,N1918)","v":"DTXSID1022556"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1918,J1918)","v":"17404526"},"[One episode of meningoencephalitis, three diagnoses].","17404526","Central Nervous System Diseases","D008590","Meningoencephalitis","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1919,D1919)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1919,M1919)","v":"Mononeuropathies"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1919,N1919)","v":"DTXSID1022556"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1919,J1919)","v":"15159513"},"Vasculitic mononeuritis multiplex induced by valacyclovir.","15159513","Neuromuscular Diseases","D020422","Mononeuropathies","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1920,D1920)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1920,M1920)","v":"Muscular Atrophy"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1920,N1920)","v":"DTXSID1022556"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1920,J1920)","v":"15159513"},"Vasculitic mononeuritis multiplex induced by valacyclovir.","15159513","Neurologic Manifestations","D009133","Muscular Atrophy","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1921,D1921)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1921,M1921)","v":"Myoclonus"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1921,N1921)","v":"DTXSID1022556"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1921,J1921)","v":"7571352"},"Hemodialysis removal of acyclovir.","7571352","Neurologic Manifestations","D009207","Myoclonus","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1922,D1922)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1922,M1922)","v":"Myoclonus"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1922,N1922)","v":"DTXSID1022556"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1922,J1922)","v":"7949522"},"Oral acyclovir and neurologic adverse effects in endstage renal disease.","7949522","Neurologic Manifestations","D009207","Myoclonus","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1923,D1923)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1923,M1923)","v":"Myoclonus"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1923,N1923)","v":"DTXSID1022556"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1923,J1923)","v":"25784625"},"Death Delusions and Myoclonus: Acyclovir Toxicity.","25784625","Neurologic Manifestations","D009207","Myoclonus","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1924,D1924)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1924,M1924)","v":"Myoclonus"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1924,N1924)","v":"DTXSID1022556"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1924,J1924)","v":"22294022"},"Aciclovir and valaciclovir neurotoxicity in patients with renal failure.","22294022","Neurologic Manifestations","D009207","Myoclonus","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1925,D1925)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1925,M1925)","v":"Myoclonus"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1925,N1925)","v":"DTXSID1022556"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1925,J1925)","v":"21959734"},"Warning against unexpected medication in haemodialysis.","21959734","Neurologic Manifestations","D009207","Myoclonus","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1926,D1926)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1926,M1926)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1926,N1926)","v":"DTXSID1022556"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1926,J1926)","v":"6305245"},"Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation.","6305245","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1927,D1927)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1927,M1927)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1927,N1927)","v":"DTXSID1022556"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1927,J1927)","v":"6651045"},"Acyclovir and neurologic manifestations.","6651045","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1928,D1928)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1928,M1928)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1928,N1928)","v":"DTXSID1022556"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1928,J1928)","v":"7949522"},"Oral acyclovir and neurologic adverse effects in endstage renal disease.","7949522","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1929,D1929)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1929,M1929)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1929,N1929)","v":"DTXSID1022556"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1929,J1929)","v":"8416680"},"Case report: acyclovir neurotoxicity and nephrotoxicity--the role for hemodialysis.","8416680","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1930,D1930)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1930,M1930)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1930,N1930)","v":"DTXSID1022556"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1930,J1930)","v":"8190194"},"Acyclovir neurotoxicity following oral therapy: prevention and treatment in patients on haemodialysis.","8190194","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1931,D1931)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1931,M1931)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1931,N1931)","v":"DTXSID1022556"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1931,J1931)","v":"9438656"},"Acute acyclovir neurotoxicity in a hemodialyzed child.","9438656","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1932,D1932)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1932,M1932)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1932,N1932)","v":"DTXSID1022556"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1932,J1932)","v":"9712461"},"Neurotoxicity caused by valacyclovir in a patient on hemodialysis.","9712461","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1933,D1933)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1933,M1933)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1933,N1933)","v":"DTXSID1022556"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1933,J1933)","v":"9496746"},"More about acyclovir neurotoxicity in patients on haemodialysis.","9496746","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1934,D1934)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1934,M1934)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1934,N1934)","v":"DTXSID1022556"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1934,J1934)","v":"4062110"},"Adverse effects with acyclovir and meperidine.","4062110","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1935,D1935)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1935,M1935)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1935,N1935)","v":"DTXSID1022556"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1935,J1935)","v":"2742255"},"Oral acyclovir and neurotoxicity.","2742255","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1936,D1936)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1936,M1936)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1936,N1936)","v":"DTXSID1022556"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1936,J1936)","v":"25784625"},"Death Delusions and Myoclonus: Acyclovir Toxicity.","25784625","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1937,D1937)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1937,M1937)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1937,N1937)","v":"DTXSID1022556"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1937,J1937)","v":"27418364"},"Neurological deterioration in the treatment of Herpes zoster: encephalitis or neurotoxic effect of acyclovir?","27418364","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1938,D1938)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1938,M1938)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1938,N1938)","v":"DTXSID1022556"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1938,J1938)","v":"2964805"},"Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study.","2964805","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1939,D1939)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1939,M1939)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1939,N1939)","v":"DTXSID1022556"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1939,J1939)","v":"3335815"},"Excessive serum concentrations of acyclovir and neurotoxicity.","3335815","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1940,D1940)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1940,M1940)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1940,N1940)","v":"DTXSID1022556"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1940,J1940)","v":"2329108"},"Neurotoxicity of acyclovir in end stage renal disease.","2329108","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1941,D1941)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1941,M1941)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1941,N1941)","v":"DTXSID1022556"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1941,J1941)","v":"1598021"},"[Severe neurologic toxicity from oral acyclovir].","1598021","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1942,D1942)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1942,M1942)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1942,N1942)","v":"DTXSID1022556"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1942,J1942)","v":"12602377"},"Neurological disturbances with valaciclovir.","12602377","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1943,D1943)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1943,M1943)","v":"Nervous System Diseases"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1943,N1943)","v":"DTXSID1022556"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1943,J1943)","v":"14632597"},"Possible valacyclovir-related neurotoxicity and aseptic meningitis.","14632597","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1944,D1944)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1944,M1944)","v":"Paresthesia"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1944,N1944)","v":"DTXSID1022556"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1944,J1944)","v":"6305245"},"Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation.","6305245","Neurologic Manifestations","D010292","Paresthesia","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1945,D1945)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1945,M1945)","v":"Paresthesia"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1945,N1945)","v":"DTXSID1022556"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1945,J1945)","v":"15159513"},"Vasculitic mononeuritis multiplex induced by valacyclovir.","15159513","Neurologic Manifestations","D010292","Paresthesia","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1946,D1946)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1946,M1946)","v":"Seizures"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1946,N1946)","v":"DTXSID1022556"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1946,J1946)","v":"8038467"},"Acute renal failure and neurotoxicity following oral acyclovir.","8038467","Neurologic Manifestations","D012640","Seizures","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1947,D1947)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1947,M1947)","v":"Seizures"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1947,N1947)","v":"DTXSID1022556"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1947,J1947)","v":"14632595"},"Valacyclovir-induced seizures in end-stage renal disease.","14632595","Neurologic Manifestations","D012640","Seizures","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1948,D1948)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1948,M1948)","v":"Speech Disorders"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1948,N1948)","v":"DTXSID1022556"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1948,J1948)","v":"24777077"},"Herpes zoster encephalopathy or acyclovir neurotoxicity: a management dilemma.","24777077","Neurologic Manifestations","D013064","Speech Disorders","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1949,D1949)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1949,M1949)","v":"Spina Bifida Occulta"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1949,N1949)","v":"DTXSID1022556"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1949,J1949)","v":"1810578"},"Prenatal diagnosis of fetal diastematomyelia in a pregnancy exposed to acyclovir.","1810578","Nervous System Malformations","D016136","Spina Bifida Occulta","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1950,D1950)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1950,M1950)","v":"Status Epilepticus"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1950,N1950)","v":"DTXSID1022556"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1950,J1950)","v":"25539699"},"Case files of the Harvard medical toxicology fellowship: valacyclovir neurotoxicity and unintentional overdose.","25539699","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1951,D1951)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1951,M1951)","v":"Status Epilepticus"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1951,N1951)","v":"DTXSID1022556"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1951,J1951)","v":"24368610"},"Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus.","24368610","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1952,D1952)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1952,M1952)","v":"Status Epilepticus"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1952,N1952)","v":"DTXSID1022556"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1952,J1952)","v":"15482711"},"[Epilepticus status and valaciclovir in chronic renal failure].","15482711","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1953,D1953)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1953,M1953)","v":"Tibial Neuropathy"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1953,N1953)","v":"DTXSID1022556"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1953,J1953)","v":"15159513"},"Vasculitic mononeuritis multiplex induced by valacyclovir.","15159513","Neuromuscular Diseases","D020429","Tibial Neuropathy","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1954,D1954)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1954,M1954)","v":"Tremor"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1954,N1954)","v":"DTXSID1022556"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1954,J1954)","v":"6313597"},"The use of acyclovir for cytomegalovirus infections in the immunocompromised host.","6313597","Neurologic Manifestations","D014202","Tremor","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1955,D1955)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1955,M1955)","v":"Tremor"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1955,N1955)","v":"DTXSID1022556"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1955,J1955)","v":"6305245"},"Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation.","6305245","Neurologic Manifestations","D014202","Tremor","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1956,D1956)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1956,M1956)","v":"Tremor"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1956,N1956)","v":"DTXSID1022556"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1956,J1956)","v":"9197149"},"[Neurotoxicity of acyclovir].","9197149","Neurologic Manifestations","D014202","Tremor","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1957,D1957)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1957,M1957)","v":"Tremor"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1957,N1957)","v":"DTXSID1022556"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1957,J1957)","v":"22294022"},"Aciclovir and valaciclovir neurotoxicity in patients with renal failure.","22294022","Neurologic Manifestations","D014202","Tremor","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1958,D1958)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1958,M1958)","v":"Tremor"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1958,N1958)","v":"DTXSID1022556"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1958,J1958)","v":"21959734"},"Warning against unexpected medication in haemodialysis.","21959734","Neurologic Manifestations","D014202","Tremor","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1959,D1959)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1959,M1959)","v":"Ulnar Neuropathies"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1959,N1959)","v":"DTXSID1022556"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1959,J1959)","v":"15159513"},"Vasculitic mononeuritis multiplex induced by valacyclovir.","15159513","Neuromuscular Diseases","D020424","Ulnar Neuropathies","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1960,D1960)","v":"Acyclovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1960,M1960)","v":"Unconsciousness"},"D000212","Acyclovir","59277-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1960,N1960)","v":"DTXSID1022556"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1960,J1960)","v":"8430717"},"Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdose.","8430717","Neurologic Manifestations","D014474","Unconsciousness","DTXSID1022556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1961,D1961)","v":"Adamantane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1961,M1961)","v":"Cerebrovascular Disorders"},"D000218","Adamantane","281-23-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1961,N1961)","v":"DTXSID5022017"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1961,J1961)","v":"20518804"},"Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population.","20518804","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID5022017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1962,D1962)","v":"Adamantane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1962,M1962)","v":"Dementia"},"D000218","Adamantane","281-23-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1962,N1962)","v":"DTXSID5022017"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1962,J1962)","v":"28832656"},"Involvement of insulin resistance in D-galactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin.","28832656","Central Nervous System Diseases","D003704","Dementia","DTXSID5022017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1963,D1963)","v":"Adamantane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1963,M1963)","v":"Hallucinations"},"D000218","Adamantane","281-23-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1963,N1963)","v":"DTXSID5022017"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1963,J1963)","v":"27456262"},"Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.","27456262","Neurologic Manifestations","D006212","Hallucinations","DTXSID5022017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1964,D1964)","v":"Adamantane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1964,M1964)","v":"Nervous System Diseases"},"D000218","Adamantane","281-23-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1964,N1964)","v":"DTXSID5022017"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1964,J1964)","v":"19949363"},"Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.","19949363","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5022017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1965,D1965)","v":"Adamantane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1965,M1965)","v":"Seizures"},"D000218","Adamantane","281-23-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1965,N1965)","v":"DTXSID5022017"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1965,J1965)","v":"27108618"},"Four analytically confirmed cases of use of third-generation synthetic cannabinoid receptor agonists incorporating an adamantyl group.","27108618","Neurologic Manifestations","D012640","Seizures","DTXSID5022017"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1966,D1966)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1966,M1966)","v":"Central Nervous System Diseases"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1966,N1966)","v":"DTXSID6022557"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1966,J1966)","v":"22441251"},"Discontinuation of Atripla as first-line therapy in HIV-1 infected individuals.","22441251","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1967,D1967)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1967,M1967)","v":"Encephalitis"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1967,N1967)","v":"DTXSID6022557"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1967,J1967)","v":"25298201"},"Brain toxicity and inflammation induced in vivo in mice by the amyloid-β forty-two inducer aftin-4, a roscovitine derivative.","25298201","Central Nervous System Diseases","D004660","Encephalitis","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1968,D1968)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1968,M1968)","v":"Learning Disorders"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1968,N1968)","v":"DTXSID6022557"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1968,J1968)","v":"25298201"},"Brain toxicity and inflammation induced in vivo in mice by the amyloid-β forty-two inducer aftin-4, a roscovitine derivative.","25298201","Neurologic Manifestations","D007859","Learning Disorders","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1969,D1969)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1969,M1969)","v":"Memory Disorders"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1969,N1969)","v":"DTXSID6022557"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1969,J1969)","v":"25298201"},"Brain toxicity and inflammation induced in vivo in mice by the amyloid-β forty-two inducer aftin-4, a roscovitine derivative.","25298201","Neurologic Manifestations","D008569","Memory Disorders","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1970,D1970)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1970,M1970)","v":"Muscle Weakness"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1970,N1970)","v":"DTXSID6022557"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1970,J1970)","v":"22126791"},"[Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B].","22126791","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1971,D1971)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1971,M1971)","v":"Muscular Atrophy, Spinal"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1971,N1971)","v":"DTXSID6022557"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1971,J1971)","v":"25259710"},"Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report.","25259710","Neuromuscular Diseases","D009134","Muscular Atrophy, Spinal","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1972,D1972)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1972,M1972)","v":"Muscular Diseases"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1972,N1972)","v":"DTXSID6022557"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1972,J1972)","v":"18617410"},"Continuous single motor unit electromyographic activity in adefovir associated myopathy.","18617410","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1973,D1973)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1973,M1973)","v":"Muscular Diseases"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1973,N1973)","v":"DTXSID6022557"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1973,J1973)","v":"16156882"},"The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.","16156882","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1974,D1974)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1974,M1974)","v":"Nervous System Diseases"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1974,N1974)","v":"DTXSID6022557"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1974,J1974)","v":"19049696"},"Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate and tacrolimus at steady state when administered alone or in combination.","19049696","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1975,D1975)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1975,M1975)","v":"Peripheral Nervous System Diseases"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1975,N1975)","v":"DTXSID6022557"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1975,J1975)","v":"15234836"},"Unexpected drug interactions and adverse events with antiretroviral drugs.","15234836","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1976,D1976)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1976,M1976)","v":"Sleep Initiation and Maintenance Disorders"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1976,N1976)","v":"DTXSID6022557"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1976,J1976)","v":"25890673"},"Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.","25890673","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1977,D1977)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1977,M1977)","v":"Sleep Initiation and Maintenance Disorders"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1977,N1977)","v":"DTXSID6022557"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1977,J1977)","v":"18156608"},"Minor emtricitabine intolerance in treatment-stable patients switched from tenofovir/lamivudine to a fixed-dose combination of tenofovir/emtricitabine (Truvada).","18156608","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1978,D1978)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1978,M1978)","v":"Sleep Initiation and Maintenance Disorders"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1978,N1978)","v":"DTXSID6022557"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1978,J1978)","v":"16640107"},"Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases.","16640107","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1979,D1979)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1979,M1979)","v":"Sleep Initiation and Maintenance Disorders"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1979,N1979)","v":"DTXSID6022557"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1979,J1979)","v":"22441251"},"Discontinuation of Atripla as first-line therapy in HIV-1 infected individuals.","22441251","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1980,D1980)","v":"Adenine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1980,M1980)","v":"Tinnitus"},"D000225","Adenine","73-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1980,N1980)","v":"DTXSID6022557"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1980,J1980)","v":"16640107"},"Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases.","16640107","Neurologic Manifestations","D014012","Tinnitus","DTXSID6022557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1981,D1981)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1981,M1981)","v":"Basal Ganglia Diseases"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1981,N1981)","v":"DTXSID1022558"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1981,J1981)","v":"12478214"},"The adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeys.","12478214","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1982,D1982)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1982,M1982)","v":"Catalepsy"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1982,N1982)","v":"DTXSID1022558"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1982,J1982)","v":"8045270"},"KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.","8045270","Neurologic Manifestations","D002375","Catalepsy","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1983,D1983)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1983,M1983)","v":"Catatonia"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1983,N1983)","v":"DTXSID1022558"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1983,J1983)","v":"12597016"},"Role of adenosine in drug-induced catatonia in mice.","12597016","Neurologic Manifestations","D002389","Catatonia","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1984,D1984)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1984,M1984)","v":"Cerebral Infarction"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1984,N1984)","v":"DTXSID1022558"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1984,J1984)","v":"9497983"},"Stroke complicating adenosine perfusion imaging.","9497983","Central Nervous System Diseases","D002544","Cerebral Infarction","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1985,D1985)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1985,M1985)","v":"Encephalomyelitis, Autoimmune, Experimental"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1985,N1985)","v":"DTXSID1022558"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1985,J1985)","v":"20670985"},"Preclinical studies of methylthioadenosine for the treatment of multiple sclerosis.","20670985","Demyelinating Diseases","D004681","Encephalomyelitis, Autoimmune, Experimental","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1986,D1986)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1986,M1986)","v":"Hematoma, Subdural"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1986,N1986)","v":"DTXSID1022558"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1986,J1986)","v":"26995425"},"Spontaneous subdural hematoma and antiplatelet therapy: Does efficacy of Ticagrelor come with added risk?","26995425","Central Nervous System Diseases","D006408","Hematoma, Subdural","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1987,D1987)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1987,M1987)","v":"Hyperalgesia"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1987,N1987)","v":"DTXSID1022558"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1987,J1987)","v":"26588695"},"Adenosine-A1 receptor agonist induced hyperalgesic priming type II.","26588695","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1988,D1988)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1988,M1988)","v":"Hyperalgesia"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1988,N1988)","v":"DTXSID1022558"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1988,J1988)","v":"18285398"},"Adenosine modulates oesophageal sensorimotor function in humans.","18285398","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1989,D1989)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1989,M1989)","v":"Hyperalgesia"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1989,N1989)","v":"DTXSID1022558"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1989,J1989)","v":"12357162"},"Dose response of intrathecal adenosine in experimental pain and allodynia.","12357162","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1990,D1990)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1990,M1990)","v":"Intracranial Hemorrhages"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1990,N1990)","v":"DTXSID1022558"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1990,J1990)","v":"25773268"},"Long-term use of ticagrelor in patients with prior myocardial infarction.","25773268","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1991,D1991)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1991,M1991)","v":"Migraine Disorders"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1991,N1991)","v":"DTXSID1022558"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1991,J1991)","v":"7715531"},"Migraine precipitated by adenosine.","7715531","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1992,D1992)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1992,M1992)","v":"Seizures"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1992,N1992)","v":"DTXSID1022558"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1992,J1992)","v":"8476467"},"Prolonged bradyasystole and seizures following intravenous adenosine for supraventricular tachycardia.","8476467","Neurologic Manifestations","D012640","Seizures","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1993,D1993)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1993,M1993)","v":"Stroke"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1993,N1993)","v":"DTXSID1022558"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1993,J1993)","v":"25564918"},"Inefficacy of platelet transfusion to reverse ticagrelor.","25564918","Central Nervous System Diseases","D020521","Stroke","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1994,D1994)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1994,M1994)","v":"Stroke"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1994,N1994)","v":"DTXSID1022558"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1994,J1994)","v":"22090660"},"Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.","22090660","Central Nervous System Diseases","D020521","Stroke","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1995,D1995)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1995,M1995)","v":"Stroke"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1995,N1995)","v":"DTXSID1022558"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1995,J1995)","v":"22261200"},"Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.","22261200","Central Nervous System Diseases","D020521","Stroke","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1996,D1996)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1996,M1996)","v":"Syncope"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1996,N1996)","v":"DTXSID1022558"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1996,J1996)","v":"17526988"},"Safety of and tolerance to adenosine infusion for myocardial perfusion single-photon emission computed tomography in a Japanese population.","17526988","Neurologic Manifestations","D013575","Syncope","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1997,D1997)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1997,M1997)","v":"Syncope"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1997,N1997)","v":"DTXSID1022558"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1997,J1997)","v":"17206549"},"[Morgagni-Adams-Stokes after adenosine injection in a patient with WPW syndrome--a case report].","17206549","Neurologic Manifestations","D013575","Syncope","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1998,D1998)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1998,M1998)","v":"Syncope"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1998,N1998)","v":"DTXSID1022558"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1998,J1998)","v":"24987036"},"In reply.","24987036","Neurologic Manifestations","D013575","Syncope","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C1999,D1999)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L1999,M1999)","v":"Syncope"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N1999,N1999)","v":"DTXSID1022558"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J1999,J1999)","v":"24987035"},"A serious complication of a common stress test (May 2014).","24987035","Neurologic Manifestations","D013575","Syncope","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2000,D2000)","v":"Adenosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2000,M2000)","v":"Syncope"},"D000241","Adenosine","58-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2000,N2000)","v":"DTXSID1022558"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2000,J2000)","v":"24789585"},"Syncope during a pharmacologic nuclear stress test.","24789585","Neurologic Manifestations","D013575","Syncope","DTXSID1022558"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2021,D2021)","v":"Ajmaline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2021,M2021)","v":"Paralysis"},"D000404","Ajmaline","4360-12-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2021,N2021)","v":"DTXSID6045537"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2021,J2021)","v":"7123073"},"[Neurologic complications of monochloroacetylajmaline poisoning].","7123073","Neurologic Manifestations","D010243","Paralysis","DTXSID6045537"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2050,D2050)","v":"Albuterol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2050,M2050)","v":"Seizures"},"D000420","Albuterol","18559-94-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2050,N2050)","v":"DTXSID5021255"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2050,J2050)","v":"7074823"},"Abuse of salbutamol inhalers in young people.","7074823","Neurologic Manifestations","D012640","Seizures","DTXSID5021255"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2073,D2073)","v":"Albuterol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2073,M2073)","v":"Tremor"},"D000420","Albuterol","18559-94-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2073,N2073)","v":"DTXSID5021255"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2073,J2073)","v":"2951798"},"Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.","2951798","Neurologic Manifestations","D014202","Tremor","DTXSID5021255"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2085,D2085)","v":"Albuterol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2085,M2085)","v":"Tremor"},"D000420","Albuterol","18559-94-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2085,N2085)","v":"DTXSID5021255"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2085,J2085)","v":"1687131"},"Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease.","1687131","Neurologic Manifestations","D014202","Tremor","DTXSID5021255"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2118,D2118)","v":"Alfaxalone Alfadolone Mixture"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2118,M2118)","v":"Seizures"},"D000530","Alfaxalone Alfadolone Mixture",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2118,N2118)","v":"DTXSID001001405"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2118,J2118)","v":"7435943"},"Convulsions following althesin.","7435943","Neurologic Manifestations","D012640","Seizures","DTXSID001001405"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2141,D2141)","v":"Alfentanil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2141,M2141)","v":"Muscle Rigidity"},"D015760","Alfentanil","70879-28-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2141,N2141)","v":"DTXSID50221107"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2141,J2141)","v":"3096494"},"The role of the nucleus raphe pontis and the caudate nucleus in alfentanil rigidity in the rat.","3096494","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID50221107"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2179,D2179)","v":"Allopurinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2179,M2179)","v":"Muscular Diseases"},"D000493","Allopurinol","315-30-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2179,N2179)","v":"DTXSID4022573"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2179,J2179)","v":"64886"},"Myopathy after allopurinol.","64886","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID4022573"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2186,D2186)","v":"Allopurinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2186,M2186)","v":"Paresthesia"},"D000493","Allopurinol","315-30-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2186,N2186)","v":"DTXSID4022573"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2186,J2186)","v":"168528"},"Allopurinol-induced mandibular neuropathy. Abbreviated case report.","168528","Neurologic Manifestations","D010292","Paresthesia","DTXSID4022573"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2230,D2230)","v":"alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2230,M2230)","v":"Hyperalgesia"},"D018350","alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2230,N2230)","v":"DTXSID20868301"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2230,J2230)","v":"8813540"},"Pharmacological characterization of AMPA-induced biting behaviour in mice.","8813540","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID20868301"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2247,D2247)","v":"Alprazolam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2247,M2247)","v":"Coma"},"D000525","Alprazolam","28981-97-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2247,N2247)","v":"DTXSID4022577"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2247,J2247)","v":"8967683"},"Coma from the health food store: interaction between kava and alprazolam.","8967683","Neurologic Manifestations","D003128","Coma","DTXSID4022577"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2280,D2280)","v":"Alprazolam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2280,M2280)","v":"Seizures"},"D000525","Alprazolam","28981-97-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2280,N2280)","v":"DTXSID4022577"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2280,J2280)","v":"2218947"},"Alprazolam withdrawal.","2218947","Neurologic Manifestations","D012640","Seizures","DTXSID4022577"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2298,D2298)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2298,M2298)","v":"Alzheimer Disease"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2298,N2298)","v":"DTXSID3040273"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2298,J2298)","v":"7094562"},"Aluminum as a cause of senile dementia.","7094562","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2315,D2315)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2315,M2315)","v":"Alzheimer Disease"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2315,N2315)","v":"DTXSID3040273"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2315,J2315)","v":"7859190"},"Aluminum and Alzheimer's disease.","7859190","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2348,D2348)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2348,M2348)","v":"Alzheimer Disease"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2348,N2348)","v":"DTXSID3040273"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2348,J2348)","v":"2562879"},"Geographical relation between Alzheimer's disease and aluminum in drinking water.","2562879","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2366,D2366)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2366,M2366)","v":"Alzheimer Disease"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2366,N2366)","v":"DTXSID3040273"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2366,J2366)","v":"3243700"},"Control of aluminium ingestion and its relation to longevity.","3243700","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2409,D2409)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2409,M2409)","v":"Alzheimer Disease"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2409,N2409)","v":"DTXSID3040273"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2409,J2409)","v":"1912063"},"Aluminium in the drinking water--is it safe?","1912063","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2418,D2418)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2418,M2418)","v":"Alzheimer Disease"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2418,N2418)","v":"DTXSID3040273"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2418,J2418)","v":"22099160"},"Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease.","22099160","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2444,D2444)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2444,M2444)","v":"Amyotrophic Lateral Sclerosis"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2444,N2444)","v":"DTXSID3040273"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2444,J2444)","v":"9891607"},"Experimental aluminum encephalomyelopathy. Relationship to human neurodegenerative disease.","9891607","Central Nervous System Diseases","D000690","Amyotrophic Lateral Sclerosis","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2477,D2477)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2477,M2477)","v":"Brain Diseases"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2477,N2477)","v":"DTXSID3040273"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2477,J2477)","v":"7396323"},"[Aluminum gels in chronic kidney failrue patients. A potential risk of encephalopathy and osteopathy].","7396323","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2511,D2511)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2511,M2511)","v":"Brain Diseases"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2511,N2511)","v":"DTXSID3040273"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2511,J2511)","v":"2947210"},"[Intermittent isolated dysarthria disclosing an encephalopathy caused by aluminum].","2947210","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2538,D2538)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2538,M2538)","v":"Brain Diseases"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2538,N2538)","v":"DTXSID3040273"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2538,J2538)","v":"6118738"},"Treatment of early stages of dialysis encephalopathy by aluminium depletion.","6118738","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2541,D2541)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2541,M2541)","v":"Brain Diseases"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2541,N2541)","v":"DTXSID3040273"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2541,J2541)","v":"2357954"},"Changes in excitability of CA1 pyramidal neurons in slices prepared from AlCl3-treated rabbits.","2357954","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2579,D2579)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2579,M2579)","v":"Coma"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2579,N2579)","v":"DTXSID3040273"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2579,J2579)","v":"2913801"},"Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids.","2913801","Neurologic Manifestations","D003128","Coma","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2606,D2606)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2606,M2606)","v":"Dementia"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2606,N2606)","v":"DTXSID3040273"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2606,J2606)","v":"4736728"},"Aluminum induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention.","4736728","Central Nervous System Diseases","D003704","Dementia","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2635,D2635)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2635,M2635)","v":"Dysarthria"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2635,N2635)","v":"DTXSID3040273"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2635,J2635)","v":"6502319"},"Encephalopathy in childhood secondary to aluminum toxicity.","6502319","Neurologic Manifestations","D004401","Dysarthria","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2647,D2647)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2647,M2647)","v":"Epilepsy"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2647,N2647)","v":"DTXSID3040273"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2647,J2647)","v":"2862341"},"Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?","2862341","Central Nervous System Diseases","D004827","Epilepsy","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2674,D2674)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2674,M2674)","v":"Muscular Diseases"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2674,N2674)","v":"DTXSID3040273"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2674,J2674)","v":"10613107"},"Vaccine safety. Vaccine Safety Advisory Committee.","10613107","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2703,D2703)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2703,M2703)","v":"Nervous System Diseases"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2703,N2703)","v":"DTXSID3040273"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2703,J2703)","v":"2883097"},"[Aluminum--are all antacids really harmless?].","2883097","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2740,D2740)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2740,M2740)","v":"Neurodegenerative Diseases"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2740,N2740)","v":"DTXSID3040273"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2740,J2740)","v":"11470320"},"Aluminium incorporation into the brain of rat fetuses and sucklings.","11470320","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2764,D2764)","v":"Aluminum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2764,M2764)","v":"Speech Disorders"},"D000535","Aluminum","7429-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2764,N2764)","v":"DTXSID3040273"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2764,J2764)","v":"6502319"},"Encephalopathy in childhood secondary to aluminum toxicity.","6502319","Neurologic Manifestations","D013064","Speech Disorders","DTXSID3040273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2792,D2792)","v":"aluminum chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2792,M2792)","v":"Memory Disorders"},"C010845","aluminum chloride","7446-70-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2792,N2792)","v":"DTXSID6029674"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2792,J2792)","v":"27834136"},"Pharmacological Evaluation of the Recuperative Effect of Morusin Against Aluminium Trichloride (AlCl3)-Induced Memory Impairment in Rats.","27834136","Neurologic Manifestations","D008569","Memory Disorders","DTXSID6029674"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2803,D2803)","v":"aluminum chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2803,M2803)","v":"Neuromuscular Diseases"},"C010845","aluminum chloride","7446-70-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2803,N2803)","v":"DTXSID6029674"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2803,J2803)","v":"3713960"},"Effects of prenatal aluminum exposure on neuromotor maturation in the rat.","3713960","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID6029674"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2832,D2832)","v":"Aluminum Hydroxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2832,M2832)","v":"Motor Neuron Disease"},"D000536","Aluminum Hydroxide","21645-51-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2832,N2832)","v":"DTXSID2036405"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2832,J2832)","v":"19740540"},"Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration.","19740540","Neurodegenerative Diseases","D016472","Motor Neuron Disease","DTXSID2036405"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2860,D2860)","v":"aluminum sulfate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2860,M2860)","v":"Brain Damage, Chronic"},"C041524","aluminum sulfate","10043-67-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2860,N2860)","v":"DTXSID9039234"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2860,J2860)","v":"7760298"},"The legend of Camelford: medical consequences of a water pollution accident.","7760298","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID9039234"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2897,D2897)","v":"Amantadine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2897,M2897)","v":"Confusion"},"D000547","Amantadine","768-94-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2897,N2897)","v":"DTXSID8022117"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2897,J2897)","v":"10695649"},"Bupropion-amantadine-associated neurotoxicity.","10695649","Neurologic Manifestations","D003221","Confusion","DTXSID8022117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2900,D2900)","v":"Amantadine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2900,M2900)","v":"Delirium"},"D000547","Amantadine","768-94-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2900,N2900)","v":"DTXSID8022117"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2900,J2900)","v":"18823813"},"Plasma amantadine concentrations in patients with Parkinson's disease.","18823813","Neurologic Manifestations","D003693","Delirium","DTXSID8022117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2928,D2928)","v":"Amantadine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2928,M2928)","v":"Learning Disorders"},"D000547","Amantadine","768-94-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2928,N2928)","v":"DTXSID8022117"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2928,J2928)","v":"14532914"},"Motor-learning impairment by amantadine in healthy volunteers.","14532914","Neurologic Manifestations","D007859","Learning Disorders","DTXSID8022117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2961,D2961)","v":"Amantadine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2961,M2961)","v":"Seizures"},"D000547","Amantadine","768-94-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2961,N2961)","v":"DTXSID8022117"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2961,J2961)","v":"19135627"},"Status epilepticus in a pediatric patient with amantadine overdose.","19135627","Neurologic Manifestations","D012640","Seizures","DTXSID8022117"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C2994,D2994)","v":"Amikacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L2994,M2994)","v":"Hearing Disorders"},"D000583","Amikacin","37517-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N2994,N2994)","v":"DTXSID3022586"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J2994,J2994)","v":"7020413"},"Antimicrobial spectrum, pharmacology, adverse effects, and therapeutic use of amikacin sulfate.","7020413","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID3022586"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3021,D3021)","v":"Amikacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3021,M3021)","v":"Hearing Loss"},"D000583","Amikacin","37517-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3021,N3021)","v":"DTXSID3022586"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3021,J3021)","v":"6765414"},"Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.","6765414","Neurologic Manifestations","D034381","Hearing Loss","DTXSID3022586"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3029,D3029)","v":"Amikacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3029,M3029)","v":"Hearing Loss"},"D000583","Amikacin","37517-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3029,N3029)","v":"DTXSID3022586"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3029,J3029)","v":"28696239"},"Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.","28696239","Neurologic Manifestations","D034381","Hearing Loss","DTXSID3022586"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3062,D3062)","v":"Amikacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3062,M3062)","v":"Tetany"},"D000583","Amikacin","37517-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3062,N3062)","v":"DTXSID3022586"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3062,J3062)","v":"20392363"},"Amikacin-induced hypomagnesaemic tetany complicating multidrug-resistant tuberculosis treatment.","20392363","Neurologic Manifestations","D013746","Tetany","DTXSID3022586"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3085,D3085)","v":"Aminophylline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3085,M3085)","v":"Epilepsy, Tonic-Clonic"},"D000628","Aminophylline","63907-40-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3085,N3085)","v":"DTXSID90213602"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3085,J3085)","v":"114264"},"Seizures after aminophylline by suppository.","114264","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID90213602"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3123,D3123)","v":"Aminopropionitrile"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3123,M3123)","v":"Nervous System Diseases"},"D000629","Aminopropionitrile","151-18-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3123,N3123)","v":"DTXSID6048418"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3123,J3123)","v":"6790924"},"Occupationally related neurologic abnormalities--Massachusetts.","6790924","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID6048418"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3141,D3141)","v":"Aminopyrine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3141,M3141)","v":"Seizures"},"D000632","Aminopyrine","58-15-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3141,N3141)","v":"DTXSID7020504"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3141,J3141)","v":"6056536"},"[Acute poisoning with scorbopyrin in a 2-year-old boy].","6056536","Neurologic Manifestations","D012640","Seizures","DTXSID7020504"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3158,D3158)","v":"Amiodarone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3158,M3158)","v":"Autonomic Nervous System Diseases"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3158,N3158)","v":"DTXSID7037185"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3158,J3158)","v":"3310943"},"Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature.","3310943","Autonomic Nervous System Diseases","D001342","Autonomic Nervous System Diseases","DTXSID7037185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3191,D3191)","v":"Amiodarone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3191,M3191)","v":"Dysarthria"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3191,N3191)","v":"DTXSID7037185"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3191,J3191)","v":"10091644"},"Acetazolamide-responsive periodic ataxia induced by amiodarone.","10091644","Neurologic Manifestations","D004401","Dysarthria","DTXSID7037185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3209,D3209)","v":"Amiodarone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3209,M3209)","v":"Ischemic Attack, Transient"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3209,N3209)","v":"DTXSID7037185"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3209,J3209)","v":"7109162"},"Adverse effects of amiodarone.","7109162","Central Nervous System Diseases","D002546","Ischemic Attack, Transient","DTXSID7037185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3252,D3252)","v":"Amiodarone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3252,M3252)","v":"Neuromuscular Diseases"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3252,N3252)","v":"DTXSID7037185"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3252,J3252)","v":"22507462"},"Amiodarone-associated neuromyopathy: a report of four cases.","22507462","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID7037185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3259,D3259)","v":"Amiodarone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3259,M3259)","v":"Optic Atrophy"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3259,N3259)","v":"DTXSID7037185"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3259,J3259)","v":"10412703"},"[Amiodarone-induced bilateral optic atrophy--a case report].","10412703","Cranial Nerve Diseases","D009896","Optic Atrophy","DTXSID7037185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3298,D3298)","v":"Amiodarone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3298,M3298)","v":"Optic Neuritis"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3298,N3298)","v":"DTXSID7037185"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3298,J3298)","v":"10680416"},"Ocular toxicity of systemic medications: a case series.","10680416","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID7037185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3320,D3320)","v":"Amiodarone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3320,M3320)","v":"Papilledema"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3320,N3320)","v":"DTXSID7037185"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3320,J3320)","v":"11263051"},"[Acute papilledema. A 69-year-old patient with acute bilateral papilledema].","11263051","Cranial Nerve Diseases","D010211","Papilledema","DTXSID7037185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3353,D3353)","v":"Amiodarone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3353,M3353)","v":"Peripheral Nervous System Diseases"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3353,N3353)","v":"DTXSID7037185"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3353,J3353)","v":"3034178"},"Unusual neurotoxicity associated with amiodarone therapy.","3034178","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7037185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3366,D3366)","v":"Amiodarone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3366,M3366)","v":"Peripheral Nervous System Diseases"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3366,N3366)","v":"DTXSID7037185"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3366,J3366)","v":"1668551"},"[Peripheral neuropathy possibly caused by amiodarone therapy].","1668551","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7037185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3388,D3388)","v":"Amiodarone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3388,M3388)","v":"Pseudotumor Cerebri"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3388,N3388)","v":"DTXSID7037185"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3388,J3388)","v":"4017601"},"Acute intracranial hypertension during amiodarone infusion.","4017601","Central Nervous System Diseases","D011559","Pseudotumor Cerebri","DTXSID7037185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3417,D3417)","v":"Amiodarone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3417,M3417)","v":"Tremor"},"D000638","Amiodarone","19774-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3417,N3417)","v":"DTXSID7037185"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3417,J3417)","v":"2314744"},"Survey of neurological problems with amiodarone in the New Zealand Intensive Medicines Monitoring Programme.","2314744","Neurologic Manifestations","D014202","Tremor","DTXSID7037185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3459,D3459)","v":"Amitriptyline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3459,M3459)","v":"Basal Ganglia Diseases"},"D000639","Amitriptyline","17086-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3459,N3459)","v":"DTXSID60168958"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3459,J3459)","v":"21356508"},"Extrapyramidal symptoms with concomitant use of amitriptyline and amiodarone in an elderly patient.","21356508","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID60168958"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3482,D3482)","v":"Amitriptyline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3482,M3482)","v":"Coma"},"D000639","Amitriptyline","17086-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3482,N3482)","v":"DTXSID60168958"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3482,J3482)","v":"1588667"},"Severe amitriptyline overdose: relationship between toxicokinetics and toxicodynamics.","1588667","Neurologic Manifestations","D003128","Coma","DTXSID60168958"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3511,D3511)","v":"Amitriptyline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3511,M3511)","v":"Delirium"},"D000639","Amitriptyline","17086-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3511,N3511)","v":"DTXSID60168958"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3511,J3511)","v":"12850665"},"Delirium associated with amitriptyline/fluconazole drug.","12850665","Neurologic Manifestations","D003693","Delirium","DTXSID60168958"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3517,D3517)","v":"Amitriptyline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3517,M3517)","v":"Dystonia"},"D000639","Amitriptyline","17086-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3517,N3517)","v":"DTXSID60168958"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3517,J3517)","v":"3358469"},"Dystonic reactions to amitriptyline and doxepin.","3358469","Neurologic Manifestations","D004421","Dystonia","DTXSID60168958"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3550,D3550)","v":"Amitriptyline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3550,M3550)","v":"Muscle Cramp"},"D000639","Amitriptyline","17086-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3550,N3550)","v":"DTXSID60168958"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3550,J3550)","v":"4429931"},"Letter: Reaction to amitriptyline.","4429931","Neurologic Manifestations","D009120","Muscle Cramp","DTXSID60168958"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3579,D3579)","v":"Amitriptyline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3579,M3579)","v":"Peripheral Nervous System Diseases"},"D000639","Amitriptyline","17086-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3579,N3579)","v":"DTXSID60168958"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3579,J3579)","v":"6293793"},"Amitriptyline-related peripheral neuropathy relieved during pyridoxine hydrochloride administration.","6293793","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID60168958"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3611,D3611)","v":"Amitriptyline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3611,M3611)","v":"Seizures"},"D000639","Amitriptyline","17086-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3611,N3611)","v":"DTXSID60168958"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3611,J3611)","v":"16430415"},"Amitriptyline poisoning in a 2-year old.","16430415","Neurologic Manifestations","D012640","Seizures","DTXSID60168958"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3640,D3640)","v":"Amitriptyline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3640,M3640)","v":"Tinnitus"},"D000639","Amitriptyline","17086-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3640,N3640)","v":"DTXSID60168958"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3640,J3640)","v":"18308819"},"An unusual case of prolonged tinnitus following low-dose amitriptyline.","18308819","Neurologic Manifestations","D014012","Tinnitus","DTXSID60168958"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3647,D3647)","v":"Amitriptyline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3647,M3647)","v":"Tremor"},"D000639","Amitriptyline","17086-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3647,N3647)","v":"DTXSID60168958"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3647,J3647)","v":"11270916"},"Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline.","11270916","Neurologic Manifestations","D014202","Tremor","DTXSID60168958"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3679,D3679)","v":"Ammonia"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3679,M3679)","v":"Brain Diseases"},"D000641","Ammonia","7664-41-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3679,N3679)","v":"DTXSID0023872"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3679,J3679)","v":"102455"},"[Acute inhalation toxicity of ammonia in rabbits].","102455","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID0023872"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3708,D3708)","v":"Ammonia"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3708,M3708)","v":"Eye Burns"},"D000641","Ammonia","7664-41-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3708,N3708)","v":"DTXSID0023872"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3708,J3708)","v":"6660462"},"Inhalation of ammonia vapour. A report on the management of eight patients during the acute stages.","6660462","Trauma, Nervous System","D005126","Eye Burns","DTXSID0023872"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3740,D3740)","v":"Ammonia"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3740,M3740)","v":"Nervous System Diseases"},"D000641","Ammonia","7664-41-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3740,N3740)","v":"DTXSID0023872"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3740,J3740)","v":"9469566"},"Roles of neuroactive amino acids in ammonia neurotoxicity.","9469566","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0023872"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3747,D3747)","v":"Ammonia"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3747,M3747)","v":"Paralysis"},"D000641","Ammonia","7664-41-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3747,N3747)","v":"DTXSID0023872"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3747,J3747)","v":"8279112"},"Paralysis in farmed Arctic char (Salvelinus alpinus) associated with ammonia toxicity.","8279112","Neurologic Manifestations","D010243","Paralysis","DTXSID0023872"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3776,D3776)","v":"Amobarbital"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3776,M3776)","v":"Ischemic Attack, Transient"},"D000654","Amobarbital","64-43-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3776,N3776)","v":"DTXSID40213975"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3776,J3776)","v":"7985574"},"Potential toxic effects of superselective injection of amobarbital sodium on microvasculature: a study in an animal model.","7985574","Central Nervous System Diseases","D002546","Ischemic Attack, Transient","DTXSID40213975"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3808,D3808)","v":"Amoxapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3808,M3808)","v":"Basal Ganglia Diseases"},"D000657","Amoxapine","14028-44-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3808,N3808)","v":"DTXSID7022598"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3808,J3808)","v":"2864332"},"Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.","2864332","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID7022598"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3837,D3837)","v":"Amoxapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3837,M3837)","v":"Parkinson Disease, Secondary"},"D000657","Amoxapine","14028-44-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3837,N3837)","v":"DTXSID7022598"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3837,J3837)","v":"6701099"},"Adverse reactions due to dopamine blockade by amoxapine. A case report and review of the literature.","6701099","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID7022598"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3860,D3860)","v":"Amoxapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3860,M3860)","v":"Status Epilepticus"},"D000657","Amoxapine","14028-44-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3860,N3860)","v":"DTXSID7022598"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3860,J3860)","v":"7621219"},"Successful treatment of amoxapine-induced refractory status epilepticus with propofol (diprivan)","7621219","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID7022598"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3876,D3876)","v":"Amoxicillin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3876,M3876)","v":"Meningitis, Aseptic"},"D000658","Amoxicillin","26889-93-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3876,N3876)","v":"DTXSID30181396"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3876,J3876)","v":"10068320"},"[Amoxicillin caused aseptic meningoencephalitis].","10068320","Central Nervous System Diseases","D008582","Meningitis, Aseptic","DTXSID30181396"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3905,D3905)","v":"Amphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3905,M3905)","v":"Cerebral Hemorrhage"},"D000661","Amphetamine","60-13-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3905,N3905)","v":"DTXSID4020082"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3905,J3905)","v":"10962919"},"[Fatal intracerebral hemorrhage after amphetamine intake].","10962919","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID4020082"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3928,D3928)","v":"Amphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3928,M3928)","v":"Hallucinations"},"D000661","Amphetamine","60-13-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3928,N3928)","v":"DTXSID4020082"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3928,J3928)","v":"1149593"},"Amphetamine psychosis: overview and a hypothesis.","1149593","Neurologic Manifestations","D006212","Hallucinations","DTXSID4020082"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3966,D3966)","v":"Amphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3966,M3966)","v":"Seizures"},"D000661","Amphetamine","60-13-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3966,N3966)","v":"DTXSID4020082"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3966,J3966)","v":"2217500"},"Antagonism of cocaine, amphetamine, and methamphetamine toxicity.","2217500","Neurologic Manifestations","D012640","Seizures","DTXSID4020082"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C3999,D3999)","v":"Amphotericin B"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L3999,M3999)","v":"Delirium"},"D000666","Amphotericin B","1397-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N3999,N3999)","v":"DTXSID9022601"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J3999,J3999)","v":"7178410"},"Delirium and depression associated with amphotericin B.","7178410","Neurologic Manifestations","D003693","Delirium","DTXSID9022601"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4021,D4021)","v":"Amphotericin B"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4021,M4021)","v":"Seizures"},"D000666","Amphotericin B","1397-89-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4021,N4021)","v":"DTXSID9022601"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4021,J4021)","v":"11573852"},"Amphotericin B-induced seizures in a patient with AIDS.","11573852","Neurologic Manifestations","D012640","Seizures","DTXSID9022601"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4034,D4034)","v":"Ampicillin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4034,M4034)","v":"Hearing Disorders"},"D000667","Ampicillin","69-53-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4034,N4034)","v":"DTXSID4022602"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4034,J4034)","v":"876235"},"[Hearing damage in meningitides under ampicillin therapy].","876235","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID4022602"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4067,D4067)","v":"amyl acetate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4067,M4067)","v":"Basal Ganglia Diseases"},"C005716","amyl acetate","628-63-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4067,N4067)","v":"DTXSID1027263"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4067,J4067)","v":"18344055"},"Severe extrapyramidal syndrome after exposition to isoamyl acetate vapour.","18344055","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID1027263"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4089,D4089)","v":"anastrozole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4089,M4089)","v":"Memory Disorders"},"C090450","anastrozole","120511-73-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4089,N4089)","v":"DTXSID9022607"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4089,J4089)","v":"14745746"},"Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.","14745746","Neurologic Manifestations","D008569","Memory Disorders","DTXSID9022607"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4128,D4128)","v":"apixaban"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4128,M4128)","v":"Cerebral Hemorrhage"},"C522181","apixaban","503612-47-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4128,N4128)","v":"DTXSID80436500"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4128,J4128)","v":"24916911"},"Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation: a secondary analysis of the AVERROES study.","24916911","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID80436500"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4135,D4135)","v":"apixaban"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4135,M4135)","v":"Intracranial Hemorrhages"},"C522181","apixaban","503612-47-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4135,N4135)","v":"DTXSID80436500"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4135,J4135)","v":"26596056"},"[COMPARATIVE EFFECTIVENESS AND SAFETY OF NEW ORAL ANTICOAGULANTS AND WARFARIN IN PATIENTS WITH AGE-SPECIFIC NON-VALVULAR ATRIAL FIBRILLATION].","26596056","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID80436500"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4178,D4178)","v":"apraclonidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4178,M4178)","v":"Vision Disorders"},"C016986","apraclonidine","66711-21-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4178,N4178)","v":"DTXSID1048415"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4178,J4178)","v":"1347973"},"Reformulation and drop size of apraclonidine hydrochloride.","1347973","Neurologic Manifestations","D014786","Vision Disorders","DTXSID1048415"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4196,D4196)","v":"Arabinofuranosyluracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4196,M4196)","v":"Muscular Diseases"},"D001086","Arabinofuranosyluracil","3083-77-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4196,N4196)","v":"DTXSID80184832"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4196,J4196)","v":"20466447"},"Clinical, biochemical, and pathological characteristics of clevudine-associated myopathy.","20466447","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID80184832"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4209,D4209)","v":"Arachidonic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4209,M4209)","v":"Brain Ischemia"},"D016718","Arachidonic Acid","506-32-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4209,N4209)","v":"DTXSID4040420"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4209,J4209)","v":"19815959"},"Neuroprotective effect of N-acetylcysteine in neurons exposed to arachidonic acid during simulated ischemia in vitro.","19815959","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID4040420"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4231,D4231)","v":"Aripiprazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4231,M4231)","v":"Basal Ganglia Diseases"},"D000068180","Aripiprazole","129722-12-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4231,N4231)","v":"DTXSID3046083"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4231,J4231)","v":"17631314"},"A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.","17631314","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID3046083"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4264,D4264)","v":"Aripiprazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4264,M4264)","v":"Consciousness Disorders"},"D000068180","Aripiprazole","129722-12-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4264,N4264)","v":"DTXSID3046083"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4264,J4264)","v":"19461396"},"Aripiprazole in treatment-refractory schizophrenia.","19461396","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID3046083"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4302,D4302)","v":"Aripiprazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4302,M4302)","v":"Hyperkinesis"},"D000068180","Aripiprazole","129722-12-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4302,N4302)","v":"DTXSID3046083"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4302,J4302)","v":"19170197"},"Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.","19170197","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID3046083"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4325,D4325)","v":"Aripiprazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4325,M4325)","v":"Ocular Motility Disorders"},"D000068180","Aripiprazole","129722-12-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4325,N4325)","v":"DTXSID3046083"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4325,J4325)","v":"18053627"},"Tardive dystonic symptoms associated with aripiprazole treatment.","18053627","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID3046083"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4358,D4358)","v":"Aripiprazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4358,M4358)","v":"Sleep Wake Disorders"},"D000068180","Aripiprazole","129722-12-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4358,N4358)","v":"DTXSID3046083"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4358,J4358)","v":"16523807"},"[Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug].","16523807","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID3046083"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4366,D4366)","v":"Aripiprazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4366,M4366)","v":"Torticollis"},"D000068180","Aripiprazole","129722-12-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4366,N4366)","v":"DTXSID3046083"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4366,J4366)","v":"23174451"},"Torticollis after low-dose aripiprazole administration in a Thai schizophrenia patient.","23174451","Central Nervous System Diseases","D014103","Torticollis","DTXSID3046083"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4393,D4393)","v":"Arsenic"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4393,M4393)","v":"Brain Diseases"},"D001151","Arsenic","7440-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4393,N4393)","v":"DTXSID4023886"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4393,J4393)","v":"571575"},"Therapy of arsenical encephalopathy.","571575","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID4023886"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4426,D4426)","v":"Arsenic"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4426,M4426)","v":"Encephalocele"},"D001151","Arsenic","7440-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4426,N4426)","v":"DTXSID4023886"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4426,J4426)","v":"3631535"},"Developmental analysis of cephalic axial dysraphic disorders in arsenic-treated hamster embryos.","3631535","Nervous System Malformations","D004677","Encephalocele","DTXSID4023886"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4459,D4459)","v":"Arsenic"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4459,M4459)","v":"Muscular Atrophy"},"D001151","Arsenic","7440-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4459,N4459)","v":"DTXSID4023886"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4459,J4459)","v":"5925401"},"Chronic arsenic poisoning resembling muscular dystrophy.","5925401","Neurologic Manifestations","D009133","Muscular Atrophy","DTXSID4023886"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4487,D4487)","v":"Arsenic"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4487,M4487)","v":"Nervous System Diseases"},"D001151","Arsenic","7440-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4487,N4487)","v":"DTXSID4023886"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4487,J4487)","v":"6066957"},"Arsenical neuropathy.","6066957","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID4023886"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4490,D4490)","v":"Arsenic"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4490,M4490)","v":"Nervous System Diseases"},"D001151","Arsenic","7440-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4490,N4490)","v":"DTXSID4023886"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4490,J4490)","v":"16440511"},"Murshidabad--one of the nine groundwater arsenic-affected districts of West Bengal, India. Part II: dermatological, neurological, and obstetric findings.","16440511","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID4023886"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4527,D4527)","v":"Arsenic"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4527,M4527)","v":"Paresthesia"},"D001151","Arsenic","7440-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4527,N4527)","v":"DTXSID4023886"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4527,J4527)","v":"15311647"},"Arsenic in a child's world.","15311647","Neurologic Manifestations","D010292","Paresthesia","DTXSID4023886"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4555,D4555)","v":"Arsenic"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4555,M4555)","v":"Peripheral Nervous System Diseases"},"D001151","Arsenic","7440-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4555,N4555)","v":"DTXSID4023886"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4555,J4555)","v":"3002219"},"[Arsenous anhydride poisoning. Peripheral neuropathy and changes in cognitive functions].","3002219","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4023886"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4579,D4579)","v":"Arsenic"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4579,M4579)","v":"Peripheral Nervous System Diseases"},"D001151","Arsenic","7440-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4579,N4579)","v":"DTXSID4023886"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4579,J4579)","v":"227646"},"Acute respiratory failure following severe arsenic poisoning.","227646","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4023886"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4590,D4590)","v":"Arsenic"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4590,M4590)","v":"Peripheral Nervous System Diseases"},"D001151","Arsenic","7440-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4590,N4590)","v":"DTXSID4023886"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4590,J4590)","v":"1333468"},"Arsenic induced neuropathy.","1333468","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4023886"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4623,D4623)","v":"arsenic trioxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4623,M4623)","v":"Brain Diseases"},"C006632","arsenic trioxide","1327-53-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4623,N4623)","v":"DTXSID0020103"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4623,J4623)","v":"24825822"},"In the war against solid tumors arsenic trioxide needs partners.","24825822","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID0020103"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4647,D4647)","v":"artemether"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4647,M4647)","v":"Nervous System Diseases"},"C032942","artemether","71963-77-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4647,N4647)","v":"DTXSID7040651"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4647,J4647)","v":"9745911"},"The role of iron in neurotoxicity: a study of novel antimalarial drugs.","9745911","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7040651"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4684,D4684)","v":"artesunate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4684,M4684)","v":"Chorea"},"C039726","artesunate","82864-68-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4684,N4684)","v":"DTXSID70232038"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4684,J4684)","v":"18069028"},"Chorea in a 29-year-old Nigerian following antimalarial treatment with artesunate.","18069028","Central Nervous System Diseases","D002819","Chorea","DTXSID70232038"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4713,D4713)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4713,M4713)","v":"Brain Ischemia"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4713,N4713)","v":"DTXSID5020108"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4713,J4713)","v":"24869717"},"Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials.","24869717","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4740,D4740)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4740,M4740)","v":"Cerebral Hemorrhage"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4740,N4740)","v":"DTXSID5020108"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4740,J4740)","v":"9742986"},"Risk of aspirin use plus thrombolysis after acute ischaemic stroke: a further MAST-I analysis. MAST-I Collaborative Group. Multicentre Acute Stroke Trial--Italy.","9742986","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4752,D4752)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4752,M4752)","v":"Cerebral Hemorrhage"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4752,N4752)","v":"DTXSID5020108"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4752,J4752)","v":"17303765"},"Emerging therapies: ESPRIT.","17303765","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4781,D4781)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4781,M4781)","v":"Cerebral Hemorrhage"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4781,N4781)","v":"DTXSID5020108"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4781,J4781)","v":"19222632"},"Aspirin in cardiology--benefits and risks.","19222632","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4808,D4808)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4808,M4808)","v":"Cerebral Infarction"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4808,N4808)","v":"DTXSID5020108"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4808,J4808)","v":"3952585"},"Cerebral infarct after an overdose of anti-cold medicines.","3952585","Central Nervous System Diseases","D002544","Cerebral Infarction","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4842,D4842)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4842,M4842)","v":"Deafness"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4842,N4842)","v":"DTXSID5020108"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4842,J4842)","v":"4425599"},"[Research on the acute audio-toxicity of aspirin in the guinea pig].","4425599","Neurologic Manifestations","D003638","Deafness","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4849,D4849)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4849,M4849)","v":"Deafness"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4849,N4849)","v":"DTXSID5020108"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4849,J4849)","v":"5491794"},"[Ototoxic effect of readily soluble acetylsalicylic acid].","5491794","Neurologic Manifestations","D003638","Deafness","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4876,D4876)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4876,M4876)","v":"Hearing Loss"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4876,N4876)","v":"DTXSID5020108"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4876,J4876)","v":"19155962"},"Hearing loss in a woman on aspirin: the silent pharmacokinetic parameter.","19155962","Neurologic Manifestations","D034381","Hearing Loss","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4910,D4910)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4910,M4910)","v":"Hyperkinesis"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4910,N4910)","v":"DTXSID5020108"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4910,J4910)","v":"6944135"},"Aspirin and food dye reactions.","6944135","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4943,D4943)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4943,M4943)","v":"Intracranial Hemorrhages"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4943,N4943)","v":"DTXSID5020108"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4943,J4943)","v":"19927175"},"Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke.","19927175","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4969,D4969)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4969,M4969)","v":"Neural Tube Defects"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4969,N4969)","v":"DTXSID5020108"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4969,J4969)","v":"7649600"},"Aspirin by virtue of its acidic property may act as teratogen in early chick embryo.","7649600","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C4978,D4978)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L4978,M4978)","v":"Pseudotumor Cerebri"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N4978,N4978)","v":"DTXSID5020108"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J4978,J4978)","v":"2594560"},"[Benign intracranial hypertension during treatment with acetylsalicylic acid: presentation of 2 cases in children].","2594560","Central Nervous System Diseases","D011559","Pseudotumor Cerebri","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5021,D5021)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5021,M5021)","v":"Reye Syndrome"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5021,N5021)","v":"DTXSID5020108"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5021,J5021)","v":"3810583"},"[Acetylsalicylic acid and Reye's syndrome].","3810583","Central Nervous System Diseases","D012202","Reye Syndrome","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5039,D5039)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5039,M5039)","v":"Reye Syndrome"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5039,N5039)","v":"DTXSID5020108"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5039,J5039)","v":"2903294"},"Reye's syndrome in children travelling abroad.","2903294","Central Nervous System Diseases","D012202","Reye Syndrome","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5072,D5072)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5072,M5072)","v":"Reye Syndrome"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5072,N5072)","v":"DTXSID5020108"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5072,J5072)","v":"16388216"},"Reye's syndrome.","16388216","Central Nervous System Diseases","D012202","Reye Syndrome","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5089,D5089)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5089,M5089)","v":"Reye Syndrome"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5089,N5089)","v":"DTXSID5020108"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5089,J5089)","v":"11799026"},"Government sued for 11 week delay in warning about aspirin.","11799026","Central Nervous System Diseases","D012202","Reye Syndrome","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5107,D5107)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5107,M5107)","v":"Seizures"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5107,N5107)","v":"DTXSID5020108"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5107,J5107)","v":"5298268"},"The acute rectal toxicity of acetylsalicylic acid.","5298268","Neurologic Manifestations","D012640","Seizures","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5140,D5140)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5140,M5140)","v":"Stroke"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5140,N5140)","v":"DTXSID5020108"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5140,J5140)","v":"23165316"},"Association of aspirin resistance with increased stroke severity and infarct size.","23165316","Central Nervous System Diseases","D020521","Stroke","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5157,D5157)","v":"Aspirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5157,M5157)","v":"Syncope"},"D001241","Aspirin","50-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5157,N5157)","v":"DTXSID5020108"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5157,J5157)","v":"24987036"},"In reply.","24987036","Neurologic Manifestations","D013575","Syncope","DTXSID5020108"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5201,D5201)","v":"Atenolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5201,M5201)","v":"Amnesia"},"D001262","Atenolol","29122-68-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5201,N5201)","v":"DTXSID2022628"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5201,J5201)","v":"8942269"},"Atenolol induced memory impairment: a case report.","8942269","Neurologic Manifestations","D000647","Amnesia","DTXSID2022628"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5208,D5208)","v":"Atenolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5208,M5208)","v":"Hallucinations"},"D001262","Atenolol","29122-68-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5208,N5208)","v":"DTXSID2022628"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5208,J5208)","v":"3374196"},"[Adverse effects of atenolol on the central nervous system].","3374196","Neurologic Manifestations","D006212","Hallucinations","DTXSID2022628"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5246,D5246)","v":"Atomoxetine Hydrochloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5246,M5246)","v":"Tic Disorders"},"D000069445","Atomoxetine Hydrochloride","82248-59-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5246,N5246)","v":"DTXSID2044266"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5246,J5246)","v":"18408649"},"Development of tics in a thirteen-year-old male following atomoxetine use.","18408649","Central Nervous System Diseases","D013981","Tic Disorders","DTXSID2044266"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5269,D5269)","v":"Atorvastatin Calcium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5269,M5269)","v":"Diplopia"},"D000069059","Atorvastatin Calcium","134523-03-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5269,N5269)","v":"DTXSID6044303"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5269,J5269)","v":"18727677"},"Ptosis, diplopia and statins: an association?","18727677","Neurologic Manifestations","D004172","Diplopia","DTXSID6044303"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5302,D5302)","v":"Atorvastatin Calcium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5302,M5302)","v":"Muscular Diseases"},"D000069059","Atorvastatin Calcium","134523-03-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5302,N5302)","v":"DTXSID6044303"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5302,J5302)","v":"23287848"},"A piece of my mind: A pain in the tuches.","23287848","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID6044303"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5314,D5314)","v":"Atorvastatin Calcium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5314,M5314)","v":"Muscular Diseases"},"D000069059","Atorvastatin Calcium","134523-03-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5314,N5314)","v":"DTXSID6044303"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5314,J5314)","v":"15596782"},"Statin-associated exacerbation of myasthenia gravis.","15596782","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID6044303"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5337,D5337)","v":"Atorvastatin Calcium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5337,M5337)","v":"Myasthenia Gravis"},"D000069059","Atorvastatin Calcium","134523-03-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5337,N5337)","v":"DTXSID6044303"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5337,J5337)","v":"12241896"},"Statins, fibrates, and ocular myasthenia.","12241896","Autoimmune Diseases of the Nervous System","D009157","Myasthenia Gravis","DTXSID6044303"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5366,D5366)","v":"Atracurium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5366,M5366)","v":"Muscle Hypotonia"},"D001279","Atracurium","64228-79-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5366,N5366)","v":"DTXSID9043726"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5366,J5366)","v":"7624274"},"Prolonged neuromuscular blockade in two critically ill patients treated with atracurium.","7624274","Neurologic Manifestations","D009123","Muscle Hypotonia","DTXSID9043726"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5398,D5398)","v":"Atropine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5398,M5398)","v":"Amblyopia"},"D001285","Atropine","51-55-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5398,N5398)","v":"DTXSID4020113"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5398,J5398)","v":"8328347"},"[The development of occlusion amblyopia following atropine therapy for strabismic amblyopia].","8328347","Neurologic Manifestations","D000550","Amblyopia","DTXSID4020113"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5431,D5431)","v":"Atropine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5431,M5431)","v":"Coma"},"D001285","Atropine","51-55-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5431,N5431)","v":"DTXSID4020113"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5431,J5431)","v":"1391571"},"[Febrile coma with polynucleosis from atropine intoxication].","1391571","Neurologic Manifestations","D003128","Coma","DTXSID4020113"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5459,D5459)","v":"Atropine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5459,M5459)","v":"Muscle Rigidity"},"D001285","Atropine","51-55-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5459,N5459)","v":"DTXSID4020113"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5459,J5459)","v":"4124577"},"Drugs causing rigidity in malignant hyperthermia.","4124577","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID4020113"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5466,D5466)","v":"Atropine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5466,M5466)","v":"Photophobia"},"D001285","Atropine","51-55-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5466,N5466)","v":"DTXSID4020113"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5466,J5466)","v":"17311576"},"A case of accidental mydriasis.","17311576","Neurologic Manifestations","D020795","Photophobia","DTXSID4020113"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5499,D5499)","v":"aurotioprol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5499,M5499)","v":"Chorea"},"C013394","aurotioprol",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5499,N5499)","v":"DTXSID60912312"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5499,J5499)","v":"2657992"},"[Morvan's fibrillary chorea in patients on chrysotherapy for rheumatoid polyarthritis].","2657992","Central Nervous System Diseases","D002819","Chorea","DTXSID60912312"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5527,D5527)","v":"Azathioprine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5527,M5527)","v":"Central Nervous System Neoplasms"},"D001379","Azathioprine","446-86-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5527,N5527)","v":"DTXSID4020119"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5527,J5527)","v":"10805346"},"Association of primary central nervous system lymphoma with long-term azathioprine therapy for myasthenia gravis?","10805346","Nervous System Neoplasms","D016543","Central Nervous System Neoplasms","DTXSID4020119"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5560,D5560)","v":"Azithromycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5560,M5560)","v":"Chorea"},"D017963","Azithromycin","83905-01-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5560,N5560)","v":"DTXSID8030760"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5560,J5560)","v":"21397177"},"Azithromycin-induced agitation and choreoathetosis.","21397177","Central Nervous System Diseases","D002819","Chorea","DTXSID8030760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5589,D5589)","v":"Baclofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5589,M5589)","v":"Amnesia"},"D001418","Baclofen","1134-47-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5589,N5589)","v":"DTXSID5022641"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5589,J5589)","v":"26599496"},"The GABAB receptor agonist, baclofen, contributes to three distinct varieties of amnesia in the human brain - A detailed case report.","26599496","Neurologic Manifestations","D000647","Amnesia","DTXSID5022641"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5595,D5595)","v":"Baclofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5595,M5595)","v":"Brain Diseases"},"D001418","Baclofen","1134-47-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5595,N5595)","v":"DTXSID5022641"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5595,J5595)","v":"3390037"},"Periodic sharp waves in baclofen-induced encephalopathy.","3390037","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID5022641"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5628,D5628)","v":"Baclofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5628,M5628)","v":"Coma"},"D001418","Baclofen","1134-47-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5628,N5628)","v":"DTXSID5022641"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5628,J5628)","v":"16844547"},"[EEG contribution to the diagnosis of baclofen overdose].","16844547","Neurologic Manifestations","D003128","Coma","DTXSID5022641"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5657,D5657)","v":"Baclofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5657,M5657)","v":"Disorders of Excessive Somnolence"},"D001418","Baclofen","1134-47-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5657,N5657)","v":"DTXSID5022641"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5657,J5657)","v":"28233010"},"Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen.","28233010","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID5022641"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5688,D5688)","v":"Baclofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5688,M5688)","v":"Meningitis, Aseptic"},"D001418","Baclofen","1134-47-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5688,N5688)","v":"DTXSID5022641"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5688,J5688)","v":"17418354"},"Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy.","17418354","Central Nervous System Diseases","D008582","Meningitis, Aseptic","DTXSID5022641"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5718,D5718)","v":"Baclofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5718,M5718)","v":"Respiratory Paralysis"},"D001418","Baclofen","1134-47-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5718,N5718)","v":"DTXSID5022641"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5718,J5718)","v":"1576939"},"[Baclofen intoxication in chronic hemodialysis and kidney transplantation].","1576939","Neurologic Manifestations","D012133","Respiratory Paralysis","DTXSID5022641"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5740,D5740)","v":"Baclofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5740,M5740)","v":"Spasm"},"D001418","Baclofen","1134-47-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5740,N5740)","v":"DTXSID5022641"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5740,J5740)","v":"12821743"},"Intrathecal baclofen for stiff-person syndrome: life-threatening intermittent catheter leakage.","12821743","Neurologic Manifestations","D013035","Spasm","DTXSID5022641"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5757,D5757)","v":"Barbital"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5757,M5757)","v":"Seizures"},"D001462","Barbital","57-44-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5757,N5757)","v":"DTXSID5022643"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5757,J5757)","v":"6682167"},"Effects of central monoamine compounds on tranylcypromine-induced barbital-withdrawal convulsions.","6682167","Neurologic Manifestations","D012640","Seizures","DTXSID5022643"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5786,D5786)","v":"Barium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5786,M5786)","v":"Respiratory Paralysis"},"D001464","Barium","7440-39-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5786,N5786)","v":"DTXSID8023894"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5786,J5786)","v":"5568798"},"The pathophysiology of barium: hypokalemic and cardiovascular effects.","5568798","Neurologic Manifestations","D012133","Respiratory Paralysis","DTXSID8023894"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5808,D5808)","v":"barium nitrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5808,M5808)","v":"Brain Damage, Chronic"},"C023545","barium nitrate","10022-31-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5808,N5808)","v":"DTXSID8049200"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5808,J5808)","v":"15675995"},"Acute barium nitrate intoxication treated by hemodialysis.","15675995","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID8049200"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5825,D5825)","v":"Beclomethasone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5825,M5825)","v":"Muscular Diseases"},"D001507","Beclomethasone","5534-09-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5825,N5825)","v":"DTXSID3048730"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5825,J5825)","v":"8685167"},"[Acute myopathy in an asthmatic patient treated with corticoids and muscle relaxants in the intensive care unit].","8685167","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID3048730"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5854,D5854)","v":"Benserazide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5854,M5854)","v":"Migraine Disorders"},"D001545","Benserazide","14919-77-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5854,N5854)","v":"DTXSID0045412"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5854,J5854)","v":"554794"},"Benserazide induces migraine attacks. Irrelevance of concomitant hyperprolactinemia.","554794","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID0045412"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5876,D5876)","v":"Benzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5876,M5876)","v":"Memory Disorders"},"D001554","Benzene","71-43-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5876,N5876)","v":"DTXSID3039242"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5876,J5876)","v":"19802953"},"[Combined effects of benzene and chromium on navigation learning and long-term spatial memory in rats].","19802953","Neurologic Manifestations","D008569","Memory Disorders","DTXSID3039242"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5915,D5915)","v":"benzonidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5915,M5915)","v":"Quadriplegia"},"C009999","benzonidazole","22994-85-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5915,N5915)","v":"DTXSID9046570"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5915,J5915)","v":"9260852"},"Experimental benznidazole encephalopathy: I. Clinical-neurological alterations.","9260852","Neurologic Manifestations","D011782","Quadriplegia","DTXSID9046570"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5948,D5948)","v":"Benzyl Alcohol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5948,M5948)","v":"Seizures"},"D019905","Benzyl Alcohol","100-51-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5948,N5948)","v":"DTXSID5020152"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5948,J5948)","v":"11401189"},"Fatal hemolysis after high-dose etoposide: is benzyl alcohol to blame?","11401189","Neurologic Manifestations","D012640","Seizures","DTXSID5020152"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5969,D5969)","v":"Betamethasone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5969,M5969)","v":"Memory Disorders"},"D001623","Betamethasone","378-44-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5969,N5969)","v":"DTXSID3022667"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5969,J5969)","v":"23240317"},"[Effects of glucocorticoids administration on memory. Cognitive impairment in Cushing's disease].","23240317","Neurologic Manifestations","D008569","Memory Disorders","DTXSID3022667"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C5983,D5983)","v":"Betamethasone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L5983,M5983)","v":"Muscular Diseases"},"D001623","Betamethasone","378-44-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N5983,N5983)","v":"DTXSID3022667"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J5983,J5983)","v":"5230216"},"Factors influencing the development of steroid-induced myopathies.","5230216","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID3022667"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6016,D6016)","v":"Bezafibrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6016,M6016)","v":"Muscular Diseases"},"D001629","Bezafibrate","41859-67-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6016,N6016)","v":"DTXSID3029869"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6016,J6016)","v":"2046439"},"[Bezafibrate-induced necrotizing myopathy].","2046439","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID3029869"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6037,D6037)","v":"Bicuculline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6037,M6037)","v":"Epilepsy"},"D001640","Bicuculline","485-49-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6037,N6037)","v":"DTXSID3042687"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6037,J6037)","v":"9824455"},"Involvement of GABA(B) receptors in convulsant-induced epileptiform activity in rat neocortex in vitro.","9824455","Central Nervous System Diseases","D004827","Epilepsy","DTXSID3042687"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6077,D6077)","v":"Biperiden"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6077,M6077)","v":"Dysarthria"},"D001712","Biperiden","1235-82-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6077,N6077)","v":"DTXSID2047856"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6077,J6077)","v":"1935662"},"[Central anticholinergic intoxication syndrome. A contribution to the differential diagnosis of exogenous psychoses].","1935662","Neurologic Manifestations","D004401","Dysarthria","DTXSID2047856"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6089,D6089)","v":"Biperiden"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6089,M6089)","v":"Seizures"},"D001712","Biperiden","1235-82-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6089,N6089)","v":"DTXSID2047856"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6089,J6089)","v":"648381"},"[Akineton delir and other emergencies caused by psychopharmaca].","648381","Neurologic Manifestations","D012640","Seizures","DTXSID2047856"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6112,D6112)","v":"Bismuth"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6112,M6112)","v":"Brain Diseases"},"D001729","Bismuth","7440-69-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6112,N6112)","v":"DTXSID3052484"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6112,J6112)","v":"7132858"},"Encephalopathy from bismuth subsalicylate.","7132858","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID3052484"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6145,D6145)","v":"Bismuth"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6145,M6145)","v":"Brain Diseases"},"D001729","Bismuth","7440-69-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6145,N6145)","v":"DTXSID3052484"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6145,J6145)","v":"370750"},"[Chromatography of urinary amino-acid in bismuth encephalopathy (author's transl)].","370750","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID3052484"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6157,D6157)","v":"Bismuth"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6157,M6157)","v":"Brain Diseases"},"D001729","Bismuth","7440-69-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6157,N6157)","v":"DTXSID3052484"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6157,J6157)","v":"229554"},"[Evolutive correlations with clinical, electrical, CT scan and toxicological data in five cases of oral bismuthic encephalopathies (author's transl)].","229554","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID3052484"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6180,D6180)","v":"Bismuth"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6180,M6180)","v":"Coma"},"D001729","Bismuth","7440-69-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6180,N6180)","v":"DTXSID3052484"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6180,J6180)","v":"970827"},"[Psychiatric aspects of encephalopathy caused by bismuth salts].","970827","Neurologic Manifestations","D003128","Coma","DTXSID3052484"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6213,D6213)","v":"Bismuth"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6213,M6213)","v":"Hallucinations"},"D001729","Bismuth","7440-69-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6213,N6213)","v":"DTXSID3052484"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6213,J6213)","v":"1153303"},"[Letter: Encephalopathies due to insoluble salts of bismuth].","1153303","Neurologic Manifestations","D006212","Hallucinations","DTXSID3052484"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6246,D6246)","v":"Bismuth"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6246,M6246)","v":"Myoclonus"},"D001729","Bismuth","7440-69-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6246,N6246)","v":"DTXSID3052484"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6246,J6246)","v":"4459861"},"[Letter: Myoclonic encephalopathy and bismuth salt poisoning].","4459861","Neurologic Manifestations","D009207","Myoclonus","DTXSID3052484"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6274,D6274)","v":"Bismuth"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6274,M6274)","v":"Myoclonus"},"D001729","Bismuth","7440-69-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6274,N6274)","v":"DTXSID3052484"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6274,J6274)","v":"1230925"},"[Polygraphic study of bismuth-induced myoclonic encephalopathy].","1230925","Neurologic Manifestations","D009207","Myoclonus","DTXSID3052484"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6307,D6307)","v":"Bismuth"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6307,M6307)","v":"Vertigo"},"D001729","Bismuth","7440-69-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6307,N6307)","v":"DTXSID3052484"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6307,J6307)","v":"5123059"},"[Nicolau syndrome, form of drug-induced embolism. (Clinical picture--etiology and pathogenesis--prevention--comparison with Hoigné syndrome)].","5123059","Neurologic Manifestations","D014717","Vertigo","DTXSID3052484"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6314,D6314)","v":"bismuth iodoform paraffin paste"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6314,M6314)","v":"Delirium"},"C045757","bismuth iodoform paraffin paste",null,null,2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6314,J6314)","v":"12956799"},"Beware of bismuth.","12956799","Neurologic Manifestations","D003693","Delirium"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6342,D6342)","v":"Bisoprolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6342,M6342)","v":"Quadriplegia"},"D017298","Bisoprolol","66722-44-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6342,N6342)","v":"DTXSID6022682"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6342,J6342)","v":"15313766"},"Beta-blocker-induced quadriparesis.","15313766","Neurologic Manifestations","D011782","Quadriplegia","DTXSID6022682"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6375,D6375)","v":"bisphenol A"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6375,M6375)","v":"Nervous System Malformations"},"C006780","bisphenol A","80-05-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6375,N6375)","v":"DTXSID7020182"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6375,J6375)","v":"16427766"},"Neonatal genistein or bisphenol-A exposure alters sexual differentiation of the AVPV.","16427766","Nervous System Malformations","D009421","Nervous System Malformations","DTXSID7020182"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6407,D6407)","v":"Bortezomib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6407,M6407)","v":"Neuralgia"},"D000069286","Bortezomib","179324-69-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6407,N6407)","v":"DTXSID3040980"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6407,J6407)","v":"26373954"},"The possible involvement of JNK activation in the spinal dorsal horn in bortezomib-induced allodynia: the role of TNF-α and IL-1β.","26373954","Neuromuscular Diseases","D009437","Neuralgia","DTXSID3040980"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6436,D6436)","v":"Bortezomib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6436,M6436)","v":"Peripheral Nervous System Diseases"},"D000069286","Bortezomib","179324-69-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6436,N6436)","v":"DTXSID3040980"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6436,J6436)","v":"28591409"},"Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma.","28591409","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID3040980"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6459,D6459)","v":"Bortezomib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6459,M6459)","v":"Peripheral Nervous System Diseases"},"D000069286","Bortezomib","179324-69-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6459,N6459)","v":"DTXSID3040980"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6459,J6459)","v":"24867959"},"A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma.","24867959","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID3040980"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6471,D6471)","v":"Bortezomib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6471,M6471)","v":"Peripheral Nervous System Diseases"},"D000069286","Bortezomib","179324-69-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6471,N6471)","v":"DTXSID3040980"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6471,J6471)","v":"16464758"},"Bortezomib-induced Sweet's syndrome.","16464758","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID3040980"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6504,D6504)","v":"Bortezomib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6504,M6504)","v":"Peripheral Nervous System Diseases"},"D000069286","Bortezomib","179324-69-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6504,N6504)","v":"DTXSID3040980"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6504,J6504)","v":"22726548"},"General aspects and mechanisms of peripheral neuropathy associated with bortezomib in patients with newly diagnosed multiple myeloma.","22726548","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID3040980"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6527,D6527)","v":"Bortezomib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6527,M6527)","v":"Posterior Leukoencephalopathy Syndrome"},"D000069286","Bortezomib","179324-69-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6527,N6527)","v":"DTXSID3040980"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6527,J6527)","v":"24903728"},"Posterior reversible encephalopathy syndrome resulting from repeat bortezomib usage.","24903728","Central Nervous System Diseases","D054038","Posterior Leukoencephalopathy Syndrome","DTXSID3040980"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6539,D6539)","v":"Brimonidine Tartrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6539,M6539)","v":"Delirium"},"D000068438","Brimonidine Tartrate",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6539,N6539)","v":"DTXSID70911371"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6539,J6539)","v":"10922214"},"A case of suspected alphagan-induced psychosis.","10922214","Neurologic Manifestations","D003693","Delirium","DTXSID70911371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6572,D6572)","v":"Bromine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6572,M6572)","v":"Hallucinations"},"D001966","Bromine","7726-95-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6572,N6572)","v":"DTXSID1035238"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6572,J6572)","v":"5070376"},"[Bromine abuse--still a reality].","5070376","Neurologic Manifestations","D006212","Hallucinations","DTXSID1035238"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6595,D6595)","v":"Bromisovalum"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6595,M6595)","v":"Peripheral Nervous System Diseases"},"D001968","Bromisovalum","496-67-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6595,N6595)","v":"DTXSID2040656"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6595,J6595)","v":"9372340"},"Cerebellar ataxia and peripheral neuropathy due to chronic bromvalerylurea poisoning.","9372340","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID2040656"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6633,D6633)","v":"Bromocriptine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6633,M6633)","v":"Dystonia"},"D001971","Bromocriptine","25614-03-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6633,N6633)","v":"DTXSID1022687"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6633,J6633)","v":"8232949"},"Bromocriptine-induced dystonia in patients with aphasia and hemiparesis.","8232949","Neurologic Manifestations","D004421","Dystonia","DTXSID1022687"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6662,D6662)","v":"Bromocriptine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6662,M6662)","v":"Hypotension, Orthostatic"},"D001971","Bromocriptine","25614-03-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6662,N6662)","v":"DTXSID1022687"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6662,J6662)","v":"3234463"},"Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventional formulation.","3234463","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID1022687"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6688,D6688)","v":"Bromocriptine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6688,M6688)","v":"Seizures"},"D001971","Bromocriptine","25614-03-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6688,N6688)","v":"DTXSID1022687"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6688,J6688)","v":"1874430"},"Bromocriptine associated with postpartum hypertension, seizures, and pituitary hemorrhage.","1874430","Neurologic Manifestations","D012640","Seizures","DTXSID1022687"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6701,D6701)","v":"Bromocriptine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6701,M6701)","v":"Vascular Headaches"},"D001971","Bromocriptine","25614-03-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6701,N6701)","v":"DTXSID1022687"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6701,J6701)","v":"1923236"},"Bromocriptine-associated headache: possible life-threatening sympathomimetic interaction.","1923236","Central Nervous System Diseases","D014653","Vascular Headaches","DTXSID1022687"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6730,D6730)","v":"Budesonide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6730,M6730)","v":"Taste Disorders"},"D019819","Budesonide","51333-22-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6730,N6730)","v":"DTXSID8020202"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6730,J6730)","v":"10070173"},"Comparison of budesonide Turbuhaler with budesonide aqua in the treatment of seasonal allergic rhinitis. Rhinocort Study Group.","10070173","Neurologic Manifestations","D013651","Taste Disorders","DTXSID8020202"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6756,D6756)","v":"Bumetanide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6756,M6756)","v":"Hearing Loss"},"D002034","Bumetanide","28395-03-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6756,N6756)","v":"DTXSID5022699"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6756,J6756)","v":"26189501"},"Pilot evaluation of the population pharmacokinetics of bumetanide in term newborn infants with seizures.","26189501","Neurologic Manifestations","D034381","Hearing Loss","DTXSID5022699"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6791,D6791)","v":"Bupivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6791,M6791)","v":"Epilepsy, Tonic-Clonic"},"D002045","Bupivacaine","14252-80-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6791,N6791)","v":"DTXSID0030877"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6791,J6791)","v":"12677626"},"Central nervous system toxicity following the administration of levobupivacaine for lumbar plexus block: A report of two cases.","12677626","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID0030877"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6808,D6808)","v":"Bupivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6808,M6808)","v":"Horner Syndrome"},"D002045","Bupivacaine","14252-80-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6808,N6808)","v":"DTXSID0030877"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6808,J6808)","v":"19628545"},"eComment: Post-thoracotomy Horner syndrome associated with extrapleural infusion of bupivacaine.","19628545","Neurologic Manifestations","D006732","Horner Syndrome","DTXSID0030877"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6830,D6830)","v":"Bupivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6830,M6830)","v":"Muscular Atrophy"},"D002045","Bupivacaine","14252-80-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6830,N6830)","v":"DTXSID0030877"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6830,J6830)","v":"3407988"},"Muscle atrophy following nerve block therapy.","3407988","Neurologic Manifestations","D009133","Muscular Atrophy","DTXSID0030877"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6859,D6859)","v":"Bupivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6859,M6859)","v":"Nervous System Diseases"},"D002045","Bupivacaine","14252-80-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6859,N6859)","v":"DTXSID0030877"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6859,J6859)","v":"9060033"},"Neurological impairment during long-term intrathecal infusion of bupivacaine in cancer patients: a sign of spinal cord compression.","9060033","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0030877"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6876,D6876)","v":"Bupivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6876,M6876)","v":"Paralysis"},"D002045","Bupivacaine","14252-80-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6876,N6876)","v":"DTXSID0030877"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6876,J6876)","v":"3986072"},"Neurological toxicity of the subarachnoid infusion of bupivacaine, lignocaine or 2-chloroprocaine in the rat.","3986072","Neurologic Manifestations","D010243","Paralysis","DTXSID0030877"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6898,D6898)","v":"Bupivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6898,M6898)","v":"Peripheral Nervous System Diseases"},"D002045","Bupivacaine","14252-80-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6898,N6898)","v":"DTXSID0030877"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6898,J6898)","v":"1314913"},"Accidental femoral nerve block following administration of local anesthetic for varicocele repair.","1314913","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0030877"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6927,D6927)","v":"Bupivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6927,M6927)","v":"Seizures"},"D002045","Bupivacaine","14252-80-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6927,N6927)","v":"DTXSID0030877"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6927,J6927)","v":"6829942"},"Comparative CNS toxicity of lidocaine, etidocaine, bupivacaine, and tetracaine in awake dogs following rapid intravenous administration.","6829942","Neurologic Manifestations","D012640","Seizures","DTXSID0030877"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6969,D6969)","v":"Bupivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6969,M6969)","v":"Seizures"},"D002045","Bupivacaine","14252-80-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6969,N6969)","v":"DTXSID0030877"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6969,J6969)","v":"1632544"},"Seizures occurring in pediatric patients receiving continuous infusion of bupivacaine.","1632544","Neurologic Manifestations","D012640","Seizures","DTXSID0030877"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C6988,D6988)","v":"Bupivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L6988,M6988)","v":"Seizures"},"D002045","Bupivacaine","14252-80-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N6988,N6988)","v":"DTXSID0030877"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J6988,J6988)","v":"10899380"},"Nitric oxide modulation affects the tissue distribution and toxicity of bupivacaine.","10899380","Neurologic Manifestations","D012640","Seizures","DTXSID0030877"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7021,D7021)","v":"Bupivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7021,M7021)","v":"Urinary Bladder, Neurogenic"},"D002045","Bupivacaine","14252-80-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7021,N7021)","v":"DTXSID0030877"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7021,J7021)","v":"11685017"},"Bowel and bladder dysfunction after spinal bupivacaine.","11685017","Neurologic Manifestations","D001750","Urinary Bladder, Neurogenic","DTXSID0030877"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7037,D7037)","v":"Buprenorphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7037,M7037)","v":"Gait Disorders, Neurologic"},"D002047","Buprenorphine","53152-21-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7037,N7037)","v":"DTXSID2048905"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7037,J7037)","v":"19653810"},"Molecular, anatomical, physiological, and behavioral studies of rats treated with buprenorphine after spinal cord injury.","19653810","Neurologic Manifestations","D020233","Gait Disorders, Neurologic","DTXSID2048905"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7056,D7056)","v":"Buprenorphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7056,M7056)","v":"Psychomotor Disorders"},"D002047","Buprenorphine","53152-21-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7056,N7056)","v":"DTXSID2048905"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7056,J7056)","v":"17517480"},"Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.","17517480","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID2048905"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7089,D7089)","v":"Bupropion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7089,M7089)","v":"Delirium"},"D016642","Bupropion","34911-55-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7089,N7089)","v":"DTXSID7022706"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7089,J7089)","v":"2115897"},"Delirium associated with bupropion.","2115897","Neurologic Manifestations","D003693","Delirium","DTXSID7022706"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7126,D7126)","v":"Bupropion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7126,M7126)","v":"Hallucinations"},"D016642","Bupropion","34911-55-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7126,N7126)","v":"DTXSID7022706"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7126,J7126)","v":"21677231"},"Gustatory and olfactory hallucinations under therapeutic dosing of bupropion.","21677231","Neurologic Manifestations","D006212","Hallucinations","DTXSID7022706"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7150,D7150)","v":"Bupropion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7150,M7150)","v":"Seizures"},"D016642","Bupropion","34911-55-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7150,N7150)","v":"DTXSID7022706"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7150,J7150)","v":"8885123"},"Bupropion plasma levels and CYP2D6 phenotype.","8885123","Neurologic Manifestations","D012640","Seizures","DTXSID7022706"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7157,D7157)","v":"Bupropion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7157,M7157)","v":"Seizures"},"D016642","Bupropion","34911-55-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7157,N7157)","v":"DTXSID7022706"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7157,J7157)","v":"27648505"},"Atypical Findings in Massive Bupropion Overdose: A Case Report and Discussion of Psychopharmacologic Issues.","27648505","Neurologic Manifestations","D012640","Seizures","DTXSID7022706"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7185,D7185)","v":"Bupropion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7185,M7185)","v":"Seizures"},"D016642","Bupropion","34911-55-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7185,N7185)","v":"DTXSID7022706"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7185,J7185)","v":"20213217"},"The outcome of unintentional pediatric bupropion ingestions: a NPDS database review.","20213217","Neurologic Manifestations","D012640","Seizures","DTXSID7022706"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7218,D7218)","v":"Bupropion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7218,M7218)","v":"Sleep Initiation and Maintenance Disorders"},"D016642","Bupropion","34911-55-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7218,N7218)","v":"DTXSID7022706"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7218,J7218)","v":"9448656"},"Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.","9448656","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID7022706"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7250,D7250)","v":"Buspirone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7250,M7250)","v":"Epilepsy, Tonic-Clonic"},"D002065","Buspirone","33386-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7250,N7250)","v":"DTXSID1037193"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7250,J7250)","v":"1552045"},"Seizure associated with fluoxetine and adjuvant buspirone therapy.","1552045","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID1037193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7279,D7279)","v":"Busulfan"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7279,M7279)","v":"Seizures"},"D002066","Busulfan","55-98-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7279,N7279)","v":"DTXSID3020910"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7279,J7279)","v":"7570271"},"[Extramedullary toxicity in bone marrow transplantation using busulfan and cyclophosphamide conditioning].","7570271","Neurologic Manifestations","D012640","Seizures","DTXSID3020910"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7286,D7286)","v":"Busulfan"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7286,M7286)","v":"Seizures"},"D002066","Busulfan","55-98-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7286,N7286)","v":"DTXSID3020910"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7286,J7286)","v":"23575621"},"Clonazepam for seizure prophylaxis in adult patients treated with high dose busulfan.","23575621","Neurologic Manifestations","D012640","Seizures","DTXSID3020910"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7314,D7314)","v":"butane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7314,M7314)","v":"Brain Damage, Chronic"},"C046888","butane","106-97-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7314,N7314)","v":"DTXSID7024665"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7314,J7314)","v":"12235546"},"Butane abuse associated Encephalopathy.","12235546","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID7024665"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7347,D7347)","v":"cabergoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7347,M7347)","v":"Hyperprolactinemia"},"C047047","cabergoline","81409-90-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7347,N7347)","v":"DTXSID6022719"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7347,J7347)","v":"15003071"},"Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study.","15003071","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID6022719"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7380,D7380)","v":"Cadmium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7380,M7380)","v":"Hearing Disorders"},"D002104","Cadmium","7440-43-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7380,N7380)","v":"DTXSID1023940"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7380,J7380)","v":"19182378"},"Hwanggunchungyitang prevents cadmium-induced ototoxicity through suppression of the activation of caspase-9 and extracellular signal-related kinase in auditory HEI-OC1 cells.","19182378","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID1023940"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7407,D7407)","v":"Cadmium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7407,M7407)","v":"Neural Tube Defects"},"D002104","Cadmium","7440-43-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7407,N7407)","v":"DTXSID1023940"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7407,J7407)","v":"3972075"},"Evidence for reopening of the cranial neural tube in mouse embryos treated with cadmium chloride.","3972075","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID1023940"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7415,D7415)","v":"Cadmium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7415,M7415)","v":"Olfaction Disorders"},"D002104","Cadmium","7440-43-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7415,N7415)","v":"DTXSID1023940"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7415,J7415)","v":"17706735"},"Brief embryonic cadmium exposure induces a stress response and cell death in the developing olfactory system followed by long-term olfactory deficits in juvenile zebrafish.","17706735","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID1023940"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7448,D7448)","v":"Caffeine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7448,M7448)","v":"Cerebral Hemorrhage"},"D002110","Caffeine","58-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7448,N7448)","v":"DTXSID0020232"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7448,J7448)","v":"6695415"},"Cerebral hemorrhage associated with phenylpropanolamine in combination with caffeine.","6695415","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID0020232"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7475,D7475)","v":"Caffeine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7475,M7475)","v":"Hallucinations"},"D002110","Caffeine","58-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7475,N7475)","v":"DTXSID0020232"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7475,J7475)","v":"8767052"},"[Delusion and sleep deprivation].","8767052","Neurologic Manifestations","D006212","Hallucinations","DTXSID0020232"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7509,D7509)","v":"Caffeine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7509,M7509)","v":"Muscular Diseases"},"D002110","Caffeine","58-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7509,N7509)","v":"DTXSID0020232"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7509,J7509)","v":"9105382"},"Silicone breast implants and drug-induced arthralgia.","9105382","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID0020232"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7527,D7527)","v":"Caffeine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7527,M7527)","v":"Paresthesia"},"D002110","Caffeine","58-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7527,N7527)","v":"DTXSID0020232"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7527,J7527)","v":"7140516"},"Caffeine and burning feet.","7140516","Neurologic Manifestations","D010292","Paresthesia","DTXSID0020232"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7544,D7544)","v":"Caffeine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7544,M7544)","v":"Seizures"},"D002110","Caffeine","58-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7544,N7544)","v":"DTXSID0020232"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7544,J7544)","v":"6728873"},"Interstrain variation in acute toxic response to caffeine among inbred mice.","6728873","Neurologic Manifestations","D012640","Seizures","DTXSID0020232"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7577,D7577)","v":"Caffeine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7577,M7577)","v":"Sleep Initiation and Maintenance Disorders"},"D002110","Caffeine","58-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7577,N7577)","v":"DTXSID0020232"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7577,J7577)","v":"6851408"},"Caffeine metabolism and coffee-attributed sleep disturbances.","6851408","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID0020232"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7595,D7595)","v":"Caffeine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7595,M7595)","v":"Sleep Initiation and Maintenance Disorders"},"D002110","Caffeine","58-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7595,N7595)","v":"DTXSID0020232"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7595,J7595)","v":"19351801"},"Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers.","19351801","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID0020232"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7638,D7638)","v":"Caffeine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7638,M7638)","v":"Tremor"},"D002110","Caffeine","58-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7638,N7638)","v":"DTXSID0020232"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7638,J7638)","v":"12044659"},"Effect of acute caffeine on severity of harmaline induced tremor in rats.","12044659","Neurologic Manifestations","D014202","Tremor","DTXSID0020232"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7667,D7667)","v":"Calcium Hydroxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7667,M7667)","v":"Eye Burns"},"D002126","Calcium Hydroxide","1305-62-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7667,N7667)","v":"DTXSID7034410"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7667,J7667)","v":"15510690"},"Alkali burns to the right eye.","15510690","Trauma, Nervous System","D005126","Eye Burns","DTXSID7034410"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7688,D7688)","v":"calomel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7688,M7688)","v":"Tremor"},"C015728","calomel","10112-91-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7688,N7688)","v":"DTXSID6044351"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7688,J7688)","v":"25756767"},"Mercury poisoning: a case of a complex neuropsychiatric illness.","25756767","Neurologic Manifestations","D014202","Tremor","DTXSID6044351"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7706,D7706)","v":"Camphor"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7706,M7706)","v":"Seizures"},"D002164","Camphor","76-22-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7706,N7706)","v":"DTXSID5030955"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7706,J7706)","v":"4383203"},"Studies on chloral hydrate and camphor sensitivity in rats of different ages.","4383203","Neurologic Manifestations","D012640","Seizures","DTXSID5030955"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7735,D7735)","v":"Camptothecin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7735,M7735)","v":"Dysarthria"},"D002166","Camptothecin","7689-03-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7735,N7735)","v":"DTXSID0030956"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7735,J7735)","v":"11562394"},"Irinotecan-induced dysarthria.","11562394","Neurologic Manifestations","D004401","Dysarthria","DTXSID0030956"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7756,D7756)","v":"Cannabidiol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7756,M7756)","v":"Seizures"},"D002185","Cannabidiol",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7756,N7756)","v":"DTXSID00871959"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7756,J7756)","v":"113206"},"The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats.","113206","Neurologic Manifestations","D012640","Seizures","DTXSID00871959"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7774,D7774)","v":"Capecitabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7774,M7774)","v":"Coma"},"D000069287","Capecitabine","154361-50-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7774,N7774)","v":"DTXSID3046451"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7774,J7774)","v":"16333678"},"5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma.","16333678","Neurologic Manifestations","D003128","Coma","DTXSID3046451"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7803,D7803)","v":"Capecitabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7803,M7803)","v":"Paresthesia"},"D000069287","Capecitabine","154361-50-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7803,N7803)","v":"DTXSID3046451"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7803,J7803)","v":"20722491"},"Safety of capecitabine: a review.","20722491","Neurologic Manifestations","D010292","Paresthesia","DTXSID3046451"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7824,D7824)","v":"Capecitabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7824,M7824)","v":"Stroke"},"D000069287","Capecitabine","154361-50-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7824,N7824)","v":"DTXSID3046451"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7824,J7824)","v":"17682013"},"Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients.","17682013","Central Nervous System Diseases","D020521","Stroke","DTXSID3046451"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7864,D7864)","v":"Capsaicin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7864,M7864)","v":"Hyperalgesia"},"D002211","Capsaicin","404-86-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7864,N7864)","v":"DTXSID9020241"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7864,J7864)","v":"11022922"},"Capsaicin and nociception: from basic mechanisms to novel drugs.","11022922","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID9020241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7897,D7897)","v":"Capsaicin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7897,M7897)","v":"Paresthesia"},"D002211","Capsaicin","404-86-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7897,N7897)","v":"DTXSID9020241"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7897,J7897)","v":"10228629"},"Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia.","10228629","Neurologic Manifestations","D010292","Paresthesia","DTXSID9020241"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7917,D7917)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7917,M7917)","v":"Ataxia"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7917,N7917)","v":"DTXSID00235052"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7917,J7917)","v":"6695215"},"Acute carbamazepine intoxication: clinical spectrum and management.","6695215","Neurologic Manifestations","D001259","Ataxia","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7932,D7932)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7932,M7932)","v":"Ataxia"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7932,N7932)","v":"DTXSID00235052"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7932,J7932)","v":"11927746"},"Index of suspicion.","11927746","Neurologic Manifestations","D001259","Ataxia","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7969,D7969)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7969,M7969)","v":"Color Vision Defects"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7969,N7969)","v":"DTXSID00235052"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7969,J7969)","v":"7715759"},"[Disorders of color perception and increase glare sensitivity in phenytoin and carbamazepine therapy. Ocular side effects of anticonvulsants].","7715759","Neurologic Manifestations","D003117","Color Vision Defects","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C7997,D7997)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L7997,M7997)","v":"Coma"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N7997,N7997)","v":"DTXSID00235052"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J7997,J7997)","v":"11725522"},"[A case of carbamazepine intoxication with alpha coma and status epilepticus].","11725522","Neurologic Manifestations","D003128","Coma","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8026,D8026)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8026,M8026)","v":"Dysarthria"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8026,N8026)","v":"DTXSID00235052"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8026,J8026)","v":"3957629"},"Carbamazepine poisoning: a case report.","3957629","Neurologic Manifestations","D004401","Dysarthria","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8037,D8037)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8037,M8037)","v":"Encephalitis"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8037,N8037)","v":"DTXSID00235052"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8037,J8037)","v":"14970374"},"Acute encephalopathy induced by oxcarbazepine and furosemide.","14970374","Central Nervous System Diseases","D004660","Encephalitis","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8061,D8061)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8061,M8061)","v":"Epilepsy, Absence"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8061,N8061)","v":"DTXSID00235052"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8061,J8061)","v":"3929090"},"Exacerbation of seizures in children by carbamazepine.","3929090","Central Nervous System Diseases","D004832","Epilepsy, Absence","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8094,D8094)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8094,M8094)","v":"Hearing Disorders"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8094,N8094)","v":"DTXSID00235052"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8094,J8094)","v":"14642372"},"Pitch perception abnormality as a side effect of carbamazepine.","14642372","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8105,D8105)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8105,M8105)","v":"Inappropriate ADH Syndrome"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8105,N8105)","v":"DTXSID00235052"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8105,J8105)","v":"7841583"},"Syndrome of inappropriate antidiuretic hormone secretion induced by different drugs.","7841583","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8129,D8129)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8129,M8129)","v":"Learning Disorders"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8129,N8129)","v":"DTXSID00235052"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8129,J8129)","v":"6588711"},"The influence of carbamazepine and phenytoin on memory and other aspects of cognitive function in new referrals with epilepsy.","6588711","Neurologic Manifestations","D007859","Learning Disorders","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8162,D8162)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8162,M8162)","v":"Nervous System Diseases"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8162,N8162)","v":"DTXSID00235052"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8162,J8162)","v":"6424398"},"Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy.","6424398","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8194,D8194)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8194,M8194)","v":"Nystagmus, Pathologic"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8194,N8194)","v":"DTXSID00235052"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8194,J8194)","v":"8140026"},"Dystonia--a rare manifestation of carbamazepine toxicity.","8140026","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8223,D8223)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8223,M8223)","v":"Psychomotor Disorders"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8223,N8223)","v":"DTXSID00235052"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8223,J8223)","v":"6588711"},"The influence of carbamazepine and phenytoin on memory and other aspects of cognitive function in new referrals with epilepsy.","6588711","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8256,D8256)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8256,M8256)","v":"Seizures"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8256,N8256)","v":"DTXSID00235052"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8256,J8256)","v":"11753195"},"Management of carbamazepine overdose.","11753195","Neurologic Manifestations","D012640","Seizures","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8262,D8262)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8262,M8262)","v":"Sleep Wake Disorders"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8262,N8262)","v":"DTXSID00235052"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8262,J8262)","v":"2862408"},"Carbamazepine-induced drowsiness.","2862408","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8291,D8291)","v":"Carbamazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8291,M8291)","v":"Tic Disorders"},"D002220","Carbamazepine","85756-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8291,N8291)","v":"DTXSID00235052"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8291,J8291)","v":"6479475"},"Carbamazepine-induced tics.","6479475","Central Nervous System Diseases","D013981","Tic Disorders","DTXSID00235052"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8318,D8318)","v":"carbamazepine epoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8318,M8318)","v":"Diplopia"},"C012227","carbamazepine epoxide","36507-30-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8318,N8318)","v":"DTXSID60891456"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8318,J8318)","v":"9577998"},"Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?","9577998","Neurologic Manifestations","D004172","Diplopia","DTXSID60891456"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8352,D8352)","v":"Carbidopa"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8352,M8352)","v":"Dementia"},"D002230","Carbidopa","28860-95-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8352,N8352)","v":"DTXSID4022735"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8352,J8352)","v":"8420214"},"Treatment of drug-induced psychosis in Parkinson's disease with clozapine.","8420214","Central Nervous System Diseases","D003704","Dementia","DTXSID4022735"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8385,D8385)","v":"Carbidopa"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8385,M8385)","v":"Polyneuropathies"},"D002230","Carbidopa","28860-95-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8385,N8385)","v":"DTXSID4022735"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8385,J8385)","v":"23818953"},"Neuropathy in Parkinson's disease patients with intestinal levodopa infusion versus oral drugs.","23818953","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID4022735"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8407,D8407)","v":"Carbimazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8407,M8407)","v":"Taste Disorders"},"D002231","Carbimazole","22232-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8407,N8407)","v":"DTXSID9022736"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8407,J8407)","v":"3561618"},"[Disorders of smell and taste in treatment with thiamazole and carbimazole].","3561618","Neurologic Manifestations","D013651","Taste Disorders","DTXSID9022736"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8420,D8420)","v":"Carbon Dioxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8420,M8420)","v":"Amnesia"},"D002245","Carbon Dioxide","124-38-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8420,N8420)","v":"DTXSID4027028"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8420,J8420)","v":"15219772"},"Effect of pretraining administration of NC-1900, a vasopressin fragment analog, on memory performance in non- or CO2-amnesic mice.","15219772","Neurologic Manifestations","D000647","Amnesia","DTXSID4027028"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8453,D8453)","v":"Carbon Disulfide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8453,M8453)","v":"Brain Damage, Chronic"},"D002246","Carbon Disulfide","75-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8453,N8453)","v":"DTXSID6023947"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8453,J8453)","v":"7087409"},"Cerebral damage following a single high exposure to carbon disulphide.","7087409","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID6023947"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8475,D8475)","v":"Carbon Disulfide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8475,M8475)","v":"Cerebrovascular Disorders"},"D002246","Carbon Disulfide","75-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8475,N8475)","v":"DTXSID6023947"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8475,J8475)","v":"838511"},"[Electroencephalography in diagnosis of early cerebral changes due to carbon disulfide].","838511","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID6023947"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8488,D8488)","v":"Carbon Disulfide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8488,M8488)","v":"Encephalitis"},"D002246","Carbon Disulfide","75-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8488,N8488)","v":"DTXSID6023947"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8488,J8488)","v":"4656267"},"[The state of the optic analyzer in diencephalitis of carbon disulfide etiology].","4656267","Central Nervous System Diseases","D004660","Encephalitis","DTXSID6023947"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8517,D8517)","v":"Carbon Disulfide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8517,M8517)","v":"Nervous System Diseases"},"D002246","Carbon Disulfide","75-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8517,N8517)","v":"DTXSID6023947"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8517,J8517)","v":"749370"},"[Problems in the diagnosis of polyneuropathy in epidemiological studies involving chemical exposure (with special reference to carbon disulfide)].","749370","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID6023947"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8543,D8543)","v":"Carbon Disulfide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8543,M8543)","v":"Neuromuscular Diseases"},"D002246","Carbon Disulfide","75-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8543,N8543)","v":"DTXSID6023947"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8543,J8543)","v":"6157800"},"Clinical and electrophysiological studies of carbon disulphide polyneuropathy.","6157800","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID6023947"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8582,D8582)","v":"Carbon Disulfide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8582,M8582)","v":"Polyneuropathies"},"D002246","Carbon Disulfide","75-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8582,N8582)","v":"DTXSID6023947"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8582,J8582)","v":"5451697"},"Investigation of serum LDH and its isoenzymatic model in carbon disulphide polyneuritis.","5451697","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID6023947"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8611,D8611)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8611,M8611)","v":"Amnesia"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8611,N8611)","v":"DTXSID5027273"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8611,J8611)","v":"2807836"},"A case of transient choreoathetosis with amnesic syndrome after acute monoxide poisoning.","2807836","Neurologic Manifestations","D000647","Amnesia","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8636,D8636)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8636,M8636)","v":"Brain Damage, Chronic"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8636,N8636)","v":"DTXSID5027273"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8636,J8636)","v":"813158"},"Fetal brain injury after maternal carbon monoxide intoxication. Clinical and neuropathologic aspects.","813158","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8650,D8650)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8650,M8650)","v":"Brain Diseases"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8650,N8650)","v":"DTXSID5027273"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8650,J8650)","v":"676680"},"[Myelinopathy due to carbon monoxyde poisoning. A study in ultrastructural neuropathology (author's transl)].","676680","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8688,D8688)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8688,M8688)","v":"Brain Diseases"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8688,N8688)","v":"DTXSID5027273"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8688,J8688)","v":"1609067"},"Delayed encephalopathy after acute carbon monoxide intoxication: MR imaging features and distribution of cerebral white matter lesions.","1609067","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8711,D8711)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8711,M8711)","v":"Brain Edema"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8711,N8711)","v":"DTXSID5027273"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8711,J8711)","v":"2919402"},"Cardiovascular, metabolic and neurologic effects of acute carbon monoxide poisoning in the rat.","2919402","Central Nervous System Diseases","D001929","Brain Edema","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8740,D8740)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8740,M8740)","v":"Chorea"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8740,N8740)","v":"DTXSID5027273"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8740,J8740)","v":"2807836"},"A case of transient choreoathetosis with amnesic syndrome after acute monoxide poisoning.","2807836","Central Nervous System Diseases","D002819","Chorea","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8756,D8756)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8756,M8756)","v":"Coma"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8756,N8756)","v":"DTXSID5027273"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8756,J8756)","v":"2106810"},"The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology.","2106810","Neurologic Manifestations","D003128","Coma","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8779,D8779)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8779,M8779)","v":"Encephalomyelitis"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8779,N8779)","v":"DTXSID5027273"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8779,J8779)","v":"4598965"},"[Possible damage of the central nervous system due to toxic industrial substances].","4598965","Central Nervous System Diseases","D004679","Encephalomyelitis","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8808,D8808)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8808,M8808)","v":"Hypoxia, Brain"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8808,N8808)","v":"DTXSID5027273"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8808,J8808)","v":"8975424"},"[Hypoxic brain damage after carbon monoxide poisoning. Visual agnosia, reduced initiative and memory and delayed sequelae].","8975424","Central Nervous System Diseases","D002534","Hypoxia, Brain","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8824,D8824)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8824,M8824)","v":"Lethargy"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8824,N8824)","v":"DTXSID5027273"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8824,J8824)","v":"24204005"},"The bird it was that died.","24204005","Neurologic Manifestations","D053609","Lethargy","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8847,D8847)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8847,M8847)","v":"Muscular Diseases"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8847,N8847)","v":"DTXSID5027273"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8847,J8847)","v":"968558"},"[Myorenal syndrome in acute poisonings].","968558","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8876,D8876)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8876,M8876)","v":"Nervous System Diseases"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8876,N8876)","v":"DTXSID5027273"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8876,J8876)","v":"15510905"},"[Neurological disorders after carbon monoxide intoxication].","15510905","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8917,D8917)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8917,M8917)","v":"Peripheral Nervous System Diseases"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8917,N8917)","v":"DTXSID5027273"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8917,J8917)","v":"4340697"},"Deafness and peripheral neuropathy following carbon monoxide intoxication--report of a case.","4340697","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8937,D8937)","v":"Carbon Monoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8937,M8937)","v":"Syncope"},"D002248","Carbon Monoxide","630-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8937,N8937)","v":"DTXSID5027273"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8937,J8937)","v":"12001477"},"[Headache, nausea and fainting attacks].","12001477","Neurologic Manifestations","D013575","Syncope","DTXSID5027273"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8970,D8970)","v":"Carbon Tetrachloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8970,M8970)","v":"Hepatic Encephalopathy"},"D002251","Carbon Tetrachloride","56-23-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8970,N8970)","v":"DTXSID8020250"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8970,J8970)","v":"6119654"},"[Ammonia content and glutamine synthetase and glutaminase activity in the brain in experimental hepatic coma].","6119654","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID8020250"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C8985,D8985)","v":"Carbon Tetrachloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L8985,M8985)","v":"Paralysis"},"D002251","Carbon Tetrachloride","56-23-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N8985,N8985)","v":"DTXSID8020250"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J8985,J8985)","v":"5090688"},"Factors affecting neurotoxicity by p-bromophenylacetylurea in rats.","5090688","Neurologic Manifestations","D010243","Paralysis","DTXSID8020250"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9005,D9005)","v":"Carboplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9005,M9005)","v":"Hearing Disorders"},"D016190","Carboplatin","41575-94-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9005,N9005)","v":"DTXSID3046742"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9005,J9005)","v":"9818694"},"Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.","9818694","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID3046742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9037,D9037)","v":"Carboplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9037,M9037)","v":"Hearing Loss"},"D016190","Carboplatin","41575-94-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9037,N9037)","v":"DTXSID3046742"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9037,J9037)","v":"22851560"},"Carboplatin dosing in infants with retinoblastoma: a case for therapeutic drug monitoring.","22851560","Neurologic Manifestations","D034381","Hearing Loss","DTXSID3046742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9066,D9066)","v":"Carboplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9066,M9066)","v":"Hypesthesia"},"D016190","Carboplatin","41575-94-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9066,N9066)","v":"DTXSID3046742"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9066,J9066)","v":"11103240"},"[Evaluation of adverse effects including neurotoxicity of combination chemotherapy with paclitaxel and carboplatin].","11103240","Neurologic Manifestations","D006987","Hypesthesia","DTXSID3046742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9099,D9099)","v":"Carboplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9099,M9099)","v":"Peripheral Nervous System Diseases"},"D016190","Carboplatin","41575-94-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9099,N9099)","v":"DTXSID3046742"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9099,J9099)","v":"15163172"},"Vinorelbine-induced acute reversible peripheral neuropathy in a patient with ovarian carcinoma pretreated with carboplatin and paclitaxel.","15163172","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID3046742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9105,D9105)","v":"Carboplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9105,M9105)","v":"Peripheral Nervous System Diseases"},"D016190","Carboplatin","41575-94-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9105,N9105)","v":"DTXSID3046742"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9105,J9105)","v":"21750553"},"Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.","21750553","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID3046742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9134,D9134)","v":"Carmustine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9134,M9134)","v":"Brain Diseases"},"D002330","Carmustine","154-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9134,N9134)","v":"DTXSID8022743"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9134,J9134)","v":"3543256"},"Reevaluating the efficacy of intra-arterial BCNU.","3543256","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8022743"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9167,D9167)","v":"Carnitine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9167,M9167)","v":"Neuromuscular Diseases"},"D002331","Carnitine","541-15-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9167,N9167)","v":"DTXSID4023208"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9167,J9167)","v":"7167076"},"A note on \"orthomolecular aids for dieting\"--myasthenic syndrome due to dl-carnitine.","7167076","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID4023208"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9198,D9198)","v":"Carticaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9198,M9198)","v":"Kearns-Sayre Syndrome"},"D002355","Carticaine","23964-58-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9198,N9198)","v":"DTXSID7048536"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9198,J9198)","v":"16239771"},"Re: deterioration of Kearns-Sayre syndrome following articaine administration for local anesthesia.","16239771","Neurologic Manifestations","D007625","Kearns-Sayre Syndrome","DTXSID7048536"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9228,D9228)","v":"cathinone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9228,M9228)","v":"Delirium"},"C023665","cathinone","71031-15-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9228,N9228)","v":"DTXSID0050427"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9228,J9228)","v":"26074741"},"Cathinone neurotoxicity (\"The \"3Ms\").","26074741","Neurologic Manifestations","D003693","Delirium","DTXSID0050427"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9235,D9235)","v":"cathinone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9235,M9235)","v":"Neurogenic Inflammation"},"C023665","cathinone","71031-15-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9235,N9235)","v":"DTXSID0050427"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9235,J9235)","v":"23845561"},"Hypothesizing that designer drugs containing cathinones (\"bath salts\") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption.","23845561","Neurologic Manifestations","D020078","Neurogenic Inflammation","DTXSID0050427"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9262,D9262)","v":"cefditoren pivoxil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9262,M9262)","v":"Seizures"},"C057710","cefditoren pivoxil","117467-28-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9262,N9262)","v":"DTXSID2048743"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9262,J9262)","v":"17724113"},"Carnitine-associated encephalopathy caused by long-term treatment with an antibiotic containing pivalic acid.","17724113","Neurologic Manifestations","D012640","Seizures","DTXSID2048743"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9296,D9296)","v":"cefepime"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9296,M9296)","v":"Myoclonus"},"C043266","cefepime","123171-59-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9296,N9296)","v":"DTXSID7045603"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9296,J9296)","v":"25780020"},"Cefepime-induced jaw myoclonus.","25780020","Neurologic Manifestations","D009207","Myoclonus","DTXSID7045603"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9329,D9329)","v":"Cefotaxime"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9329,M9329)","v":"Brain Diseases"},"D002439","Cefotaxime","64485-93-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9329,N9329)","v":"DTXSID4046991"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9329,J9329)","v":"2782775"},"[Encephalopathy caused by cefotaxime. A case in an aged patient with renal failure].","2782775","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID4046991"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9355,D9355)","v":"Ceftazidime"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9355,M9355)","v":"Seizures"},"D002442","Ceftazidime","78439-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9355,N9355)","v":"DTXSID0045599"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9355,J9355)","v":"7855759"},"[Convulsions associated with the administration of excessive dose of ceftazidime in patients with renal failure].","7855759","Neurologic Manifestations","D012640","Seizures","DTXSID0045599"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9364,D9364)","v":"Ceftriaxone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9364,M9364)","v":"Chorea"},"D002443","Ceftriaxone","73384-59-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9364,N9364)","v":"DTXSID0022773"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9364,J9364)","v":"20724905"},"Reversible choreoathetosis after the administration of ceftriaxone sodium in patients with end-stage renal disease.","20724905","Central Nervous System Diseases","D002819","Chorea","DTXSID0022773"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9407,D9407)","v":"Celecoxib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9407,M9407)","v":"Vision Disorders"},"D000068579","Celecoxib","169590-42-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9407,N9407)","v":"DTXSID0022777"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9407,J9407)","v":"14630760"},"Celecoxib, rofecoxib, and acute temporary visual impairment.","14630760","Neurologic Manifestations","D014786","Vision Disorders","DTXSID0022777"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9425,D9425)","v":"Cephalexin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9425,M9425)","v":"Nervous System Diseases"},"D002506","Cephalexin","59695-59-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9425,N9425)","v":"DTXSID20208400"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9425,J9425)","v":"4589401"},"Cephalexin dosage in general practice assessed by double-blind trial.","4589401","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID20208400"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9458,D9458)","v":"cerivastatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9458,M9458)","v":"Muscular Diseases"},"C086276","cerivastatin","145599-86-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9458,N9458)","v":"DTXSID9022786"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9458,J9458)","v":"12883940"},"Intestinal pseudobstruction as presenting event of fatal cerivastatin-induced myopathy.","12883940","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID9022786"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9475,D9475)","v":"Cetirizine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9475,M9475)","v":"Disorders of Excessive Somnolence"},"D017332","Cetirizine","83881-52-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9475,N9475)","v":"DTXSID2044268"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9475,J9475)","v":"26990040"},"Placebo-controlled assessment of somnolence effect of cetirizine: a meta-analysis.","26990040","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID2044268"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9493,D9493)","v":"Chloral Hydrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9493,M9493)","v":"Cerebral Infarction"},"D002697","Chloral Hydrate","302-17-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9493,N9493)","v":"DTXSID7020261"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9493,J9493)","v":"9605729"},"Reversible segmental cerebral arterial vasospasm and cerebral infarction: possible association with excessive use of sumatriptan and Midrin.","9605729","Central Nervous System Diseases","D002544","Cerebral Infarction","DTXSID7020261"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9526,D9526)","v":"Chloralose"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9526,M9526)","v":"Myoclonus"},"D002698","Chloralose","15879-93-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9526,N9526)","v":"DTXSID4020088"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9526,J9526)","v":"7574072"},"Propofol in the management of myoclonus syndrome induced by chloralose poisoning.","7574072","Neurologic Manifestations","D009207","Myoclonus","DTXSID4020088"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9543,D9543)","v":"Chlorambucil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9543,M9543)","v":"Epilepsies, Myoclonic"},"D002699","Chlorambucil","305-03-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9543,N9543)","v":"DTXSID7020263"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9543,J9543)","v":"6786208"},"Myoclonic seizures following chlorambucil overdose.","6786208","Central Nervous System Diseases","D004831","Epilepsies, Myoclonic","DTXSID7020263"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9587,D9587)","v":"Chloramphenicol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9587,M9587)","v":"Hearing Disorders"},"D002701","Chloramphenicol","56-75-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9587,N9587)","v":"DTXSID7020265"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9587,J9587)","v":"967425"},"[A case of triple drug damage].","967425","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID7020265"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9616,D9616)","v":"Chloramphenicol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9616,M9616)","v":"Optic Neuritis"},"D002701","Chloramphenicol","56-75-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9616,N9616)","v":"DTXSID7020265"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9616,J9616)","v":"4738320"},"[Case of chloramphenicol optico-neuropathy].","4738320","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID7020265"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9636,D9636)","v":"Chloramphenicol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9636,M9636)","v":"Paralysis"},"D002701","Chloramphenicol","56-75-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9636,N9636)","v":"DTXSID7020265"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9636,J9636)","v":"3590619"},"Incompatibility between lasalocid and chloramphenicol in broiler chicks after a long-term simultaneous administration.","3590619","Neurologic Manifestations","D010243","Paralysis","DTXSID7020265"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9655,D9655)","v":"Chlordan"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9655,M9655)","v":"Seizures"},"D002706","Chlordan","57-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9655,N9655)","v":"DTXSID7020267"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9655,J9655)","v":"5773973"},"Acute chlordane poisoning. Clinical and chemical studies.","5773973","Neurologic Manifestations","D012640","Seizures","DTXSID7020267"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9684,D9684)","v":"Chlordecone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9684,M9684)","v":"Tremor"},"D007631","Chlordecone","143-50-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9684,N9684)","v":"DTXSID1020770"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9684,J9684)","v":"2581190"},"An electron microscopic study of alterations in mouse peripheral nerve and skeletal muscle after chlordecone exposure.","2581190","Neurologic Manifestations","D014202","Tremor","DTXSID1020770"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9704,D9704)","v":"Chlordiazepoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9704,M9704)","v":"Coma"},"D002707","Chlordiazepoxide","58-25-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9704,N9704)","v":"DTXSID4046022"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9704,J9704)","v":"2710011"},"Chlordiazepoxide metabolite accumulation in liver disease.","2710011","Neurologic Manifestations","D003128","Coma","DTXSID4046022"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9723,D9723)","v":"Chlorhexidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9723,M9723)","v":"Eye Burns"},"D002710","Chlorhexidine","3697-42-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9723,N9723)","v":"DTXSID7047144"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9723,J9723)","v":"22081151"},"Ocular surface reconstruction after exposure to high concentrations of antiseptic solutions.","22081151","Trauma, Nervous System","D005126","Eye Burns","DTXSID7047144"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9756,D9756)","v":"Chlormadinone Acetate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9756,M9756)","v":"Carotid Artery Thrombosis"},"D002715","Chlormadinone Acetate","302-22-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9756,N9756)","v":"DTXSID6020274"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9756,J9756)","v":"4101693"},"[Thrombosis of the right internal carotid artery following continuous contraceptive treatment with chlormadinone acetate in a 28-year-old woman].","4101693","Central Nervous System Diseases","D002341","Carotid Artery Thrombosis","DTXSID6020274"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9784,D9784)","v":"chloroacetic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9784,M9784)","v":"Coma"},"C006972","chloroacetic acid","79-11-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9784,N9784)","v":"DTXSID4020901"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9784,J9784)","v":"7303472"},"Acute topical exposure to a mixture of benzene, chloracetyl chloride and xylidine.","7303472","Neurologic Manifestations","D003128","Coma","DTXSID4020901"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9813,D9813)","v":"chloroprocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9813,M9813)","v":"Epilepsy, Tonic-Clonic"},"C004616","chloroprocaine","133-16-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9813,N9813)","v":"DTXSID8022799"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9813,J9813)","v":"3111302"},"Grand mal seizures after 2-chloroprocaine epidural anesthesia in a patient with plasma cholinesterase deficiency.","3111302","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID8022799"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9824,D9824)","v":"chloroprocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9824,M9824)","v":"Paralysis"},"C004616","chloroprocaine","133-16-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9824,N9824)","v":"DTXSID8022799"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9824,J9824)","v":"6711853"},"Chloroprocaine not absolved of neurotoxicity.","6711853","Neurologic Manifestations","D010243","Paralysis","DTXSID8022799"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9852,D9852)","v":"Chloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9852,M9852)","v":"Central Nervous System Diseases"},"D002738","Chloroquine","54-05-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9852,N9852)","v":"DTXSID2040446"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9852,J9852)","v":"4297587"},"Study of chloroquine toxicity and a drug-induced cerebrospinal lipodystrophy in swine.","4297587","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID2040446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9881,D9881)","v":"Chloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9881,M9881)","v":"Epilepsy"},"D002738","Chloroquine","54-05-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9881,N9881)","v":"DTXSID2040446"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9881,J9881)","v":"11769070"},"[Epileptic crisis after antimalaria chemoprophylaxis with chloroquine].","11769070","Central Nervous System Diseases","D004827","Epilepsy","DTXSID2040446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9917,D9917)","v":"Chloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9917,M9917)","v":"Muscular Diseases"},"D002738","Chloroquine","54-05-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9917,N9917)","v":"DTXSID2040446"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9917,J9917)","v":"4211437"},"[Experimental lesions of the nervous and muscular systems due to chloroquine: models of various storage dystrophies (author's transl)].","4211437","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID2040446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9942,D9942)","v":"Chloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9942,M9942)","v":"Muscular Diseases"},"D002738","Chloroquine","54-05-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9942,N9942)","v":"DTXSID2040446"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9942,J9942)","v":"11983070"},"The first molecular evidence that autophagy relates rimmed vacuole formation in chloroquine myopathy.","11983070","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID2040446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9975,D9975)","v":"Chloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9975,M9975)","v":"Neuromuscular Diseases"},"D002738","Chloroquine","54-05-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9975,N9975)","v":"DTXSID2040446"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9975,J9975)","v":"4779781"},"[Chloroquine neuromyopathy (apropos of a case of simple poisoning in a Negro)].","4779781","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID2040446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C9985,D9985)","v":"Chloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L9985,M9985)","v":"Neuromuscular Diseases"},"D002738","Chloroquine","54-05-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N9985,N9985)","v":"DTXSID2040446"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J9985,J9985)","v":"217080"},"Muscular and pyramidal tract involvement following a prolonged treatment with chloroquine.","217080","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID2040446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10010,D10010)","v":"Chloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10010,M10010)","v":"Scotoma"},"D002738","Chloroquine","54-05-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10010,N10010)","v":"DTXSID2040446"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10010,J10010)","v":"7348132"},"[Monitoring and prevention of iatrogenic ocular effect in general therapy].","7348132","Neurologic Manifestations","D012607","Scotoma","DTXSID2040446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10043,D10043)","v":"Chloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10043,M10043)","v":"Syncope"},"D002738","Chloroquine","54-05-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10043,N10043)","v":"DTXSID2040446"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10043,J10043)","v":"8219437"},"Neurologic adverse effects during concomitant treatment with ciprofloxacin, NSAIDS, and chloroquine: possible drug interaction.","8219437","Neurologic Manifestations","D013575","Syncope","DTXSID2040446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10053,D10053)","v":"Chloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10053,M10053)","v":"Vision Disorders"},"D002738","Chloroquine","54-05-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10053,N10053)","v":"DTXSID2040446"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10053,J10053)","v":"8197491"},"Visual function and long-term chloroquine treatment.","8197491","Neurologic Manifestations","D014786","Vision Disorders","DTXSID2040446"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10078,D10078)","v":"Chlorothiazide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10078,M10078)","v":"Ophthalmoplegia"},"D002740","Chlorothiazide","58-94-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10078,N10078)","v":"DTXSID0022800"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10078,J10078)","v":"691201"},"Transient oculomotor nerve palsy. Association with thiazide-induced glucose intolerance.","691201","Neurologic Manifestations","D009886","Ophthalmoplegia","DTXSID0022800"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10105,D10105)","v":"Chlorpromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10105,M10105)","v":"Basal Ganglia Diseases"},"D002746","Chlorpromazine","580-48-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10105,N10105)","v":"DTXSID6041765"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10105,J10105)","v":"823040"},"[On the problem of irreversible brain damage due to neuroleptic long-term therapy. Experimental studies on rats (author's transl)].","823040","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID6041765"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10139,D10139)","v":"Chlorpromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10139,M10139)","v":"Blindness"},"D002746","Chlorpromazine","580-48-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10139,N10139)","v":"DTXSID6041765"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10139,J10139)","v":"7663839"},"Chlorpromazine-induced retinopathy.","7663839","Neurologic Manifestations","D001766","Blindness","DTXSID6041765"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10172,D10172)","v":"Chlorpromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10172,M10172)","v":"Dystonia"},"D002746","Chlorpromazine","580-48-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10172,N10172)","v":"DTXSID6041765"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10172,J10172)","v":"8564339"},"Laryngeal dystonia.","8564339","Neurologic Manifestations","D004421","Dystonia","DTXSID6041765"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10198,D10198)","v":"Chlorpromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10198,M10198)","v":"Hypotension, Orthostatic"},"D002746","Chlorpromazine","580-48-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10198,N10198)","v":"DTXSID6041765"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10198,J10198)","v":"3530167"},"Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril.","3530167","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID6041765"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10207,D10207)","v":"Chlorpromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10207,M10207)","v":"Movement Disorders"},"D002746","Chlorpromazine","580-48-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10207,N10207)","v":"DTXSID6041765"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10207,J10207)","v":"4728916"},"Rapid reversal of tardive dyskinesia.","4728916","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID6041765"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10240,D10240)","v":"Chlorpromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10240,M10240)","v":"Parkinson Disease, Secondary"},"D002746","Chlorpromazine","580-48-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10240,N10240)","v":"DTXSID6041765"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10240,J10240)","v":"6577485"},"Lateral ventricular size and drug-induced Parkinsonism.","6577485","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID6041765"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10266,D10266)","v":"Chlorpromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10266,M10266)","v":"Seizures"},"D002746","Chlorpromazine","580-48-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10266,N10266)","v":"DTXSID6041765"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10266,J10266)","v":"5020345"},"Spontaneous seizures in rats treated with chlorpromazine during postnatal development.","5020345","Neurologic Manifestations","D012640","Seizures","DTXSID6041765"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10301,D10301)","v":"Chlorpromazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10301,M10301)","v":"Vision Disorders"},"D002746","Chlorpromazine","580-48-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10301,N10301)","v":"DTXSID6041765"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10301,J10301)","v":"5226613"},"Ocular complications of phenothiazines.","5226613","Neurologic Manifestations","D014786","Vision Disorders","DTXSID6041765"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10334,D10334)","v":"Chlorprothixene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10334,M10334)","v":"Polyneuropathies"},"D002749","Chlorprothixene","113-59-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10334,N10334)","v":"DTXSID4022810"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10334,J10334)","v":"1314010"},"Polyneuropathy caused by chlorprothixene.","1314010","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID4022810"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10355,D10355)","v":"Chlorpyrifos"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10355,M10355)","v":"Memory Disorders"},"D004390","Chlorpyrifos","2921-88-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10355,N10355)","v":"DTXSID4020458"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10355,J10355)","v":"22024239"},"Chronic impairments in spatial learning and memory in rats previously exposed to chlorpyrfos or diisopropylfluorophosphate.","22024239","Neurologic Manifestations","D008569","Memory Disorders","DTXSID4020458"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10369,D10369)","v":"Chlorpyrifos"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10369,M10369)","v":"Nervous System Diseases"},"D004390","Chlorpyrifos","2921-88-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10369,N10369)","v":"DTXSID4020458"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10369,J10369)","v":"21370952"},"Severe and prolonged neurologic toxicity following subcutaneous chlorpyrifos self-administration: a case report.","21370952","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID4020458"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10402,D10402)","v":"Chlorpyrifos"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10402,M10402)","v":"Spinal Cord Diseases"},"D004390","Chlorpyrifos","2921-88-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10402,N10402)","v":"DTXSID4020458"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10402,J10402)","v":"22735254"},"Chlorpyrifos-induced delayed myelopathy and pure motor neuropathy: a case report.","22735254","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID4020458"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10423,D10423)","v":"Cholesterol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10423,M10423)","v":"Meningioma"},"D002784","Cholesterol","57-88-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10423,N10423)","v":"DTXSID3022401"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10423,J10423)","v":"9384204"},"Nutritional factors in the etiology of brain tumors: potential role of nitrosamines, fat, and cholesterol.","9384204","Nervous System Neoplasms","D008579","Meningioma","DTXSID3022401"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10437,D10437)","v":"Choline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10437,M10437)","v":"Memory Disorders"},"D002794","Choline","67-48-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10437,N10437)","v":"DTXSID4020325"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10437,J10437)","v":"1360154"},"Reversal by 3,3',5-triido-L-thyronine of the working memory deficit, and the decrease in acetylcholine, glutamate and gamma-aminobutyric acid induced by ethylcholine aziridinium ion in mice.","1360154","Neurologic Manifestations","D008569","Memory Disorders","DTXSID4020325"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10475,D10475)","v":"cifenline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10475,M10475)","v":"Myasthenia Gravis"},"C032151","cifenline","53267-01-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10475,N10475)","v":"DTXSID9022819"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10475,J10475)","v":"19069153"},"[Myasthenia-like syndrome induced by cibenzoline overdose in a patient with chronic kidney disease].","19069153","Autoimmune Diseases of the Nervous System","D009157","Myasthenia Gravis","DTXSID9022819"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10498,D10498)","v":"Cilastatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10498,M10498)","v":"Seizures"},"D015377","Cilastatin","82009-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10498,N10498)","v":"DTXSID8048238"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10498,J10498)","v":"11033734"},"Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.","11033734","Neurologic Manifestations","D012640","Seizures","DTXSID8048238"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10531,D10531)","v":"Cimetidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10531,M10531)","v":"Brain Diseases"},"D002927","Cimetidine","51481-61-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10531,N10531)","v":"DTXSID4020329"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10531,J10531)","v":"6847003"},"Pseudohypoparathyroidism, cimetidine, and neurologic toxicity.","6847003","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID4020329"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10543,D10543)","v":"Cimetidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10543,M10543)","v":"Chorea"},"D002927","Cimetidine","51481-61-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10543,N10543)","v":"DTXSID4020329"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10543,J10543)","v":"7065573"},"Cimetidine-theophylline-terbutaline.","7065573","Central Nervous System Diseases","D002819","Chorea","DTXSID4020329"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10566,D10566)","v":"Cimetidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10566,M10566)","v":"Confusion"},"D002927","Cimetidine","51481-61-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10566,N10566)","v":"DTXSID4020329"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10566,J10566)","v":"6968898"},"Cimetidine: clinical uses and possible side effects.","6968898","Neurologic Manifestations","D003221","Confusion","DTXSID4020329"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10599,D10599)","v":"Cimetidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10599,M10599)","v":"Dementia"},"D002927","Cimetidine","51481-61-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10599,N10599)","v":"DTXSID4020329"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10599,J10599)","v":"7053303"},"Age and renal clearance of cimetidine.","7053303","Central Nervous System Diseases","D003704","Dementia","DTXSID4020329"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10636,D10636)","v":"Cimetidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10636,M10636)","v":"Polyradiculoneuropathy"},"D002927","Cimetidine","51481-61-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10636,N10636)","v":"DTXSID4020329"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10636,J10636)","v":"6104247"},"Neurological dysfunction in two patients receiving captopril and cimetidine.","6104247","Demyelinating Diseases","D011129","Polyradiculoneuropathy","DTXSID4020329"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10660,D10660)","v":"Cinnarizine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10660,M10660)","v":"Parkinson Disease, Secondary"},"D002936","Cinnarizine","298-57-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10660,N10660)","v":"DTXSID3022821"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10660,J10660)","v":"9613736"},"Cinnarizine-induced parkinsonism: ten years later.","9613736","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID3022821"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10689,D10689)","v":"Ciprofloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10689,M10689)","v":"Basal Ganglia Diseases"},"D002939","Ciprofloxacin","86393-32-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10689,N10689)","v":"DTXSID00273974"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10689,J10689)","v":"7875902"},"Extrapyramidal syndrome following ciprofloxacin treatment.","7875902","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00273974"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10704,D10704)","v":"Ciprofloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10704,M10704)","v":"Decerebrate State"},"D002939","Ciprofloxacin","86393-32-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10704,N10704)","v":"DTXSID00273974"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10704,J10704)","v":"11281089"},"Case report: severe neurologic reaction to ciprofloxacin.","11281089","Neurologic Manifestations","D003655","Decerebrate State","DTXSID00273974"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10728,D10728)","v":"Ciprofloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10728,M10728)","v":"Hearing Disorders"},"D002939","Ciprofloxacin","86393-32-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10728,N10728)","v":"DTXSID00273974"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10728,J10728)","v":"1854158"},"Lack of ciprofloxacin ototoxicity after repeated ototopical application.","1854158","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID00273974"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10757,D10757)","v":"Ciprofloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10757,M10757)","v":"Peripheral Nervous System Diseases"},"D002939","Ciprofloxacin","86393-32-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10757,N10757)","v":"DTXSID00273974"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10757,J10757)","v":"8219437"},"Neurologic adverse effects during concomitant treatment with ciprofloxacin, NSAIDS, and chloroquine: possible drug interaction.","8219437","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID00273974"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10772,D10772)","v":"Ciprofloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10772,M10772)","v":"Seizures"},"D002939","Ciprofloxacin","86393-32-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10772,N10772)","v":"DTXSID00273974"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10772,J10772)","v":"19473592"},"Ciprofloxacin-associated seizures in a patient with underlying thyrotoxicosis: case report and literature review.","19473592","Neurologic Manifestations","D012640","Seizures","DTXSID00273974"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10818,D10818)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10818,M10818)","v":"Autonomic Nervous System Diseases"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10818,N10818)","v":"DTXSID4024983"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10818,J10818)","v":"6538810"},"Cisplatin-induced autonomic neuropathy.","6538810","Autonomic Nervous System Diseases","D001342","Autonomic Nervous System Diseases","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10825,D10825)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10825,M10825)","v":"Basal Ganglia Diseases"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10825,N10825)","v":"DTXSID4024983"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10825,J10825)","v":"3566848"},"Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis.","3566848","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10865,D10865)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10865,M10865)","v":"Carotid Stenosis"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10865,N10865)","v":"DTXSID4024983"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10865,J10865)","v":"20016238"},"Cisplatin-associated occlusion of the internal carotid artery.","20016238","Central Nervous System Diseases","D016893","Carotid Stenosis","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10886,D10886)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10886,M10886)","v":"Color Vision Defects"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10886,N10886)","v":"DTXSID4024983"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10886,J10886)","v":"8119103"},"Negative-type electroretinogram from cisplatin toxicity.","8119103","Neurologic Manifestations","D003117","Color Vision Defects","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10917,D10917)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10917,M10917)","v":"Deafness"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10917,N10917)","v":"DTXSID4024983"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10917,J10917)","v":"1416374"},"Evaluation of a one-hour saline diuresis protocol for administration of cisplatin to dogs.","1416374","Neurologic Manifestations","D003638","Deafness","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10925,D10925)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10925,M10925)","v":"Encephalocele"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10925,N10925)","v":"DTXSID4024983"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10925,J10925)","v":"3397766"},"Cerebral herniation in patients receiving cisplatin.","3397766","Nervous System Malformations","D004677","Encephalocele","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10954,D10954)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10954,M10954)","v":"Hearing Disorders"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10954,N10954)","v":"DTXSID4024983"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10954,J10954)","v":"8960474"},"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.","8960474","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C10985,D10985)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L10985,M10985)","v":"Hearing Disorders"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N10985,N10985)","v":"DTXSID4024983"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J10985,J10985)","v":"1581592"},"Audiometric test criteria in the detection of cisplatin ototoxicity.","1581592","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11015,D11015)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11015,M11015)","v":"Hearing Loss"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11015,N11015)","v":"DTXSID4024983"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11015,J11015)","v":"6681630"},"Hearing loss in children receiving cisplatin chemotherapy.","6681630","Neurologic Manifestations","D034381","Hearing Loss","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11048,D11048)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11048,M11048)","v":"Hearing Loss"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11048,N11048)","v":"DTXSID4024983"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11048,J11048)","v":"25831807"},"[Ototoxicity of cisplatin].","25831807","Neurologic Manifestations","D034381","Hearing Loss","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11053,D11053)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11053,M11053)","v":"Hearing Loss"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11053,N11053)","v":"DTXSID4024983"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11053,J11053)","v":"27286730"},"Audiological Monitoring in Children Treated with Platinum Chemotherapy.","27286730","Neurologic Manifestations","D034381","Hearing Loss","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11083,D11083)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11083,M11083)","v":"Hearing Loss"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11083,N11083)","v":"DTXSID4024983"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11083,J11083)","v":"28448657"},"Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.","28448657","Neurologic Manifestations","D034381","Hearing Loss","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11116,D11116)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11116,M11116)","v":"Hearing Loss"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11116,N11116)","v":"DTXSID4024983"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11116,J11116)","v":"23429908"},"Statistical model for prediction of hearing loss in patients receiving cisplatin chemotherapy.","23429908","Neurologic Manifestations","D034381","Hearing Loss","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11146,D11146)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11146,M11146)","v":"Hearing Loss"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11146,N11146)","v":"DTXSID4024983"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11146,J11146)","v":"24224985"},"ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring.","24224985","Neurologic Manifestations","D034381","Hearing Loss","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11177,D11177)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11177,M11177)","v":"Hearing Loss"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11177,N11177)","v":"DTXSID4024983"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11177,J11177)","v":"19564816"},"Effect of noise conditioning on cisplatin-induced ototoxicity: a pilot study.","19564816","Neurologic Manifestations","D034381","Hearing Loss","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11184,D11184)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11184,M11184)","v":"Hearing Loss"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11184,N11184)","v":"DTXSID4024983"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11184,J11184)","v":"19042049"},"Efficacy of low-dose cisplatin-based chemo-irradiation in assessing hearing loss for locally advanced head and neck cancer.","19042049","Neurologic Manifestations","D034381","Hearing Loss","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11210,D11210)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11210,M11210)","v":"Hearing Loss"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11210,N11210)","v":"DTXSID4024983"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11210,J11210)","v":"21787192"},"Pharmacogenomics of cisplatin-induced ototoxicity.","21787192","Neurologic Manifestations","D034381","Hearing Loss","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11245,D11245)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11245,M11245)","v":"Hearing Loss, Bilateral"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11245,N11245)","v":"DTXSID4024983"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11245,J11245)","v":"8859195"},"Cisplatin administration to gynecologic cancer patients. Long-term effects on hearing.","8859195","Neurologic Manifestations","D006312","Hearing Loss, Bilateral","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11266,D11266)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11266,M11266)","v":"Hearing Loss, Bilateral"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11266,N11266)","v":"DTXSID4024983"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11266,J11266)","v":"1900608"},"The \"plateau effect\" of cis-platinum-induced hearing loss.","1900608","Neurologic Manifestations","D006312","Hearing Loss, Bilateral","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11306,D11306)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11306,M11306)","v":"Hearing Loss, High-Frequency"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11306,N11306)","v":"DTXSID4024983"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11306,J11306)","v":"3583423"},"Ototoxicity of cisplatin.","3583423","Neurologic Manifestations","D006316","Hearing Loss, High-Frequency","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11313,D11313)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11313,M11313)","v":"Hearing Loss, High-Frequency"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11313,N11313)","v":"DTXSID4024983"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11313,J11313)","v":"15519518"},"Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.","15519518","Neurologic Manifestations","D006316","Hearing Loss, High-Frequency","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11355,D11355)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11355,M11355)","v":"Hearing Loss, Sensorineural"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11355,N11355)","v":"DTXSID4024983"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11355,J11355)","v":"2779137"},"[Ototoxicity of cisplatin in children with malignant diseases].","2779137","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11374,D11374)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11374,M11374)","v":"Hearing Loss, Sensorineural"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11374,N11374)","v":"DTXSID4024983"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11374,J11374)","v":"23946126"},"Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients.","23946126","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11407,D11407)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11407,M11407)","v":"Hearing Loss, Sensorineural"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11407,N11407)","v":"DTXSID4024983"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11407,J11407)","v":"21521888"},"Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.","21521888","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11423,D11423)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11423,M11423)","v":"Hearing Loss, Sensorineural"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11423,N11423)","v":"DTXSID4024983"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11423,J11423)","v":"12003999"},"Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action.","12003999","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11442,D11442)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11442,M11442)","v":"Hyperalgesia"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11442,N11442)","v":"DTXSID4024983"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11442,J11442)","v":"17962345"},"Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia.","17962345","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11475,D11475)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11475,M11475)","v":"Infarction, Middle Cerebral Artery"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11475,N11475)","v":"DTXSID4024983"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11475,J11475)","v":"10895000"},"Ischemic stroke following cisplatin and 5-fluorouracil therapy: a transcranial Doppler study.","10895000","Central Nervous System Diseases","D020244","Infarction, Middle Cerebral Artery","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11491,D11491)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11491,M11491)","v":"Muscular Atrophy"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11491,N11491)","v":"DTXSID4024983"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11491,J11491)","v":"25231802"},"[Effects of antioxidant on reduction of hindlimb muscle atrophy induced by cisplatin in rats].","25231802","Neurologic Manifestations","D009133","Muscular Atrophy","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11536,D11536)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11536,M11536)","v":"Nervous System Diseases"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11536,N11536)","v":"DTXSID4024983"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11536,J11536)","v":"10362115"},"Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer.","10362115","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11565,D11565)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11565,M11565)","v":"Optic Neuritis"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11565,N11565)","v":"DTXSID4024983"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11565,J11565)","v":"709562"},"Ophthalmologic toxicity after cis-dichlorodiammineplatinum(II) therapy.","709562","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11584,D11584)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11584,M11584)","v":"Paresthesia"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11584,N11584)","v":"DTXSID4024983"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11584,J11584)","v":"3440227"},"The development of Lhermitte's sign during cisplatin chemotherapy. Possible drug-induced toxicity causing spinal cord demyelination.","3440227","Neurologic Manifestations","D010292","Paresthesia","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11604,D11604)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11604,M11604)","v":"Peripheral Nervous System Diseases"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11604,N11604)","v":"DTXSID4024983"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11604,J11604)","v":"6314324"},"[Peripheral neuropathy due to cisplatin].","6314324","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11636,D11636)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11636,M11636)","v":"Peripheral Nervous System Diseases"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11636,N11636)","v":"DTXSID4024983"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11636,J11636)","v":"2999870"},"Polyneuropathy induced by cisplatin.","2999870","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11665,D11665)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11665,M11665)","v":"Peripheral Nervous System Diseases"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11665,N11665)","v":"DTXSID4024983"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11665,J11665)","v":"24072474"},"Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children.","24072474","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11668,D11668)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11668,M11668)","v":"Peripheral Nervous System Diseases"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11668,N11668)","v":"DTXSID4024983"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11668,J11668)","v":"25277379"},"Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR.","25277379","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11704,D11704)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11704,M11704)","v":"Peripheral Nervous System Diseases"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11704,N11704)","v":"DTXSID4024983"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11704,J11704)","v":"2160314"},"Low prevalence of cisplatin-induced neuropathy after 4-day continuous infusion in head and neck cancer.","2160314","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11733,D11733)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11733,M11733)","v":"Peripheral Nervous System Diseases"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11733,N11733)","v":"DTXSID4024983"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11733,J11733)","v":"1336008"},"Evaluation by somatosensory evoked potentials of the neurotoxicity of cisplatin alone or in combination with glutathione.","1336008","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11762,D11762)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11762,M11762)","v":"Seizures"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11762,N11762)","v":"DTXSID4024983"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11762,J11762)","v":"2802533"},"Cisplatin-induced neurotoxicity with seizures in frogs.","2802533","Neurologic Manifestations","D012640","Seizures","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11772,D11772)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11772,M11772)","v":"Seizures"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11772,N11772)","v":"DTXSID4024983"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11772,J11772)","v":"12853886"},"Cisplatin-induced encephalopathy and seizures.","12853886","Neurologic Manifestations","D012640","Seizures","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11801,D11801)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11801,M11801)","v":"Tetany"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11801,N11801)","v":"DTXSID4024983"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11801,J11801)","v":"6108477"},"Tetany associated with cis-platin.","6108477","Neurologic Manifestations","D013746","Tetany","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11830,D11830)","v":"Cisplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11830,M11830)","v":"Tinnitus"},"D002945","Cisplatin","15663-27-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11830,N11830)","v":"DTXSID4024983"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11830,J11830)","v":"19940282"},"Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.","19940282","Neurologic Manifestations","D014012","Tinnitus","DTXSID4024983"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11865,D11865)","v":"Citalopram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11865,M11865)","v":"Confusion"},"D015283","Citalopram","128196-01-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11865,N11865)","v":"DTXSID8048440"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11865,J11865)","v":"10830154"},"Citalopram and clozapine: potential drug interaction.","10830154","Neurologic Manifestations","D003221","Confusion","DTXSID8048440"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11891,D11891)","v":"Citalopram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11891,M11891)","v":"Inappropriate ADH Syndrome"},"D015283","Citalopram","128196-01-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11891,N11891)","v":"DTXSID8048440"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11891,J11891)","v":"17202465"},"Hyponatremia associated with escitalopram.","17202465","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID8048440"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11924,D11924)","v":"Citalopram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11924,M11924)","v":"Parkinsonian Disorders"},"D015283","Citalopram","128196-01-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11924,N11924)","v":"DTXSID8048440"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11924,J11924)","v":"24176515"},"Escitalopram-induced Parkinsonism.","24176515","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8048440"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11933,D11933)","v":"Citalopram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11933,M11933)","v":"Seizures"},"D015283","Citalopram","128196-01-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11933,N11933)","v":"DTXSID8048440"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11933,J11933)","v":"27186623"},"Citalopram, escitalopram: no more effective than other SSRIs, but more toxic.","27186623","Neurologic Manifestations","D012640","Seizures","DTXSID8048440"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11959,D11959)","v":"Citalopram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11959,M11959)","v":"Sleep Wake Disorders"},"D015283","Citalopram","128196-01-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11959,N11959)","v":"DTXSID8048440"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11959,J11959)","v":"22057726"},"Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder.","22057726","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID8048440"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C11985,D11985)","v":"Cladribine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L11985,M11985)","v":"Brain Ischemia"},"D017338","Cladribine","4291-63-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N11985,N11985)","v":"DTXSID8022828"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J11985,J11985)","v":"15360010"},"Richter's syndrome in the brain first manifested as an ischaemic stroke.","15360010","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID8022828"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12024,D12024)","v":"Clarithromycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12024,M12024)","v":"Intracranial Hemorrhages"},"D017291","Clarithromycin","81103-11-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12024,N12024)","v":"DTXSID3022829"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12024,J12024)","v":"26811362"},"Bleeding associated with coadministration of rivaroxaban and clarithromycin.","26811362","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID3022829"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12027,D12027)","v":"Clarithromycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12027,M12027)","v":"Muscle Weakness"},"D017291","Clarithromycin","81103-11-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12027,N12027)","v":"DTXSID3022829"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12027,J12027)","v":"21125536"},"[88 years old woman with acute muscular weakness and diffuse muscular pain: have you thought about the drugs?].","21125536","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID3022829"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12053,D12053)","v":"clebopride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12053,M12053)","v":"Dystonia"},"C014417","clebopride","57645-39-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12053,N12053)","v":"DTXSID10206339"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12053,J12053)","v":"10079694"},"[Acute familial dystonia caused by antidopaminergic drugs].","10079694","Neurologic Manifestations","D004421","Dystonia","DTXSID10206339"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12088,D12088)","v":"Clevudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12088,M12088)","v":"Muscular Diseases"},"C034935","Clevudine","163252-36-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12088,N12088)","v":"DTXSID2057659"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12088,J12088)","v":"21225424"},"18F-FDG PET/CT of drug-induced myopathy in a patient with chronic hepatitis B on long-term clevudine therapy.","21225424","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID2057659"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12121,D12121)","v":"Clioquinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12121,M12121)","v":"Brain Diseases"},"D007464","Clioquinol","130-26-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12121,N12121)","v":"DTXSID7022837"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12121,J12121)","v":"6103216"},"Idiosyncratic neurotoxicity: clioquinol and bismuth.","6103216","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID7022837"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12146,D12146)","v":"Clioquinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12146,M12146)","v":"Myelitis"},"D007464","Clioquinol","130-26-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12146,N12146)","v":"DTXSID7022837"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12146,J12146)","v":"9414602"},"[SMON and pharmacokinetics of chinoform with special reference to animal species difference].","9414602","Central Nervous System Diseases","D009187","Myelitis","DTXSID7022837"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12156,D12156)","v":"Clioquinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12156,M12156)","v":"Myelitis"},"D007464","Clioquinol","130-26-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12156,N12156)","v":"DTXSID7022837"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12156,J12156)","v":"4268933"},"Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.","4268933","Central Nervous System Diseases","D009187","Myelitis","DTXSID7022837"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12189,D12189)","v":"Clioquinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12189,M12189)","v":"Myelitis"},"D007464","Clioquinol","130-26-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12189,N12189)","v":"DTXSID7022837"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12189,J12189)","v":"136536"},"Experimental reproduction of SMON in animals by prolonged administration of clioquinol: clinico-pathological findings.","136536","Central Nervous System Diseases","D009187","Myelitis","DTXSID7022837"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12210,D12210)","v":"Clioquinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12210,M12210)","v":"Nervous System Diseases"},"D007464","Clioquinol","130-26-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12210,N12210)","v":"DTXSID7022837"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12210,J12210)","v":"6229623"},"Appearance of intoxication in rats by intraperitoneal administration of clioquinol.","6229623","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7022837"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12250,D12250)","v":"Clioquinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12250,M12250)","v":"Optic Neuritis"},"D007464","Clioquinol","130-26-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12250,N12250)","v":"DTXSID7022837"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12250,J12250)","v":"6460590"},"Clioquinol intoxication occurring in the treatment of acrodermatitis enteropathica with reference to SMON outside of Japan.","6460590","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID7022837"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12283,D12283)","v":"Clioquinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12283,M12283)","v":"Optic Neuritis"},"D007464","Clioquinol","130-26-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12283,N12283)","v":"DTXSID7022837"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12283,J12283)","v":"4108984"},"Subacute myelo-optic neuropathy in Australia.","4108984","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID7022837"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12303,D12303)","v":"Clioquinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12303,M12303)","v":"Optic Neuritis"},"D007464","Clioquinol","130-26-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12303,N12303)","v":"DTXSID7022837"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12303,J12303)","v":"159200"},"[Subacute myelo-optic-neuropathy during treatment with chloro-iodo-hydroxyquinoleine (author's transl)].","159200","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID7022837"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12318,D12318)","v":"Clioquinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12318,M12318)","v":"Optic Neuritis"},"D007464","Clioquinol","130-26-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12318,N12318)","v":"DTXSID7022837"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12318,J12318)","v":"127638"},"Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis.","127638","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID7022837"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12359,D12359)","v":"Clioquinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12359,M12359)","v":"Spinal Cord Diseases"},"D007464","Clioquinol","130-26-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12359,N12359)","v":"DTXSID7022837"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12359,J12359)","v":"230316"},"Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan.","230316","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID7022837"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12379,D12379)","v":"clobazam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12379,M12379)","v":"Ocular Motility Disorders"},"C012255","clobazam","22316-47-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12379,N12379)","v":"DTXSID2046759"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12379,J12379)","v":"16780634"},"Eye rolling as a manifestation of clobazam toxicity in a child with epilepsy.","16780634","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID2046759"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12386,D12386)","v":"Clofibrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12386,M12386)","v":"Muscular Diseases"},"D002994","Clofibrate","637-07-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12386,N12386)","v":"DTXSID3020336"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12386,J12386)","v":"6511338"},"Clofibrate-induced muscular syndrome. Case report with ultrastructural findings and review of the literature.","6511338","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID3020336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12423,D12423)","v":"Clofibric Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12423,M12423)","v":"Muscular Diseases"},"D002995","Clofibric Acid","882-09-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12423,N12423)","v":"DTXSID1040661"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12423,J12423)","v":"1853004"},"[Does hypothyroidism predispose muscular toxicity of fibrates?].","1853004","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID1040661"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12447,D12447)","v":"Clomiphene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12447,M12447)","v":"Meningomyelocele"},"D002996","Clomiphene","14158-65-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12447,N12447)","v":"DTXSID40747361"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12447,J12447)","v":"650331"},"Possible relationship between clomiphene and neural tube defects.","650331","Nervous System Malformations","D008591","Meningomyelocele","DTXSID40747361"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12480,D12480)","v":"Clomipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12480,M12480)","v":"Basal Ganglia Diseases"},"D002997","Clomipramine","303-49-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12480,N12480)","v":"DTXSID6022844"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12480,J12480)","v":"11476129"},"Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study.","11476129","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID6022844"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12491,D12491)","v":"Clomipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12491,M12491)","v":"Delirium"},"D002997","Clomipramine","303-49-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12491,N12491)","v":"DTXSID6022844"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12491,J12491)","v":"11145466"},"Delirious episodes induced by intravenous administration of clomipramine associated with an acute increase in its plasma concentrations.","11145466","Neurologic Manifestations","D003693","Delirium","DTXSID6022844"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12515,D12515)","v":"Clomipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12515,M12515)","v":"Inappropriate ADH Syndrome"},"D002997","Clomipramine","303-49-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12515,N12515)","v":"DTXSID6022844"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12515,J12515)","v":"450841"},"Syndrome of dilutional hyponatraemia secondary to tricyclic antidepressant.","450841","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID6022844"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12548,D12548)","v":"Clomipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12548,M12548)","v":"Status Epilepticus"},"D002997","Clomipramine","303-49-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12548,N12548)","v":"DTXSID6022844"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12548,J12548)","v":"9663805"},"Non-convulsive status epilepticus induced by antidepressants.","9663805","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID6022844"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12584,D12584)","v":"Clonazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12584,M12584)","v":"Epilepsy"},"D002998","Clonazepam","1622-61-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12584,N12584)","v":"DTXSID1022845"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12584,J12584)","v":"10838112"},"Seizure-inducing paradoxical reaction to antiepileptic drugs.","10838112","Central Nervous System Diseases","D004827","Epilepsy","DTXSID1022845"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12609,D12609)","v":"Clonazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12609,M12609)","v":"Seizures"},"D002998","Clonazepam","1622-61-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12609,N12609)","v":"DTXSID1022845"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12609,J12609)","v":"1656808"},"Induced microseizures in West syndrome.","1656808","Neurologic Manifestations","D012640","Seizures","DTXSID1022845"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12638,D12638)","v":"Clonidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12638,M12638)","v":"Consciousness Disorders"},"D003000","Clonidine","4205-90-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12638,N12638)","v":"DTXSID6022846"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12638,J12638)","v":"24411570"},"[Transplacental or breast milk intoxication to clonidine: a case of neonatal hypotonia and drowsiness].","24411570","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID6022846"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12652,D12652)","v":"Clonidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12652,M12652)","v":"Epilepsy, Absence"},"D003000","Clonidine","4205-90-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12652,N12652)","v":"DTXSID6022846"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12652,J12652)","v":"15639550"},"Reduction of adrenergic neurotransmission with clonidine aggravates spike-wave seizures and alters activity in the cortex and the thalamus in WAG/Rij rats.","15639550","Central Nervous System Diseases","D004832","Epilepsy, Absence","DTXSID6022846"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12677,D12677)","v":"Clonidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12677,M12677)","v":"Memory Disorders"},"D003000","Clonidine","4205-90-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12677,N12677)","v":"DTXSID6022846"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12677,J12677)","v":"3569890"},"Memory deficits associated with clonidine.","3569890","Neurologic Manifestations","D008569","Memory Disorders","DTXSID6022846"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12704,D12704)","v":"Clonidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12704,M12704)","v":"Sleep Wake Disorders"},"D003000","Clonidine","4205-90-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12704,N12704)","v":"DTXSID6022846"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12704,J12704)","v":"17572343"},"Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.","17572343","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID6022846"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12738,D12738)","v":"Clopenthixol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12738,M12738)","v":"Hallucinations"},"D003006","Clopenthixol","53772-83-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12738,N12738)","v":"DTXSID3048233"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12738,J12738)","v":"2535646"},"Oculogyric crises and schizophrenia.","2535646","Neurologic Manifestations","D006212","Hallucinations","DTXSID3048233"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12767,D12767)","v":"clopidogrel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12767,M12767)","v":"Cerebral Hemorrhage"},"C055162","clopidogrel","744256-69-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12767,N12767)","v":"DTXSID30225441"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12767,J12767)","v":"23275598"},"Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.","23275598","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID30225441"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12772,D12772)","v":"clopidogrel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12772,M12772)","v":"Cerebral Hemorrhage"},"C055162","clopidogrel","744256-69-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12772,N12772)","v":"DTXSID30225441"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12772,J12772)","v":"11793622"},"Intracerebral hemorrhage following possible interaction between celecoxib and clopidogrel.","11793622","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID30225441"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12806,D12806)","v":"clopidogrel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12806,M12806)","v":"Stroke"},"C055162","clopidogrel","744256-69-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12806,N12806)","v":"DTXSID30225441"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12806,J12806)","v":"23362935"},"Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.","23362935","Central Nervous System Diseases","D020521","Stroke","DTXSID30225441"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12835,D12835)","v":"closantel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12835,M12835)","v":"Blindness"},"C023342","closantel","57808-65-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12835,N12835)","v":"DTXSID6040662"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12835,J12835)","v":"8101337"},"Harmful human use of donated veterinary drug.","8101337","Neurologic Manifestations","D001766","Blindness","DTXSID6040662"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12865,D12865)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12865,M12865)","v":"Basal Ganglia Diseases"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12865,N12865)","v":"DTXSID5022855"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12865,J12865)","v":"8048341"},"The tolerability and efficacy of the atypical neuroleptic remoxipride compared with clozapine and haloperidol in acute schizophrenia.","8048341","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12874,D12874)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12874,M12874)","v":"Basal Ganglia Diseases"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12874,N12874)","v":"DTXSID5022855"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12874,J12874)","v":"8941170"},"Side effect profiles of new antipsychotic agents.","8941170","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12903,D12903)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12903,M12903)","v":"Basal Ganglia Diseases"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12903,N12903)","v":"DTXSID5022855"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12903,J12903)","v":"11812517"},"Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol.","11812517","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12933,D12933)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12933,M12933)","v":"Catatonia"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12933,N12933)","v":"DTXSID5022855"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12933,J12933)","v":"11441795"},"Suspected neuroleptic catatonia induced by clozapine.","11441795","Neurologic Manifestations","D002389","Catatonia","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12964,D12964)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12964,M12964)","v":"Delirium"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12964,N12964)","v":"DTXSID5022855"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12964,J12964)","v":"9228890"},"Clozapine withdrawal resulting in delirium with psychosis: a report of three cases.","9228890","Neurologic Manifestations","D003693","Delirium","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C12997,D12997)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L12997,M12997)","v":"Encephalitis"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N12997,N12997)","v":"DTXSID5022855"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J12997,J12997)","v":"27482955"},"Encephalitis With Antibodies to GluN2B During Administration of Clozapine.","27482955","Central Nervous System Diseases","D004660","Encephalitis","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13026,D13026)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13026,M13026)","v":"Epilepsy, Tonic-Clonic"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13026,N13026)","v":"DTXSID5022855"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13026,J13026)","v":"7884026"},"Seizures in two patients after the addition of lithium to a clozapine regimen.","7884026","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13032,D13032)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13032,M13032)","v":"Epilepsy, Tonic-Clonic"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13032,N13032)","v":"DTXSID5022855"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13032,J13032)","v":"23601795"},"The CYP1A2 -163C&gt;A polymorphism is associated with clozapine-induced generalized tonic-clonic seizures in Brazilian schizophrenia patients.","23601795","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13053,D13053)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13053,M13053)","v":"Hypokinesia"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13053,N13053)","v":"DTXSID5022855"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13053,J13053)","v":"28845867"},"Clozapine-related extrapyramidal side effects: a case report.","28845867","Neurologic Manifestations","D018476","Hypokinesia","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13093,D13093)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13093,M13093)","v":"Paralysis"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13093,N13093)","v":"DTXSID5022855"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13093,J13093)","v":"11125862"},"Hyperglycemia, hyperlipemia, and periodic paralysis: a case report of new side effects of clozapine.","11125862","Neurologic Manifestations","D010243","Paralysis","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13126,D13126)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13126,M13126)","v":"Seizures"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13126,N13126)","v":"DTXSID5022855"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13126,J13126)","v":"9990571"},"Grand mal seizures with liver toxicity in a case of clozapine treatment.","9990571","Neurologic Manifestations","D012640","Seizures","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13146,D13146)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13146,M13146)","v":"Seizures"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13146,N13146)","v":"DTXSID5022855"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13146,J13146)","v":"23996793"},"Use of anticonvulsants as prophylaxis for seizures in patients on clozapine.","23996793","Neurologic Manifestations","D012640","Seizures","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13161,D13161)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13161,M13161)","v":"Seizures"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13161,N13161)","v":"DTXSID5022855"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13161,J13161)","v":"1962511"},"[EEG changes and seizures with clozapine medication in schizophrenic adolescents].","1962511","Neurologic Manifestations","D012640","Seizures","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13194,D13194)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13194,M13194)","v":"Stuttering"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13194,N13194)","v":"DTXSID5022855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13194,J13194)","v":"15179972"},"Olanzapine- and clozapine-induced stuttering. A case series.","15179972","Neurologic Manifestations","D013342","Stuttering","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13214,D13214)","v":"Clozapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13214,M13214)","v":"Tremor"},"D003024","Clozapine","5786-21-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13214,N13214)","v":"DTXSID5022855"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13214,J13214)","v":"28845867"},"Clozapine-related extrapyramidal side effects: a case report.","28845867","Neurologic Manifestations","D014202","Tremor","DTXSID5022855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13255,D13255)","v":"Cobalt"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13255,M13255)","v":"Vision Disorders"},"D003035","Cobalt","7440-48-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13255,N13255)","v":"DTXSID1031040"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13255,J13255)","v":"25380579"},"The effect of cobalt on the human eye.","25380579","Neurologic Manifestations","D014786","Vision Disorders","DTXSID1031040"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13262,D13262)","v":"cobaltous chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13262,M13262)","v":"Hypoxia, Brain"},"C018021","cobaltous chloride","7646-79-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13262,N13262)","v":"DTXSID9040180"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13262,J13262)","v":"18635243"},"Cobalt chloride attenuates hypobaric hypoxia induced vascular leakage in rat brain: molecular mechanisms of action of cobalt chloride.","18635243","Central Nervous System Diseases","D002534","Hypoxia, Brain","DTXSID9040180"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13303,D13303)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13303,M13303)","v":"Brain Ischemia"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13303,N13303)","v":"DTXSID2038443"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13303,J13303)","v":"7801738"},"Neurovascular complications of cocaine.","7801738","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13323,D13323)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13323,M13323)","v":"Central Nervous System Diseases"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13323,N13323)","v":"DTXSID2038443"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13323,J13323)","v":"12935600"},"The neuropathology of cocaine abuse.","12935600","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13356,D13356)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13356,M13356)","v":"Cerebral Hemorrhage"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13356,N13356)","v":"DTXSID2038443"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13356,J13356)","v":"12762548"},"The analysis of an intracerebral hematoma for drugs of abuse.","12762548","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13371,D13371)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13371,M13371)","v":"Cerebrovascular Disorders"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13371,N13371)","v":"DTXSID2038443"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13371,J13371)","v":"8690958"},"How to have a stroke at an early age: the effects of crack, cocaine and other illicit drugs.","8690958","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13391,D13391)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13391,M13391)","v":"Confusion"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13391,N13391)","v":"DTXSID2038443"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13391,J13391)","v":"17566008"},"Odd behaviour in the airport arrivals lounge--what is the diagnosis?","17566008","Neurologic Manifestations","D003221","Confusion","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13424,D13424)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13424,M13424)","v":"Epilepsy"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13424,N13424)","v":"DTXSID2038443"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13424,J13424)","v":"2141159"},"[Neurologic complications of cocaine abuse].","2141159","Central Nervous System Diseases","D004827","Epilepsy","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13439,D13439)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13439,M13439)","v":"Gait Disorders, Neurologic"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13439,N13439)","v":"DTXSID2038443"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13439,J13439)","v":"22981082"},"[Reply].","22981082","Neurologic Manifestations","D020233","Gait Disorders, Neurologic","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13485,D13485)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13485,M13485)","v":"Ischemic Attack, Transient"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13485,N13485)","v":"DTXSID2038443"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13485,J13485)","v":"10079695"},"[Cerebral infarction caused after cocaine consumption].","10079695","Central Nervous System Diseases","D002546","Ischemic Attack, Transient","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13491,D13491)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13491,M13491)","v":"Language Development Disorders"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13491,N13491)","v":"DTXSID2038443"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13491,J13491)","v":"21256422"},"Estimated effects of in utero cocaine exposure on language development through early adolescence.","21256422","Neurologic Manifestations","D007805","Language Development Disorders","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13520,D13520)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13520,M13520)","v":"Memory Disorders"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13520,N13520)","v":"DTXSID2038443"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13520,J13520)","v":"11831501"},"Cognitive performance of current methamphetamine and cocaine abusers.","11831501","Neurologic Manifestations","D008569","Memory Disorders","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13553,D13553)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13553,M13553)","v":"Neural Tube Defects"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13553,N13553)","v":"DTXSID2038443"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13553,J13553)","v":"8059426"},"Role of oxygen free radicals in cocaine-induced vascular disruption in mice.","8059426","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13584,D13584)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13584,M13584)","v":"Seizures"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13584,N13584)","v":"DTXSID2038443"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13584,J13584)","v":"8613919"},"Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.","8613919","Neurologic Manifestations","D012640","Seizures","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13614,D13614)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13614,M13614)","v":"Seizures"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13614,N13614)","v":"DTXSID2038443"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13614,J13614)","v":"9610951"},"Brain beta-endorphin immunoreactivity as an index of cocaine and combined cocaine-ethanol toxicities.","9610951","Neurologic Manifestations","D012640","Seizures","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13617,D13617)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13617,M13617)","v":"Seizures"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13617,N13617)","v":"DTXSID2038443"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13617,J13617)","v":"3950828"},"Perinatal cerebral infarction and maternal cocaine use.","3950828","Neurologic Manifestations","D012640","Seizures","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13652,D13652)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13652,M13652)","v":"Seizures"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13652,N13652)","v":"DTXSID2038443"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13652,J13652)","v":"24739034"},"Presumptive cocaine toxicosis in 19 dogs: 2004-2012.","24739034","Neurologic Manifestations","D012640","Seizures","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13682,D13682)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13682,M13682)","v":"Seizures"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13682,N13682)","v":"DTXSID2038443"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13682,J13682)","v":"21481548"},"Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats.","21481548","Neurologic Manifestations","D012640","Seizures","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13711,D13711)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13711,M13711)","v":"Seizures"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13711,N13711)","v":"DTXSID2038443"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13711,J13711)","v":"12218537"},"Dexmedetomidine increases the cocaine seizure threshold in rats.","12218537","Neurologic Manifestations","D012640","Seizures","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13720,D13720)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13720,M13720)","v":"Seizures"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13720,N13720)","v":"DTXSID2038443"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13720,J13720)","v":"14745842"},"Microarray profile analysis of toxic cocaine-induced alterations in the expression of mouse brain gene sequences: a possible 'protective' effect of buprenorphine.","14745842","Neurologic Manifestations","D012640","Seizures","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13750,D13750)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13750,M13750)","v":"Stroke"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13750,N13750)","v":"DTXSID2038443"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13750,J13750)","v":"9195892"},"Magnesium protects against cocaine-induced hemorrhagic stroke in a rat model: a 31P-NMR in-vivo study.","9195892","Central Nervous System Diseases","D020521","Stroke","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13779,D13779)","v":"Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13779,M13779)","v":"Tremor"},"D003042","Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13779,N13779)","v":"DTXSID2038443"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13779,J13779)","v":"8516418"},"Motoric signs of CNS dysfunction associated with alcohol and cocaine withdrawal.","8516418","Neurologic Manifestations","D014202","Tremor","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13813,D13813)","v":"Codeine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13813,M13813)","v":"Lethargy"},"D003061","Codeine","14168-11-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13813,N13813)","v":"DTXSID10161797"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13813,J13813)","v":"21996159"},"Is it safe to use opioids for obstetric pain while breastfeeding?","21996159","Neurologic Manifestations","D053609","Lethargy","DTXSID10161797"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13840,D13840)","v":"Colchicine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13840,M13840)","v":"Ataxia"},"D003078","Colchicine","75520-89-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13840,N13840)","v":"DTXSID60226466"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13840,J13840)","v":"17505274"},"Acute colchicine intoxication in a child: a case report.","17505274","Neurologic Manifestations","D001259","Ataxia","DTXSID60226466"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13865,D13865)","v":"Colchicine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13865,M13865)","v":"Muscle Weakness"},"D003078","Colchicine","75520-89-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13865,N13865)","v":"DTXSID60226466"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13865,J13865)","v":"14744269"},"Severe respiratory muscle weakness related to long-term colchicine therapy.","14744269","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID60226466"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13879,D13879)","v":"Colchicine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13879,M13879)","v":"Muscular Diseases"},"D003078","Colchicine","75520-89-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13879,N13879)","v":"DTXSID60226466"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13879,J13879)","v":"15914514"},"Acute myopathy in a patient with concomitant use of pravastatin and colchicine.","15914514","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID60226466"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13908,D13908)","v":"Colchicine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13908,M13908)","v":"Myotonia"},"D003078","Colchicine","75520-89-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13908,N13908)","v":"DTXSID60226466"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13908,J13908)","v":"8965841"},"Myotonia in colchicine myoneuropathy.","8965841","Neurologic Manifestations","D009222","Myotonia","DTXSID60226466"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13933,D13933)","v":"Colchicine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13933,M13933)","v":"Neuromuscular Diseases"},"D003078","Colchicine","75520-89-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13933,N13933)","v":"DTXSID60226466"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13933,J13933)","v":"17421021"},"Severe colchicine-induced bilateral optico-neuromyopathy.","17421021","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID60226466"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13973,D13973)","v":"Copper"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13973,M13973)","v":"Acrodynia"},"D003300","Copper","7440-50-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13973,N13973)","v":"DTXSID2023985"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13973,J13973)","v":"4028035"},"Antitumor activity of trans-bis(salicylaldoximato)copper(II): a novel antiproliferative metal complex.","4028035","Neurotoxicity Syndromes","D000170","Acrodynia","DTXSID2023985"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C13976,D13976)","v":"Copper"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L13976,M13976)","v":"Alzheimer Disease"},"D003300","Copper","7440-50-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N13976,N13976)","v":"DTXSID2023985"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J13976,J13976)","v":"24051629"},"Alzheimer's disease linked to brain copper buildup.","24051629","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID2023985"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14026,D14026)","v":"Copper"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14026,M14026)","v":"Neurodegenerative Diseases"},"D003300","Copper","7440-50-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14026,N14026)","v":"DTXSID2023985"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14026,J14026)","v":"24470097"},"Copper: effects of deficiency and overload.","24470097","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID2023985"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14037,D14037)","v":"Copper"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14037,M14037)","v":"Peripheral Nervous System Diseases"},"D003300","Copper","7440-50-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14037,N14037)","v":"DTXSID2023985"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14037,J14037)","v":"3017104"},"Psychological performance in relation to central and peripheral nerve conduction in workers exposed to lead, zinc, and copper.","3017104","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID2023985"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14070,D14070)","v":"Crack Cocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14070,M14070)","v":"Ischemic Attack, Transient"},"D016578","Crack Cocaine","50-36-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14070,N14070)","v":"DTXSID2038443"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14070,J14070)","v":"7762031"},"Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine.","7762031","Central Nervous System Diseases","D002546","Ischemic Attack, Transient","DTXSID2038443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14094,D14094)","v":"crizotinib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14094,M14094)","v":"Brain Neoplasms"},"C551994","crizotinib",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14094,N14094)","v":"DTXSID701009329"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14094,J14094)","v":"26314227"},"Cystic Brain Metastases Occurring in Anaplastic Lymphoma Kinase Gene Rearranged Non-Small-Cell Lung Cancer Patients Receiving Crizotinib.","26314227","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID701009329"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14105,D14105)","v":"Cromolyn Sodium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14105,M14105)","v":"Unconsciousness"},"D004205","Cromolyn Sodium","16110-51-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14105,N14105)","v":"DTXSID4022860"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14105,J14105)","v":"9030998"},"Near-death asthmatic reaction induced by disodium cromoglycate.","9030998","Neurologic Manifestations","D014474","Unconsciousness","DTXSID4022860"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14138,D14138)","v":"Cuprizone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14138,M14138)","v":"Demyelinating Diseases"},"D003471","Cuprizone","370-81-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14138,N14138)","v":"DTXSID30861909"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14138,J14138)","v":"18938062"},"Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse.","18938062","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID30861909"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14158,D14158)","v":"Cuprizone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14158,M14158)","v":"Demyelinating Diseases"},"D003471","Cuprizone","370-81-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14158,N14158)","v":"DTXSID30861909"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14158,J14158)","v":"19084049"},"Demyelination of the hippocampus is prominent in the cuprizone model.","19084049","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID30861909"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14199,D14199)","v":"Cyclizine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14199,M14199)","v":"Hallucinations"},"D003501","Cyclizine","82-92-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14199,N14199)","v":"DTXSID4022864"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14199,J14199)","v":"1196654"},"[Cyclizine-intoxication in six children (author's transl)].","1196654","Neurologic Manifestations","D006212","Hallucinations","DTXSID4022864"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14214,D14214)","v":"cyclobenzaprine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14214,M14214)","v":"Acute Febrile Encephalopathy"},"C004704","cyclobenzaprine","303-53-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14214,N14214)","v":"DTXSID0046933"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14214,J14214)","v":"27940505"},"A Previously Healthy Adolescent With Acute Encephalopathy and Decorticate Posturing.","27940505","Central Nervous System Diseases","D000071072","Acute Febrile Encephalopathy","DTXSID0046933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14234,D14234)","v":"Cycloheximide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14234,M14234)","v":"Amnesia"},"D003513","Cycloheximide","66-81-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14234,N14234)","v":"DTXSID6024882"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14234,J14234)","v":"21535411"},"Tacrine and bis(7)-tacrine attenuate cycloheximide-induced amnesia in mice, with attention to acute toxicity.","21535411","Neurologic Manifestations","D000647","Amnesia","DTXSID6024882"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14267,D14267)","v":"Cyclopentolate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14267,M14267)","v":"Central Nervous System Diseases"},"D003519","Cyclopentolate","512-15-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14267,N14267)","v":"DTXSID3048528"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14267,J14267)","v":"10750080"},"Systemic toxicity with cyclopentolate eye drops.","10750080","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID3048528"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14307,D14307)","v":"Cyclophosphamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14307,M14307)","v":"Hydrocephalus"},"D003520","Cyclophosphamide","60030-72-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14307,N14307)","v":"DTXSID00208761"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14307,J14307)","v":"4435904"},"Cyclophosphamide induced hydrocephalus in chick embryos.","4435904","Central Nervous System Diseases","D006849","Hydrocephalus","DTXSID00208761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14328,D14328)","v":"Cyclophosphamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14328,M14328)","v":"Nervous System Diseases"},"D003520","Cyclophosphamide","60030-72-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14328,N14328)","v":"DTXSID00208761"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14328,J14328)","v":"4551303"},"Combination sequential chemotherapy in advanced reticulum cell sarcoma.","4551303","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID00208761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14335,D14335)","v":"Cyclophosphamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14335,M14335)","v":"Neural Tube Defects"},"D003520","Cyclophosphamide","60030-72-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14335,N14335)","v":"DTXSID00208761"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14335,J14335)","v":"11485512"},"What is proper treatment for Wegener granulomatosis?","11485512","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID00208761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14371,D14371)","v":"cypermethrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14371,M14371)","v":"Seizures"},"C017160","cypermethrin","65732-07-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14371,N14371)","v":"DTXSID8058247"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14371,J14371)","v":"7649605"},"Pharmacodynamic interactions of cypermethrin and centrally acting drugs in mice.","7649605","Neurologic Manifestations","D012640","Seizures","DTXSID8058247"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14396,D14396)","v":"Cyproterone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14396,M14396)","v":"Meningeal Neoplasms"},"D003534","Cyproterone","2098-66-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14396,N14396)","v":"DTXSID3022873"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14396,J14396)","v":"20053802"},"Abrupt regression of a meningioma after discontinuation of cyproterone treatment.","20053802","Nervous System Neoplasms","D008577","Meningeal Neoplasms","DTXSID3022873"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14429,D14429)","v":"Cytarabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14429,M14429)","v":"Ataxia"},"D003561","Cytarabine","69-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14429,N14429)","v":"DTXSID5024891"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14429,J14429)","v":"11442472"},"Acute cerebellar syndrome following intermediate-dose cytarabine.","11442472","Neurologic Manifestations","D001259","Ataxia","DTXSID5024891"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14439,D14439)","v":"Cytarabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14439,M14439)","v":"Brain Diseases"},"D003561","Cytarabine","69-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14439,N14439)","v":"DTXSID5024891"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14439,J14439)","v":"925819"},"Intracranial calcifications in childhood leukemia. An association with systemic chemotherapy.","925819","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID5024891"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14464,D14464)","v":"Cytarabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14464,M14464)","v":"Cerebellar Ataxia"},"D003561","Cytarabine","69-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14464,N14464)","v":"DTXSID5024891"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14464,J14464)","v":"6223674"},"High-dose cytosine arabinoside therapy for refractory leukemia.","6223674","Central Nervous System Diseases","D002524","Cerebellar Ataxia","DTXSID5024891"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14493,D14493)","v":"Cytarabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14493,M14493)","v":"Cerebellar Diseases"},"D003561","Cytarabine","69-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14493,N14493)","v":"DTXSID5024891"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14493,J14493)","v":"2245495"},"Cerebellar toxicity during cytarabine therapy associated with renal insufficiency.","2245495","Central Nervous System Diseases","D002526","Cerebellar Diseases","DTXSID5024891"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14532,D14532)","v":"Cytarabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14532,M14532)","v":"Muscle Spasticity"},"D003561","Cytarabine","69-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14532,N14532)","v":"DTXSID5024891"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14532,J14532)","v":"271037"},"Paraparesis following intrathecal cytosine arabinoside: a case report with neuropathologic findings.","271037","Neurologic Manifestations","D009128","Muscle Spasticity","DTXSID5024891"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14558,D14558)","v":"Cytarabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14558,M14558)","v":"Optic Neuritis"},"D003561","Cytarabine","69-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14558,N14558)","v":"DTXSID5024891"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14558,J14558)","v":"8504443"},"Encephalopathy, myelopathy, optic neuropathy, and anosmia associated with intravenous cytosine arabinoside.","8504443","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID5024891"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14584,D14584)","v":"Cytarabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14584,M14584)","v":"Polyradiculopathy"},"D003561","Cytarabine","69-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14584,N14584)","v":"DTXSID5024891"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14584,J14584)","v":"11754193"},"Ventral polyradiculopathy with pediatric acute lymphocytic leukemia.","11754193","Neuromuscular Diseases","D011128","Polyradiculopathy","DTXSID5024891"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14593,D14593)","v":"Cytarabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14593,M14593)","v":"Seizures, Febrile"},"D003561","Cytarabine","69-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14593,N14593)","v":"DTXSID5024891"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14593,J14593)","v":"276417"},"Seizures following intrathecal cytosine arabinoside in young children with acute lymphoblastic leukemia.","276417","Neurologic Manifestations","D003294","Seizures, Febrile","DTXSID5024891"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14626,D14626)","v":"Dabigatran"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14626,M14626)","v":"Cerebral Hemorrhage"},"D000069604","Dabigatran","211914-51-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14626,N14626)","v":"DTXSID50175419"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14626,J14626)","v":"24412008"},"[New anticoagulants: stop or more?].","24412008","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID50175419"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14652,D14652)","v":"Dabigatran"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14652,M14652)","v":"Intracranial Hemorrhages"},"D000069604","Dabigatran","211914-51-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14652,N14652)","v":"DTXSID50175419"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14652,J14652)","v":"26596056"},"[COMPARATIVE EFFECTIVENESS AND SAFETY OF NEW ORAL ANTICOAGULANTS AND WARFARIN IN PATIENTS WITH AGE-SPECIFIC NON-VALVULAR ATRIAL FIBRILLATION].","26596056","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID50175419"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14687,D14687)","v":"Dabigatran"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14687,M14687)","v":"Stroke"},"D000069604","Dabigatran","211914-51-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14687,N14687)","v":"DTXSID50175419"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14687,J14687)","v":"25251519"},"Additional events in the RE-LY trial.","25251519","Central Nervous System Diseases","D020521","Stroke","DTXSID50175419"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14716,D14716)","v":"Danazol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14716,M14716)","v":"Hearing Loss, Bilateral"},"D003613","Danazol","17230-88-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14716,N14716)","v":"DTXSID2022880"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14716,J14716)","v":"6726709"},"Bilateral sensorineural hearing loss from danazol therapy. A case report.","6726709","Neurologic Manifestations","D006312","Hearing Loss, Bilateral","DTXSID2022880"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14720,D14720)","v":"Danazol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14720,M14720)","v":"Muscle Cramp"},"D003613","Danazol","17230-88-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14720,N14720)","v":"DTXSID2022880"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14720,J14720)","v":"6453026"},"Combined laparoscopic surgery and danazol therapy for pelvic endometriosis.","6453026","Neurologic Manifestations","D009120","Muscle Cramp","DTXSID2022880"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14755,D14755)","v":"dapoxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14755,M14755)","v":"Syncope"},"C080598","dapoxetine","119356-77-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14755,N14755)","v":"DTXSID0057627"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14755,J14755)","v":"20455331"},"Dapoxetine. Premature ejaculation: not worth the risk.","20455331","Neurologic Manifestations","D013575","Syncope","DTXSID0057627"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14784,D14784)","v":"Dapsone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14784,M14784)","v":"Paresthesia"},"D003622","Dapsone","80-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14784,N14784)","v":"DTXSID4020371"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14784,J14784)","v":"10327817"},"Lessons to be learned: a case study approach: prolonged methaemoglobinaemia due to inadvertent dapsone poisoning; treatment with methylene blue and exchange transfusion.","10327817","Neurologic Manifestations","D010292","Paresthesia","DTXSID4020371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14813,D14813)","v":"Dapsone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14813,M14813)","v":"Vision Disorders"},"D003622","Dapsone","80-08-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14813,N14813)","v":"DTXSID4020371"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14813,J14813)","v":"25858136"},"Acute visual loss following dapsone-induced methemoglobinemia and hemolysis.","25858136","Neurologic Manifestations","D014786","Vision Disorders","DTXSID4020371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14823,D14823)","v":"DDT"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14823,M14823)","v":"Central Nervous System Diseases"},"D003634","DDT","50-29-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14823,N14823)","v":"DTXSID4020375"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14823,J14823)","v":"5664537"},"[Specific features of the neurologic symptomatology of chronic poisonings by DDT].","5664537","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID4020375"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14852,D14852)","v":"DDT"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14852,M14852)","v":"Tremor"},"D003634","DDT","50-29-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14852,N14852)","v":"DTXSID4020375"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14852,J14852)","v":"4791022"},"The effect of DDT on muscle dystrophy and its role in producing rest tremor.","4791022","Neurologic Manifestations","D014202","Tremor","DTXSID4020375"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14881,D14881)","v":"decamethrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14881,M14881)","v":"Peripheral Nervous System Diseases"},"C017180","decamethrin","52820-00-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14881,N14881)","v":"DTXSID8041822"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14881,J14881)","v":"6314930"},"Intoxication with four synthetic pyrethroids fails to show any correlation between neuromuscular dysfunction and neurobiochemical abnormalities in rats.","6314930","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8041822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14913,D14913)","v":"DEET"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14913,M14913)","v":"Nervous System Diseases"},"D003671","DEET","134-62-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14913,N14913)","v":"DTXSID2021995"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14913,J14913)","v":"8954750"},"Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos.","8954750","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2021995"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14933,D14933)","v":"deferiprone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14933,M14933)","v":"Muscle Hypertonia"},"C044919","deferiprone","30652-11-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14933,N14933)","v":"DTXSID6040666"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14933,J14933)","v":"26165407"},"Neurological Complications and Cataract in a Child With Thalassemia Major Treated With Deferiprone.","26165407","Neurologic Manifestations","D009122","Muscle Hypertonia","DTXSID6040666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14952,D14952)","v":"Deferoxamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14952,M14952)","v":"Hearing Disorders"},"D003676","Deferoxamine","70-51-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14952,N14952)","v":"DTXSID7022887"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14952,J14952)","v":"9106087"},"Desferrioxamine ototoxicity in an adult transfusion-dependent population.","9106087","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID7022887"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C14981,D14981)","v":"Deferoxamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L14981,M14981)","v":"Hearing Loss, Sensorineural"},"D003676","Deferoxamine","70-51-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N14981,N14981)","v":"DTXSID7022887"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J14981,J14981)","v":"2380834"},"Vision and hearing during deferoxamine therapy.","2380834","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID7022887"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15026,D15026)","v":"Deferoxamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15026,M15026)","v":"Vision Disorders"},"D003676","Deferoxamine","70-51-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15026,N15026)","v":"DTXSID7022887"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15026,J15026)","v":"6142370"},"Visual loss in patient on high-dose subcutaneous desferrioxamine.","6142370","Neurologic Manifestations","D014786","Vision Disorders","DTXSID7022887"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15042,D15042)","v":"Deoxycytidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15042,M15042)","v":"Brain Edema"},"D003841","Deoxycytidine","951-77-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15042,N15042)","v":"DTXSID70883620"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15042,J15042)","v":"24631316"},"Subacute reversible toxic encephalopathy related to treatment with capecitabine: a case report with literature review and discussion of pathophysiology.","24631316","Central Nervous System Diseases","D001929","Brain Edema","DTXSID70883620"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15075,D15075)","v":"Deoxycytidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15075,M15075)","v":"Nervous System Diseases"},"D003841","Deoxycytidine","951-77-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15075,N15075)","v":"DTXSID70883620"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15075,J15075)","v":"18701848"},"[Management of hand-foot syndrome in patient treated with capecitabine].","18701848","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID70883620"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15094,D15094)","v":"Deoxycytidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15094,M15094)","v":"Paresthesia"},"D003841","Deoxycytidine","951-77-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15094,N15094)","v":"DTXSID70883620"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15094,J15094)","v":"16188440"},"Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.","16188440","Neurologic Manifestations","D010292","Paresthesia","DTXSID70883620"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15110,D15110)","v":"Deoxycytidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15110,M15110)","v":"Peripheral Nervous System Diseases"},"D003841","Deoxycytidine","951-77-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15110,N15110)","v":"DTXSID70883620"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15110,J15110)","v":"15501952"},"A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer.","15501952","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID70883620"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15143,D15143)","v":"Desipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15143,M15143)","v":"Autonomic Nervous System Diseases"},"D003891","Desipramine","50-47-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15143,N15143)","v":"DTXSID6022896"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15143,J15143)","v":"6822481"},"Somatic symptoms in depression and antidepressants.","6822481","Autonomic Nervous System Diseases","D001342","Autonomic Nervous System Diseases","DTXSID6022896"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15162,D15162)","v":"Desipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15162,M15162)","v":"Inappropriate ADH Syndrome"},"D003891","Desipramine","50-47-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15162,N15162)","v":"DTXSID6022896"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15162,J15162)","v":"7413917"},"Inappropriate ADH secretion: the role of drug re-challenge.","7413917","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID6022896"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15204,D15204)","v":"Desvenlafaxine Succinate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15204,M15204)","v":"Inappropriate ADH Syndrome"},"D000069468","Desvenlafaxine Succinate",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15204,N15204)","v":"DTXSID70959511"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15204,J15204)","v":"24234943"},"Syndrome of inappropriate antidiuretic hormone secretion  associated with desvenlafaxine.","24234943","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID70959511"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15211,D15211)","v":"Deuterium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15211,M15211)","v":"Brain Edema"},"D003903","Deuterium","7782-39-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15211,N15211)","v":"DTXSID2064810"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15211,J15211)","v":"15843741"},"Pharmaco-thermodynamics of deuterium-induced oedema in living rat brain via 1H2O MRI: implications for boron neutron capture therapy of malignant brain tumours.","15843741","Central Nervous System Diseases","D001929","Brain Edema","DTXSID2064810"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15251,D15251)","v":"Dexamethasone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15251,M15251)","v":"Encephalomyelitis, Autoimmune, Experimental"},"D003907","Dexamethasone","50-02-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15251,N15251)","v":"DTXSID3020384"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15251,J15251)","v":"28078304"},"Prenatal Dexamethasone Exposure Increases the Susceptibility to Autoimmunity in Offspring Rats by Epigenetic Programing of Glucocorticoid Receptor.","28078304","Demyelinating Diseases","D004681","Encephalomyelitis, Autoimmune, Experimental","DTXSID3020384"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15272,D15272)","v":"Dexamethasone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15272,M15272)","v":"Leukoencephalopathies"},"D003907","Dexamethasone","50-02-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15272,N15272)","v":"DTXSID3020384"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15272,J15272)","v":"27658980"},"Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.","27658980","Central Nervous System Diseases","D056784","Leukoencephalopathies","DTXSID3020384"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15307,D15307)","v":"Dexamethasone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15307,M15307)","v":"Muscular Atrophy"},"D003907","Dexamethasone","50-02-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15307,N15307)","v":"DTXSID3020384"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15307,J15307)","v":"23297411"},"Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy.","23297411","Neurologic Manifestations","D009133","Muscular Atrophy","DTXSID3020384"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15333,D15333)","v":"Dexamethasone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15333,M15333)","v":"Muscular Diseases"},"D003907","Dexamethasone","50-02-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15333,N15333)","v":"DTXSID3020384"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15333,J15333)","v":"1866012"},"Steroid-induced weakness in patients with primary brain tumors.","1866012","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID3020384"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15340,D15340)","v":"Dexamethasone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15340,M15340)","v":"Muscular Diseases"},"D003907","Dexamethasone","50-02-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15340,N15340)","v":"DTXSID3020384"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15340,J15340)","v":"19681914"},"Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1--implications for steroid-induced myopathy.","19681914","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID3020384"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15371,D15371)","v":"Dexamethasone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15371,M15371)","v":"Sleep Initiation and Maintenance Disorders"},"D003907","Dexamethasone","50-02-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15371,N15371)","v":"DTXSID3020384"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15371,J15371)","v":"27189086"},"A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study.","27189086","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID3020384"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15401,D15401)","v":"Dexmedetomidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15401,M15401)","v":"Epilepsy"},"D020927","Dexmedetomidine","113775-47-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15401,N15401)","v":"DTXSID10873388"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15401,J15401)","v":"22727734"},"Epileptic seizures induced by dexmedetomidine in a neonate.","22727734","Central Nervous System Diseases","D004827","Epilepsy","DTXSID10873388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15434,D15434)","v":"Dextroamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15434,M15434)","v":"Sleep Initiation and Maintenance Disorders"},"D003913","Dextroamphetamine","51-63-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15434,N15434)","v":"DTXSID2057865"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15434,J15434)","v":"9455325"},"A prescription refill causes a problem.","9455325","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID2057865"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15439,D15439)","v":"Dextroamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15439,M15439)","v":"Sleep Initiation and Maintenance Disorders"},"D003913","Dextroamphetamine","51-63-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15439,N15439)","v":"DTXSID2057865"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15439,J15439)","v":"4504174"},"Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.","4504174","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID2057865"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15469,D15469)","v":"Dextromethorphan"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15469,M15469)","v":"Hallucinations"},"D003915","Dextromethorphan","125-71-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15469,N15469)","v":"DTXSID3022908"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15469,J15469)","v":"16318953"},"Dextromethorphan psychosis, dependence and physical withdrawal.","16318953","Neurologic Manifestations","D006212","Hallucinations","DTXSID3022908"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15502,D15502)","v":"Dextropropoxyphene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15502,M15502)","v":"Coma"},"D011431","Dextropropoxyphene","1639-60-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15502,N15502)","v":"DTXSID6048913"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15502,J15502)","v":"781967"},"[21 cases of dextro-propoxyphene poisoning alone or in combination with other drugs].","781967","Neurologic Manifestations","D003128","Coma","DTXSID6048913"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15532,D15532)","v":"Dextropropoxyphene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15532,M15532)","v":"Seizures"},"D011431","Dextropropoxyphene","1639-60-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15532,N15532)","v":"DTXSID6048913"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15532,J15532)","v":"17122535"},"Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity.","17122535","Neurologic Manifestations","D012640","Seizures","DTXSID6048913"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15563,D15563)","v":"Diatrizoate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15563,M15563)","v":"Nervous System Diseases"},"D003973","Diatrizoate","737-31-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15563,N15563)","v":"DTXSID7022912"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15563,J15563)","v":"4637752"},"[Contrast medium accidents in cerebral angiography].","4637752","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7022912"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15566,D15566)","v":"Diatrizoate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15566,M15566)","v":"Paresthesia"},"D003973","Diatrizoate","737-31-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15566,N15566)","v":"DTXSID7022912"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15566,J15566)","v":"3972525"},"Iohexol vs. diatrizoate. A comparative study in intravenous urography.","3972525","Neurologic Manifestations","D010292","Paresthesia","DTXSID7022912"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15600,D15600)","v":"Diatrizoate Meglumine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15600,M15600)","v":"Myoclonus"},"D003974","Diatrizoate Meglumine","131-49-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15600,N15600)","v":"DTXSID20897171"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15600,J15600)","v":"9199689"},"Inadvertent intraoperative myelography with Hypaque: case report and discussion.","9199689","Neurologic Manifestations","D009207","Myoclonus","DTXSID20897171"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15631,D15631)","v":"Diazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15631,M15631)","v":"Amnesia"},"D003975","Diazepam","439-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15631,N15631)","v":"DTXSID4020406"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15631,J15631)","v":"5105102"},"\"Pentazepam\": a supplementary agent.","5105102","Neurologic Manifestations","D000647","Amnesia","DTXSID4020406"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15652,D15652)","v":"Diazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15652,M15652)","v":"Ataxia"},"D003975","Diazepam","439-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15652,N15652)","v":"DTXSID4020406"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15652,J15652)","v":"5068376"},"[Treatment of anxiety neuroses in general practice using Lorazepam (Tavor)].","5068376","Neurologic Manifestations","D001259","Ataxia","DTXSID4020406"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15692,D15692)","v":"Diazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15692,M15692)","v":"Diplopia"},"D003975","Diazepam","439-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15692,N15692)","v":"DTXSID4020406"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15692,J15692)","v":"1969462"},"Divergence paralysis associated with the ingestion of diazepam.","1969462","Neurologic Manifestations","D004172","Diplopia","DTXSID4020406"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15699,D15699)","v":"Diazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15699,M15699)","v":"Dystonia"},"D003975","Diazepam","439-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15699,N15699)","v":"DTXSID4020406"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15699,J15699)","v":"18710159"},"[Unexpected adverse effect of benzodiazepines].","18710159","Neurologic Manifestations","D004421","Dystonia","DTXSID4020406"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15720,D15720)","v":"Diazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15720,M15720)","v":"Kernicterus"},"D003975","Diazepam","439-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15720,N15720)","v":"DTXSID4020406"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15720,J15720)","v":"5064911"},"Diazepam (Valium) for neonatal narcotic withdrawal: a question of safety.","5064911","Central Nervous System Diseases","D007647","Kernicterus","DTXSID4020406"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15760,D15760)","v":"Diazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15760,M15760)","v":"Ophthalmoplegia"},"D003975","Diazepam","439-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15760,N15760)","v":"DTXSID4020406"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15760,J15760)","v":"1969462"},"Divergence paralysis associated with the ingestion of diazepam.","1969462","Neurologic Manifestations","D009886","Ophthalmoplegia","DTXSID4020406"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15789,D15789)","v":"Diazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15789,M15789)","v":"Seizures"},"D003975","Diazepam","439-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15789,N15789)","v":"DTXSID4020406"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15789,J15789)","v":"9644553"},"[Effect of calcium channel blocker nifedipine on anxiety and seizure manifestations of abstinence syndrome in rats after withdrawal of long-term diazepam administration].","9644553","Neurologic Manifestations","D012640","Seizures","DTXSID4020406"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15813,D15813)","v":"Diazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15813,M15813)","v":"Sleep Wake Disorders"},"D003975","Diazepam","439-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15813,N15813)","v":"DTXSID4020406"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15813,J15813)","v":"4759814"},"[A new, particular syndrome induced by large doses of diazepam?].","4759814","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID4020406"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15828,D15828)","v":"Diazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15828,M15828)","v":"Status Epilepticus"},"D003975","Diazepam","439-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15828,N15828)","v":"DTXSID4020406"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15828,J15828)","v":"6781886"},"Anticonvulsant-induced status epilepticus in Lennox-Gastaut syndrome.","6781886","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID4020406"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15857,D15857)","v":"Diazinon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15857,M15857)","v":"Ocular Motility Disorders"},"D003976","Diazinon","333-41-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15857,N15857)","v":"DTXSID9020407"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15857,J15857)","v":"12700320"},"Supranuclear gaze palsy and opsoclonus after Diazinon poisoning.","12700320","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID9020407"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15881,D15881)","v":"Dibucaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15881,M15881)","v":"Phantom Limb"},"D003992","Dibucaine","85-79-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15881,N15881)","v":"DTXSID3045271"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15881,J15881)","v":"8447585"},"Return of the phantom.","8447585","Neurologic Manifestations","D010591","Phantom Limb","DTXSID3045271"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15918,D15918)","v":"Dichlorodiphenyl Dichloroethylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15918,M15918)","v":"Reflex, Abnormal"},"D003633","Dichlorodiphenyl Dichloroethylene","72-55-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15918,N15918)","v":"DTXSID9020374"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15918,J15918)","v":"3090217"},"Neonatal effects of transplacental exposure to PCBs and DDE.","3090217","Neurologic Manifestations","D012021","Reflex, Abnormal","DTXSID9020374"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15925,D15925)","v":"Dichlorvos"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15925,M15925)","v":"Ataxia"},"D004006","Dichlorvos","62-73-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15925,N15925)","v":"DTXSID5020449"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15925,J15925)","v":"1236842"},"Ataxia, depression, and dermatitis associated with the use of dichlorvos-impregnated collars in the laboratory cat.","1236842","Neurologic Manifestations","D001259","Ataxia","DTXSID5020449"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15974,D15974)","v":"Diclofenac"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15974,M15974)","v":"Epilepsies, Myoclonic"},"D004008","Diclofenac","15307-81-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15974,N15974)","v":"DTXSID30165212"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15974,J15974)","v":"15573326"},"[Myoclonias triggered by diclofenac].","15573326","Central Nervous System Diseases","D004831","Epilepsies, Myoclonic","DTXSID30165212"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C15986,D15986)","v":"Diclofenac"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L15986,M15986)","v":"Meningitis, Aseptic"},"D004008","Diclofenac","15307-81-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N15986,N15986)","v":"DTXSID30165212"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J15986,J15986)","v":"3706353"},"Adverse reactions to nonsteroidal anti-inflammatory drugs. Diclofenac compared with other nonsteroidal anti-inflammatory drugs.","3706353","Central Nervous System Diseases","D008582","Meningitis, Aseptic","DTXSID30165212"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16026,D16026)","v":"Didanosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16026,M16026)","v":"Peripheral Nervous System Diseases"},"D016049","Didanosine","69655-05-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16026,N16026)","v":"DTXSID6022927"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16026,J16026)","v":"1974724"},"The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles.","1974724","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID6022927"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16051,D16051)","v":"Dieldrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16051,M16051)","v":"Parkinson Disease, Secondary"},"D004026","Dieldrin","60-57-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16051,N16051)","v":"DTXSID9020453"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16051,J16051)","v":"28192238"},"Molecular networks related to the immune system and mitochondria are targets for the pesticide dieldrin in the zebrafish (Danio rerio) central nervous system.","28192238","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID9020453"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16054,D16054)","v":"Dieldrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16054,M16054)","v":"Parkinsonian Disorders"},"D004026","Dieldrin","60-57-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16054,N16054)","v":"DTXSID9020453"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16054,J16054)","v":"15987830"},"Dieldrin induces ubiquitin-proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death.","15987830","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID9020453"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16094,D16094)","v":"Diethylhexyl Phthalate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16094,M16094)","v":"Pituitary Neoplasms"},"D004051","Diethylhexyl Phthalate","117-81-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16094,N16094)","v":"DTXSID5020607"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16094,J16094)","v":"7161829"},"The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice.","7161829","Central Nervous System Diseases","D010911","Pituitary Neoplasms","DTXSID5020607"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16115,D16115)","v":"Diethylstilbestrol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16115,M16115)","v":"Intracranial Embolism and Thrombosis"},"D004054","Diethylstilbestrol","56-53-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16115,N16115)","v":"DTXSID3020465"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16115,J16115)","v":"3992737"},"Adverse effects during endocrine therapy for prostatic carcinoma with a high dose of estrogen.","3992737","Central Nervous System Diseases","D002542","Intracranial Embolism and Thrombosis","DTXSID3020465"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16148,D16148)","v":"Diethylstilbestrol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16148,M16148)","v":"Pituitary Neoplasms"},"D004054","Diethylstilbestrol","56-53-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16148,N16148)","v":"DTXSID3020465"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16148,J16148)","v":"10342874"},"Genetic bases of estrogen-induced pituitary growth in an intercross between the ACI and Copenhagen rat strains: dominant mendelian inheritance of the ACI phenotype.","10342874","Central Nervous System Diseases","D010911","Pituitary Neoplasms","DTXSID3020465"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16162,D16162)","v":"diethyltoluamide, ethanol, glycerin, terpineol, water drug combination"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16162,M16162)","v":"Seizures"},"C032866","diethyltoluamide, ethanol, glycerin, terpineol, water drug combination",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16162,N16162)","v":"DTXSID501009323"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16162,J16162)","v":"3690996"},"Insect-repellent-induced toxic encephalopathy in a child.","3690996","Neurologic Manifestations","D012640","Seizures","DTXSID501009323"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16183,D16183)","v":"Digitoxin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16183,M16183)","v":"Tremor"},"D004074","Digitoxin","71-63-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16183,N16183)","v":"DTXSID0022933"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16183,J16183)","v":"7146044"},"Effect of age, clonidine or propranolol on behavioral toxicity induced with digitoxin in mice.","7146044","Neurologic Manifestations","D014202","Tremor","DTXSID0022933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16216,D16216)","v":"Digoxin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16216,M16216)","v":"Delirium"},"D004077","Digoxin","20830-75-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16216,N16216)","v":"DTXSID5022934"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16216,J16216)","v":"1082701"},"Massive digoxin intoxication. Report of a case with serum digoxin level correlation.","1082701","Neurologic Manifestations","D003693","Delirium","DTXSID5022934"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16255,D16255)","v":"Digoxin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16255,M16255)","v":"Vision Disorders"},"D004077","Digoxin","20830-75-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16255,N16255)","v":"DTXSID5022934"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16255,J16255)","v":"857453"},"[Digitalis intoxication: specifity and significance of cardiac and extracardiac symptoms. part II. Patients with extracardiac symptoms of digitalis intoxications (author's transl)].","857453","Neurologic Manifestations","D014786","Vision Disorders","DTXSID5022934"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16277,D16277)","v":"Dihydroergotamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16277,M16277)","v":"Nervous System Diseases"},"D004087","Dihydroergotamine","511-12-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16277,N16277)","v":"DTXSID6045614"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16277,J16277)","v":"8777772"},"Onset of neurologic deficits after treatment with dihydroergotamine in a patient with sagittal sinus thrombosis.","8777772","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID6045614"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16284,D16284)","v":"Dihydroergotamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16284,M16284)","v":"Spasm"},"D004087","Dihydroergotamine","511-12-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16284,N16284)","v":"DTXSID6045614"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16284,J16284)","v":"3691005"},"Vascular spasm during heparin-dihydroergotamine prophylaxis.","3691005","Neurologic Manifestations","D013035","Spasm","DTXSID6045614"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16319,D16319)","v":"Diltiazem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16319,M16319)","v":"Delirium"},"D004110","Diltiazem","33286-22-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16319,N16319)","v":"DTXSID8040147"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16319,J16319)","v":"21112467"},"Case report: delirium due to a diltiazem-fentanyl CYP3A4 drug interaction.","21112467","Neurologic Manifestations","D003693","Delirium","DTXSID8040147"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16345,D16345)","v":"Diltiazem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16345,M16345)","v":"Psychomotor Disorders"},"D004110","Diltiazem","33286-22-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16345,N16345)","v":"DTXSID8040147"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16345,J16345)","v":"3410836"},"Diltiazem-lithium interaction: an opposing viewpoint.","3410836","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID8040147"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16378,D16378)","v":"Dimethoate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16378,M16378)","v":"Brain Edema"},"D004117","Dimethoate","60-51-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16378,N16378)","v":"DTXSID7020479"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16378,J16378)","v":"21417632"},"Escin attenuates cerebral edema induced by acute omethoate poisoning.","21417632","Central Nervous System Diseases","D001929","Brain Edema","DTXSID7020479"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16387,D16387)","v":"Dimethoate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16387,M16387)","v":"Nervous System Diseases"},"D004117","Dimethoate","60-51-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16387,N16387)","v":"DTXSID7020479"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16387,J16387)","v":"7316761"},"Enzyme studies with human and hen autopsy tissue suggest omethoate does not cause delayed neuropathy in man.","7316761","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7020479"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16413,D16413)","v":"Dimethyl Fumarate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16413,M16413)","v":"Leukoencephalopathy, Progressive Multifocal"},"D000069462","Dimethyl Fumarate","624-49-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16413,N16413)","v":"DTXSID4060787"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16413,J16413)","v":"23614605"},"Manufacturer's response to case reports of PML.","23614605","Central Nervous System Diseases","D007968","Leukoencephalopathy, Progressive Multifocal","DTXSID4060787"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16439,D16439)","v":"Dimethyl Sulfoxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16439,M16439)","v":"Hypoxia-Ischemia, Brain"},"D004121","Dimethyl Sulfoxide","67-68-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16439,N16439)","v":"DTXSID2021735"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16439,J16439)","v":"17664413"},"Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation.","17664413","Central Nervous System Diseases","D020925","Hypoxia-Ischemia, Brain","DTXSID2021735"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16474,D16474)","v":"Diphenhydramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16474,M16474)","v":"Coma"},"D004155","Diphenhydramine","88637-37-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16474,N16474)","v":"DTXSID80237211"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16474,J16474)","v":"3168512"},"Survival in complicated diphenhydramine overdose.","3168512","Neurologic Manifestations","D003128","Coma","DTXSID80237211"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16507,D16507)","v":"Diphenhydramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16507,M16507)","v":"Nervous System Diseases"},"D004155","Diphenhydramine","88637-37-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16507,N16507)","v":"DTXSID80237211"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16507,J16507)","v":"3974767"},"[Poisoning psychoses following suicide attempts with diphenhydramine].","3974767","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID80237211"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16532,D16532)","v":"Diphenhydramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16532,M16532)","v":"Status Epilepticus"},"D004155","Diphenhydramine","88637-37-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16532,N16532)","v":"DTXSID80237211"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16532,J16532)","v":"3168512"},"Survival in complicated diphenhydramine overdose.","3168512","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID80237211"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16542,D16542)","v":"diphenyldiselenide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16542,M16542)","v":"Seizures"},"C061132","diphenyldiselenide","1666-13-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16542,N16542)","v":"DTXSID6061864"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16542,J16542)","v":"20047088"},"Convulsant action of diphenyl diselenide in rat pups: measurement and correlation with plasma, liver and brain levels of compound.","20047088","Neurologic Manifestations","D012640","Seizures","DTXSID6061864"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16575,D16575)","v":"Dipyrone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16575,M16575)","v":"Vasospasm, Intracranial"},"D004177","Dipyrone","50567-35-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16575,N16575)","v":"DTXSID6044143"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16575,J16575)","v":"14606052"},"[Multifocal brain haemorrhage associated with migraine and medication abuse].","14606052","Central Nervous System Diseases","D020301","Vasospasm, Intracranial","DTXSID6044143"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16600,D16600)","v":"Disulfiram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16600,M16600)","v":"Brain Damage, Chronic"},"D004221","Disulfiram","97-77-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16600,N16600)","v":"DTXSID1021322"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16600,J16600)","v":"5809961"},"Acute disulfiram poisoning in a child.","5809961","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID1021322"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16636,D16636)","v":"Disulfiram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16636,M16636)","v":"Delirium"},"D004221","Disulfiram","97-77-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16636,N16636)","v":"DTXSID1021322"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16636,J16636)","v":"972549"},"Disulfiram-induced convulsions without challenge by alcohol.","972549","Neurologic Manifestations","D003693","Delirium","DTXSID1021322"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16665,D16665)","v":"Disulfiram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16665,M16665)","v":"Myoclonus"},"D004221","Disulfiram","97-77-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16665,N16665)","v":"DTXSID1021322"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16665,J16665)","v":"7705518"},"An unusual presentation of a disulfiram-alcohol reaction.","7705518","Neurologic Manifestations","D009207","Myoclonus","DTXSID1021322"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16693,D16693)","v":"Disulfiram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16693,M16693)","v":"Paralysis"},"D004221","Disulfiram","97-77-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16693,N16693)","v":"DTXSID1021322"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16693,J16693)","v":"222249"},"Neuropathy associated with disulfiram administration.","222249","Neurologic Manifestations","D010243","Paralysis","DTXSID1021322"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16704,D16704)","v":"Disulfiram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16704,M16704)","v":"Peripheral Nervous System Diseases"},"D004221","Disulfiram","97-77-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16704,N16704)","v":"DTXSID1021322"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16704,J16704)","v":"6245358"},"Peripheral neuropathy associated with disulfiram administration.","6245358","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID1021322"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16733,D16733)","v":"Disulfiram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16733,M16733)","v":"Peripheral Nervous System Diseases"},"D004221","Disulfiram","97-77-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16733,N16733)","v":"DTXSID1021322"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16733,J16733)","v":"203806"},"[Peripheral neurologic manifestations in conjunction with prolonged use of disulfiram].","203806","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID1021322"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16761,D16761)","v":"Disulfiram"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16761,M16761)","v":"Seizures"},"D004221","Disulfiram","97-77-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16761,N16761)","v":"DTXSID1021322"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16761,J16761)","v":"972549"},"Disulfiram-induced convulsions without challenge by alcohol.","972549","Neurologic Manifestations","D012640","Seizures","DTXSID1021322"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16794,D16794)","v":"Dizocilpine Maleate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16794,M16794)","v":"Amnesia"},"D016291","Dizocilpine Maleate","77086-21-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16794,N16794)","v":"DTXSID3048447"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16794,J16794)","v":"21473108"},"[Induction of amnesia induced by disturbance of memory consolidation by antagonists of glutamate or serotonin receptors will be suppressed by the protein synthesis inhibitor].","21473108","Neurologic Manifestations","D000647","Amnesia","DTXSID3048447"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16813,D16813)","v":"Dizocilpine Maleate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16813,M16813)","v":"Hyperkinesis"},"D016291","Dizocilpine Maleate","77086-21-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16813,N16813)","v":"DTXSID3048447"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16813,J16813)","v":"9369362"},"MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.","9369362","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID3048447"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16833,D16833)","v":"Dizocilpine Maleate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16833,M16833)","v":"Memory Disorders"},"D016291","Dizocilpine Maleate","77086-21-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16833,N16833)","v":"DTXSID3048447"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16833,J16833)","v":"17924525"},"A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats.","17924525","Neurologic Manifestations","D008569","Memory Disorders","DTXSID3048447"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16862,D16862)","v":"docetaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16862,M16862)","v":"Cerebral Infarction"},"C067311","docetaxel","114977-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16862,N16862)","v":"DTXSID0040464"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16862,J16862)","v":"21566436"},"[Evaluation of combination chemotherapy with oral S-1 administration followed by docetaxel by superselective intra-arterial infusion for patients with oral squamous cell carcinomas].","21566436","Central Nervous System Diseases","D002544","Cerebral Infarction","DTXSID0040464"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16881,D16881)","v":"docetaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16881,M16881)","v":"Nervous System Diseases"},"C067311","docetaxel","114977-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16881,N16881)","v":"DTXSID0040464"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16881,J16881)","v":"7918126"},"Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.","7918126","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0040464"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16901,D16901)","v":"docetaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16901,M16901)","v":"Paresthesia"},"C067311","docetaxel","114977-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16901,N16901)","v":"DTXSID0040464"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16901,J16901)","v":"7907667"},"Prevention of docetaxel-induced erythrodysesthesia with local hypothermia.","7907667","Neurologic Manifestations","D010292","Paresthesia","DTXSID0040464"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16930,D16930)","v":"docetaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16930,M16930)","v":"Peripheral Nervous System Diseases"},"C067311","docetaxel","114977-28-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16930,N16930)","v":"DTXSID0040464"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16930,J16930)","v":"10603043"},"Docetaxel neuropathy: a distal axonopathy.","10603043","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0040464"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16974,D16974)","v":"domoic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16974,M16974)","v":"Nervous System Diseases"},"C012301","domoic acid","14277-97-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16974,N16974)","v":"DTXSID20274180"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16974,J16974)","v":"9398488"},"Repeated independent exposures to domoic acid do not enhance symptomatic toxicity in outbred or seizure-sensitive inbred mice.","9398488","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID20274180"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C16991,D16991)","v":"domoic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L16991,M16991)","v":"Paralysis"},"C012301","domoic acid","14277-97-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N16991,N16991)","v":"DTXSID20274180"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J16991,J16991)","v":"10752872"},"Systemic administration of domoic acid-induced spinal cord lesions in neonatal rats.","10752872","Neurologic Manifestations","D010243","Paralysis","DTXSID20274180"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17024,D17024)","v":"Domperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17024,M17024)","v":"Basal Ganglia Diseases"},"D004294","Domperidone","57808-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17024,N17024)","v":"DTXSID1045116"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17024,J17024)","v":"3843241"},"Extrapyramidal dysfunction after domperidone.","3843241","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID1045116"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17042,D17042)","v":"Domperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17042,M17042)","v":"Hyperprolactinemia"},"D004294","Domperidone","57808-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17042,N17042)","v":"DTXSID1045116"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17042,J17042)","v":"16960712"},"Domperidone toxicity in an infant on maintenance haemodialysis.","16960712","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID1045116"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17059,D17059)","v":"donepezil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17059,M17059)","v":"Confusion"},"C076946","donepezil","120014-06-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17059,N17059)","v":"DTXSID8048317"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17059,J17059)","v":"24026732"},"Donepezil-induced confusional state in a patient with autopsy-proven behavioral-variant frontotemporal dementia.","24026732","Neurologic Manifestations","D003221","Confusion","DTXSID8048317"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17092,D17092)","v":"donepezil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17092,M17092)","v":"Spasm"},"C076946","donepezil","120014-06-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17092,N17092)","v":"DTXSID8048317"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17092,J17092)","v":"19949165"},"Safety and tolerability of donepezil in mild cognitive impairment: open-label extension study.","19949165","Neurologic Manifestations","D013035","Spasm","DTXSID8048317"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17110,D17110)","v":"Dopamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17110,M17110)","v":"Chorea"},"D004298","Dopamine","51-61-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17110,N17110)","v":"DTXSID6022420"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17110,J17110)","v":"15767637"},"Choreoathetosis with dopamine.","15767637","Central Nervous System Diseases","D002819","Chorea","DTXSID6022420"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17153,D17153)","v":"Doxepin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17153,M17153)","v":"Brain Diseases"},"D004316","Doxepin","1229-29-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17153,N17153)","v":"DTXSID8045145"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17153,J17153)","v":"20463135"},"Recurrent episodes of stroke-like symptoms due to accidental intoxication with doxepin.","20463135","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8045145"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17162,D17162)","v":"Doxepin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17162,M17162)","v":"Hallucinations"},"D004316","Doxepin","1229-29-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17162,N17162)","v":"DTXSID8045145"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17162,J17162)","v":"6963177"},"Doxepin and visual hallucinations.","6963177","Neurologic Manifestations","D006212","Hallucinations","DTXSID8045145"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17188,D17188)","v":"doxifluridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17188,M17188)","v":"Nervous System Diseases"},"C025034","doxifluridine","3094-09-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17188,N17188)","v":"DTXSID2022967"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17188,J17188)","v":"2941966"},"Wernicke-Korsakoff-like syndrome in patients with colorectal carcinoma treated with high-dose doxifluridine (5'-dFUrd).","2941966","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2022967"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17221,D17221)","v":"Doxorubicin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17221,M17221)","v":"Muscle Weakness"},"D004317","Doxorubicin","23214-92-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17221,N17221)","v":"DTXSID8021480"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17221,J17221)","v":"21171100"},"Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy.","21171100","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID8021480"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17255,D17255)","v":"Doxorubicin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17255,M17255)","v":"Paresthesia"},"D004317","Doxorubicin","23214-92-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17255,N17255)","v":"DTXSID8021480"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17255,J17255)","v":"11759299"},"Hand-foot syndrome.","11759299","Neurologic Manifestations","D010292","Paresthesia","DTXSID8021480"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17282,D17282)","v":"Doxorubicin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17282,M17282)","v":"Vision Disorders"},"D004317","Doxorubicin","23214-92-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17282,N17282)","v":"DTXSID8021480"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17282,J17282)","v":"1162754"},"[Description of a case of acute neurological toxicity after DTIC-adriamycin-vincristine therapy (author's transl)].","1162754","Neurologic Manifestations","D014786","Vision Disorders","DTXSID8021480"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17289,D17289)","v":"Doxycycline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17289,M17289)","v":"Intracranial Hypertension"},"D004318","Doxycycline","24390-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17289,N17289)","v":"DTXSID4041020"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17289,J17289)","v":"15210900"},"Doxycycline and intracranial hypertension.","15210900","Central Nervous System Diseases","D019586","Intracranial Hypertension","DTXSID4041020"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17319,D17319)","v":"Dronabinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17319,M17319)","v":"Catalepsy"},"D013759","Dronabinol","1972-08-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17319,N17319)","v":"DTXSID6021327"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17319,J17319)","v":"2897447"},"Inhibition of the cataleptic effect of tetrahydrocannabinol by other constituents of Cannabis sativa L.","2897447","Neurologic Manifestations","D002375","Catalepsy","DTXSID6021327"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17350,D17350)","v":"Dronabinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17350,M17350)","v":"Memory Disorders"},"D013759","Dronabinol","1972-08-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17350,N17350)","v":"DTXSID6021327"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17350,J17350)","v":"18029074"},"Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats.","18029074","Neurologic Manifestations","D008569","Memory Disorders","DTXSID6021327"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17383,D17383)","v":"Droperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17383,M17383)","v":"Athetosis"},"D004329","Droperidol","548-73-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17383,N17383)","v":"DTXSID6022973"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17383,J17383)","v":"653997"},"[Rare complication after fentanyl and droperidol administration to arrest renal colic].","653997","Neurologic Manifestations","D001264","Athetosis","DTXSID6022973"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17387,D17387)","v":"Droperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17387,M17387)","v":"Basal Ganglia Diseases"},"D004329","Droperidol","548-73-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17387,N17387)","v":"DTXSID6022973"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17387,J17387)","v":"8214563"},"Lack of extrapyramidal side-effects from droperidol in low dose.","8214563","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID6022973"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17418,D17418)","v":"Droperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17418,M17418)","v":"Muscle Rigidity"},"D004329","Droperidol","548-73-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17418,N17418)","v":"DTXSID6022973"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17418,J17418)","v":"4830297"},"Dangers of innovar.","4830297","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID6022973"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17451,D17451)","v":"Duloxetine Hydrochloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17451,M17451)","v":"Inappropriate ADH Syndrome"},"D000068736","Duloxetine Hydrochloride","136434-34-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17451,N17451)","v":"DTXSID9046443"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17451,J17451)","v":"16534127"},"Duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion and seizures.","16534127","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID9046443"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17480,D17480)","v":"Edetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17480,M17480)","v":"Seizures"},"D004492","Edetic Acid","76353-66-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17480,N17480)","v":"DTXSID20227212"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17480,J17480)","v":"4272892"},"The epileptogenic effects of Na2EDTA topical treatment of rat cerebral cortex.","4272892","Neurologic Manifestations","D012640","Seizures","DTXSID20227212"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17512,D17512)","v":"efavirenz"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17512,M17512)","v":"Central Nervous System Diseases"},"C098320","efavirenz","154598-52-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17512,N17512)","v":"DTXSID9046029"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17512,J17512)","v":"12187501"},"Safety and tolerance of efavirenz in different antiretroviral regimens: results from a national multicenter prospective study in 1,033 HIV-infected patients.","12187501","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID9046029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17532,D17532)","v":"efavirenz"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17532,M17532)","v":"Nervous System Diseases"},"C098320","efavirenz","154598-52-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17532,N17532)","v":"DTXSID9046029"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17532,J17532)","v":"10622041"},"Efavirenz: practicalities, considerations and new issues.","10622041","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID9046029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17547,D17547)","v":"efavirenz"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17547,M17547)","v":"Sleep Initiation and Maintenance Disorders"},"C098320","efavirenz","154598-52-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17547,N17547)","v":"DTXSID9046029"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17547,J17547)","v":"14727217"},"Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.","14727217","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID9046029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17580,D17580)","v":"EMLA"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17580,M17580)","v":"Epilepsy, Tonic-Clonic"},"C036626","EMLA","101362-25-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17580,N17580)","v":"DTXSID60893697"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17580,J17580)","v":"10607341"},"Adverse effects associated with EMLA cream used as topical anesthetic for the mechanical debridement of leg ulcers.","10607341","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID60893697"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17600,D17600)","v":"Endosulfan"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17600,M17600)","v":"Epilepsies, Partial"},"D004726","Endosulfan","115-29-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17600,N17600)","v":"DTXSID1020560"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17600,J17600)","v":"1593988"},"Proconvulsant activity of endosulfan in amygdala kindling.","1593988","Central Nervous System Diseases","D004828","Epilepsies, Partial","DTXSID1020560"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17641,D17641)","v":"Endrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17641,M17641)","v":"Seizures"},"D004732","Endrin","72-20-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17641,N17641)","v":"DTXSID6020561"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17641,J17641)","v":"3965780"},"Leads from the MMWR. Acute convulsions associated with endrin poisoning--Pakistan.","3965780","Neurologic Manifestations","D012640","Seizures","DTXSID6020561"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17648,D17648)","v":"Enflurane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17648,M17648)","v":"Epilepsy"},"D004737","Enflurane","13838-16-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17648,N17648)","v":"DTXSID1020562"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17648,J17648)","v":"95709"},"Local cerebral metabolism during enflurane anesthesia: identification of epileptogenic foci.","95709","Central Nervous System Diseases","D004827","Epilepsy","DTXSID1020562"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17693,D17693)","v":"Enoxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17693,M17693)","v":"Seizures"},"D015365","Enoxacin","74011-58-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17693,N17693)","v":"DTXSID5022984"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17693,J17693)","v":"11345761"},"[Convulsion following the combination of single preoperative oral administration of enoxacine and single postoperative intravenous administration of flurbiprofen axetil].","11345761","Neurologic Manifestations","D012640","Seizures","DTXSID5022984"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17709,D17709)","v":"Enoxaparin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17709,M17709)","v":"Hematoma, Subdural, Acute"},"D017984","Enoxaparin","679809-58-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17709,N17709)","v":"DTXSID0045969"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17709,J17709)","v":"21802883"},"Delayed subdural hematoma after receiving enoxaparin for prevention of thromboembolic events from high-risk surgery.","21802883","Trauma, Nervous System","D020199","Hematoma, Subdural, Acute","DTXSID0045969"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17738,D17738)","v":"enrofloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17738,M17738)","v":"Blindness"},"C052904","enrofloxacin","93106-60-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17738,N17738)","v":"DTXSID1045619"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17738,J17738)","v":"11842601"},"History and clinical signs.","11842601","Neurologic Manifestations","D001766","Blindness","DTXSID1045619"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17761,D17761)","v":"Ephedrine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17761,M17761)","v":"Cerebral Hemorrhage"},"D004809","Ephedrine","50-98-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17761,N17761)","v":"DTXSID1045825"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17761,J17761)","v":"12791938"},"Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs.","12791938","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID1045825"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17777,D17777)","v":"Ephedrine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17777,M17777)","v":"Hallucinations"},"D004809","Ephedrine","50-98-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17777,N17777)","v":"DTXSID1045825"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17777,J17777)","v":"6144900"},"Hallucinations in a child after drinking triprolidine/pseudoephedrine linctus.","6144900","Neurologic Manifestations","D006212","Hallucinations","DTXSID1045825"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17806,D17806)","v":"Ephedrine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17806,M17806)","v":"Paresis"},"D004809","Ephedrine","50-98-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17806,N17806)","v":"DTXSID1045825"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17806,J17806)","v":"17022787"},"TIA associated with over-the-counter cold preparation.","17022787","Neurologic Manifestations","D010291","Paresis","DTXSID1045825"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17829,D17829)","v":"Ephedrine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17829,M17829)","v":"Subarachnoid Hemorrhage"},"D004809","Ephedrine","50-98-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17829,N17829)","v":"DTXSID1045825"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17829,J17829)","v":"12791938"},"Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs.","12791938","Central Nervous System Diseases","D013345","Subarachnoid Hemorrhage","DTXSID1045825"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17867,D17867)","v":"Epinephrine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17867,M17867)","v":"Scotoma"},"D004837","Epinephrine","97289-42-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17867,N17867)","v":"DTXSID80242845"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17867,J17867)","v":"23839702"},"Acute macular neuroretinopathy following rhinosurgery.","23839702","Neurologic Manifestations","D012607","Scotoma","DTXSID80242845"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17881,D17881)","v":"Epinephrine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17881,M17881)","v":"Syncope"},"D004837","Epinephrine","97289-42-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17881,N17881)","v":"DTXSID80242845"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17881,J17881)","v":"5526412"},"Syncope in children following epinephrine.","5526412","Neurologic Manifestations","D013575","Syncope","DTXSID80242845"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17906,D17906)","v":"Ergonovine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17906,M17906)","v":"Spasm"},"D004874","Ergonovine","60-79-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17906,N17906)","v":"DTXSID8046323"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17906,J17906)","v":"6988081"},"The provocation of coronary artery spasm.","6988081","Neurologic Manifestations","D013035","Spasm","DTXSID8046323"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17935,D17935)","v":"Ergotamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17935,M17935)","v":"Hemiplegia"},"D004878","Ergotamine","113-15-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17935,N17935)","v":"DTXSID9043774"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17935,J17935)","v":"909345"},"[Carotid spasm with hemiparesis--complication after migraine treatment].","909345","Neurologic Manifestations","D006429","Hemiplegia","DTXSID9043774"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C17974,D17974)","v":"Ergotamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L17974,M17974)","v":"Vasospasm, Intracranial"},"D004878","Ergotamine","113-15-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N17974,N17974)","v":"DTXSID9043774"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J17974,J17974)","v":"11524501"},"Cerebral ergotism under treatment with ergotamine and ritonavir.","11524501","Central Nervous System Diseases","D020301","Vasospasm, Intracranial","DTXSID9043774"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18000,D18000)","v":"Erlotinib Hydrochloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18000,M18000)","v":"Stroke"},"D000069347","Erlotinib Hydrochloride","183319-69-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18000,N18000)","v":"DTXSID10171412"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18000,J18000)","v":"21675910"},"Erlotinib or gefitinib for non-small-cell lung cancer.","21675910","Central Nervous System Diseases","D020521","Stroke","DTXSID10171412"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18003,D18003)","v":"ertapenem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18003,M18003)","v":"Central Nervous System Diseases"},"C446479","ertapenem","153832-46-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18003,N18003)","v":"DTXSID50165456"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18003,J18003)","v":"25487647"},"The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in haemodialysis patients - case reports and literature reviews.","25487647","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID50165456"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18042,D18042)","v":"Erythromycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18042,M18042)","v":"Hearing Disorders"},"D004917","Erythromycin","114-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18042,N18042)","v":"DTXSID4022991"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18042,J18042)","v":"3494560"},"Changes in erythromycin pharmacokinetics induced by renal failure.","3494560","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID4022991"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18064,D18064)","v":"Erythromycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18064,M18064)","v":"Hearing Loss, Bilateral"},"D004917","Erythromycin","114-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18064,N18064)","v":"DTXSID4022991"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18064,J18064)","v":"8976138"},"[Erythromycin-induced hearing loss in a patient with Listeria monocytogenes meningo-ventriculitis].","8976138","Neurologic Manifestations","D006312","Hearing Loss, Bilateral","DTXSID4022991"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18097,D18097)","v":"Erythromycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18097,M18097)","v":"Ophthalmoplegia"},"D004917","Erythromycin","114-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18097,N18097)","v":"DTXSID4022991"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18097,J18097)","v":"1818551"},"Complete external ophthalmoplegia and asterixis with carbamazepine toxicity.","1818551","Neurologic Manifestations","D009886","Ophthalmoplegia","DTXSID4022991"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18110,D18110)","v":"Erythromycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18110,M18110)","v":"Trismus"},"D004917","Erythromycin","114-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18110,N18110)","v":"DTXSID4022991"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18110,J18110)","v":"589734"},"[Rare and unusual drug intolerances, apropos of 6 cases].","589734","Neurologic Manifestations","D014313","Trismus","DTXSID4022991"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18132,D18132)","v":"Etanidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18132,M18132)","v":"Nervous System Diseases"},"D017341","Etanidazole","22668-01-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18132,N18132)","v":"DTXSID8045434"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18132,J18132)","v":"8398704"},"Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide.","8398704","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8045434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18165,D18165)","v":"Ethacrynic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18165,M18165)","v":"Deafness"},"D004976","Ethacrynic Acid","6500-81-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18165,N18165)","v":"DTXSID10215320"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18165,J18165)","v":"1159337"},"Deafness. Review of intravenous ethacrynic acid.","1159337","Neurologic Manifestations","D003638","Deafness","DTXSID10215320"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18199,D18199)","v":"Ethacrynic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18199,M18199)","v":"Nystagmus, Pathologic"},"D004976","Ethacrynic Acid","6500-81-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18199,N18199)","v":"DTXSID10215320"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18199,J18199)","v":"5308658"},"Ethacrynic acid: its usefulness and untoward effects.","5308658","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID10215320"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18226,D18226)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18226,M18226)","v":"Color Vision Defects"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18226,N18226)","v":"DTXSID8023006"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18226,J18226)","v":"6980723"},"[Subjective color desaturation test in the diagnosis of the effects of ethambutol on the anterior optic tract].","6980723","Neurologic Manifestations","D003117","Color Vision Defects","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18255,D18255)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18255,M18255)","v":"Myositis"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18255,N18255)","v":"DTXSID8023006"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18255,J18255)","v":"18583892"},"Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs.","18583892","Neuromuscular Diseases","D009220","Myositis","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18261,D18261)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18261,M18261)","v":"Optic Atrophy"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18261,N18261)","v":"DTXSID8023006"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18261,J18261)","v":"7222808"},"[Ophthalmologic control examinations during therapy with ethambutol (author's transl)].","7222808","Cranial Nerve Diseases","D009896","Optic Atrophy","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18294,D18294)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18294,M18294)","v":"Optic Nerve Diseases"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18294,N18294)","v":"DTXSID8023006"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18294,J18294)","v":"18647459"},"Ethambutol-induced optical neuropathy: risk of overdosing in obese subjects.","18647459","Cranial Nerve Diseases","D009901","Optic Nerve Diseases","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18323,D18323)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18323,M18323)","v":"Optic Nerve Diseases"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18323,N18323)","v":"DTXSID8023006"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18323,J18323)","v":"15058748"},"Ethambutol-induced optic neuropathy in a patient with pituitary macroadenoma: case report.","15058748","Cranial Nerve Diseases","D009901","Optic Nerve Diseases","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18355,D18355)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18355,M18355)","v":"Optic Neuritis"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18355,N18355)","v":"DTXSID8023006"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18355,J18355)","v":"4530778"},"Experimental myelo-optico-neuropathy due to ethambutol.","4530778","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18362,D18362)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18362,M18362)","v":"Optic Neuritis"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18362,N18362)","v":"DTXSID8023006"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18362,J18362)","v":"4794562"},"[Optic neuritis caused by ethambutol].","4794562","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18387,D18387)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18387,M18387)","v":"Optic Neuritis"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18387,N18387)","v":"DTXSID8023006"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18387,J18387)","v":"554577"},"[Importance of early performance of the Farnsworth test in the course of anti-tubercular therapy with ethambutol].","554577","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18423,D18423)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18423,M18423)","v":"Peripheral Nervous System Diseases"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18423,N18423)","v":"DTXSID8023006"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18423,J18423)","v":"6248440"},"Ethambutol neurophathy: clinical and electroneuromyographic studies.","6248440","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18456,D18456)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18456,M18456)","v":"Vision Disorders"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18456,N18456)","v":"DTXSID8023006"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18456,J18456)","v":"7214635"},"[Ophthalmologic surveillance of patients treated with ethambutol].","7214635","Neurologic Manifestations","D014786","Vision Disorders","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18480,D18480)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18480,M18480)","v":"Vision Disorders"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18480,N18480)","v":"DTXSID8023006"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18480,J18480)","v":"3345472"},"Toxic ocular effects of ethambutol.","3345472","Neurologic Manifestations","D014786","Vision Disorders","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18491,D18491)","v":"Ethambutol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18491,M18491)","v":"Vision Disorders"},"D004977","Ethambutol","74-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18491,N18491)","v":"DTXSID8023006"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18491,J18491)","v":"4906373"},"Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.","4906373","Neurologic Manifestations","D014786","Vision Disorders","DTXSID8023006"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18524,D18524)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18524,M18524)","v":"Alcohol Withdrawal Delirium"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18524,N18524)","v":"DTXSID9020584"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18524,J18524)","v":"3665832"},"Alcohol withdrawal seizures.","3665832","Neurotoxicity Syndromes","D000430","Alcohol Withdrawal Delirium","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18548,D18548)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18548,M18548)","v":"Amnesia"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18548,N18548)","v":"DTXSID9020584"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18548,J18548)","v":"874187"},"Storage and retrieval processes of alcohol-induced amnesia.","874187","Neurologic Manifestations","D000647","Amnesia","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18585,D18585)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18585,M18585)","v":"Ataxia"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18585,N18585)","v":"DTXSID9020584"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18585,J18585)","v":"18940087"},"[Interoceptive and exteroceptive cues in the tolerance of the ethanol ataxic effect in rats].","18940087","Neurologic Manifestations","D001259","Ataxia","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18600,D18600)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18600,M18600)","v":"Ataxia"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18600,N18600)","v":"DTXSID9020584"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18600,J18600)","v":"11296488"},"Self-administration cues as signals: drug self-administration and tolerance.","11296488","Neurologic Manifestations","D001259","Ataxia","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18620,D18620)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18620,M18620)","v":"Brain Damage, Chronic"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18620,N18620)","v":"DTXSID9020584"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18620,J18620)","v":"6935917"},"Reversal of tolerance to ethanol--a possible consequence of ethanol brain damage.","6935917","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18653,D18653)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18653,M18653)","v":"Brain Edema"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18653,N18653)","v":"DTXSID9020584"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18653,J18653)","v":"16227640"},"Taurine prevents ethanol-induced alterations in lipids and ATPases in rat tissues.","16227640","Central Nervous System Diseases","D001929","Brain Edema","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18693,D18693)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18693,M18693)","v":"Chronobiology Disorders"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18693,N18693)","v":"DTXSID9020584"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18693,J18693)","v":"18313227"},"Acute ethanol modulates glutamatergic and serotonergic phase shifts of the mouse circadian clock in vitro.","18313227","Chronobiology Disorders","D021081","Chronobiology Disorders","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18714,D18714)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18714,M18714)","v":"Coma"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18714,N18714)","v":"DTXSID9020584"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18714,J18714)","v":"21246093"},"Evaluation of the neurological status in experimental acute alcohol intoxication.","21246093","Neurologic Manifestations","D003128","Coma","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18743,D18743)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18743,M18743)","v":"Demyelinating Diseases"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18743,N18743)","v":"DTXSID9020584"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18743,J18743)","v":"8113961"},"Potential neurotoxicity of the solvent vehicle for cyclosporine.","8113961","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18761,D18761)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18761,M18761)","v":"Epilepsy"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18761,N18761)","v":"DTXSID9020584"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18761,J18761)","v":"3665832"},"Alcohol withdrawal seizures.","3665832","Central Nervous System Diseases","D004827","Epilepsy","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18782,D18782)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18782,M18782)","v":"Facial Paralysis"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18782,N18782)","v":"DTXSID9020584"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18782,J18782)","v":"960426"},"[Peripheral paresis of the facial nerve after administration into the ear of alcoholic drugs in chronic purulent mesotympanitis, and therapeutic tactics in these cases].","960426","Neurologic Manifestations","D005158","Facial Paralysis","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18811,D18811)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18811,M18811)","v":"Holoprosencephaly"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18811,N18811)","v":"DTXSID9020584"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18811,J18811)","v":"1957260"},"Holoprosencephaly in a fetal macaque (Macaca nemestrina) following weekly exposure to ethanol.","1957260","Nervous System Malformations","D016142","Holoprosencephaly","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18829,D18829)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18829,M18829)","v":"Hyperkinesis"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18829,N18829)","v":"DTXSID9020584"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18829,J18829)","v":"2949158"},"Prenatal alcohol exposure and offspring hyperactivity: effects of para-chlorophenylalanine and methysergide.","2949158","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18850,D18850)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18850,M18850)","v":"Intracranial Embolism and Thrombosis"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18850,N18850)","v":"DTXSID9020584"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18850,J18850)","v":"10470837"},"Intratumoral ethanol injection.","10470837","Central Nervous System Diseases","D002542","Intracranial Embolism and Thrombosis","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18879,D18879)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18879,M18879)","v":"Memory Disorders"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18879,N18879)","v":"DTXSID9020584"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18879,J18879)","v":"8590611"},"Clinical physiological study of the therapeutic effects of phenytoin in acute alcohol withdrawal and the asthenic-autonomic syndrome in patients with chronic alcoholism.","8590611","Neurologic Manifestations","D008569","Memory Disorders","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18922,D18922)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18922,M18922)","v":"Memory Disorders"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18922,N18922)","v":"DTXSID9020584"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18922,J18922)","v":"22562040"},"Sensitivity of modified Biel-maze task, compared with Y-maze task, to measure spatial learning and memory deficits of ethanol teratogenicity in the guinea pig.","22562040","Neurologic Manifestations","D008569","Memory Disorders","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18940,D18940)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18940,M18940)","v":"Migraine Disorders"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18940,N18940)","v":"DTXSID9020584"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18940,J18940)","v":"47139"},"Letter: Stimulation of prostaglandin biosynthesis by capsaicin, ethanol, and tyramine.","47139","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18974,D18974)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18974,M18974)","v":"Muscular Diseases"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18974,N18974)","v":"DTXSID9020584"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18974,J18974)","v":"11331201"},"Alcohol myopathy: impairment of protein synthesis and translation initiation.","11331201","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C18979,D18979)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L18979,M18979)","v":"Muscular Diseases"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N18979,N18979)","v":"DTXSID9020584"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J18979,J18979)","v":"12885717"},"Influence of nutritional status on alcoholic myopathy.","12885717","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19008,D19008)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19008,M19008)","v":"Nervous System Malformations"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19008,N19008)","v":"DTXSID9020584"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19008,J19008)","v":"12460654"},"Second trimester prenatal alcohol exposure alters development of rat corpus callosum.","12460654","Nervous System Malformations","D009421","Nervous System Malformations","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19042,D19042)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19042,M19042)","v":"Nystagmus, Pathologic"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19042,N19042)","v":"DTXSID9020584"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19042,J19042)","v":"4549007"},"Vestibular and optokinetic responses to diazepam and alcohol.","4549007","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19069,D19069)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19069,M19069)","v":"Parkinson Disease, Secondary"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19069,N19069)","v":"DTXSID9020584"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19069,J19069)","v":"25451756"},"Modulatory effect of Decalepis hamiltonii on ethanol-induced toxicity in transgenic Drosophila model of Parkinson's disease.","25451756","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19102,D19102)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19102,M19102)","v":"Seizures"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19102,N19102)","v":"DTXSID9020584"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19102,J19102)","v":"6684796"},"Clonidine enhancement of ethanol withdrawal in mice.","6684796","Neurologic Manifestations","D012640","Seizures","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19110,D19110)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19110,M19110)","v":"Seizures"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19110,N19110)","v":"DTXSID9020584"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19110,J19110)","v":"6335250"},"Recognition and treatment of acute alcohol withdrawal syndromes.","6335250","Neurologic Manifestations","D012640","Seizures","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19137,D19137)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19137,M19137)","v":"Seizures"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19137,N19137)","v":"DTXSID9020584"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19137,J19137)","v":"9670216"},"Ethanol and neurotransmitter interactions--from molecular to integrative effects.","9670216","Neurologic Manifestations","D012640","Seizures","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19170,D19170)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19170,M19170)","v":"Seizures"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19170,N19170)","v":"DTXSID9020584"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19170,J19170)","v":"18045626"},"Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice.","18045626","Neurologic Manifestations","D012640","Seizures","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19203,D19203)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19203,M19203)","v":"Sensation Disorders"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19203,N19203)","v":"DTXSID9020584"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19203,J19203)","v":"26085462"},"Choline Ameliorates Deficits in Balance Caused by Acute Neonatal Ethanol Exposure.","26085462","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19231,D19231)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19231,M19231)","v":"Status Epilepticus"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19231,N19231)","v":"DTXSID9020584"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19231,J19231)","v":"1915171"},"Complex partial status epilepticus provoked by ingestion of alcohol: a case report.","1915171","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19238,D19238)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19238,M19238)","v":"Stupor"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19238,N19238)","v":"DTXSID9020584"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19238,J19238)","v":"26438669"},"Elemental mercury mixed with alcohol injected intravenously as a suicide attempt.","26438669","Neurologic Manifestations","D053608","Stupor","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19267,D19267)","v":"Ethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19267,M19267)","v":"Tremor"},"D000431","Ethanol","64-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19267,N19267)","v":"DTXSID9020584"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19267,J19267)","v":"11757994"},"Ethanol toxicosis from the ingestion of rotten apples by a dog.","11757994","Neurologic Manifestations","D014202","Tremor","DTXSID9020584"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19299,D19299)","v":"Ethchlorvynol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19299,M19299)","v":"Nystagmus, Pathologic"},"D004984","Ethchlorvynol","113-18-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19299,N19299)","v":"DTXSID2023010"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19299,J19299)","v":"1173627"},"Letter: Unusual nystagmus after ethchlorvynol use.","1173627","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID2023010"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19332,D19332)","v":"Ethosuximide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19332,M19332)","v":"Epilepsy, Tonic-Clonic"},"D005013","Ethosuximide","77-67-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19332,N19332)","v":"DTXSID7023019"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19332,J19332)","v":"2126870"},"[Possibility for provoking grand mal series in ethosuximide therapy--2 case reports].","2126870","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID7023019"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19360,D19360)","v":"ethylcholine aziridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19360,M19360)","v":"Alzheimer Disease"},"C044894","ethylcholine aziridinium","63918-38-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19360,N19360)","v":"DTXSID20213695"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19360,J19360)","v":"7897396"},"AF64A-induced brain damage and its relation to dementia.","7897396","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID20213695"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19367,D19367)","v":"ethylcholine aziridinium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19367,M19367)","v":"Learning Disorders"},"C044894","ethylcholine aziridinium","63918-38-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19367,N19367)","v":"DTXSID20213695"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19367,J19367)","v":"7865174"},"Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice.","7865174","Neurologic Manifestations","D007859","Learning Disorders","DTXSID20213695"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19391,D19391)","v":"Ethylene Glycol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19391,M19391)","v":"Blindness"},"D019855","Ethylene Glycol","107-21-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19391,N19391)","v":"DTXSID8020597"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19391,J19391)","v":"2870460"},"The alcohols: ethanol, methanol, isopropanol, ethylene glycol.","2870460","Neurologic Manifestations","D001766","Blindness","DTXSID8020597"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19428,D19428)","v":"Ethylene Glycol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19428,M19428)","v":"Delirium"},"D019855","Ethylene Glycol","107-21-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19428,N19428)","v":"DTXSID8020597"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19428,J19428)","v":"26230209"},"The Case | Elevated lactate and osmolar gap after levothyroxine overdose.","26230209","Neurologic Manifestations","D003693","Delirium","DTXSID8020597"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19461,D19461)","v":"Ethylene Glycol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19461,M19461)","v":"Seizures"},"D019855","Ethylene Glycol","107-21-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19461,N19461)","v":"DTXSID8020597"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19461,J19461)","v":"16226155"},"Ethylene glycol poisoning.","16226155","Neurologic Manifestations","D012640","Seizures","DTXSID8020597"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19480,D19480)","v":"Ethylene Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19480,M19480)","v":"Muscular Atrophy"},"D005027","Ethylene Oxide","75-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19480,N19480)","v":"DTXSID0020600"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19480,J19480)","v":"6298660"},"Ethylene oxide polyneuropathy.","6298660","Neurologic Manifestations","D009133","Muscular Atrophy","DTXSID0020600"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19496,D19496)","v":"Ethylene Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19496,M19496)","v":"Paralysis"},"D005027","Ethylene Oxide","75-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19496,N19496)","v":"DTXSID0020600"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19496,J19496)","v":"2772435"},"[Effects of inhalation of ethylene oxide on female rats].","2772435","Neurologic Manifestations","D010243","Paralysis","DTXSID0020600"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19529,D19529)","v":"Ethylmercuric Chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19529,M19529)","v":"Brain Diseases"},"D005034","Ethylmercuric Chloride","107-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19529,N19529)","v":"DTXSID9042128"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19529,J19529)","v":"6222453"},"[Aspects of occupational toxic encephalopathy caused by ethylmercury chloride].","6222453","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID9042128"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19548,D19548)","v":"Ethylnitrosourea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19548,M19548)","v":"Brain Neoplasms"},"D005038","Ethylnitrosourea","759-73-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19548,N19548)","v":"DTXSID8020593"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19548,J19548)","v":"7839836"},"Neuroblastic differentiation in ethyl-nitrosourea-induced brain tumors.","7839836","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID8020593"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19590,D19590)","v":"Ethylnitrosourea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19590,M19590)","v":"Microcephaly"},"D005038","Ethylnitrosourea","759-73-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19590,N19590)","v":"DTXSID8020593"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19590,J19590)","v":"1264354"},"[Protein biosynthesis in the brain of the offspring following transplacental administration of ethylnitrosourea (ENU) to female rats].","1264354","Nervous System Malformations","D008831","Microcephaly","DTXSID8020593"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19593,D19593)","v":"Ethylnitrosourea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19593,M19593)","v":"Nervous System Diseases"},"D005038","Ethylnitrosourea","759-73-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19593,N19593)","v":"DTXSID8020593"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19593,J19593)","v":"15170223"},"Three ENU-induced neurological mutations in the pore loop of sodium channel Scn8a (Na(v)1.6) and a genetically linked retinal mutation, rd13.","15170223","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8020593"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19641,D19641)","v":"Etidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19641,M19641)","v":"Seizures"},"D005041","Etidocaine","36637-18-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19641,N19641)","v":"DTXSID1023027"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19641,J19641)","v":"402143"},"Relation of etidocaine and bupivacaine toxicity to rate of infusion in rhesus monkeys.","402143","Neurologic Manifestations","D012640","Seizures","DTXSID1023027"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19658,D19658)","v":"etiracetam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19658,M19658)","v":"Delirium"},"C026098","etiracetam","33996-58-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19658,N19658)","v":"DTXSID5046510"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19658,J19658)","v":"20439066"},"Separate episodes of delirium associated with levetiracetam and amiodarone treatment in an elderly woman.","20439066","Neurologic Manifestations","D003693","Delirium","DTXSID5046510"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19687,D19687)","v":"etiracetam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19687,M19687)","v":"Myoclonus"},"C026098","etiracetam","33996-58-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19687,N19687)","v":"DTXSID5046510"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19687,J19687)","v":"22805231"},"Levetiracetam may worsen myoclonus in patients with juvenile myoclonic epilepsy:  case reports.","22805231","Neurologic Manifestations","D009207","Myoclonus","DTXSID5046510"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19709,D19709)","v":"Etomidate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19709,M19709)","v":"Brain Ischemia"},"D005045","Etomidate","33125-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19709,N19709)","v":"DTXSID5023033"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19709,J19709)","v":"8559304"},"Focal cerebral ischemia during anesthesia with etomidate, isoflurane, or thiopental: a comparison of the extent of cerebral injury.","8559304","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID5023033"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19726,D19726)","v":"Etomidate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19726,M19726)","v":"Myoclonus"},"D005045","Etomidate","33125-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19726,N19726)","v":"DTXSID5023033"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19726,J19726)","v":"6696228"},"The prevention of etomidate-induced myoclonus.","6696228","Neurologic Manifestations","D009207","Myoclonus","DTXSID5023033"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19761,D19761)","v":"Etomidate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19761,M19761)","v":"Myoclonus"},"D005045","Etomidate","33125-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19761,N19761)","v":"DTXSID5023033"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19761,J19761)","v":"24529669"},"Priming with atracurium efficiently suppresses etomidate-induced myoclonus.","24529669","Neurologic Manifestations","D009207","Myoclonus","DTXSID5023033"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19787,D19787)","v":"Etoposide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19787,M19787)","v":"Brain Edema"},"D005047","Etoposide","33419-42-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19787,N19787)","v":"DTXSID5023035"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19787,J19787)","v":"1432030"},"Effect of intracarotid infusion of etoposide with angiotensin II-induced hypertension on the blood-brain barrier and the brain tissue.","1432030","Central Nervous System Diseases","D001929","Brain Edema","DTXSID5023035"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19816,D19816)","v":"Eugenol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19816,M19816)","v":"Coma"},"D005054","Eugenol","97-53-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19816,N19816)","v":"DTXSID9020617"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19816,J19816)","v":"8215554"},"Near fatal ingestion of oil of cloves.","8215554","Neurologic Manifestations","D003128","Coma","DTXSID9020617"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19829,D19829)","v":"Ezetimibe"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19829,M19829)","v":"Muscular Diseases"},"D000069438","Ezetimibe","163222-33-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19829,N19829)","v":"DTXSID1044223"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19829,J19829)","v":"27039291"},"Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.","27039291","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID1044223"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19855,D19855)","v":"Famotidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19855,M19855)","v":"Epilepsy"},"D015738","Famotidine","76824-35-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19855,N19855)","v":"DTXSID5023039"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19855,J19855)","v":"12163986"},"H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures.","12163986","Central Nervous System Diseases","D004827","Epilepsy","DTXSID5023039"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19884,D19884)","v":"fenbufen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19884,M19884)","v":"Seizures"},"C010725","fenbufen","36330-85-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19884,N19884)","v":"DTXSID9023043"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19884,J19884)","v":"9623721"},"Role of nitric oxide in the convulsions following the coadministration of enoxacin with fenbufen in mice.","9623721","Neurologic Manifestations","D012640","Seizures","DTXSID9023043"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19922,D19922)","v":"Fenfluramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19922,M19922)","v":"Vertigo"},"D005277","Fenfluramine","37577-24-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19922,N19922)","v":"DTXSID60191009"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19922,J19922)","v":"1124579"},"[Treatment of obesity with fenfluramine].","1124579","Neurologic Manifestations","D014717","Vertigo","DTXSID60191009"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19949,D19949)","v":"Fenoterol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19949,M19949)","v":"Tremor"},"D005280","Fenoterol","1944-12-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19949,N19949)","v":"DTXSID5045419"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19949,J19949)","v":"7023862"},"Bronchodilator effects of nebulized fenoterol: a comparison with isoproterenol.","7023862","Neurologic Manifestations","D014202","Tremor","DTXSID5045419"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19952,D19952)","v":"Fenoterol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19952,M19952)","v":"Tremor"},"D005280","Fenoterol","1944-12-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19952,N19952)","v":"DTXSID5045419"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19952,J19952)","v":"2829953"},"Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.","2829953","Neurologic Manifestations","D014202","Tremor","DTXSID5045419"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C19990,D19990)","v":"Fentanyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L19990,M19990)","v":"Confusion"},"D005283","Fentanyl","990-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N19990,N19990)","v":"DTXSID80243933"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J19990,J19990)","v":"1267895"},"Reversal of Innovar-induced postanesthetic somnolence and disorientation with physostigmine.","1267895","Neurologic Manifestations","D003221","Confusion","DTXSID80243933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20013,D20013)","v":"Fentanyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20013,M20013)","v":"Dystonia"},"D005283","Fentanyl","990-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20013,N20013)","v":"DTXSID80243933"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20013,J20013)","v":"9557916"},"Dystonic movements following thalamonal and alfentanil induction--a case report.","9557916","Neurologic Manifestations","D004421","Dystonia","DTXSID80243933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20046,D20046)","v":"Fentanyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20046,M20046)","v":"Hyperalgesia"},"D005283","Fentanyl","990-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20046,N20046)","v":"DTXSID80243933"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20046,J20046)","v":"19697012"},"Magnesium modifies fentanyl-induced local antinociception and hyperalgesia.","19697012","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID80243933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20058,D20058)","v":"Fentanyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20058,M20058)","v":"Intracranial Hypertension"},"D005283","Fentanyl","990-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20058,N20058)","v":"DTXSID80243933"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20058,J20058)","v":"25233812"},"When used for sedation, does ketamine increase intracranial pressure more than fentanyl or sufentanil?","25233812","Central Nervous System Diseases","D019586","Intracranial Hypertension","DTXSID80243933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20081,D20081)","v":"Fentanyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20081,M20081)","v":"Muscle Rigidity"},"D005283","Fentanyl","990-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20081,N20081)","v":"DTXSID80243933"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20081,J20081)","v":"8577396"},"Involvement of potassium and calcium channels at the locus coeruleus in fentanyl-induced muscular rigidity in the rat.","8577396","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID80243933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20110,D20110)","v":"Fentanyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20110,M20110)","v":"Muscle Rigidity"},"D005283","Fentanyl","990-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20110,N20110)","v":"DTXSID80243933"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20110,J20110)","v":"2499224"},"Fentanyl-induced muscle rigidity in unanesthetized and ketamine- or thiopental-anesthetized rats.","2499224","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID80243933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20142,D20142)","v":"Fentanyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20142,M20142)","v":"Reflex, Abnormal"},"D005283","Fentanyl","990-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20142,N20142)","v":"DTXSID80243933"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20142,J20142)","v":"5165426"},"Effects of Innovar and innovar plus nitrous oxide on muscle tone and \"H\" reflex.","5165426","Neurologic Manifestations","D012021","Reflex, Abnormal","DTXSID80243933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20175,D20175)","v":"Fentanyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20175,M20175)","v":"Spasm"},"D005283","Fentanyl","990-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20175,N20175)","v":"DTXSID80243933"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20175,J20175)","v":"7196706"},"Incidence of choledochoduodenal sphincter spasm during fentanyl-supplemented anesthesia.","7196706","Neurologic Manifestations","D013035","Spasm","DTXSID80243933"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20203,D20203)","v":"Fenthion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20203,M20203)","v":"Paralysis"},"D005284","Fenthion","55-38-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20203,N20203)","v":"DTXSID8020620"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20203,J20203)","v":"1665780"},"The neurophysiologic examination in organophosphate ester poisoning. Case report and review of the literature.","1665780","Neurologic Manifestations","D010243","Paralysis","DTXSID8020620"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20210,D20210)","v":"fenvalerate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20210,M20210)","v":"Paresthesia"},"C017690","fenvalerate","66267-77-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20210,N20210)","v":"DTXSID3058450"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20210,J20210)","v":"6526564"},"Inhibition of cutaneous paresthesia resulting from synthetic pyrethroid exposure.","6526564","Neurologic Manifestations","D010292","Paresthesia","DTXSID3058450"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20243,D20243)","v":"Fingolimod Hydrochloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20243,M20243)","v":"Brain Neoplasms"},"D000068876","Fingolimod Hydrochloride","162359-56-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20243,N20243)","v":"DTXSID00167364"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20243,J20243)","v":"26970935"},"Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.","26970935","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID00167364"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20271,D20271)","v":"Flecainide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20271,M20271)","v":"Dystonia"},"D005424","Flecainide","54143-56-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20271,N20271)","v":"DTXSID8020626"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20271,J20271)","v":"1557067"},"Persistent dystonia possibly induced by flecainide.","1557067","Neurologic Manifestations","D004421","Dystonia","DTXSID8020626"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20304,D20304)","v":"Floxuridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20304,M20304)","v":"Central Nervous System Diseases"},"D005467","Floxuridine","50-91-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20304,N20304)","v":"DTXSID3023057"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20304,J20304)","v":"2942245"},"Phase II clinical evaluation of doxifluridine.","2942245","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID3023057"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20311,D20311)","v":"Floxuridine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20311,M20311)","v":"Nystagmus, Pathologic"},"D005467","Floxuridine","50-91-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20311,N20311)","v":"DTXSID3023057"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20311,J20311)","v":"15184640"},"Doxifluridine-induced neurotoxicity with normal dihydropyrimidine dehydrogenase activity.","15184640","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID3023057"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20360,D20360)","v":"fludarabine phosphate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20360,M20360)","v":"Blindness"},"C042382","fludarabine phosphate","75607-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20360,N20360)","v":"DTXSID2023060"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20360,J20360)","v":"2428488"},"Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study.","2428488","Neurologic Manifestations","D001766","Blindness","DTXSID2023060"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20372,D20372)","v":"Flumazenil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20372,M20372)","v":"Amnesia"},"D005442","Flumazenil","78755-81-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20372,N20372)","v":"DTXSID2023064"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20372,J20372)","v":"3120485"},"Antagonism of diazepam-induced sedative effects by Ro15-1788 in patients after surgery under lumbar epidural block. A double-blind placebo-controlled investigation of efficacy and safety.","3120485","Neurologic Manifestations","D000647","Amnesia","DTXSID2023064"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20405,D20405)","v":"Flumazenil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20405,M20405)","v":"Tremor"},"D005442","Flumazenil","78755-81-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20405,N20405)","v":"DTXSID2023064"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20405,J20405)","v":"9023073"},"Intrathecally administered flumazenil and PK 11195 precipitate abstinence syndrome in freely moving diazepam dependent rats.","9023073","Neurologic Manifestations","D014202","Tremor","DTXSID2023064"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20428,D20428)","v":"Flunarizine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20428,M20428)","v":"Catalepsy"},"D005444","Flunarizine","30484-77-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20428,N20428)","v":"DTXSID80184554"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20428,J20428)","v":"15290004"},"Atypical antipsychotic profile of flunarizine in animal models.","15290004","Neurologic Manifestations","D002375","Catalepsy","DTXSID80184554"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20440,D20440)","v":"Flunarizine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20440,M20440)","v":"Parkinson Disease, Secondary"},"D005444","Flunarizine","30484-77-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20440,N20440)","v":"DTXSID80184554"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20440,J20440)","v":"7503767"},"Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine.","7503767","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID80184554"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20480,D20480)","v":"Flunitrazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20480,M20480)","v":"Amnesia, Anterograde"},"D005445","Flunitrazepam","1622-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20480,N20480)","v":"DTXSID7023065"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20480,J20480)","v":"12108561"},"Violent behavior, impulsive decision-making, and anterograde amnesia while intoxicated with flunitrazepam and alcohol or other drugs: a case study in forensic psychiatric patients.","12108561","Neurologic Manifestations","D020324","Amnesia, Anterograde","DTXSID7023065"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20501,D20501)","v":"Flunitrazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20501,M20501)","v":"Epilepsy, Tonic-Clonic"},"D005445","Flunitrazepam","1622-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20501,N20501)","v":"DTXSID7023065"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20501,J20501)","v":"10706979"},"Convulsive status epilepticus following abrupt high-dose benzodiazepine discontinuation.","10706979","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID7023065"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20534,D20534)","v":"Fluorine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20534,M20534)","v":"Nervous System Diseases"},"D005461","Fluorine","7782-41-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20534,N20534)","v":"DTXSID3024106"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20534,J20534)","v":"4839908"},"[Occupational pathology of the nervous system in welders working with flux].","4839908","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID3024106"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20548,D20548)","v":"fluoroacetic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20548,M20548)","v":"Seizures"},"C014815","fluoroacetic acid","63905-88-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20548,N20548)","v":"DTXSID60213553"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20548,J20548)","v":"2633850"},"Is monofluoracetic acid the active neurotoxic principle in Palicourea marcgravii (St. Hill) leaves?","2633850","Neurologic Manifestations","D012640","Seizures","DTXSID60213553"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20569,D20569)","v":"Fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20569,M20569)","v":"Brain Diseases"},"D005472","Fluorouracil","51-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20569,N20569)","v":"DTXSID2020634"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20569,J20569)","v":"7858459"},"Acute confusion induced by a high-dose infusion of 5-fluorouracil and folinic acid.","7858459","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2020634"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20602,D20602)","v":"Fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20602,M20602)","v":"Cerebellar Ataxia"},"D005472","Fluorouracil","51-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20602,N20602)","v":"DTXSID2020634"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20602,J20602)","v":"9528059"},"[Acute cerebellar syndrome due to 5-fluorouracil].","9528059","Central Nervous System Diseases","D002524","Cerebellar Ataxia","DTXSID2020634"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20641,D20641)","v":"Fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20641,M20641)","v":"Encephalomalacia"},"D005472","Fluorouracil","51-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20641,N20641)","v":"DTXSID2020634"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20641,J20641)","v":"11734966"},"Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy.","11734966","Central Nervous System Diseases","D004678","Encephalomalacia","DTXSID2020634"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20663,D20663)","v":"Fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20663,M20663)","v":"Leukoencephalopathy, Progressive Multifocal"},"D005472","Fluorouracil","51-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20663,N20663)","v":"DTXSID2020634"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20663,J20663)","v":"9296206"},"Multifocal inflammatory leukoencephalopathy after fluorouracil and levamisole therapy for colon cancer.","9296206","Central Nervous System Diseases","D007968","Leukoencephalopathy, Progressive Multifocal","DTXSID2020634"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20692,D20692)","v":"Fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20692,M20692)","v":"Nervous System Neoplasms"},"D005472","Fluorouracil","51-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20692,N20692)","v":"DTXSID2020634"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20692,J20692)","v":"7309284"},"Carcinogenic activity in rats of combined treatment with cyclophosphamide, methotrexate and 5-fluorouracil.","7309284","Nervous System Neoplasms","D009423","Nervous System Neoplasms","DTXSID2020634"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20709,D20709)","v":"Fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20709,M20709)","v":"Paresthesia"},"D005472","Fluorouracil","51-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20709,N20709)","v":"DTXSID2020634"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20709,J20709)","v":"17637558"},"[A case of severe hand-foot syndrome caused by capecitabine].","17637558","Neurologic Manifestations","D010292","Paresthesia","DTXSID2020634"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20731,D20731)","v":"Fluorouracil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20731,M20731)","v":"Seizures"},"D005472","Fluorouracil","51-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20731,N20731)","v":"DTXSID2020634"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20731,J20731)","v":"5535078"},"The acute cerebellar syndrome in 5-fluorouracil chemotherapy: a manifestation of fluoroacetate intoxication.","5535078","Neurologic Manifestations","D012640","Seizures","DTXSID2020634"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20760,D20760)","v":"Fluoxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20760,M20760)","v":"Basal Ganglia Diseases"},"D005473","Fluoxetine","59333-67-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20760,N20760)","v":"DTXSID7020635"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20760,J20760)","v":"8379573"},"Serotonin syndrome produced by a combination of fluoxetine and lithium.","8379573","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID7020635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20777,D20777)","v":"Fluoxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20777,M20777)","v":"Basal Ganglia Diseases"},"D005473","Fluoxetine","59333-67-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20777,N20777)","v":"DTXSID7020635"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20777,J20777)","v":"1407229"},"[Pharmacotoxic psychosis and extrapyramidal motor syndrome. A case of acute adverse effect of fluoxetine and flupenthixol].","1407229","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID7020635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20799,D20799)","v":"Fluoxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20799,M20799)","v":"Delirium"},"D005473","Fluoxetine","59333-67-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20799,N20799)","v":"DTXSID7020635"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20799,J20799)","v":"17110836"},"Delirium associated with concomitant use of low-dose bupropion sustained release and fluoxetine.","17110836","Neurologic Manifestations","D003693","Delirium","DTXSID7020635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20829,D20829)","v":"Fluoxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20829,M20829)","v":"Epilepsy, Tonic-Clonic"},"D005473","Fluoxetine","59333-67-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20829,N20829)","v":"DTXSID7020635"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20829,J20829)","v":"9803888"},"Tonic clonic seizures and tachycardia induced by fluoxetine (Prozac) overdose.","9803888","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID7020635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20860,D20860)","v":"Fluoxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20860,M20860)","v":"Inappropriate ADH Syndrome"},"D005473","Fluoxetine","59333-67-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20860,N20860)","v":"DTXSID7020635"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20860,J20860)","v":"8146848"},"[Hyponatremia caused by inappropriate antidiuretic hormone secretion syndrome during treatment with fluoxetine].","8146848","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID7020635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20889,D20889)","v":"Fluoxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20889,M20889)","v":"Migraine Disorders"},"D005473","Fluoxetine","59333-67-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20889,N20889)","v":"DTXSID7020635"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20889,J20889)","v":"7836342"},"Fluoxetine and sumatriptan: possibly a counterproductive combination.","7836342","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID7020635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20922,D20922)","v":"Fluoxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20922,M20922)","v":"Parkinson Disease, Secondary"},"D005473","Fluoxetine","59333-67-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20922,N20922)","v":"DTXSID7020635"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20922,J20922)","v":"7997141"},"[Exacerbation of parkinsonism caused by fluoxetine].","7997141","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID7020635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20928,D20928)","v":"Fluoxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20928,M20928)","v":"Polyradiculoneuropathy"},"D005473","Fluoxetine","59333-67-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20928,N20928)","v":"DTXSID7020635"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20928,J20928)","v":"2531772"},"The specificity of the zimelidine reaction.","2531772","Demyelinating Diseases","D011129","Polyradiculoneuropathy","DTXSID7020635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20957,D20957)","v":"Fluoxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20957,M20957)","v":"Sensation Disorders"},"D005473","Fluoxetine","59333-67-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20957,N20957)","v":"DTXSID7020635"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20957,J20957)","v":"10755087"},"Fluoxetine-induced anaesthesia of vagina and nipples.","10755087","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID7020635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C20990,D20990)","v":"Fluoxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L20990,M20990)","v":"Stuttering"},"D005473","Fluoxetine","59333-67-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N20990,N20990)","v":"DTXSID7020635"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J20990,J20990)","v":"2298709"},"Fluoxetine-induced stuttering.","2298709","Neurologic Manifestations","D013342","Stuttering","DTXSID7020635"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21018,D21018)","v":"Flupenthixol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21018,M21018)","v":"Basal Ganglia Diseases"},"D005475","Flupenthixol","2709-56-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21018,N21018)","v":"DTXSID3058749"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21018,J21018)","v":"7816158"},"[Tardive dystonia. A rare neuroleptic-induced disease picture].","7816158","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID3058749"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21051,D21051)","v":"Fluphenazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21051,M21051)","v":"Basal Ganglia Diseases"},"D005476","Fluphenazine","69-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21051,N21051)","v":"DTXSID2023068"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21051,J21051)","v":"6779147"},"[Fluspirilen and fluphenazine in schizophrenic patients. Comparative study].","6779147","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID2023068"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21058,D21058)","v":"Fluphenazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21058,M21058)","v":"Basal Ganglia Diseases"},"D005476","Fluphenazine","69-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21058,N21058)","v":"DTXSID2023068"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21058,J21058)","v":"8267132"},"Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.","8267132","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID2023068"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21086,D21086)","v":"Fluphenazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21086,M21086)","v":"Basal Ganglia Diseases"},"D005476","Fluphenazine","69-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21086,N21086)","v":"DTXSID2023068"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21086,J21086)","v":"17874990"},"Mis-deca-n identity?","17874990","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID2023068"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21119,D21119)","v":"Fluphenazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21119,M21119)","v":"Consciousness Disorders"},"D005476","Fluphenazine","69-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21119,N21119)","v":"DTXSID2023068"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21119,J21119)","v":"7118846"},"A case of neuroleptic malignant syndrome successfully treated with amantadine.","7118846","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID2023068"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21151,D21151)","v":"Fluphenazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21151,M21151)","v":"Movement Disorders"},"D005476","Fluphenazine","69-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21151,N21151)","v":"DTXSID2023068"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21151,J21151)","v":"4990944"},"Long acting phenothiazines and long term psychotic patients: the role of fluphenazine enanthate in treatment.","4990944","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID2023068"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21180,D21180)","v":"Fluphenazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21180,M21180)","v":"Muscle Rigidity"},"D005476","Fluphenazine","69-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21180,N21180)","v":"DTXSID2023068"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21180,J21180)","v":"15570541"},"[Alterations of gait parameters under external cueing in schizophrenic patients: a switch study].","15570541","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID2023068"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21203,D21203)","v":"Fluphenazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21203,M21203)","v":"Parkinson Disease, Secondary"},"D005476","Fluphenazine","69-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21203,N21203)","v":"DTXSID2023068"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21203,J21203)","v":"3227508"},"[Striatal hypersensitivity to neuroleptics. Therapeutic difficulties and medico-legal aspects].","3227508","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID2023068"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21215,D21215)","v":"Fluphenazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21215,M21215)","v":"Parkinson Disease, Secondary"},"D005476","Fluphenazine","69-23-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21215,N21215)","v":"DTXSID2023068"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21215,J21215)","v":"23919"},"Effects of lergotrile on schizophrenia &amp; drug induced parkinsonism.","23919","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID2023068"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21248,D21248)","v":"fluphenazine depot"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21248,M21248)","v":"Catalepsy"},"C011825","fluphenazine depot","5002-47-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21248,N21248)","v":"DTXSID7023069"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21248,J21248)","v":"7200248"},"Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.","7200248","Neurologic Manifestations","D002375","Catalepsy","DTXSID7023069"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21271,D21271)","v":"flupirtine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21271,M21271)","v":"Syncope"},"C034161","flupirtine","56995-20-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21271,N21271)","v":"DTXSID4048436"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21271,J21271)","v":"19252777"},"A girl with headache, confusion and green urine.","19252777","Neurologic Manifestations","D013575","Syncope","DTXSID4048436"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21309,D21309)","v":"Flurothyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21309,M21309)","v":"Seizures"},"D005481","Flurothyl","333-36-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21309,N21309)","v":"DTXSID5046516"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21309,J21309)","v":"22442080"},"Repetitive convulsant-induced seizures reduce the number but not precision of hippocampal place cells.","22442080","Neurologic Manifestations","D012640","Seizures","DTXSID5046516"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21316,D21316)","v":"Fluspirilene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21316,M21316)","v":"Dystonia"},"D005484","Fluspirilene","1841-19-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21316,N21316)","v":"DTXSID7045152"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21316,J21316)","v":"2049986"},"[Severe late-onset dystonia while on fluspirilene].","2049986","Neurologic Manifestations","D004421","Dystonia","DTXSID7045152"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21360,D21360)","v":"Fluvoxamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21360,M21360)","v":"Basal Ganglia Diseases"},"D016666","Fluvoxamine","89035-92-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21360,N21360)","v":"DTXSID60237496"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21360,J21360)","v":"1583525"},"Extrapyramidal symptoms in a patient treated with fluvoxamine.","1583525","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID60237496"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21377,D21377)","v":"Fluvoxamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21377,M21377)","v":"Epilepsy, Tonic-Clonic"},"D016666","Fluvoxamine","89035-92-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21377,N21377)","v":"DTXSID60237496"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21377,J21377)","v":"8473723"},"Seizures induced by combined levomepromazine-fluvoxamine treatment.","8473723","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID60237496"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21410,D21410)","v":"Fluvoxamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21410,M21410)","v":"Sleep Initiation and Maintenance Disorders"},"D016666","Fluvoxamine","89035-92-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21410,N21410)","v":"DTXSID60237496"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21410,J21410)","v":"3918993"},"A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.","3918993","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID60237496"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21428,D21428)","v":"Folic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21428,M21428)","v":"Epilepsy"},"D005492","Folic Acid","59-30-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21428,N21428)","v":"DTXSID0022519"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21428,J21428)","v":"6462463"},"A multidisciplinary study of folic acid neurotoxicity: interactions with kainate binding sites and relevance to the aetiology of epilepsy.","6462463","Central Nervous System Diseases","D004827","Epilepsy","DTXSID0022519"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21445,D21445)","v":"Folic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21445,M21445)","v":"Neural Tube Defects"},"D005492","Folic Acid","59-30-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21445,N21445)","v":"DTXSID0022519"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21445,J21445)","v":"24817375"},"A critical role of noggin in developing folate-nonresponsive NTD in Fkbp8 -/- embryos.","24817375","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID0022519"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21478,D21478)","v":"Formaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21478,M21478)","v":"Brain Neoplasms"},"D005557","Formaldehyde","NOCAS_47796",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21478,N21478)","v":"DTXSID5047796"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21478,J21478)","v":"4085446"},"Formaldehyde, cancer, and social class.","4085446","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID5047796"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21496,D21496)","v":"Formaldehyde"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21496,M21496)","v":"Hypesthesia"},"D005557","Formaldehyde","NOCAS_47796",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21496,N21496)","v":"DTXSID5047796"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21496,J21496)","v":"16731404"},"Anesthesia following overfilling of a root canal sealer into the mandibular canal: a case report.","16731404","Neurologic Manifestations","D006987","Hypesthesia","DTXSID5047796"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21539,D21539)","v":"Foscarnet"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21539,M21539)","v":"Seizures"},"D017245","Foscarnet","4428-95-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21539,N21539)","v":"DTXSID0048478"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21539,J21539)","v":"9113493"},"Minimising the dosage-limiting toxicities of foscarnet induction therapy.","9113493","Neurologic Manifestations","D012640","Seizures","DTXSID0048478"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21548,D21548)","v":"Framycetin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21548,M21548)","v":"Hearing Disorders"},"D005601","Framycetin","119-04-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21548,N21548)","v":"DTXSID2023359"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21548,J21548)","v":"6659116"},"[Reduction of perceptive hearing following prolonged use of framycetin ear drops].","6659116","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID2023359"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21574,D21574)","v":"Fructose"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21574,M21574)","v":"Confusion"},"D005632","Fructose","57-48-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21574,N21574)","v":"DTXSID5023081"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21574,J21574)","v":"11552960"},"Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder.","11552960","Neurologic Manifestations","D003221","Confusion","DTXSID5023081"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21607,D21607)","v":"Fructose"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21607,M21607)","v":"Language Disorders"},"D005632","Fructose","57-48-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21607,N21607)","v":"DTXSID5023081"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21607,J21607)","v":"18025973"},"Topiramate in traumatic brain injury: adverse effects on cognitive function.","18025973","Neurologic Manifestations","D007806","Language Disorders","DTXSID5023081"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21641,D21641)","v":"Fructose"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21641,M21641)","v":"Paresthesia"},"D005632","Fructose","57-48-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21641,N21641)","v":"DTXSID5023081"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21641,J21641)","v":"17803343"},"Tolerability and safety of topiramate in Chinese patients with epilepsy : an open-label, long-term, prospective study.","17803343","Neurologic Manifestations","D010292","Paresthesia","DTXSID5023081"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21668,D21668)","v":"Fructose"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21668,M21668)","v":"Sleep Wake Disorders"},"D005632","Fructose","57-48-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21668,N21668)","v":"DTXSID5023081"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21668,J21668)","v":"15857429"},"Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.","15857429","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID5023081"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21675,D21675)","v":"Fructose"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21675,M21675)","v":"Speech Disorders"},"D005632","Fructose","57-48-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21675,N21675)","v":"DTXSID5023081"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21675,J21675)","v":"14745074"},"Reversible language regression as an adverse effect of topiramate treatment in children.","14745074","Neurologic Manifestations","D013064","Speech Disorders","DTXSID5023081"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21709,D21709)","v":"Furosemide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21709,M21709)","v":"Deafness"},"D005665","Furosemide","41733-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21709,N21709)","v":"DTXSID90194528"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21709,J21709)","v":"5476222"},"Deafness from furosemide.","5476222","Neurologic Manifestations","D003638","Deafness","DTXSID90194528"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21736,D21736)","v":"Furosemide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21736,M21736)","v":"Hearing Disorders"},"D005665","Furosemide","41733-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21736,N21736)","v":"DTXSID90194528"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21736,J21736)","v":"5539343"},"Case report. Diuretic induced ototoxicity in preeclampsia.","5539343","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID90194528"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21765,D21765)","v":"Furosemide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21765,M21765)","v":"Hepatic Encephalopathy"},"D005665","Furosemide","41733-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21765,N21765)","v":"DTXSID90194528"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21765,J21765)","v":"4895969"},"[Importance of hyperammoniemia of the renal origin in the pathogenesis of hepatic coma released in cirrhotic patients by diuretics generating hypokaliemia].","4895969","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID90194528"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21777,D21777)","v":"Furosemide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21777,M21777)","v":"Quadriplegia"},"D005665","Furosemide","41733-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21777,N21777)","v":"DTXSID90194528"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21777,J21777)","v":"6816569"},"[Electromyographic signs of neurogenic involvement in hypokalemic paralysis as a result of diuretic abuse].","6816569","Neurologic Manifestations","D011782","Quadriplegia","DTXSID90194528"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21804,D21804)","v":"gadodiamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21804,M21804)","v":"Diplopia"},"C064925","gadodiamide","122795-43-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21804,N21804)","v":"DTXSID9048647"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21804,J21804)","v":"9400053"},"Safety and efficacy of contrast-enhanced MRI in the brain, head and neck: gadodiamide injection versus gadopentate dimeglumine.","9400053","Neurologic Manifestations","D004172","Diplopia","DTXSID9048647"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21833,D21833)","v":"Gadolinium DTPA"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21833,M21833)","v":"Seizures"},"D019786","Gadolinium DTPA","86050-77-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21833,N21833)","v":"DTXSID70235367"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21833,J21833)","v":"8796597"},"Neurotoxicity of contrast media for magnetic resonance imaging after generalized breakdown of the blood-brain barrier.","8796597","Neurologic Manifestations","D012640","Seizures","DTXSID70235367"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21870,D21870)","v":"Galactose"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21870,M21870)","v":"Memory Disorders"},"D005690","Galactose","59-23-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21870,N21870)","v":"DTXSID0023088"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21870,J21870)","v":"23216110"},"Cordyceps militaris extract attenuates D-galactose-induced memory impairment in mice.","23216110","Neurologic Manifestations","D008569","Memory Disorders","DTXSID0023088"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21894,D21894)","v":"Galantamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21894,M21894)","v":"Sleep Wake Disorders"},"D005702","Galantamine","357-70-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21894,N21894)","v":"DTXSID2045606"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21894,J21894)","v":"19326812"},"[Effects of anti-dementia drugs on sleep-wake patterns in sleep-disturbed rats].","19326812","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID2045606"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21922,D21922)","v":"Gallic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21922,M21922)","v":"Brain Diseases"},"D005707","Gallic Acid","149-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21922,N21922)","v":"DTXSID0020650"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21922,J21922)","v":"4453224"},"Is this subgallate poisoning?","4453224","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID0020650"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21933,D21933)","v":"Gallic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21933,M21933)","v":"Tremor"},"D005707","Gallic Acid","149-91-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21933,N21933)","v":"DTXSID0020650"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21933,J21933)","v":"4453225"},"Adverse effects of bismuth subgallate. A further report from the Australian Drug Evaluation Committee.","4453225","Neurologic Manifestations","D014202","Tremor","DTXSID0020650"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21962,D21962)","v":"gatifloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21962,M21962)","v":"Hallucinations"},"C078049","gatifloxacin","112811-59-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21962,N21962)","v":"DTXSID5045704"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21962,J21962)","v":"16844899"},"Gatifloxacin-induced hallucinations in a 19-year-old man.","16844899","Neurologic Manifestations","D006212","Hallucinations","DTXSID5045704"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C21990,D21990)","v":"gemcitabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L21990,M21990)","v":"Myositis"},"C056507","gemcitabine","95058-81-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N21990,N21990)","v":"DTXSID3040487"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J21990,J21990)","v":"21811892"},"Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.","21811892","Neuromuscular Diseases","D009220","Myositis","DTXSID3040487"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22027,D22027)","v":"Gemfibrozil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22027,M22027)","v":"Muscular Diseases"},"D015248","Gemfibrozil","25812-30-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22027,N22027)","v":"DTXSID0020652"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22027,J22027)","v":"2243420"},"Myopathy and rhabdomyolysis with lovastatin taken with gemfibrozil.","2243420","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID0020652"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22030,D22030)","v":"Gemfibrozil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22030,M22030)","v":"Myositis"},"D015248","Gemfibrozil","25812-30-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22030,N22030)","v":"DTXSID0020652"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22030,J22030)","v":"8417294"},"Acute compartment syndrome: an unusual presentation of gemfibrozil induced myositis.","8417294","Neuromuscular Diseases","D009220","Myositis","DTXSID0020652"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22058,D22058)","v":"Germanium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22058,M22058)","v":"Muscular Diseases"},"D005857","Germanium","7440-56-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22058,N22058)","v":"DTXSID8052483"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22058,J22058)","v":"1950478"},"Experimental germanium myopathy.","1950478","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8052483"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22091,D22091)","v":"Glucose"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22091,M22091)","v":"Alzheimer Disease"},"D005947","Glucose","50-99-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22091,N22091)","v":"DTXSID7022910"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22091,J22091)","v":"16965861"},"A wake-up call: are degenerative diseases provoked by some of our normal food constituents? A case for nutrigenomics.","16965861","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID7022910"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22124,D22124)","v":"Glutethimide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22124,M22124)","v":"Brain Edema"},"D005984","Glutethimide","77-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22124,N22124)","v":"DTXSID1023102"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22124,J22124)","v":"5969236"},"Treatment of glutethimide intoxication.","5969236","Central Nervous System Diseases","D001929","Brain Edema","DTXSID1023102"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22151,D22151)","v":"Glyburide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22151,M22151)","v":"Aphasia"},"D005905","Glyburide","10238-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22151,N22151)","v":"DTXSID0037237"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22151,J22151)","v":"9662945"},"[Diagnostic pitfalls in sulfonylurea-induced neuroglycopenic syndrome with hemiparesis, dysphasia and somnolence].","9662945","Neurologic Manifestations","D001037","Aphasia","DTXSID0037237"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22159,D22159)","v":"Glyburide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22159,M22159)","v":"Consciousness Disorders"},"D005905","Glyburide","10238-21-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22159,N22159)","v":"DTXSID0037237"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22159,J22159)","v":"9662945"},"[Diagnostic pitfalls in sulfonylurea-induced neuroglycopenic syndrome with hemiparesis, dysphasia and somnolence].","9662945","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID0037237"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22192,D22192)","v":"Glycerol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22192,M22192)","v":"Nervous System Diseases"},"D005990","Glycerol","56-81-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22192,N22192)","v":"DTXSID9020663"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22192,J22192)","v":"11392447"},"Role of formulation vehicles in taxane pharmacology.","11392447","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID9020663"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22219,D22219)","v":"Gold"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22219,M22219)","v":"Auditory Perceptual Disorders"},"D006046","Gold","7440-57-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22219,N22219)","v":"DTXSID3064697"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22219,J22219)","v":"21103728"},"Evaluation of central auditory processing in adolescents exposed to metallic mercury.","21103728","Neurologic Manifestations","D001308","Auditory Perceptual Disorders","DTXSID3064697"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22253,D22253)","v":"Gold"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22253,M22253)","v":"Vertigo"},"D006046","Gold","7440-57-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22253,N22253)","v":"DTXSID3064697"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22253,J22253)","v":"371565"},"Complications of chrysotherapy: a review of recent studies.","371565","Neurologic Manifestations","D014717","Vertigo","DTXSID3064697"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22260,D22260)","v":"Gold Sodium Thiomalate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22260,M22260)","v":"Delirium"},"D006052","Gold Sodium Thiomalate","33796-26-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22260,N22260)","v":"DTXSID80329685"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22260,J22260)","v":"1672936"},"Gold-induced neuroencephalopathy responding to dimercaprol.","1672936","Neurologic Manifestations","D003693","Delirium","DTXSID80329685"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22308,D22308)","v":"Griseofulvin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22308,M22308)","v":"Peripheral Nervous System Diseases"},"D006118","Griseofulvin","126-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22308,N22308)","v":"DTXSID8020674"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22308,J22308)","v":"1967699"},"Griseofulvin-induced neuropathy.","1967699","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8020674"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22321,D22321)","v":"Guanethidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22321,M22321)","v":"Hypotension, Orthostatic"},"D006145","Guanethidine","60-02-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22321,N22321)","v":"DTXSID7046966"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22321,J22321)","v":"981091"},"Exertional hypotension due to postganglionic sympathetic blocking drugs.","981091","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID7046966"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22339,D22339)","v":"Guanfacine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22339,M22339)","v":"Disorders of Excessive Somnolence"},"D016316","Guanfacine","29110-47-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22339,N22339)","v":"DTXSID9046944"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22339,J22339)","v":"21476931"},"Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder.","21476931","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID9046944"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22382,D22382)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22382,M22382)","v":"Basal Ganglia Diseases"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22382,N22382)","v":"DTXSID4034150"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22382,J22382)","v":"7117086"},"Toxic haloperidol reactions with observation of serum haloperidol concentration in two children.","7117086","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22389,D22389)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22389,M22389)","v":"Basal Ganglia Diseases"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22389,N22389)","v":"DTXSID4034150"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22389,J22389)","v":"7694306"},"Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.","7694306","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22428,D22428)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22428,M22428)","v":"Basal Ganglia Diseases"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22428,N22428)","v":"DTXSID4034150"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22428,J22428)","v":"3927369"},"Conditioned taste aversion to chlorpromazine, but not to haloperidol.","3927369","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22450,D22450)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22450,M22450)","v":"Basal Ganglia Diseases"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22450,N22450)","v":"DTXSID4034150"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22450,J22450)","v":"347878"},"Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.","347878","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22483,D22483)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22483,M22483)","v":"Basal Ganglia Diseases"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22483,N22483)","v":"DTXSID4034150"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22483,J22483)","v":"16697060"},"Behavioural effects of chronic haloperidol and risperidone treatment in rats.","16697060","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22496,D22496)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22496,M22496)","v":"Basal Ganglia Diseases"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22496,N22496)","v":"DTXSID4034150"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22496,J22496)","v":"11156818"},"Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine.","11156818","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22518,D22518)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22518,M22518)","v":"Basal Ganglia Diseases"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22518,N22518)","v":"DTXSID4034150"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22518,J22518)","v":"1470186"},"[Extrapyramidal movement disorders after \"Isostar Cocktail\"].","1470186","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22551,D22551)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22551,M22551)","v":"Catalepsy"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22551,N22551)","v":"DTXSID4034150"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22551,J22551)","v":"4386815"},"Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.","4386815","Neurologic Manifestations","D002375","Catalepsy","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22589,D22589)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22589,M22589)","v":"Catalepsy"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22589,N22589)","v":"DTXSID4034150"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22589,J22589)","v":"10193906"},"Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat.","10193906","Neurologic Manifestations","D002375","Catalepsy","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22612,D22612)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22612,M22612)","v":"Catatonia"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22612,N22612)","v":"DTXSID4034150"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22612,J22612)","v":"6831138"},"Neuroleptic-induced catatonic symptoms.","6831138","Neurologic Manifestations","D002389","Catatonia","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22641,D22641)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22641,M22641)","v":"Delirium"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22641,N22641)","v":"DTXSID4034150"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22641,J22641)","v":"2922084"},"[Lasting neurologic injury in therapeutic lithium plasma levels].","2922084","Neurologic Manifestations","D003693","Delirium","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22657,D22657)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22657,M22657)","v":"Dystonia"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22657,N22657)","v":"DTXSID4034150"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22657,J22657)","v":"8018801"},"Overflow movements may predict neuroleptic-induced dystonia.","8018801","Neurologic Manifestations","D004421","Dystonia","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22680,D22680)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22680,M22680)","v":"Dystonia"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22680,N22680)","v":"DTXSID4034150"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22680,J22680)","v":"2330407"},"Acute laryngeal dystonic reactions.","2330407","Neurologic Manifestations","D004421","Dystonia","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22709,D22709)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22709,M22709)","v":"Hallucinations"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22709,N22709)","v":"DTXSID4034150"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22709,J22709)","v":"1935662"},"[Central anticholinergic intoxication syndrome. A contribution to the differential diagnosis of exogenous psychoses].","1935662","Neurologic Manifestations","D006212","Hallucinations","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22741,D22741)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22741,M22741)","v":"Memory Disorders"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22741,N22741)","v":"DTXSID4034150"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22741,J22741)","v":"22884478"},"Chronic haloperidol-induced spatial memory deficits accompany the upregulation of D(1) and D(2) receptors in the caudate putamen of C57BL/6 mouse.","22884478","Neurologic Manifestations","D008569","Memory Disorders","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22770,D22770)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22770,M22770)","v":"Muscle Rigidity"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22770,N22770)","v":"DTXSID4034150"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22770,J22770)","v":"6732389"},"Neuroleptic malignant syndrome complicated by disseminated intravascular coagulation.","6732389","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22777,D22777)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22777,M22777)","v":"Muscle Rigidity"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22777,N22777)","v":"DTXSID4034150"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22777,J22777)","v":"3711363"},"Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study.","3711363","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22809,D22809)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22809,M22809)","v":"Parkinson Disease, Secondary"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22809,N22809)","v":"DTXSID4034150"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22809,J22809)","v":"7021451"},"Clinical evaluation of bromperidol versus haloperidol in psychotic patients.","7021451","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22838,D22838)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22838,M22838)","v":"Parkinson Disease, Secondary"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22838,N22838)","v":"DTXSID4034150"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22838,J22838)","v":"1751940"},"Side effects during long-term treatment with depot antipsychotic medication.","1751940","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22870,D22870)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22870,M22870)","v":"Pituitary Diseases"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22870,N22870)","v":"DTXSID4034150"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22870,J22870)","v":"860939"},"Syndrome of inappropriate secretion of antidiuretic hormone in patients treated with psychotherapeutic drugs.","860939","Central Nervous System Diseases","D010900","Pituitary Diseases","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22877,D22877)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22877,M22877)","v":"Seizures"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22877,N22877)","v":"DTXSID4034150"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22877,J22877)","v":"6844982"},"Neuroleptic malignant syndrome after haloperidol therapy.","6844982","Neurologic Manifestations","D012640","Seizures","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22906,D22906)","v":"Haloperidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22906,M22906)","v":"Tremor"},"D006220","Haloperidol","52-86-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22906,N22906)","v":"DTXSID4034150"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22906,J22906)","v":"2738729"},"Withdrawal emergent syndrome in an infant associated with maternal haloperidol therapy.","2738729","Neurologic Manifestations","D014202","Tremor","DTXSID4034150"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22938,D22938)","v":"Halothane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22938,M22938)","v":"Coma"},"D006221","Halothane","151-67-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22938,N22938)","v":"DTXSID4025371"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22938,J22938)","v":"6869714"},"Coma following ingestion of halothane. Its successful management.","6869714","Neurologic Manifestations","D003128","Coma","DTXSID4025371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C22967,D22967)","v":"Halothane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L22967,M22967)","v":"Muscle Rigidity"},"D006221","Halothane","151-67-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N22967,N22967)","v":"DTXSID4025371"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J22967,J22967)","v":"8059048"},"[Freeman-Sheldon syndrome: generalized muscular rigidity after anesthetic induction].","8059048","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID4025371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23000,D23000)","v":"Harmaline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23000,M23000)","v":"Ataxia"},"D006246","Harmaline","304-21-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23000,N23000)","v":"DTXSID8041038"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23000,J23000)","v":"22975288"},"Effects of riluzole on harmaline induced tremor and ataxia in rats: biochemical, histological and behavioral studies.","22975288","Neurologic Manifestations","D001259","Ataxia","DTXSID8041038"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23006,D23006)","v":"Harmaline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23006,M23006)","v":"Tremor"},"D006246","Harmaline","304-21-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23006,N23006)","v":"DTXSID8041038"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23006,J23006)","v":"6252504"},"Neurophysiological and behavioral maturation of cerebellar function studied with tremorogenic drugs.","6252504","Neurologic Manifestations","D014202","Tremor","DTXSID8041038"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23035,D23035)","v":"Harmine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23035,M23035)","v":"Learning Disorders"},"D006247","Harmine","442-51-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23035,N23035)","v":"DTXSID30196066"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23035,J23035)","v":"23103833"},"Involvement of nitrergic system of CA1in harmane induced learning and memory deficits.","23103833","Neurologic Manifestations","D007859","Learning Disorders","DTXSID30196066"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23058,D23058)","v":"Helium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23058,M23058)","v":"Tremor"},"D006371","Helium","7440-59-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23058,N23058)","v":"DTXSID7036402"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23058,J23058)","v":"5971157"},"[Preliminary experimental observations on a cardiocirculatory syndrome caused by hyperbaric helium respiration].","5971157","Neurologic Manifestations","D014202","Tremor","DTXSID7036402"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23100,D23100)","v":"Heparin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23100,M23100)","v":"Cerebral Hemorrhage"},"D006493","Heparin","9005-49-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23100,N23100)","v":"DTXSID20872761"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23100,J23100)","v":"17308287"},"Lowering the bleeding risk in intra-arterial thrombolysis without losing efficiency by excluding adjunctive heparin?","17308287","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID20872761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23129,D23129)","v":"Heparin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23129,M23129)","v":"Cerebral Hemorrhage"},"D006493","Heparin","9005-49-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23129,N23129)","v":"DTXSID20872761"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23129,J23129)","v":"12879517"},"Stroke risk with higher heparin, hirudin dosages halts studies.","12879517","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID20872761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23151,D23151)","v":"Heparin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23151,M23151)","v":"Hematoma, Subdural"},"D006493","Heparin","9005-49-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23151,N23151)","v":"DTXSID20872761"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23151,J23151)","v":"4186046"},"Subdural haematoma and anticoagulant treatment.","4186046","Central Nervous System Diseases","D006408","Hematoma, Subdural","DTXSID20872761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23164,D23164)","v":"Heparin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23164,M23164)","v":"Intracranial Hemorrhages"},"D006493","Heparin","9005-49-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23164,N23164)","v":"DTXSID20872761"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23164,J23164)","v":"27240121"},"Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.","27240121","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID20872761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23197,D23197)","v":"Heparin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23197,M23197)","v":"Muscular Diseases"},"D006493","Heparin","9005-49-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23197,N23197)","v":"DTXSID20872761"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23197,J23197)","v":"5309575"},"The clinical, functional, and histologic response to heparin in chronic renal disease.","5309575","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID20872761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23219,D23219)","v":"Heparin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23219,M23219)","v":"Sinus Thrombosis, Intracranial"},"D006493","Heparin","9005-49-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23219,N23219)","v":"DTXSID20872761"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23219,J23219)","v":"16038130"},"[Sinus thrombosis in heparin-induced thrombocytopenia type II].","16038130","Central Nervous System Diseases","D012851","Sinus Thrombosis, Intracranial","DTXSID20872761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23258,D23258)","v":"Heparin, Low-Molecular-Weight"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23258,M23258)","v":"Hematoma, Epidural, Cranial"},"D006495","Heparin, Low-Molecular-Weight","9005-49-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23258,N23258)","v":"DTXSID20872761"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23258,J23258)","v":"14663565"},"Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery.","14663565","Trauma, Nervous System","D006407","Hematoma, Epidural, Cranial","DTXSID20872761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23265,D23265)","v":"Heparin, Low-Molecular-Weight"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23265,M23265)","v":"Intracranial Hemorrhages"},"D006495","Heparin, Low-Molecular-Weight","9005-49-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23265,N23265)","v":"DTXSID20872761"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23265,J23265)","v":"15933857"},"Fatal intracranial haemorrhage associated with the administration of low-molecular-weight-heparin in a child.","15933857","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID20872761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23308,D23308)","v":"Heroin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23308,M23308)","v":"Brain Diseases"},"D003932","Heroin","1502-95-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23308,N23308)","v":"DTXSID2048909"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23308,J23308)","v":"4344820"},"Neurological complications of addiction to heroin.","4344820","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2048909"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23326,D23326)","v":"Heroin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23326,M23326)","v":"Brain Ischemia"},"D003932","Heroin","1502-95-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23326,N23326)","v":"DTXSID2048909"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23326,J23326)","v":"9491301"},"Ballistic movements due to ischemic infarcts after intravenous heroin overdose: report of two cases.","9491301","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID2048909"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23359,D23359)","v":"Heroin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23359,M23359)","v":"Decerebrate State"},"D003932","Heroin","1502-95-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23359,N23359)","v":"DTXSID2048909"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23359,J23359)","v":"5559439"},"Delayed postanoxic encephalopathy after heroin use.","5559439","Neurologic Manifestations","D003655","Decerebrate State","DTXSID2048909"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23376,D23376)","v":"Heroin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23376,M23376)","v":"Hearing Loss, Sensorineural"},"D003932","Heroin","1502-95-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23376,N23376)","v":"DTXSID2048909"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23376,J23376)","v":"6716028"},"Sensorineural hearing loss in a heroin addict.","6716028","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID2048909"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23394,D23394)","v":"Heroin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23394,M23394)","v":"Leukoencephalopathies"},"D003932","Heroin","1502-95-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23394,N23394)","v":"DTXSID2048909"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23394,J23394)","v":"26267994"},"Intravenous Heroin-Associated Delayed Spongiform Leukoencephalopathy: Case Report and Reviews of the Literature.","26267994","Central Nervous System Diseases","D056784","Leukoencephalopathies","DTXSID2048909"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23432,D23432)","v":"Heroin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23432,M23432)","v":"Nystagmus, Pathologic"},"D003932","Heroin","1502-95-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23432,N23432)","v":"DTXSID2048909"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23432,J23432)","v":"21336801"},"\"Chasing the dragon\"--heroin-associated spongiform leukoencephalopathy.","21336801","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID2048909"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23455,D23455)","v":"Heroin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23455,M23455)","v":"Peripheral Nervous System Diseases"},"D003932","Heroin","1502-95-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23455,N23455)","v":"DTXSID2048909"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23455,J23455)","v":"17117938"},"Acute heroin-related neuropathy.","17117938","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID2048909"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23488,D23488)","v":"Hexachlorobenzene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23488,M23488)","v":"Myotonia"},"D006581","Hexachlorobenzene","118-74-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23488,N23488)","v":"DTXSID2020682"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23488,J23488)","v":"3596726"},"Decreased conduction velocity and pseudomyotonia in hexachlorobenzene-fed rats.","3596726","Neurologic Manifestations","D009222","Myotonia","DTXSID2020682"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23496,D23496)","v":"Hexachlorophene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23496,M23496)","v":"Brain Diseases"},"D006582","Hexachlorophene","70-30-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23496,N23496)","v":"DTXSID6020690"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23496,J23496)","v":"7236127"},"Hexachlorophene--time to stop.","7236127","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID6020690"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23523,D23523)","v":"Hexachlorophene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23523,M23523)","v":"Brain Edema"},"D006582","Hexachlorophene","70-30-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23523,N23523)","v":"DTXSID6020690"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23523,J23523)","v":"4934184"},"Review of the toxicity of hexachlorophene.","4934184","Central Nervous System Diseases","D001929","Brain Edema","DTXSID6020690"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23556,D23556)","v":"Hexachlorophene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23556,M23556)","v":"Paralysis"},"D006582","Hexachlorophene","70-30-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23556,N23556)","v":"DTXSID6020690"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23556,J23556)","v":"4212172"},"Modification of hexachlorophene toxicity by dieldrin and aroclor 1254.","4212172","Neurologic Manifestations","D010243","Paralysis","DTXSID6020690"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23589,D23589)","v":"homatropine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23589,M23589)","v":"Confusion"},"C100236","homatropine","87-00-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23589,N23589)","v":"DTXSID6044014"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23589,J23589)","v":"3568523"},"Repeated delirium from homatropine eye-drops. A case report.","3568523","Neurologic Manifestations","D003221","Confusion","DTXSID6044014"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23617,D23617)","v":"Hyaluronic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23617,M23617)","v":"Ocular Motility Disorders"},"D006820","Hyaluronic Acid","9067-32-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23617,N23617)","v":"DTXSID30238233"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23617,J23617)","v":"22082564"},"Ocular ischemia with hypotony after injection of hyaluronic acid gel.","22082564","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID30238233"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23624,D23624)","v":"Hydralazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23624,M23624)","v":"Cranial Nerve Diseases"},"D006830","Hydralazine","86-54-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23624,N23624)","v":"DTXSID4023129"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23624,J23624)","v":"3179548"},"Acute laryngeal stridor with respiratory arrest in drug induced systemic lupus erythematosus.","3179548","Cranial Nerve Diseases","D003389","Cranial Nerve Diseases","DTXSID4023129"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23657,D23657)","v":"Hydrochlorothiazide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23657,M23657)","v":"Hypotension, Orthostatic"},"D006852","Hydrochlorothiazide","58-93-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23657,N23657)","v":"DTXSID2020713"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23657,J23657)","v":"3548301"},"Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.","3548301","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID2020713"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23685,D23685)","v":"Hydrocodone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23685,M23685)","v":"Seizures"},"D006853","Hydrocodone","143-71-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23685,N23685)","v":"DTXSID40162277"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23685,J23685)","v":"23995596"},"In vivo activity of norhydrocodone: an active metabolite of hydrocodone.","23995596","Neurologic Manifestations","D012640","Seizures","DTXSID40162277"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23714,D23714)","v":"Hydrogen Peroxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23714,M23714)","v":"Brain Ischemia"},"D006861","Hydrogen Peroxide","7722-84-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23714,N23714)","v":"DTXSID2020715"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23714,J23714)","v":"24304268"},"Air-embolism and cerebral ischaemia following epidural hydrogen peroxide irrigation in a closed lumbar cavity.","24304268","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID2020715"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23725,D23725)","v":"Hydrogen Peroxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23725,M23725)","v":"Intracranial Embolism"},"D006861","Hydrogen Peroxide","7722-84-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23725,N23725)","v":"DTXSID2020715"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23725,J23725)","v":"27335000"},"Cerebral arterial gas embolism after pre-flight ingestion of hydrogen peroxide.","27335000","Central Nervous System Diseases","D020766","Intracranial Embolism","DTXSID2020715"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23753,D23753)","v":"Hydrogen Sulfide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23753,M23753)","v":"Brain Edema"},"D006862","Hydrogen Sulfide","13465-07-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23753,N23753)","v":"DTXSID10158844"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23753,J23753)","v":"20618164"},"Hyperbaric oxygen in the treatment of hydrogen sulphide intoxication.","20618164","Central Nervous System Diseases","D001929","Brain Edema","DTXSID10158844"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23777,D23777)","v":"Hydrogen Sulfide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23777,M23777)","v":"Nervous System Diseases"},"D006862","Hydrogen Sulfide","13465-07-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23777,N23777)","v":"DTXSID10158844"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23777,J23777)","v":"27442775"},"Acute hydrogen sulfide-induced neuropathology and neurological sequelae: challenges for translational neuroprotective research.","27442775","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID10158844"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23814,D23814)","v":"Hydromorphone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23814,M23814)","v":"Hyperalgesia"},"D004091","Hydromorphone","466-99-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23814,N23814)","v":"DTXSID8023133"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23814,J23814)","v":"23340535"},"A negative correlation between hyperalgesia and analgesia in patients with chronic radicular pain: is hydromorphone therapy a double-edged sword?","23340535","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID8023133"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23843,D23843)","v":"Hydroxocobalamin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23843,M23843)","v":"Syncope"},"D006879","Hydroxocobalamin","13422-51-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23843,N23843)","v":"DTXSID60897433"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23843,J23843)","v":"20352539"},"Hemodialysis complications of hydroxocobalamin: a case report.","20352539","Neurologic Manifestations","D013575","Syncope","DTXSID60897433"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23870,D23870)","v":"Hydroxychloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23870,M23870)","v":"Muscular Diseases"},"D006886","Hydroxychloroquine","747-36-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23870,N23870)","v":"DTXSID1047811"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23870,J23870)","v":"17803043"},"Severe, reversible dysphagia from chloroquine and hydroxychloroquine myopathy.","17803043","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID1047811"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23882,D23882)","v":"Hydroxychloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23882,M23882)","v":"Myasthenia Gravis"},"D006886","Hydroxychloroquine","747-36-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23882,N23882)","v":"DTXSID1047811"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23882,J23882)","v":"26876193"},"Myasthenia gravis due to hydroxychloroquine.","26876193","Autoimmune Diseases of the Nervous System","D009157","Myasthenia Gravis","DTXSID1047811"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23911,D23911)","v":"Hydroxychloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23911,M23911)","v":"Scotoma"},"D006886","Hydroxychloroquine","747-36-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23911,N23911)","v":"DTXSID1047811"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23911,J23911)","v":"12972762"},"Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine.","12972762","Neurologic Manifestations","D012607","Scotoma","DTXSID1047811"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23938,D23938)","v":"Hydroxychloroquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23938,M23938)","v":"Vision, Low"},"D006886","Hydroxychloroquine","747-36-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23938,N23938)","v":"DTXSID1047811"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23938,J23938)","v":"11409112"},"Rheumatologists' attitudes toward routine screening for hydroxychloroquine retinopathy.","11409112","Neurologic Manifestations","D015354","Vision, Low","DTXSID1047811"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23976,D23976)","v":"Hydroxyzine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23976,M23976)","v":"Amnesia"},"D006919","Hydroxyzine","2192-20-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23976,N23976)","v":"DTXSID2040737"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23976,J23976)","v":"4738192"},"Pediatric premedication with diazepam or hydroxyzine: oral versus intramuscular route.","4738192","Neurologic Manifestations","D000647","Amnesia","DTXSID2040737"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C23979,D23979)","v":"Hydroxyzine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L23979,M23979)","v":"Cerebrovascular Disorders"},"D006919","Hydroxyzine","2192-20-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N23979,N23979)","v":"DTXSID2040737"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J23979,J23979)","v":"23769656"},"Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage triggered by hydroxyzine pamoate.","23769656","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID2040737"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24006,D24006)","v":"Ibuprofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24006,M24006)","v":"Coma"},"D007052","Ibuprofen","31121-93-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24006,N24006)","v":"DTXSID4040501"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24006,J24006)","v":"3780253"},"Coma caused by ibuprofen overdose.","3780253","Neurologic Manifestations","D003128","Coma","DTXSID4040501"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24040,D24040)","v":"Ibuprofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24040,M24040)","v":"Meningitis"},"D007052","Ibuprofen","31121-93-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24040,N24040)","v":"DTXSID4040501"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24040,J24040)","v":"483800"},"Ibuprofen-associated aseptic meningitis in systemic lupus erythematosus.","483800","Central Nervous System Diseases","D008581","Meningitis","DTXSID4040501"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24073,D24073)","v":"Ibuprofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24073,M24073)","v":"Meningitis, Aseptic"},"D007052","Ibuprofen","31121-93-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24073,N24073)","v":"DTXSID4040501"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24073,J24073)","v":"2213786"},"Acute central nervous system symptoms caused by ibuprofen in connective tissue disease.","2213786","Central Nervous System Diseases","D008582","Meningitis, Aseptic","DTXSID4040501"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24099,D24099)","v":"Ibuprofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24099,M24099)","v":"Seizures"},"D007052","Ibuprofen","31121-93-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24099,N24099)","v":"DTXSID4040501"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24099,J24099)","v":"21121909"},"Aggravation of seizure-associated microvascular injuries by ibuprofen may involve multiple pathways.","21121909","Neurologic Manifestations","D012640","Seizures","DTXSID4040501"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24108,D24108)","v":"Ibuprofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24108,M24108)","v":"Vision Disorders"},"D007052","Ibuprofen","31121-93-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24108,N24108)","v":"DTXSID4040501"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24108,J24108)","v":"2627094"},"Visual disturbances associated with over-the-counter ibuprofen in three patients.","2627094","Neurologic Manifestations","D014786","Vision Disorders","DTXSID4040501"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24151,D24151)","v":"Ifosfamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24151,M24151)","v":"Brain Diseases"},"D007069","Ifosfamide","3778-73-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24151,N24151)","v":"DTXSID7020760"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24151,J24151)","v":"24664476"},"An assessment of risk factors associated with ifosfamide-induced encephalopathy in a large academic cancer center.","24664476","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID7020760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24169,D24169)","v":"Ifosfamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24169,M24169)","v":"Central Nervous System Diseases"},"D007069","Ifosfamide","3778-73-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24169,N24169)","v":"DTXSID7020760"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24169,J24169)","v":"3819813"},"Ifosfamide neurotoxicity in children.","3819813","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID7020760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24202,D24202)","v":"Ifosfamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24202,M24202)","v":"Nervous System Diseases"},"D007069","Ifosfamide","3778-73-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24202,N24202)","v":"DTXSID7020760"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24202,J24202)","v":"18840018"},"Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.","18840018","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7020760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24219,D24219)","v":"Imatinib Mesylate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24219,M24219)","v":"Brain Edema"},"D000068877","Imatinib Mesylate","220127-57-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24219,N24219)","v":"DTXSID9040502"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24219,J24219)","v":"12049868"},"Cerebral oedema as a possible complication of treatment with imatinib.","12049868","Central Nervous System Diseases","D001929","Brain Edema","DTXSID9040502"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24237,D24237)","v":"Imatinib Mesylate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24237,M24237)","v":"Muscle Cramp"},"D000068877","Imatinib Mesylate","220127-57-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24237,N24237)","v":"DTXSID9040502"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24237,J24237)","v":"24446903"},"Correlation of plasma trough levels of imatinib with molecular response in patients with chronic myeloid leukemia.","24446903","Neurologic Manifestations","D009120","Muscle Cramp","DTXSID9040502"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24270,D24270)","v":"Imipenem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24270,M24270)","v":"Epilepsy"},"D015378","Imipenem","64221-86-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24270,N24270)","v":"DTXSID2023143"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24270,J24270)","v":"11879372"},"Seizures in the critically ill: the role of imipenem.","11879372","Central Nervous System Diseases","D004827","Epilepsy","DTXSID2023143"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24287,D24287)","v":"Imipenem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24287,M24287)","v":"Seizures"},"D015378","Imipenem","64221-86-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24287,N24287)","v":"DTXSID2023143"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24287,J24287)","v":"3890538"},"Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.","3890538","Neurologic Manifestations","D012640","Seizures","DTXSID2023143"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24331,D24331)","v":"Imipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24331,M24331)","v":"Coma"},"D007099","Imipramine","50-49-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24331,N24331)","v":"DTXSID1043881"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24331,J24331)","v":"1142523"},"Imipramine toxicity.","1142523","Neurologic Manifestations","D003128","Coma","DTXSID1043881"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24338,D24338)","v":"Imipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24338,M24338)","v":"Delirium"},"D007099","Imipramine","50-49-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24338,N24338)","v":"DTXSID1043881"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24338,J24338)","v":"3381941"},"Relationship of plasma imipramine levels to CNS toxicity in children.","3381941","Neurologic Manifestations","D003693","Delirium","DTXSID1043881"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24376,D24376)","v":"Imipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24376,M24376)","v":"Hypotension, Orthostatic"},"D007099","Imipramine","50-49-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24376,N24376)","v":"DTXSID1043881"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24376,J24376)","v":"4794856"},"A study of toxic effects of certain psychotropic drugs with special emphasis on their cardiotoxicity.","4794856","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID1043881"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24399,D24399)","v":"Imipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24399,M24399)","v":"Reflex, Abnormal"},"D007099","Imipramine","50-49-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24399,N24399)","v":"DTXSID1043881"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24399,J24399)","v":"5764781"},"Myocardial damage due to imipramine intoxication.","5764781","Neurologic Manifestations","D012021","Reflex, Abnormal","DTXSID1043881"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24432,D24432)","v":"Imipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24432,M24432)","v":"Syncope"},"D007099","Imipramine","50-49-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24432,N24432)","v":"DTXSID1043881"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24432,J24432)","v":"4852352"},"Imipramine side effects in children.","4852352","Neurologic Manifestations","D013575","Syncope","DTXSID1043881"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24444,D24444)","v":"Imipramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24444,M24444)","v":"Tremor"},"D007099","Imipramine","50-49-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24444,N24444)","v":"DTXSID1043881"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24444,J24444)","v":"4852352"},"Imipramine side effects in children.","4852352","Neurologic Manifestations","D014202","Tremor","DTXSID1043881"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24467,D24467)","v":"Indinavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24467,M24467)","v":"Hypertensive Encephalopathy"},"D019469","Indinavir","150378-17-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24467,N24467)","v":"DTXSID4043802"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24467,J24467)","v":"12022250"},"Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: a case report.","12022250","Central Nervous System Diseases","D020343","Hypertensive Encephalopathy","DTXSID4043802"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24500,D24500)","v":"Indomethacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24500,M24500)","v":"Central Nervous System Diseases"},"D007213","Indomethacin","74252-25-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24500,N24500)","v":"DTXSID00225256"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24500,J24500)","v":"4625681"},"[Tolerance of long-term indomethacin treatment].","4625681","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID00225256"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24528,D24528)","v":"Indomethacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24528,M24528)","v":"Hearing Loss"},"D007213","Indomethacin","74252-25-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24528,N24528)","v":"DTXSID00225256"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24528,J24528)","v":"10193129"},"[\"Sudden deafness\" has not been classified as a side-effect. No compensation from the Drug Insurance Authority].","10193129","Neurologic Manifestations","D034381","Hearing Loss","DTXSID00225256"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24561,D24561)","v":"Indomethacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24561,M24561)","v":"Tinnitus"},"D007213","Indomethacin","74252-25-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24561,N24561)","v":"DTXSID00225256"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24561,J24561)","v":"4547663"},"[Preliminary studies of the possible audio-toxicity of indomethacin].","4547663","Neurologic Manifestations","D014012","Tinnitus","DTXSID00225256"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24589,D24589)","v":"intetrix"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24589,M24589)","v":"Optic Neuritis"},"C037666","intetrix","87453-65-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24589,N24589)","v":"DTXSID00236347"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24589,J24589)","v":"6442219"},"[SMON syndrome. First case after abuse of a methylated hydroxyquinoline derivative].","6442219","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID00236347"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24596,D24596)","v":"iocarmate meglumine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24596,M24596)","v":"Epilepsy, Tonic-Clonic"},"C025504","iocarmate meglumine",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24596,N24596)","v":"DTXSID101009319"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24596,J24596)","v":"6442496"},"[Side effects of Dimer X used in radiculography].","6442496","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID101009319"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24629,D24629)","v":"iodixanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24629,M24629)","v":"Spasm"},"C044834","iodixanol","92339-11-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24629,N24629)","v":"DTXSID2045523"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24629,J24629)","v":"9851819"},"Prevention of contrast medium-induced renal vasospasm by phosphodiesterase inhibition.","9851819","Neurologic Manifestations","D013035","Spasm","DTXSID2045523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24657,D24657)","v":"Iodoquinol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24657,M24657)","v":"Optic Neuritis"},"D004103","Iodoquinol","83-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24657,N24657)","v":"DTXSID6023155"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24657,J24657)","v":"4276320"},"Warning on diiodohydroxyquin.","4276320","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID6023155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24690,D24690)","v":"Iohexol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24690,M24690)","v":"Confusion"},"D007472","Iohexol","66108-95-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24690,N24690)","v":"DTXSID6023157"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24690,J24690)","v":"3882614"},"Lumbar myelography with iohexol and metrizamide. A comparative multicenter prospective study.","3882614","Neurologic Manifestations","D003221","Confusion","DTXSID6023157"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24719,D24719)","v":"Iohexol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24719,M24719)","v":"Paralysis"},"D007472","Iohexol","66108-95-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24719,N24719)","v":"DTXSID6023157"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24719,J24719)","v":"22985093"},"Permanent monoparesis in a dog after intramedullary injection of iohexol into the lumbar spinal cord.","22985093","Neurologic Manifestations","D010243","Paralysis","DTXSID6023157"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24725,D24725)","v":"Iohexol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24725,M24725)","v":"Paresthesia"},"D007472","Iohexol","66108-95-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24725,N24725)","v":"DTXSID6023157"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24725,J24725)","v":"6382930"},"Iohexol in lower extremity, renal and visceral angiography. Survey and present state.","6382930","Neurologic Manifestations","D010292","Paresthesia","DTXSID6023157"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24758,D24758)","v":"iomeprol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24758,M24758)","v":"Blindness, Cortical"},"C057937","iomeprol","78649-41-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24758,N24758)","v":"DTXSID1049061"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24758,J24758)","v":"9492782"},"Transient bilateral cortical blindness after coronary angiography.","9492782","Neurologic Manifestations","D019575","Blindness, Cortical","DTXSID1049061"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24787,D24787)","v":"Iopamidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24787,M24787)","v":"Hearing Loss, Sensorineural"},"D007479","Iopamidol","60166-93-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24787,N24787)","v":"DTXSID1023158"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24787,J24787)","v":"8073892"},"Transient deafness with iopamidol following angiography.","8073892","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID1023158"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24818,D24818)","v":"Iopamidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24818,M24818)","v":"Seizures"},"D007479","Iopamidol","60166-93-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24818,N24818)","v":"DTXSID1023158"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24818,J24818)","v":"15010060"},"Status epilepticus and seizures induced by iopamidol myelography.","15010060","Neurologic Manifestations","D012640","Seizures","DTXSID1023158"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24826,D24826)","v":"Iopamidol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24826,M24826)","v":"Taste Disorders"},"D007479","Iopamidol","60166-93-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24826,N24826)","v":"DTXSID1023158"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24826,J24826)","v":"6858170"},"[Jopamidol, a non-ionic x-ray contrast medium--tolerance from a neurological viewpoint].","6858170","Neurologic Manifestations","D013651","Taste Disorders","DTXSID1023158"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24855,D24855)","v":"Iophendylate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24855,M24855)","v":"Meningitis"},"D007481","Iophendylate","99-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24855,N24855)","v":"DTXSID2052869"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24855,J24855)","v":"63690"},"Isophendylate myelography in multiple sclerosis.","63690","Central Nervous System Diseases","D008581","Meningitis","DTXSID2052869"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24886,D24886)","v":"iopromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24886,M24886)","v":"Cerebrovascular Disorders"},"C038192","iopromide","73334-07-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24886,N24886)","v":"DTXSID0023163"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24886,J24886)","v":"16628721"},"Cerebral vaso-occlusive event with low-osmolar intravenous contrast in a patient with sickle cell disease.","16628721","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID0023163"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24916,D24916)","v":"Iothalamate Meglumine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24916,M24916)","v":"Paresthesia"},"D007482","Iothalamate Meglumine","519-25-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24916,N24916)","v":"DTXSID90199856"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24916,J24916)","v":"6382932"},"Adult peripheral angiography. Results from four North American randomized clinical trials of ionic media versus iohexol.","6382932","Neurologic Manifestations","D010292","Paresthesia","DTXSID90199856"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24938,D24938)","v":"Iothalamate Meglumine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24938,M24938)","v":"Unconsciousness"},"D007482","Iothalamate Meglumine","519-25-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24938,N24938)","v":"DTXSID90199856"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24938,J24938)","v":"904759"},"[Cerebral convulsions after lumbar myelography with dimer X (further case studies)].","904759","Neurologic Manifestations","D014474","Unconsciousness","DTXSID90199856"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24955,D24955)","v":"Iothalamic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24955,M24955)","v":"Cerebral Hemorrhage"},"D007483","Iothalamic Acid","2276-90-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24955,N24955)","v":"DTXSID5023164"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24955,J24955)","v":"6012486"},"[Indications and adverse effects of cerebral angiography with special reference to acute stroke].","6012486","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID5023164"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C24984,D24984)","v":"Iothalamic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L24984,M24984)","v":"Myoclonus"},"D007483","Iothalamic Acid","2276-90-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N24984,N24984)","v":"DTXSID5023164"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J24984,J24984)","v":"824862"},"[The problem of spinal seizure patterns. Neurotoxic complications after lumbosacral myelography with Conray 60].","824862","Neurologic Manifestations","D009207","Myoclonus","DTXSID5023164"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25006,D25006)","v":"Iothalamic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25006,M25006)","v":"Seizures"},"D007483","Iothalamic Acid","2276-90-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25006,N25006)","v":"DTXSID5023164"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25006,J25006)","v":"4537662"},"Experiences with the technique and complications of meglumine iothalamate (Conray) ventriculography.","4537662","Neurologic Manifestations","D012640","Seizures","DTXSID5023164"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25045,D25045)","v":"iotrolan"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25045,M25045)","v":"Brain Edema"},"C033300","iotrolan","79770-24-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25045,N25045)","v":"DTXSID0023165"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25045,J25045)","v":"15477562"},"Severe symptomatic aseptic chemical meningitis following myelography: the role of procalcitonin.","15477562","Central Nervous System Diseases","D001929","Brain Edema","DTXSID0023165"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25078,D25078)","v":"Ipratropium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25078,M25078)","v":"Tremor"},"D009241","Ipratropium","60205-81-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25078,N25078)","v":"DTXSID9048437"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25078,J25078)","v":"2951826"},"Treatment of asthma bronchiale with a combination of ipratropium bromide and fenoterol.","2951826","Neurologic Manifestations","D014202","Tremor","DTXSID9048437"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25099,D25099)","v":"irinotecan"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25099,M25099)","v":"Muscle Cramp"},"C051890","irinotecan","86639-52-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25099,N25099)","v":"DTXSID4040399"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25099,J25099)","v":"8275479"},"Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.","8275479","Neurologic Manifestations","D009120","Muscle Cramp","DTXSID4040399"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25113,D25113)","v":"Iron"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25113,M25113)","v":"Central Nervous System Diseases"},"D007501","Iron","7439-89-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25113,N25113)","v":"DTXSID5043710"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25113,J25113)","v":"6148170"},"Acute iron poisoning in children.","6148170","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID5043710"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25146,D25146)","v":"Iron"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25146,M25146)","v":"Spinal Cord Injuries"},"D007501","Iron","7439-89-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25146,N25146)","v":"DTXSID5043710"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25146,J25146)","v":"12435430"},"Neurotrophin potentiation of iron-induced spinal cord injury.","12435430","Trauma, Nervous System","D013119","Spinal Cord Injuries","DTXSID5043710"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25167,D25167)","v":"isofenphos"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25167,M25167)","v":"Brain Diseases"},"C035019","isofenphos","25311-71-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25167,N25167)","v":"DTXSID8032417"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25167,J25167)","v":"7740724"},"Delayed neuropathy in pigs induced by isofenphos.","7740724","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8032417"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25207,D25207)","v":"Isoflurane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25207,M25207)","v":"Epilepsy, Generalized"},"D007530","Isoflurane","26675-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25207,N25207)","v":"DTXSID3020752"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25207,J25207)","v":"18674885"},"Isoflurane exacerbates electrically evoked seizures in amygdala-kindled rats during recovery.","18674885","Central Nervous System Diseases","D004829","Epilepsy, Generalized","DTXSID3020752"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25214,D25214)","v":"Isoflurane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25214,M25214)","v":"Learning Disorders"},"D007530","Isoflurane","26675-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25214,N25214)","v":"DTXSID3020752"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25214,J25214)","v":"25597859"},"S6 inhibition contributes to isoflurane neurotoxicity in the developing brain.","25597859","Neurologic Manifestations","D007859","Learning Disorders","DTXSID3020752"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25256,D25256)","v":"Isoflurane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25256,M25256)","v":"Paraplegia"},"D007530","Isoflurane","26675-46-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25256,N25256)","v":"DTXSID3020752"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25256,J25256)","v":"1363005"},"Reversible sensorimotor impairment following prolonged ventilation with isoflurane and vecuronium for acute severe asthma.","1363005","Neurologic Manifestations","D010264","Paraplegia","DTXSID3020752"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25275,D25275)","v":"Isoflurophate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25275,M25275)","v":"Ataxia"},"D007531","Isoflurophate","55-91-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25275,N25275)","v":"DTXSID1040667"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25275,J25275)","v":"7482578"},"Selective promotion by phenylmethanesulfonyl fluoride of peripheral and spinal cord neuropathies initiated by diisopropyl phosphorofluoridate in the hen.","7482578","Neurologic Manifestations","D001259","Ataxia","DTXSID1040667"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25287,D25287)","v":"Isoflurophate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25287,M25287)","v":"Encephalitis"},"D007531","Isoflurophate","55-91-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25287,N25287)","v":"DTXSID1040667"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25287,J25287)","v":"25880399"},"Neuregulin-1 inhibits neuroinflammatory responses in a rat model of organophosphate-nerve agent-induced delayed neuronal injury.","25880399","Central Nervous System Diseases","D004660","Encephalitis","DTXSID1040667"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25310,D25310)","v":"Isoflurophate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25310,M25310)","v":"Nervous System Diseases"},"D007531","Isoflurophate","55-91-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25310,N25310)","v":"DTXSID1040667"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25310,J25310)","v":"3873040"},"Absence of a protective effect of corticosterone on 0-0-diisopropyl phosphorofluoridate (DFP) induced delayed neurotoxicity in chickens.","3873040","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1040667"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25343,D25343)","v":"Isoflurophate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25343,M25343)","v":"Status Epilepticus"},"D007531","Isoflurophate","55-91-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25343,N25343)","v":"DTXSID1040667"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25343,J25343)","v":"25656476"},"Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus.","25656476","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID1040667"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25380,D25380)","v":"Isoniazid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25380,M25380)","v":"Cerebellar Diseases"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25380,N25380)","v":"DTXSID3020758"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25380,J25380)","v":"17269604"},"Isoniazid induced acute bilateral cerebellar syndrome in chronic kidney disease.","17269604","Central Nervous System Diseases","D002526","Cerebellar Diseases","DTXSID3020758"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25404,D25404)","v":"Isoniazid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25404,M25404)","v":"Confusion"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25404,N25404)","v":"DTXSID3020758"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25404,J25404)","v":"8324207"},"Isoniazid induced encephalopathy in dialysis patients.","8324207","Neurologic Manifestations","D003221","Confusion","DTXSID3020758"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25437,D25437)","v":"Isoniazid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25437,M25437)","v":"Hepatic Encephalopathy"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25437,N25437)","v":"DTXSID3020758"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25437,J25437)","v":"7402379"},"[Acute liver insufficiency caused by rifampicin-isoniazid].","7402379","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID3020758"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25444,D25444)","v":"Isoniazid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25444,M25444)","v":"Hepatic Encephalopathy"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25444,N25444)","v":"DTXSID3020758"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25444,J25444)","v":"5642965"},"Exchange transfusion as treatment of acute hepatic failure due to antituberculosis drugs.","5642965","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID3020758"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25472,D25472)","v":"Isoniazid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25472,M25472)","v":"Nervous System Diseases"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25472,N25472)","v":"DTXSID3020758"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25472,J25472)","v":"1179375"},"[Isoniazid; adverse effects].","1179375","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID3020758"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25505,D25505)","v":"Isoniazid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25505,M25505)","v":"Peripheral Nervous System Diseases"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25505,N25505)","v":"DTXSID3020758"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25505,J25505)","v":"6328384"},"Positive tuberculin skin tests and isoniazid chemoprophylaxis.","6328384","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID3020758"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25537,D25537)","v":"Isoniazid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25537,M25537)","v":"Polyneuropathies"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25537,N25537)","v":"DTXSID3020758"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25537,J25537)","v":"5505060"},"Mental disorders caused by isonicotinic acid hydrazide (INH) in the course of treatment of pulmonary tuberculosis.","5505060","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID3020758"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25566,D25566)","v":"Isoniazid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25566,M25566)","v":"Seizures"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25566,N25566)","v":"DTXSID3020758"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25566,J25566)","v":"4813614"},"Isoniazid toxicity. Reversal with pyridoxine.","4813614","Neurologic Manifestations","D012640","Seizures","DTXSID3020758"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25569,D25569)","v":"Isoniazid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25569,M25569)","v":"Seizures"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25569,N25569)","v":"DTXSID3020758"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25569,J25569)","v":"4652956"},"[The hazards of intravenous infusions of tubazid].","4652956","Neurologic Manifestations","D012640","Seizures","DTXSID3020758"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25605,D25605)","v":"Isoniazid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25605,M25605)","v":"Seizures"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25605,N25605)","v":"DTXSID3020758"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25605,J25605)","v":"2221419"},"Treatment of refractory seizures in massive isoniazid overdose.","2221419","Neurologic Manifestations","D012640","Seizures","DTXSID3020758"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25634,D25634)","v":"Isoniazid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25634,M25634)","v":"Status Epilepticus"},"D007538","Isoniazid","149-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25634,N25634)","v":"DTXSID3020758"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25634,J25634)","v":"16999664"},"Acute isoniazid toxicity and the need for adequate pyridoxine supplies.","16999664","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID3020758"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25657,D25657)","v":"Isosorbide Dinitrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25657,M25657)","v":"Cluster Headache"},"D007548","Isosorbide Dinitrate","87-33-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25657,N25657)","v":"DTXSID0045832"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25657,J25657)","v":"533253"},"Cluster headaches from isosorbide dinitrate.","533253","Central Nervous System Diseases","D003027","Cluster Headache","DTXSID0045832"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25669,D25669)","v":"Isosorbide Dinitrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25669,M25669)","v":"Migraine Disorders"},"D007548","Isosorbide Dinitrate","87-33-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25669,N25669)","v":"DTXSID0045832"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25669,J25669)","v":"11037739"},"Headache characteristics during the development of tolerance to nitrates: pathophysiological implications.","11037739","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID0045832"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25702,D25702)","v":"Ivermectin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25702,M25702)","v":"Ataxia"},"D007559","Ivermectin","70288-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25702,N25702)","v":"DTXSID7040235"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25702,J25702)","v":"3840468"},"Extra-label use of drugs.","3840468","Neurologic Manifestations","D001259","Ataxia","DTXSID7040235"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25725,D25725)","v":"Ivermectin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25725,M25725)","v":"Coma"},"D007559","Ivermectin","70288-86-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25725,N25725)","v":"DTXSID7040235"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25725,J25725)","v":"24065325"},"Persistent coma in Strongyloides hyperinfection syndrome associated with persistently increased ivermectin levels.","24065325","Neurologic Manifestations","D003128","Coma","DTXSID7040235"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25763,D25763)","v":"ixabepilone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25763,M25763)","v":"Peripheral Nervous System Diseases"},"C430592","ixabepilone","219989-84-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25763,N25763)","v":"DTXSID70870252"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25763,J25763)","v":"18296423"},"A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study.","18296423","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID70870252"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25792,D25792)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25792,M25792)","v":"Amnesia"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25792,N25792)","v":"DTXSID7040526"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25792,J25792)","v":"15019178"},"Amnesic shellfish poison.","15019178","Neurologic Manifestations","D000647","Amnesia","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25818,D25818)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25818,M25818)","v":"Cerebellar Diseases"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25818,N25818)","v":"DTXSID7040526"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25818,J25818)","v":"3526174"},"Ionic requirements for neurotoxic effects of excitatory amino acid analogues in rat cerebellar slices.","3526174","Central Nervous System Diseases","D002526","Cerebellar Diseases","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25831,D25831)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25831,M25831)","v":"Epilepsy"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25831,N25831)","v":"DTXSID7040526"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25831,J25831)","v":"7904192"},"Hyperexcitability and cell loss in kainate-treated hippocampal slice cultures.","7904192","Central Nervous System Diseases","D004827","Epilepsy","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25860,D25860)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25860,M25860)","v":"Epilepsy"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25860,N25860)","v":"DTXSID7040526"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25860,J25860)","v":"22437342"},"Somatostatin and neuropeptide Y neurons undergo different plasticity in parahippocampal regions in kainic acid-induced epilepsy.","22437342","Central Nervous System Diseases","D004827","Epilepsy","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25886,D25886)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25886,M25886)","v":"Epilepsy, Temporal Lobe"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25886,N25886)","v":"DTXSID7040526"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25886,J25886)","v":"17785345"},"Multiparametric MRI evaluation of kainic acid-induced neuronal activation in rat hippocampus.","17785345","Central Nervous System Diseases","D004833","Epilepsy, Temporal Lobe","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25925,D25925)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25925,M25925)","v":"Memory Disorders"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25925,N25925)","v":"DTXSID7040526"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25925,J25925)","v":"10998428"},"Domoic acid-induced neurodegeneration resulting in memory loss is mediated by Ca2+ overload and inhibition of Ca2+ + calmodulin-stimulated adenylate cyclase in rat brain (review).","10998428","Neurologic Manifestations","D008569","Memory Disorders","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25928,D25928)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25928,M25928)","v":"Myoclonus"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25928,N25928)","v":"DTXSID7040526"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25928,J25928)","v":"1971710"},"Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels.","1971710","Neurologic Manifestations","D009207","Myoclonus","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25954,D25954)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25954,M25954)","v":"Neurodegenerative Diseases"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25954,N25954)","v":"DTXSID7040526"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25954,J25954)","v":"22561409"},"Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function.","22561409","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C25989,D25989)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L25989,M25989)","v":"Seizures"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N25989,N25989)","v":"DTXSID7040526"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J25989,J25989)","v":"7774662"},"Depletion of cortical cholecystokinin levels after excitotoxin injection into the nucleus basalis: sensitivity to MK-801.","7774662","Neurologic Manifestations","D012640","Seizures","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26006,D26006)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26006,M26006)","v":"Seizures"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26006,N26006)","v":"DTXSID7040526"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26006,J26006)","v":"9119897"},"DNA fragmentation and Prolonged expression of c-fos, c-jun, and hsp70 in kainic acid-induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase.","9119897","Neurologic Manifestations","D012640","Seizures","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26028,D26028)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26028,M26028)","v":"Seizures"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26028,N26028)","v":"DTXSID7040526"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26028,J26028)","v":"27173148"},"Kainic acid-induced albumin leak across the blood-brain barrier facilitates epileptiform hyperexcitability in limbic regions.","27173148","Neurologic Manifestations","D012640","Seizures","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26057,D26057)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26057,M26057)","v":"Seizures"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26057,N26057)","v":"DTXSID7040526"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26057,J26057)","v":"17827730"},"Effects of manganese complexes of curcumin and diacetylcurcumin on kainic acid-induced neurotoxic responses in the rat hippocampus.","17827730","Neurologic Manifestations","D012640","Seizures","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26099,D26099)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26099,M26099)","v":"Seizures"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26099,N26099)","v":"DTXSID7040526"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26099,J26099)","v":"20351014"},"Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus.","20351014","Neurologic Manifestations","D012640","Seizures","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26118,D26118)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26118,M26118)","v":"Seizures"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26118,N26118)","v":"DTXSID7040526"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26118,J26118)","v":"22612817"},"Acute, but reversible, kainic acid-induced DNA damage in hippocampal CA1 pyramidal cells of p53-deficient mice.","22612817","Neurologic Manifestations","D012640","Seizures","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26151,D26151)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26151,M26151)","v":"Seizures"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26151,N26151)","v":"DTXSID7040526"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26151,J26151)","v":"11812529"},"Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats.","11812529","Neurologic Manifestations","D012640","Seizures","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26167,D26167)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26167,M26167)","v":"Seizures"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26167,N26167)","v":"DTXSID7040526"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26167,J26167)","v":"12783416"},"Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death.","12783416","Neurologic Manifestations","D012640","Seizures","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26186,D26186)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26186,M26186)","v":"Status Epilepticus"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26186,N26186)","v":"DTXSID7040526"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26186,J26186)","v":"26245156"},"Long-term intracerebroventricular infusion of angiotensin II after kainate-induced status epilepticus: Effects on epileptogenesis, brain damage, and diurnal behavioral changes.","26245156","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26219,D26219)","v":"Kainic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26219,M26219)","v":"Status Epilepticus"},"D007608","Kainic Acid","487-79-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26219,N26219)","v":"DTXSID7040526"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26219,J26219)","v":"11358452"},"AIT-082 is neuroprotective against kainate-induced neuronal injury in rats.","11358452","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID7040526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26235,D26235)","v":"Kanamycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26235,M26235)","v":"Deafness"},"D007612","Kanamycin","8063-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26235,N26235)","v":"DTXSID2041171"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26235,J26235)","v":"2562070"},"[Effect of kanamycin on the cochleas in guinea pigs].","2562070","Neurologic Manifestations","D003638","Deafness","DTXSID2041171"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26280,D26280)","v":"Kanamycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26280,M26280)","v":"Hearing Disorders"},"D007612","Kanamycin","8063-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26280,N26280)","v":"DTXSID2041171"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26280,J26280)","v":"5314836"},"[Pathology of the vestibular apparatus in streptomycin and kanamycin ototoxicosis].","5314836","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID2041171"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26287,D26287)","v":"Kanamycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26287,M26287)","v":"Hearing Disorders"},"D007612","Kanamycin","8063-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26287,N26287)","v":"DTXSID2041171"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26287,J26287)","v":"5628042"},"[Safety margin of kanamycin in newborn and young infants. Effect of kanamycin on hearing].","5628042","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID2041171"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26324,D26324)","v":"Kanamycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26324,M26324)","v":"Hearing Loss, Sensorineural"},"D007612","Kanamycin","8063-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26324,N26324)","v":"DTXSID2041171"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26324,J26324)","v":"7233504"},"Comparative ototoxicity of chloramphenicol and kanamycin with ethacrynic acid.","7233504","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID2041171"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26348,D26348)","v":"Kanamycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26348,M26348)","v":"Seizures"},"D007612","Kanamycin","8063-07-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26348,N26348)","v":"DTXSID2041171"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26348,J26348)","v":"7357478"},"Acoustic priming and kanamycin-induced chochlear damage.","7357478","Neurologic Manifestations","D012640","Seizures","DTXSID2041171"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26380,D26380)","v":"Ketamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26380,M26380)","v":"Ataxia"},"D007649","Ketamine","1867-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26380,N26380)","v":"DTXSID4040137"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26380,J26380)","v":"8803880"},"The effect of intravenous administration of variable-dose midazolam after fixed-dose ketamine in healthy awake cats.","8803880","Neurologic Manifestations","D001259","Ataxia","DTXSID4040137"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26409,D26409)","v":"Ketamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26409,M26409)","v":"Delirium"},"D007649","Ketamine","1867-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26409,N26409)","v":"DTXSID4040137"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26409,J26409)","v":"4822390"},"A comparative evaluation of ketamine anesthesia in children and adults.","4822390","Neurologic Manifestations","D003693","Delirium","DTXSID4040137"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26416,D26416)","v":"Ketamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26416,M26416)","v":"Delirium"},"D007649","Ketamine","1867-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26416,N26416)","v":"DTXSID4040137"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26416,J26416)","v":"12598297"},"Hypnosis first, then dissociation.","12598297","Neurologic Manifestations","D003693","Delirium","DTXSID4040137"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26444,D26444)","v":"Ketamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26444,M26444)","v":"Hallucinations"},"D007649","Ketamine","1867-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26444,N26444)","v":"DTXSID4040137"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26444,J26444)","v":"4562467"},"Reduction of the psychotomimetic and circulatory side-effects of ketamine by droperidol.","4562467","Neurologic Manifestations","D006212","Hallucinations","DTXSID4040137"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26477,D26477)","v":"Ketamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26477,M26477)","v":"Hallucinations"},"D007649","Ketamine","1867-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26477,N26477)","v":"DTXSID4040137"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26477,J26477)","v":"5133995"},"[200+200 anaesthesias with Ketalar--a comparison].","5133995","Neurologic Manifestations","D006212","Hallucinations","DTXSID4040137"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26510,D26510)","v":"Ketamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26510,M26510)","v":"Hyperalgesia"},"D007649","Ketamine","1867-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26510,N26510)","v":"DTXSID4040137"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26510,J26510)","v":"11808827"},"Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia.","11808827","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID4040137"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26537,D26537)","v":"Ketamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26537,M26537)","v":"Memory Disorders"},"D007649","Ketamine","1867-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26537,N26537)","v":"DTXSID4040137"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26537,J26537)","v":"21777321"},"Ketamine use: a review.","21777321","Neurologic Manifestations","D008569","Memory Disorders","DTXSID4040137"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26545,D26545)","v":"Ketamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26545,M26545)","v":"Memory Disorders"},"D007649","Ketamine","1867-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26545,N26545)","v":"DTXSID4040137"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26545,J26545)","v":"12888783"},"Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory.","12888783","Neurologic Manifestations","D008569","Memory Disorders","DTXSID4040137"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26578,D26578)","v":"Ketamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26578,M26578)","v":"Seizures"},"D007649","Ketamine","1867-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26578,N26578)","v":"DTXSID4040137"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26578,J26578)","v":"942230"},"Ketamine anaesthesia for medical procedures in children.","942230","Neurologic Manifestations","D012640","Seizures","DTXSID4040137"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26605,D26605)","v":"Ketamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26605,M26605)","v":"Spinal Cord Diseases"},"D007649","Ketamine","1867-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26605,N26605)","v":"DTXSID4040137"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26605,J26605)","v":"17006081"},"Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S(+)-ketamine.","17006081","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID4040137"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26639,D26639)","v":"Ketoprofen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26639,M26639)","v":"Disorders of Excessive Somnolence"},"D007660","Ketoprofen","22071-15-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26639,N26639)","v":"DTXSID6020771"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26639,J26639)","v":"10572520"},"[Characteristic somnolence after dexketoprofen, a new analgesic].","10572520","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID6020771"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26668,D26668)","v":"Labetalol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26668,M26668)","v":"Paresthesia"},"D007741","Labetalol","36894-69-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26668,N26668)","v":"DTXSID2023191"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26668,J26668)","v":"69898"},"Scalp tingling in patients on labetalol.","69898","Neurologic Manifestations","D010292","Paresthesia","DTXSID2023191"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26673,D26673)","v":"lacosamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26673,M26673)","v":"Ataxia"},"C403507","lacosamide","175481-36-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26673,N26673)","v":"DTXSID1057666"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26673,J26673)","v":"23623245"},"Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.","23623245","Neurologic Manifestations","D001259","Ataxia","DTXSID1057666"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26707,D26707)","v":"Lamivudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26707,M26707)","v":"Peripheral Nervous System Diseases"},"D019259","Lamivudine","134678-17-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26707,N26707)","v":"DTXSID7023194"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26707,J26707)","v":"16029231"},"Fatal exacerbation of peripheral neuropathy during lamivudine therapy: evidence for iatrogenic mitochondrial damage.","16029231","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7023194"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26725,D26725)","v":"lamotrigine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26725,M26725)","v":"Coma"},"C047781","lamotrigine","84057-84-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26725,N26725)","v":"DTXSID2023195"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26725,J26725)","v":"11554897"},"Stupor from lamotrigine toxicity.","11554897","Neurologic Manifestations","D003128","Coma","DTXSID2023195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26768,D26768)","v":"lamotrigine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26768,M26768)","v":"Memory Disorders"},"C047781","lamotrigine","84057-84-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26768,N26768)","v":"DTXSID2023195"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26768,J26768)","v":"15985582"},"Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers.","15985582","Neurologic Manifestations","D008569","Memory Disorders","DTXSID2023195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26775,D26775)","v":"lamotrigine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26775,M26775)","v":"Meningitis, Aseptic"},"C047781","lamotrigine","84057-84-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26775,N26775)","v":"DTXSID2023195"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26775,J26775)","v":"19385984"},"Recurrent lamotrigine-induced aseptic meningitis.","19385984","Central Nervous System Diseases","D008582","Meningitis, Aseptic","DTXSID2023195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26818,D26818)","v":"lamotrigine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26818,M26818)","v":"Sleep Wake Disorders"},"C047781","lamotrigine","84057-84-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26818,N26818)","v":"DTXSID2023195"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26818,J26818)","v":"9024186"},"Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).","9024186","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID2023195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26836,D26836)","v":"lamotrigine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26836,M26836)","v":"Unconsciousness"},"C047781","lamotrigine","84057-84-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26836,N26836)","v":"DTXSID2023195"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26836,J26836)","v":"17448068"},"Self-poisoning with lamotrigine and pregabalin.","17448068","Neurologic Manifestations","D014474","Unconsciousness","DTXSID2023195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26865,D26865)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26865,M26865)","v":"Alzheimer Disease"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26865,N26865)","v":"DTXSID2024161"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26865,J26865)","v":"28460650"},"Developmental toxicant exposure in a mouse model of Alzheimer's disease induces differential sex-associated microglial activation and increased susceptibility to amyloid accumulation.","28460650","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26886,D26886)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26886,M26886)","v":"Ataxia"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26886,N26886)","v":"DTXSID2024161"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26886,J26886)","v":"2993587"},"Lead induction of crop dysfunction in pigeons through a direct action on neural or smooth muscle components of crop tissue.","2993587","Neurologic Manifestations","D001259","Ataxia","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26904,D26904)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26904,M26904)","v":"Brain Damage, Chronic"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26904,N26904)","v":"DTXSID2024161"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26904,J26904)","v":"7375299"},"Effects of lead poisoning on cognitive test performance.","7375299","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26933,D26933)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26933,M26933)","v":"Brain Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26933,N26933)","v":"DTXSID2024161"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26933,J26933)","v":"968689"},"Lead encephalopathy: case reports.","968689","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26954,D26954)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26954,M26954)","v":"Brain Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26954,N26954)","v":"DTXSID2024161"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26954,J26954)","v":"4691065"},"Lead intoxication in children in Birmingham.","4691065","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C26994,D26994)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L26994,M26994)","v":"Brain Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N26994,N26994)","v":"DTXSID2024161"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J26994,J26994)","v":"236223"},"Neuropsychological manifestations of lead poisoning.","236223","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27027,D27027)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27027,M27027)","v":"Brain Neoplasms"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27027,N27027)","v":"DTXSID2024161"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27027,J27027)","v":"9830598"},"Brain cancer and occupational exposure to lead.","9830598","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27047,D27047)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27047,M27047)","v":"Central Nervous System Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27047,N27047)","v":"DTXSID2024161"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27047,J27047)","v":"4326632"},"Lead toxicity: a problem in environmental pathology.","4326632","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27062,D27062)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27062,M27062)","v":"Central Nervous System Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27062,N27062)","v":"DTXSID2024161"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27062,J27062)","v":"12851117"},"Relationship between oxidative stress, pathology, and behavioral signs of lead poisoning in mallards.","12851117","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27099,D27099)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27099,M27099)","v":"Demyelinating Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27099,N27099)","v":"DTXSID2024161"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27099,J27099)","v":"7452321"},"Blood nerve barrier in rat and cellular mechanisms of lead-induced segmental demyelination.","7452321","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27127,D27127)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27127,M27127)","v":"Hallucinations"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27127,N27127)","v":"DTXSID2024161"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27127,J27127)","v":"7056707"},"Organic lead encephalopathy: behavioral change and movement disorder following gasoline inhalation.","7056707","Neurologic Manifestations","D006212","Hallucinations","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27156,D27156)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27156,M27156)","v":"Hyperkinesis"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27156,N27156)","v":"DTXSID2024161"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27156,J27156)","v":"355634"},"Lead and human behaviour.","355634","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27167,D27167)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27167,M27167)","v":"Hypesthesia"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27167,N27167)","v":"DTXSID2024161"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27167,J27167)","v":"2823156"},"[Late sequelae of recurrent occupational lead poisoning--the status of the nervous system].","2823156","Neurologic Manifestations","D006987","Hypesthesia","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27191,D27191)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27191,M27191)","v":"Intellectual Disability"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27191,N27191)","v":"DTXSID2024161"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27191,J27191)","v":"423050"},"Neurologic effects of exposure to lead.","423050","Neurologic Manifestations","D008607","Intellectual Disability","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27224,D27224)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27224,M27224)","v":"Learning Disorders"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27224,N27224)","v":"DTXSID2024161"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27224,J27224)","v":"7598500"},"Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions.","7598500","Neurologic Manifestations","D007859","Learning Disorders","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27235,D27235)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27235,M27235)","v":"Learning Disorders"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27235,N27235)","v":"DTXSID2024161"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27235,J27235)","v":"27136451"},"Crumbling Infrastructure and Learning Impairment: A Call for Responsibility.","27136451","Neurologic Manifestations","D007859","Learning Disorders","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27259,D27259)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27259,M27259)","v":"Memory Disorders"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27259,N27259)","v":"DTXSID2024161"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27259,J27259)","v":"27936013"},"β-Asarone Rescues Pb-Induced Impairments of Spatial Memory and Synaptogenesis in Rats.","27936013","Neurologic Manifestations","D008569","Memory Disorders","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27292,D27292)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27292,M27292)","v":"Muscular Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27292,N27292)","v":"DTXSID2024161"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27292,J27292)","v":"9745908"},"Myopathy: a possible effect of chronic low level lead exposure.","9745908","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27324,D27324)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27324,M27324)","v":"Nervous System Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27324,N27324)","v":"DTXSID2024161"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27324,J27324)","v":"8409078"},"A review of persistent, low-grade lead challenge: neurological and cardiovascular consequences.","8409078","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27353,D27353)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27353,M27353)","v":"Nervous System Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27353,N27353)","v":"DTXSID2024161"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27353,J27353)","v":"4209446"},"[Exogenic toxic symptoms in the nervous system (author's transl)].","4209446","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27386,D27386)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27386,M27386)","v":"Nervous System Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27386,N27386)","v":"DTXSID2024161"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27386,J27386)","v":"16729647"},"[Chronic lead poisoning].","16729647","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27392,D27392)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27392,M27392)","v":"Nervous System Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27392,N27392)","v":"DTXSID2024161"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27392,J27392)","v":"198205"},"Toxicological properties of lead.","198205","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27421,D27421)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27421,M27421)","v":"Neuromuscular Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27421,N27421)","v":"DTXSID2024161"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27421,J27421)","v":"3015834"},"An unusual case of lead neuropathy.","3015834","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27448,D27448)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27448,M27448)","v":"Paresthesia"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27448,N27448)","v":"DTXSID2024161"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27448,J27448)","v":"9894292"},"[A brachial form of motor neuropathy caused by lead poisoning].","9894292","Neurologic Manifestations","D010292","Paresthesia","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27482,D27482)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27482,M27482)","v":"Peripheral Nervous System Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27482,N27482)","v":"DTXSID2024161"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27482,J27482)","v":"2823156"},"[Late sequelae of recurrent occupational lead poisoning--the status of the nervous system].","2823156","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27515,D27515)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27515,M27515)","v":"Peripheral Nervous System Diseases"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27515,N27515)","v":"DTXSID2024161"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27515,J27515)","v":"2165428"},"Physiological changes in the sciatic nerve endoneurium of lead-intoxicated rats: a model of endoneurial homeostasis.","2165428","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27537,D27537)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27537,M27537)","v":"Psychomotor Disorders"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27537,N27537)","v":"DTXSID2024161"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27537,J27537)","v":"7342780"},"Lead exposure and behavioral changes: comparisons of four occupational groups with different levels of lead absorption.","7342780","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27550,D27550)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27550,M27550)","v":"Seizures"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27550,N27550)","v":"DTXSID2024161"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27550,J27550)","v":"6307000"},"Indirectly acting neurotoxins.","6307000","Neurologic Manifestations","D012640","Seizures","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27583,D27583)","v":"Lead"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27583,M27583)","v":"Strabismus"},"D007854","Lead","7439-92-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27583,N27583)","v":"DTXSID2024161"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27583,J27583)","v":"1994698"},"Occupational lead exposure and strabismus in offspring: a case-control study.","1994698","Cranial Nerve Diseases","D013285","Strabismus","DTXSID2024161"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27605,D27605)","v":"lead acetate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27605,M27605)","v":"Hearing Loss, Noise-Induced"},"C008261","lead acetate","15347-57-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27605,N27605)","v":"DTXSID10274073"},2018,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27605,J27605)","v":"29746905"},"Chronic lead exposure induces cochlear oxidative stress and potentiates noise-induced hearing loss.","29746905","Neurologic Manifestations","D006317","Hearing Loss, Noise-Induced","DTXSID10274073"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27618,D27618)","v":"leflunomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27618,M27618)","v":"Cerebral Palsy"},"C045463","leflunomide","75706-12-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27618,N27618)","v":"DTXSID9023201"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27618,J27618)","v":"17602201"},"Maternal exposure to leflunomide associated with blindness and cerebral palsy.","17602201","Central Nervous System Diseases","D002547","Cerebral Palsy","DTXSID9023201"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27651,D27651)","v":"lenalidomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27651,M27651)","v":"Sleep Initiation and Maintenance Disorders"},"C467567","lenalidomide","191732-72-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27651,N27651)","v":"DTXSID8046664"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27651,J27651)","v":"23217273"},"Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus.","23217273","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID8046664"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27673,D27673)","v":"Leptophos"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27673,M27673)","v":"Nervous System Diseases"},"D010773","Leptophos","21609-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27673,N27673)","v":"DTXSID3040279"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27673,J27673)","v":"6184852"},"Delayed neurotoxicity resulting from administration of leptophos to the comb of domestic fowl.","6184852","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID3040279"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27712,D27712)","v":"Levamisole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27712,M27712)","v":"Encephalitis"},"D007978","Levamisole","16595-80-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27712,N27712)","v":"DTXSID7047518"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27712,J27712)","v":"1303843"},"[Relationship between levamisole and encephalitis syndrome].","1303843","Central Nervous System Diseases","D004660","Encephalitis","DTXSID7047518"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27741,D27741)","v":"Levamisole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27741,M27741)","v":"Nervous System Diseases"},"D007978","Levamisole","16595-80-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27741,N27741)","v":"DTXSID7047518"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27741,J27741)","v":"12567708"},"[Toxic effects of levamisole].","12567708","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7047518"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27766,D27766)","v":"Levofloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27766,M27766)","v":"Dysgeusia"},"D064704","Levofloxacin","100986-85-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27766,N27766)","v":"DTXSID0041060"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27766,J27766)","v":"24334337"},"Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis.","24334337","Neurologic Manifestations","D004408","Dysgeusia","DTXSID0041060"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27780,D27780)","v":"Levofloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27780,M27780)","v":"Optic Neuritis"},"D064704","Levofloxacin","100986-85-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27780,N27780)","v":"DTXSID0041060"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27780,J27780)","v":"22377742"},"Oral levofloxacin-induced optic neuritis progressing in loss of vision.","22377742","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID0041060"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27809,D27809)","v":"Levonorgestrel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27809,M27809)","v":"Myasthenia Gravis"},"D016912","Levonorgestrel","797-63-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27809,N27809)","v":"DTXSID3036496"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27809,J27809)","v":"7491061"},"Myasthenia gravis and levonorgestrel implant.","7491061","Autoimmune Diseases of the Nervous System","D009157","Myasthenia Gravis","DTXSID3036496"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27834,D27834)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27834,M27834)","v":"Blindness"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27834,N27834)","v":"DTXSID80209953"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27834,J27834)","v":"9292686"},"Transient no light perception visual acuity after intracameral lidocaine injection.","9292686","Neurologic Manifestations","D001766","Blindness","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27870,D27870)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27870,M27870)","v":"Confusion"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27870,N27870)","v":"DTXSID80209953"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27870,J27870)","v":"6553038"},"Routine prophylactic lidocaine in acute myocardial infarction.","6553038","Neurologic Manifestations","D003221","Confusion","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27886,D27886)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27886,M27886)","v":"Diplopia"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27886,N27886)","v":"DTXSID80209953"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27886,J27886)","v":"15177599"},"Persistent diplopia after retrobulbar anesthesia.","15177599","Neurologic Manifestations","D004172","Diplopia","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27909,D27909)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27909,M27909)","v":"Epilepsy, Tonic-Clonic"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27909,N27909)","v":"DTXSID80209953"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27909,J27909)","v":"4625728"},"Lignocaine overdose and ampoule labelling.","4625728","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27938,D27938)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27938,M27938)","v":"Hyperalgesia"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27938,N27938)","v":"DTXSID80209953"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27938,J27938)","v":"19224819"},"Lidocaine injection into the rat dorsal root ganglion causes neuroinflammation.","19224819","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27954,D27954)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27954,M27954)","v":"Muscle Weakness"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27954,N27954)","v":"DTXSID80209953"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27954,J27954)","v":"27662067"},"Local Anesthetic-Induced Myotoxicity After Continuous Adductor Canal Block.","27662067","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C27977,D27977)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L27977,M27977)","v":"Nervous System Diseases"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N27977,N27977)","v":"DTXSID80209953"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J27977,J27977)","v":"9526941"},"Cauda equina syndrome after incidental total spinal anesthesia with 2% lidocaine.","9526941","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28006,D28006)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28006,M28006)","v":"Ophthalmoplegia"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28006,N28006)","v":"DTXSID80209953"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28006,J28006)","v":"7644801"},"[Internuclear ophthalmoplegia in relation to lidocaine and pentothal].","7644801","Neurologic Manifestations","D009886","Ophthalmoplegia","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28047,D28047)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28047,M28047)","v":"Polyradiculopathy"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28047,N28047)","v":"DTXSID80209953"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28047,J28047)","v":"12430107"},"Local anesthetic neurotoxicity: clinical injury and strategies that may minimize risk.","12430107","Neuromuscular Diseases","D011128","Polyradiculopathy","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28067,D28067)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28067,M28067)","v":"Respiratory Paralysis"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28067,N28067)","v":"DTXSID80209953"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28067,J28067)","v":"945016"},"An unusual complication of lumbosacral plexus block: a case report.","945016","Neurologic Manifestations","D012133","Respiratory Paralysis","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28100,D28100)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28100,M28100)","v":"Seizures"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28100,N28100)","v":"DTXSID80209953"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28100,J28100)","v":"8000199"},"Propofol prevents or elevates the threshold for lidocaine-induced seizures in rats.","8000199","Neurologic Manifestations","D012640","Seizures","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28115,D28115)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28115,M28115)","v":"Seizures"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28115,N28115)","v":"DTXSID80209953"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28115,J28115)","v":"4037401"},"Toxicity and resuscitation in lidocaine- or bupivacaine-infused cats.","4037401","Neurologic Manifestations","D012640","Seizures","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28135,D28135)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28135,M28135)","v":"Seizures"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28135,N28135)","v":"DTXSID80209953"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28135,J28135)","v":"279595"},"Alteration of lidocaine-induced convulsions by meperidine and nitrous oxide.","279595","Neurologic Manifestations","D012640","Seizures","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28168,D28168)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28168,M28168)","v":"Seizures"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28168,N28168)","v":"DTXSID80209953"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28168,J28168)","v":"5695299"},"EEG evaluation of lidocaine convulsions.","5695299","Neurologic Manifestations","D012640","Seizures","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28183,D28183)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28183,M28183)","v":"Seizures"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28183,N28183)","v":"DTXSID80209953"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28183,J28183)","v":"16321"},"Cardiorespiratory and behavioral reactions to the lidocaine-induced convulsions in the dog.","16321","Neurologic Manifestations","D012640","Seizures","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28229,D28229)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28229,M28229)","v":"Sensation Disorders"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28229,N28229)","v":"DTXSID80209953"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28229,J28229)","v":"1343088"},"Accidental total spinal block: a complication of an epidural test dose.","1343088","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28235,D28235)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28235,M28235)","v":"Spasm"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28235,N28235)","v":"DTXSID80209953"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28235,J28235)","v":"12969115"},"Does lidocaine provoke clinically significant vasospasm?","12969115","Neurologic Manifestations","D013035","Spasm","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28264,D28264)","v":"Lidocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28264,M28264)","v":"Unconsciousness"},"D008012","Lidocaine","6108-05-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28264,N28264)","v":"DTXSID80209953"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28264,J28264)","v":"20151528"},"[Loss of consciousness and respiratory depression after a retrobulbar intraorbital block for eye surgery: a case report].","20151528","Neurologic Manifestations","D014474","Unconsciousness","DTXSID80209953"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28297,D28297)","v":"Lincomycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28297,M28297)","v":"Respiratory Paralysis"},"D008034","Lincomycin","859-18-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28297,N28297)","v":"DTXSID7047803"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28297,J28297)","v":"1167742"},"Lincomycin-curare interaction.","1167742","Neurologic Manifestations","D012133","Respiratory Paralysis","DTXSID7047803"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28328,D28328)","v":"Lindane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28328,M28328)","v":"Seizures"},"D001556","Lindane","58-89-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28328,N28328)","v":"DTXSID2020686"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28328,J28328)","v":"7689801"},"Cholestyramine as an adsorbent in acute lindane poisoning: a murine model.","7689801","Neurologic Manifestations","D012640","Seizures","DTXSID2020686"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28358,D28358)","v":"Lindane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28358,M28358)","v":"Seizures"},"D001556","Lindane","58-89-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28358,N28358)","v":"DTXSID2020686"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28358,J28358)","v":"2410825"},"Effects of lindane-type insecticides in mammals: unsolved problems.","2410825","Neurologic Manifestations","D012640","Seizures","DTXSID2020686"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28365,D28365)","v":"Lindane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28365,M28365)","v":"Seizures"},"D001556","Lindane","58-89-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28365,N28365)","v":"DTXSID2020686"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28365,J28365)","v":"2451320"},"CNS biochemical and pharmacological effects of the isomers of hexachlorocyclohexane (lindane) in the mouse.","2451320","Neurologic Manifestations","D012640","Seizures","DTXSID2020686"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28392,D28392)","v":"Linezolid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28392,M28392)","v":"Hearing Loss, Bilateral"},"D000069349","Linezolid","165800-03-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28392,N28392)","v":"DTXSID5046489"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28392,J28392)","v":"19131899"},"Auditory nerve neuropathy in a neonate after linezolid treatment.","19131899","Neurologic Manifestations","D006312","Hearing Loss, Bilateral","DTXSID5046489"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28426,D28426)","v":"Linezolid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28426,M28426)","v":"Optic Nerve Diseases"},"D000069349","Linezolid","165800-03-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28426,N28426)","v":"DTXSID5046489"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28426,J28426)","v":"12225284"},"Linezolid-induced neuropathy.","12225284","Cranial Nerve Diseases","D009901","Optic Nerve Diseases","DTXSID5046489"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28459,D28459)","v":"Linezolid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28459,M28459)","v":"Vision Disorders"},"D000069349","Linezolid","165800-03-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28459,N28459)","v":"DTXSID5046489"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28459,J28459)","v":"17179125"},"Linezolid-induced optic neuropathy: a mitochondrial disorder?","17179125","Neurologic Manifestations","D014786","Vision Disorders","DTXSID5046489"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28485,D28485)","v":"Lisdexamfetamine Dimesylate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28485,M28485)","v":"Sleep Initiation and Maintenance Disorders"},"D000069478","Lisdexamfetamine Dimesylate","608137-33-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28485,N28485)","v":"DTXSID60209653"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28485,J28485)","v":"21824454"},"Impact of stimulant pharmacotherapy on sleep quality: post hoc analyses of 2 large, double-blind, randomized, placebo-controlled trials.","21824454","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID60209653"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28494,D28494)","v":"Lisuride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28494,M28494)","v":"Somnambulism"},"D008090","Lisuride","140387-89-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28494,N28494)","v":"DTXSID30274075"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28494,J28494)","v":"3776723"},"[Somnambulism as a result of dopaminomimetics?].","3776723","Sleep Wake Disorders","D013009","Somnambulism","DTXSID30274075"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28527,D28527)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28527,M28527)","v":"Ataxia"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28527,N28527)","v":"DTXSID5036761"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28527,J28527)","v":"24579242"},"Drug-related admissions due to interaction with an old drug, lithium.","24579242","Neurologic Manifestations","D001259","Ataxia","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28553,D28553)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28553,M28553)","v":"Basal Ganglia Diseases"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28553,N28553)","v":"DTXSID5036761"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28553,J28553)","v":"476365"},"Brain damage with lithium/haloperidol.","476365","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28588,D28588)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28588,M28588)","v":"Brain Diseases"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28588,N28588)","v":"DTXSID5036761"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28588,J28588)","v":"2732745"},"Reversible lithium neurotoxicity at normal serum level may refer to intracranial pathology.","2732745","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28605,D28605)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28605,M28605)","v":"Central Nervous System Diseases"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28605,N28605)","v":"DTXSID5036761"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28605,J28605)","v":"6797383"},"Clinical and neuropathological aspects of long-term damage to the central nervous system after lithium medication.","6797383","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28623,D28623)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28623,M28623)","v":"Cerebellar Ataxia"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28623,N28623)","v":"DTXSID5036761"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28623,J28623)","v":"3106579"},"Cerebellar syndrome in lithium poisoning: a case of partial recovery.","3106579","Central Nervous System Diseases","D002524","Cerebellar Ataxia","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28656,D28656)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28656,M28656)","v":"Chorea"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28656,N28656)","v":"DTXSID5036761"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28656,J28656)","v":"2512332"},"Choreoathetosis induced by verapamil and lithium treatment.","2512332","Central Nervous System Diseases","D002819","Chorea","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28673,D28673)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28673,M28673)","v":"Coma"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28673,N28673)","v":"DTXSID5036761"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28673,J28673)","v":"2773973"},"Myxedema coma associated with lithium therapy.","2773973","Neurologic Manifestations","D003128","Coma","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28717,D28717)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28717,M28717)","v":"Creutzfeldt-Jakob Syndrome"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28717,N28717)","v":"DTXSID5036761"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28717,J28717)","v":"2494302"},"A Creutzfeldt-Jakob like syndrome due to lithium toxicity.","2494302","Central Nervous System Diseases","D007562","Creutzfeldt-Jakob Syndrome","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28746,D28746)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28746,M28746)","v":"Diplopia"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28746,N28746)","v":"DTXSID5036761"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28746,J28746)","v":"6813010"},"[A case of malignant syndrome with persistent nystagmus and diplopia].","6813010","Neurologic Manifestations","D004172","Diplopia","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28766,D28766)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28766,M28766)","v":"Epilepsies, Partial"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28766,N28766)","v":"DTXSID5036761"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28766,J28766)","v":"3081054"},"EEG observations during combined haloperidol-lithium treatment.","3081054","Central Nervous System Diseases","D004828","Epilepsies, Partial","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28785,D28785)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28785,M28785)","v":"Epilepsy, Tonic-Clonic"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28785,N28785)","v":"DTXSID5036761"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28785,J28785)","v":"8043101"},"Propofol, seizure and antidepressants.","8043101","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28814,D28814)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28814,M28814)","v":"Memory Disorders"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28814,N28814)","v":"DTXSID5036761"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28814,J28814)","v":"4826041"},"Lithium treatment of depression.","4826041","Neurologic Manifestations","D008569","Memory Disorders","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28834,D28834)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28834,M28834)","v":"Muscle Cramp"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28834,N28834)","v":"DTXSID5036761"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28834,J28834)","v":"3132325"},"Writers' cramp associated with lithium.","3132325","Neurologic Manifestations","D009120","Muscle Cramp","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28853,D28853)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28853,M28853)","v":"Muscular Diseases"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28853,N28853)","v":"DTXSID5036761"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28853,J28853)","v":"6438414"},"[Toxic myopathy caused by lithium carbonate: apropos of a case].","6438414","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28882,D28882)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28882,M28882)","v":"Nervous System Diseases"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28882,N28882)","v":"DTXSID5036761"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28882,J28882)","v":"6433860"},"Lithium salt intoxication and neurologic sequelae.","6433860","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28902,D28902)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28902,M28902)","v":"Nervous System Diseases"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28902,N28902)","v":"DTXSID5036761"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28902,J28902)","v":"2717661"},"The syndrome of irreversible lithium-effectuated neurotoxicity (SILENT).","2717661","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28943,D28943)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28943,M28943)","v":"Nystagmus, Pathologic"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28943,N28943)","v":"DTXSID5036761"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28943,J28943)","v":"4758552"},"Letter: Permanent brain damage after lithium intoxication.","4758552","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28954,D28954)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28954,M28954)","v":"Nystagmus, Pathologic"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28954,N28954)","v":"DTXSID5036761"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28954,J28954)","v":"212241"},"[A case with neurological disturbances due to lithium intoxication--a special reference to peripheral neuropathy and cerebellar involvement (author's transl)].","212241","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C28982,D28982)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L28982,M28982)","v":"Parkinson Disease, Secondary"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N28982,N28982)","v":"DTXSID5036761"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J28982,J28982)","v":"5552974"},"[Remarkable thymoanaleptic effect of lithium gluconate in recurrent melancholic states].","5552974","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29011,D29011)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29011,M29011)","v":"Sagittal Sinus Thrombosis"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29011,N29011)","v":"DTXSID5036761"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29011,J29011)","v":"10668740"},"Superior sagittal sinus thrombosis due to lithium: local urokinase thrombolysis treatment.","10668740","Central Nervous System Diseases","D020225","Sagittal Sinus Thrombosis","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29047,D29047)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29047,M29047)","v":"Sleep Wake Disorders"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29047,N29047)","v":"DTXSID5036761"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29047,J29047)","v":"346519"},"[Symptomatology and therapy of lithium intoxication].","346519","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29076,D29076)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29076,M29076)","v":"Stuttering"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29076,N29076)","v":"DTXSID5036761"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29076,J29076)","v":"11485152"},"Lithium-induced exacerbation of stutter.","11485152","Neurologic Manifestations","D013342","Stuttering","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29105,D29105)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29105,M29105)","v":"Tremor"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29105,N29105)","v":"DTXSID5036761"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29105,J29105)","v":"7457166"},"Clinically significant side effects of lithium treatment. A survey of 237 patients in long-term treatment.","7457166","Neurologic Manifestations","D014202","Tremor","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29115,D29115)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29115,M29115)","v":"Tremor"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29115,N29115)","v":"DTXSID5036761"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29115,J29115)","v":"917159"},"[Ten years lithium catamnesis (author's transl)].","917159","Neurologic Manifestations","D014202","Tremor","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29140,D29140)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29140,M29140)","v":"Tremor"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29140,N29140)","v":"DTXSID5036761"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29140,J29140)","v":"372839"},"The profile and severity of lithium-induced side effects in mentally healthy subjects.","372839","Neurologic Manifestations","D014202","Tremor","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29173,D29173)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29173,M29173)","v":"Tremor"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29173,N29173)","v":"DTXSID5036761"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29173,J29173)","v":"1221796"},"[Proceedings: Tremors as an adverse effect of lithium therapy].","1221796","Neurologic Manifestations","D014202","Tremor","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29183,D29183)","v":"Lithium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29183,M29183)","v":"Vertigo"},"D008094","Lithium","7439-93-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29183,N29183)","v":"DTXSID5036761"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29183,J29183)","v":"1111885"},"Letter: Side effects from lithium.","1111885","Neurologic Manifestations","D014717","Vertigo","DTXSID5036761"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29208,D29208)","v":"Lithium Carbonate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29208,M29208)","v":"Basal Ganglia Diseases"},"D016651","Lithium Carbonate","554-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29208,N29208)","v":"DTXSID1023784"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29208,J29208)","v":"6426962"},"Oculogyric crisis induced by lithium carbonate.","6426962","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID1023784"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29241,D29241)","v":"Lithium Carbonate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29241,M29241)","v":"Cerebellar Ataxia"},"D016651","Lithium Carbonate","554-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29241,N29241)","v":"DTXSID1023784"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29241,J29241)","v":"3130040"},"A case of lithium intoxication with downbeat vertical nystagmus.","3130040","Central Nervous System Diseases","D002524","Cerebellar Ataxia","DTXSID1023784"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29272,D29272)","v":"Lithium Carbonate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29272,M29272)","v":"Creutzfeldt-Jakob Syndrome"},"D016651","Lithium Carbonate","554-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29272,N29272)","v":"DTXSID1023784"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29272,J29272)","v":"2494302"},"A Creutzfeldt-Jakob like syndrome due to lithium toxicity.","2494302","Central Nervous System Diseases","D007562","Creutzfeldt-Jakob Syndrome","DTXSID1023784"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29302,D29302)","v":"Lithium Carbonate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29302,M29302)","v":"Memory Disorders"},"D016651","Lithium Carbonate","554-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29302,N29302)","v":"DTXSID1023784"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29302,J29302)","v":"28802897"},"The different effects of lithium and tamoxifen on memory formation and the levels of neurotrophic factors in the brain of male and female rats.","28802897","Neurologic Manifestations","D008569","Memory Disorders","DTXSID1023784"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29328,D29328)","v":"Lithium Carbonate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29328,M29328)","v":"Nervous System Diseases"},"D016651","Lithium Carbonate","554-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29328,N29328)","v":"DTXSID1023784"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29328,J29328)","v":"2500494"},"Severe lithium toxicity treated by hemodialysis: a case report.","2500494","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1023784"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29337,D29337)","v":"Lithium Carbonate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29337,M29337)","v":"Nystagmus, Pathologic"},"D016651","Lithium Carbonate","554-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29337,N29337)","v":"DTXSID1023784"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29337,J29337)","v":"6813010"},"[A case of malignant syndrome with persistent nystagmus and diplopia].","6813010","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID1023784"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29370,D29370)","v":"Lithium Carbonate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29370,M29370)","v":"Pseudotumor Cerebri"},"D016651","Lithium Carbonate","554-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29370,N29370)","v":"DTXSID1023784"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29370,J29370)","v":"7962691"},"The natural course of pseudotumor cerebri in lithium-treated patients.","7962691","Central Nervous System Diseases","D011559","Pseudotumor Cerebri","DTXSID1023784"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29396,D29396)","v":"Lithium Carbonate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29396,M29396)","v":"Subarachnoid Hemorrhage, Traumatic"},"D016651","Lithium Carbonate","554-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29396,N29396)","v":"DTXSID1023784"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29396,J29396)","v":"23066556"},"Lithium induced diabetes insipidus, trauma and the shrunken brain.","23066556","Trauma, Nervous System","D020206","Subarachnoid Hemorrhage, Traumatic","DTXSID1023784"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29431,D29431)","v":"Lithium Chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29431,M29431)","v":"Seizures"},"D018021","Lithium Chloride","7447-41-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29431,N29431)","v":"DTXSID2025509"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29431,J29431)","v":"6301005"},"Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats.","6301005","Neurologic Manifestations","D012640","Seizures","DTXSID2025509"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29464,D29464)","v":"Lorazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29464,M29464)","v":"Amnesia"},"D008140","Lorazepam","846-49-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29464,N29464)","v":"DTXSID7023225"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29464,J29464)","v":"6643396"},"Anterograde amnesia with oral lorazepam.","6643396","Neurologic Manifestations","D000647","Amnesia","DTXSID7023225"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29485,D29485)","v":"Lorazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29485,M29485)","v":"Catatonia"},"D008140","Lorazepam","846-49-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29485,N29485)","v":"DTXSID7023225"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29485,J29485)","v":"22495953"},"Recurrent clozapine and lorazepam withdrawal psychosis with catatonia.","22495953","Neurologic Manifestations","D002389","Catatonia","DTXSID7023225"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29499,D29499)","v":"Lorazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29499,M29499)","v":"Delirium"},"D008140","Lorazepam","846-49-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29499,N29499)","v":"DTXSID7023225"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29499,J29499)","v":"3988969"},"Inpatient clinical trial of lorazepam for the management of manic agitation.","3988969","Neurologic Manifestations","D003693","Delirium","DTXSID7023225"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29532,D29532)","v":"Lorazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29532,M29532)","v":"Seizures"},"D008140","Lorazepam","846-49-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29532,N29532)","v":"DTXSID7023225"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29532,J29532)","v":"8707372"},"Effect of calcium channel blockers on withdrawal syndrome of lorazepam in rats.","8707372","Neurologic Manifestations","D012640","Seizures","DTXSID7023225"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29553,D29553)","v":"Lorazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29553,M29553)","v":"Tinnitus"},"D008140","Lorazepam","846-49-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29553,N29553)","v":"DTXSID7023225"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29553,J29553)","v":"12420663"},"Musical hallucinations during a treatment with benzodiazepine.","12420663","Neurologic Manifestations","D014012","Tinnitus","DTXSID7023225"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29567,D29567)","v":"Losartan"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29567,M29567)","v":"Dysgeusia"},"D019808","Losartan","124750-99-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29567,N29567)","v":"DTXSID3044209"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29567,J29567)","v":"9653007"},"Reversible dysgeusia attributed to losartan.","9653007","Neurologic Manifestations","D004408","Dysgeusia","DTXSID3044209"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29600,D29600)","v":"Lovastatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29600,M29600)","v":"Muscular Diseases"},"D008148","Lovastatin","75330-75-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29600,N29600)","v":"DTXSID5020784"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29600,J29600)","v":"3055921"},"Efficacy and long-term adverse effect pattern of lovastatin.","3055921","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID5020784"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29621,D29621)","v":"Lovastatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29621,M29621)","v":"Myositis"},"D008148","Lovastatin","75330-75-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29621,N29621)","v":"DTXSID5020784"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29621,J29621)","v":"3312981"},"Lovastatin for hypercholesterolemia.","3312981","Neuromuscular Diseases","D009220","Myositis","DTXSID5020784"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29661,D29661)","v":"Loxapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29661,M29661)","v":"Epilepsy, Tonic-Clonic"},"D008152","Loxapine","54810-23-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29661,N29661)","v":"DTXSID70203304"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29661,J29661)","v":"6770772"},"Loxapine-associated rhabdomyolysis and acute renal failure.","6770772","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID70203304"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29673,D29673)","v":"Loxapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29673,M29673)","v":"Unconsciousness"},"D008152","Loxapine","54810-23-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29673,N29673)","v":"DTXSID70203304"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29673,J29673)","v":"7258388"},"Seizures induced by acute loxapine overdose.","7258388","Neurologic Manifestations","D014474","Unconsciousness","DTXSID70203304"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29696,D29696)","v":"Lysergic Acid Diethylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29696,M29696)","v":"Coma"},"D008238","Lysergic Acid Diethylamide","50-37-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29696,N29696)","v":"DTXSID1023231"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29696,J29696)","v":"4816396"},"Coma, hyperthermia and bleeding associated with massive LSD overdose. A report of eight cases.","4816396","Neurologic Manifestations","D003128","Coma","DTXSID1023231"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29729,D29729)","v":"Lysergic Acid Diethylamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29729,M29729)","v":"Hallucinations"},"D008238","Lysergic Acid Diethylamide","50-37-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29729,N29729)","v":"DTXSID1023231"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29729,J29729)","v":"19927262"},"A case of persistent visual hallucinations of faces following LSD abuse: a functional Magnetic Resonance Imaging study.","19927262","Neurologic Manifestations","D006212","Hallucinations","DTXSID1023231"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29766,D29766)","v":"Magnesium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29766,M29766)","v":"Cerebral Hemorrhage"},"D008274","Magnesium","7439-95-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29766,N29766)","v":"DTXSID0049658"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29766,J29766)","v":"23020646"},"Umbilical artery pH may be a possible confounder for neonatal adverse outcomes in preterm infants exposed to antenatal magnesium.","23020646","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID0049658"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29790,D29790)","v":"Magnesium Sulfate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29790,M29790)","v":"Cerebral Hemorrhage"},"D008278","Magnesium Sulfate","10034-99-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29790,N29790)","v":"DTXSID5040544"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29790,J29790)","v":"8885773"},"Effect of dual tocolysis on the incidence of severe intraventricular hemorrhage among extremely low-birth-weight infants.","8885773","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID5040544"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29819,D29819)","v":"Magnesium Sulfate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29819,M29819)","v":"Neuromuscular Diseases"},"D008278","Magnesium Sulfate","10034-99-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29819,N29819)","v":"DTXSID5040544"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29819,J29819)","v":"20006421"},"Neuromuscular blockade after therapy with magnesium sulfate and amlodipine.","20006421","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID5040544"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29834,D29834)","v":"Malathion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29834,M29834)","v":"Autonomic Nervous System Diseases"},"D008294","Malathion","121-75-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29834,N29834)","v":"DTXSID4020791"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29834,J29834)","v":"17418356"},"[Clinical and electrophysiological aspects of acute organophosphate intoxication].","17418356","Autonomic Nervous System Diseases","D001342","Autonomic Nervous System Diseases","DTXSID4020791"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29858,D29858)","v":"Malathion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29858,M29858)","v":"Paralysis"},"D008294","Malathion","121-75-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29858,N29858)","v":"DTXSID4020791"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29858,J29858)","v":"646252"},"Late onset of neuromuscular block in organophosphorus poisoning.","646252","Neurologic Manifestations","D010243","Paralysis","DTXSID4020791"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29887,D29887)","v":"Maneb"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29887,M29887)","v":"Hemiplegia"},"D008344","Maneb","12427-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29887,N29887)","v":"DTXSID9020794"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29887,J29887)","v":"6857188"},"Acute intoxication due to exposure to maneb and zineb. A case with behavioral and central nervous system changes.","6857188","Neurologic Manifestations","D006429","Hemiplegia","DTXSID9020794"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29902,D29902)","v":"Maneb"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29902,M29902)","v":"Parkinsonian Disorders"},"D008344","Maneb","12427-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29902,N29902)","v":"DTXSID9020794"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29902,J29902)","v":"16242641"},"Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats.","16242641","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID9020794"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29926,D29926)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29926,M29926)","v":"Basal Ganglia Diseases"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29926,N29926)","v":"DTXSID2024169"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29926,J29926)","v":"6470478"},"Manganese: a review of occupational and environmental toxicology.","6470478","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29955,D29955)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29955,M29955)","v":"Brain Diseases"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29955,N29955)","v":"DTXSID2024169"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29955,J29955)","v":"15128159"},"High signal intensities on T1-weighted MRI as a biomarker of exposure to manganese.","15128159","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C29995,D29995)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L29995,M29995)","v":"Gait Disorders, Neurologic"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N29995,N29995)","v":"DTXSID2024169"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J29995,J29995)","v":"21596707"},"Manganese toxicity in a child with iron deficiency and polycythemia.","21596707","Neurologic Manifestations","D020233","Gait Disorders, Neurologic","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30016,D30016)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30016,M30016)","v":"Memory Disorders"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30016,N30016)","v":"DTXSID2024169"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30016,J30016)","v":"19963104"},"Manganese exposure among smelting workers: relationship between blood manganese-iron ratio and early onset neurobehavioral alterations.","19963104","Neurologic Manifestations","D008569","Memory Disorders","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30047,D30047)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30047,M30047)","v":"Nervous System Diseases"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30047,N30047)","v":"DTXSID2024169"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30047,J30047)","v":"7936281"},"Levodopa failure in chronic manganism.","7936281","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30055,D30055)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30055,M30055)","v":"Nervous System Diseases"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30055,N30055)","v":"DTXSID2024169"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30055,J30055)","v":"871441"},"Occupational exposure to manganese.","871441","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30084,D30084)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30084,M30084)","v":"Nervous System Diseases"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30084,N30084)","v":"DTXSID2024169"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30084,J30084)","v":"23152376"},"Protective effects of dietary fibre against manganese-induced neurobehavioral aberrations in rats.","23152376","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30115,D30115)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30115,M30115)","v":"Olfaction Disorders"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30115,N30115)","v":"DTXSID2024169"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30115,J30115)","v":"22285144"},"ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese.","22285144","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30145,D30145)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30145,M30145)","v":"Parkinson Disease, Secondary"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30145,N30145)","v":"DTXSID2024169"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30145,J30145)","v":"28320285"},"Cells Resistant to Toxic Concentrations of Manganese Have Increased Ability to Repair DNA.","28320285","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30178,D30178)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30178,M30178)","v":"Parkinson Disease, Secondary"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30178,N30178)","v":"DTXSID2024169"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30178,J30178)","v":"10846719"},"[Follow-up study after enteral manganese poisoning: clinical, laboratory and neuroradiological findings].","10846719","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30183,D30183)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30183,M30183)","v":"Parkinson Disease, Secondary"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30183,N30183)","v":"DTXSID2024169"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30183,J30183)","v":"12738847"},"Manganese: a high-octane dispute.","12738847","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30213,D30213)","v":"Manganese"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30213,M30213)","v":"Perceptual Disorders"},"D008345","Manganese","7439-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30213,N30213)","v":"DTXSID2024169"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30213,J30213)","v":"26215118"},"Developmental exposure to manganese induces lasting motor and cognitive impairment in rats.","26215118","Neurologic Manifestations","D010468","Perceptual Disorders","DTXSID2024169"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30246,D30246)","v":"manganese chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30246,M30246)","v":"Parkinson Disease, Secondary"},"C025340","manganese chloride","7773-01-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30246,N30246)","v":"DTXSID9040681"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30246,J30246)","v":"4047404"},"[Gamma-aminobutyric acid (GABA) levels and glutamate decarboxylase (GAD) activity of the brain of rats with extrapyramidal syndrome after acute manganese chloride poisoning].","4047404","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID9040681"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30276,D30276)","v":"Maprotiline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30276,M30276)","v":"Brain Damage, Chronic"},"D008376","Maprotiline","58902-67-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30276,N30276)","v":"DTXSID30207646"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30276,J30276)","v":"11987023"},"[QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline].","11987023","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID30207646"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30307,D30307)","v":"Maprotiline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30307,M30307)","v":"Hemiplegia"},"D008376","Maprotiline","58902-67-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30307,N30307)","v":"DTXSID30207646"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30307,J30307)","v":"2003213"},"[Concerning \"Hemiparesis and torsades de pointes with low dosage sotalol therapy\" by C. Sieber, Ph. Weiss and F. Follath (Schweiz. med. Wschr. 1990; 120: 1397-1399)].","2003213","Neurologic Manifestations","D006429","Hemiplegia","DTXSID30207646"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30314,D30314)","v":"Maprotiline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30314,M30314)","v":"Seizures"},"D008376","Maprotiline","58902-67-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30314,N30314)","v":"DTXSID30207646"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30314,J30314)","v":"7091439"},"More on maprotiline-induced seizures.","7091439","Neurologic Manifestations","D012640","Seizures","DTXSID30207646"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30340,D30340)","v":"MDV 3100"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30340,M30340)","v":"Seizures"},"C540278","MDV 3100",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30340,N30340)","v":"DTXSID10912307"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30340,J30340)","v":"22894553"},"Increased survival with enzalutamide in prostate cancer after chemotherapy.","22894553","Neurologic Manifestations","D012640","Seizures","DTXSID10912307"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30375,D30375)","v":"Medroxyprogesterone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30375,M30375)","v":"Decerebrate State"},"D008525","Medroxyprogesterone","520-85-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30375,N30375)","v":"DTXSID0036508"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30375,J30375)","v":"5818499"},"Bilateral carotid artery occlusion in a young adult. Clinicopathological report of a case associated with oral contraceptives.","5818499","Neurologic Manifestations","D003655","Decerebrate State","DTXSID0036508"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30396,D30396)","v":"Medroxyprogesterone Acetate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30396,M30396)","v":"Muscle Weakness"},"D017258","Medroxyprogesterone Acetate","71-58-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30396,N30396)","v":"DTXSID0025527"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30396,J30396)","v":"8522428"},"Progestogens and Cushing's syndrome.","8522428","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID0025527"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30436,D30436)","v":"Mefloquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30436,M30436)","v":"Epilepsies, Myoclonic"},"D015767","Mefloquine","53230-10-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30436,N30436)","v":"DTXSID4037168"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30436,J30436)","v":"1795756"},"[Suspected convulsive side-effect of mefloquine (Lariam)].","1795756","Central Nervous System Diseases","D004831","Epilepsies, Myoclonic","DTXSID4037168"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30443,D30443)","v":"Mefloquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30443,M30443)","v":"Epilepsy, Tonic-Clonic"},"D015767","Mefloquine","53230-10-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30443,N30443)","v":"DTXSID4037168"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30443,J30443)","v":"1795756"},"[Suspected convulsive side-effect of mefloquine (Lariam)].","1795756","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID4037168"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30489,D30489)","v":"Mefloquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30489,M30489)","v":"Seizures"},"D015767","Mefloquine","53230-10-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30489,N30489)","v":"DTXSID4037168"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30489,J30489)","v":"10086156"},"[Convulsions during prophylactic use of mefloquine].","10086156","Neurologic Manifestations","D012640","Seizures","DTXSID4037168"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30504,D30504)","v":"Mefloquine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30504,M30504)","v":"Trigeminal Nerve Diseases"},"D015767","Mefloquine","53230-10-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30504,N30504)","v":"DTXSID4037168"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30504,J30504)","v":"11505262"},"Mefloquine-induced trigeminal sensory neuropathy.","11505262","Cranial Nerve Diseases","D020433","Trigeminal Nerve Diseases","DTXSID4037168"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30537,D30537)","v":"Meglumine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30537,M30537)","v":"Meningitis"},"D008536","Meglumine","6284-40-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30537,N30537)","v":"DTXSID0023244"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30537,J30537)","v":"4060930"},"[Complications following myelography with positive contrast media (Pantopaque, Amipaque). Pathomorphologic findings in 2 fatal cases].","4060930","Central Nervous System Diseases","D008581","Meningitis","DTXSID0023244"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30553,D30553)","v":"Melarsoprol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30553,M30553)","v":"Brain Diseases"},"D008549","Melarsoprol",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30553,N30553)","v":"DTXSID90862033"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30553,J30553)","v":"7496198"},"[2 epidemics of arsenical encephalopathy in the treatment of trypanosomiasis, Uganda, 1992-1993].","7496198","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID90862033"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30572,D30572)","v":"Melarsoprol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30572,M30572)","v":"Polyradiculoneuropathy"},"D008549","Melarsoprol",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30572,N30572)","v":"DTXSID90862033"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30572,J30572)","v":"2167451"},"Organic arsenic-induced Guillain-Barré-like syndrome due to melarsoprol: a clinical, electrophysiological, and pathological study.","2167451","Demyelinating Diseases","D011129","Polyradiculoneuropathy","DTXSID90862033"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30605,D30605)","v":"Memantine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30605,M30605)","v":"Syncope"},"D008559","Memantine","19982-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30605,N30605)","v":"DTXSID5045174"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30605,J30605)","v":"22084357"},"ACP Journal Club. Review: cholinesterase inhibitors but not memantine increase syncope in older adults with mild cognitive impairment or dementia.","22084357","Neurologic Manifestations","D013575","Syncope","DTXSID5045174"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30621,D30621)","v":"Meperidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30621,M30621)","v":"Central Nervous System Diseases"},"D008614","Meperidine","57-42-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30621,N30621)","v":"DTXSID9023253"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30621,J30621)","v":"6561927"},"Problems with meperidine.","6561927","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID9023253"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30666,D30666)","v":"Meperidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30666,M30666)","v":"Ocular Motility Disorders"},"D008614","Meperidine","57-42-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30666,N30666)","v":"DTXSID9023253"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30666,J30666)","v":"24618873"},"Cerebellar and oculomotor dysfunction induced by rapid infusion of pethidine.","24618873","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID9023253"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30695,D30695)","v":"Meperidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30695,M30695)","v":"Seizures"},"D008614","Meperidine","57-42-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30695,N30695)","v":"DTXSID9023253"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30695,J30695)","v":"10389564"},"Norpethidine accumulation and generalized seizure during pethidine patient-controlled analgesia.","10389564","Neurologic Manifestations","D012640","Seizures","DTXSID9023253"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30714,D30714)","v":"Mepivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30714,M30714)","v":"Central Nervous System Diseases"},"D008619","Mepivacaine","96-88-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30714,N30714)","v":"DTXSID9023259"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30714,J30714)","v":"987956"},"[Complications of local anesthetics in obstetrics as well as in the perinatal period].","987956","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID9023259"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30734,D30734)","v":"Mepivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30734,M30734)","v":"Paraplegia"},"D008619","Mepivacaine","96-88-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30734,N30734)","v":"DTXSID9023259"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30734,J30734)","v":"7279078"},"[Cauda equina syndrome following spinal anaesthesia with mepivacain (author's transl)].","7279078","Neurologic Manifestations","D010264","Paraplegia","DTXSID9023259"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30763,D30763)","v":"Meprobamate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30763,M30763)","v":"Coma"},"D008620","Meprobamate","57-53-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30763,N30763)","v":"DTXSID3023261"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30763,J30763)","v":"5768526"},"[Acute massive poisoning by meprobamate].","5768526","Neurologic Manifestations","D003128","Coma","DTXSID3023261"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30782,D30782)","v":"Mercaptopurine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30782,M30782)","v":"Muscular Atrophy"},"D015122","Mercaptopurine","6112-76-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30782,N30782)","v":"DTXSID9025538"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30782,J30782)","v":"7198574"},"Muscular degeneration in rats after postnatal treatment with 6-mercaptopurine.","7198574","Neurologic Manifestations","D009133","Muscular Atrophy","DTXSID9025538"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30802,D30802)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30802,M30802)","v":"Acrodynia"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30802,N30802)","v":"DTXSID1024172"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30802,J30802)","v":"7556329"},"Dental amalgam and Feer disease.","7556329","Neurotoxicity Syndromes","D000170","Acrodynia","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30834,D30834)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30834,M30834)","v":"Alzheimer Disease"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30834,N30834)","v":"DTXSID1024172"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30834,J30834)","v":"11692193"},"Mercury induced Alzheimer's disease: accelerating incidence?","11692193","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30863,D30863)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30863,M30863)","v":"Brain Damage, Chronic"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30863,N30863)","v":"DTXSID1024172"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30863,J30863)","v":"199444"},"Apallic syndrome in chronic mercury poisoning.","199444","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30892,D30892)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30892,M30892)","v":"Central Nervous System Diseases"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30892,N30892)","v":"DTXSID1024172"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30892,J30892)","v":"7858041"},"Pathology in a dog associated with elevated tissue mercury concentrations.","7858041","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30902,D30902)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30902,M30902)","v":"Central Nervous System Diseases"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30902,N30902)","v":"DTXSID1024172"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30902,J30902)","v":"4598965"},"[Possible damage of the central nervous system due to toxic industrial substances].","4598965","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30931,D30931)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30931,M30931)","v":"Color Vision Defects"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30931,N30931)","v":"DTXSID1024172"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30931,J30931)","v":"16806814"},"Associations between platelet monoamine oxidase-B activity and acquired colour vision loss in a fish-eating population.","16806814","Neurologic Manifestations","D003117","Color Vision Defects","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30960,D30960)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30960,M30960)","v":"Hearing Loss"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30960,N30960)","v":"DTXSID1024172"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30960,J30960)","v":"1608633"},"Hearing: the effects of chemicals.","1608633","Neurologic Manifestations","D034381","Hearing Loss","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C30995,D30995)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L30995,M30995)","v":"Movement Disorders"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N30995,N30995)","v":"DTXSID1024172"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J30995,J30995)","v":"5089366"},"Mercury poisoning and its treatment with N-acetyl-D,L-penicillamine.","5089366","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31021,D31021)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31021,M31021)","v":"Myoclonus"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31021,N31021)","v":"DTXSID1024172"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31021,J31021)","v":"5153345"},"[Morvan's fibrillary chorea and polyradiculoneuritis probably due to mercury poisoning].","5153345","Neurologic Manifestations","D009207","Myoclonus","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31054,D31054)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31054,M31054)","v":"Nervous System Diseases"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31054,N31054)","v":"DTXSID1024172"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31054,J31054)","v":"4664586"},"Clinical symptoms of mercury poisoning in man.","4664586","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31063,D31063)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31063,M31063)","v":"Nervous System Diseases"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31063,N31063)","v":"DTXSID1024172"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31063,J31063)","v":"4569929"},"An ultrastructural study of methylmercury-induced primary sensory neuropathy in the rat.","4569929","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31089,D31089)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31089,M31089)","v":"Nervous System Diseases"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31089,N31089)","v":"DTXSID1024172"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31089,J31089)","v":"19280727"},"[Morphologic and neurochemical effects in long-term period of mercurial intoxication (experimental data)].","19280727","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31122,D31122)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31122,M31122)","v":"Paresthesia"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31122,N31122)","v":"DTXSID1024172"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31122,J31122)","v":"5816809"},"[Clinical features of organic mercury poisoning in the Agano River area].","5816809","Neurologic Manifestations","D010292","Paresthesia","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31156,D31156)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31156,M31156)","v":"Polyneuropathies"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31156,N31156)","v":"DTXSID1024172"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31156,J31156)","v":"27793866"},"Dementia, epilepsy and polyneuropathy in a mercury-exposed patient: investigation, identification of an obscure source and treatment.","27793866","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31157,D31157)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31157,M31157)","v":"Polyneuropathies"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31157,N31157)","v":"DTXSID1024172"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31157,J31157)","v":"1803253"},"[Neural conduction in workers after long-term exposure to mercury vapors].","1803253","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31183,D31183)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31183,M31183)","v":"Sleep Initiation and Maintenance Disorders"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31183,N31183)","v":"DTXSID1024172"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31183,J31183)","v":"5275968"},"Effects of exposure to mercury in the manufacture of chlorine.","5275968","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31218,D31218)","v":"Mercury"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31218,M31218)","v":"Tremor"},"D008628","Mercury","7439-97-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31218,N31218)","v":"DTXSID1024172"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31218,J31218)","v":"18245680"},"Neurological outcomes in children with and without amalgam-related mercury exposure: seven years of longitudinal observations in a randomized trial.","18245680","Neurologic Manifestations","D014202","Tremor","DTXSID1024172"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31251,D31251)","v":"meropenem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31251,M31251)","v":"Epilepsy"},"C059500","meropenem","96036-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31251,N31251)","v":"DTXSID7045526"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31251,J31251)","v":"15701769"},"Acute seizures due to a probable interaction between valproic acid and meropenem.","15701769","Central Nervous System Diseases","D004827","Epilepsy","DTXSID7045526"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31276,D31276)","v":"Mesalamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31276,M31276)","v":"Peripheral Nervous System Diseases"},"D019804","Mesalamine","6291-36-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31276,N31276)","v":"DTXSID30212098"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31276,J31276)","v":"2557107"},"Peripheral neuropathy and mesalazine.","2557107","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID30212098"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31286,D31286)","v":"Mescaline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31286,M31286)","v":"Hallucinations"},"D008635","Mescaline","54-04-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31286,N31286)","v":"DTXSID80202303"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31286,J31286)","v":"21078481"},"Herbal hallucinations: common abuse situations seen in the emergency department.","21078481","Neurologic Manifestations","D006212","Hallucinations","DTXSID80202303"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31319,D31319)","v":"Metaproterenol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31319,M31319)","v":"Tremor"},"D009921","Metaproterenol","586-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31319,N31319)","v":"DTXSID8048529"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31319,J31319)","v":"6751176"},"Objective and subjective tremor responses to oral beta 2 agents on first exposure. A comparison of metaproterenol and terbutaline.","6751176","Neurologic Manifestations","D014202","Tremor","DTXSID8048529"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31344,D31344)","v":"Metformin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31344,M31344)","v":"Stroke"},"D008687","Metformin","1115-70-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31344,N31344)","v":"DTXSID9037246"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31344,J31344)","v":"24018893"},"Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.","24018893","Central Nervous System Diseases","D020521","Stroke","DTXSID9037246"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31380,D31380)","v":"Methadone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31380,M31380)","v":"Delirium"},"D008691","Methadone","1095-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31380,N31380)","v":"DTXSID2020501"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31380,J31380)","v":"11303498"},"Reversible delirium during opiod switching from transdermal fentanyl to methadone.","11303498","Neurologic Manifestations","D003693","Delirium","DTXSID2020501"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31413,D31413)","v":"Methadone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31413,M31413)","v":"Leukoencephalopathies"},"D008691","Methadone","1095-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31413,N31413)","v":"DTXSID2020501"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31413,J31413)","v":"22341930"},"Delayed leukoencephalopathy after alprazolam and methadone overdose: a case report and review of the literature.","22341930","Central Nervous System Diseases","D056784","Leukoencephalopathies","DTXSID2020501"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31433,D31433)","v":"Methadone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31433,M31433)","v":"Seizures"},"D008691","Methadone","1095-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31433,N31433)","v":"DTXSID2020501"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31433,J31433)","v":"1163365"},"Neurological aspects of perinatal narcotic addiction and methadone treatment.","1163365","Neurologic Manifestations","D012640","Seizures","DTXSID2020501"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31448,D31448)","v":"Methadone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31448,M31448)","v":"Sleep Wake Disorders"},"D008691","Methadone","1095-90-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31448,N31448)","v":"DTXSID2020501"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31448,J31448)","v":"16154297"},"Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients.","16154297","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID2020501"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31481,D31481)","v":"methamidophos"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31481,M31481)","v":"Peripheral Nervous System Diseases"},"C014655","methamidophos","10265-92-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31481,N31481)","v":"DTXSID6024177"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31481,J31481)","v":"2170085"},"[Clinical features of delayed polyneuropathy induced by acute methamidophos toxicosis in 74 cases].","2170085","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID6024177"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31501,D31501)","v":"Methamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31501,M31501)","v":"Brain Edema"},"D008694","Methamphetamine","537-46-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31501,N31501)","v":"DTXSID8037128"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31501,J31501)","v":"25687701"},"Not just the brain: methamphetamine disrupts blood-spinal cord barrier and induces acute glial activation and structural damage of spinal cord cells.","25687701","Central Nervous System Diseases","D001929","Brain Edema","DTXSID8037128"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31516,D31516)","v":"Methamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31516,M31516)","v":"Cerebral Hemorrhage"},"D008694","Methamphetamine","537-46-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31516,N31516)","v":"DTXSID8037128"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31516,J31516)","v":"7191505"},"Intracranial hemorrhage with amphetamine abuse.","7191505","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID8037128"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31553,D31553)","v":"Methamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31553,M31553)","v":"Hallucinations"},"D008694","Methamphetamine","537-46-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31553,N31553)","v":"DTXSID8037128"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31553,J31553)","v":"9636942"},"Disturbance of consciousness due to methamphetamine abuse. A study of 2 patients.","9636942","Neurologic Manifestations","D006212","Hallucinations","DTXSID8037128"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31577,D31577)","v":"Methamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31577,M31577)","v":"Hyperkinesis"},"D008694","Methamphetamine","537-46-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31577,N31577)","v":"DTXSID8037128"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31577,J31577)","v":"15764424"},"Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia.","15764424","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID8037128"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31610,D31610)","v":"Methamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31610,M31610)","v":"Memory Disorders"},"D008694","Methamphetamine","537-46-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31610,N31610)","v":"DTXSID8037128"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31610,J31610)","v":"16139811"},"Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice.","16139811","Neurologic Manifestations","D008569","Memory Disorders","DTXSID8037128"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31621,D31621)","v":"Methamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31621,M31621)","v":"Memory Disorders"},"D008694","Methamphetamine","537-46-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31621,N31621)","v":"DTXSID8037128"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31621,J31621)","v":"22433442"},"Methamphetamine mimics the neurochemical profile of aging in rats and impairs recognition memory.","22433442","Neurologic Manifestations","D008569","Memory Disorders","DTXSID8037128"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31645,D31645)","v":"Methamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31645,M31645)","v":"Neurodegenerative Diseases"},"D008694","Methamphetamine","537-46-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31645,N31645)","v":"DTXSID8037128"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31645,J31645)","v":"25407782"},"Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKCδ gene.","25407782","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID8037128"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31678,D31678)","v":"Methamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31678,M31678)","v":"Seizures"},"D008694","Methamphetamine","537-46-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31678,N31678)","v":"DTXSID8037128"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31678,J31678)","v":"16542420"},"Behavioral effects of ketamine and toxic interactions with psychostimulants.","16542420","Neurologic Manifestations","D012640","Seizures","DTXSID8037128"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31714,D31714)","v":"Methane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31714,M31714)","v":"Consciousness Disorders"},"D008697","Methane","74-82-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31714,N31714)","v":"DTXSID8025545"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31714,J31714)","v":"3222738"},"[Changes in the function of the cardiovascular system and cerebral circulation in patients poisoned by carbon monoxide and methane].","3222738","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID8025545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31739,D31739)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31739,M31739)","v":"Basal Ganglia Diseases"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31739,N31739)","v":"DTXSID2021731"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31739,J31739)","v":"11531765"},"Methanol intoxication with bilateral basal ganglia infarct.","11531765","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31768,D31768)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31768,M31768)","v":"Blindness"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31768,N31768)","v":"DTXSID2021731"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31768,J31768)","v":"15389282"},"Ocular manifestations and MRI findings in a case of methanol poisoning.","15389282","Neurologic Manifestations","D001766","Blindness","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31782,D31782)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31782,M31782)","v":"Blindness"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31782,N31782)","v":"DTXSID2021731"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31782,J31782)","v":"12428128"},"Neuroimaging supports the clinical diagnosis of methanol poisoning.","12428128","Neurologic Manifestations","D001766","Blindness","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31807,D31807)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31807,M31807)","v":"Brain Edema"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31807,N31807)","v":"DTXSID2021731"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31807,J31807)","v":"19782499"},"Typical bilateral putaminal lesions of methanol intoxication.","19782499","Central Nervous System Diseases","D001929","Brain Edema","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31836,D31836)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31836,M31836)","v":"Coma"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31836,N31836)","v":"DTXSID2021731"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31836,J31836)","v":"4806624"},"Comparison of peritoneal and hemodialysis: treatment of methanol intoxication.","4806624","Neurologic Manifestations","D003128","Coma","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31850,D31850)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31850,M31850)","v":"Confusion"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31850,N31850)","v":"DTXSID2021731"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31850,J31850)","v":"19793790"},"A seaman with blindness and confusion.","19793790","Neurologic Manifestations","D003221","Confusion","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31875,D31875)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31875,M31875)","v":"Nervous System Diseases"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31875,N31875)","v":"DTXSID2021731"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31875,J31875)","v":"8504908"},"Acute methanol toxicity in minipigs.","8504908","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31902,D31902)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31902,M31902)","v":"Optic Atrophy"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31902,N31902)","v":"DTXSID2021731"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31902,J31902)","v":"22131788"},"A case of optic nerve atrophy with severe disc cupping after methanol poisoning.","22131788","Cranial Nerve Diseases","D009896","Optic Atrophy","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31936,D31936)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31936,M31936)","v":"Optic Neuritis"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31936,N31936)","v":"DTXSID2021731"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31936,J31936)","v":"4437836"},"[Certain characteristics of the course of toxic optic neuritis caused by methyl alcohol poisoning].","4437836","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31965,D31965)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31965,M31965)","v":"Putaminal Hemorrhage"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31965,N31965)","v":"DTXSID2021731"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31965,J31965)","v":"27356664"},"Methanol intoxication with cerebral hemorrhage.","27356664","Basal Ganglia Diseases","D020146","Putaminal Hemorrhage","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C31995,D31995)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L31995,M31995)","v":"Vision Disorders"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N31995,N31995)","v":"DTXSID2021731"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J31995,J31995)","v":"645740"},"Hemodialysis for methanol intoxication.","645740","Neurologic Manifestations","D014786","Vision Disorders","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32004,D32004)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32004,M32004)","v":"Vision Disorders"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32004,N32004)","v":"DTXSID2021731"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32004,J32004)","v":"7940534"},"A rat model manifesting methanol-induced visual dysfunction suitable for both acute and long-term exposure studies.","7940534","Neurologic Manifestations","D014786","Vision Disorders","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32033,D32033)","v":"Methanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32033,M32033)","v":"Vision Disorders"},"D000432","Methanol","67-56-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32033,N32033)","v":"DTXSID2021731"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32033,J32033)","v":"22449350"},"Drowsy man with breathlessness and blurred vision. Methanol toxicity.","22449350","Neurologic Manifestations","D014786","Vision Disorders","DTXSID2021731"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32063,D32063)","v":"Methaqualone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32063,M32063)","v":"Paralysis"},"D008702","Methaqualone","72-44-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32063,N32063)","v":"DTXSID7023279"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32063,J32063)","v":"882610"},"[The problem of polyneuropathy in methaqualone medication].","882610","Neurologic Manifestations","D010243","Paralysis","DTXSID7023279"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32094,D32094)","v":"Methimazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32094,M32094)","v":"Olfaction Disorders"},"D008713","Methimazole","60-56-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32094,N32094)","v":"DTXSID4020820"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32094,J32094)","v":"639655"},"[Smell and taste disorder caused by thiamazole].","639655","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID4020820"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32127,D32127)","v":"Methohexital"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32127,M32127)","v":"Spasm"},"D008723","Methohexital","151-83-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32127,N32127)","v":"DTXSID1023287"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32127,J32127)","v":"1065224"},"Intra-arterial injection of a barbiturate--a case report.","1065224","Neurologic Manifestations","D013035","Spasm","DTXSID1023287"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32156,D32156)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32156,M32156)","v":"Ataxia"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32156,N32156)","v":"DTXSID4020822"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32156,J32156)","v":"4504035"},"Encephalopathy in acute leukaemia associated with methotrexate therapy.","4504035","Neurologic Manifestations","D001259","Ataxia","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32162,D32162)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32162,M32162)","v":"Brain Damage, Chronic"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32162,N32162)","v":"DTXSID4020822"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32162,J32162)","v":"17355553"},"Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate.","17355553","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32195,D32195)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32195,M32195)","v":"Brain Diseases"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32195,N32195)","v":"DTXSID4020822"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32195,J32195)","v":"3469437"},"[Transient cerebral dysfunction induced by VCR, HD-MTX in a child with acute lymphocytic leukemia].","3469437","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32224,D32224)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32224,M32224)","v":"Brain Diseases"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32224,N32224)","v":"DTXSID4020822"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32224,J32224)","v":"20463610"},"Guillain-Barré syndrome mimicking acute methotrexate-associated encephalopathy in an adolescent patient with lymphoblastic lymphoma.","20463610","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32256,D32256)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32256,M32256)","v":"Brain Edema"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32256,N32256)","v":"DTXSID4020822"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32256,J32256)","v":"15007149"},"Diffusion-weighted MRIs in an acute leukoencephalopathy following intrathecal chemotherapy.","15007149","Central Nervous System Diseases","D001929","Brain Edema","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32276,D32276)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32276,M32276)","v":"Central Nervous System Diseases"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32276,N32276)","v":"DTXSID4020822"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32276,J32276)","v":"11019787"},"Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity.","11019787","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32291,D32291)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32291,M32291)","v":"Cerebrovascular Disorders"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32291,N32291)","v":"DTXSID4020822"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32291,J32291)","v":"1390221"},"Transient neurologic disturbances in a child treated with moderate-dose methotrexate.","1390221","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32324,D32324)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32324,M32324)","v":"Demyelinating Diseases"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32324,N32324)","v":"DTXSID4020822"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32324,J32324)","v":"14872029"},"Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.","14872029","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32344,D32344)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32344,M32344)","v":"Epilepsy"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32344,N32344)","v":"DTXSID4020822"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32344,J32344)","v":"3251122"},"[Epilepsy as a late sequela of therapy in acute lymphoblastic leukosis--case report].","3251122","Central Nervous System Diseases","D004827","Epilepsy","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32385,D32385)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32385,M32385)","v":"Leukoencephalitis, Acute Hemorrhagic"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32385,N32385)","v":"DTXSID4020822"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32385,J32385)","v":"12426687"},"Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism.","12426687","Central Nervous System Diseases","D004684","Leukoencephalitis, Acute Hemorrhagic","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32392,D32392)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32392,M32392)","v":"Leukoencephalopathies"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32392,N32392)","v":"DTXSID4020822"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32392,J32392)","v":"29146215"},"[Acute methotrexate-related neurotoxicity and pseudo-stroke syndrome].","29146215","Central Nervous System Diseases","D056784","Leukoencephalopathies","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32433,D32433)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32433,M32433)","v":"Memory Disorders"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32433,N32433)","v":"DTXSID4020822"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32433,J32433)","v":"20332001"},"Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.","20332001","Neurologic Manifestations","D008569","Memory Disorders","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32453,D32453)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32453,M32453)","v":"Nervous System Diseases"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32453,N32453)","v":"DTXSID4020822"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32453,J32453)","v":"6478434"},"Transient neurologic dysfunction following moderate-dose methotrexate for undifferentiated lymphoma.","6478434","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32486,D32486)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32486,M32486)","v":"Ophthalmoplegia"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32486,N32486)","v":"DTXSID4020822"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32486,J32486)","v":"3212830"},"[Ophthalmoplegia after low-dose methotrexate].","3212830","Neurologic Manifestations","D009886","Ophthalmoplegia","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32501,D32501)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32501,M32501)","v":"Paraplegia"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32501,N32501)","v":"DTXSID4020822"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32501,J32501)","v":"6585082"},"Paraplegia after intrathecal administration of methotrexate.","6585082","Neurologic Manifestations","D010264","Paraplegia","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32521,D32521)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32521,M32521)","v":"Parkinson Disease, Secondary"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32521,N32521)","v":"DTXSID4020822"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32521,J32521)","v":"15252273"},"A case of L-dopa-responsive parkinsonian syndrome after low-dose oral methotrexate intake.","15252273","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32554,D32554)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32554,M32554)","v":"Seizures"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32554,N32554)","v":"DTXSID4020822"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32554,J32554)","v":"3469437"},"[Transient cerebral dysfunction induced by VCR, HD-MTX in a child with acute lymphocytic leukemia].","3469437","Neurologic Manifestations","D012640","Seizures","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32569,D32569)","v":"Methotrexate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32569,M32569)","v":"Spinal Cord Diseases"},"D008727","Methotrexate","59-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32569,N32569)","v":"DTXSID4020822"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32569,J32569)","v":"17207701"},"Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.","17207701","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID4020822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32615,D32615)","v":"Methoxsalen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32615,M32615)","v":"Olfaction Disorders"},"D008730","Methoxsalen","298-81-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32615,N32615)","v":"DTXSID8020830"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32615,J32615)","v":"16869874"},"8-Methoxypsoralen and neurological disorders: from dysosmia to migraine.","16869874","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID8020830"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32621,D32621)","v":"Methoxyflurane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32621,M32621)","v":"Hepatic Encephalopathy"},"D008733","Methoxyflurane","76-38-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32621,N32621)","v":"DTXSID7025556"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32621,J32621)","v":"5455938"},"Hepatic coma associated with methoxyflurane anesthesia. Report of a case.","5455938","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID7025556"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32650,D32650)","v":"methyl bromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32650,M32650)","v":"Myoclonus"},"C005218","methyl bromide","74-83-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32650,N32650)","v":"DTXSID8020832"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32650,J32650)","v":"4048610"},"[Rare cause of myoclonus with giant SEP's: methyl bromide poisoning. Apropos of a case with unilateral predominance].","4048610","Neurologic Manifestations","D009207","Myoclonus","DTXSID8020832"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32683,D32683)","v":"Methyl Chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32683,M32683)","v":"Pituitary Neoplasms"},"D008737","Methyl Chloride","74-87-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32683,N32683)","v":"DTXSID0021541"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32683,J32683)","v":"1115530"},"Inhalation carcinogenicity of alpha halo ethers. II. Chronic inhalation studies with chloromethyl methyl ether.","1115530","Central Nervous System Diseases","D010911","Pituitary Neoplasms","DTXSID0021541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32714,D32714)","v":"Methyl n-Butyl Ketone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32714,M32714)","v":"Nervous System Diseases"},"D008742","Methyl n-Butyl Ketone","591-78-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32714,N32714)","v":"DTXSID0022068"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32714,J32714)","v":"6686866"},"Interaction between neurotoxicities induced by organophosphorus and long-chain hexacarbon compounds.","6686866","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0022068"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32744,D32744)","v":"methylamphotericin B"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32744,M32744)","v":"Brain Diseases"},"C017501","methylamphotericin B",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32744,N32744)","v":"DTXSID701009331"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32744,J32744)","v":"8384812"},"Comparative neurotoxicities of amphotericin B and its mono-methyl ester derivative in rats.","8384812","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID701009331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32751,D32751)","v":"methylazoxymethanol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32751,M32751)","v":"Brain Diseases"},"C030667","methylazoxymethanol","590-96-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32751,N32751)","v":"DTXSID1035076"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32751,J32751)","v":"9761308"},"Altered connections between neocortical and heterotopic areas in methylazoxymethanol-treated rat.","9761308","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID1035076"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32782,D32782)","v":"Methylazoxymethanol Acetate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32782,M32782)","v":"Cerebellar Diseases"},"D008746","Methylazoxymethanol Acetate","592-62-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32782,N32782)","v":"DTXSID1025568"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32782,J32782)","v":"870624"},"Methylazoxymethanol-induced aberrant Purkinje cell dendritic development.","870624","Central Nervous System Diseases","D002526","Cerebellar Diseases","DTXSID1025568"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32812,D32812)","v":"Methylene Blue"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32812,M32812)","v":"Confusion"},"D008751","Methylene Blue","61-73-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32812,N32812)","v":"DTXSID0023296"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32812,J32812)","v":"17197475"},"Dose-response and postoperative confusion following methylene blue infusion during parathyroidectomy.","17197475","Neurologic Manifestations","D003221","Confusion","DTXSID0023296"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32841,D32841)","v":"Methylene Chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32841,M32841)","v":"Central Nervous System Diseases"},"D008752","Methylene Chloride","75-09-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32841,N32841)","v":"DTXSID0020868"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32841,J32841)","v":"16569727"},"Application of physiologically based pharmacokinetic modeling in setting acute exposure guideline levels for methylene chloride.","16569727","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID0020868"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32850,D32850)","v":"Methylene Chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32850,M32850)","v":"Nervous System Diseases"},"D008752","Methylene Chloride","75-09-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32850,N32850)","v":"DTXSID0020868"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32850,J32850)","v":"3049777"},"Methylene chloride poisoning: a paradigmatic review.","3049777","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0020868"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32880,D32880)","v":"Methylmalonic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32880,M32880)","v":"Brain Diseases, Metabolic"},"D008764","Methylmalonic Acid","516-05-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32880,N32880)","v":"DTXSID00199549"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32880,J32880)","v":"23422421"},"Acute renal failure potentiates brain energy dysfunction elicited by methylmalonic acid.","23422421","Central Nervous System Diseases","D001928","Brain Diseases, Metabolic","DTXSID00199549"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32909,D32909)","v":"Methylmethacrylate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32909,M32909)","v":"Myositis"},"D020366","Methylmethacrylate","80-62-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32909,N32909)","v":"DTXSID2020844"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32909,J32909)","v":"11601819"},"Pseudoankylosis of the mandible as a result of methyl methacrylate-induced inflammatory cicatricial contracture of the temporal muscle after cranioplasty.","11601819","Neuromuscular Diseases","D009220","Myositis","DTXSID2020844"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32943,D32943)","v":"Methylphenidate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32943,M32943)","v":"Chorea"},"D008774","Methylphenidate","113-45-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32943,N32943)","v":"DTXSID5023299"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32943,J32943)","v":"570658"},"Methylphenidate-induced chorea: case report and pharmacologic implications.","570658","Central Nervous System Diseases","D002819","Chorea","DTXSID5023299"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32970,D32970)","v":"Methylphenidate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32970,M32970)","v":"Hallucinations"},"D008774","Methylphenidate","113-45-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32970,N32970)","v":"DTXSID5023299"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32970,J32970)","v":"15326264"},"Hallucinations during methylphenidate therapy.","15326264","Neurologic Manifestations","D006212","Hallucinations","DTXSID5023299"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C32995,D32995)","v":"Methylphenidate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L32995,M32995)","v":"Neurodegenerative Diseases"},"D008774","Methylphenidate","113-45-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N32995,N32995)","v":"DTXSID5023299"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J32995,J32995)","v":"28552672"},"Possible involvement of CREB/BDNF signaling pathway in neuroprotective effects of topiramate against methylphenidate induced apoptosis, oxidative stress and inflammation in isolated hippocampus of rats: Molecular, biochemical and histological evidences.","28552672","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID5023299"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33009,D33009)","v":"Methylphenidate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33009,M33009)","v":"Seizures"},"D008774","Methylphenidate","113-45-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33009,N33009)","v":"DTXSID5023299"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33009,J33009)","v":"20339664"},"Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment.","20339664","Neurologic Manifestations","D012640","Seizures","DTXSID5023299"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33038,D33038)","v":"Methylphenidate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33038,M33038)","v":"Sleep Wake Disorders"},"D008774","Methylphenidate","113-45-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33038,N33038)","v":"DTXSID5023299"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33038,J33038)","v":"17520787"},"Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate.","17520787","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID5023299"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33063,D33063)","v":"Methylphenidate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33063,M33063)","v":"Tics"},"D008774","Methylphenidate","113-45-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33063,N33063)","v":"DTXSID5023299"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33063,J33063)","v":"11022478"},"Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?","11022478","Neurologic Manifestations","D020323","Tics","DTXSID5023299"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33103,D33103)","v":"Methylprednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33103,M33103)","v":"Cerebrovascular Disorders"},"D008775","Methylprednisolone","83-43-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33103,N33103)","v":"DTXSID7023300"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33103,J33103)","v":"6684745"},"Acute cerebrovascular accident after treatment with cis-platinum and methylprednisolone.","6684745","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID7023300"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33106,D33106)","v":"Methylprednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33106,M33106)","v":"Empty Sella Syndrome"},"D008775","Methylprednisolone","83-43-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33106,N33106)","v":"DTXSID7023300"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33106,J33106)","v":"9002056"},"Hypopituitarism with empty sella after steroid pulse therapy.","9002056","Central Nervous System Diseases","D004652","Empty Sella Syndrome","DTXSID7023300"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33156,D33156)","v":"Methylprednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33156,M33156)","v":"Muscular Diseases"},"D008775","Methylprednisolone","83-43-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33156,N33156)","v":"DTXSID7023300"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33156,J33156)","v":"19653137"},"Gefitinib-induced interstitial lung disease-addition of intravenous cyclophosphamide to corticosteroids is a valuable treatment option: A case report.","19653137","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID7023300"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33167,D33167)","v":"Methylprednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33167,M33167)","v":"Ocular Motility Disorders"},"D008775","Methylprednisolone","83-43-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33167,N33167)","v":"DTXSID7023300"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33167,J33167)","v":"13129887"},"Sclerosing lipogranuloma of the orbit after periocular steroid injection.","13129887","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID7023300"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33200,D33200)","v":"Methylprednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33200,M33200)","v":"Seizures"},"D008775","Methylprednisolone","83-43-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33200,N33200)","v":"DTXSID7023300"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33200,J33200)","v":"18358931"},"Stiff and partly blind--after a first dose of steroid.","18358931","Neurologic Manifestations","D012640","Seizures","DTXSID7023300"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33224,D33224)","v":"Methylprednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33224,M33224)","v":"Vision, Low"},"D008775","Methylprednisolone","83-43-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33224,N33224)","v":"DTXSID7023300"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33224,J33224)","v":"10919123"},"[Diffuse retinal pigmented epitheliopathy associated with systemic corticosteroid therapy].","10919123","Neurologic Manifestations","D015354","Vision, Low","DTXSID7023300"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33235,D33235)","v":"methylprednisolone acetate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33235,M33235)","v":"Nervous System Diseases"},"C000873","methylprednisolone acetate","13209-52-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33235,N33235)","v":"DTXSID70628391"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33235,J33235)","v":"6836502"},"Complications from Depo-Medrol R.","6836502","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID70628391"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33268,D33268)","v":"Metoclopramide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33268,M33268)","v":"Basal Ganglia Diseases"},"D008787","Metoclopramide","2576-84-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33268,N33268)","v":"DTXSID20180434"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33268,J33268)","v":"7510800"},"Metoclopramide-induced extrapyramidal syndromes.","7510800","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID20180434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33292,D33292)","v":"Metoclopramide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33292,M33292)","v":"Basal Ganglia Diseases"},"D008787","Metoclopramide","2576-84-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33292,N33292)","v":"DTXSID20180434"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33292,J33292)","v":"6117295"},"[Acute-onset extrapyramidal syndromes caused by drugs].","6117295","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID20180434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33329,D33329)","v":"Metoclopramide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33329,M33329)","v":"Dystonia"},"D008787","Metoclopramide","2576-84-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33329,N33329)","v":"DTXSID20180434"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33329,J33329)","v":"3929968"},"Extrapyramidal reactions with metoclopramide.","3929968","Neurologic Manifestations","D004421","Dystonia","DTXSID20180434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33362,D33362)","v":"Metoclopramide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33362,M33362)","v":"Dystonia"},"D008787","Metoclopramide","2576-84-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33362,N33362)","v":"DTXSID20180434"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33362,J33362)","v":"10200869"},"Acute dystonia associated with fluvoxamine-metoclopramide.","10200869","Neurologic Manifestations","D004421","Dystonia","DTXSID20180434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33381,D33381)","v":"Metoclopramide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33381,M33381)","v":"Hyperkinesis"},"D008787","Metoclopramide","2576-84-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33381,N33381)","v":"DTXSID20180434"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33381,J33381)","v":"1019273"},"[Extrapyramidal syndromes as side-effects of metoclopramide (Cerucal) medication].","1019273","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID20180434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33397,D33397)","v":"Metoclopramide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33397,M33397)","v":"Muscle Rigidity"},"D008787","Metoclopramide","2576-84-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33397,N33397)","v":"DTXSID20180434"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33397,J33397)","v":"16740451"},"Abdominal pain with rigidity secondary to the anti-emetic drug metoclopramide.","16740451","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID20180434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33437,D33437)","v":"Metoclopramide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33437,M33437)","v":"Parkinson Disease, Secondary"},"D008787","Metoclopramide","2576-84-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33437,N33437)","v":"DTXSID20180434"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33437,J33437)","v":"4038919"},"Parkinsonism following i.v. administration of high-dose metoclopramide used as an antiemetic agent during cancer chemotherapy.","4038919","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID20180434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33458,D33458)","v":"Metoclopramide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33458,M33458)","v":"Parkinson Disease, Secondary"},"D008787","Metoclopramide","2576-84-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33458,N33458)","v":"DTXSID20180434"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33458,J33458)","v":"11845569"},"[Severe parkinsonism due to metoclopramide in a patient with polypharmacy].","11845569","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID20180434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33465,D33465)","v":"Metoclopramide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33465,M33465)","v":"Spasm"},"D008787","Metoclopramide","2576-84-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33465,N33465)","v":"DTXSID20180434"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33465,J33465)","v":"4447767"},"Dystonic reactions due to metoclopramide and phenothiazines resembling tetanus.","4447767","Neurologic Manifestations","D013035","Spasm","DTXSID20180434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33501,D33501)","v":"Metoprolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33501,M33501)","v":"Muscle Cramp"},"D008790","Metoprolol","56392-17-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33501,N33501)","v":"DTXSID9037248"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33501,J33501)","v":"266273"},"Broncho-and cardioselective beta-receptor active drugs in the treatment of asthmatic patients. Clinical studies of effects and side effects of terbutaline, practolol and metoprolol.","266273","Neurologic Manifestations","D009120","Muscle Cramp","DTXSID9037248"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33526,D33526)","v":"Metrizamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33526,M33526)","v":"Arachnoiditis"},"D008793","Metrizamide","31112-62-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33526,N33526)","v":"DTXSID1023310"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33526,J33526)","v":"6949540"},"Myelography with metrizamide--an analysis of the complications encountered in cervical, thoracic and lumbar myelography.","6949540","Central Nervous System Diseases","D001100","Arachnoiditis","DTXSID1023310"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33559,D33559)","v":"Metrizamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33559,M33559)","v":"Brain Diseases, Metabolic"},"D008793","Metrizamide","31112-62-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33559,N33559)","v":"DTXSID1023310"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33559,J33559)","v":"7224601"},"Asterixis and encephalopathy following metrizamide myelography: investigations into possible mechanisms and review of the literature.","7224601","Central Nervous System Diseases","D001928","Brain Diseases, Metabolic","DTXSID1023310"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33569,D33569)","v":"Metrizamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33569,M33569)","v":"Coma"},"D008793","Metrizamide","31112-62-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33569,N33569)","v":"DTXSID1023310"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33569,J33569)","v":"6799618"},"Prevention of adverse reactions to Amipaque in cervical myelography. Report of a homogeneous series of 380 patients.","6799618","Neurologic Manifestations","D003128","Coma","DTXSID1023310"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33594,D33594)","v":"Metrizamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33594,M33594)","v":"Epilepsy"},"D008793","Metrizamide","31112-62-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33594,N33594)","v":"DTXSID1023310"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33594,J33594)","v":"6637352"},"The epileptogenicity of neurolept anaesthesia in patients during and after neuroradiological examinations with metrizamide.","6637352","Central Nervous System Diseases","D004827","Epilepsy","DTXSID1023310"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33627,D33627)","v":"Metrizamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33627,M33627)","v":"Meningitis"},"D008793","Metrizamide","31112-62-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33627,N33627)","v":"DTXSID1023310"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33627,J33627)","v":"6845160"},"Acute chemical meningitis after metrizamide-lumbar myelography.","6845160","Central Nervous System Diseases","D008581","Meningitis","DTXSID1023310"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33662,D33662)","v":"Metrizamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33662,M33662)","v":"Nervous System Diseases"},"D008793","Metrizamide","31112-62-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33662,N33662)","v":"DTXSID1023310"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33662,J33662)","v":"3557885"},"Further support for the glucose hypothesis of metrizamide toxicity. The effect of metrizamide and glucose analogue-free contrast media on hexokinase.","3557885","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1023310"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33688,D33688)","v":"Metrizamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33688,M33688)","v":"Seizures"},"D008793","Metrizamide","31112-62-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33688,N33688)","v":"DTXSID1023310"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33688,J33688)","v":"860047"},"Metrizamide--CSF contrast medium. Analysis of clinical application in 215 patients.","860047","Neurologic Manifestations","D012640","Seizures","DTXSID1023310"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33717,D33717)","v":"Metrizamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33717,M33717)","v":"Spasm"},"D008793","Metrizamide","31112-62-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33717,N33717)","v":"DTXSID1023310"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33717,J33717)","v":"4534547"},"Toxicity of metrizamide and meglumine iocarmate after suboccipital injection in rats. Acute and long-term effects.","4534547","Neurologic Manifestations","D013035","Spasm","DTXSID1023310"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33730,D33730)","v":"Metrizamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33730,M33730)","v":"Vertigo"},"D008793","Metrizamide","31112-62-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33730,N33730)","v":"DTXSID1023310"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33730,J33730)","v":"888527"},"[Thoracic and lumbar myelography with metrizamid (author's transl)].","888527","Neurologic Manifestations","D014717","Vertigo","DTXSID1023310"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33756,D33756)","v":"Metronidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33756,M33756)","v":"Brain Diseases"},"D008795","Metronidazole","69198-10-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33756,N33756)","v":"DTXSID70219228"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33756,J33756)","v":"25897460"},"Metronidazole: encephalopathy.","25897460","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID70219228"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33782,D33782)","v":"Metronidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33782,M33782)","v":"Brain Diseases"},"D008795","Metronidazole","69198-10-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33782,N33782)","v":"DTXSID70219228"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33782,J33782)","v":"10895243"},"Acute encephalopathy associated with metronidazole therapy.","10895243","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID70219228"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33817,D33817)","v":"Metronidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33817,M33817)","v":"Confusion"},"D008795","Metronidazole","69198-10-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33817,N33817)","v":"DTXSID70219228"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33817,J33817)","v":"7167392"},"Mental confusion in a patient treated with metronidazole--a concentration-related effect?","7167392","Neurologic Manifestations","D003221","Confusion","DTXSID70219228"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33846,D33846)","v":"Metronidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33846,M33846)","v":"Hallucinations"},"D008795","Metronidazole","69198-10-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33846,N33846)","v":"DTXSID70219228"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33846,J33846)","v":"7167392"},"Mental confusion in a patient treated with metronidazole--a concentration-related effect?","7167392","Neurologic Manifestations","D006212","Hallucinations","DTXSID70219228"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33850,D33850)","v":"Metronidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33850,M33850)","v":"Hearing Loss, Sensorineural"},"D008795","Metronidazole","69198-10-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33850,N33850)","v":"DTXSID70219228"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33850,J33850)","v":"26377290"},"Sudden sensorineural hearing loss secondary to metronidazole ototoxicity.","26377290","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID70219228"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33885,D33885)","v":"Metronidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33885,M33885)","v":"Paresthesia"},"D008795","Metronidazole","69198-10-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33885,N33885)","v":"DTXSID70219228"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33885,J33885)","v":"7316307"},"[Convulsive seizures and polyneuritis in a patient with lupus treated with metronidazole (author's transl)].","7316307","Neurologic Manifestations","D010292","Paresthesia","DTXSID70219228"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33914,D33914)","v":"Metronidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33914,M33914)","v":"Peripheral Nervous System Diseases"},"D008795","Metronidazole","69198-10-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33914,N33914)","v":"DTXSID70219228"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33914,J33914)","v":"22041822"},"Metronidazole-cerebellopathy associated with peripheral neuropathy, downbeat nystagmus, and bilateral ocular abduction deficit.","22041822","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID70219228"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33943,D33943)","v":"Metronidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33943,M33943)","v":"Taste Disorders"},"D008795","Metronidazole","69198-10-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33943,N33943)","v":"DTXSID70219228"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33943,J33943)","v":"22350328"},"Efficacy of the Mentha crispa in the treatment of women with Trichomonas vaginalis infection.","22350328","Neurologic Manifestations","D013651","Taste Disorders","DTXSID70219228"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33953,D33953)","v":"Metronidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33953,M33953)","v":"Vision Disorders"},"D008795","Metronidazole","69198-10-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33953,N33953)","v":"DTXSID70219228"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33953,J33953)","v":"22041822"},"Metronidazole-cerebellopathy associated with peripheral neuropathy, downbeat nystagmus, and bilateral ocular abduction deficit.","22041822","Neurologic Manifestations","D014786","Vision Disorders","DTXSID70219228"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C33982,D33982)","v":"Mianserin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L33982,M33982)","v":"Confusion"},"D008803","Mianserin","24219-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N33982,N33982)","v":"DTXSID6023317"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J33982,J33982)","v":"3863469"},"Mianserin and imipramine in the treatment of elderly depressed patients.","3863469","Neurologic Manifestations","D003221","Confusion","DTXSID6023317"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34011,D34011)","v":"Mianserin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34011,M34011)","v":"Hearing Loss, High-Frequency"},"D008803","Mianserin","24219-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34011,N34011)","v":"DTXSID6023317"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34011,J34011)","v":"2072020"},"Cochleotoxicity due to Mianserin hydrochloride.","2072020","Neurologic Manifestations","D006316","Hearing Loss, High-Frequency","DTXSID6023317"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34043,D34043)","v":"Mianserin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34043,M34043)","v":"Seizures"},"D008803","Mianserin","24219-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34043,N34043)","v":"DTXSID6023317"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34043,J34043)","v":"24791374"},"Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction.","24791374","Neurologic Manifestations","D012640","Seizures","DTXSID6023317"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34076,D34076)","v":"Midazolam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34076,M34076)","v":"Amnesia"},"D008874","Midazolam","59467-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34076,N34076)","v":"DTXSID5023320"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34076,J34076)","v":"16546038"},"Midazolam amnesia and short-term/working memory processes.","16546038","Neurologic Manifestations","D000647","Amnesia","DTXSID5023320"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34104,D34104)","v":"Midazolam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34104,M34104)","v":"Coma"},"D008874","Midazolam","59467-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34104,N34104)","v":"DTXSID5023320"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34104,J34104)","v":"24830769"},"Midazolam fails to prevent neurological damage in children with convulsive refractory febrile status epilepticus.","24830769","Neurologic Manifestations","D003128","Coma","DTXSID5023320"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34111,D34111)","v":"Midazolam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34111,M34111)","v":"Delirium"},"D008874","Midazolam","59467-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34111,N34111)","v":"DTXSID5023320"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34111,J34111)","v":"7978604"},"Emergence delirium in a child given oral midazolam for conscious sedation.","7978604","Neurologic Manifestations","D003693","Delirium","DTXSID5023320"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34156,D34156)","v":"Midazolam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34156,M34156)","v":"Myoclonus"},"D008874","Midazolam","59467-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34156,N34156)","v":"DTXSID5023320"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34156,J34156)","v":"16997680"},"Etomidate versus midazolam for procedural sedation in pediatric outpatients: a randomized controlled trial.","16997680","Neurologic Manifestations","D009207","Myoclonus","DTXSID5023320"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34176,D34176)","v":"Midazolam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34176,M34176)","v":"Sensation Disorders"},"D008874","Midazolam","59467-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34176,N34176)","v":"DTXSID5023320"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34176,J34176)","v":"17156507"},"Study on the usefulness of precise and simple dynamic balance tests for the evaluation of recovery from intravenous sedation with midazolam and propofol.","17156507","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID5023320"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34205,D34205)","v":"Mifepristone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34205,M34205)","v":"Mobius Syndrome"},"D015735","Mifepristone","84371-65-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34205,N34205)","v":"DTXSID5023322"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34205,J34205)","v":"18460590"},"Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure.","18460590","Cranial Nerve Diseases","D020331","Mobius Syndrome","DTXSID5023322"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34224,D34224)","v":"Minocycline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34224,M34224)","v":"Diplopia"},"D008911","Minocycline","13614-98-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34224,N34224)","v":"DTXSID8044545"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34224,J34224)","v":"12660705"},"A 15-year-old with blurred vision, nausea, back pain, and abdominal pain.","12660705","Neurologic Manifestations","D004172","Diplopia","DTXSID8044545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34240,D34240)","v":"Minocycline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34240,M34240)","v":"Paralysis"},"D008911","Minocycline","13614-98-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34240,N34240)","v":"DTXSID8044545"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34240,J34240)","v":"624295"},"Benign intracranial hypertension after minocycline therapy.","624295","Neurologic Manifestations","D010243","Paralysis","DTXSID8044545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34273,D34273)","v":"Minocycline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34273,M34273)","v":"Ulnar Neuropathies"},"D008911","Minocycline","13614-98-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34273,N34273)","v":"DTXSID8044545"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34273,J34273)","v":"11254246"},"Minocycline-associated lupus-like syndrome with ulnar neuropathy and antiphospholipid antibody.","11254246","Neuromuscular Diseases","D020424","Ulnar Neuropathies","DTXSID8044545"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34292,D34292)","v":"Minoxidil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34292,M34292)","v":"Scotoma"},"D008914","Minoxidil","38304-91-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34292,N34292)","v":"DTXSID9040685"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34292,J34292)","v":"6342503"},"Bilateral optic neuritis following minoxidil administration.","6342503","Neurologic Manifestations","D012607","Scotoma","DTXSID9040685"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34334,D34334)","v":"mirtazapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34334,M34334)","v":"Restless Legs Syndrome"},"C035133","mirtazapine","61337-67-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34334,N34334)","v":"DTXSID0023325"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34334,J34334)","v":"17196069"},"Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.","17196069","Sleep Wake Disorders","D012148","Restless Legs Syndrome","DTXSID0023325"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34341,D34341)","v":"mirtazapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34341,M34341)","v":"Restless Legs Syndrome"},"C035133","mirtazapine","61337-67-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34341,N34341)","v":"DTXSID0023325"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34341,J34341)","v":"12563401"},"[Worsening of autosomal dominant restless legs syndrome after use of mirtazapine: case report].","12563401","Sleep Wake Disorders","D012148","Restless Legs Syndrome","DTXSID0023325"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34381,D34381)","v":"Misonidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34381,M34381)","v":"Nervous System Diseases"},"D008920","Misonidazole","13551-87-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34381,N34381)","v":"DTXSID80864420"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34381,J34381)","v":"7107353"},"High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity.","7107353","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID80864420"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34402,D34402)","v":"Misonidazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34402,M34402)","v":"Peripheral Nervous System Diseases"},"D008920","Misonidazole","13551-87-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34402,N34402)","v":"DTXSID80864420"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34402,J34402)","v":"6201419"},"The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology.","6201419","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID80864420"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34435,D34435)","v":"Mitoxantrone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34435,M34435)","v":"Cerebellar Diseases"},"D008942","Mitoxantrone","65271-80-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34435,N34435)","v":"DTXSID4046947"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34435,J34435)","v":"3463392"},"Reversible bilateral lateral rectus muscle palsy associated with high-dose cytosine arabinoside and mitoxantrone therapy.","3463392","Central Nervous System Diseases","D002526","Cerebellar Diseases","DTXSID4046947"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34449,D34449)","v":"mivacurium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34449,M34449)","v":"Paralysis"},"C049430","mivacurium","106861-44-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34449,N34449)","v":"DTXSID5046649"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34449,J34449)","v":"19880962"},"Prolonged paralysis and apnea after receiving a neuromuscular blocking agent: what nurses should know.","19880962","Neurologic Manifestations","D010243","Paralysis","DTXSID5046649"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34470,D34470)","v":"Moclobemide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34470,M34470)","v":"Nervous System Diseases"},"D020912","Moclobemide","71320-77-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34470,N34470)","v":"DTXSID9040554"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34470,J34470)","v":"9631680"},"Serotonin syndrome in combined moclobemide and venlafaxine ingestion.","9631680","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID9040554"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34505,D34505)","v":"Molindone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34505,M34505)","v":"Dystonia"},"D008972","Molindone","7416-34-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34505,N34505)","v":"DTXSID9023332"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34505,J34505)","v":"7446763"},"Dystonic reaction during maintenance antipsychotic therapy.","7446763","Neurologic Manifestations","D004421","Dystonia","DTXSID9023332"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34531,D34531)","v":"Monocrotophos"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34531,M34531)","v":"Central Nervous System Diseases"},"D008999","Monocrotophos","6923-22-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34531,N34531)","v":"DTXSID9034816"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34531,J34531)","v":"21067471"},"Modulation of dopaminergic system and neurobehavioral functions in delayed neuropathy induced by organophosphates.","21067471","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID9034816"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34564,D34564)","v":"monomethylpropion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34564,M34564)","v":"Parkinsonian Disorders"},"C047806","monomethylpropion","5650-44-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34564,N34564)","v":"DTXSID30863589"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34564,J34564)","v":"24457624"},"Evaluation of cognitive characteristics of patients developing manifestations of parkinsonism secondary to long-term ephedrone use.","24457624","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID30863589"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34569,D34569)","v":"montelukast"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34569,M34569)","v":"Muscle Hypotonia"},"C093875","montelukast","151767-02-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34569,N34569)","v":"DTXSID8046450"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34569,J34569)","v":"11006372"},"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-2000. A 25-year-old man with asthma, cardiac failure, diarrhea, and weakness of the right hand.","11006372","Neurologic Manifestations","D009123","Muscle Hypotonia","DTXSID8046450"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34599,D34599)","v":"Morphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34599,M34599)","v":"Catalepsy"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34599,N34599)","v":"DTXSID1048914"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34599,J34599)","v":"18955042"},"Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer.","18955042","Neurologic Manifestations","D002375","Catalepsy","DTXSID1048914"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34632,D34632)","v":"Morphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34632,M34632)","v":"Diplopia"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34632,N34632)","v":"DTXSID1048914"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34632,J34632)","v":"10660246"},"Cranial nerve palsy and intracranial subdural hematoma following implantation of intrathecal drug delivery device.","10660246","Neurologic Manifestations","D004172","Diplopia","DTXSID1048914"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34662,D34662)","v":"Morphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34662,M34662)","v":"Hematoma, Subdural"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34662,N34662)","v":"DTXSID1048914"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34662,J34662)","v":"24884350"},"Subdural haemorrhage is associated with recent morphine treatment in patients with cancer: a retrospective population-based nested case-control study.","24884350","Central Nervous System Diseases","D006408","Hematoma, Subdural","DTXSID1048914"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34693,D34693)","v":"Morphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34693,M34693)","v":"Hyperalgesia"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34693,N34693)","v":"DTXSID1048914"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34693,J34693)","v":"25485877"},"Hyperalgesia induced by low-dose opioid treatment before orthopaedic surgery: An observational case-control study.","25485877","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID1048914"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34696,D34696)","v":"Morphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34696,M34696)","v":"Hyperalgesia"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34696,N34696)","v":"DTXSID1048914"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34696,J34696)","v":"16414554"},"Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.","16414554","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID1048914"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34730,D34730)","v":"Morphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34730,M34730)","v":"Hyperkinesis"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34730,N34730)","v":"DTXSID1048914"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34730,J34730)","v":"14723343"},"Inhibitory effects of glycine on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity in mice.","14723343","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID1048914"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34761,D34761)","v":"Morphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34761,M34761)","v":"Movement Disorders"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34761,N34761)","v":"DTXSID1048914"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34761,J34761)","v":"6493634"},"Akinesia after locally applied morphine near the nucleus raphe pontis of the rat.","6493634","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID1048914"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34790,D34790)","v":"Morphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34790,M34790)","v":"Myoclonus"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34790,N34790)","v":"DTXSID1048914"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34790,J34790)","v":"11506132"},"Intravenous clonidine use in a neonate experiencing opioid-induced myoclonus.","11506132","Neurologic Manifestations","D009207","Myoclonus","DTXSID1048914"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34823,D34823)","v":"Morphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34823,M34823)","v":"Seizures"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34823,N34823)","v":"DTXSID1048914"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34823,J34823)","v":"9605377"},"Near fatal intoxication with controlled-release morphine tablets in a depressed woman.","9605377","Neurologic Manifestations","D012640","Seizures","DTXSID1048914"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34829,D34829)","v":"Morphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34829,M34829)","v":"Seizures"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34829,N34829)","v":"DTXSID1048914"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34829,J34829)","v":"10446353"},"Prenatal morphine exposure differentially alters seizure susceptibility in developing female rats.","10446353","Neurologic Manifestations","D012640","Seizures","DTXSID1048914"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34850,D34850)","v":"Morphine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34850,M34850)","v":"Spasm"},"D009020","Morphine","6211-15-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34850,N34850)","v":"DTXSID1048914"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34850,J34850)","v":"12359295"},"Relief by naloxone of morphone-induced spasm of the sphincter of Oddi in a post-cholecystectomy patient.","12359295","Neurologic Manifestations","D013035","Spasm","DTXSID1048914"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34890,D34890)","v":"Muzolimine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34890,M34890)","v":"Demyelinating Diseases"},"D009156","Muzolimine",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34890,N34890)","v":"DTXSID50866476"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34890,J34890)","v":"2159946"},"[Neuromyeloencephalopathy caused by high-dose muzolimine medication in patients with renal failure].","2159946","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID50866476"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34919,D34919)","v":"Nafronyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34919,M34919)","v":"Seizures"},"D009257","Nafronyl","31329-57-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34919,N34919)","v":"DTXSID3023344"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34919,J34919)","v":"611593"},"[Electrophysiological observations on seizure activity provoked by an intracarotid injection of Naftidrofuryl (author's transl)].","611593","Neurologic Manifestations","D012640","Seizures","DTXSID3023344"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34943,D34943)","v":"Nalidixic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34943,M34943)","v":"Pseudotumor Cerebri"},"D009268","Nalidixic Acid","389-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34943,N34943)","v":"DTXSID3020912"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34943,J34943)","v":"7087847"},"Intracranial hypertension in nalidixic acid therapy.","7087847","Central Nervous System Diseases","D011559","Pseudotumor Cerebri","DTXSID3020912"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34958,D34958)","v":"Nalidixic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34958,M34958)","v":"Seizures"},"D009268","Nalidixic Acid","389-08-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34958,N34958)","v":"DTXSID3020912"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34958,J34958)","v":"3796539"},"[Convulsions with cerebrospinal fluid hypertension during treatment with nalidixic acid].","3796539","Neurologic Manifestations","D012640","Seizures","DTXSID3020912"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C34987,D34987)","v":"Naloxone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L34987,M34987)","v":"Hyperalgesia"},"D009270","Naloxone","69133-14-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N34987,N34987)","v":"DTXSID20219197"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J34987,J34987)","v":"17964860"},"The effect of subcutaneous naloxone on experimentally induced pain.","17964860","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID20219197"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35011,D35011)","v":"Naloxone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35011,M35011)","v":"Tremor"},"D009270","Naloxone","69133-14-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35011,N35011)","v":"DTXSID20219197"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35011,J35011)","v":"15167188"},"Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.","15167188","Neurologic Manifestations","D014202","Tremor","DTXSID20219197"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35052,D35052)","v":"Naproxen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35052,M35052)","v":"Brain Diseases, Metabolic"},"D009288","Naproxen","26159-34-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35052,N35052)","v":"DTXSID7045576"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35052,J35052)","v":"9660016"},"Triphasic waves associated with acute naproxen overdose: a case report.","9660016","Central Nervous System Diseases","D001928","Brain Diseases, Metabolic","DTXSID7045576"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35055,D35055)","v":"Naproxen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35055,M35055)","v":"Central Nervous System Diseases"},"D009288","Naproxen","26159-34-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35055,N35055)","v":"DTXSID7045576"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35055,J35055)","v":"3514082"},"A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis.","3514082","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID7045576"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35104,D35104)","v":"nefazodone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35104,M35104)","v":"Parkinson Disease, Secondary"},"C051752","nefazodone","83366-66-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35104,N35104)","v":"DTXSID2023357"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35104,J35104)","v":"9444544"},"Parkinson's disease worsened by nefazodone.","9444544","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID2023357"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35116,D35116)","v":"Nefopam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35116,M35116)","v":"Blindness"},"D009340","Nefopam","13669-70-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35116,N35116)","v":"DTXSID2048535"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35116,J35116)","v":"23867540"},"Unilateral permanent loss of vision after nefopam administration.","23867540","Neurologic Manifestations","D001766","Blindness","DTXSID2048535"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35149,D35149)","v":"Neomycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35149,M35149)","v":"Deafness"},"D009355","Neomycin","55298-68-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35149,N35149)","v":"DTXSID80203810"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35149,J35149)","v":"4761050"},"Acute histopathologic inner ear changes in deafness due to neomycin: a case report.","4761050","Neurologic Manifestations","D003638","Deafness","DTXSID80203810"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35172,D35172)","v":"Neomycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35172,M35172)","v":"Deafness"},"D009355","Neomycin","55298-68-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35172,N35172)","v":"DTXSID80203810"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35172,J35172)","v":"5440810"},"Intrapleural neomycin causing ototoxicity.","5440810","Neurologic Manifestations","D003638","Deafness","DTXSID80203810"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35184,D35184)","v":"Neomycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35184,M35184)","v":"Hearing Disorders"},"D009355","Neomycin","55298-68-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35184,N35184)","v":"DTXSID80203810"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35184,J35184)","v":"9473083"},"Attenuation of neomycin ototoxicity by iron chelation.","9473083","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID80203810"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35224,D35224)","v":"Neomycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35224,M35224)","v":"Hearing Loss, Sensorineural"},"D009355","Neomycin","55298-68-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35224,N35224)","v":"DTXSID80203810"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35224,J35224)","v":"15318963"},"Ototoxicity after use of neomycin eardrops is unrelated to A1555G point mutation in mitochondrial DNA.","15318963","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID80203810"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35245,D35245)","v":"Neostigmine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35245,M35245)","v":"Spasm"},"D009388","Neostigmine","51-60-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35245,N35245)","v":"DTXSID40199003"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35245,J35245)","v":"620904"},"Diffuse esophageal spasm provoked with prostigmine.","620904","Neurologic Manifestations","D013035","Spasm","DTXSID40199003"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35278,D35278)","v":"n-heptane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35278,M35278)","v":"Peripheral Nervous System Diseases"},"C028618","n-heptane","142-82-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35278,N35278)","v":"DTXSID6024127"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35278,J35278)","v":"6095491"},"Identification of volatile metabolites of inhaled n-heptane in rat urine.","6095491","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID6024127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35292,D35292)","v":"n-hexane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35292,M35292)","v":"Gait Disorders, Neurologic"},"C026385","n-hexane","27581-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35292,N35292)","v":"DTXSID10583879"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35292,J35292)","v":"14706411"},"Glue sniffing polyneuropathy: an under recognized aspect of a public health hazard.","14706411","Neurologic Manifestations","D020233","Gait Disorders, Neurologic","DTXSID10583879"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35313,D35313)","v":"n-hexane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35313,M35313)","v":"Paralysis"},"C026385","n-hexane","27581-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35313,N35313)","v":"DTXSID10583879"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35313,J35313)","v":"4049411"},"The synergism of n-hexane-induced neurotoxicity by methyl isobutyl ketone following subchronic (90 days) inhalation in hens: induction of hepatic microsomal cytochrome P-450.","4049411","Neurologic Manifestations","D010243","Paralysis","DTXSID10583879"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35346,D35346)","v":"n-hexane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35346,M35346)","v":"Peripheral Nervous System Diseases"},"C026385","n-hexane","27581-27-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35346,N35346)","v":"DTXSID10583879"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35346,J35346)","v":"10681200"},"[Toxic peripheral polyneuropathy outbreak in a labour environment].","10681200","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID10583879"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35385,D35385)","v":"Niacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35385,M35385)","v":"Muscular Diseases"},"D009525","Niacin","7069-06-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35385,N35385)","v":"DTXSID40220962"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35385,J35385)","v":"22085343"},"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.","22085343","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID40220962"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35407,D35407)","v":"Niacinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35407,M35407)","v":"Seizures"},"D009536","Niacinamide","98-92-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35407,N35407)","v":"DTXSID2020929"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35407,J35407)","v":"2964812"},"[A very strange seizure].","2964812","Neurologic Manifestations","D012640","Seizures","DTXSID2020929"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35414,D35414)","v":"Nialamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35414,M35414)","v":"Hallucinations"},"D009526","Nialamide","51-12-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35414,N35414)","v":"DTXSID1023362"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35414,J35414)","v":"6738220"},"[A recurrent case of psychotic withdrawal syndrome caused by monoamine oxidase inhibitors?].","6738220","Neurologic Manifestations","D006212","Hallucinations","DTXSID1023362"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35449,D35449)","v":"Nicotine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35449,M35449)","v":"Cerebrovascular Disorders"},"D009538","Nicotine","25162-00-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35449,N35449)","v":"DTXSID0046351"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35449,J35449)","v":"8193434"},"Stroke following application of a nicotine patch.","8193434","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID0046351"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35475,D35475)","v":"Nicotine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35475,M35475)","v":"Language Development Disorders"},"D009538","Nicotine","25162-00-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35475,N35475)","v":"DTXSID0046351"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35475,J35475)","v":"8001318"},"History of in utero cocaine exposure in language-delayed children.","8001318","Neurologic Manifestations","D007805","Language Development Disorders","DTXSID0046351"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35508,D35508)","v":"Nicotine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35508,M35508)","v":"Respiratory Paralysis"},"D009538","Nicotine","25162-00-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35508,N35508)","v":"DTXSID0046351"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35508,J35508)","v":"15749358"},"A fatal poisoning caused by methomyl and nicotine.","15749358","Neurologic Manifestations","D012133","Respiratory Paralysis","DTXSID0046351"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35517,D35517)","v":"Nicotine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35517,M35517)","v":"Seizures"},"D009538","Nicotine","25162-00-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35517,N35517)","v":"DTXSID0046351"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35517,J35517)","v":"26554375"},"A case of nicotine overdose-induced seizure on an inpatient psychiatric unit.","26554375","Neurologic Manifestations","D012640","Seizures","DTXSID0046351"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35543,D35543)","v":"Nicotine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35543,M35543)","v":"Sleep Initiation and Maintenance Disorders"},"D009538","Nicotine","25162-00-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35543,N35543)","v":"DTXSID0046351"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35543,J35543)","v":"9746444"},"Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression.","9746444","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID0046351"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35573,D35573)","v":"Nifedipine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35573,M35573)","v":"Basal Ganglia Diseases"},"D009543","Nifedipine","60299-11-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35573,N35573)","v":"DTXSID90209045"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35573,J35573)","v":"3651662"},"Prolonged oculogyric crisis on addition of nifedipine to neuroleptic medication regime.","3651662","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID90209045"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35604,D35604)","v":"Nifedipine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35604,M35604)","v":"Paralysis"},"D009543","Nifedipine","60299-11-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35604,N35604)","v":"DTXSID90209045"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35604,J35604)","v":"8193107"},"The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade.","8193107","Neurologic Manifestations","D010243","Paralysis","DTXSID90209045"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35637,D35637)","v":"Niridazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35637,M35637)","v":"Hallucinations"},"D009560","Niridazole","61-57-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35637,N35637)","v":"DTXSID6045244"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35637,J35637)","v":"4603136"},"Treatment of amebic liver abscess with emetine hydrochloride, niridazole, and metronidazole. A controlled clinical trial.","4603136","Neurologic Manifestations","D006212","Hallucinations","DTXSID6045244"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35662,D35662)","v":"Nitric Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35662,M35662)","v":"Central Nervous System Diseases"},"D009569","Nitric Oxide","10102-43-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35662,N35662)","v":"DTXSID1020938"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35662,J35662)","v":"8562443"},"Physiological and toxicological actions of nitric oxide in the central nervous system.","8562443","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID1020938"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35672,D35672)","v":"Nitric Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35672,M35672)","v":"Nervous System Diseases"},"D009569","Nitric Oxide","10102-43-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35672,N35672)","v":"DTXSID1020938"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35672,J35672)","v":"1916070"},"Acute neurotoxicity of sodium azide and nitric oxide.","1916070","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1020938"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35705,D35705)","v":"Nitrofurantoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35705,M35705)","v":"Paresthesia"},"D009582","Nitrofurantoin","54-87-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35705,N35705)","v":"DTXSID80202308"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35705,J35705)","v":"5242972"},"[Nifurantin side effects in a kidney dispensary].","5242972","Neurologic Manifestations","D010292","Paresthesia","DTXSID80202308"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35730,D35730)","v":"Nitrofurantoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35730,M35730)","v":"Peripheral Nervous System Diseases"},"D009582","Nitrofurantoin","54-87-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35730,N35730)","v":"DTXSID80202308"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35730,J35730)","v":"11987314"},"Nitrofurantoin and neuropathy.","11987314","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID80202308"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35766,D35766)","v":"Nitrofurazone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35766,M35766)","v":"Paralysis"},"D009583","Nitrofurazone","59-87-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35766,N35766)","v":"DTXSID5020944"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35766,J35766)","v":"6914849"},"Nitrofurazone toxicity.","6914849","Neurologic Manifestations","D010243","Paralysis","DTXSID5020944"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35795,D35795)","v":"Nitroglycerin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35795,M35795)","v":"Cerebrovascular Disorders"},"D005996","Nitroglycerin","55-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35795,N35795)","v":"DTXSID1021407"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35795,J35795)","v":"112227"},"A cohort study on mortality among dynamite workers.","112227","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID1021407"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35823,D35823)","v":"Nitroglycerin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35823,M35823)","v":"Migraine Disorders"},"D005996","Nitroglycerin","55-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35823,N35823)","v":"DTXSID1021407"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35823,J35823)","v":"16106903"},"[Nitroglycerin-induced headaches].","16106903","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID1021407"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35834,D35834)","v":"Nitroglycerin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35834,M35834)","v":"Migraine with Aura"},"D005996","Nitroglycerin","55-63-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35834,N35834)","v":"DTXSID1021407"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35834,J35834)","v":"11168608"},"Migraine with aura after administration of sublingual nitroglycerin tablets.","11168608","Central Nervous System Diseases","D020325","Migraine with Aura","DTXSID1021407"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35863,D35863)","v":"nitromethane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35863,M35863)","v":"Epilepsy, Tonic-Clonic"},"C008640","nitromethane","75-52-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35863,N35863)","v":"DTXSID2020977"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35863,J35863)","v":"18316694"},"Nitromethane encephalopathy MRI.","18316694","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID2020977"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35891,D35891)","v":"Nitrous Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35891,M35891)","v":"Brain Diseases"},"D009609","Nitrous Oxide","10024-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35891,N35891)","v":"DTXSID8021066"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35891,J35891)","v":"3713966"},"Behavioral effects in mice exposed to nitrous oxide or halothane: prenatal vs. postnatal exposure.","3713966","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8021066"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35902,D35902)","v":"Nitrous Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35902,M35902)","v":"Dementia"},"D009609","Nitrous Oxide","10024-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35902,N35902)","v":"DTXSID8021066"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35902,J35902)","v":"17457299"},"[Postoperative dementia: toxicity of nitrous oxide].","17457299","Central Nervous System Diseases","D003704","Dementia","DTXSID8021066"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35943,D35943)","v":"Nitrous Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35943,M35943)","v":"Nervous System Diseases"},"D009609","Nitrous Oxide","10024-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35943,N35943)","v":"DTXSID8021066"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35943,J35943)","v":"7194594"},"Exposure to nitrous oxide and neurologic disease among dental professionals.","7194594","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8021066"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35963,D35963)","v":"Nitrous Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35963,M35963)","v":"Nervous System Diseases"},"D009609","Nitrous Oxide","10024-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35963,N35963)","v":"DTXSID8021066"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35963,J35963)","v":"1403023"},"Methionine in the treatment of nitrous-oxide-induced neuropathy and myeloneuropathy.","1403023","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8021066"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C35992,D35992)","v":"Nitrous Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L35992,M35992)","v":"Peripheral Nervous System Diseases"},"D009609","Nitrous Oxide","10024-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N35992,N35992)","v":"DTXSID8021066"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J35992,J35992)","v":"205816"},"Neuropathy following abuse of nitrous oxide.","205816","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8021066"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36011,D36011)","v":"Nitrous Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36011,M36011)","v":"Seizures"},"D009609","Nitrous Oxide","10024-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36011,N36011)","v":"DTXSID8021066"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36011,J36011)","v":"3631579"},"Seizures after anesthesia: identifying the causes.","3631579","Neurologic Manifestations","D012640","Seizures","DTXSID8021066"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36031,D36031)","v":"Nitrous Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36031,M36031)","v":"Spinal Cord Diseases"},"D009609","Nitrous Oxide","10024-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36031,N36031)","v":"DTXSID8021066"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36031,J36031)","v":"17874987"},"Paralysis caused by \"nagging\".","17874987","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID8021066"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36060,D36060)","v":"Nitrous Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36060,M36060)","v":"Subacute Combined Degeneration"},"D009609","Nitrous Oxide","10024-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36060,N36060)","v":"DTXSID8021066"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36060,J36060)","v":"27854092"},"Nitrous Oxide-induced Subacute Combined Degeneration Presenting with Dystonia and Pseudoathetosis: A Case Report.","27854092","Demyelinating Diseases","D052879","Subacute Combined Degeneration","DTXSID8021066"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36104,D36104)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36104,M36104)","v":"Brain Edema"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36104,N36104)","v":"DTXSID5048893"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36104,J36104)","v":"18259964"},"Death from a possible anaphylactic reaction to ecstasy.","18259964","Central Nervous System Diseases","D001929","Brain Edema","DTXSID5048893"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36121,D36121)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36121,M36121)","v":"Cerebellar Ataxia"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36121,N36121)","v":"DTXSID5048893"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36121,J36121)","v":"11744784"},"Amnesic syndrome and severe ataxia following the recreational use of 3,4-methylene-dioxymethamphetamine (MDMA, 'ecstasy') and other substances.","11744784","Central Nervous System Diseases","D002524","Cerebellar Ataxia","DTXSID5048893"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36154,D36154)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36154,M36154)","v":"Hallucinations"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36154,N36154)","v":"DTXSID5048893"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36154,J36154)","v":"16028190"},"[3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].","16028190","Neurologic Manifestations","D006212","Hallucinations","DTXSID5048893"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36172,D36172)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36172,M36172)","v":"Inappropriate ADH Syndrome"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36172,N36172)","v":"DTXSID5048893"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36172,J36172)","v":"9715247"},"Severe hyponatremia and inappropriate antidiuretic hormone secretion following ecstasy use.","9715247","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID5048893"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36189,D36189)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36189,M36189)","v":"Memory Disorders"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36189,N36189)","v":"DTXSID5048893"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36189,J36189)","v":"25900184"},"Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.","25900184","Neurologic Manifestations","D008569","Memory Disorders","DTXSID5048893"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36222,D36222)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36222,M36222)","v":"Memory Disorders"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36222,N36222)","v":"DTXSID5048893"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36222,J36222)","v":"20668111"},"Ecstasy overdose and memory loss.","20668111","Neurologic Manifestations","D008569","Memory Disorders","DTXSID5048893"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36240,D36240)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36240,M36240)","v":"Memory Disorders"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36240,N36240)","v":"DTXSID5048893"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36240,J36240)","v":"11755138"},"Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (\"ecstasy\").","11755138","Neurologic Manifestations","D008569","Memory Disorders","DTXSID5048893"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36283,D36283)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36283,M36283)","v":"Parkinson Disease, Secondary"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36283,N36283)","v":"DTXSID5048893"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36283,J36283)","v":"10577095"},"More about parkinsonism after taking ecstasy.","10577095","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID5048893"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36290,D36290)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36290,M36290)","v":"Parkinson Disease, Secondary"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36290,N36290)","v":"DTXSID5048893"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36290,J36290)","v":"14634709"},"Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.","14634709","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID5048893"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36329,D36329)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36329,M36329)","v":"Seizures"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36329,N36329)","v":"DTXSID5048893"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36329,J36329)","v":"14592627"},"'Ecstasy'-induced subarachnoid haemorrhage: an under-reported neurological complication?","14592627","Neurologic Manifestations","D012640","Seizures","DTXSID5048893"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36351,D36351)","v":"N-Methyl-3,4-methylenedioxyamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36351,M36351)","v":"Subarachnoid Hemorrhage"},"D018817","N-Methyl-3,4-methylenedioxyamphetamine","64057-70-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36351,N36351)","v":"DTXSID5048893"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36351,J36351)","v":"12536290"},"Subarachnoid haemorrhage with \"Ecstasy\" abuse in a young adult.","12536290","Central Nervous System Diseases","D013345","Subarachnoid Hemorrhage","DTXSID5048893"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36385,D36385)","v":"Nomifensine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36385,M36385)","v":"Chorea"},"D009627","Nomifensine","24526-64-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36385,N36385)","v":"DTXSID0023377"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36385,J36385)","v":"3623824"},"Nomifensine-induced orofacial dyskinesia and Sydenham's chorea.","3623824","Central Nervous System Diseases","D002819","Chorea","DTXSID0023377"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36412,D36412)","v":"Norethindrone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36412,M36412)","v":"Carotid Artery Thrombosis"},"D009640","Norethindrone","68-22-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36412,N36412)","v":"DTXSID9023380"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36412,J36412)","v":"5794964"},"Review of arterial thrombosis in association with oral contraceptives.","5794964","Central Nervous System Diseases","D002341","Carotid Artery Thrombosis","DTXSID9023380"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36419,D36419)","v":"Norethindrone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36419,M36419)","v":"Cerebrovascular Disorders"},"D009640","Norethindrone","68-22-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36419,N36419)","v":"DTXSID9023380"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36419,J36419)","v":"5411921"},"Regression of cerebral lesions after cessation of oral contraceptives.","5411921","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID9023380"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36453,D36453)","v":"Norethynodrel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36453,M36453)","v":"Hyperkinesis"},"D009641","Norethynodrel","68-23-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36453,N36453)","v":"DTXSID3021069"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36453,J36453)","v":"15351506"},"Prenatal exposure of Long-Evans rats to 17alpha-ethinylestradiol modifies neither latent inhibition nor prepulse inhibition of the startle reflex but elicits minor deficits in exploratory behavior.","15351506","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID3021069"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36480,D36480)","v":"Norfloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36480,M36480)","v":"Vision Disorders"},"D009643","Norfloxacin","70458-96-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36480,N36480)","v":"DTXSID7037680"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36480,J36480)","v":"8746291"},"Headache and visual disturbance.","8746291","Neurologic Manifestations","D014786","Vision Disorders","DTXSID7037680"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36513,D36513)","v":"normeperidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36513,M36513)","v":"Seizures"},"C002752","normeperidine","77-17-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36513,N36513)","v":"DTXSID50227806"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36513,J36513)","v":"2237560"},"Normeperidine-induced seizures in hereditary coproporphyria.","2237560","Neurologic Manifestations","D012640","Seizures","DTXSID50227806"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36517,D36517)","v":"Nortriptyline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36517,M36517)","v":"Basal Ganglia Diseases"},"D009661","Nortriptyline","894-71-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36517,N36517)","v":"DTXSID2045109"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36517,J36517)","v":"2889"},"[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].","2889","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID2045109"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36548,D36548)","v":"Nortriptyline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36548,M36548)","v":"Seizures"},"D009661","Nortriptyline","894-71-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36548,N36548)","v":"DTXSID2045109"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36548,J36548)","v":"20306168"},"Which xenobiotic(s) could be responsible for the radiologic findings below? Answer: any proconvulsant xenobiotic, in this case tramadol, bupropion, and nortriptyline.","20306168","Neurologic Manifestations","D012640","Seizures","DTXSID2045109"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36581,D36581)","v":"Ofloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36581,M36581)","v":"Delirium"},"D015242","Ofloxacin","100986-86-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36581,N36581)","v":"DTXSID1058715"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36581,J36581)","v":"18585545"},"Levofloxacin-induced delirium with psychotic features.","18585545","Neurologic Manifestations","D003693","Delirium","DTXSID1058715"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36610,D36610)","v":"Ofloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36610,M36610)","v":"Seizures"},"D015242","Ofloxacin","100986-86-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36610,N36610)","v":"DTXSID1058715"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36610,J36610)","v":"8749646"},"Seizures associated with ofloxacin therapy.","8749646","Neurologic Manifestations","D012640","Seizures","DTXSID1058715"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36642,D36642)","v":"Okadaic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36642,M36642)","v":"Alzheimer Disease"},"D019319","Okadaic Acid","78111-17-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36642,N36642)","v":"DTXSID60880002"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36642,J36642)","v":"26295819"},"Development of a Novel and Robust Pharmacological Model of Okadaic Acid-induced Alzheimer's Disease in Zebrafish.","26295819","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID60880002"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36645,D36645)","v":"Okadaic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36645,M36645)","v":"Brain Damage, Chronic"},"D019319","Okadaic Acid","78111-17-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36645,N36645)","v":"DTXSID60880002"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36645,J36645)","v":"9681967"},"Acute or chronic administration of okadaic acid to rats induces brain damage rather than Alzheimer-like neuropathology.","9681967","Central Nervous System Diseases","D001925","Brain Damage, Chronic","DTXSID60880002"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36678,D36678)","v":"olanzapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36678,M36678)","v":"Basal Ganglia Diseases"},"C076029","olanzapine","132539-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36678,N36678)","v":"DTXSID9023388"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36678,J36678)","v":"23428782"},"Incidences of extrapyramidal symptoms in patients with schizophrenia after treatment with long-acting injection (depot) or oral formulations of olanzapine.","23428782","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID9023388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36710,D36710)","v":"olanzapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36710,M36710)","v":"Basal Ganglia Diseases"},"C076029","olanzapine","132539-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36710,N36710)","v":"DTXSID9023388"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36710,J36710)","v":"10435397"},"Effects of acute and chronic administration of olanzapine in comparison to clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons in the rat brain.","10435397","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID9023388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36730,D36730)","v":"olanzapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36730,M36730)","v":"Basal Ganglia Diseases"},"C076029","olanzapine","132539-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36730,N36730)","v":"DTXSID9023388"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36730,J36730)","v":"15064916"},"Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder.","15064916","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID9023388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36771,D36771)","v":"olanzapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36771,M36771)","v":"Delirium"},"C076029","olanzapine","132539-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36771,N36771)","v":"DTXSID9023388"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36771,J36771)","v":"15119927"},"Olanzapine may cause delirium in geriatric patients.","15119927","Neurologic Manifestations","D003693","Delirium","DTXSID9023388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36778,D36778)","v":"olanzapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36778,M36778)","v":"Disorders of Excessive Somnolence"},"C076029","olanzapine","132539-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36778,N36778)","v":"DTXSID9023388"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36778,J36778)","v":"15083933"},"The clinical picture of olanzapine poisoning with special reference to fluctuating mental status.","15083933","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID9023388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36823,D36823)","v":"olanzapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36823,M36823)","v":"Hyperprolactinemia"},"C076029","olanzapine","132539-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36823,N36823)","v":"DTXSID9023388"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36823,J36823)","v":"12650682"},"Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials.","12650682","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID9023388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36839,D36839)","v":"olanzapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36839,M36839)","v":"Myoclonus"},"C076029","olanzapine","132539-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36839,N36839)","v":"DTXSID9023388"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36839,J36839)","v":"22196307"},"Olanzapine-associated myoclonus.","22196307","Neurologic Manifestations","D009207","Myoclonus","DTXSID9023388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36868,D36868)","v":"olanzapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36868,M36868)","v":"Seizures"},"C076029","olanzapine","132539-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36868,N36868)","v":"DTXSID9023388"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36868,J36868)","v":"19820434"},"Olanzapine-induced clinical seizure: a case report.","19820434","Neurologic Manifestations","D012640","Seizures","DTXSID9023388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36891,D36891)","v":"olanzapine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36891,M36891)","v":"Stroke"},"C076029","olanzapine","132539-06-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36891,N36891)","v":"DTXSID9023388"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36891,J36891)","v":"23535349"},"Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study.","23535349","Central Nervous System Diseases","D020521","Stroke","DTXSID9023388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36907,D36907)","v":"omega-Chloroacetophenone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36907,M36907)","v":"Eye Burns"},"D002721","omega-Chloroacetophenone","532-27-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36907,N36907)","v":"DTXSID9020293"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36907,J36907)","v":"6786128"},"[Corneal damage caused by chloracetophenone].","6786128","Trauma, Nervous System","D005126","Eye Burns","DTXSID9020293"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36936,D36936)","v":"Omeprazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36936,M36936)","v":"Hepatic Encephalopathy"},"D009853","Omeprazole","73590-58-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36936,N36936)","v":"DTXSID6021080"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36936,J36936)","v":"9303628"},"[Hepatic encephalopathy related to omeprazole].","9303628","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID6021080"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36959,D36959)","v":"Omeprazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36959,M36959)","v":"Polymyositis"},"D009853","Omeprazole","73590-58-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36959,N36959)","v":"DTXSID6021080"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36959,J36959)","v":"23580790"},"Statin-associated polymyositis following omeprazole treatment.","23580790","Neuromuscular Diseases","D017285","Polymyositis","DTXSID6021080"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C36997,D36997)","v":"Ondansetron"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L36997,M36997)","v":"Epilepsy, Tonic-Clonic"},"D017294","Ondansetron","99614-58-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N36997,N36997)","v":"DTXSID60244165"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J36997,J36997)","v":"19490041"},"Ondansetron and seizures.","19490041","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID60244165"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37004,D37004)","v":"Ondansetron"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37004,M37004)","v":"Ocular Motility Disorders"},"D017294","Ondansetron","99614-58-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37004,N37004)","v":"DTXSID60244165"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37004,J37004)","v":"12962170"},"Ondansetron-induced multifocal encephalopathy.","12962170","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID60244165"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37052,D37052)","v":"Oseltamivir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37052,M37052)","v":"Delirium"},"D053139","Oseltamivir","196618-13-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37052,N37052)","v":"DTXSID9044291"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37052,J37052)","v":"16732168"},"Oseltamivir and delirious behavior in children with influenza.","16732168","Neurologic Manifestations","D003693","Delirium","DTXSID9044291"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37065,D37065)","v":"Oseltamivir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37065,M37065)","v":"Nervous System Diseases"},"D053139","Oseltamivir","196618-13-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37065,N37065)","v":"DTXSID9044291"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37065,J37065)","v":"15566030"},"Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults.","15566030","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID9044291"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37104,D37104)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37104,M37104)","v":"Hearing Loss"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37104,N37104)","v":"DTXSID0036760"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37104,J37104)","v":"23494572"},"Oxaliplatin-induced ototoxicity in adjuvant setting for colorectal cancer: unusual side effect.","23494572","Neurologic Manifestations","D034381","Hearing Loss","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37130,D37130)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37130,M37130)","v":"Hyperalgesia"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37130,N37130)","v":"DTXSID0036760"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37130,J37130)","v":"23374942"},"Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity.","23374942","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37133,D37133)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37133,M37133)","v":"Hyperalgesia"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37133,N37133)","v":"DTXSID0036760"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37133,J37133)","v":"24990115"},"Gabapentin prevents oxaliplatin-induced mechanical hyperalgesia in mice.","24990115","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37172,D37172)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37172,M37172)","v":"Nervous System Diseases"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37172,N37172)","v":"DTXSID0036760"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37172,J37172)","v":"2295116"},"Phase I study of oxaliplatin in patients with advanced cancer.","2295116","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37194,D37194)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37194,M37194)","v":"Neuralgia"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37194,N37194)","v":"DTXSID0036760"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37194,J37194)","v":"25141998"},"Establishment of opioid-induced rewarding effects under oxaliplatin- and Paclitaxel-induced neuropathy in rats.","25141998","Neuromuscular Diseases","D009437","Neuralgia","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37227,D37227)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37227,M37227)","v":"Paresthesia"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37227,N37227)","v":"DTXSID0036760"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37227,J37227)","v":"11154038"},"Oxaliplatin in colorectal cancer patients living in an arctic or subarctic area: significant cold-triggered dysesthesias and laryngeal reactions.","11154038","Neurologic Manifestations","D010292","Paresthesia","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37240,D37240)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37240,M37240)","v":"Peripheral Nervous System Diseases"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37240,N37240)","v":"DTXSID0036760"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37240,J37240)","v":"27782842"},"Aqueous extract of Lithospermi radix attenuates oxaliplatin-induced neurotoxicity in both in vitro and in vivo models.","27782842","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37262,D37262)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37262,M37262)","v":"Peripheral Nervous System Diseases"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37262,N37262)","v":"DTXSID0036760"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37262,J37262)","v":"25858589"},"Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis.","25858589","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37295,D37295)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37295,M37295)","v":"Peripheral Nervous System Diseases"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37295,N37295)","v":"DTXSID0036760"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37295,J37295)","v":"24122404"},"A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer.","24122404","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37333,D37333)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37333,M37333)","v":"Peripheral Nervous System Diseases"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37333,N37333)","v":"DTXSID0036760"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37333,J37333)","v":"15461551"},"A review of oxaliplatin and its clinical use in colorectal cancer.","15461551","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37356,D37356)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37356,M37356)","v":"Peripheral Nervous System Diseases"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37356,N37356)","v":"DTXSID0036760"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37356,J37356)","v":"23029238"},"Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging.","23029238","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37363,D37363)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37363,M37363)","v":"Peripheral Nervous System Diseases"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37363,N37363)","v":"DTXSID0036760"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37363,J37363)","v":"21897761"},"Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations.","21897761","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37397,D37397)","v":"oxaliplatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37397,M37397)","v":"Sensation Disorders"},"C030110","oxaliplatin","61825-94-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37397,N37397)","v":"DTXSID0036760"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37397,J37397)","v":"21189381"},"Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.","21189381","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID0036760"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37424,D37424)","v":"oxatomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37424,M37424)","v":"Dystonia"},"C015408","oxatomide","60607-34-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37424,N37424)","v":"DTXSID4045181"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37424,J37424)","v":"2871433"},"Acute dystonic reactions and long-lasting impaired consciousness associated with oxatomide in children.","2871433","Neurologic Manifestations","D004421","Dystonia","DTXSID4045181"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37453,D37453)","v":"Oxazepam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37453,M37453)","v":"Seizures"},"D010076","Oxazepam","604-75-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37453,N37453)","v":"DTXSID1021087"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37453,J37453)","v":"2185302"},"Oxazepam: update 1989.","2185302","Neurologic Manifestations","D012640","Seizures","DTXSID1021087"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37485,D37485)","v":"oxcarbazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37485,M37485)","v":"Migraine Disorders"},"C036006","oxcarbazepine","28721-07-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37485,N37485)","v":"DTXSID0045703"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37485,J37485)","v":"17955169"},"Uncontrolled headache induced by oxcarbazepine.","17955169","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID0045703"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37492,D37492)","v":"oxcarbazepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37492,M37492)","v":"Seizures"},"C036006","oxcarbazepine","28721-07-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37492,N37492)","v":"DTXSID0045703"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37492,J37492)","v":"18281195"},"Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring.","18281195","Neurologic Manifestations","D012640","Seizures","DTXSID0045703"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37517,D37517)","v":"Oxidopamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37517,M37517)","v":"Lesch-Nyhan Syndrome"},"D016627","Oxidopamine","636-00-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37517,N37517)","v":"DTXSID30212972"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37517,J37517)","v":"27029809"},"The Use of Perinatal 6-Hydroxydopamine to Produce a Rodent Model of Lesch-Nyhan Disease.","27029809","Central Nervous System Diseases","D007926","Lesch-Nyhan Syndrome","DTXSID30212972"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37553,D37553)","v":"Oxidopamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37553,M37553)","v":"Parkinson Disease, Secondary"},"D016627","Oxidopamine","636-00-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37553,N37553)","v":"DTXSID30212972"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37553,J37553)","v":"1684115"},"Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of parkinsonism.","1684115","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID30212972"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37586,D37586)","v":"Oxidopamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37586,M37586)","v":"Parkinsonian Disorders"},"D016627","Oxidopamine","636-00-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37586,N37586)","v":"DTXSID30212972"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37586,J37586)","v":"15901053"},"Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats.","15901053","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID30212972"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37610,D37610)","v":"Oxidopamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37610,M37610)","v":"Parkinsonian Disorders"},"D016627","Oxidopamine","636-00-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37610,N37610)","v":"DTXSID30212972"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37610,J37610)","v":"11740172"},"Prevention of neurotoxin damage of 6-OHDA to dopaminergic nigral neuron by subthalamic nucleus lesions.","11740172","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID30212972"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37621,D37621)","v":"Oxidopamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37621,M37621)","v":"Tremor"},"D016627","Oxidopamine","636-00-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37621,N37621)","v":"DTXSID30212972"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37621,J37621)","v":"1904561"},"Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat.","1904561","Neurologic Manifestations","D014202","Tremor","DTXSID30212972"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37654,D37654)","v":"Oxycodone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37654,M37654)","v":"Central Nervous System Diseases"},"D010098","Oxycodone","76-42-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37654,N37654)","v":"DTXSID5023407"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37654,J37654)","v":"23783165"},"Putative association of ABCB1 2677G&gt;T/A with oxycodone-induced central nervous system depression in breastfeeding mothers.","23783165","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID5023407"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37678,D37678)","v":"Oxycodone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37678,M37678)","v":"Miosis"},"D010098","Oxycodone","76-42-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37678,N37678)","v":"DTXSID5023407"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37678,J37678)","v":"15942522"},"Sick sisters.","15942522","Neurologic Manifestations","D015877","Miosis","DTXSID5023407"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37715,D37715)","v":"Oxygen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37715,M37715)","v":"Hypoxia, Brain"},"D010100","Oxygen","7782-44-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37715,N37715)","v":"DTXSID2037681"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37715,J37715)","v":"1155939"},"[Brain lesions linked to anoxia due to inhalation in hyperbaric conditions of different gas combinations especially O2-H2].","1155939","Central Nervous System Diseases","D002534","Hypoxia, Brain","DTXSID2037681"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37744,D37744)","v":"Oxygen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37744,M37744)","v":"Seizures"},"D010100","Oxygen","7782-44-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37744,N37744)","v":"DTXSID2037681"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37744,J37744)","v":"3942814"},"[Effect of chlorgyline on gamma-aminobutyric acid levels in hyperoxia].","3942814","Neurologic Manifestations","D012640","Seizures","DTXSID2037681"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37771,D37771)","v":"Oxygen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37771,M37771)","v":"Seizures"},"D010100","Oxygen","7782-44-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37771,N37771)","v":"DTXSID2037681"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37771,J37771)","v":"5822561"},"Sympathoadrenomedullary response of the rat to high oxygen exposures.","5822561","Neurologic Manifestations","D012640","Seizures","DTXSID2037681"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37783,D37783)","v":"Oxygen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37783,M37783)","v":"Seizures"},"D010100","Oxygen","7782-44-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37783,N37783)","v":"DTXSID2037681"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37783,J37783)","v":"11455199"},"Oxygen-induced seizures and inhibition of human glutamate decarboxylase and porcine cysteine sulfinic acid decarboxylase by oxygen and nitric oxide.","11455199","Neurologic Manifestations","D012640","Seizures","DTXSID2037681"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37823,D37823)","v":"Oxyquinoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37823,M37823)","v":"Nervous System Diseases"},"D015125","Oxyquinoline","148-24-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37823,N37823)","v":"DTXSID5020730"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37823,J37823)","v":"3081428"},"A study on the neurotoxicity of broxyquinoline and brobenzoxaldine combination in therapeutic doses.","3081428","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5020730"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37844,D37844)","v":"Ozone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37844,M37844)","v":"Brain Ischemia"},"D010126","Ozone","10028-15-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37844,N37844)","v":"DTXSID0021098"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37844,J37844)","v":"29261153"},"Protective Effects of Ambient Ozone on Incidence and Outcomes of Ischemic Stroke in Changzhou, China: A Time-Series Study.","29261153","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID0021098"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37851,D37851)","v":"Ozone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37851,M37851)","v":"Memory Disorders"},"D010126","Ozone","10028-15-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37851,N37851)","v":"DTXSID0021098"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37851,J37851)","v":"19356678"},"Estradiol prevents ozone-induced increases in brain lipid peroxidation and impaired social recognition memory in female rats.","19356678","Neurologic Manifestations","D008569","Memory Disorders","DTXSID0021098"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37891,D37891)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37891,M37891)","v":"Dysgeusia"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37891,N37891)","v":"DTXSID9023413"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37891,J37891)","v":"22864536"},"Taste alteration in breast cancer patients treated with taxane chemotherapy: experience, effect, and coping strategies.","22864536","Neurologic Manifestations","D004408","Dysgeusia","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37912,D37912)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37912,M37912)","v":"Hyperalgesia"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37912,N37912)","v":"DTXSID9023413"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37912,J37912)","v":"26512050"},"A Hyperresponsive HPA Axis May Confer Resilience Against Persistent Paclitaxel-Induced Mechanical Hypersensitivity.","26512050","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37941,D37941)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37941,M37941)","v":"Hyperalgesia"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37941,N37941)","v":"DTXSID9023413"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37941,J37941)","v":"21118710"},"Role of satellite cell-derived L-serine in the dorsal root ganglion in paclitaxel-induced painful peripheral neuropathy.","21118710","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37959,D37959)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37959,M37959)","v":"Hypotension, Orthostatic"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37959,N37959)","v":"DTXSID9023413"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37959,J37959)","v":"7903950"},"Incapacitating autonomic neuropathy precipitated by taxol.","7903950","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C37980,D37980)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L37980,M37980)","v":"Muscular Diseases"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N37980,N37980)","v":"DTXSID9023413"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J37980,J37980)","v":"12442916"},"Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum.","12442916","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38009,D38009)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38009,M38009)","v":"Nervous System Diseases"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38009,N38009)","v":"DTXSID9023413"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38009,J38009)","v":"2887641"},"Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.","2887641","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38052,D38052)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38052,M38052)","v":"Neuralgia"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38052,N38052)","v":"DTXSID9023413"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38052,J38052)","v":"25388329"},"Activation of TLR-4 to produce tumour necrosis factor-α in neuropathic pain caused by paclitaxel.","25388329","Neuromuscular Diseases","D009437","Neuralgia","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38070,D38070)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38070,M38070)","v":"Neuralgia"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38070,N38070)","v":"DTXSID9023413"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38070,J38070)","v":"22037390"},"Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat.","22037390","Neuromuscular Diseases","D009437","Neuralgia","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38103,D38103)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38103,M38103)","v":"Peripheral Nervous System Diseases"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38103,N38103)","v":"DTXSID9023413"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38103,J38103)","v":"8102016"},"Current dosage and schedule issues in the development of paclitaxel (Taxol).","8102016","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38120,D38120)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38120,M38120)","v":"Peripheral Nervous System Diseases"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38120,N38120)","v":"DTXSID9023413"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38120,J38120)","v":"8636011"},"Phase I study of paclitaxel by three-hour infusion: hypotension just after infusion is one of the major dose-limiting toxicities.","8636011","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38138,D38138)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38138,M38138)","v":"Peripheral Nervous System Diseases"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38138,N38138)","v":"DTXSID9023413"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38138,J38138)","v":"9007122"},"Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer.","9007122","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38172,D38172)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38172,M38172)","v":"Peripheral Nervous System Diseases"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38172,N38172)","v":"DTXSID9023413"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38172,J38172)","v":"27117347"},"Identification of fluocinolone acetonide to prevent paclitaxel-induced peripheral neuropathy.","27117347","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38203,D38203)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38203,M38203)","v":"Peripheral Nervous System Diseases"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38203,N38203)","v":"DTXSID9023413"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38203,J38203)","v":"17005179"},"Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells.","17005179","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38232,D38232)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38232,M38232)","v":"Peripheral Nervous System Diseases"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38232,N38232)","v":"DTXSID9023413"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38232,J38232)","v":"23461065"},"Factors exacerbating peripheral neuropathy induced by paclitaxel plus carboplatin in non-small cell lung cancer.","23461065","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38240,D38240)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38240,M38240)","v":"Peripheral Nervous System Diseases"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38240,N38240)","v":"DTXSID9023413"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38240,J38240)","v":"15948540"},"A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy.","15948540","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38267,D38267)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38267,M38267)","v":"Peripheral Nervous System Diseases"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38267,N38267)","v":"DTXSID9023413"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38267,J38267)","v":"19429028"},"Differential effects of paclitaxel treatment on cognitive functioning and mechanical sensitivity.","19429028","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38300,D38300)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38300,M38300)","v":"Peripheral Nervous System Diseases"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38300,N38300)","v":"DTXSID9023413"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38300,J38300)","v":"10603043"},"Docetaxel neuropathy: a distal axonopathy.","10603043","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38333,D38333)","v":"Paclitaxel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38333,M38333)","v":"Sensation Disorders"},"D017239","Paclitaxel","33069-62-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38333,N38333)","v":"DTXSID9023413"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38333,J38333)","v":"7837287"},"Protection by an ACTH4-9 analogue against the toxic effects of cisplatin and taxol on sensory neurons and glial cells in vitro.","7837287","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID9023413"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38361,D38361)","v":"Paliperidone Palmitate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38361,M38361)","v":"Delirium"},"D000068882","Paliperidone Palmitate","199739-10-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38361,N38361)","v":"DTXSID70870217"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38361,J38361)","v":"26872118"},"The Delirium Related to Oral Paliperidone in Dementia: A Case Report.","26872118","Neurologic Manifestations","D003693","Delirium","DTXSID70870217"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38368,D38368)","v":"Paliperidone Palmitate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38368,M38368)","v":"Hyperkinesis"},"D000068882","Paliperidone Palmitate","199739-10-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38368,N38368)","v":"DTXSID70870217"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38368,J38368)","v":"20662826"},"Studies on the acute toxicity, pharmacokinetics and pharmacodynamics of paliperidone derivatives--comparison to paliperidone and risperidone in mice and rats.","20662826","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID70870217"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38397,D38397)","v":"Paliperidone Palmitate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38397,M38397)","v":"Tremor"},"D000068882","Paliperidone Palmitate","199739-10-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38397,N38397)","v":"DTXSID70870217"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38397,J38397)","v":"24590546"},"Pharmacokinetics and tolerability of paliperidone palmitate injection in Chinese subjects.","24590546","Neurologic Manifestations","D014202","Tremor","DTXSID70870217"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38429,D38429)","v":"Pancuronium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38429,M38429)","v":"Muscular Dystrophies"},"D010197","Pancuronium","16974-53-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38429,N38429)","v":"DTXSID7048405"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38429,J38429)","v":"2957684"},"[Acute myopathy after status asthmaticus].","2957684","Neuromuscular Diseases","D009136","Muscular Dystrophies","DTXSID7048405"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38462,D38462)","v":"Papaverine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38462,M38462)","v":"Blindness"},"D010208","Papaverine","58-74-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38462,N38462)","v":"DTXSID4023418"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38462,J38462)","v":"19901231"},"Intracisternal irrigation of papaverine leading to choroidal infarction.","19901231","Neurologic Manifestations","D001766","Blindness","DTXSID4023418"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38490,D38490)","v":"Paraoxon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38490,M38490)","v":"Peripheral Nervous System Diseases"},"D010261","Paraoxon","311-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38490,N38490)","v":"DTXSID6024046"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38490,J38490)","v":"9463518"},"Reversible inhibition can profoundly mislead studies on progressive inhibition of enzymes: the interaction of paraoxon with soluble neuropathy target esterase.","9463518","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID6024046"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38497,D38497)","v":"Paraoxon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38497,M38497)","v":"Status Epilepticus"},"D010261","Paraoxon","311-45-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38497,N38497)","v":"DTXSID6024046"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38497,J38497)","v":"27224207"},"Pharmacological blockade of the calcium plateau provides neuroprotection following organophosphate paraoxon induced status epilepticus in rats.","27224207","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID6024046"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38521,D38521)","v":"Paraquat"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38521,M38521)","v":"Eye Injuries"},"D010269","Paraquat","4685-14-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38521,N38521)","v":"DTXSID3034799"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38521,J38521)","v":"4781693"},"Ocular toxicity of paraquat.","4781693","Trauma, Nervous System","D005131","Eye Injuries","DTXSID3034799"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38558,D38558)","v":"Paraquat"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38558,M38558)","v":"Parkinson Disease, Secondary"},"D010269","Paraquat","4685-14-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38558,N38558)","v":"DTXSID3034799"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38558,J38558)","v":"20542017"},"Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease.","20542017","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID3034799"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38591,D38591)","v":"Paraquat"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38591,M38591)","v":"Seizures"},"D010269","Paraquat","4685-14-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38591,N38591)","v":"DTXSID3034799"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38591,J38591)","v":"1480553"},"Production of limbic motor seizures and brain damage by systemic and intracerebral injections of paraquat in rats.","1480553","Neurologic Manifestations","D012640","Seizures","DTXSID3034799"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38610,D38610)","v":"Parathion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38610,M38610)","v":"Nervous System Diseases"},"D010278","Parathion","56-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38610,N38610)","v":"DTXSID7021100"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38610,J38610)","v":"5462904"},"[Neuropathies caused by pesticides].","5462904","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7021100"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38626,D38626)","v":"Parathion"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38626,M38626)","v":"Seizures"},"D010278","Parathion","56-38-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38626,N38626)","v":"DTXSID7021100"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38626,J38626)","v":"22217889"},"Deadly drop--cholinergic syndrome from wearing a laundered uniform.","22217889","Neurologic Manifestations","D012640","Seizures","DTXSID7021100"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38659,D38659)","v":"Paroxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38659,M38659)","v":"Delirium"},"D017374","Paroxetine","72471-80-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38659,N38659)","v":"DTXSID70222772"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38659,J38659)","v":"7485639"},"Possible paroxetine-zolpidem interaction.","7485639","Neurologic Manifestations","D003693","Delirium","DTXSID70222772"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38678,D38678)","v":"Paroxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38678,M38678)","v":"Hallucinations"},"D017374","Paroxetine","72471-80-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38678,N38678)","v":"DTXSID70222772"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38678,J38678)","v":"8766220"},"Nightmares and hallucinations after long-term intake of tramadol combined with antidepressants.","8766220","Neurologic Manifestations","D006212","Hallucinations","DTXSID70222772"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38720,D38720)","v":"Paroxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38720,M38720)","v":"Perceptual Disorders"},"D017374","Paroxetine","72471-80-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38720,N38720)","v":"DTXSID70222772"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38720,J38720)","v":"12000213"},"Palinopsia and paroxetine withdrawal.","12000213","Neurologic Manifestations","D010468","Perceptual Disorders","DTXSID70222772"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38727,D38727)","v":"Paroxetine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38727,M38727)","v":"Seizures"},"D017374","Paroxetine","72471-80-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38727,N38727)","v":"DTXSID70222772"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38727,J38727)","v":"7844577"},"Spontaneous seizure after concurrent use of methohexital anesthesia for electroconvulsive therapy and paroxetine: a case report.","7844577","Neurologic Manifestations","D012640","Seizures","DTXSID70222772"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38771,D38771)","v":"p-Chloroamphetamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38771,M38771)","v":"Nervous System Diseases"},"D010133","p-Chloroamphetamine","64-12-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38771,N38771)","v":"DTXSID90897229"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38771,J38771)","v":"80767"},"Evaluation of the neurotoxic effects of p-chloroamphetamine: a histological and biochemical study.","80767","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID90897229"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38788,D38788)","v":"Pefloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38788,M38788)","v":"Peripheral Nervous System Diseases"},"D015366","Pefloxacin","70458-92-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38788,N38788)","v":"DTXSID3048493"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38788,J38788)","v":"1352007"},"Peripheral neuropathy associated with fluoroquinolones.","1352007","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID3048493"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38817,D38817)","v":"Pemoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38817,M38817)","v":"Tic Disorders"},"D010389","Pemoline","2152-34-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38817,N38817)","v":"DTXSID3023427"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38817,J38817)","v":"11349243"},"Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.","11349243","Central Nervous System Diseases","D013981","Tic Disorders","DTXSID3023427"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38839,D38839)","v":"Penicillin G"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38839,M38839)","v":"Central Nervous System Diseases"},"D010400","Penicillin G","75333-20-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38839,N38839)","v":"DTXSID50226293"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38839,J38839)","v":"6075112"},"Central nervous system toxicity secondary to massive doses of penicillin 'G' in the treatment of overwhelming infections.","6075112","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID50226293"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38856,D38856)","v":"Penicillin G"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38856,M38856)","v":"Epilepsy"},"D010400","Penicillin G","75333-20-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38856,N38856)","v":"DTXSID50226293"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38856,J38856)","v":"21294084"},"Effects of the hippocampal deep brain stimulation on cortical epileptic discharges in penicillin - induced epilepsy model in rats.","21294084","Central Nervous System Diseases","D004827","Epilepsy","DTXSID50226293"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38891,D38891)","v":"Penicillin G"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38891,M38891)","v":"Seizures"},"D010400","Penicillin G","75333-20-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38891,N38891)","v":"DTXSID50226293"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38891,J38891)","v":"3942109"},"Hoigne's syndrome.","3942109","Neurologic Manifestations","D012640","Seizures","DTXSID50226293"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38917,D38917)","v":"Penicillin G"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38917,M38917)","v":"Vision Disorders"},"D010400","Penicillin G","75333-20-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38917,N38917)","v":"DTXSID50226293"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38917,J38917)","v":"5420872"},"[Nicolau syndrome following retacillin compositum injection].","5420872","Neurologic Manifestations","D014786","Vision Disorders","DTXSID50226293"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38946,D38946)","v":"Penicillin G Procaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38946,M38946)","v":"Brain Edema"},"D010402","Penicillin G Procaine","6130-64-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38946,N38946)","v":"DTXSID40210207"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38946,J38946)","v":"5764068"},"Benign intracranial hypertension associated with a delayed penicillin reaction.","5764068","Central Nervous System Diseases","D001929","Brain Edema","DTXSID40210207"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38959,D38959)","v":"Penicillin G Procaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38959,M38959)","v":"Hallucinations"},"D010402","Penicillin G Procaine","6130-64-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38959,N38959)","v":"DTXSID40210207"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38959,J38959)","v":"292747"},"Hoigné's syndrome-its course and symptomatology.","292747","Neurologic Manifestations","D006212","Hallucinations","DTXSID40210207"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C38985,D38985)","v":"Penicillin G Procaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L38985,M38985)","v":"Psychomotor Disorders"},"D010402","Penicillin G Procaine","6130-64-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N38985,N38985)","v":"DTXSID40210207"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J38985,J38985)","v":"11503262"},"[Hoigne syndrome as an acute non-allergic reaction to different drugs: case reports].","11503262","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID40210207"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39014,D39014)","v":"Pentachlorophenol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39014,M39014)","v":"Peripheral Nervous System Diseases"},"D010416","Pentachlorophenol","131-52-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39014,N39014)","v":"DTXSID4040264"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39014,J39014)","v":"2850746"},"[Penta-chlorophenol (Xylophene) poisoning].","2850746","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4040264"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39052,D39052)","v":"Pentazocine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39052,M39052)","v":"Hallucinations"},"D010423","Pentazocine","359-83-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39052,N39052)","v":"DTXSID7023433"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39052,J39052)","v":"5469859"},"Hallucinations following pentazocine. Case reports.","5469859","Neurologic Manifestations","D006212","Hallucinations","DTXSID7023433"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39079,D39079)","v":"Pentazocine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39079,M39079)","v":"Muscular Diseases"},"D010423","Pentazocine","359-83-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39079,N39079)","v":"DTXSID7023433"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39079,J39079)","v":"1242485"},"Letter: Pentazocine-induced fibrous myopathy.","1242485","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID7023433"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39082,D39082)","v":"Pentazocine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39082,M39082)","v":"Neurofibroma"},"D010423","Pentazocine","359-83-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39082,N39082)","v":"DTXSID7023433"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39082,J39082)","v":"9737132"},"Pentazocine-induced fibrous myopathy and localized neuropathy.","9737132","Nervous System Neoplasms","D009455","Neurofibroma","DTXSID7023433"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39120,D39120)","v":"Pentetic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39120,M39120)","v":"Seizures"},"D004369","Pentetic Acid","67-43-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39120,N39120)","v":"DTXSID2023434"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39120,J39120)","v":"1882740"},"Generalized seizure after i.v. administration of gadopentetate dimeglumine.","1882740","Neurologic Manifestations","D012640","Seizures","DTXSID2023434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39143,D39143)","v":"Pentobarbital"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39143,M39143)","v":"Language Development Disorders"},"D010424","Pentobarbital","57-33-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39143,N39143)","v":"DTXSID9021712"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39143,J39143)","v":"3380050"},"Effect of anticonvulsant medication in the preschool years on later language development.","3380050","Neurologic Manifestations","D007805","Language Development Disorders","DTXSID9021712"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39176,D39176)","v":"Pentoxifylline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39176,M39176)","v":"Tremor"},"D010431","Pentoxifylline","6493-05-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39176,N39176)","v":"DTXSID7023437"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39176,J39176)","v":"11999342"},"Effects of pentoxifylline on inflammatory cytokine expression and acute pleuropneumonia in swine.","11999342","Neurologic Manifestations","D014202","Tremor","DTXSID7023437"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39188,D39188)","v":"Pentylenetetrazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39188,M39188)","v":"Epilepsy"},"D010433","Pentylenetetrazole","54-95-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39188,N39188)","v":"DTXSID7041091"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39188,J39188)","v":"28587936"},"Intra-hippocampal microinjection of oxytocin produced antiepileptic effect on the pentylenetetrazol-induced epilepsy in rats.","28587936","Central Nervous System Diseases","D004827","Epilepsy","DTXSID7041091"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39211,D39211)","v":"Pentylenetetrazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39211,M39211)","v":"Epilepsy"},"D010433","Pentylenetetrazole","54-95-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39211,N39211)","v":"DTXSID7041091"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39211,J39211)","v":"12419525"},"Cysteamine pre-treatment reduces pentylenetetrazol-induced plasticity and epileptiform discharge in the CA1 region of rat hippocampal slices.","12419525","Central Nervous System Diseases","D004827","Epilepsy","DTXSID7041091"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39244,D39244)","v":"Pentylenetetrazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39244,M39244)","v":"Seizures"},"D010433","Pentylenetetrazole","54-95-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39244,N39244)","v":"DTXSID7041091"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39244,J39244)","v":"9805607"},"[Effect of carotid glomectomy on seizures induced by corasol].","9805607","Neurologic Manifestations","D012640","Seizures","DTXSID7041091"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39281,D39281)","v":"Pentylenetetrazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39281,M39281)","v":"Seizures"},"D010433","Pentylenetetrazole","54-95-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39281,N39281)","v":"DTXSID7041091"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39281,J39281)","v":"28495313"},"Posterior hypothalamus glutamate infusion decreases pentylenetetrazol-induced seizures of male rats through hippocampal histamine increase.","28495313","Neurologic Manifestations","D012640","Seizures","DTXSID7041091"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39305,D39305)","v":"Pentylenetetrazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39305,M39305)","v":"Seizures"},"D010433","Pentylenetetrazole","54-95-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39305,N39305)","v":"DTXSID7041091"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39305,J39305)","v":"23499834"},"The threshold of pentylenetetrazole-induced convulsive seizures, but not that of nonconvulsive seizures, is controlled by the nitric oxide levels in murine brains.","23499834","Neurologic Manifestations","D012640","Seizures","DTXSID7041091"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39333,D39333)","v":"Pentylenetetrazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39333,M39333)","v":"Seizures"},"D010433","Pentylenetetrazole","54-95-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39333,N39333)","v":"DTXSID7041091"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39333,J39333)","v":"19393274"},"Additive anticonvulsant effects of creatine supplementation and physical exercise against pentylenetetrazol-induced seizures.","19393274","Neurologic Manifestations","D012640","Seizures","DTXSID7041091"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39340,D39340)","v":"Pentylenetetrazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39340,M39340)","v":"Seizures"},"D010433","Pentylenetetrazole","54-95-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39340,N39340)","v":"DTXSID7041091"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39340,J39340)","v":"2079649"},"Effect of orally administered dextromethorphan on theophylline- and pentylenetetrazol-induced seizures in rats.","2079649","Neurologic Manifestations","D012640","Seizures","DTXSID7041091"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39373,D39373)","v":"Pentylenetetrazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39373,M39373)","v":"Seizures"},"D010433","Pentylenetetrazole","54-95-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39373,N39373)","v":"DTXSID7041091"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39373,J39373)","v":"10850549"},"Effects of ammonia on pentylenetetrazole-induced seizure threshold.","10850549","Neurologic Manifestations","D012640","Seizures","DTXSID7041091"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39401,D39401)","v":"perampanel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39401,M39401)","v":"Epilepsy"},"C551441","perampanel","380917-97-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39401,N39401)","v":"DTXSID80191501"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39401,J39401)","v":"27820603"},"Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism.","27820603","Central Nervous System Diseases","D004827","Epilepsy","DTXSID80191501"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39434,D39434)","v":"Pergolide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39434,M39434)","v":"Sleep Wake Disorders"},"D010479","Pergolide","66104-22-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39434,N39434)","v":"DTXSID2023438"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39434,J39434)","v":"15851743"},"Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy.","15851743","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID2023438"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39441,D39441)","v":"Perhexiline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39441,M39441)","v":"Brain Diseases"},"D010480","Perhexiline","6621-47-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39441,N39441)","v":"DTXSID7023439"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39441,J39441)","v":"6522775"},"[Treatment of angina pectoris with perhexiline maleate. Results and secondary effects].","6522775","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID7023439"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39490,D39490)","v":"Perhexiline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39490,M39490)","v":"Parkinson Disease, Secondary"},"D010480","Perhexiline","6621-47-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39490,N39490)","v":"DTXSID7023439"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39490,J39490)","v":"6263960"},"Perhexiline maleate as a cause of reversible parkinsonism and peripheral neuropathy.","6263960","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID7023439"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39502,D39502)","v":"Perhexiline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39502,M39502)","v":"Peripheral Nervous System Diseases"},"D010480","Perhexiline","6621-47-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39502,N39502)","v":"DTXSID7023439"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39502,J39502)","v":"81769"},"[Electrophysiological study of latent neuropathies induced by perhexiline].","81769","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7023439"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39535,D39535)","v":"Perhexiline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39535,M39535)","v":"Polyradiculoneuropathy"},"D010480","Perhexiline","6621-47-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39535,N39535)","v":"DTXSID7023439"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39535,J39535)","v":"502946"},"Perhexiline maleate.","502946","Demyelinating Diseases","D011129","Polyradiculoneuropathy","DTXSID7023439"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39558,D39558)","v":"perhexiline maleate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39558,M39558)","v":"Parkinson Disease, Secondary"},"C023470","perhexiline maleate","6724-53-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39558,N39558)","v":"DTXSID1021114"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39558,J39558)","v":"6263960"},"Perhexiline maleate as a cause of reversible parkinsonism and peripheral neuropathy.","6263960","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID1021114"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39570,D39570)","v":"periciazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39570,M39570)","v":"Ocular Motility Disorders"},"C084584","periciazine","2622-26-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39570,N39570)","v":"DTXSID5045910"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39570,J39570)","v":"16860706"},"Antipsychotics-induced hypersensitivity of visual perception.","16860706","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID5045910"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39603,D39603)","v":"Permethrin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39603,M39603)","v":"Tremor"},"D026023","Permethrin","61949-76-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39603,N39603)","v":"DTXSID0038338"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39603,J39603)","v":"9743715"},"Warning against use of some permethrin products in cats.","9743715","Neurologic Manifestations","D014202","Tremor","DTXSID0038338"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39626,D39626)","v":"Perphenazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39626,M39626)","v":"Catalepsy"},"D010546","Perphenazine","58-39-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39626,N39626)","v":"DTXSID1023441"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39626,J39626)","v":"18757185"},"BL-1020: a novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia.","18757185","Neurologic Manifestations","D002375","Catalepsy","DTXSID1023441"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39664,D39664)","v":"Phenacetin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39664,M39664)","v":"Ataxia"},"D010615","Phenacetin","62-44-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39664,N39664)","v":"DTXSID1021116"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39664,J39664)","v":"5660814"},"The toxicity of phenacetin at the range of the oral LD50(100 days) in albino rats.","5660814","Neurologic Manifestations","D001259","Ataxia","DTXSID1021116"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39678,D39678)","v":"Phencyclidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39678,M39678)","v":"Amaurosis Fugax"},"D010622","Phencyclidine","2981-31-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39678,N39678)","v":"DTXSID70183950"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39678,J39678)","v":"11528160"},"Amaurosis fugax associated with phencyclidine inhalation.","11528160","Neurologic Manifestations","D020757","Amaurosis Fugax","DTXSID70183950"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39699,D39699)","v":"Phencyclidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39699,M39699)","v":"Coma"},"D010622","Phencyclidine","2981-31-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39699,N39699)","v":"DTXSID70183950"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39699,J39699)","v":"7431422"},"A therapeutic approach to the acutely overdosed PCP patient.","7431422","Neurologic Manifestations","D003128","Coma","DTXSID70183950"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39732,D39732)","v":"Phencyclidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39732,M39732)","v":"Hyperkinesis"},"D010622","Phencyclidine","2981-31-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39732,N39732)","v":"DTXSID70183950"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39732,J39732)","v":"21733237"},"Mouse strain differences in phencyclidine-induced behavioural changes.","21733237","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID70183950"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39771,D39771)","v":"Phencyclidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39771,M39771)","v":"Unconsciousness"},"D010622","Phencyclidine","2981-31-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39771,N39771)","v":"DTXSID70183950"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39771,J39771)","v":"18797376"},"An infant with obtundation and tongue thrusting. Phencyclidine poisoning.","18797376","Neurologic Manifestations","D014474","Unconsciousness","DTXSID70183950"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39793,D39793)","v":"Phenelzine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39793,M39793)","v":"Epilepsy, Tonic-Clonic"},"D010624","Phenelzine","51-71-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39793,N39793)","v":"DTXSID2041094"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39793,J39793)","v":"9928719"},"Seizures in a diabetic patient on monoamine oxidase inhibitors.","9928719","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID2041094"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39822,D39822)","v":"Phenelzine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39822,M39822)","v":"Psychomotor Disorders"},"D010624","Phenelzine","51-71-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39822,N39822)","v":"DTXSID2041094"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39822,J39822)","v":"650199"},"A follow-up study on the chemotherapy of neurodermatitis with a monoamine oxidase inhibitor.","650199","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID2041094"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39839,D39839)","v":"Phenformin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39839,M39839)","v":"Blindness"},"D010629","Phenformin","114-86-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39839,N39839)","v":"DTXSID1023449"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39839,J39839)","v":"404836"},"Transitory blindness during ethanol and phenethylbiguanide induced lactic acidosis in a subject with diabetes mellitus. A case report.","404836","Neurologic Manifestations","D001766","Blindness","DTXSID1023449"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39861,D39861)","v":"Phenobarbital"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39861,M39861)","v":"Brain Diseases"},"D010634","Phenobarbital","57-30-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39861,N39861)","v":"DTXSID0021123"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39861,J39861)","v":"4041913"},"Early phenobarbital-induced alterations in hippocampal acetylcholinesterase activity and behavior.","4041913","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID0021123"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39890,D39890)","v":"Phenobarbital"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39890,M39890)","v":"Coma"},"D010634","Phenobarbital","57-30-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39890,N39890)","v":"DTXSID0021123"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39890,J39890)","v":"23243948"},"[Prolonged toxic coma and anisocoria secondary to doxepin, lorazepam and phenobarbital poisoning--case study].","23243948","Neurologic Manifestations","D003128","Coma","DTXSID0021123"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39907,D39907)","v":"Phenobarbital"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39907,M39907)","v":"Hyperkinesis"},"D010634","Phenobarbital","57-30-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39907,N39907)","v":"DTXSID0021123"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39907,J39907)","v":"6504639"},"Phenobarbital side effects: hyperactivity with speech delay.","6504639","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID0021123"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39929,D39929)","v":"Phenobarbital"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39929,M39929)","v":"Nervous System Diseases"},"D010634","Phenobarbital","57-30-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39929,N39929)","v":"DTXSID0021123"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39929,J39929)","v":"2912718"},"Neuroocular side effects of carbamazepine and phenobarbital in epileptic patients as measured by saccadic eye movements analysis.","2912718","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0021123"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C39958,D39958)","v":"Phenobarbital"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L39958,M39958)","v":"Reflex Sympathetic Dystrophy"},"D010634","Phenobarbital","57-30-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N39958,N39958)","v":"DTXSID0021123"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J39958,J39958)","v":"2464337"},"Phenobarbital rheumatism in patients with brain tumor.","2464337","Neuromuscular Diseases","D012019","Reflex Sympathetic Dystrophy","DTXSID0021123"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40000,D40000)","v":"Phenprocoumon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40000,M40000)","v":"Cerebral Hemorrhage"},"D010644","Phenprocoumon","435-97-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40000,N40000)","v":"DTXSID5023459"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40000,J40000)","v":"10327224"},"Phenprocoumon from a neurosurgical perspective.","10327224","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID5023459"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40019,D40019)","v":"Phentermine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40019,M40019)","v":"Memory Disorders"},"D010645","Phentermine","122-09-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40019,N40019)","v":"DTXSID9023461"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40019,J40019)","v":"9829290"},"Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine.","9829290","Neurologic Manifestations","D008569","Memory Disorders","DTXSID9023461"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40052,D40052)","v":"Phenylbutazone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40052,M40052)","v":"Vertigo"},"D010653","Phenylbutazone","50-33-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40052,N40052)","v":"DTXSID9021136"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40052,J40052)","v":"4890973"},"Clinical test of Kebuzon versus phenylbutazone in rheumatoid arthritis.","4890973","Neurologic Manifestations","D014717","Vertigo","DTXSID9021136"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40058,D40058)","v":"Phenylephrine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40058,M40058)","v":"Cerebral Hemorrhage"},"D010656","Phenylephrine","61-76-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40058,N40058)","v":"DTXSID3021142"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40058,J40058)","v":"8367757"},"Intracerebral hemorrhage after topical administration of mydriatic agents.","8367757","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID3021142"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40087,D40087)","v":"Phenylmethylsulfonyl Fluoride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40087,M40087)","v":"Spinal Cord Diseases"},"D010664","Phenylmethylsulfonyl Fluoride","329-98-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40087,N40087)","v":"DTXSID6059819"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40087,J40087)","v":"7482578"},"Selective promotion by phenylmethanesulfonyl fluoride of peripheral and spinal cord neuropathies initiated by diisopropyl phosphorofluoridate in the hen.","7482578","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID6059819"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40120,D40120)","v":"Phenylpropanolamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40120,M40120)","v":"Cerebral Hemorrhage"},"D010665","Phenylpropanolamine","154-41-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40120,N40120)","v":"DTXSID2025896"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40120,J40120)","v":"3822132"},"Intracerebral hemorrhage and phenylpropanolamine use.","3822132","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID2025896"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40152,D40152)","v":"Phenylpropanolamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40152,M40152)","v":"Cerebral Infarction"},"D010665","Phenylpropanolamine","154-41-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40152,N40152)","v":"DTXSID2025896"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40152,J40152)","v":"3828020"},"Cerebral infarction with a single oral dose of phenylpropanolamine.","3828020","Central Nervous System Diseases","D002544","Cerebral Infarction","DTXSID2025896"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40181,D40181)","v":"Phenylpropanolamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40181,M40181)","v":"Ischemic Attack, Transient"},"D010665","Phenylpropanolamine","154-41-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40181,N40181)","v":"DTXSID2025896"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40181,J40181)","v":"3960341"},"Phenylpropanolamine and vasospasm.","3960341","Central Nervous System Diseases","D002546","Ischemic Attack, Transient","DTXSID2025896"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40188,D40188)","v":"Phenylpropanolamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40188,M40188)","v":"Nervous System Diseases"},"D010665","Phenylpropanolamine","154-41-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40188,N40188)","v":"DTXSID2025896"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40188,J40188)","v":"3998456"},"Neurologic signs and symptoms related to over-the-counter diet pills.","3998456","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2025896"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40216,D40216)","v":"Phenylpropanolamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40216,M40216)","v":"Stroke"},"D010665","Phenylpropanolamine","154-41-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40216,N40216)","v":"DTXSID2025896"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40216,J40216)","v":"11754672"},"Underreporting of hemorrhagic stroke associated with phenylpropanolamine.","11754672","Central Nervous System Diseases","D020521","Stroke","DTXSID2025896"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40249,D40249)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40249,M40249)","v":"Ataxia"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40249,N40249)","v":"DTXSID8020541"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40249,J40249)","v":"7072345"},"Drug interactions on an alcohol unit.","7072345","Neurologic Manifestations","D001259","Ataxia","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40281,D40281)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40281,M40281)","v":"Ataxia"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40281,N40281)","v":"DTXSID8020541"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40281,J40281)","v":"5786055"},"Use of diphenylhydantoin in epilepsy treatment.","5786055","Neurologic Manifestations","D001259","Ataxia","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40310,D40310)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40310,M40310)","v":"Athetosis"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40310,N40310)","v":"DTXSID8020541"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40310,J40310)","v":"2084667"},"Phenytoin-induced choreoathetosis.","2084667","Neurologic Manifestations","D001264","Athetosis","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40317,D40317)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40317,M40317)","v":"Basal Ganglia Diseases"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40317,N40317)","v":"DTXSID8020541"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40317,J40317)","v":"4413402"},"Extrapyramidal disturbance and vascular changes during diphenylhydantoin intoxication.","4413402","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40345,D40345)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40345,M40345)","v":"Central Nervous System Diseases"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40345,N40345)","v":"DTXSID8020541"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40345,J40345)","v":"6217226"},"Downbeat nystagmus with phenytoin.","6217226","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40378,D40378)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40378,M40378)","v":"Cerebellar Diseases"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40378,N40378)","v":"DTXSID8020541"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40378,J40378)","v":"6543814"},"Neurobiological studies of experimental diphenylhydantoin intoxication--III. Electron microscopic studies on development and disintegration mechanism of altered axon terminals and synaptic endings in rat cerebellum with chronic diphenylhydantoin intoxication.","6543814","Central Nervous System Diseases","D002526","Cerebellar Diseases","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40401,D40401)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40401,M40401)","v":"Cerebellar Diseases"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40401,N40401)","v":"DTXSID8020541"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40401,J40401)","v":"5440585"},"Digoxin-phenytoin interaction.","5440585","Central Nervous System Diseases","D002526","Cerebellar Diseases","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40439,D40439)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40439,M40439)","v":"Chorea"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40439,N40439)","v":"DTXSID8020541"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40439,J40439)","v":"11792164"},"Anticonvulsants-induced chorea: a role for pharmacodynamic drug interaction?","11792164","Central Nervous System Diseases","D002819","Chorea","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40446,D40446)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40446,M40446)","v":"Coma"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40446,N40446)","v":"DTXSID8020541"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40446,J40446)","v":"5697977"},"Acute diphenylhydantoin intoxication.","5697977","Neurologic Manifestations","D003128","Coma","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40469,D40469)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40469,M40469)","v":"Dysarthria"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40469,N40469)","v":"DTXSID8020541"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40469,J40469)","v":"726532"},"[Severe cerebellar lesions caused by diphenylhydantoin--a contribution to the problem of hydantoin poisoning].","726532","Neurologic Manifestations","D004401","Dysarthria","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40507,D40507)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40507,M40507)","v":"Hepatic Encephalopathy"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40507,N40507)","v":"DTXSID8020541"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40507,J40507)","v":"814030"},"Diphenylhydantoin-induced hepatic necrosis. A case study.","814030","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40540,D40540)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40540,M40540)","v":"Movement Disorders"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40540,N40540)","v":"DTXSID8020541"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40540,J40540)","v":"655669"},"Bilateral ballismus in phenytoin intoxication.","655669","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40558,D40558)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40558,M40558)","v":"Muscular Diseases"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40558,N40558)","v":"DTXSID8020541"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40558,J40558)","v":"944401"},"Phenytoin-induced dystonia and choreoathetosis in two retarded epileptic children.","944401","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40575,D40575)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40575,M40575)","v":"Myoclonus"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40575,N40575)","v":"DTXSID8020541"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40575,J40575)","v":"5698971"},"[Transitory healing of psoriaisis efflorescences during hydantoin poisoning with unusual central nervous symptoms].","5698971","Neurologic Manifestations","D009207","Myoclonus","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40608,D40608)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40608,M40608)","v":"Neurologic Manifestations"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40608,N40608)","v":"DTXSID8020541"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40608,J40608)","v":"4210823"},"[Phenytoine poisoning during therapeutic association with disulfiram].","4210823","Neurologic Manifestations","D009461","Neurologic Manifestations","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40626,D40626)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40626,M40626)","v":"Nystagmus, Pathologic"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40626,N40626)","v":"DTXSID8020541"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40626,J40626)","v":"4734509"},"Primidone, diphenylhydantoin and phenobarbital. Aspects of acute and chronic toxicity.","4734509","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40669,D40669)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40669,M40669)","v":"Papilledema"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40669,N40669)","v":"DTXSID8020541"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40669,J40669)","v":"6035961"},"Oral disorders associated with ocular disease. 3. Disorders affecting the alveoli and gums.","6035961","Cranial Nerve Diseases","D010211","Papilledema","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40672,D40672)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40672,M40672)","v":"Paresis"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40672,N40672)","v":"DTXSID8020541"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40672,J40672)","v":"16376047"},"Benign angiopathy of the central nervous system associated with phenytoin intoxication.","16376047","Neurologic Manifestations","D010291","Paresis","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40719,D40719)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40719,M40719)","v":"Seizures"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40719,N40719)","v":"DTXSID8020541"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40719,J40719)","v":"9475922"},"Risk of seizures from concomitant use of ciprofloxacin and phenytoin in patients with epilepsy.","9475922","Neurologic Manifestations","D012640","Seizures","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40737,D40737)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40737,M40737)","v":"Seizures"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40737,N40737)","v":"DTXSID8020541"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40737,J40737)","v":"3709079"},"Seizures associated with phenytoin toxicity.","3709079","Neurologic Manifestations","D012640","Seizures","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40771,D40771)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40771,M40771)","v":"Status Epilepticus"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40771,N40771)","v":"DTXSID8020541"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40771,J40771)","v":"10897162"},"Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine.","10897162","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40798,D40798)","v":"Phenytoin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40798,M40798)","v":"Vision Disorders"},"D010672","Phenytoin","57-41-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40798,N40798)","v":"DTXSID8020541"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40798,J40798)","v":"15008507"},"Acute visual dysfunction following phenytoin-induced toxicity.","15008507","Neurologic Manifestations","D014786","Vision Disorders","DTXSID8020541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40805,D40805)","v":"Phosphamidon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40805,M40805)","v":"Ataxia"},"D010707","Phosphamidon","13171-21-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40805,N40805)","v":"DTXSID7021156"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40805,J40805)","v":"7495383"},"Interaction of phosphamidon with neuropathy target esterase and acetylcholinesterase of hen brain.","7495383","Neurologic Manifestations","D001259","Ataxia","DTXSID7021156"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40839,D40839)","v":"Physostigmine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40839,M40839)","v":"Delirium"},"D010830","Physostigmine","57-47-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40839,N40839)","v":"DTXSID3023471"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40839,J40839)","v":"12827117"},"Complications of diagnostic physostigmine administration to emergency department patients.","12827117","Neurologic Manifestations","D003693","Delirium","DTXSID3023471"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40866,D40866)","v":"Picrotoxin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40866,M40866)","v":"Basal Ganglia Diseases"},"D010852","Picrotoxin","124-87-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40866,N40866)","v":"DTXSID7045605"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40866,J40866)","v":"7443083"},"Experimental hemiballismus in the baboon produced by injection of a gamma-aminobutyric acid antagonist into the basal ganglia.","7443083","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID7045605"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40895,D40895)","v":"Picrotoxin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40895,M40895)","v":"Seizures"},"D010852","Picrotoxin","124-87-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40895,N40895)","v":"DTXSID7045605"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40895,J40895)","v":"2087256"},"Threshold to elicit seizures by picrotoxin is lowered in pentylenetetrazol-kindled mice.","2087256","Neurologic Manifestations","D012640","Seizures","DTXSID7045605"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40907,D40907)","v":"Pilocarpine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40907,M40907)","v":"Catalepsy"},"D010862","Pilocarpine","54-71-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40907,N40907)","v":"DTXSID2041096"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40907,J40907)","v":"6794090"},"Effect of muscimol, a central GABA receptor agonist, on the catalepsy, striatal homovanillic acid increase, and analgesia induced by pilocarpine in rats.","6794090","Neurologic Manifestations","D002375","Catalepsy","DTXSID2041096"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40934,D40934)","v":"Pilocarpine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40934,M40934)","v":"Epilepsy"},"D010862","Pilocarpine","54-71-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40934,N40934)","v":"DTXSID2041096"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40934,J40934)","v":"20865722"},"Perirhinal cortex hyperexcitability in pilocarpine-treated epileptic rats.","20865722","Central Nervous System Diseases","D004827","Epilepsy","DTXSID2041096"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C40963,D40963)","v":"Pilocarpine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L40963,M40963)","v":"Epilepsy, Temporal Lobe"},"D010862","Pilocarpine","54-71-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N40963,N40963)","v":"DTXSID2041096"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J40963,J40963)","v":"22246993"},"Dynamic expression of adenylate kinase 2 in the hippocampus of pilocarpine model rats.","22246993","Central Nervous System Diseases","D004833","Epilepsy, Temporal Lobe","DTXSID2041096"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41000,D41000)","v":"Pilocarpine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41000,M41000)","v":"Seizures"},"D010862","Pilocarpine","54-71-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41000,N41000)","v":"DTXSID2041096"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41000,J41000)","v":"2570598"},"D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine.","2570598","Neurologic Manifestations","D012640","Seizures","DTXSID2041096"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41028,D41028)","v":"Pilocarpine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41028,M41028)","v":"Seizures"},"D010862","Pilocarpine","54-71-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41028,N41028)","v":"DTXSID2041096"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41028,J41028)","v":"22761705"},"Lovastatin modulates glycogen synthase kinase-3β pathway and inhibits mossy fiber sprouting after pilocarpine-induced status epilepticus.","22761705","Neurologic Manifestations","D012640","Seizures","DTXSID2041096"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41031,D41031)","v":"Pilocarpine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41031,M41031)","v":"Seizures"},"D010862","Pilocarpine","54-71-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41031,N41031)","v":"DTXSID2041096"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41031,J41031)","v":"22038587"},"Synchrotron radiation Fourier-transform infrared and Raman microspectroscopy study showing an increased frequency of creatine inclusions in the rat hippocampal formation following pilocarpine-induced seizures.","22038587","Neurologic Manifestations","D012640","Seizures","DTXSID2041096"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41068,D41068)","v":"Pilocarpine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41068,M41068)","v":"Status Epilepticus"},"D010862","Pilocarpine","54-71-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41068,N41068)","v":"DTXSID2041096"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41068,J41068)","v":"24935084"},"Temporally unstructured electrical stimulation to the amygdala suppresses behavioral chronic seizures of the pilocarpine animal model.","24935084","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID2041096"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41092,D41092)","v":"Pilocarpine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41092,M41092)","v":"Status Epilepticus"},"D010862","Pilocarpine","54-71-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41092,N41092)","v":"DTXSID2041096"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41092,J41092)","v":"21070218"},"Altered physiology and pharmacology in the corticostriatal system in a model of temporal lobe epilepsy.","21070218","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID2041096"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41120,D41120)","v":"Pimozide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41120,M41120)","v":"Basal Ganglia Diseases"},"D010868","Pimozide","2062-78-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41120,N41120)","v":"DTXSID8023474"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41120,J41120)","v":"8496127"},"Acute dystonic reaction with low-dose pimozide.","8496127","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8023474"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41157,D41157)","v":"Pimozide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41157,M41157)","v":"Tremor"},"D010868","Pimozide","2062-78-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41157,N41157)","v":"DTXSID8023474"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41157,J41157)","v":"19467297"},"Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.","19467297","Neurologic Manifestations","D014202","Tremor","DTXSID8023474"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41160,D41160)","v":"Pindolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41160,M41160)","v":"Hallucinations"},"D010869","Pindolol","13523-86-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41160,N41160)","v":"DTXSID8023476"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41160,J41160)","v":"493028"},"[Hallucinations after taking pindolol (author's transl)].","493028","Neurologic Manifestations","D006212","Hallucinations","DTXSID8023476"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41188,D41188)","v":"Piperacillin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41188,M41188)","v":"Neuralgia"},"D010878","Piperacillin","61477-96-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41188,N41188)","v":"DTXSID2023482"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41188,J41188)","v":"22627576"},"A case of severe toxicity during coadministration of vincristine and piperacillin:  are drug transporters involved in vincristine hypersensitivity and drug-drug interactions?","22627576","Neuromuscular Diseases","D009437","Neuralgia","DTXSID2023482"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41221,D41221)","v":"Piracetam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41221,M41221)","v":"Disorders of Excessive Somnolence"},"D010889","Piracetam","7491-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41221,N41221)","v":"DTXSID5044491"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41221,J41221)","v":"16674605"},"Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.","16674605","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID5044491"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41254,D41254)","v":"Piracetam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41254,M41254)","v":"Sensation Disorders"},"D010889","Piracetam","7491-74-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41254,N41254)","v":"DTXSID5044491"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41254,J41254)","v":"16674605"},"Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.","16674605","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID5044491"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41281,D41281)","v":"Pirenzepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41281,M41281)","v":"Basal Ganglia Diseases"},"D010890","Pirenzepine","28797-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41281,N41281)","v":"DTXSID7023487"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41281,J41281)","v":"10811240"},"Adverse events related to olanzapine.","10811240","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID7023487"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41289,D41289)","v":"Pirenzepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41289,M41289)","v":"Basal Ganglia Diseases"},"D010890","Pirenzepine","28797-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41289,N41289)","v":"DTXSID7023487"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41289,J41289)","v":"10997865"},"Olanzapine optimal dose: results of an open-label multicenter study in schizophrenic patients. Olanzapine Late-Phase II Study Group.","10997865","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID7023487"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41322,D41322)","v":"Pirenzepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41322,M41322)","v":"Dystonia"},"D010890","Pirenzepine","28797-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41322,N41322)","v":"DTXSID7023487"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41322,J41322)","v":"10518183"},"Olanzapine-induced tardive dystonia.","10518183","Neurologic Manifestations","D004421","Dystonia","DTXSID7023487"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41349,D41349)","v":"Pirenzepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41349,M41349)","v":"Seizures"},"D010890","Pirenzepine","28797-61-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41349,N41349)","v":"DTXSID7023487"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41349,J41349)","v":"8941170"},"Side effect profiles of new antipsychotic agents.","8941170","Neurologic Manifestations","D012640","Seizures","DTXSID7023487"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41383,D41383)","v":"Piroxicam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41383,M41383)","v":"Central Nervous System Diseases"},"D010894","Piroxicam","36322-90-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41383,N41383)","v":"DTXSID5021170"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41383,J41383)","v":"3305037"},"Toleration and safety of piroxicam.","3305037","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID5021170"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41390,D41390)","v":"Piroxicam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41390,M41390)","v":"Hypotension, Orthostatic"},"D010894","Piroxicam","36322-90-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41390,N41390)","v":"DTXSID5021170"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41390,J41390)","v":"18027541"},"Analgesic effects of lornoxicam after total abdominal hysterectomy.","18027541","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID5021170"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41438,D41438)","v":"polymaleinate ionomer"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41438,M41438)","v":"Brain Diseases"},"C088058","polymaleinate ionomer",null,null,1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41438,J41438)","v":"7912334"},"Post-otoneurosurgery aluminium encephalopathy.","7912334","Central Nervous System Diseases","D001927","Brain Diseases"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41451,D41451)","v":"Polymethyl Methacrylate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41451,M41451)","v":"Spinal Cord Compression"},"D019904","Polymethyl Methacrylate","9011-14-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41451,N41451)","v":"DTXSID1042152"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41451,J41451)","v":"17632393"},"Neurologic deficit following percutaneous vertebral stabilization.","17632393","Central Nervous System Diseases","D013117","Spinal Cord Compression","DTXSID1042152"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41469,D41469)","v":"posaconazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41469,M41469)","v":"Stupor"},"C101425","posaconazole","171228-49-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41469,N41469)","v":"DTXSID6049066"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41469,J41469)","v":"19620171"},"Posaconazole-induced topiramate toxicity.","19620171","Neurologic Manifestations","D053608","Stupor","DTXSID6049066"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41512,D41512)","v":"Potassium Cyanide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41512,M41512)","v":"Basal Ganglia Diseases"},"D011190","Potassium Cyanide","151-50-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41512,N41512)","v":"DTXSID0024268"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41512,J41512)","v":"1753244"},"Extrapyramidal disturbances after cyanide poisoning (first MRT-investigation of the brain).","1753244","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID0024268"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41519,D41519)","v":"Potassium Cyanide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41519,M41519)","v":"Central Nervous System Diseases"},"D011190","Potassium Cyanide","151-50-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41519,N41519)","v":"DTXSID0024268"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41519,J41519)","v":"12176095"},"Neuropathologic study of long term cyanide administration to goats.","12176095","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID0024268"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41562,D41562)","v":"Povidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41562,M41562)","v":"Papilledema"},"D011205","Povidone","9003-39-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41562,N41562)","v":"DTXSID0025941"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41562,J41562)","v":"326119"},"[A case of polyvisceral thesaurismosis caused by polyvinyl pyrrolidone].","326119","Cranial Nerve Diseases","D010211","Papilledema","DTXSID0025941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41580,D41580)","v":"Practolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41580,M41580)","v":"Hearing Disorders"},"D011217","Practolol","6673-35-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41580,N41580)","v":"DTXSID0021179"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41580,J41580)","v":"124969"},"[Actual late effects. Skin, eye and hearing changes during treatment with practolol (Eraldin)].","124969","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID0021179"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41613,D41613)","v":"pramipexole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41613,M41613)","v":"Nervous System Diseases"},"C061333","pramipexole","191217-81-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41613,N41613)","v":"DTXSID1044227"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41613,J41613)","v":"22903628"},"Spontaneous unwelcome orgasms due to pramipexole and ropinirole.","22903628","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID1044227"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41626,D41626)","v":"pramipexole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41626,M41626)","v":"Torticollis"},"C061333","pramipexole","191217-81-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41626,N41626)","v":"DTXSID1044227"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41626,J41626)","v":"17914721"},"Reversible dopamine agonist induced anterocollis in a multiple system atrophy patient.","17914721","Central Nervous System Diseases","D014103","Torticollis","DTXSID1044227"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41648,D41648)","v":"Pravastatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41648,M41648)","v":"Muscular Diseases"},"D017035","Pravastatin","NOCAS_110050",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41648,N41648)","v":"DTXSID80110050"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41648,J41648)","v":"8154521"},"Lovastatin and myopathy.","8154521","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID80110050"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41681,D41681)","v":"Praziquantel"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41681,M41681)","v":"Epilepsy, Tonic-Clonic"},"D011223","Praziquantel","55268-74-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41681,N41681)","v":"DTXSID9021182"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41681,J41681)","v":"3126947"},"Convulsive seizures after treatment with praziquantel.","3126947","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID9021182"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41719,D41719)","v":"Prazosin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41719,M41719)","v":"Hypotension, Orthostatic"},"D011224","Prazosin","19237-84-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41719,N41719)","v":"DTXSID50172822"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41719,J41719)","v":"339373"},"Prazosin in the therapy of uncontrolled hypertension.","339373","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID50172822"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41742,D41742)","v":"Prednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41742,M41742)","v":"Cavernous Sinus Thrombosis"},"D011239","Prednisolone","50-24-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41742,N41742)","v":"DTXSID9021184"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41742,J41742)","v":"10713653"},"Overwhelming septic cavernous sinus thrombosis in a woman after combination of high-dose steroid and intravenous cyclophosphamide therapy for lupus nephritis.","10713653","Central Nervous System Diseases","D020226","Cavernous Sinus Thrombosis","DTXSID9021184"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41771,D41771)","v":"Prednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41771,M41771)","v":"Muscular Diseases"},"D011239","Prednisolone","50-24-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41771,N41771)","v":"DTXSID9021184"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41771,J41771)","v":"6272538"},"[Corticoid myopathy in children].","6272538","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID9021184"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41787,D41787)","v":"Prednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41787,M41787)","v":"Myositis"},"D011239","Prednisolone","50-24-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41787,N41787)","v":"DTXSID9021184"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41787,J41787)","v":"25775144"},"Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis.","25775144","Neuromuscular Diseases","D009220","Myositis","DTXSID9021184"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41810,D41810)","v":"Prednisolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41810,M41810)","v":"Spinal Cord Compression"},"D011239","Prednisolone","50-24-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41810,N41810)","v":"DTXSID9021184"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41810,J41810)","v":"6725330"},"Paraplegia as a complication of corticosteroid therapy. A case report.","6725330","Central Nervous System Diseases","D013117","Spinal Cord Compression","DTXSID9021184"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41839,D41839)","v":"Prednisone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41839,M41839)","v":"Confusion"},"D011241","Prednisone","53-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41839,N41839)","v":"DTXSID4021185"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41839,J41839)","v":"17661993"},"Transient lesion in the splenium of the corpus callosum after oral corticoid therapy.","17661993","Neurologic Manifestations","D003221","Confusion","DTXSID4021185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41871,D41871)","v":"Prednisone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41871,M41871)","v":"Muscular Atrophy"},"D011241","Prednisone","53-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41871,N41871)","v":"DTXSID4021185"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41871,J41871)","v":"2699922"},"[Various new data on steroid-induced myopathy].","2699922","Neurologic Manifestations","D009133","Muscular Atrophy","DTXSID4021185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41878,D41878)","v":"Prednisone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41878,M41878)","v":"Muscular Diseases"},"D011241","Prednisone","53-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41878,N41878)","v":"DTXSID4021185"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41878,J41878)","v":"7213447"},"Acute prednisone-induced disabling myalgias in scleroderma.","7213447","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID4021185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41907,D41907)","v":"Prednisone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41907,M41907)","v":"Polyneuropathies"},"D011241","Prednisone","53-03-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41907,N41907)","v":"DTXSID4021185"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41907,J41907)","v":"22006703"},"Prednisone can worsen ataxic neuropathy with anti-disialosyl IgM antibodies.","22006703","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID4021185"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41939,D41939)","v":"Pregnanolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41939,M41939)","v":"Seizures"},"D011280","Pregnanolone","128-20-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41939,N41939)","v":"DTXSID1046342"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41939,J41939)","v":"11960630"},"Withdrawal properties of a neuroactive steroid: implications for GABA(A) receptor gene regulation in the brain and anxiety behavior.","11960630","Neurologic Manifestations","D012640","Seizures","DTXSID1046342"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C41968,D41968)","v":"Prilocaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L41968,M41968)","v":"Eye Burns"},"D011318","Prilocaine","721-50-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N41968,N41968)","v":"DTXSID7031955"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J41968,J41968)","v":"8543097"},"Alkaline chemical ocular injury from Emla cream.","8543097","Trauma, Nervous System","D005126","Eye Burns","DTXSID7031955"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42000,D42000)","v":"Primidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42000,M42000)","v":"Ataxia"},"D011324","Primidone","125-33-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42000,N42000)","v":"DTXSID7023510"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42000,J42000)","v":"4734509"},"Primidone, diphenylhydantoin and phenobarbital. Aspects of acute and chronic toxicity.","4734509","Neurologic Manifestations","D001259","Ataxia","DTXSID7023510"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42007,D42007)","v":"Primidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42007,M42007)","v":"Coma"},"D011324","Primidone","125-33-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42007,N42007)","v":"DTXSID7023510"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42007,J42007)","v":"6655772"},"Coma and crystalluria: a massive primidone intoxication treated with haemoperfusion.","6655772","Neurologic Manifestations","D003128","Coma","DTXSID7023510"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42036,D42036)","v":"Procainamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42036,M42036)","v":"Muscular Diseases"},"D011342","Procainamide","51-06-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42036,N42036)","v":"DTXSID7023512"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42036,J42036)","v":"3081184"},"Myopathy after short term administration of procainamide.","3081184","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID7023512"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42068,D42068)","v":"Procaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42068,M42068)","v":"Horner Syndrome"},"D011343","Procaine","59-46-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42068,N42068)","v":"DTXSID7045021"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42068,J42068)","v":"4259451"},"[Horner's syndrome after paravertebral lumbar nerve-root blockade].","4259451","Neurologic Manifestations","D006732","Horner Syndrome","DTXSID7045021"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42097,D42097)","v":"Procaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42097,M42097)","v":"Seizures"},"D011343","Procaine","59-46-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42097,N42097)","v":"DTXSID7045021"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42097,J42097)","v":"6450781"},"Alteration of lidocaine- or procaine-induced convulsions by manipulation of brain amines.","6450781","Neurologic Manifestations","D012640","Seizures","DTXSID7045021"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42130,D42130)","v":"Prochlorperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42130,M42130)","v":"Basal Ganglia Diseases"},"D011346","Prochlorperazine","84-02-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42130,N42130)","v":"DTXSID1049015"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42130,J42130)","v":"7014918"},"Compazine complications: a review.","7014918","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID1049015"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42136,D42136)","v":"Prochlorperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42136,M42136)","v":"Basal Ganglia Diseases"},"D011346","Prochlorperazine","84-02-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42136,N42136)","v":"DTXSID1049015"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42136,J42136)","v":"20486582"},"[Antiemetic-induced extrapyramidal symptoms seen by our palliative care team].","20486582","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID1049015"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42165,D42165)","v":"Prochlorperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42165,M42165)","v":"Movement Disorders"},"D011346","Prochlorperazine","84-02-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42165,N42165)","v":"DTXSID1049015"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42165,J42165)","v":"5979570"},"[Hyperkinetic attacks in pregnant women with prochlorperazine (stemetil)].","5979570","Central Nervous System Diseases","D009069","Movement Disorders","DTXSID1049015"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42198,D42198)","v":"Promazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42198,M42198)","v":"Delirium"},"D011395","Promazine","58-40-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42198,N42198)","v":"DTXSID2023517"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42198,J42198)","v":"1167259"},"[Eatan poisoning in childhood. Dyskinetic, deliriant syndrome with unilateral symptoms and cerebellar deficit].","1167259","Neurologic Manifestations","D003693","Delirium","DTXSID2023517"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42229,D42229)","v":"Promethazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42229,M42229)","v":"Seizures"},"D011398","Promethazine","58-33-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42229,N42229)","v":"DTXSID3021192"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42229,J42229)","v":"6020981"},"Epileptiform convulsions in children following premedication with Pamergan SP100.","6020981","Neurologic Manifestations","D012640","Seizures","DTXSID3021192"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42259,D42259)","v":"Propafenone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42259,M42259)","v":"Seizures"},"D011405","Propafenone","54063-53-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42259,N42259)","v":"DTXSID9045184"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42259,J42259)","v":"20373066"},"Propafenone poisoning--a case report with plasma propafenone concentrations.","20373066","Neurologic Manifestations","D012640","Seizures","DTXSID9045184"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42281,D42281)","v":"Propofol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42281,M42281)","v":"Amnesia"},"D015742","Propofol","2078-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42281,N42281)","v":"DTXSID6023523"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42281,J42281)","v":"23222112"},"Ketamine, propofol, and ketofol use for pediatric sedation.","23222112","Neurologic Manifestations","D000647","Amnesia","DTXSID6023523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42294,D42294)","v":"Propofol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42294,M42294)","v":"Brain Ischemia"},"D015742","Propofol","2078-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42294,N42294)","v":"DTXSID6023523"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42294,J42294)","v":"15448519"},"Do indomethacin and propofol cause cerebral ischemic damage? Diffusion-weighted magnetic resonance imaging in patients undergoing craniotomy for brain tumors.","15448519","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID6023523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42327,D42327)","v":"Propofol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42327,M42327)","v":"Dystonia"},"D015742","Propofol","2078-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42327,N42327)","v":"DTXSID6023523"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42327,J42327)","v":"8214699"},"Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol.","8214699","Neurologic Manifestations","D004421","Dystonia","DTXSID6023523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42349,D42349)","v":"Propofol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42349,M42349)","v":"Epilepsy"},"D015742","Propofol","2078-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42349,N42349)","v":"DTXSID6023523"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42349,J42349)","v":"11014005"},"[Case of uncommon motor reaction to administration of diprivan].","11014005","Central Nervous System Diseases","D004827","Epilepsy","DTXSID6023523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42388,D42388)","v":"Propofol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42388,M42388)","v":"Memory Disorders"},"D015742","Propofol","2078-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42388,N42388)","v":"DTXSID6023523"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42388,J42388)","v":"26957054"},"Piracetam prevents memory deficit induced by postnatal propofol exposure in mice.","26957054","Neurologic Manifestations","D008569","Memory Disorders","DTXSID6023523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42395,D42395)","v":"Propofol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42395,M42395)","v":"Memory Disorders"},"D015742","Propofol","2078-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42395,N42395)","v":"DTXSID6023523"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42395,J42395)","v":"15448514"},"Information loss over time defines the memory defect of propofol: a comparative response with thiopental and dexmedetomidine.","15448514","Neurologic Manifestations","D008569","Memory Disorders","DTXSID6023523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42417,D42417)","v":"Propofol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42417,M42417)","v":"Myoclonus"},"D015742","Propofol","2078-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42417,N42417)","v":"DTXSID6023523"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42417,J42417)","v":"18486797"},"Seizure-like activity and prolonged central nervous system side effects after intravenous sedation.","18486797","Neurologic Manifestations","D009207","Myoclonus","DTXSID6023523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42456,D42456)","v":"Propofol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42456,M42456)","v":"Seizures"},"D015742","Propofol","2078-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42456,N42456)","v":"DTXSID6023523"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42456,J42456)","v":"29101936"},"Propofol Frenzy: Clinical Spectrum in 3 Patients.","29101936","Neurologic Manifestations","D012640","Seizures","DTXSID6023523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42489,D42489)","v":"Propofol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42489,M42489)","v":"Sleep Deprivation"},"D015742","Propofol","2078-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42489,N42489)","v":"DTXSID6023523"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42489,J42489)","v":"11323352"},"Prolonged sedation with propofol in the rat does not result in sleep deprivation.","11323352","Sleep Wake Disorders","D012892","Sleep Deprivation","DTXSID6023523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42506,D42506)","v":"Propofol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42506,M42506)","v":"Status Epilepticus"},"D015742","Propofol","2078-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42506,N42506)","v":"DTXSID6023523"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42506,J42506)","v":"15920242"},"Total suppression of cerebral activity by thiopental mimicking propofol infusion syndrome: a fatal common pathway?","15920242","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID6023523"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42524,D42524)","v":"Propranolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42524,M42524)","v":"Basal Ganglia Diseases"},"D011433","Propranolol","318-98-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42524,N42524)","v":"DTXSID3021198"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42524,J42524)","v":"44877"},"Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.","44877","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID3021198"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42557,D42557)","v":"Propranolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42557,M42557)","v":"Hallucinations"},"D011433","Propranolol","318-98-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42557,N42557)","v":"DTXSID3021198"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42557,J42557)","v":"7065308"},"Propranolol, hallucinations, and sleep disturbance.","7065308","Neurologic Manifestations","D006212","Hallucinations","DTXSID3021198"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42574,D42574)","v":"Propranolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42574,M42574)","v":"Hepatic Encephalopathy"},"D011433","Propranolol","318-98-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42574,N42574)","v":"DTXSID3021198"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42574,J42574)","v":"6412951"},"Cirrhosis, hepatic encephalopathy, and propranolol.","6412951","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID3021198"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42618,D42618)","v":"Propranolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42618,M42618)","v":"Sleep Initiation and Maintenance Disorders"},"D011433","Propranolol","318-98-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42618,N42618)","v":"DTXSID3021198"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42618,J42618)","v":"7065308"},"Propranolol, hallucinations, and sleep disturbance.","7065308","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID3021198"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42626,D42626)","v":"Propranolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42626,M42626)","v":"Sleep Wake Disorders"},"D011433","Propranolol","318-98-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42626,N42626)","v":"DTXSID3021198"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42626,J42626)","v":"3665616"},"Hypersomnolence with beta-adrenergic blockers.","3665616","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID3021198"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42653,D42653)","v":"Propranolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42653,M42653)","v":"Vision Disorders"},"D011433","Propranolol","318-98-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42653,N42653)","v":"DTXSID3021198"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42653,J42653)","v":"4224228"},"Unwanted effects of propranolol.","4224228","Neurologic Manifestations","D014786","Vision Disorders","DTXSID3021198"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42686,D42686)","v":"Pseudoephedrine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42686,M42686)","v":"Hallucinations"},"D054199","Pseudoephedrine","90-82-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42686,N42686)","v":"DTXSID0023537"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42686,J42686)","v":"9583036"},"[\"Of snakes and crocodiles\". Central side effects caused by nose drops].","9583036","Neurologic Manifestations","D006212","Hallucinations","DTXSID0023537"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42719,D42719)","v":"Pyrazinamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42719,M42719)","v":"Muscle Cramp"},"D011718","Pyrazinamide","98-96-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42719,N42719)","v":"DTXSID9021215"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42719,J42719)","v":"18232182"},"Pyrazinamide induced hyperuricaemia presenting as severe bilateral leg cramps.","18232182","Neurologic Manifestations","D009120","Muscle Cramp","DTXSID9021215"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42747,D42747)","v":"Pyridostigmine Bromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42747,M42747)","v":"Nervous System Diseases"},"D011729","Pyridostigmine Bromide","155-97-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42747,N42747)","v":"DTXSID20165786"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42747,J42747)","v":"8954750"},"Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos.","8954750","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID20165786"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42754,D42754)","v":"Pyridostigmine Bromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42754,M42754)","v":"Seizures"},"D011729","Pyridostigmine Bromide","155-97-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42754,N42754)","v":"DTXSID20165786"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42754,J42754)","v":"10416276"},"Anticonvulsant-resistant seizures following pyridostigmine bromide (PB) and N,N-diethyl-m-toluamide (DEET).","10416276","Neurologic Manifestations","D012640","Seizures","DTXSID20165786"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42787,D42787)","v":"Pyridoxine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42787,M42787)","v":"Nervous System Diseases"},"D011736","Pyridoxine","65-23-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42787,N42787)","v":"DTXSID4023541"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42787,J42787)","v":"7878600"},"[Pyridoxine neuropathies. Review of the literature].","7878600","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID4023541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42815,D42815)","v":"Pyridoxine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42815,M42815)","v":"Peripheral Nervous System Diseases"},"D011736","Pyridoxine","65-23-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42815,N42815)","v":"DTXSID4023541"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42815,J42815)","v":"6322063"},"Vitamin B6 toxicity: a new megavitamin syndrome.","6322063","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID4023541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42844,D42844)","v":"Pyridoxine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42844,M42844)","v":"Seizures"},"D011736","Pyridoxine","65-23-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42844,N42844)","v":"DTXSID4023541"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42844,J42844)","v":"9551787"},"Proconvulsant effects induced by pyridoxine in young rats.","9551787","Neurologic Manifestations","D012640","Seizures","DTXSID4023541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42855,D42855)","v":"Pyridoxine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42855,M42855)","v":"Sensation Disorders"},"D011736","Pyridoxine","65-23-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42855,N42855)","v":"DTXSID4023541"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42855,J42855)","v":"8987762"},"Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy.","8987762","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID4023541"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42883,D42883)","v":"Pyrimethamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42883,M42883)","v":"Seizures"},"D011739","Pyrimethamine","58-14-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42883,N42883)","v":"DTXSID9021217"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42883,J42883)","v":"25174072"},"FDA investigation focuses on compounded drugs.","25174072","Neurologic Manifestations","D012640","Seizures","DTXSID9021217"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42912,D42912)","v":"Quetiapine Fumarate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42912,M42912)","v":"Basal Ganglia Diseases"},"D000069348","Quetiapine Fumarate","111974-72-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42912,N42912)","v":"DTXSID3044201"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42912,J42912)","v":"27297785"},"Post authorization safety study comparing quetiapine to risperidone and olanzapine.","27297785","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID3044201"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42948,D42948)","v":"Quetiapine Fumarate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42948,M42948)","v":"Coma"},"D000069348","Quetiapine Fumarate","111974-72-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42948,N42948)","v":"DTXSID3044201"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42948,J42948)","v":"16628129"},"Quetiapine in overdosage: a clinical and pharmacokinetic analysis of 14 cases.","16628129","Neurologic Manifestations","D003128","Coma","DTXSID3044201"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C42977,D42977)","v":"Quetiapine Fumarate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L42977,M42977)","v":"Epilepsy, Absence"},"D000069348","Quetiapine Fumarate","111974-72-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N42977,N42977)","v":"DTXSID3044201"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J42977,J42977)","v":"27758061"},"Quetiapine-induced absence seizures in a dementia patient.","27758061","Central Nervous System Diseases","D004832","Epilepsy, Absence","DTXSID3044201"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43000,D43000)","v":"Quetiapine Fumarate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43000,M43000)","v":"Meige Syndrome"},"D000069348","Quetiapine Fumarate","111974-72-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43000,N43000)","v":"DTXSID3044201"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43000,J43000)","v":"12404689"},"A case of Meige dystonia induced by short-term quetiapine treatment.","12404689","Basal Ganglia Diseases","D008538","Meige Syndrome","DTXSID3044201"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43012,D43012)","v":"Quetiapine Fumarate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43012,M43012)","v":"Parkinson Disease, Secondary"},"D000069348","Quetiapine Fumarate","111974-72-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43012,N43012)","v":"DTXSID3044201"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43012,J43012)","v":"21545624"},"Reversible parkinsonism and cognitive decline due to a possible interaction of valproic acid and quetiapine.","21545624","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID3044201"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43041,D43041)","v":"Quetiapine Fumarate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43041,M43041)","v":"Sleep Wake Disorders"},"D000069348","Quetiapine Fumarate","111974-72-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43041,N43041)","v":"DTXSID3044201"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43041,J43041)","v":"17854242"},"Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study.","17854242","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID3044201"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43068,D43068)","v":"Quinidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43068,M43068)","v":"Coma"},"D011802","Quinidine","56-54-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43068,N43068)","v":"DTXSID4023549"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43068,J43068)","v":"5557506"},"Quinidine overdose. Neurological and cardiovascular toxicity in a normal person.","5557506","Neurologic Manifestations","D003128","Coma","DTXSID4023549"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43106,D43106)","v":"Quinidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43106,M43106)","v":"Syncope"},"D011802","Quinidine","56-54-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43106,N43106)","v":"DTXSID4023549"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43106,J43106)","v":"5667551"},"[Quinidine in the treatment of cardiac arrhythmias].","5667551","Neurologic Manifestations","D013575","Syncope","DTXSID4023549"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43109,D43109)","v":"Quinidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43109,M43109)","v":"Syncope"},"D011802","Quinidine","56-54-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43109,N43109)","v":"DTXSID4023549"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43109,J43109)","v":"2270707"},"[Quinidine-induced syncope--an example of the arrhythmogenic effect of anti-arrhythmia agents].","2270707","Neurologic Manifestations","D013575","Syncope","DTXSID4023549"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43136,D43136)","v":"Quinine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43136,M43136)","v":"Blindness"},"D011803","Quinine","130-89-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43136,N43136)","v":"DTXSID7044213"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43136,J43136)","v":"6942576"},"Management of quinine toxicity.","6942576","Neurologic Manifestations","D001766","Blindness","DTXSID7044213"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43170,D43170)","v":"Quinine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43170,M43170)","v":"Blindness"},"D011803","Quinine","130-89-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43170,N43170)","v":"DTXSID7044213"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43170,J43170)","v":"1928126"},"Labeling of nonprescription quinine needs revision.","1928126","Neurologic Manifestations","D001766","Blindness","DTXSID7044213"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43203,D43203)","v":"Quinine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43203,M43203)","v":"Hearing Disorders"},"D011803","Quinine","130-89-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43203,N43203)","v":"DTXSID7044213"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43203,J43203)","v":"12597290"},"Effects of nimodipine on quinine ototoxicity.","12597290","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID7044213"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43229,D43229)","v":"Quinine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43229,M43229)","v":"Neuromuscular Diseases"},"D011803","Quinine","130-89-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43229,N43229)","v":"DTXSID7044213"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43229,J43229)","v":"4816315"},"Myelo-optico-neuropathy following quinine poisoning.","4816315","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID7044213"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43238,D43238)","v":"Quinine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43238,M43238)","v":"Peripheral Nervous System Diseases"},"D011803","Quinine","130-89-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43238,N43238)","v":"DTXSID7044213"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43238,J43238)","v":"6287159"},"[A particular nervous traumatology: lesions of sciatic nerve by quinine intragluteal injections (author's transl)].","6287159","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7044213"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43271,D43271)","v":"Quinine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43271,M43271)","v":"Vision Disorders"},"D011803","Quinine","130-89-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43271,N43271)","v":"DTXSID7044213"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43271,J43271)","v":"4816315"},"Myelo-optico-neuropathy following quinine poisoning.","4816315","Neurologic Manifestations","D014786","Vision Disorders","DTXSID7044213"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43297,D43297)","v":"Quinolinic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43297,M43297)","v":"Huntington Disease"},"D017378","Quinolinic Acid","87314-99-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43297,N43297)","v":"DTXSID20236283"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43297,J43297)","v":"16310773"},"Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion.","16310773","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID20236283"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43332,D43332)","v":"Quinolinic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43332,M43332)","v":"Status Epilepticus"},"D017378","Quinolinic Acid","87314-99-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43332,N43332)","v":"DTXSID20236283"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43332,J43332)","v":"17996456"},"Genes on distal chromosome 18 determine vulnerability to excitotoxic neurodegeneration following status epilepticus, but not striatal neurodegeneration induced by quinolinic acid.","17996456","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID20236283"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43349,D43349)","v":"Raltegravir Potassium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43349,M43349)","v":"Muscle Weakness"},"D000068898","Raltegravir Potassium",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43349,N43349)","v":"DTXSID501007339"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43349,J43349)","v":"24756601"},"Sustained increase of serum creatine phosphokinase levels and progressive muscle abnormalities associated with raltegravir use during 32-week follow-up in an HIV-1 experienced patient on simplified HAART regimen, intolerant to protease inhibitors and abacavir: a case report.","24756601","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID501007339"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43367,D43367)","v":"Ranitidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43367,M43367)","v":"Confusion"},"D011899","Ranitidine","71130-06-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43367,N43367)","v":"DTXSID0052835"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43367,J43367)","v":"3946668"},"Mental confusion as a side effect of ranitidine.","3946668","Neurologic Manifestations","D003221","Confusion","DTXSID0052835"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43400,D43400)","v":"Ranitidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43400,M43400)","v":"Nervous System Diseases"},"D011899","Ranitidine","71130-06-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43400,N43400)","v":"DTXSID0052835"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43400,J43400)","v":"3984961"},"Bradycardia and neurologic disorders associated with ranitidine in a child.","3984961","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0052835"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43417,D43417)","v":"Ranolazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43417,M43417)","v":"Seizures"},"D000069458","Ranolazine","95635-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43417,N43417)","v":"DTXSID3045196"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43417,J43417)","v":"26072257"},"Ranolazine overdose-induced seizures.","26072257","Neurologic Manifestations","D012640","Seizures","DTXSID3045196"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43461,D43461)","v":"remifentanil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43461,M43461)","v":"Hyperalgesia"},"C071741","remifentanil","132539-07-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43461,N43461)","v":"DTXSID50157614"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43461,J43461)","v":"27687343"},"Low-dose butorphanol alleviates remifetanil-induced hyperalgesia in patients undergoing laparoscopic cholecystectomy.","27687343","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID50157614"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43468,D43468)","v":"remifentanil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43468,M43468)","v":"Hyperalgesia"},"C071741","remifentanil","132539-07-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43468,N43468)","v":"DTXSID50157614"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43468,J43468)","v":"26550961"},"Involvement of CCL3/CCR5 Signaling in Dorsal Root Ganglion in Remifentanil-induced Hyperalgesia in Rats.","26550961","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID50157614"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43506,D43506)","v":"remifentanil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43506,M43506)","v":"Hyperalgesia"},"C071741","remifentanil","132539-07-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43506,N43506)","v":"DTXSID50157614"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43506,J43506)","v":"22025495"},"Intravenous infusion of remifentanil induces transient withdrawal hyperalgesia depending on administration duration in rats.","22025495","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID50157614"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43529,D43529)","v":"remifentanil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43529,M43529)","v":"Sleep Apnea Syndromes"},"C071741","remifentanil","132539-07-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43529,N43529)","v":"DTXSID50157614"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43529,J43529)","v":"28829527"},"Does caffeine improve respiratory rate during remifentanil target controlled infusion sedation? A case report in endoscopic sedation.","28829527","Sleep Wake Disorders","D012891","Sleep Apnea Syndromes","DTXSID50157614"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43562,D43562)","v":"Reserpine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43562,M43562)","v":"Myasthenia Gravis"},"D012110","Reserpine","50-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43562,N43562)","v":"DTXSID7021237"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43562,J43562)","v":"4048571"},"[A case of myasthenia gravis made worse by the administration of reserpine].","4048571","Autoimmune Diseases of the Nervous System","D009157","Myasthenia Gravis","DTXSID7021237"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43574,D43574)","v":"Reserpine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43574,M43574)","v":"Torticollis"},"D012110","Reserpine","50-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43574,N43574)","v":"DTXSID7021237"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43574,J43574)","v":"4702802"},"Reserpine: cause and treatment of oral-facial dyskinesia.","4702802","Central Nervous System Diseases","D014103","Torticollis","DTXSID7021237"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43597,D43597)","v":"Ribavirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43597,M43597)","v":"Hypopituitarism"},"D012254","Ribavirin","36791-04-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43597,N43597)","v":"DTXSID8023557"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43597,J43597)","v":"17490932"},"Granulomatous adenohypophysitis after interferon and ribavirin therapy.","17490932","Central Nervous System Diseases","D007018","Hypopituitarism","DTXSID8023557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43630,D43630)","v":"Ribavirin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43630,M43630)","v":"Vision Disorders"},"D012254","Ribavirin","36791-04-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43630,N43630)","v":"DTXSID8023557"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43630,J43630)","v":"15771758"},"Retinal toxicity during pegylated alpha-interferon therapy for chronic hepatitis C: a multifocal electroretinogram investigation.","15771758","Neurologic Manifestations","D014786","Vision Disorders","DTXSID8023557"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43667,D43667)","v":"Rifampin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43667,M43667)","v":"Seizures"},"D012293","Rifampin","13292-46-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43667,N43667)","v":"DTXSID6021244"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43667,J43667)","v":"2496358"},"Accidental poisoning with isoniazid and rifampicin in an infant: role of peritoneal dialysis.","2496358","Neurologic Manifestations","D012640","Seizures","DTXSID6021244"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43691,D43691)","v":"rimonabant"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43691,M43691)","v":"Huntington Disease"},"C089032","rimonabant","158681-13-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43691,N43691)","v":"DTXSID20166495"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43691,J43691)","v":"12858038"},"Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate.","12858038","Basal Ganglia Diseases","D006816","Huntington Disease","DTXSID20166495"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43719,D43719)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43719,M43719)","v":"Basal Ganglia Diseases"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43719,N43719)","v":"DTXSID8045193"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43719,J43719)","v":"9241011"},"Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone.","9241011","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43726,D43726)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43726,M43726)","v":"Basal Ganglia Diseases"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43726,N43726)","v":"DTXSID8045193"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43726,J43726)","v":"9818633"},"Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study.","9818633","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43759,D43759)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43759,M43759)","v":"Basal Ganglia Diseases"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43759,N43759)","v":"DTXSID8045193"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43759,J43759)","v":"15812261"},"Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies.","15812261","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43787,D43787)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43787,M43787)","v":"Basal Ganglia Diseases"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43787,N43787)","v":"DTXSID8045193"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43787,J43787)","v":"23082694"},"Risperidone-induced rabbit syndrome: an unusual movement disorder.","23082694","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43820,D43820)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43820,M43820)","v":"Basal Ganglia Diseases"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43820,N43820)","v":"DTXSID8045193"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43820,J43820)","v":"12802745"},"[Risperidone].","12802745","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43827,D43827)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43827,M43827)","v":"Basal Ganglia Diseases"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43827,N43827)","v":"DTXSID8045193"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43827,J43827)","v":"11978161"},"Extrapyramidal symptoms with ritonavir/indinavir plus risperidone.","11978161","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43855,D43855)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43855,M43855)","v":"Confusion"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43855,N43855)","v":"DTXSID8045193"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43855,J43855)","v":"7540799"},"Behavioral stimulation associated with risperidone initiation.","7540799","Neurologic Manifestations","D003221","Confusion","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43888,D43888)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43888,M43888)","v":"Dystonia"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43888,N43888)","v":"DTXSID8045193"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43888,J43888)","v":"18315457"},"Acute dystonic reaction in an adolescent on risperidone when a concomitant stimulant medication is discontinued.","18315457","Neurologic Manifestations","D004421","Dystonia","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43917,D43917)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43917,M43917)","v":"Hyperkinesis"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43917,N43917)","v":"DTXSID8045193"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43917,J43917)","v":"20662826"},"Studies on the acute toxicity, pharmacokinetics and pharmacodynamics of paliperidone derivatives--comparison to paliperidone and risperidone in mice and rats.","20662826","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43948,D43948)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43948,M43948)","v":"Hyperprolactinemia"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43948,N43948)","v":"DTXSID8045193"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43948,J43948)","v":"23851570"},"The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.","23851570","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43956,D43956)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43956,M43956)","v":"Hyperprolactinemia"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43956,N43956)","v":"DTXSID8045193"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43956,J43956)","v":"16379509"},"Elevated prolactin levels in male youths treated with risperidone and quetiapine.","16379509","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C43985,D43985)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L43985,M43985)","v":"Hyperprolactinemia"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N43985,N43985)","v":"DTXSID8045193"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J43985,J43985)","v":"21192158"},"Preliminary report: a naturalistic study of the effect of aripiprazole addition on risperidone-related hyperprolactinemia in patients treated with risperidone long-acting injection.","21192158","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44016,D44016)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44016,M44016)","v":"Ischemic Attack, Transient"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44016,N44016)","v":"DTXSID8045193"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44016,J44016)","v":"15945589"},"A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour.","15945589","Central Nervous System Diseases","D002546","Ischemic Attack, Transient","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44046,D44046)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44046,M44046)","v":"Parkinsonian Disorders"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44046,N44046)","v":"DTXSID8045193"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44046,J44046)","v":"25987672"},"Teaching NeuroImages: Drug-induced parkinsonism with asymmetrical putaminal DaT binding.","25987672","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44068,D44068)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44068,M44068)","v":"Sleep Initiation and Maintenance Disorders"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44068,N44068)","v":"DTXSID8045193"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44068,J44068)","v":"8610833"},"Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study.","8610833","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44085,D44085)","v":"Risperidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44085,M44085)","v":"Stroke"},"D018967","Risperidone","106266-06-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44085,N44085)","v":"DTXSID8045193"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44085,J44085)","v":"15945589"},"A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour.","15945589","Central Nervous System Diseases","D020521","Stroke","DTXSID8045193"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44114,D44114)","v":"Ritodrine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44114,M44114)","v":"Tremor"},"D012312","Ritodrine","26652-09-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44114,N44114)","v":"DTXSID7048534"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44114,J44114)","v":"28391406"},"Association between CACNA1C gene polymorphisms and ritodrine-induced adverse events in preterm labor patients.","28391406","Neurologic Manifestations","D014202","Tremor","DTXSID7048534"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44136,D44136)","v":"Ritonavir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44136,M44136)","v":"Vertigo"},"D019438","Ritonavir","155213-67-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44136,N44136)","v":"DTXSID1048627"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44136,J44136)","v":"11197575"},"Ritonavir-induced carbamazepine toxicity.","11197575","Neurologic Manifestations","D014717","Vertigo","DTXSID1048627"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44179,D44179)","v":"Rivaroxaban"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44179,M44179)","v":"Intracranial Thrombosis"},"D000069552","Rivaroxaban","366789-02-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44179,N44179)","v":"DTXSID3057723"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44179,J44179)","v":"27131792"},"Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation.","27131792","Central Nervous System Diseases","D020767","Intracranial Thrombosis","DTXSID3057723"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44208,D44208)","v":"rocuronium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44208,M44208)","v":"Muscle Weakness"},"C061870","rocuronium","143558-00-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44208,N44208)","v":"DTXSID6048339"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44208,J44208)","v":"19537261"},"[Muscle weakness and tolerance of low doses of rocuronium in healthy awake volunteers breathing spontaneously].","19537261","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID6048339"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44229,D44229)","v":"rofecoxib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44229,M44229)","v":"Cerebral Infarction"},"C116926","rofecoxib","162011-90-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44229,N44229)","v":"DTXSID2023567"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44229,J44229)","v":"20157701"},"Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study.","20157701","Central Nervous System Diseases","D002544","Cerebral Infarction","DTXSID2023567"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44243,D44243)","v":"rofecoxib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44243,M44243)","v":"Stroke"},"C116926","rofecoxib","162011-90-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44243,N44243)","v":"DTXSID2023567"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44243,J44243)","v":"17303969"},"Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs.","17303969","Central Nervous System Diseases","D020521","Stroke","DTXSID2023567"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44276,D44276)","v":"ropinirole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44276,M44276)","v":"Disorders of Excessive Somnolence"},"C046649","ropinirole","91374-21-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44276,N44276)","v":"DTXSID8045195"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44276,J44276)","v":"11839850"},"Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers.","11839850","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID8045195"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44297,D44297)","v":"ropivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44297,M44297)","v":"Central Nervous System Diseases"},"C037663","ropivacaine","84057-95-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44297,N44297)","v":"DTXSID4040187"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44297,J44297)","v":"11524350"},"Systemic toxicity and resuscitation in bupivacaine-, levobupivacaine-, or ropivacaine-infused rats.","11524350","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID4040187"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44337,D44337)","v":"ropivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44337,M44337)","v":"Paresis"},"C037663","ropivacaine","84057-95-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44337,N44337)","v":"DTXSID4040187"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44337,J44337)","v":"21751435"},"Decreasing the local anesthetic volume from 20 to 10 mL for ultrasound-guided interscalene block at the cricoid level does not reduce the incidence of hemidiaphragmatic paresis.","21751435","Neurologic Manifestations","D010291","Paresis","DTXSID4040187"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44344,D44344)","v":"ropivacaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44344,M44344)","v":"Polyradiculopathy"},"C037663","ropivacaine","84057-95-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44344,N44344)","v":"DTXSID4040187"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44344,J44344)","v":"21519981"},"Cauda equina syndrome following combined spinal and epidural anesthesia: a case report.","21519981","Neuromuscular Diseases","D011128","Polyradiculopathy","DTXSID4040187"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44386,D44386)","v":"roquefortine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44386,M44386)","v":"Ataxia"},"C012536","roquefortine","58735-64-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44386,N44386)","v":"DTXSID20891816"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44386,J44386)","v":"12458614"},"Tremorgenic mycotoxicosis in four dogs from a single household.","12458614","Neurologic Manifestations","D001259","Ataxia","DTXSID20891816"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44405,D44405)","v":"rosiglitazone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44405,M44405)","v":"Stroke"},"C089730","rosiglitazone","155141-29-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44405,N44405)","v":"DTXSID2023569"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44405,J44405)","v":"23895806"},"Results of a reevaluation of cardiovascular outcomes in the RECORD trial.","23895806","Central Nervous System Diseases","D020521","Stroke","DTXSID2023569"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44417,D44417)","v":"Rosuvastatin Calcium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44417,M44417)","v":"Muscular Diseases"},"D000068718","Rosuvastatin Calcium","147098-20-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44417,N44417)","v":"DTXSID9045928"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44417,J44417)","v":"27815113"},"Rosuvastatin safety: An experimental study of myotoxic effects and mitochondrial alterations in rats.","27815113","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID9045928"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44440,D44440)","v":"Rosuvastatin Calcium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44440,M44440)","v":"Muscular Diseases"},"D000068718","Rosuvastatin Calcium","147098-20-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44440,N44440)","v":"DTXSID9045928"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44440,J44440)","v":"20176986"},"Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.","20176986","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID9045928"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44473,D44473)","v":"Rotenone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44473,M44473)","v":"Parkinson Disease, Secondary"},"D012402","Rotenone","83-79-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44473,N44473)","v":"DTXSID6021248"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44473,J44473)","v":"27866991"},"Parkinson's disease-like motor and non-motor symptoms in rotenone-treated zebrafish.","27866991","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID6021248"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44510,D44510)","v":"Rotenone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44510,M44510)","v":"Parkinsonian Disorders"},"D012402","Rotenone","83-79-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44510,N44510)","v":"DTXSID6021248"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44510,J44510)","v":"15574749"},"Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster.","15574749","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID6021248"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44534,D44534)","v":"rotigotine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44534,M44534)","v":"Muscle Weakness"},"C047508","rotigotine","99755-59-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44534,N44534)","v":"DTXSID5046772"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44534,J44534)","v":"28816836"},"Reversal of Dropped Head Syndrome After the Cessation of Dopaminergic Agonist Treatment in Parkinson Disease.","28816836","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID5046772"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44567,D44567)","v":"Salicylic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44567,M44567)","v":"Hearing Loss, Sensorineural"},"D020156","Salicylic Acid","69-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44567,N44567)","v":"DTXSID7026368"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44567,J44567)","v":"9333282"},"[Toxic inner ear damage in topical treatment of psoriasis with salicylates].","9333282","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID7026368"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44574,D44574)","v":"Salicylic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44574,M44574)","v":"Seizures"},"D020156","Salicylic Acid","69-72-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44574,N44574)","v":"DTXSID7026368"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44574,J44574)","v":"6511630"},"Salicylate-induced seizures in a dog.","6511630","Neurologic Manifestations","D012640","Seizures","DTXSID7026368"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44602,D44602)","v":"Saline Solution, Hypertonic"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44602,M44602)","v":"Dystonia"},"D012462","Saline Solution, Hypertonic",null,null,1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44602,J44602)","v":"2057010"},"Delayed onset movement disorders as a complication of central pontine myelinolysis.","2057010","Neurologic Manifestations","D004421","Dystonia"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44635,D44635)","v":"Sarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44635,M44635)","v":"Autonomic Nervous System Diseases"},"D012524","Sarin","107-44-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44635,N44635)","v":"DTXSID0042371"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44635,J44635)","v":"9789830"},"Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning.","9789830","Autonomic Nervous System Diseases","D001342","Autonomic Nervous System Diseases","DTXSID0042371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44667,D44667)","v":"Sarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44667,M44667)","v":"Miosis"},"D012524","Sarin","107-44-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44667,N44667)","v":"DTXSID0042371"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44667,J44667)","v":"22247005"},"Efficacy assessment of various anticholinergic agents against topical sarin-induced miosis and visual impairment in rats.","22247005","Neurologic Manifestations","D015877","Miosis","DTXSID0042371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44696,D44696)","v":"Sarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44696,M44696)","v":"Seizures"},"D012524","Sarin","107-44-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44696,N44696)","v":"DTXSID0042371"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44696,J44696)","v":"19680820"},"Treatment with tertiary oximes prevents seizures and improves survival following sarin intoxication.","19680820","Neurologic Manifestations","D012640","Seizures","DTXSID0042371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44703,D44703)","v":"Sarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44703,M44703)","v":"Seizures"},"D012524","Sarin","107-44-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44703,N44703)","v":"DTXSID0042371"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44703,J44703)","v":"12818696"},"Partial adenosine A(1) receptor agonists inhibit sarin-induced epileptiform activity in the hippocampal slice.","12818696","Neurologic Manifestations","D012640","Seizures","DTXSID0042371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44735,D44735)","v":"Scopolamine Hydrobromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44735,M44735)","v":"Amnesia"},"D012601","Scopolamine Hydrobromide","114-49-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44735,N44735)","v":"DTXSID0032029"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44735,J44735)","v":"17369909"},"Combined administration of NAN-190 and 17beta-estradiol abolishes the amnesic effect of scopolamine in middle-aged ovariectomized rats.","17369909","Neurologic Manifestations","D000647","Amnesia","DTXSID0032029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44764,D44764)","v":"Scopolamine Hydrobromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44764,M44764)","v":"Coma"},"D012601","Scopolamine Hydrobromide","114-49-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44764,N44764)","v":"DTXSID0032029"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44764,J44764)","v":"7188673"},"Coma and abnormal neurologic signs following premedication.","7188673","Neurologic Manifestations","D003128","Coma","DTXSID0032029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44793,D44793)","v":"Scopolamine Hydrobromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44793,M44793)","v":"Hallucinations"},"D012601","Scopolamine Hydrobromide","114-49-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44793,N44793)","v":"DTXSID0032029"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44793,J44793)","v":"8070000"},"Unattended continuous infusion of hyoscine leading to delayed visual disturbances.","8070000","Neurologic Manifestations","D006212","Hallucinations","DTXSID0032029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44803,D44803)","v":"Scopolamine Hydrobromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44803,M44803)","v":"Hallucinations"},"D012601","Scopolamine Hydrobromide","114-49-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44803,N44803)","v":"DTXSID0032029"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44803,J44803)","v":"603022"},"Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).","603022","Neurologic Manifestations","D006212","Hallucinations","DTXSID0032029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44832,D44832)","v":"Scopolamine Hydrobromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44832,M44832)","v":"Memory Disorders"},"D012601","Scopolamine Hydrobromide","114-49-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44832,N44832)","v":"DTXSID0032029"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44832,J44832)","v":"28164395"},"Cognitive Ameliorating Effect of Acanthopanax koreanum Against Scopolamine-Induced Memory Impairment in Mice.","28164395","Neurologic Manifestations","D008569","Memory Disorders","DTXSID0032029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44855,D44855)","v":"Scopolamine Hydrobromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44855,M44855)","v":"Memory Disorders"},"D012601","Scopolamine Hydrobromide","114-49-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44855,N44855)","v":"DTXSID0032029"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44855,J44855)","v":"15351791"},"Determination of the effectiveness of components of the herbal medicine Toki-Shakuyaku-San and fractions of Angelica acutiloba in improving the scopolamine-induced impairment of rat's spatial cognition in eight-armed radial maze test.","15351791","Neurologic Manifestations","D008569","Memory Disorders","DTXSID0032029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44893,D44893)","v":"Scopolamine Hydrobromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44893,M44893)","v":"Seizures"},"D012601","Scopolamine Hydrobromide","114-49-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44893,N44893)","v":"DTXSID0032029"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44893,J44893)","v":"4383706"},"Enteral absorption of hyoscine N-butylbromide.","4383706","Neurologic Manifestations","D012640","Seizures","DTXSID0032029"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44922,D44922)","v":"Selegiline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44922,M44922)","v":"Hallucinations"},"D012642","Selegiline","4528-52-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44922,N44922)","v":"DTXSID20196459"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44922,J44922)","v":"10572371"},"Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine.","10572371","Neurologic Manifestations","D006212","Hallucinations","DTXSID20196459"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44948,D44948)","v":"Selenium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44948,M44948)","v":"Nervous System Diseases"},"D012643","Selenium","7782-49-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44948,N44948)","v":"DTXSID9021261"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44948,J44948)","v":"8466987"},"Naturally occurring selenosis in Wyoming.","8466987","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID9021261"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44961,D44961)","v":"Selenium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44961,M44961)","v":"Paresis"},"D012643","Selenium","7782-49-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44961,N44961)","v":"DTXSID9021261"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44961,J44961)","v":"20464684"},"[Feed-related selenium poisoning in swine].","20464684","Neurologic Manifestations","D010291","Paresis","DTXSID9021261"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C44990,D44990)","v":"Sertraline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L44990,M44990)","v":"Carotid Artery Diseases"},"D020280","Sertraline","79559-97-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N44990,N44990)","v":"DTXSID1040243"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J44990,J44990)","v":"28609387"},"Long-term sertraline treatment and depression effects on carotid artery atherosclerosis in premenopausal female primates.","28609387","Central Nervous System Diseases","D002340","Carotid Artery Diseases","DTXSID1040243"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45016,D45016)","v":"Sertraline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45016,M45016)","v":"Hallucinations"},"D020280","Sertraline","79559-97-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45016,N45016)","v":"DTXSID1040243"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45016,J45016)","v":"9048728"},"Triphasic waves in serotonin syndrome.","9048728","Neurologic Manifestations","D006212","Hallucinations","DTXSID1040243"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45055,D45055)","v":"Sertraline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45055,M45055)","v":"Nocturnal Myoclonus Syndrome"},"D020280","Sertraline","79559-97-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45055,N45055)","v":"DTXSID1040243"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45055,J45055)","v":"24210602"},"Sertraline and periodic limb movements during sleep: an 8-week open-label study in depressed patients with insomnia.","24210602","Sleep Wake Disorders","D020189","Nocturnal Myoclonus Syndrome","DTXSID1040243"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45058,D45058)","v":"Sertraline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45058,M45058)","v":"Optic Nerve Diseases"},"D020280","Sertraline","79559-97-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45058,N45058)","v":"DTXSID1040243"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45058,J45058)","v":"10608673"},"Toxic optic neuropathy after concomitant use of melatonin, zoloft, and a high-protein diet.","10608673","Cranial Nerve Diseases","D009901","Optic Nerve Diseases","DTXSID1040243"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45084,D45084)","v":"Sertraline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45084,M45084)","v":"Sensation Disorders"},"D020280","Sertraline","79559-97-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45084,N45084)","v":"DTXSID1040243"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45084,J45084)","v":"7726327"},"Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.","7726327","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID1040243"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45119,D45119)","v":"sevoflurane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45119,M45119)","v":"Delirium"},"C009250","sevoflurane","28523-86-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45119,N45119)","v":"DTXSID8046614"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45119,J45119)","v":"26466503"},"[Effects of Sevoflurane or Desflurane Anesthesia on Perioperative Delirium in Elderly Patients Undergoing Surgical Repair of Hip Fracture].","26466503","Neurologic Manifestations","D003693","Delirium","DTXSID8046614"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45152,D45152)","v":"sevoflurane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45152,M45152)","v":"Epilepsy"},"C009250","sevoflurane","28523-86-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45152,N45152)","v":"DTXSID8046614"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45152,J45152)","v":"20124973"},"Bumetanide alleviates epileptogenic and neurotoxic effects of sevoflurane in neonatal rat brain.","20124973","Central Nervous System Diseases","D004827","Epilepsy","DTXSID8046614"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45177,D45177)","v":"sevoflurane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45177,M45177)","v":"Learning Disorders"},"C009250","sevoflurane","28523-86-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45177,N45177)","v":"DTXSID8046614"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45177,J45177)","v":"26621121"},"Beta-arrestin1 and 2 differently modulate metabotropic glutamate receptor 7 signaling in rat developmental sevoflurane-induced neuronal apoptosis.","26621121","Neurologic Manifestations","D007859","Learning Disorders","DTXSID8046614"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45187,D45187)","v":"sevoflurane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45187,M45187)","v":"Memory Disorders"},"C009250","sevoflurane","28523-86-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45187,N45187)","v":"DTXSID8046614"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45187,J45187)","v":"26621121"},"Beta-arrestin1 and 2 differently modulate metabotropic glutamate receptor 7 signaling in rat developmental sevoflurane-induced neuronal apoptosis.","26621121","Neurologic Manifestations","D008569","Memory Disorders","DTXSID8046614"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45229,D45229)","v":"sevoflurane"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45229,M45229)","v":"Seizures"},"C009250","sevoflurane","28523-86-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45229,N45229)","v":"DTXSID8046614"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45229,J45229)","v":"10411761"},"Changing aspects of sevoflurane in paediatric anaesthesia: 1975-99.","10411761","Neurologic Manifestations","D012640","Seizures","DTXSID8046614"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45252,D45252)","v":"sibutramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45252,M45252)","v":"Sleep Initiation and Maintenance Disorders"},"C058254","sibutramine","106650-56-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45252,N45252)","v":"DTXSID1023578"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45252,J45252)","v":"19471631"},"Chinese slimming capsules containing sibutramine sold over the Internet: a case series.","19471631","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID1023578"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45281,D45281)","v":"Sildenafil Citrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45281,M45281)","v":"Cerebral Infarction"},"D000068677","Sildenafil Citrate","171599-83-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45281,N45281)","v":"DTXSID4046076"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45281,J45281)","v":"17386250"},"[Lacunar stroke after sildenafil administration].","17386250","Central Nervous System Diseases","D002544","Cerebral Infarction","DTXSID4046076"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45297,D45297)","v":"Sildenafil Citrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45297,M45297)","v":"Hearing Disorders"},"D000068677","Sildenafil Citrate","171599-83-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45297,N45297)","v":"DTXSID4046076"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45297,J45297)","v":"19900167"},"Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.","19900167","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID4046076"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45316,D45316)","v":"Sildenafil Citrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45316,M45316)","v":"Oculomotor Nerve Diseases"},"D000068677","Sildenafil Citrate","171599-83-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45316,N45316)","v":"DTXSID4046076"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45316,J45316)","v":"9744392"},"Pupil-sparing third nerve palsy associated with sildenafil citrate (Viagra).","9744392","Cranial Nerve Diseases","D015840","Oculomotor Nerve Diseases","DTXSID4046076"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45349,D45349)","v":"Sildenafil Citrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45349,M45349)","v":"Scotoma"},"D000068677","Sildenafil Citrate","171599-83-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45349,N45349)","v":"DTXSID4046076"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45349,J45349)","v":"27316292"},"Bilateral posterior ischemic optic neuropathy associated with the use of Sildenafil for pulmonary hypertension.","27316292","Neurologic Manifestations","D012607","Scotoma","DTXSID4046076"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45365,D45365)","v":"Sildenafil Citrate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45365,M45365)","v":"Subarachnoid Hemorrhage"},"D000068677","Sildenafil Citrate","171599-83-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45365,N45365)","v":"DTXSID4046076"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45365,J45365)","v":"26037192"},"Subarachnoid and intracerebral hemorrhage after alcohol ingestion and illicit use of sildenafil.","26037192","Central Nervous System Diseases","D013345","Subarachnoid Hemorrhage","DTXSID4046076"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45410,D45410)","v":"Silicon Dioxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45410,M45410)","v":"Taste Disorders"},"D012822","Silicon Dioxide","14464-46-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45410,N45410)","v":"DTXSID5041801"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45410,J45410)","v":"17873673"},"Efficacy of a new oral lubricant solution in the management of psychotropic drug-induced xerostomia: a randomized controlled trial.","17873673","Neurologic Manifestations","D013651","Taste Disorders","DTXSID5041801"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45417,D45417)","v":"Silver"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45417,M45417)","v":"Central Nervous System Diseases"},"D012834","Silver","7440-22-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45417,N45417)","v":"DTXSID4024305"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45417,J45417)","v":"5730378"},"[On the necessity of limiting the amount of silver in drinking water].","5730378","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID4024305"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45454,D45454)","v":"Simvastatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45454,M45454)","v":"Intracranial Hemorrhages"},"D019821","Simvastatin","79902-63-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45454,N45454)","v":"DTXSID0023581"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45454,J45454)","v":"17304269"},"[Interaction risk with statin switch].","17304269","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID0023581"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45478,D45478)","v":"Simvastatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45478,M45478)","v":"Muscular Diseases"},"D019821","Simvastatin","79902-63-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45478,N45478)","v":"DTXSID0023581"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45478,J45478)","v":"9200964"},"Simvastatin-induced myopathy in a patient treated for hypercholesterolemia. Morphological aspects.","9200964","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID0023581"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45511,D45511)","v":"Simvastatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45511,M45511)","v":"Muscular Diseases"},"D019821","Simvastatin","79902-63-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45511,N45511)","v":"DTXSID0023581"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45511,J45511)","v":"24742497"},"Low vitamin D as a risk factor for the development of myalgia in patients taking high-dose simvastatin: a retrospective review.","24742497","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID0023581"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45522,D45522)","v":"Simvastatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45522,M45522)","v":"Muscular Diseases"},"D019821","Simvastatin","79902-63-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45522,N45522)","v":"DTXSID0023581"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45522,J45522)","v":"19908627"},"[Warning for simvastatin 80 mg!].","19908627","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID0023581"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45546,D45546)","v":"Simvastatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45546,M45546)","v":"Muscular Diseases"},"D019821","Simvastatin","79902-63-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45546,N45546)","v":"DTXSID0023581"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45546,J45546)","v":"2233483"},"Muscle side effects associated with simvastatin therapy.","2233483","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID0023581"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45578,D45578)","v":"Simvastatin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45578,M45578)","v":"Polymyositis"},"D019821","Simvastatin","79902-63-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45578,N45578)","v":"DTXSID0023581"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45578,J45578)","v":"12793123"},"[Generalized muscle pain in a 67-year-old patient. Myalgia/myositis in therapy with Zocor].","12793123","Neuromuscular Diseases","D017285","Polymyositis","DTXSID0023581"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45607,D45607)","v":"Sirolimus"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45607,M45607)","v":"Polyneuropathies"},"D020123","Sirolimus","53123-88-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45607,N45607)","v":"DTXSID5023582"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45607,J45607)","v":"18589148"},"Demyelinating sensorimotor polyneuropathy associated with the use of sirolimus: a case report.","18589148","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID5023582"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45640,D45640)","v":"Sodium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45640,M45640)","v":"Spinal Cord Neoplasms"},"D012964","Sodium","7440-23-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45640,N45640)","v":"DTXSID1049774"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45640,J45640)","v":"5467521"},"[Induction of malignant tumors in rats by oral administration of N,N'-dimethylurea and nitrite].","5467521","Nervous System Neoplasms","D013120","Spinal Cord Neoplasms","DTXSID1049774"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45667,D45667)","v":"Sodium Azide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45667,M45667)","v":"Eye Injuries"},"D019810","Sodium Azide","26628-22-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45667,N45667)","v":"DTXSID8020121"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45667,J45667)","v":"18385003"},"Sodium azide-associated laryngospasm after air bag deployment.","18385003","Trauma, Nervous System","D005131","Eye Injuries","DTXSID8020121"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45675,D45675)","v":"Sodium Bicarbonate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45675,M45675)","v":"Myoclonus"},"D017693","Sodium Bicarbonate","144-55-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45675,N45675)","v":"DTXSID9021269"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45675,J45675)","v":"10946818"},"Baking soda toxicity.","10946818","Neurologic Manifestations","D009207","Myoclonus","DTXSID9021269"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45708,D45708)","v":"Sodium Chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45708,M45708)","v":"Cerebrovascular Disorders"},"D012965","Sodium Chloride","7647-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45708,N45708)","v":"DTXSID3021271"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45708,J45708)","v":"6875444"},"Salt and geographical mortality of gastric cancer and stroke in Japan.","6875444","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID3021271"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45735,D45735)","v":"Sodium Chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45735,M45735)","v":"Quadriplegia"},"D012965","Sodium Chloride","7647-14-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45735,N45735)","v":"DTXSID3021271"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45735,J45735)","v":"1173818"},"Adverse reactions to intrathecal saline injection for control of pain.","1173818","Neurologic Manifestations","D011782","Quadriplegia","DTXSID3021271"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45769,D45769)","v":"Sodium Hydroxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45769,M45769)","v":"Eye Burns"},"D012972","Sodium Hydroxide","1310-73-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45769,N45769)","v":"DTXSID0029634"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45769,J45769)","v":"8591911"},"Alkali-burned collagen produces a locomotory and metabolic stimulant to neutrophils.","8591911","Trauma, Nervous System","D005126","Eye Burns","DTXSID0029634"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45798,D45798)","v":"Sodium Hypochlorite"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45798,M45798)","v":"Facial Hemiatrophy"},"D012973","Sodium Hypochlorite","7681-52-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45798,N45798)","v":"DTXSID8021276"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45798,J45798)","v":"19287421"},"Facial atrophy following accidental subcutaneous extrusion of sodium hypochlorite.","19287421","Cranial Nerve Diseases","D005150","Facial Hemiatrophy","DTXSID8021276"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45803,D45803)","v":"Sodium Hypochlorite"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45803,M45803)","v":"Facial Paralysis"},"D012973","Sodium Hypochlorite","7681-52-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45803,N45803)","v":"DTXSID8021276"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45803,J45803)","v":"16218978"},"Neurological complications following extrusion of sodium hypochlorite solution during root canal treatment.","16218978","Neurologic Manifestations","D005158","Facial Paralysis","DTXSID8021276"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45837,D45837)","v":"Sodium Oxybate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45837,M45837)","v":"Coma"},"D012978","Sodium Oxybate","502-85-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45837,N45837)","v":"DTXSID3048940"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45837,J45837)","v":"9153356"},"From the Centers for Disease Control and Prevention. Gamma hydroxy butyrate use--New York and Texas, 1995-1996.","9153356","Neurologic Manifestations","D003128","Coma","DTXSID3048940"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45866,D45866)","v":"Sodium Oxybate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45866,M45866)","v":"Consciousness Disorders"},"D012978","Sodium Oxybate","502-85-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45866,N45866)","v":"DTXSID3048940"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45866,J45866)","v":"19125832"},"Gamma-hydroxybutyrate: a 30 month emergency department review.","19125832","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID3048940"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45896,D45896)","v":"Sodium Oxybate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45896,M45896)","v":"Parasomnias"},"D012978","Sodium Oxybate","502-85-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45896,N45896)","v":"DTXSID3048940"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45896,J45896)","v":"25444412"},"Sexsomnia and sleep eating secondary to sodium oxybate consumption.","25444412","Sleep Wake Disorders","D020447","Parasomnias","DTXSID3048940"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45905,D45905)","v":"Sodium Oxybate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45905,M45905)","v":"Seizures"},"D012978","Sodium Oxybate","502-85-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45905,N45905)","v":"DTXSID3048940"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45905,J45905)","v":"8937431"},"Relation of the [3H] gamma-hydroxybutyric acid (GHB) binding site to the gamma-aminobutyric acidB (GABAB) receptor in rat brain.","8937431","Neurologic Manifestations","D012640","Seizures","DTXSID3048940"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45948,D45948)","v":"sodium phosphate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45948,M45948)","v":"Seizures"},"C018279","sodium phosphate","7601-54-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45948,N45948)","v":"DTXSID2035223"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45948,J45948)","v":"16673304"},"Hyponatremic convulsion after oral sodium phosphate for bowel preparation in a patient with previous gastrectomy.","16673304","Neurologic Manifestations","D012640","Seizures","DTXSID2035223"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45966,D45966)","v":"Sodium Salicylate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45966,M45966)","v":"Hearing Loss"},"D012980","Sodium Salicylate","54-21-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45966,N45966)","v":"DTXSID5021708"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45966,J45966)","v":"7131637"},"Salicylate ototoxicity in the chinchilla: a behavioral and electron microscope study.","7131637","Neurologic Manifestations","D034381","Hearing Loss","DTXSID5021708"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C45995,D45995)","v":"Sodium Salicylate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L45995,M45995)","v":"Tinnitus"},"D012980","Sodium Salicylate","54-21-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N45995,N45995)","v":"DTXSID5021708"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J45995,J45995)","v":"22464181"},"Amygdala hyperactivity and tonotopic shift after salicylate exposure.","22464181","Neurologic Manifestations","D014012","Tinnitus","DTXSID5021708"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46016,D46016)","v":"Soman"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46016,M46016)","v":"Encephalitis"},"D012999","Soman","96-64-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46016,N46016)","v":"DTXSID2031906"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46016,J46016)","v":"23000013"},"Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy.","23000013","Central Nervous System Diseases","D004660","Encephalitis","DTXSID2031906"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46034,D46034)","v":"Soman"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46034,M46034)","v":"Nervous System Diseases"},"D012999","Soman","96-64-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46034,N46034)","v":"DTXSID2031906"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46034,J46034)","v":"4092887"},"Can soman cause delayed neuropathy?","4092887","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2031906"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46063,D46063)","v":"Soman"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46063,M46063)","v":"Seizures"},"D012999","Soman","96-64-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46063,N46063)","v":"DTXSID2031906"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46063,J46063)","v":"4418567"},"Reduction by diazepam of repetitive electrical activity and toxicity resulting from soman.","4418567","Neurologic Manifestations","D012640","Seizures","DTXSID2031906"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46084,D46084)","v":"Soman"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46084,M46084)","v":"Seizures"},"D012999","Soman","96-64-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46084,N46084)","v":"DTXSID2031906"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46084,J46084)","v":"16525814"},"Anticonvulsant effects of GABA(A) modulators microinfused into area tempestas or substantia nigra in rats exposed to soman.","16525814","Neurologic Manifestations","D012640","Seizures","DTXSID2031906"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46128,D46128)","v":"Soman"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46128,M46128)","v":"Seizures"},"D012999","Soman","96-64-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46128,N46128)","v":"DTXSID2031906"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46128,J46128)","v":"11360433"},"Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.","11360433","Neurologic Manifestations","D012640","Seizures","DTXSID2031906"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46157,D46157)","v":"Soman"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46157,M46157)","v":"Status Epilepticus"},"D012999","Soman","96-64-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46157,N46157)","v":"DTXSID2031906"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46157,J46157)","v":"20649973"},"The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations.","20649973","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID2031906"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46177,D46177)","v":"sorafenib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46177,M46177)","v":"Sarcopenia"},"C471405","sorafenib","284461-73-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46177,N46177)","v":"DTXSID7041128"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46177,J46177)","v":"20089558"},"Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma.","20089558","Neurologic Manifestations","D055948","Sarcopenia","DTXSID7041128"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46192,D46192)","v":"Sorbitol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46192,M46192)","v":"Muscle Cramp"},"D013012","Sorbitol","50-70-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46192,N46192)","v":"DTXSID5023588"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46192,J46192)","v":"10715225"},"Effects of olestra and sorbitol consumption on objective measures of diarrhea: impact of stool viscosity on common gastrointestinal symptoms.","10715225","Neurologic Manifestations","D009120","Muscle Cramp","DTXSID5023588"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46225,D46225)","v":"Sphingosine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46225,M46225)","v":"Encephalitis"},"D013110","Sphingosine",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46225,N46225)","v":"DTXSID90861763"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46225,J46225)","v":"19289744"},"Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.","19289744","Central Nervous System Diseases","D004660","Encephalitis","DTXSID90861763"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46245,D46245)","v":"Spironolactone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46245,M46245)","v":"Hepatic Encephalopathy"},"D013148","Spironolactone","52-01-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46245,N46245)","v":"DTXSID6034186"},1966,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46245,J46245)","v":"5230290"},"The complications of diuretic therapy in patients with cirrhosis.","5230290","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID6034186"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46286,D46286)","v":"Stavudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46286,M46286)","v":"Peripheral Nervous System Diseases"},"D018119","Stavudine","3056-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46286,N46286)","v":"DTXSID1023819"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46286,J46286)","v":"24874810"},"Peripheral neuropathy in children on stauvudine therapy.","24874810","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID1023819"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46297,D46297)","v":"Stavudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46297,M46297)","v":"Peripheral Nervous System Diseases"},"D018119","Stavudine","3056-17-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46297,N46297)","v":"DTXSID1023819"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46297,J46297)","v":"11737385"},"Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.","11737385","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID1023819"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46321,D46321)","v":"Streptomycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46321,M46321)","v":"Deafness"},"D013307","Streptomycin","3810-74-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46321,N46321)","v":"DTXSID9026053"},1971,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46321,J46321)","v":"4131355"},"Familial incidence of streptomycin hearing loss and hereditary weakness of the cochlea.","4131355","Neurologic Manifestations","D003638","Deafness","DTXSID9026053"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46354,D46354)","v":"Streptomycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46354,M46354)","v":"Hearing Disorders"},"D013307","Streptomycin","3810-74-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46354,N46354)","v":"DTXSID9026053"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46354,J46354)","v":"4129648"},"[Organ of hearing and equilibrium following streptomycin therapy].","4129648","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID9026053"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46365,D46365)","v":"Streptomycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46365,M46365)","v":"Hearing Disorders"},"D013307","Streptomycin","3810-74-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46365,N46365)","v":"DTXSID9026053"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46365,J46365)","v":"2777365"},"Cochlear toxicity of streptomycin in man.","2777365","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID9026053"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46389,D46389)","v":"Streptomycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46389,M46389)","v":"Hearing Disorders"},"D013307","Streptomycin","3810-74-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46389,N46389)","v":"DTXSID9026053"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46389,J46389)","v":"579091"},"[The effects of intratympanally applied streptomycin-sulfate on the ipsi- and contralateral hearing potentials in the guinea pig (author's transl)].","579091","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID9026053"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46422,D46422)","v":"Streptomycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46422,M46422)","v":"Hyperacusis"},"D013307","Streptomycin","3810-74-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46422,N46422)","v":"DTXSID9026053"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46422,J46422)","v":"6336480"},"The assessment of recruitment in rhinoscleroma patients with hearing loss after streptomycin therapy.","6336480","Neurologic Manifestations","D012001","Hyperacusis","DTXSID9026053"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46458,D46458)","v":"Streptomycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46458,M46458)","v":"Vertigo"},"D013307","Streptomycin","3810-74-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46458,N46458)","v":"DTXSID9026053"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46458,J46458)","v":"5660586"},"A comparison of two regimens of streptomycin plus PAS in the retreatment of pulmonary tuberculosis.","5660586","Neurologic Manifestations","D014717","Vertigo","DTXSID9026053"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46483,D46483)","v":"Streptozocin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46483,M46483)","v":"Alzheimer Disease"},"D013311","Streptozocin","18883-66-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46483,N46483)","v":"DTXSID2021282"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46483,J46483)","v":"23061885"},"Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease.","23061885","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID2021282"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46516,D46516)","v":"Streptozocin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46516,M46516)","v":"Neurodegenerative Diseases"},"D013311","Streptozocin","18883-66-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46516,N46516)","v":"DTXSID2021282"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46516,J46516)","v":"25472801"},"Cognitive effects of vanillic acid against streptozotocin-induced neurodegeneration in mice.","25472801","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID2021282"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46522,D46522)","v":"Strychnine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46522,M46522)","v":"Epilepsy, Tonic-Clonic"},"D013331","Strychnine","57-24-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46522,N46522)","v":"DTXSID6023600"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46522,J46522)","v":"18432030"},"Strychnine--a killer from the past.","18432030","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID6023600"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46551,D46551)","v":"Strychnine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46551,M46551)","v":"Seizures"},"D013331","Strychnine","57-24-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46551,N46551)","v":"DTXSID6023600"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46551,J46551)","v":"4067548"},"Fatal strychnine poisoning--a case report and review of the literature.","4067548","Neurologic Manifestations","D012640","Seizures","DTXSID6023600"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46584,D46584)","v":"Styrene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46584,M46584)","v":"Color Vision Defects"},"D020058","Styrene","100-42-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46584,N46584)","v":"DTXSID2021284"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46584,J46584)","v":"8571095"},"Visual dysfunction among styrene-exposed workers.","8571095","Neurologic Manifestations","D003117","Color Vision Defects","DTXSID2021284"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46615,D46615)","v":"Styrene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46615,M46615)","v":"Hearing Loss, Sensorineural"},"D020058","Styrene","100-42-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46615,N46615)","v":"DTXSID2021284"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46615,J46615)","v":"12633735"},"Solvent ototoxicity in the rat and guinea pig.","12633735","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID2021284"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46645,D46645)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46645,M46645)","v":"Diplopia"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46645,N46645)","v":"DTXSID7048455"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46645,J46645)","v":"6517301"},"Suxamethonium pre-treatment.","6517301","Neurologic Manifestations","D004172","Diplopia","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46667,D46667)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46667,M46667)","v":"Fasciculation"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46667,N46667)","v":"DTXSID7048455"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46667,J46667)","v":"8214528"},"Suxamethonium in the deadspace of an adult's indwelling intravenous cannula.","8214528","Neurologic Manifestations","D005207","Fasciculation","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46680,D46680)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46680,M46680)","v":"Fasciculation"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46680,N46680)","v":"DTXSID7048455"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46680,J46680)","v":"435349"},"Suxamethonium infusion rate and observed fasciculations. A dose-response study.","435349","Neurologic Manifestations","D005207","Fasciculation","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46713,D46713)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46713,M46713)","v":"Fasciculation"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46713,N46713)","v":"DTXSID7048455"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46713,J46713)","v":"21606827"},"Consequences of succinylcholine administration to patients using statins.","21606827","Neurologic Manifestations","D005207","Fasciculation","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46735,D46735)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46735,M46735)","v":"Muscle Hypertonia"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46735,N46735)","v":"DTXSID7048455"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46735,J46735)","v":"7171420"},"Suxamethonium associated hypertonicity and cardiac arrest in unsuspected pseudohypertrophic muscular dystrophy.","7171420","Neurologic Manifestations","D009122","Muscle Hypertonia","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46748,D46748)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46748,M46748)","v":"Muscle Rigidity"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46748,N46748)","v":"DTXSID7048455"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46748,J46748)","v":"4113637"},"Hyperpyrexia during pregnancy.","4113637","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46781,D46781)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46781,M46781)","v":"Muscular Diseases"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46781,N46781)","v":"DTXSID7048455"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46781,J46781)","v":"8123399"},"Effect of preoperative i.m. administration of diclofenac on suxamethonium-induced myalgia.","8123399","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46803,D46803)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46803,M46803)","v":"Muscular Diseases"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46803,N46803)","v":"DTXSID7048455"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46803,J46803)","v":"5757446"},"[Prevention of succinylcholine-induced fasciculations and myalgias by administration of small doses of competitive muscle relaxants: clinical results].","5757446","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46842,D46842)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46842,M46842)","v":"Myalgia"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46842,N46842)","v":"DTXSID7048455"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46842,J46842)","v":"26952225"},"Prophylactic use of pregabalin for prevention of succinylcholine-induced fasciculation and myalgia: a randomized, double-blinded, placebo-controlled study.","26952225","Neuromuscular Diseases","D063806","Myalgia","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46871,D46871)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46871,M46871)","v":"Paralysis"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46871,N46871)","v":"DTXSID7048455"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46871,J46871)","v":"25350885"},"[Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].","25350885","Neurologic Manifestations","D010243","Paralysis","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46896,D46896)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46896,M46896)","v":"Spasm"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46896,N46896)","v":"DTXSID7048455"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46896,J46896)","v":"4730171"},"Masseter spasm following intravenous suxamethonium: a case report.","4730171","Neurologic Manifestations","D013035","Spasm","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46910,D46910)","v":"Succinylcholine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46910,M46910)","v":"Spasm"},"D013390","Succinylcholine","306-40-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46910,N46910)","v":"DTXSID7048455"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46910,J46910)","v":"5453253"},"Hypertonic syndrome associated with suxamethonium administration.","5453253","Neurologic Manifestations","D013035","Spasm","DTXSID7048455"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46939,D46939)","v":"Sucrose"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46939,M46939)","v":"Hyperkinesis"},"D013395","Sucrose","57-50-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46939,N46939)","v":"DTXSID2021288"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46939,J46939)","v":"6387615"},"Effect of sucrose on hyperkinetic children.","6387615","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID2021288"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C46964,D46964)","v":"Sufentanil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L46964,M46964)","v":"Myoclonus"},"D017409","Sufentanil","60561-17-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N46964,N46964)","v":"DTXSID5048928"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J46964,J46964)","v":"8135401"},"Postoperative myoclonus and rigidity after anesthesia with opioids.","8135401","Neurologic Manifestations","D009207","Myoclonus","DTXSID5048928"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47004,D47004)","v":"Sulfamethoxazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47004,M47004)","v":"Meningitis, Aseptic"},"D013420","Sulfamethoxazole","723-46-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47004,N47004)","v":"DTXSID8026064"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47004,J47004)","v":"25227653"},"Drug-induced aseptic meningitis secondary to trimethoprim/sulfamethoxazole: a headache to be aware of.","25227653","Central Nervous System Diseases","D008582","Meningitis, Aseptic","DTXSID8026064"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47016,D47016)","v":"Sulfasalazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47016,M47016)","v":"Brain Diseases"},"D012460","Sulfasalazine","599-79-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47016,N47016)","v":"DTXSID0021256"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47016,J47016)","v":"8103282"},"Sulfasalazine-associated encephalopathy in a patient with Crohn's disease.","8103282","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID0021256"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47039,D47039)","v":"Sulfasalazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47039,M47039)","v":"Multiple Sclerosis"},"D012460","Sulfasalazine","599-79-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47039,N47039)","v":"DTXSID0021256"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47039,J47039)","v":"1968133"},"Development of multiple sclerosis in patient on long-term sulfasalazine.","1968133","Demyelinating Diseases","D009103","Multiple Sclerosis","DTXSID0021256"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47068,D47068)","v":"Sulfur"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47068,M47068)","v":"Brain Diseases"},"D013455","Sulfur","7704-34-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47068,N47068)","v":"DTXSID9034941"},1968,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47068,J47068)","v":"5733505"},"[The character of the reflex action of subthreshold concentrations of anhydrous sulfur combined with phenol and carbon monoxide in atmospheric air].","5733505","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID9034941"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47084,D47084)","v":"Sulfur Dioxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47084,M47084)","v":"Brain Diseases"},"D013458","Sulfur Dioxide","7446-09-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47084,N47084)","v":"DTXSID6029672"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47084,J47084)","v":"4693116"},"[Sulfur dioxide poisoning].","4693116","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID6029672"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47107,D47107)","v":"Sulindac"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47107,M47107)","v":"Paresthesia"},"D013467","Sulindac","38194-50-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47107,N47107)","v":"DTXSID4023624"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47107,J47107)","v":"6093724"},"Hypersensitivity reaction to sulindac (Clinoril).","6093724","Neurologic Manifestations","D010292","Paresthesia","DTXSID4023624"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47136,D47136)","v":"Sulpiride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47136,M47136)","v":"Catatonia"},"D013469","Sulpiride","15676-16-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47136,N47136)","v":"DTXSID1042574"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47136,J47136)","v":"18562406"},"Catatonia, neuroleptics and brain damage--a case report.","18562406","Neurologic Manifestations","D002389","Catatonia","DTXSID1042574"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47177,D47177)","v":"Sulpiride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47177,M47177)","v":"Hyperprolactinemia"},"D013469","Sulpiride","15676-16-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47177,N47177)","v":"DTXSID1042574"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47177,J47177)","v":"14997280"},"Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.","14997280","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID1042574"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47197,D47197)","v":"Sulpiride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47197,M47197)","v":"Pituitary Neoplasms"},"D013469","Sulpiride","15676-16-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47197,N47197)","v":"DTXSID1042574"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47197,J47197)","v":"18562408"},"Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.","18562408","Central Nervous System Diseases","D010911","Pituitary Neoplasms","DTXSID1042574"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47230,D47230)","v":"sultopride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47230,M47230)","v":"Basal Ganglia Diseases"},"C012052","sultopride","71675-85-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47230,N47230)","v":"DTXSID5042613"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47230,J47230)","v":"11252520"},"Is amisulpride an 'atypical' atypical antipsychotic agent?","11252520","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID5042613"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47245,D47245)","v":"sultopride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47245,M47245)","v":"Hyperprolactinemia"},"C012052","sultopride","71675-85-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47245,N47245)","v":"DTXSID5042613"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47245,J47245)","v":"18063941"},"Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.","18063941","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID5042613"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47265,D47265)","v":"sultopride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47265,M47265)","v":"Ocular Motility Disorders"},"C012052","sultopride","71675-85-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47265,N47265)","v":"DTXSID5042613"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47265,J47265)","v":"18603743"},"Amisulpride-induced both oculogyric crisis and trismus.","18603743","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID5042613"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47298,D47298)","v":"Sumatriptan"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47298,M47298)","v":"Cerebrovascular Disorders"},"D018170","Sumatriptan","103628-46-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47298,N47298)","v":"DTXSID4023628"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47298,J47298)","v":"15199757"},"[Postpartum cerebral angiopathy--a case report the vasculopathy associated with co-administration of two vasoconstrictives, methylergometrine maleate and sumatriptan].","15199757","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID4023628"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47313,D47313)","v":"Sumatriptan"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47313,M47313)","v":"Hemiplegia"},"D018170","Sumatriptan","103628-46-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47313,N47313)","v":"DTXSID4023628"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47313,J47313)","v":"8100026"},"Adverse reactions and sumatriptan.","8100026","Neurologic Manifestations","D006429","Hemiplegia","DTXSID4023628"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47359,D47359)","v":"sunitinib"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47359,M47359)","v":"Seizures"},"C473478","sunitinib","557795-19-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47359,N47359)","v":"DTXSID1041134"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47359,J47359)","v":"17687168"},"Reversible posterior leukoencephalopathy syndrome induced by sunitinib.","17687168","Neurologic Manifestations","D012640","Seizures","DTXSID1041134"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47365,D47365)","v":"Suramin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47365,M47365)","v":"Demyelinating Diseases"},"D013498","Suramin","145-63-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47365,N47365)","v":"DTXSID1046344"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47365,J47365)","v":"8995587"},"Evaluation of neuropathy in patients on suramin treatment.","8995587","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID1046344"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47394,D47394)","v":"suvorexant"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47394,M47394)","v":"Disorders of Excessive Somnolence"},"C551624","suvorexant","1030377-33-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47394,N47394)","v":"DTXSID90145616"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47394,J47394)","v":"28265715"},"Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data.","28265715","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID90145616"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47427,D47427)","v":"Tacrine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47427,M47427)","v":"Seizures"},"D013619","Tacrine","321-64-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47427,N47427)","v":"DTXSID1037272"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47427,J47427)","v":"9500967"},"Systemic administration of N omega-nitro-L-arginine methyl ester and indomethacin reduces the elevation of brain PGE2 content and prevents seizures and hippocampal damage evoked by LiCl and tacrine in rat.","9500967","Neurologic Manifestations","D012640","Seizures","DTXSID1037272"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47458,D47458)","v":"Tacrolimus"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47458,M47458)","v":"Brain Diseases"},"D016559","Tacrolimus","104987-11-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47458,N47458)","v":"DTXSID5046354"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47458,J47458)","v":"11071440"},"Delayed transient neurologic toxicity due to tacrolimus: CT and MRI.","11071440","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID5046354"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47488,D47488)","v":"Tacrolimus"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47488,M47488)","v":"Confusion"},"D016559","Tacrolimus","104987-11-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47488,N47488)","v":"DTXSID5046354"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47488,J47488)","v":"7527953"},"Neurological disorders in liver and kidney transplant recipients.","7527953","Neurologic Manifestations","D003221","Confusion","DTXSID5046354"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47495,D47495)","v":"Tacrolimus"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47495,M47495)","v":"Delirium"},"D016559","Tacrolimus","104987-11-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47495,N47495)","v":"DTXSID5046354"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47495,J47495)","v":"9427854"},"Neuropsychiatric side effects of FK506 vs. cyclosporine A. First-week postoperative findings.","9427854","Neurologic Manifestations","D003693","Delirium","DTXSID5046354"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47526,D47526)","v":"Tacrolimus"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47526,M47526)","v":"Hypertensive Encephalopathy"},"D016559","Tacrolimus","104987-11-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47526,N47526)","v":"DTXSID5046354"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47526,J47526)","v":"17321367"},"[Posterior reversible encephalopathy].","17321367","Central Nervous System Diseases","D020343","Hypertensive Encephalopathy","DTXSID5046354"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47556,D47556)","v":"Tacrolimus"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47556,M47556)","v":"Myoclonic Cerebellar Dyssynergia"},"D016559","Tacrolimus","104987-11-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47556,N47556)","v":"DTXSID5046354"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47556,J47556)","v":"17234523"},"Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.","17234523","Neurodegenerative Diseases","D002527","Myoclonic Cerebellar Dyssynergia","DTXSID5046354"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47589,D47589)","v":"Tacrolimus"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47589,M47589)","v":"Paresis"},"D016559","Tacrolimus","104987-11-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47589,N47589)","v":"DTXSID5046354"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47589,J47589)","v":"15587428"},"Transient diffusion-weighted imaging changes in a patient with reversible leukoencephalopathy syndrome.","15587428","Neurologic Manifestations","D010291","Paresis","DTXSID5046354"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47615,D47615)","v":"Tacrolimus"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47615,M47615)","v":"Posterior Leukoencephalopathy Syndrome"},"D016559","Tacrolimus","104987-11-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47615,N47615)","v":"DTXSID5046354"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47615,J47615)","v":"24061786"},"Reversible cerebral vasoconstriction syndrome resulted in cerebral infarction after allogeneic stem cell transplantation: a case report.","24061786","Central Nervous System Diseases","D054038","Posterior Leukoencephalopathy Syndrome","DTXSID5046354"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47624,D47624)","v":"Tacrolimus"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47624,M47624)","v":"Posterior Leukoencephalopathy Syndrome"},"D016559","Tacrolimus","104987-11-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47624,N47624)","v":"DTXSID5046354"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47624,J47624)","v":"23128973"},"Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation.","23128973","Central Nervous System Diseases","D054038","Posterior Leukoencephalopathy Syndrome","DTXSID5046354"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47657,D47657)","v":"Tacrolimus"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47657,M47657)","v":"Subarachnoid Hemorrhage"},"D016559","Tacrolimus","104987-11-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47657,N47657)","v":"DTXSID5046354"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47657,J47657)","v":"25370549"},"Cerebellar superficial siderosis of chronic subarachnoid hemorrhage in a patient with Tacrolimus-associated posterior reversible encephalopathy.","25370549","Central Nervous System Diseases","D013345","Subarachnoid Hemorrhage","DTXSID5046354"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47683,D47683)","v":"Tadalafil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47683,M47683)","v":"Brain Ischemia"},"D000068581","Tadalafil","171596-29-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47683,N47683)","v":"DTXSID9046786"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47683,J47683)","v":"22130048"},"Recurrent ischemic stroke associated with sildenafil and tadalafil use in a young adult.","22130048","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID9046786"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47718,D47718)","v":"Tamoxifen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47718,M47718)","v":"Brain Ischemia"},"D013629","Tamoxifen","54965-24-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47718,N47718)","v":"DTXSID8021301"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47718,J47718)","v":"15477543"},"Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis.","15477543","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID8021301"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47747,D47747)","v":"Tamoxifen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47747,M47747)","v":"Muscle Cramp"},"D013629","Tamoxifen","54965-24-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47747,N47747)","v":"DTXSID8021301"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47747,J47747)","v":"27273968"},"Leg cramps associated with tamoxifen use--possible mechanism and treatment recommendations.","27273968","Neurologic Manifestations","D009120","Muscle Cramp","DTXSID8021301"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47751,D47751)","v":"Tamoxifen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47751,M47751)","v":"Optic Neuritis"},"D013629","Tamoxifen","54965-24-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47751,N47751)","v":"DTXSID8021301"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47751,J47751)","v":"8963159"},"Screening for tamoxifen ocular toxicity: a prospective study.","8963159","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID8021301"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47786,D47786)","v":"Tamoxifen"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47786,M47786)","v":"Vision Disorders"},"D013629","Tamoxifen","54965-24-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47786,N47786)","v":"DTXSID8021301"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47786,J47786)","v":"1312376"},"Tamoxifen retinopathy: a rare but serious complication.","1312376","Neurologic Manifestations","D014786","Vision Disorders","DTXSID8021301"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47803,D47803)","v":"tamsulosin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47803,M47803)","v":"Vertigo"},"C088482","tamsulosin","106463-17-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47803,N47803)","v":"DTXSID2046628"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47803,J47803)","v":"9643668"},"A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing.","9643668","Neurologic Manifestations","D014717","Vertigo","DTXSID2046628"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47847,D47847)","v":"Tegafur"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47847,M47847)","v":"Brain Edema"},"D005641","Tegafur","37076-68-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47847,N47847)","v":"DTXSID8021305"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47847,J47847)","v":"17682013"},"Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients.","17682013","Central Nervous System Diseases","D001929","Brain Edema","DTXSID8021305"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47854,D47854)","v":"Tegafur"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47854,M47854)","v":"Leukoencephalopathy, Progressive Multifocal"},"D005641","Tegafur","37076-68-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47854,N47854)","v":"DTXSID8021305"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47854,J47854)","v":"3149920"},"[A case of autonomic dysfunctions and leucoencephalopathy occurring during the administration of 5-fluoro-uracil derivative, tegafur].","3149920","Central Nervous System Diseases","D007968","Leukoencephalopathy, Progressive Multifocal","DTXSID8021305"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47896,D47896)","v":"Tellurium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47896,M47896)","v":"Demyelinating Diseases"},"D013691","Tellurium","13494-80-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47896,N47896)","v":"DTXSID9032119"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47896,J47896)","v":"3173411"},"Tellurium-induced demyelination: an electrophysiological and morphological study.","3173411","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID9032119"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47915,D47915)","v":"Tellurium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47915,M47915)","v":"Peripheral Nervous System Diseases"},"D013691","Tellurium","13494-80-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47915,N47915)","v":"DTXSID9032119"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47915,J47915)","v":"2824703"},"Schwann cell vulnerability to demyelination is associated with internodal length in tellurium neuropathy.","2824703","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9032119"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47944,D47944)","v":"Tenofovir"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47944,M47944)","v":"Sleep Initiation and Maintenance Disorders"},"D000068698","Tenofovir","147127-20-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47944,N47944)","v":"DTXSID9040132"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47944,J47944)","v":"16640107"},"Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases.","16640107","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID9040132"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47964,D47964)","v":"terbinafine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47964,M47964)","v":"Olfaction Disorders"},"C041359","terbinafine","78628-80-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47964,N47964)","v":"DTXSID90229223"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47964,J47964)","v":"10081177"},"[Terbinafine-induced ageusia and hyposmia].","10081177","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID90229223"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C47983,D47983)","v":"terbinafine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L47983,M47983)","v":"Vertigo"},"C041359","terbinafine","78628-80-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N47983,N47983)","v":"DTXSID90229223"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J47983,J47983)","v":"10530361"},"[Overdose of nortriptyline during treatment with terbinafine (1st reported case)].","10530361","Neurologic Manifestations","D014717","Vertigo","DTXSID90229223"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48012,D48012)","v":"Terbutaline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48012,M48012)","v":"Tremor"},"D013726","Terbutaline","23031-32-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48012,N48012)","v":"DTXSID3045437"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48012,J48012)","v":"266273"},"Broncho-and cardioselective beta-receptor active drugs in the treatment of asthmatic patients. Clinical studies of effects and side effects of terbutaline, practolol and metoprolol.","266273","Neurologic Manifestations","D014202","Tremor","DTXSID3045437"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48032,D48032)","v":"Terfenadine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48032,M48032)","v":"Epilepsy, Tonic-Clonic"},"D016593","Terfenadine","50679-08-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48032,N48032)","v":"DTXSID2023642"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48032,J48032)","v":"8369689"},"Generalised seizure due to terfenadine.","8369689","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID2023642"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48073,D48073)","v":"Tetracaine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48073,M48073)","v":"Seizures"},"D013748","Tetracaine","94-24-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48073,N48073)","v":"DTXSID1043883"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48073,J48073)","v":"11000675"},"Unexpected recurrent seizures following repeated spinal injections of tetracaine--a case report.","11000675","Neurologic Manifestations","D012640","Seizures","DTXSID1043883"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48106,D48106)","v":"Tetrachloroethylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48106,M48106)","v":"Seizures"},"D013750","Tetrachloroethylene","127-18-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48106,N48106)","v":"DTXSID2021319"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48106,J48106)","v":"11788157"},"Behavioural effects of tetrachloroethylene exposure in rats: acute and subchronic studies.","11788157","Neurologic Manifestations","D012640","Seizures","DTXSID2021319"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48125,D48125)","v":"Tetracycline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48125,M48125)","v":"Papilledema"},"D013752","Tetracycline","60-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48125,N48125)","v":"DTXSID7023645"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48125,J48125)","v":"6449976"},"Tetracycline and benign intracranial hypertension: report of five cases.","6449976","Cranial Nerve Diseases","D010211","Papilledema","DTXSID7023645"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48141,D48141)","v":"Tetracycline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48141,M48141)","v":"Pseudotumor Cerebri"},"D013752","Tetracycline","60-54-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48141,N48141)","v":"DTXSID7023645"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48141,J48141)","v":"7959395"},"[Idiopathic intracranial hypertension and tetracycline].","7959395","Central Nervous System Diseases","D011559","Pseudotumor Cerebri","DTXSID7023645"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48177,D48177)","v":"tetramethylenedisulfotetramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48177,M48177)","v":"Seizures"},"C010349","tetramethylenedisulfotetramine","80-12-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48177,N48177)","v":"DTXSID8040307"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48177,J48177)","v":"22328574"},"Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine.","22328574","Neurologic Manifestations","D012640","Seizures","DTXSID8040307"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48206,D48206)","v":"Thalidomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48206,M48206)","v":"Duane Retraction Syndrome"},"D013792","Thalidomide","50-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48206,N48206)","v":"DTXSID9022524"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48206,J48206)","v":"1808819"},"Thalidomide embryopathy: a model for the study of congenital incomitant horizontal strabismus.","1808819","Cranial Nerve Diseases","D004370","Duane Retraction Syndrome","DTXSID9022524"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48235,D48235)","v":"Thalidomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48235,M48235)","v":"Meningocele"},"D013792","Thalidomide","50-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48235,N48235)","v":"DTXSID9022524"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48235,J48235)","v":"4238697"},"[Teratologic study of a new, structurally related to thalidomide, sedative-hypnotic effective compound (K-2004)].","4238697","Nervous System Malformations","D008588","Meningocele","DTXSID9022524"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48245,D48245)","v":"Thalidomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48245,M48245)","v":"Nervous System Diseases"},"D013792","Thalidomide","50-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48245,N48245)","v":"DTXSID9022524"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48245,J48245)","v":"6659088"},"[Treatment of prurigo nodularis Hyde with thalidomide].","6659088","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID9022524"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48270,D48270)","v":"Thalidomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48270,M48270)","v":"Neuritis"},"D013792","Thalidomide","50-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48270,N48270)","v":"DTXSID9022524"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48270,J48270)","v":"4129733"},"Letter: Thalidomine neuropathy and leprous neuritis.","4129733","Neuromuscular Diseases","D009443","Neuritis","DTXSID9022524"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48303,D48303)","v":"Thalidomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48303,M48303)","v":"Peripheral Nervous System Diseases"},"D013792","Thalidomide","50-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48303,N48303)","v":"DTXSID9022524"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48303,J48303)","v":"3003871"},"[Neuropathies caused by thalidomide].","3003871","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9022524"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48313,D48313)","v":"Thalidomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48313,M48313)","v":"Peripheral Nervous System Diseases"},"D013792","Thalidomide","50-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48313,N48313)","v":"DTXSID9022524"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48313,J48313)","v":"17679676"},"Neuropathy in multiple myeloma treated with thalidomide: a prospective study.","17679676","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9022524"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48338,D48338)","v":"Thalidomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48338,M48338)","v":"Peripheral Nervous System Diseases"},"D013792","Thalidomide","50-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48338,N48338)","v":"DTXSID9022524"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48338,J48338)","v":"16038106"},"Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients.","16038106","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9022524"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48371,D48371)","v":"Thalidomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48371,M48371)","v":"Peripheral Nervous System Diseases"},"D013792","Thalidomide","50-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48371,N48371)","v":"DTXSID9022524"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48371,J48371)","v":"12696209"},"Thalidomide: current therapeutic uses and management of its toxicities.","12696209","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID9022524"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48406,D48406)","v":"Thalidomide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48406,M48406)","v":"Sensation Disorders"},"D013792","Thalidomide","50-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48406,N48406)","v":"DTXSID9022524"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48406,J48406)","v":"12499476"},"Thalidomide-induced neuropathy.","12499476","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID9022524"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48432,D48432)","v":"Thallium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48432,M48432)","v":"Ataxia"},"D013793","Thallium","7440-28-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48432,N48432)","v":"DTXSID2036035"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48432,J48432)","v":"1273820"},"[Thallium poisoning in cats].","1273820","Neurologic Manifestations","D001259","Ataxia","DTXSID2036035"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48465,D48465)","v":"Thallium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48465,M48465)","v":"Optic Atrophy"},"D013793","Thallium","7440-28-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48465,N48465)","v":"DTXSID2036035"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48465,J48465)","v":"9587831"},"A case of localized retinal damage in thallium poisoning.","9587831","Cranial Nerve Diseases","D009896","Optic Atrophy","DTXSID2036035"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48470,D48470)","v":"Thallium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48470,M48470)","v":"Optic Neuritis"},"D013793","Thallium","7440-28-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48470,N48470)","v":"DTXSID2036035"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48470,J48470)","v":"7133245"},"[Subacute myelo-optical neuropathy (SMON) in thallium poisoning].","7133245","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID2036035"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48500,D48500)","v":"Thallium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48500,M48500)","v":"Polyneuropathies"},"D013793","Thallium","7440-28-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48500,N48500)","v":"DTXSID2036035"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48500,J48500)","v":"7072344"},"[Thallium poisoning].","7072344","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID2036035"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48526,D48526)","v":"Thallium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48526,M48526)","v":"Vision Disorders"},"D013793","Thallium","7440-28-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48526,N48526)","v":"DTXSID2036035"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48526,J48526)","v":"19755458"},"Two-year follow-up of two patients after severe thallium intoxication.","19755458","Neurologic Manifestations","D014786","Vision Disorders","DTXSID2036035"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48561,D48561)","v":"Theophylline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48561,M48561)","v":"Epilepsy, Tonic-Clonic"},"D013806","Theophylline","58-55-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48561,N48561)","v":"DTXSID5021336"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48561,J48561)","v":"8222017"},"[Theophylline and seizures].","8222017","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID5021336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48594,D48594)","v":"Theophylline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48594,M48594)","v":"Nervous System Diseases"},"D013806","Theophylline","58-55-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48594,N48594)","v":"DTXSID5021336"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48594,J48594)","v":"2339096"},"Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure.","2339096","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5021336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48615,D48615)","v":"Theophylline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48615,M48615)","v":"Seizures"},"D013806","Theophylline","58-55-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48615,N48615)","v":"DTXSID5021336"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48615,J48615)","v":"876414"},"A child with theophylline poisoning.","876414","Neurologic Manifestations","D012640","Seizures","DTXSID5021336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48629,D48629)","v":"Theophylline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48629,M48629)","v":"Seizures"},"D013806","Theophylline","58-55-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48629,N48629)","v":"DTXSID5021336"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48629,J48629)","v":"8046614"},"Cyclosporine enhances theophylline neurotoxicity in rats.","8046614","Neurologic Manifestations","D012640","Seizures","DTXSID5021336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48662,D48662)","v":"Theophylline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48662,M48662)","v":"Seizures"},"D013806","Theophylline","58-55-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48662,N48662)","v":"DTXSID5021336"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48662,J48662)","v":"3113297"},"Theophylline: primary or tertiary drug? A brief review.","3113297","Neurologic Manifestations","D012640","Seizures","DTXSID5021336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48683,D48683)","v":"Theophylline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48683,M48683)","v":"Seizures"},"D013806","Theophylline","58-55-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48683,N48683)","v":"DTXSID5021336"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48683,J48683)","v":"1625070"},"Effect of acute versus chronic intoxication on clinical features of theophylline poisoning in children.","1625070","Neurologic Manifestations","D012640","Seizures","DTXSID5021336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48697,D48697)","v":"Theophylline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48697,M48697)","v":"Seizures"},"D013806","Theophylline","58-55-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48697,N48697)","v":"DTXSID5021336"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48697,J48697)","v":"10326941"},"Life-threatening events after theophylline overdose: a 10-year prospective analysis.","10326941","Neurologic Manifestations","D012640","Seizures","DTXSID5021336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48730,D48730)","v":"Theophylline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48730,M48730)","v":"Status Epilepticus"},"D013806","Theophylline","58-55-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48730,N48730)","v":"DTXSID5021336"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48730,J48730)","v":"10565195"},"[A case of acute theophylline intoxication with repeated status convulsivus].","10565195","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID5021336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48751,D48751)","v":"Theophylline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48751,M48751)","v":"Vertigo"},"D013806","Theophylline","58-55-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48751,N48751)","v":"DTXSID5021336"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48751,J48751)","v":"4198297"},"Oral aminophylline and dikydroxypropyl theophylline in reversible obstructive airway disease: a single-dose, double-blind, crossover comparison.","4198297","Neurologic Manifestations","D014717","Vertigo","DTXSID5021336"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48791,D48791)","v":"Thiethylperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48791,M48791)","v":"Spasm"},"D013847","Thiethylperazine","52239-63-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48791,N48791)","v":"DTXSID1045586"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48791,J48791)","v":"4184863"},"Dystonia and pyramidal signs after thiethylperazine overdose.","4184863","Neurologic Manifestations","D013035","Spasm","DTXSID1045586"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48820,D48820)","v":"Thioacetamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48820,M48820)","v":"Hepatic Encephalopathy"},"D013853","Thioacetamide","62-55-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48820,N48820)","v":"DTXSID9021340"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48820,J48820)","v":"6669230"},"Thioacetamide-induced hepatic encephalopathy in the rat. II. Cytochemical and ultrastructural studies on astrocytes cultured in vitro.","6669230","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID9021340"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48844,D48844)","v":"Thiopental"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48844,M48844)","v":"Amnesia"},"D013874","Thiopental","71-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48844,N48844)","v":"DTXSID1021744"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48844,J48844)","v":"2197898"},"[Recovery, amnesia and affective state following propofol in comparison with thiopental].","2197898","Neurologic Manifestations","D000647","Amnesia","DTXSID1021744"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48859,D48859)","v":"Thiopental"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48859,M48859)","v":"Delirium"},"D013874","Thiopental","71-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48859,N48859)","v":"DTXSID1021744"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48859,J48859)","v":"26002229"},"Is postoperative delirium a relevant outcome?","26002229","Neurologic Manifestations","D003693","Delirium","DTXSID1021744"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48896,D48896)","v":"Thioridazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48896,M48896)","v":"Brain Diseases"},"D013881","Thioridazine","50-52-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48896,N48896)","v":"DTXSID6023656"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48896,J48896)","v":"4739612"},"Thioridazine toxicity. Agranulocytosis and hepatitis with encephalopathy.","4739612","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID6023656"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48920,D48920)","v":"Thioridazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48920,M48920)","v":"Hydrocephalus"},"D013881","Thioridazine","50-52-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48920,N48920)","v":"DTXSID6023656"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48920,J48920)","v":"5763432"},"Congenital malformations following phenothiazine administration during pregnancy.","5763432","Central Nervous System Diseases","D006849","Hydrocephalus","DTXSID6023656"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48953,D48953)","v":"Thioridazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48953,M48953)","v":"Tourette Syndrome"},"D013881","Thioridazine","50-52-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48953,N48953)","v":"DTXSID6023656"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48953,J48953)","v":"3459568"},"Tourette-like syndrome following low dose short-term neuroleptic treatment.","3459568","Basal Ganglia Diseases","D005879","Tourette Syndrome","DTXSID6023656"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48964,D48964)","v":"Thiotepa"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48964,M48964)","v":"Nervous System Diseases"},"D013852","Thiotepa","52-24-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48964,N48964)","v":"DTXSID0021339"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48964,J48964)","v":"408003"},"Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study.","408003","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0021339"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C48988,D48988)","v":"Thiourea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L48988,M48988)","v":"Neuromuscular Diseases"},"D013890","Thiourea","62-56-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N48988,N48988)","v":"DTXSID9021348"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J48988,J48988)","v":"6782707"},"Potential neuromuscular toxicity of 2,4-dithiobiuret in the rat.","6782707","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID9021348"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49017,D49017)","v":"Thymidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49017,M49017)","v":"Muscular Diseases"},"D013936","Thymidine","50-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49017,N49017)","v":"DTXSID5023661"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49017,J49017)","v":"27611456"},"Clinicopathological Features of Telbivudine-Associated Myopathy.","27611456","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID5023661"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49032,D49032)","v":"Thymidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49032,M49032)","v":"Wernicke Encephalopathy"},"D013936","Thymidine","50-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49032,N49032)","v":"DTXSID5023661"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49032,J49032)","v":"2882316"},"Wernicke's encephalopathy in AIDS patient treated with zidovudine.","2882316","Central Nervous System Diseases","D014899","Wernicke Encephalopathy","DTXSID5023661"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49056,D49056)","v":"tiagabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49056,M49056)","v":"Nervous System Diseases"},"C059205","tiagabine","115103-54-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49056,N49056)","v":"DTXSID5023663"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49056,J49056)","v":"9118850"},"Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function.","9118850","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID5023663"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49085,D49085)","v":"tiagabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49085,M49085)","v":"Status Epilepticus"},"C059205","tiagabine","115103-54-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49085,N49085)","v":"DTXSID5023663"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49085,J49085)","v":"12810347"},"Nonconvulsive status epilepticus due to a de novo contralateral focus during tiagabine adjunctive therapy.","12810347","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID5023663"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49125,D49125)","v":"Ticlopidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49125,M49125)","v":"Ageusia"},"D013988","Ticlopidine","53885-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49125,N49125)","v":"DTXSID80202141"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49125,J49125)","v":"16804280"},"Reversible ageusia associated with clopidogrel treatment.","16804280","Neurologic Manifestations","D000370","Ageusia","DTXSID80202141"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49146,D49146)","v":"Ticlopidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49146,M49146)","v":"Cerebral Hemorrhage"},"D013988","Ticlopidine","53885-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49146,N49146)","v":"DTXSID80202141"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49146,J49146)","v":"23830689"},"Multiple electrode aggregometry in antiplatelet-related intracerebral haemorrhage.","23830689","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID80202141"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49179,D49179)","v":"Ticlopidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49179,M49179)","v":"Muscular Diseases"},"D013988","Ticlopidine","53885-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49179,N49179)","v":"DTXSID80202141"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49179,J49179)","v":"11779099"},"Retroperitoneal hematoma associated with femoral neuropathy: a complication under antiplatelets therapy.","11779099","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID80202141"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49193,D49193)","v":"Ticlopidine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49193,M49193)","v":"Stroke"},"D013988","Ticlopidine","53885-35-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49193,N49193)","v":"DTXSID80202141"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49193,J49193)","v":"20938037"},"Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.","20938037","Central Nervous System Diseases","D020521","Stroke","DTXSID80202141"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49214,D49214)","v":"Timolol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49214,M49214)","v":"Cerebrovascular Disorders"},"D013999","Timolol","91524-16-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49214,N49214)","v":"DTXSID70238611"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49214,J49214)","v":"7224942"},"Timolol and glaucoma.","7224942","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID70238611"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49245,D49245)","v":"Tin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49245,M49245)","v":"Brain Edema"},"D014001","Tin","7440-31-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49245,N49245)","v":"DTXSID1049801"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49245,J49245)","v":"4271437"},"Effect of chronic triethyl tin intoxication on the morphological and histoenzymic pattern of rat brain.","4271437","Central Nervous System Diseases","D001929","Brain Edema","DTXSID1049801"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49279,D49279)","v":"Titanium"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49279,M49279)","v":"Paresthesia"},"D014025","Titanium","7440-32-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49279,N49279)","v":"DTXSID3047764"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49279,J49279)","v":"3856599"},"Paresthesia of the mental nerve after overextension with AH26 and gutta-percha: report of case.","3856599","Neurologic Manifestations","D010292","Paresthesia","DTXSID3047764"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49308,D49308)","v":"Tobramycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49308,M49308)","v":"Hearing Disorders"},"D014031","Tobramycin","32986-56-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49308,N49308)","v":"DTXSID8023680"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49308,J49308)","v":"6982875"},"Ototoxicity of tobramycin in humans - influence of renal impairment.","6982875","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID8023680"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49313,D49313)","v":"Tobramycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49313,M49313)","v":"Hearing Disorders"},"D014031","Tobramycin","32986-56-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49313,N49313)","v":"DTXSID8023680"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49313,J49313)","v":"479061"},"Tobramycin ototoxicity. Repeated courses of high dosage treatment in children with cystic fibrosis.","479061","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID8023680"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49343,D49343)","v":"Tobramycin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49343,M49343)","v":"Hearing Loss, Sensorineural"},"D014031","Tobramycin","32986-56-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49343,N49343)","v":"DTXSID8023680"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49343,J49343)","v":"11801948"},"Aminoglycoside ototoxicity: a human temporal bone study.","11801948","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID8023680"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49376,D49376)","v":"Tolmetin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49376,M49376)","v":"Nervous System Diseases"},"D014046","Tolmetin","26171-23-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49376,N49376)","v":"DTXSID2043951"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49376,J49376)","v":"6967492"},"A comparison of the effects of zomepirac and aspirin on fecal blood loss.","6967492","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID2043951"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49406,D49406)","v":"Toluene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49406,M49406)","v":"Central Nervous System Diseases"},"D014050","Toluene","108-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49406,N49406)","v":"DTXSID7021360"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49406,J49406)","v":"6518699"},"[Two cases of chronic toluene intoxication with various central nervous system disorders].","6518699","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID7021360"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49437,D49437)","v":"Toluene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49437,M49437)","v":"Delirium"},"D014050","Toluene","108-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49437,N49437)","v":"DTXSID7021360"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49437,J49437)","v":"17136656"},"[\"Ghost peak\" in gas chromatography in a delirious woman with severe metabolic acidosis. Intoxication with an unknown substance?].","17136656","Neurologic Manifestations","D003693","Delirium","DTXSID7021360"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49444,D49444)","v":"Toluene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49444,M49444)","v":"Epilepsy, Tonic-Clonic"},"D014050","Toluene","108-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49444,N49444)","v":"DTXSID7021360"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49444,J49444)","v":"85522"},"Petit mal and grand mal seizures produced by toluene or benzene intoxication in the cat.","85522","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID7021360"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49470,D49470)","v":"Toluene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49470,M49470)","v":"Hearing Loss"},"D014050","Toluene","108-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49470,N49470)","v":"DTXSID7021360"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49470,J49470)","v":"10560776"},"Comparison of toluene-induced and styrene-induced hearing losses.","10560776","Neurologic Manifestations","D034381","Hearing Loss","DTXSID7021360"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49505,D49505)","v":"Toluene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49505,M49505)","v":"Microcephaly"},"D014050","Toluene","108-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49505,N49505)","v":"DTXSID7021360"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49505,J49505)","v":"2471833"},"Toluene embryopathy: two new cases.","2471833","Nervous System Malformations","D008831","Microcephaly","DTXSID7021360"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49538,D49538)","v":"Toluene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49538,M49538)","v":"Optic Nerve Diseases"},"D014050","Toluene","108-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49538,N49538)","v":"DTXSID7021360"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49538,J49538)","v":"727750"},"Toluene optic neuropathy.","727750","Cranial Nerve Diseases","D009901","Optic Nerve Diseases","DTXSID7021360"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49563,D49563)","v":"Toluene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49563,M49563)","v":"Seizures"},"D014050","Toluene","108-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49563,N49563)","v":"DTXSID7021360"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49563,J49563)","v":"85522"},"Petit mal and grand mal seizures produced by toluene or benzene intoxication in the cat.","85522","Neurologic Manifestations","D012640","Seizures","DTXSID7021360"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49573,D49573)","v":"Toluene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49573,M49573)","v":"Spinal Cord Diseases"},"D014050","Toluene","108-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49573,N49573)","v":"DTXSID7021360"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49573,J49573)","v":"10845207"},"[A case of chronic toluene intoxication presenting stimulus-sensitive segmental spinal myoclonus].","10845207","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID7021360"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49619,D49619)","v":"topiramate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49619,M49619)","v":"Epilepsy"},"C052342","topiramate","97240-79-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49619,N49619)","v":"DTXSID8023688"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49619,J49619)","v":"12940832"},"Seizure worsening with topiramate amongst Indians with refractory epilepsy.","12940832","Central Nervous System Diseases","D004827","Epilepsy","DTXSID8023688"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49634,D49634)","v":"topiramate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49634,M49634)","v":"Hemiplegia"},"C052342","topiramate","97240-79-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49634,N49634)","v":"DTXSID8023688"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49634,J49634)","v":"10092263"},"Transient hemiparesis with topiramate.","10092263","Neurologic Manifestations","D006429","Hemiplegia","DTXSID8023688"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49667,D49667)","v":"topiramate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49667,M49667)","v":"Paresthesia"},"C052342","topiramate","97240-79-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49667,N49667)","v":"DTXSID8023688"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49667,J49667)","v":"17539944"},"Paresthesia as a favorable predictor of migraine prophylaxis using topiramate.","17539944","Neurologic Manifestations","D010292","Paresthesia","DTXSID8023688"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49683,D49683)","v":"topiramate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49683,M49683)","v":"Paresthesia"},"C052342","topiramate","97240-79-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49683,N49683)","v":"DTXSID8023688"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49683,J49683)","v":"11903524"},"Topiramate in migraine prevention: a double-blind, placebo-controlled study.","11903524","Neurologic Manifestations","D010292","Paresthesia","DTXSID8023688"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49702,D49702)","v":"topiramate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49702,M49702)","v":"Speech Disorders"},"C052342","topiramate","97240-79-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49702,N49702)","v":"DTXSID8023688"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49702,J49702)","v":"22827489"},"Impaired verbal fluency under topiramate--evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy.","22827489","Neurologic Manifestations","D013064","Speech Disorders","DTXSID8023688"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49735,D49735)","v":"Tramadol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49735,M49735)","v":"Hallucinations"},"D014147","Tramadol","27203-92-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49735,N49735)","v":"DTXSID90858931"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49735,J49735)","v":"11124199"},"Hear my song: auditory hallucinations with tramadol hydrochloride.","11124199","Neurologic Manifestations","D006212","Hallucinations","DTXSID90858931"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49751,D49751)","v":"Tramadol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49751,M49751)","v":"Seizures"},"D014147","Tramadol","27203-92-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49751,N49751)","v":"DTXSID90858931"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49751,J49751)","v":"9388083"},"Seizures reported with tramadol.","9388083","Neurologic Manifestations","D012640","Seizures","DTXSID90858931"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49796,D49796)","v":"Tranexamic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49796,M49796)","v":"Carotid Artery Thrombosis"},"D014148","Tranexamic Acid","1197-18-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49796,N49796)","v":"DTXSID3045350"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49796,J49796)","v":"15668433"},"Thrombotic cocktail in stroke.","15668433","Central Nervous System Diseases","D002341","Carotid Artery Thrombosis","DTXSID3045350"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49803,D49803)","v":"Tranexamic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49803,M49803)","v":"Ischemic Attack, Transient"},"D014148","Tranexamic Acid","1197-18-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49803,N49803)","v":"DTXSID3045350"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49803,J49803)","v":"505491"},"Tranexamic acid in subarachnoid hemorrhage. A double-blind study.","505491","Central Nervous System Diseases","D002546","Ischemic Attack, Transient","DTXSID3045350"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49844,D49844)","v":"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49844,M49844)","v":"Epilepsy, Absence"},"D001371","trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49844,N49844)","v":"DTXSID10957874"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49844,J49844)","v":"22471338"},"Environmental enrichment improves behavioral outcome in the AY-9944 model of childhood atypical absence epilepsy.","22471338","Central Nervous System Diseases","D004832","Epilepsy, Absence","DTXSID10957874"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49864,D49864)","v":"Tranylcypromine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49864,M49864)","v":"Delirium"},"D014191","Tranylcypromine","155-09-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49864,N49864)","v":"DTXSID2023694"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49864,J49864)","v":"10770472"},"Tranylcypromine abuse associated with delirium and thrombocytopenia.","10770472","Neurologic Manifestations","D003693","Delirium","DTXSID2023694"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49893,D49893)","v":"Trazodone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49893,M49893)","v":"Coma"},"D014196","Trazodone","19794-93-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49893,N49893)","v":"DTXSID5045043"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49893,J49893)","v":"6718657"},"Acute trazodone poisoning: clinical signs and plasma concentrations.","6718657","Neurologic Manifestations","D003128","Coma","DTXSID5045043"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49912,D49912)","v":"Trazodone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49912,M49912)","v":"Hallucinations"},"D014196","Trazodone","19794-93-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49912,N49912)","v":"DTXSID5045043"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49912,J49912)","v":"2310343"},"Trazodone-induced palinopsia.","2310343","Neurologic Manifestations","D006212","Hallucinations","DTXSID5045043"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49932,D49932)","v":"Trazodone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49932,M49932)","v":"Seizures"},"D014196","Trazodone","19794-93-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49932,N49932)","v":"DTXSID5045043"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49932,J49932)","v":"3729101"},"Relative toxicity of cyclic antidepressants.","3729101","Neurologic Manifestations","D012640","Seizures","DTXSID5045043"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49964,D49964)","v":"Triamcinolone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49964,M49964)","v":"Muscular Diseases"},"D014221","Triamcinolone","124-94-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49964,N49964)","v":"DTXSID1040742"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49964,J49964)","v":"17993993"},"Strenuous exercise-induced alterations of muscle fiber cross-sectional area and fiber-type distribution in steroid myopathy rats.","17993993","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID1040742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C49993,D49993)","v":"Triamcinolone Acetonide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L49993,M49993)","v":"Cerebral Infarction"},"D014222","Triamcinolone Acetonide","76-25-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N49993,N49993)","v":"DTXSID6021371"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J49993,J49993)","v":"24685869"},"Central retinal artery occlusion and cerebral inrfaction following forehead injection with a corticosteroid suspension for vitiligo.","24685869","Central Nervous System Diseases","D002544","Cerebral Infarction","DTXSID6021371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50022,D50022)","v":"Triamcinolone Acetonide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50022,M50022)","v":"Optic Nerve Diseases"},"D014222","Triamcinolone Acetonide","76-25-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50022,N50022)","v":"DTXSID6021371"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50022,J50022)","v":"16910865"},"Triamcinolone acetonide-induced ocular hypertension.","16910865","Cranial Nerve Diseases","D009901","Optic Nerve Diseases","DTXSID6021371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50032,D50032)","v":"Triamcinolone Acetonide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50032,M50032)","v":"Vision Disorders"},"D014222","Triamcinolone Acetonide","76-25-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50032,N50032)","v":"DTXSID6021371"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50032,J50032)","v":"18618083"},"Loss of visual function after repeated intravitreal injections of triamcinolone acetonide in refractory uveitic macular oedema.","18618083","Neurologic Manifestations","D014786","Vision Disorders","DTXSID6021371"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50061,D50061)","v":"Triazolam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50061,M50061)","v":"Amnesia"},"D014229","Triazolam","28911-01-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50061,N50061)","v":"DTXSID6046763"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50061,J50061)","v":"1487483"},"Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature.","1487483","Neurologic Manifestations","D000647","Amnesia","DTXSID6046763"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50090,D50090)","v":"Triazolam"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50090,M50090)","v":"Memory Disorders"},"D014229","Triazolam","28911-01-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50090,N50090)","v":"DTXSID6046763"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50090,J50090)","v":"9233284"},"[The controversy about Halcion in Great Britain: a sociological study].","9233284","Neurologic Manifestations","D008569","Memory Disorders","DTXSID6046763"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50125,D50125)","v":"Trichlorfon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50125,M50125)","v":"Brain Diseases"},"D014236","Trichlorfon","52-68-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50125,N50125)","v":"DTXSID0021389"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50125,J50125)","v":"2351284"},"[An electroencephalographic study of characteristics of the functional state of the central nervous system in workers of chlorophos producing industry].","2351284","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID0021389"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50155,D50155)","v":"Trichlorfon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50155,M50155)","v":"Peripheral Nervous System Diseases"},"D014236","Trichlorfon","52-68-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50155,N50155)","v":"DTXSID0021389"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50155,J50155)","v":"6277540"},"[Dipterex polyneuropathy--ultrastructural study of the axonal change (author's transl)].","6277540","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0021389"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50184,D50184)","v":"Trichloroethylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50184,M50184)","v":"Bulbar Palsy, Progressive"},"D014241","Trichloroethylene","79-01-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50184,N50184)","v":"DTXSID0021383"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50184,J50184)","v":"7305154"},"Chronic dysphagia and trigeminal anesthesia after trichloroethylene exposure.","7305154","Neuromuscular Diseases","D010244","Bulbar Palsy, Progressive","DTXSID0021383"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50193,D50193)","v":"Trichloroethylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50193,M50193)","v":"Coma"},"D014241","Trichloroethylene","79-01-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50193,N50193)","v":"DTXSID0021383"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50193,J50193)","v":"600417"},"[Trieline poisoning. Clinical cases].","600417","Neurologic Manifestations","D003128","Coma","DTXSID0021383"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50219,D50219)","v":"Trichloroethylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50219,M50219)","v":"Hearing Disorders"},"D014241","Trichloroethylene","79-01-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50219,N50219)","v":"DTXSID0021383"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50219,J50219)","v":"9538045"},"Trichloroethylene ototoxicity: evidence for a cochlear origin.","9538045","Neurologic Manifestations","D006311","Hearing Disorders","DTXSID0021383"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50252,D50252)","v":"Trichloroethylene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50252,M50252)","v":"Paralysis"},"D014241","Trichloroethylene","79-01-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50252,N50252)","v":"DTXSID0021383"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50252,J50252)","v":"8765111"},"Encephalopathy and cranial nerve palsies caused by intentional trichloroethylene inhalation.","8765111","Neurologic Manifestations","D010243","Paralysis","DTXSID0021383"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50286,D50286)","v":"triethylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50286,M50286)","v":"Vision Disorders"},"C016162","triethylamine","5204-74-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50286,N50286)","v":"DTXSID5063736"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50286,J50286)","v":"7795757"},"Ocular effects of exposure to triethylamine in the sand core cold box of a foundry.","7795757","Neurologic Manifestations","D014786","Vision Disorders","DTXSID5063736"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50287,D50287)","v":"triethylamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50287,M50287)","v":"Vision Disorders"},"C016162","triethylamine","5204-74-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50287,N50287)","v":"DTXSID5063736"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50287,J50287)","v":"9282124"},"Contrast sensitivity measurement in evaluations of visual symptoms caused by exposure to triethylamine.","9282124","Neurologic Manifestations","D014786","Vision Disorders","DTXSID5063736"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50313,D50313)","v":"Trifluoperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50313,M50313)","v":"Basal Ganglia Diseases"},"D014268","Trifluoperazine","117-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50313,N50313)","v":"DTXSID1046928"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50313,J50313)","v":"4627828"},"[Morpho-functional changes in the pyramidal and extrapyramidal systems due to triftazin].","4627828","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID1046928"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50348,D50348)","v":"Trifluoperazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50348,M50348)","v":"Parkinson Disease, Secondary"},"D014268","Trifluoperazine","117-89-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50348,N50348)","v":"DTXSID1046928"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50348,J50348)","v":"619844"},"Dopamine excretion and vulnerability to drug-induced Parkinsonism. Schizophrenic patients.","619844","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID1046928"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50381,D50381)","v":"Trihexyphenidyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50381,M50381)","v":"Chorea"},"D014282","Trihexyphenidyl","52-49-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50381,N50381)","v":"DTXSID8045802"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50381,J50381)","v":"1434066"},"[A case of choreoathetoid movements induced by anticholinergic drugs, trihexyphenidyl HCl and dosulepin HCl].","1434066","Central Nervous System Diseases","D002819","Chorea","DTXSID8045802"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50406,D50406)","v":"Trihexyphenidyl"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50406,M50406)","v":"Memory Disorders"},"D014282","Trihexyphenidyl","52-49-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50406,N50406)","v":"DTXSID8045802"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50406,J50406)","v":"14735126"},"Increased anticholinergic challenge-induced memory impairment associated with the APOE-epsilon4 allele in the elderly: a controlled pilot study.","14735126","Neurologic Manifestations","D008569","Memory Disorders","DTXSID8045802"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50416,D50416)","v":"Trimeprazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50416,M50416)","v":"Brain Edema"},"D014291","Trimeprazine","84-96-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50416,N50416)","v":"DTXSID9023708"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50416,J50416)","v":"4451595"},"Letter: Hyperpyrexia caused by trimeprazine.","4451595","Central Nervous System Diseases","D001929","Brain Edema","DTXSID9023708"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50449,D50449)","v":"Trimethoprim"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50449,M50449)","v":"Hepatic Encephalopathy"},"D014295","Trimethoprim","738-70-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50449,N50449)","v":"DTXSID3023712"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50449,J50449)","v":"80611"},"Multisystem toxicity after co-trimoxazole.","80611","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID3023712"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50474,D50474)","v":"Trimethoprim"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50474,M50474)","v":"Meningitis, Aseptic"},"D014295","Trimethoprim","738-70-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50474,N50474)","v":"DTXSID3023712"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50474,J50474)","v":"11025739"},"Trimethoprim-sulfamethoxazole induced recurrent aseptic meningitis.","11025739","Central Nervous System Diseases","D008582","Meningitis, Aseptic","DTXSID3023712"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50510,D50510)","v":"Trimethoprim, Sulfamethoxazole Drug Combination"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50510,M50510)","v":"Meningitis"},"D015662","Trimethoprim, Sulfamethoxazole Drug Combination","8064-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50510,N50510)","v":"DTXSID0032233"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50510,J50510)","v":"8006651"},"Antibiotic induced meningitis.","8006651","Central Nervous System Diseases","D008581","Meningitis","DTXSID0032233"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50543,D50543)","v":"Trimethoprim, Sulfamethoxazole Drug Combination"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50543,M50543)","v":"Meningitis, Aseptic"},"D015662","Trimethoprim, Sulfamethoxazole Drug Combination","8064-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50543,N50543)","v":"DTXSID0032233"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50543,J50543)","v":"10784311"},"Trimethoprim-sulfamethoxazole-induced aseptic meningitis: case report and literature review.","10784311","Central Nervous System Diseases","D008582","Meningitis, Aseptic","DTXSID0032233"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50563,D50563)","v":"Trimethoprim, Sulfamethoxazole Drug Combination"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50563,M50563)","v":"Tremor"},"D015662","Trimethoprim, Sulfamethoxazole Drug Combination","8064-90-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50563,N50563)","v":"DTXSID0032233"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50563,J50563)","v":"11002706"},"[Tremor produced by trimethoprim-sulfamethoxazole].","11002706","Neurologic Manifestations","D014202","Tremor","DTXSID0032233"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50578,D50578)","v":"trimethyltin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50578,M50578)","v":"Hearing Loss"},"C046488","trimethyltin","1631-73-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50578,N50578)","v":"DTXSID6035102"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50578,J50578)","v":"2046633"},"Trimethyltin disrupts auditory function and cochlear morphology in pigmented rats.","2046633","Neurologic Manifestations","D034381","Hearing Loss","DTXSID6035102"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50611,D50611)","v":"trimethyltin chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50611,M50611)","v":"Nervous System Diseases"},"C040533","trimethyltin chloride","1066-45-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50611,N50611)","v":"DTXSID6042496"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50611,J50611)","v":"6425393"},"The neurotoxicity of trimethyltin chloride in hamsters, gerbils and marmosets.","6425393","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID6042496"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50631,D50631)","v":"Trinitrotoluene"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50631,M50631)","v":"Seizures"},"D014303","Trinitrotoluene","118-96-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50631,N50631)","v":"DTXSID7024372"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50631,J50631)","v":"18551238"},"Acute toxicity of 2,4,6-trinitrotoluene, 2,4-dinitrotoluene, and 2,6-dinitrotoluene in the adult bullfrog (Lithobates catesbeiana).","18551238","Neurologic Manifestations","D012640","Seizures","DTXSID7024372"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50646,D50646)","v":"tri-o-cresyl phosphate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50646,M50646)","v":"Central Nervous System Diseases"},"C025541","tri-o-cresyl phosphate","78-30-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50646,N50646)","v":"DTXSID6032192"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50646,J50646)","v":"12425964"},"Organophosphate induced delayed neuropathy in genetically dissimilar chickens: studies with tri-ortho-cresyl phosphate (TOCP) and trichlorfon.","12425964","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID6032192"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50679,D50679)","v":"tri-o-cresyl phosphate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50679,M50679)","v":"Paralysis"},"C025541","tri-o-cresyl phosphate","78-30-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50679,N50679)","v":"DTXSID6032192"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50679,J50679)","v":"4049409"},"Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate.","4049409","Neurologic Manifestations","D010243","Paralysis","DTXSID6032192"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50699,D50699)","v":"Tripelennamine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50699,M50699)","v":"Myoclonus"},"D014309","Tripelennamine","494-40-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50699,N50699)","v":"DTXSID20197784"},1967,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50699,J50699)","v":"4227701"},"An unusual case of antihistamine intoxication.","4227701","Neurologic Manifestations","D009207","Myoclonus","DTXSID20197784"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50740,D50740)","v":"trovafloxacin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50740,M50740)","v":"Nervous System Diseases"},"C080163","trovafloxacin","147059-72-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50740,N50740)","v":"DTXSID0041145"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50740,J50740)","v":"10492332"},"Trovafloxacin neurotoxicity.","10492332","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID0041145"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50751,D50751)","v":"Tubocurarine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50751,M50751)","v":"Hallucinations"},"D014403","Tubocurarine","57-95-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50751,N50751)","v":"DTXSID0048393"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50751,J50751)","v":"4856138"},"Abdominal and thoracic surgery in adults with ketamine, nitrous oxide, and d-tubocurarine.","4856138","Neurologic Manifestations","D006212","Hallucinations","DTXSID0048393"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50775,D50775)","v":"Tyramine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50775,M50775)","v":"Migraine Disorders"},"D014439","Tyramine","51-67-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50775,N50775)","v":"DTXSID2043874"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50775,J50775)","v":"4599015"},"A clinical study of tyramine as an etiological factor in migraine.","4599015","Central Nervous System Diseases","D008881","Migraine Disorders","DTXSID2043874"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50808,D50808)","v":"Urea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50808,M50808)","v":"Hepatic Encephalopathy"},"D014508","Urea","57-13-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50808,N50808)","v":"DTXSID4021426"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50808,J50808)","v":"3715"},"[Toxic liver disintegration coma with consumption coagulopathy following carbromal poisoning].","3715","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID4021426"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50844,D50844)","v":"Urea"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50844,M50844)","v":"Spinal Cord Neoplasms"},"D014508","Urea","57-13-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50844,N50844)","v":"DTXSID4021426"},1973,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50844,J50844)","v":"4767477"},"[Ascorbic acid hinderance of the prenatal carcinogenic effect of ethylurea and nitrite].","4767477","Nervous System Neoplasms","D013120","Spinal Cord Neoplasms","DTXSID4021426"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50869,D50869)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50869,M50869)","v":"Ataxia"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50869,N50869)","v":"DTXSID70227388"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50869,J50869)","v":"6092902"},"Genetic influences on the central nervous system depressant and membrane-disordering actions of ethanol and sodium valproate.","6092902","Neurologic Manifestations","D001259","Ataxia","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50898,D50898)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50898,M50898)","v":"Brain Diseases"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50898,N50898)","v":"DTXSID70227388"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50898,J50898)","v":"3149216"},"Effect of sodium valproate (VPA) on cerebral amino acids: mechanism of gamma-aminobutyric acid (GABA) elevation and possible causal relation of VPA-induced encephalopathy and glutamine level.","3149216","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50912,D50912)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50912,M50912)","v":"Brain Diseases"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50912,N50912)","v":"DTXSID70227388"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50912,J50912)","v":"23865136"},"Valproic acid induced hyperammonaemic encephalopathy.","23865136","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50937,D50937)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50937,M50937)","v":"Brain Diseases"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50937,N50937)","v":"DTXSID70227388"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50937,J50937)","v":"10655774"},"[A case report of valproate encephalopathy].","10655774","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50966,D50966)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50966,M50966)","v":"Brain Edema"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50966,N50966)","v":"DTXSID70227388"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50966,J50966)","v":"25558630"},"[Cerebral oedema caused by sodium valproate].","25558630","Central Nervous System Diseases","D001929","Brain Edema","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C50980,D50980)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L50980,M50980)","v":"Carotid Artery Diseases"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N50980,N50980)","v":"DTXSID70227388"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J50980,J50980)","v":"25821310"},"Effects of valproate on the carotid artery intima-media thickness in epileptics.","25821310","Central Nervous System Diseases","D002340","Carotid Artery Diseases","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51005,D51005)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51005,M51005)","v":"Coma"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51005,N51005)","v":"DTXSID70227388"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51005,J51005)","v":"7993403"},"Impairment of consciousness induced by valproate treatment following neurosurgical operation.","7993403","Neurologic Manifestations","D003128","Coma","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51034,D51034)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51034,M51034)","v":"Coma"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51034,N51034)","v":"DTXSID70227388"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51034,J51034)","v":"11581089"},"Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy.","11581089","Neurologic Manifestations","D003128","Coma","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51073,D51073)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51073,M51073)","v":"Dementia"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51073,N51073)","v":"DTXSID70227388"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51073,J51073)","v":"7574471"},"Reversible dementia and apparent brain atrophy during valproate therapy.","7574471","Central Nervous System Diseases","D003704","Dementia","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51095,D51095)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51095,M51095)","v":"Epilepsies, Myoclonic"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51095,N51095)","v":"DTXSID70227388"},1982,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51095,J51095)","v":"6123046"},"Acute intoxication with valproate.","6123046","Central Nervous System Diseases","D004831","Epilepsies, Myoclonic","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51125,D51125)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51125,M51125)","v":"Headache Disorders"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51125,N51125)","v":"DTXSID70227388"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51125,J51125)","v":"12167141"},"Intravenous valproate sodium in the treatment of daily headache.","12167141","Central Nervous System Diseases","D020773","Headache Disorders","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51134,D51134)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51134,M51134)","v":"Hepatic Encephalopathy"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51134,N51134)","v":"DTXSID70227388"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51134,J51134)","v":"8157021"},"Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency.","8157021","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51163,D51163)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51163,M51163)","v":"Hydrocephalus"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51163,N51163)","v":"DTXSID70227388"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51163,J51163)","v":"3080718"},"Prenatal detection of a neural tube defect after fetal exposure to valproic acid.","3080718","Central Nervous System Diseases","D006849","Hydrocephalus","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51193,D51193)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51193,M51193)","v":"Learning Disorders"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51193,N51193)","v":"DTXSID70227388"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51193,J51193)","v":"27469996"},"Maternal DHA supplementation protects rat offspring against impairment of learning and memory following prenatal exposure to valproic acid.","27469996","Neurologic Manifestations","D007859","Learning Disorders","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51228,D51228)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51228,M51228)","v":"Muscular Diseases"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51228,N51228)","v":"DTXSID70227388"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51228,J51228)","v":"6780925"},"Asterixis associated with sodium valproate.","6780925","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51257,D51257)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51257,M51257)","v":"Neural Tube Defects"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51257,N51257)","v":"DTXSID70227388"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51257,J51257)","v":"9704382"},"VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione.","9704382","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51286,D51286)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51286,M51286)","v":"Neural Tube Defects"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51286,N51286)","v":"DTXSID70227388"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51286,J51286)","v":"2405447"},"Use of anticonvulsants for manic depression during pregnancy.","2405447","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51292,D51292)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51292,M51292)","v":"Neural Tube Defects"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51292,N51292)","v":"DTXSID70227388"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51292,J51292)","v":"15794725"},"Teratogenicity of sodium valproate.","15794725","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51325,D51325)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51325,M51325)","v":"Neural Tube Defects"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51325,N51325)","v":"DTXSID70227388"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51325,J51325)","v":"12692401"},"Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.","12692401","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51354,D51354)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51354,M51354)","v":"Parkinsonian Disorders"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51354,N51354)","v":"DTXSID70227388"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51354,J51354)","v":"18841554"},"[Reversible Parkinsonism and cognitive impairment following treatment with valproate].","18841554","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51386,D51386)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51386,M51386)","v":"Reye Syndrome"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51386,N51386)","v":"DTXSID70227388"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51386,J51386)","v":"6419536"},"Treatment of epileptic patients with valproic acid does not modify plasma and urine short-chain-fatty acids.","6419536","Central Nervous System Diseases","D012202","Reye Syndrome","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51393,D51393)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51393,M51393)","v":"Seizures"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51393,N51393)","v":"DTXSID70227388"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51393,J51393)","v":"6428923"},"Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy.","6428923","Neurologic Manifestations","D012640","Seizures","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51418,D51418)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51418,M51418)","v":"Seizures"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51418,N51418)","v":"DTXSID70227388"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51418,J51418)","v":"23104247"},"Effects of Korean red ginseng extracts on neural tube defects and impairment of social interaction induced by prenatal exposure to valproic acid.","23104247","Neurologic Manifestations","D012640","Seizures","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51454,D51454)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51454,M51454)","v":"Spina Bifida Occulta"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51454,N51454)","v":"DTXSID70227388"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51454,J51454)","v":"6136822"},"Valproic acid and spina bifida.","6136822","Nervous System Malformations","D016136","Spina Bifida Occulta","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51474,D51474)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51474,M51474)","v":"Status Epilepticus"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51474,N51474)","v":"DTXSID70227388"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51474,J51474)","v":"7894843"},"Temporary abolition of seizure activity by flumazenil.","7894843","Neurologic Manifestations","D013226","Status Epilepticus","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51515,D51515)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51515,M51515)","v":"Unconsciousness"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51515,N51515)","v":"DTXSID70227388"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51515,J51515)","v":"3107333"},"[Stuporous state in an epileptic treated with sodium valproate. Diagnostic problems].","3107333","Neurologic Manifestations","D014474","Unconsciousness","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51522,D51522)","v":"Valproic Acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51522,M51522)","v":"Vision Disorders"},"D014635","Valproic Acid","76584-70-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51522,N51522)","v":"DTXSID70227388"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51522,J51522)","v":"12093128"},"Visual functions in epilepsy patients on valproate monotherapy.","12093128","Neurologic Manifestations","D014786","Vision Disorders","DTXSID70227388"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51567,D51567)","v":"Varenicline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51567,M51567)","v":"Sleep Wake Disorders"},"D000068580","Varenicline","249296-44-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51567,N51567)","v":"DTXSID70891447"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51567,J51567)","v":"25767129"},"Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis.","25767129","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID70891447"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51583,D51583)","v":"Vecuronium Bromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51583,M51583)","v":"Muscle Weakness"},"D014673","Vecuronium Bromide","86029-43-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51583,N51583)","v":"DTXSID1044146"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51583,J51583)","v":"10848680"},"Is vecuronium toxicity abolished by hemodialysis? A case report.","10848680","Neurologic Manifestations","D018908","Muscle Weakness","DTXSID1044146"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51616,D51616)","v":"Vecuronium Bromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51616,M51616)","v":"Paralysis"},"D014673","Vecuronium Bromide","86029-43-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51616,N51616)","v":"DTXSID1044146"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51616,J51616)","v":"1360147"},"Persistent paralysis after vecuronium administration.","1360147","Neurologic Manifestations","D010243","Paralysis","DTXSID1044146"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51631,D51631)","v":"Vecuronium Bromide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51631,M51631)","v":"Sensation Disorders"},"D014673","Vecuronium Bromide","86029-43-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51631,N51631)","v":"DTXSID1044146"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51631,J51631)","v":"20337001"},"[Sugammadex, a novel drug for neuromuscular blockade reversal].","20337001","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID1044146"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51651,D51651)","v":"Venlafaxine Hydrochloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51651,M51651)","v":"Central Nervous System Diseases"},"D000069470","Venlafaxine Hydrochloride","99300-78-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51651,N51651)","v":"DTXSID8047397"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51651,J51651)","v":"9674820"},"Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports.","9674820","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID8047397"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51684,D51684)","v":"Venlafaxine Hydrochloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51684,M51684)","v":"Inappropriate ADH Syndrome"},"D000069470","Venlafaxine Hydrochloride","99300-78-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51684,N51684)","v":"DTXSID8047397"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51684,J51684)","v":"9232089"},"Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine.","9232089","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID8047397"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51699,D51699)","v":"Venlafaxine Hydrochloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51699,M51699)","v":"Myoclonus"},"D000069470","Venlafaxine Hydrochloride","99300-78-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51699,N51699)","v":"DTXSID8047397"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51699,J51699)","v":"22010456"},"[Serotonin syndrome in the course of drug-poisoning--case presentation].","22010456","Neurologic Manifestations","D009207","Myoclonus","DTXSID8047397"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51745,D51745)","v":"Venlafaxine Hydrochloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51745,M51745)","v":"Sleep Wake Disorders"},"D000069470","Venlafaxine Hydrochloride","99300-78-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51745,N51745)","v":"DTXSID8047397"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51745,J51745)","v":"10982204"},"Venlafaxine and vivid dreaming.","10982204","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID8047397"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51774,D51774)","v":"Verapamil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51774,M51774)","v":"Cerebrovascular Disorders"},"D014700","Verapamil","52-53-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51774,N51774)","v":"DTXSID9041152"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51774,J51774)","v":"9160770"},"Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.","9160770","Central Nervous System Diseases","D002561","Cerebrovascular Disorders","DTXSID9041152"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51792,D51792)","v":"Verapamil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51792,M51792)","v":"Hyperprolactinemia"},"D014700","Verapamil","52-53-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51792,N51792)","v":"DTXSID9041152"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51792,J51792)","v":"11268556"},"[Hyperprolactinemia secondary to hypotensive treatment with verapamil].","11268556","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID9041152"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51813,D51813)","v":"Verapamil"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51813,M51813)","v":"Seizures"},"D014700","Verapamil","52-53-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51813,N51813)","v":"DTXSID9041152"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51813,J51813)","v":"3371379"},"Verapamil-induced carbamazepine neurotoxicity. A report of two cases.","3371379","Neurologic Manifestations","D012640","Seizures","DTXSID9041152"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51844,D51844)","v":"Vidarabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51844,M51844)","v":"Demyelinating Diseases"},"D014740","Vidarabine","5536-17-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51844,N51844)","v":"DTXSID80873976"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51844,J51844)","v":"17264526"},"Fatal leukoencephalopathy after reduced-intensity allogeneic stem cell transplantation.","17264526","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID80873976"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51874,D51874)","v":"Vidarabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51874,M51874)","v":"Posterior Leukoencephalopathy Syndrome"},"D014740","Vidarabine","5536-17-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51874,N51874)","v":"DTXSID80873976"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51874,J51874)","v":"20399878"},"Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation.","20399878","Central Nervous System Diseases","D054038","Posterior Leukoencephalopathy Syndrome","DTXSID80873976"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51881,D51881)","v":"Vidarabine Phosphate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51881,M51881)","v":"Blindness"},"D001084","Vidarabine Phosphate",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51881,N51881)","v":"DTXSID401009318"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51881,J51881)","v":"2428488"},"Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study.","2428488","Neurologic Manifestations","D001766","Blindness","DTXSID401009318"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51912,D51912)","v":"Viloxazine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51912,M51912)","v":"Seizures"},"D014745","Viloxazine","46817-91-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51912,N51912)","v":"DTXSID6057900"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51912,J51912)","v":"1827182"},"[Convulsive seizures under viloxazine therapy].","1827182","Neurologic Manifestations","D012640","Seizures","DTXSID6057900"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51942,D51942)","v":"Vinblastine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51942,M51942)","v":"Nervous System Diseases"},"D014747","Vinblastine","18556-44-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51942,N51942)","v":"DTXSID7047853"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51942,J51942)","v":"9364543"},"Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.","9364543","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7047853"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51971,D51971)","v":"Vinblastine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51971,M51971)","v":"Peripheral Nervous System Diseases"},"D014747","Vinblastine","18556-44-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51971,N51971)","v":"DTXSID7047853"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51971,J51971)","v":"6299598"},"Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma.","6299598","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7047853"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C51980,D51980)","v":"Vinblastine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L51980,M51980)","v":"Peripheral Nervous System Diseases"},"D014747","Vinblastine","18556-44-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N51980,N51980)","v":"DTXSID7047853"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J51980,J51980)","v":"9256899"},"Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients.","9256899","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7047853"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52010,D52010)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52010,M52010)","v":"Blindness"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52010,N52010)","v":"DTXSID8044331"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52010,J52010)","v":"6894223"},"Blindness and vincristine.","6894223","Neurologic Manifestations","D001766","Blindness","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52039,D52039)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52039,M52039)","v":"Central Nervous System Diseases"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52039,N52039)","v":"DTXSID8044331"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52039,J52039)","v":"10434725"},"[Neurologic complications of chemotherapy (vincristine etc.)].","10434725","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52073,D52073)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52073,M52073)","v":"Diplopia"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52073,N52073)","v":"DTXSID8044331"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52073,J52073)","v":"14970804"},"Isolated abducens nerve palsy induced by vincristine therapy.","14970804","Neurologic Manifestations","D004172","Diplopia","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52104,D52104)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52104,M52104)","v":"Hearing Loss, Sensorineural"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52104,N52104)","v":"DTXSID8044331"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52104,J52104)","v":"17255889"},"Neurotoxicity of BFM-95 on the medial olivocochlear bundle assessed by means of contralateral suppression of 2f1-f2 distortion product otoacoustic emissions.","17255889","Neurologic Manifestations","D006319","Hearing Loss, Sensorineural","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52133,D52133)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52133,M52133)","v":"Hypotension, Orthostatic"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52133,N52133)","v":"DTXSID8044331"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52133,J52133)","v":"7407771"},"Vincristine-induced orthostatic hypotension: a prospective clinical study.","7407771","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52141,D52141)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52141,M52141)","v":"Inappropriate ADH Syndrome"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52141,N52141)","v":"DTXSID8044331"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52141,J52141)","v":"1863543"},"Vincristine overdose: experience with 3 patients.","1863543","Central Nervous System Diseases","D007177","Inappropriate ADH Syndrome","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52168,D52168)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52168,M52168)","v":"Muscular Diseases"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52168,N52168)","v":"DTXSID8044331"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52168,J52168)","v":"4314181"},"The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies.","4314181","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52193,D52193)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52193,M52193)","v":"Nervous System Diseases"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52193,N52193)","v":"DTXSID8044331"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52193,J52193)","v":"3941623"},"Vincristine neurotoxicity.","3941623","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52233,D52233)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52233,M52233)","v":"Nervous System Diseases"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52233,N52233)","v":"DTXSID8044331"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52233,J52233)","v":"1212732"},"[Neurotoxicity of vincristine].","1212732","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52236,D52236)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52236,M52236)","v":"Neuralgia"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52236,N52236)","v":"DTXSID8044331"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52236,J52236)","v":"25726750"},"Dose-related neuropathic and anti-neuropathic effects of simvastatin in vincristine-induced neuropathic pain in rats.","25726750","Neuromuscular Diseases","D009437","Neuralgia","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52286,D52286)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52286,M52286)","v":"Optic Nerve Diseases"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52286,N52286)","v":"DTXSID8044331"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52286,J52286)","v":"3026667"},"[Neuropathy caused by vincristine].","3026667","Cranial Nerve Diseases","D009901","Optic Nerve Diseases","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52297,D52297)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52297,M52297)","v":"Paralysis"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52297,N52297)","v":"DTXSID8044331"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52297,J52297)","v":"5813374"},"Vincristine-induced neuropathy. A clinical study of fifty leukemic patients.","5813374","Neurologic Manifestations","D010243","Paralysis","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52330,D52330)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52330,M52330)","v":"Paresthesia"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52330,N52330)","v":"DTXSID8044331"},1969,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52330,J52330)","v":"4899921"},"[Clinical and physiopathological effects of Vincristine on the nervous system].","4899921","Neurologic Manifestations","D010292","Paresthesia","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52354,D52354)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52354,M52354)","v":"Peripheral Nervous System Diseases"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52354,N52354)","v":"DTXSID8044331"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52354,J52354)","v":"7603395"},"Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy).","7603395","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52365,D52365)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52365,M52365)","v":"Peripheral Nervous System Diseases"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52365,N52365)","v":"DTXSID8044331"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52365,J52365)","v":"4330694"},"Vincristine neuropathy--a case report.","4330694","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52398,D52398)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52398,M52398)","v":"Peripheral Nervous System Diseases"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52398,N52398)","v":"DTXSID8044331"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52398,J52398)","v":"2981498"},"Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome.","2981498","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52422,D52422)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52422,M52422)","v":"Peripheral Nervous System Diseases"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52422,N52422)","v":"DTXSID8044331"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52422,J52422)","v":"24632247"},"Probing for chemotherapy-induced peripheral neuropathy in live dorsal root ganglion neurons with atomic force microscopy.","24632247","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52459,D52459)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52459,M52459)","v":"Peripheral Nervous System Diseases"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52459,N52459)","v":"DTXSID8044331"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52459,J52459)","v":"11957264"},"Experience with vincristine--associated neurotoxicity.","11957264","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52492,D52492)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52492,M52492)","v":"Quadriplegia"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52492,N52492)","v":"DTXSID8044331"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52492,J52492)","v":"25583593"},"[Therapeutic response to pyridoxine and pyridostigmine in a paediatric case of severe peripheral and cranial polyneuropathy due to vincristine].","25583593","Neurologic Manifestations","D011782","Quadriplegia","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52511,D52511)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52511,M52511)","v":"Seizures"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52511,N52511)","v":"DTXSID8044331"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52511,J52511)","v":"4364934"},"Vincristine neurotoxicity.","4364934","Neurologic Manifestations","D012640","Seizures","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52527,D52527)","v":"Vincristine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52527,M52527)","v":"Sensation Disorders"},"D014750","Vincristine","2068-78-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52527,N52527)","v":"DTXSID8044331"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52527,J52527)","v":"10499201"},"Clinical and electrophysiological studies in vincristine induced neuropathy.","10499201","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID8044331"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52567,D52567)","v":"Vindesine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52567,M52567)","v":"Brain Ischemia"},"D014751","Vindesine","53643-48-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52567,N52567)","v":"DTXSID6023739"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52567,J52567)","v":"2312856"},"Cortical blindness during chemotherapy: clinical, CT, and MR correlations.","2312856","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID6023739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52588,D52588)","v":"Vindesine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52588,M52588)","v":"Peripheral Nervous System Neoplasms"},"D014751","Vindesine","53643-48-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52588,N52588)","v":"DTXSID6023739"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52588,J52588)","v":"7273021"},"Broad phase II study of vindesine.","7273021","Neuromuscular Diseases","D010524","Peripheral Nervous System Neoplasms","DTXSID6023739"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52595,D52595)","v":"vinorelbine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52595,M52595)","v":"Nervous System Diseases"},"C030852","vinorelbine","71486-22-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52595,N52595)","v":"DTXSID8040640"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52595,J52595)","v":"8995513"},"Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel--a phase II study.","8995513","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8040640"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52631,D52631)","v":"Vinyl Chloride"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52631,M52631)","v":"Brain Neoplasms"},"D014752","Vinyl Chloride","75-01-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52631,N52631)","v":"DTXSID8021434"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52631,J52631)","v":"12848022"},"[Damned liars (Part II)].","12848022","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID8021434"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52656,D52656)","v":"Vitamin B 12"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52656,M52656)","v":"Coma"},"D014805","Vitamin B 12","68-19-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52656,N52656)","v":"DTXSID7044346"},1974,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52656,J52656)","v":"4815245"},"[Letter: Anaphylactic shock due to hydroxocobalamine].","4815245","Neurologic Manifestations","D003128","Coma","DTXSID7044346"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52689,D52689)","v":"Vitamin D"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52689,M52689)","v":"Williams Syndrome"},"D014807","Vitamin D","1406-16-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52689,N52689)","v":"DTXSID1026295"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52689,J52689)","v":"9463624"},"Huldre folk of elfame: a case of hidden infirmities.","9463624","Neurologic Manifestations","D018980","Williams Syndrome","DTXSID1026295"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52699,D52699)","v":"Vitamin E"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52699,M52699)","v":"Muscular Diseases"},"D014810","Vitamin E","1406-18-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52699,N52699)","v":"DTXSID9051458"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52699,J52699)","v":"18599852"},"Interaction of ionophore and vitamin E in knockdown syndrome of turkeys.","18599852","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID9051458"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52724,D52724)","v":"Voriconazole"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52724,M52724)","v":"Myositis"},"D065819","Voriconazole","137234-62-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52724,N52724)","v":"DTXSID5046485"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52724,J52724)","v":"20009971"},"Voriconazole-associated myositis.","20009971","Neuromuscular Diseases","D009220","Myositis","DTXSID5046485"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52757,D52757)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52757,M52757)","v":"Auditory Perceptual Disorders"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52757,N52757)","v":"DTXSID5023742"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52757,J52757)","v":"25899236"},"Importance of a multidisciplinary approach and monitoring in fetal warfarin syndrome.","25899236","Neurologic Manifestations","D001308","Auditory Perceptual Disorders","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52792,D52792)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52792,M52792)","v":"Cerebral Hemorrhage"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52792,N52792)","v":"DTXSID5023742"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52792,J52792)","v":"26058438"},"[Fatal intracerebral haemorrhage possibly caused by interaction between paracetamol and warfarin].","26058438","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52818,D52818)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52818,M52818)","v":"Cerebral Hemorrhage"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52818,N52818)","v":"DTXSID5023742"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52818,J52818)","v":"17607559"},"The headache over warfarin in British neurosurgical intensive care units: a national survey of current practice.","17607559","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52847,D52847)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52847,M52847)","v":"Cerebral Hemorrhage"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52847,N52847)","v":"DTXSID5023742"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52847,J52847)","v":"25150286"},"APOE ε variants increase risk of warfarin-related intracerebral hemorrhage.","25150286","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52860,D52860)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52860,M52860)","v":"Cerebral Hemorrhage"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52860,N52860)","v":"DTXSID5023742"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52860,J52860)","v":"19762702"},"Cerebral microbleeds in ischemic stroke patients on warfarin treatment.","19762702","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52886,D52886)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52886,M52886)","v":"Cerebral Hemorrhage"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52886,N52886)","v":"DTXSID5023742"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52886,J52886)","v":"21799168"},"Effect of increased warfarin use on warfarin-related cerebral hemorrhage: a longitudinal population-based study.","21799168","Central Nervous System Diseases","D002543","Cerebral Hemorrhage","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52912,D52912)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52912,M52912)","v":"Cluster Headache"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52912,N52912)","v":"DTXSID5023742"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52912,J52912)","v":"12807529"},"Cluster-like headache due to warfarin therapy?","12807529","Central Nervous System Diseases","D003027","Cluster Headache","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52947,D52947)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52947,M52947)","v":"Hematoma, Subdural"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52947,N52947)","v":"DTXSID5023742"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52947,J52947)","v":"10994537"},"Herbs and the brain: friend or foe? The effects of ginkgo and garlic on warfarin use.","10994537","Central Nervous System Diseases","D006408","Hematoma, Subdural","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52954,D52954)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52954,M52954)","v":"Hematoma, Subdural"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52954,N52954)","v":"DTXSID5023742"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52954,J52954)","v":"12691397"},"The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings.","12691397","Central Nervous System Diseases","D006408","Hematoma, Subdural","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C52980,D52980)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L52980,M52980)","v":"Intracranial Hemorrhages"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N52980,N52980)","v":"DTXSID5023742"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J52980,J52980)","v":"26597063"},"Predictors of hospital mortality and serious complications in patients admitted with excessive warfarin anticoagulation.","26597063","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53015,D53015)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53015,M53015)","v":"Intracranial Hemorrhages"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53015,N53015)","v":"DTXSID5023742"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53015,J53015)","v":"24623731"},"Towards evidence-based emergency medicine: Best BETs from the Manchester Royal Infirmary. BET 3: Observation is unnecessary following a normal CT brain in warfarinised head injuries: an update.","24623731","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53044,D53044)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53044,M53044)","v":"Intracranial Hemorrhages"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53044,N53044)","v":"DTXSID5023742"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53044,J53044)","v":"19404899"},"Warfarin-associated fetal intracranial hemorrhage in woman with mitral valve replacements: a case report.","19404899","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53073,D53073)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53073,M53073)","v":"Microcephaly"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53073,N53073)","v":"DTXSID5023742"},1976,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53073,J53073)","v":"58352"},"Letter: Warfarin and fetal abnormality.","58352","Nervous System Malformations","D008831","Microcephaly","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53083,D53083)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53083,M53083)","v":"Optic Nerve Diseases"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53083,N53083)","v":"DTXSID5023742"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53083,J53083)","v":"17896319"},"Optic nerve dysfunction in a child following low-dose maternal warfarin exposure.","17896319","Cranial Nerve Diseases","D009901","Optic Nerve Diseases","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53112,D53112)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53112,M53112)","v":"Stroke"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53112,N53112)","v":"DTXSID5023742"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53112,J53112)","v":"28910806"},"Warfarin Use and Increased Mortality in End-Stage Renal Disease.","28910806","Central Nervous System Diseases","D020521","Stroke","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53141,D53141)","v":"Warfarin"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53141,M53141)","v":"Subarachnoid Hemorrhage"},"D014859","Warfarin","81-81-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53141,N53141)","v":"DTXSID5023742"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53141,J53141)","v":"6697623"},"Potentiation of oral anticoagulant effect by L-thyroxine.","6697623","Central Nervous System Diseases","D013345","Subarachnoid Hemorrhage","DTXSID5023742"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53173,D53173)","v":"Water"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53173,M53173)","v":"Epilepsy, Tonic-Clonic"},"D014867","Water","7732-18-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53173,N53173)","v":"DTXSID6026296"},1970,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53173,J53173)","v":"4988877"},"Water intoxication and grand mal seizure due to oxytocin.","4988877","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID6026296"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53206,D53206)","v":"Win 55212-2"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53206,M53206)","v":"Parkinson Disease, Secondary"},"C070417","Win 55212-2","131543-22-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53206,N53206)","v":"DTXSID40894849"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53206,J53206)","v":"9398468"},"The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease.","9398468","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID40894849"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53234,D53234)","v":"xylometazoline"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53234,M53234)","v":"Headache Disorders"},"C009695","xylometazoline","526-36-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53234,N53234)","v":"DTXSID8046957"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53234,J53234)","v":"21712403"},"Hypertensive crisis and end-organ damage induced by over-the-counter nasal decongestant abuse.","21712403","Central Nervous System Diseases","D020773","Headache Disorders","DTXSID8046957"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53241,D53241)","v":"Zalcitabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53241,M53241)","v":"Hyperalgesia"},"D016047","Zalcitabine","7481-89-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53241,N53241)","v":"DTXSID0023747"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53241,J53241)","v":"17761732"},"Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain.","17761732","Neurologic Manifestations","D006930","Hyperalgesia","DTXSID0023747"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53274,D53274)","v":"Zalcitabine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53274,M53274)","v":"Peripheral Nervous System Diseases"},"D016047","Zalcitabine","7481-89-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53274,N53274)","v":"DTXSID0023747"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53274,J53274)","v":"1309931"},"Ultrastructure of peripheral neuropathy induced in rabbits by 2',3'-dideoxycytidine.","1309931","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID0023747"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53288,D53288)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53288,M53288)","v":"Hallucinations"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53288,N53288)","v":"DTXSID5023748"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53288,J53288)","v":"17852167"},"Dose-related illusions and hallucinations with zaleplon.","17852167","Neurologic Manifestations","D006212","Hallucinations","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53289,D53289)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53289,M53289)","v":"Hallucinations"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53289,N53289)","v":"DTXSID5023748"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53289,J53289)","v":"19238743"},"A case of zaleplon overdose.","19238743","Neurologic Manifestations","D006212","Hallucinations","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53290,D53290)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53290,M53290)","v":"Hallucinations"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53290,N53290)","v":"DTXSID5023748"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53290,J53290)","v":"11141544"},"Perceptual disturbances with zaleplon.","11141544","Neurologic Manifestations","D006212","Hallucinations","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53291,D53291)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53291,M53291)","v":"Psychomotor Disorders"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53291,N53291)","v":"DTXSID5023748"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53291,J53291)","v":"23456542"},"In the Zzz zone: the effects of Z-drugs on human performance and driving.","23456542","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53292,D53292)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53292,M53292)","v":"Psychomotor Disorders"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53292,N53292)","v":"DTXSID5023748"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53292,J53292)","v":"11905433"},"Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.","11905433","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53293,D53293)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53293,M53293)","v":"Psychomotor Disorders"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53293,N53293)","v":"DTXSID5023748"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53293,J53293)","v":"11978165"},"Safety of zaleplon in the treatment of insomnia.","11978165","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53294,D53294)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53294,M53294)","v":"Sleep Initiation and Maintenance Disorders"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53294,N53294)","v":"DTXSID5023748"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53294,J53294)","v":"10485636"},"Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.","10485636","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53295,D53295)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53295,M53295)","v":"Sleep Wake Disorders"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53295,N53295)","v":"DTXSID5023748"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53295,J53295)","v":"20193650"},"A case of zaleplon-induced amnestic sleep-related eating disorder.","20193650","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53296,D53296)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53296,M53296)","v":"Somnambulism"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53296,N53296)","v":"DTXSID5023748"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53296,J53296)","v":"26147892"},"Drugs for Insomnia.","26147892","Sleep Wake Disorders","D013009","Somnambulism","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53297,D53297)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53297,M53297)","v":"Somnambulism"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53297,N53297)","v":"DTXSID5023748"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53297,J53297)","v":"26082420"},"Zaleplon-induced Anemsic Somnambulism with Eating Behaviors Under Once Dose.","26082420","Sleep Wake Disorders","D013009","Somnambulism","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53298,D53298)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53298,M53298)","v":"Somnambulism"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53298,N53298)","v":"DTXSID5023748"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53298,J53298)","v":"15266187"},"Zaleplon overdose associated with sleepwalking and complex behavior.","15266187","Sleep Wake Disorders","D013009","Somnambulism","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53299,D53299)","v":"zaleplon"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53299,M53299)","v":"Unconsciousness"},"C085665","zaleplon","151319-34-5",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53299,N53299)","v":"DTXSID5023748"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53299,J53299)","v":"12640975"},"[In cases of coma and blue-green urine should overdosage of zaleplon be considered. First case reports].","12640975","Neurologic Manifestations","D014474","Unconsciousness","DTXSID5023748"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53300,D53300)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53300,M53300)","v":"Ataxia"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53300,N53300)","v":"DTXSID8020127"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53300,J53300)","v":"3163905"},"Zidovudine overdosage.","3163905","Neurologic Manifestations","D001259","Ataxia","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53301,D53301)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53301,M53301)","v":"Brain Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53301,N53301)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53301,J53301)","v":"8208709"},"[Cacosmia during treatment with zidovudine].","8208709","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53302,D53302)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53302,M53302)","v":"Central Nervous System Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53302,N53302)","v":"DTXSID8020127"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53302,J53302)","v":"2071083"},"[Azidothymidine and the nervous system].","2071083","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53303,D53303)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53303,M53303)","v":"Central Nervous System Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53303,N53303)","v":"DTXSID8020127"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53303,J53303)","v":"1360277"},"A randomized trial of reduced doses of azidothymidine in Japanese patients with human immunodeficiency virus type 1 infection.","1360277","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53304,D53304)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53304,M53304)","v":"Color Vision Defects"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53304,N53304)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53304,J53304)","v":"8318471"},"Impairment of tritan colour vision after initiation of treatment with zidovudine in patients with HIV disease or AIDS.","8318471","Neurologic Manifestations","D003117","Color Vision Defects","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53305,D53305)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53305,M53305)","v":"Coma"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53305,N53305)","v":"DTXSID8020127"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53305,J53305)","v":"2709071"},"Coma during azidothymidine therapy for AIDS.","2709071","Neurologic Manifestations","D003128","Coma","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53306,D53306)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53306,M53306)","v":"Epilepsies, Partial"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53306,N53306)","v":"DTXSID8020127"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53306,J53306)","v":"2878246"},"Azidothymidine neurotoxicity.","2878246","Central Nervous System Diseases","D004828","Epilepsies, Partial","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53307,D53307)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53307,M53307)","v":"Epilepsies, Partial"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53307,N53307)","v":"DTXSID8020127"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53307,J53307)","v":"2500498"},"Lethal neurotoxicity associated to azidothymidine therapy.","2500498","Central Nervous System Diseases","D004828","Epilepsies, Partial","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53308,D53308)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53308,M53308)","v":"Epilepsy"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53308,N53308)","v":"DTXSID8020127"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53308,J53308)","v":"2525711"},"[Crisis of generalized epilepsy after absorption of zidovudine at a toxic dose].","2525711","Central Nervous System Diseases","D004827","Epilepsy","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53309,D53309)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53309,M53309)","v":"Epilepsy, Generalized"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53309,N53309)","v":"DTXSID8020127"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53309,J53309)","v":"17304745"},"[Zidovudine-associated mitochondriopathy: three possible observations in Abidjan, Côte d'Ivoire].","17304745","Central Nervous System Diseases","D004829","Epilepsy, Generalized","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53310,D53310)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53310,M53310)","v":"Epilepsy, Tonic-Clonic"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53310,N53310)","v":"DTXSID8020127"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53310,J53310)","v":"2563536"},"Seizure after zidovudine overdose.","2563536","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53311,D53311)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53311,M53311)","v":"Hearing Loss"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53311,N53311)","v":"DTXSID8020127"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53311,J53311)","v":"16504011"},"A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people.","16504011","Neurologic Manifestations","D034381","Hearing Loss","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53312,D53312)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53312,M53312)","v":"Hepatic Encephalopathy"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53312,N53312)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53312,J53312)","v":"8438867"},"Fulminant hepatic failure in an AIDS patient: possible zidovudine-induced hepatotoxicity.","8438867","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53313,D53313)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53313,M53313)","v":"Hypotension, Orthostatic"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53313,N53313)","v":"DTXSID8020127"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53313,J53313)","v":"2105796"},"Postural hypotension related to zidovudine in a patient infected with HIV.","2105796","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53314,D53314)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53314,M53314)","v":"Learning Disorders"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53314,N53314)","v":"DTXSID8020127"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53314,J53314)","v":"9302705"},"Learning disturbances in offsprings of zidovudine (AZT) treated rats.","9302705","Neurologic Manifestations","D007859","Learning Disorders","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53315,D53315)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53315,M53315)","v":"Mitochondrial Encephalomyopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53315,N53315)","v":"DTXSID8020127"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53315,J53315)","v":"15814907"},"Cerebral MR imaging in uninfected children born to HIV-seropositive mothers and perinatally exposed to zidovudine.","15814907","Neuromuscular Diseases","D017237","Mitochondrial Encephalomyopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53316,D53316)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53316,M53316)","v":"Mitochondrial Encephalomyopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53316,N53316)","v":"DTXSID8020127"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53316,J53316)","v":"20032772"},"Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues.","20032772","Neuromuscular Diseases","D017237","Mitochondrial Encephalomyopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53317,D53317)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53317,M53317)","v":"Mitochondrial Encephalomyopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53317,N53317)","v":"DTXSID8020127"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53317,J53317)","v":"10509500"},"Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.","10509500","Neuromuscular Diseases","D017237","Mitochondrial Encephalomyopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53318,D53318)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53318,M53318)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53318,N53318)","v":"DTXSID8020127"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53318,J53318)","v":"8745244"},"Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells.","8745244","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53319,D53319)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53319,M53319)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53319,N53319)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53319,J53319)","v":"8278024"},"Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.","8278024","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53320,D53320)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53320,M53320)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53320,N53320)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53320,J53320)","v":"8438050"},"Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.","8438050","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53321,D53321)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53321,M53321)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53321,N53321)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53321,J53321)","v":"8338345"},"Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.","8338345","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53322,D53322)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53322,M53322)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53322,N53322)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53322,J53322)","v":"7944307"},"Muscle carnitine deficiency associated with zidovudine-induced mitochondrial myopathy.","7944307","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53323,D53323)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53323,M53323)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53323,N53323)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53323,J53323)","v":"8328750"},"Lactic acidosis and AIDS.","8328750","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53324,D53324)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53324,M53324)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53324,N53324)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53324,J53324)","v":"7979221"},"Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers.","7979221","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53325,D53325)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53325,M53325)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53325,N53325)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53325,J53325)","v":"8309597"},"HIV or zidovudine myopathy?","8309597","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53326,D53326)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53326,M53326)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53326,N53326)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53326,J53326)","v":"8309595"},"HIV or zidovudine myopathy?","8309595","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53327,D53327)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53327,M53327)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53327,N53327)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53327,J53327)","v":"7518879"},"Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro.","7518879","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53328,D53328)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53328,M53328)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53328,N53328)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53328,J53328)","v":"8309594"},"HIV or zidovudine myopathy?","8309594","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53329,D53329)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53329,M53329)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53329,N53329)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53329,J53329)","v":"8215243"},"Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.","8215243","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53330,D53330)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53330,M53330)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53330,N53330)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53330,J53330)","v":"8060560"},"Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease?","8060560","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53331,D53331)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53331,M53331)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53331,N53331)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53331,J53331)","v":"7807166"},"Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy.","7807166","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53332,D53332)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53332,M53332)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53332,N53332)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53332,J53332)","v":"7856620"},"Zidovudine-associated myopathy.","7856620","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53333,D53333)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53333,M53333)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53333,N53333)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53333,J53333)","v":"8147937"},"Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy.","8147937","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53334,D53334)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53334,M53334)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53334,N53334)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53334,J53334)","v":"8154877"},"Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage.","8154877","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53335,D53335)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53335,M53335)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53335,N53335)","v":"DTXSID8020127"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53335,J53335)","v":"7599207"},"The universality of bioenergetic disease and amelioration with redox therapy.","7599207","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53336,D53336)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53336,M53336)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53336,N53336)","v":"DTXSID8020127"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53336,J53336)","v":"9741412"},"Clinical, histological and molecular reversibility of zidovudine myopathy.","9741412","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53337,D53337)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53337,M53337)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53337,N53337)","v":"DTXSID8020127"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53337,J53337)","v":"8815162"},"Turns-amplitude analysis assessment of myopathies in HIV-infected patients.","8815162","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53338,D53338)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53338,M53338)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53338,N53338)","v":"DTXSID8020127"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53338,J53338)","v":"18163507"},"Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.","18163507","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53339,D53339)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53339,M53339)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53339,N53339)","v":"DTXSID8020127"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53339,J53339)","v":"20032772"},"Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues.","20032772","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53340,D53340)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53340,M53340)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53340,N53340)","v":"DTXSID8020127"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53340,J53340)","v":"10636397"},"HIV-1 therapy and fetal mitochondrial dysfunction.","10636397","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53341,D53341)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53341,M53341)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53341,N53341)","v":"DTXSID8020127"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53341,J53341)","v":"11131711"},"A comparison of genetic mitochondrial disease and nucleoside analogue toxicity. Does fetal nucleoside toxicity underlie reports of mitochondrial disease in infants born to women treated for HIV infection?","11131711","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53342,D53342)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53342,M53342)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53342,N53342)","v":"DTXSID8020127"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53342,J53342)","v":"10791874"},"Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine.","10791874","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53343,D53343)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53343,M53343)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53343,N53343)","v":"DTXSID8020127"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53343,J53343)","v":"10912924"},"Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits.","10912924","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53344,D53344)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53344,M53344)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53344,N53344)","v":"DTXSID8020127"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53344,J53344)","v":"10904790"},"[Antiretroviral drugs and pregnancy: apropos of an alert regarding mitochondrial pathology and nucleoside analogs].","10904790","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53345,D53345)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53345,M53345)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53345,N53345)","v":"DTXSID8020127"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53345,J53345)","v":"10475107"},"Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damage.","10475107","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53346,D53346)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53346,M53346)","v":"Mitochondrial Myopathies"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53346,N53346)","v":"DTXSID8020127"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53346,J53346)","v":"1336487"},"AZT-induced mitochondrial myopathy.","1336487","Neuromuscular Diseases","D017240","Mitochondrial Myopathies","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53347,D53347)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53347,M53347)","v":"Muscle Hypotonia"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53347,N53347)","v":"DTXSID8020127"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53347,J53347)","v":"17304745"},"[Zidovudine-associated mitochondriopathy: three possible observations in Abidjan, Côte d'Ivoire].","17304745","Neurologic Manifestations","D009123","Muscle Hypotonia","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53348,D53348)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53348,M53348)","v":"Muscular Atrophy"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53348,N53348)","v":"DTXSID8020127"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53348,J53348)","v":"2170584"},"Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment.","2170584","Neurologic Manifestations","D009133","Muscular Atrophy","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53349,D53349)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53349,M53349)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53349,N53349)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53349,J53349)","v":"8278024"},"Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.","8278024","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53350,D53350)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53350,M53350)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53350,N53350)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53350,J53350)","v":"8309597"},"HIV or zidovudine myopathy?","8309597","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53351,D53351)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53351,M53351)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53351,N53351)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53351,J53351)","v":"8309596"},"HIV or zidovudine myopathy?","8309596","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53352,D53352)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53352,M53352)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53352,N53352)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53352,J53352)","v":"8309594"},"HIV or zidovudine myopathy?","8309594","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53353,D53353)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53353,M53353)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53353,N53353)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53353,J53353)","v":"8109910"},"Zidovudine therapy and myopathies associated with human immunodeficiency virus infection.","8109910","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53354,D53354)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53354,M53354)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53354,N53354)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53354,J53354)","v":"8060543"},"Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study Group.","8060543","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53355,D53355)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53355,M53355)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53355,N53355)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53355,J53355)","v":"8492955"},"Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?","8492955","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53356,D53356)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53356,M53356)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53356,N53356)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53356,J53356)","v":"8176648"},"The drugs 2',3'-dideoxyinosine (ddI) and 2',3'-dideoxycytidine (ddC) are safe alternatives in people with AIDS with zidovudine-induced myopathy.","8176648","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53357,D53357)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53357,M53357)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53357,N53357)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53357,J53357)","v":"8263554"},"Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine.","8263554","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53358,D53358)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53358,M53358)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53358,N53358)","v":"DTXSID8020127"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53358,J53358)","v":"9432697"},"[Toxic drug-induced proximal myopathy in CDC C3 HIV-infection].","9432697","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53359,D53359)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53359,M53359)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53359,N53359)","v":"DTXSID8020127"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53359,J53359)","v":"9927163"},"Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion.","9927163","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53360,D53360)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53360,M53360)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53360,N53360)","v":"DTXSID8020127"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53360,J53360)","v":"8815162"},"Turns-amplitude analysis assessment of myopathies in HIV-infected patients.","8815162","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53361,D53361)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53361,M53361)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53361,N53361)","v":"DTXSID8020127"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53361,J53361)","v":"9052824"},"Analysis of myopathy in a placebo-controlled zidovudine trial.","9052824","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53362,D53362)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53362,M53362)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53362,N53362)","v":"DTXSID8020127"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53362,J53362)","v":"2757521"},"Polymyositislike syndromes in acquired immunodeficiency syndrome.","2757521","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53363,D53363)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53363,M53363)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53363,N53363)","v":"DTXSID8020127"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53363,J53363)","v":"2929650"},"Myalgias in human immunodeficiency virus-infected patients.","2929650","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53364,D53364)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53364,M53364)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53364,N53364)","v":"DTXSID8020127"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53364,J53364)","v":"2896888"},"Necrotising myopathy and zidovudine.","2896888","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53365,D53365)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53365,M53365)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53365,N53365)","v":"DTXSID8020127"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53365,J53365)","v":"2901551"},"Zidovudine-associated myopathy.","2901551","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53366,D53366)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53366,M53366)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53366,N53366)","v":"DTXSID8020127"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53366,J53366)","v":"1892364"},"Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.","1892364","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53367,D53367)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53367,M53367)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53367,N53367)","v":"DTXSID8020127"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53367,J53367)","v":"1748434"},"Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.","1748434","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53368,D53368)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53368,M53368)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53368,N53368)","v":"DTXSID8020127"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53368,J53368)","v":"18504416"},"Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.","18504416","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53369,D53369)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53369,M53369)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53369,N53369)","v":"DTXSID8020127"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53369,J53369)","v":"1714057"},"Prognosis in AZT myopathy.","1714057","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53370,D53370)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53370,M53370)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53370,N53370)","v":"DTXSID8020127"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53370,J53370)","v":"2521663"},"Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.","2521663","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53371,D53371)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53371,M53371)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53371,N53371)","v":"DTXSID8020127"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53371,J53371)","v":"2402267"},"Mitochondrial myopathy caused by long-term zidovudine therapy.","2402267","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53372,D53372)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53372,M53372)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53372,N53372)","v":"DTXSID8020127"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53372,J53372)","v":"15849374"},"Drug-induced myopathies. An overview of the possible mechanisms.","15849374","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53373,D53373)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53373,M53373)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53373,N53373)","v":"DTXSID8020127"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53373,J53373)","v":"1641255"},"Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.","1641255","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53374,D53374)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53374,M53374)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53374,N53374)","v":"DTXSID8020127"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53374,J53374)","v":"1603356"},"Zidovudine myopathy.","1603356","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53375,D53375)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53375,M53375)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53375,N53375)","v":"DTXSID8020127"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53375,J53375)","v":"1549225"},"31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients.","1549225","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53376,D53376)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53376,M53376)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53376,N53376)","v":"DTXSID8020127"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53376,J53376)","v":"1975486"},"Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?","1975486","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53377,D53377)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53377,M53377)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53377,N53377)","v":"DTXSID8020127"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53377,J53377)","v":"2031699"},"Exacerbation of HIV-associated myopathy by zidovudine.","2031699","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53378,D53378)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53378,M53378)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53378,N53378)","v":"DTXSID8020127"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53378,J53378)","v":"2041882"},"Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy.","2041882","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53379,D53379)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53379,M53379)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53379,N53379)","v":"DTXSID8020127"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53379,J53379)","v":"2320079"},"Mitochondrial myopathy caused by long-term zidovudine therapy.","2320079","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53380,D53380)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53380,M53380)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53380,N53380)","v":"DTXSID8020127"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53380,J53380)","v":"2201071"},"Zidovudine intolerance.","2201071","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53381,D53381)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53381,M53381)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53381,N53381)","v":"DTXSID8020127"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53381,J53381)","v":"10912924"},"Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits.","10912924","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53382,D53382)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53382,M53382)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53382,N53382)","v":"DTXSID8020127"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53382,J53382)","v":"10091858"},"Zidovudine [AZT] myotoxicity: quantitative separation of AZT effects on proliferation and differentiation of muscle cells in vitro. Lack of myotoxicity potentiation by retrovirus.","10091858","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53383,D53383)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53383,M53383)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53383,N53383)","v":"DTXSID8020127"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53383,J53383)","v":"1489776"},"[Myopathy and zidovudine].","1489776","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53384,D53384)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53384,M53384)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53384,N53384)","v":"DTXSID8020127"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53384,J53384)","v":"1285495"},"Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.","1285495","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53385,D53385)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53385,M53385)","v":"Muscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53385,N53385)","v":"DTXSID8020127"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53385,J53385)","v":"1324428"},"Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine.","1324428","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53386,D53386)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53386,M53386)","v":"Myositis"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53386,N53386)","v":"DTXSID8020127"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53386,J53386)","v":"3422706"},"Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC.","3422706","Neuromuscular Diseases","D009220","Myositis","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53387,D53387)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53387,M53387)","v":"Myositis"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53387,N53387)","v":"DTXSID8020127"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53387,J53387)","v":"1671889"},"Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy.","1671889","Neuromuscular Diseases","D009220","Myositis","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53388,D53388)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53388,M53388)","v":"Myositis"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53388,N53388)","v":"DTXSID8020127"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53388,J53388)","v":"11555911"},"[Retrovirus associated myopathy, others].","11555911","Neuromuscular Diseases","D009220","Myositis","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53389,D53389)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53389,M53389)","v":"Myositis"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53389,N53389)","v":"DTXSID8020127"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53389,J53389)","v":"10448412"},"Influenza myositis and rhabdomyolysis in an HIV positive man: was zidovudine a co-factor?","10448412","Neuromuscular Diseases","D009220","Myositis","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53390,D53390)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53390,M53390)","v":"Nervous System Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53390,N53390)","v":"DTXSID8020127"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53390,J53390)","v":"2964805"},"Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study.","2964805","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53391,D53391)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53391,M53391)","v":"Nervous System Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53391,N53391)","v":"DTXSID8020127"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53391,J53391)","v":"2500498"},"Lethal neurotoxicity associated to azidothymidine therapy.","2500498","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53392,D53392)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53392,M53392)","v":"Nervous System Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53392,N53392)","v":"DTXSID8020127"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53392,J53392)","v":"2261143"},"Zidovudine overdose in an intravenous drug user.","2261143","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53393,D53393)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53393,M53393)","v":"Neuromuscular Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53393,N53393)","v":"DTXSID8020127"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53393,J53393)","v":"2729341"},"Zidovudine-associated myopathy.","2729341","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53394,D53394)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53394,M53394)","v":"Nystagmus, Pathologic"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53394,N53394)","v":"DTXSID8020127"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53394,J53394)","v":"3163905"},"Zidovudine overdosage.","3163905","Cranial Nerve Diseases","D009759","Nystagmus, Pathologic","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53395,D53395)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53395,M53395)","v":"Paresthesia"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53395,N53395)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53395,J53395)","v":"7905523"},"The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.","7905523","Neurologic Manifestations","D010292","Paresthesia","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53396,D53396)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53396,M53396)","v":"Peripheral Nervous System Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53396,N53396)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53396,J53396)","v":"8094279"},"Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.","8094279","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53397,D53397)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53397,M53397)","v":"Peripheral Nervous System Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53397,N53397)","v":"DTXSID8020127"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53397,J53397)","v":"7519674"},"Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: results of the Canadian Open ddI Treatment Program.","7519674","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53398,D53398)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53398,M53398)","v":"Peripheral Nervous System Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53398,N53398)","v":"DTXSID8020127"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53398,J53398)","v":"8387218"},"The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT)","8387218","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53399,D53399)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53399,M53399)","v":"Peripheral Nervous System Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53399,N53399)","v":"DTXSID8020127"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53399,J53399)","v":"1654410"},"Peripheral nerve function in persons with asymptomatic or minimally symptomatic HIV disease: absence of zidovudine neurotoxicity.","1654410","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53400,D53400)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53400,M53400)","v":"Peripheral Nervous System Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53400,N53400)","v":"DTXSID8020127"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53400,J53400)","v":"11518007"},"Rapidly progressing peripheral neuropathy with lactic acidosis and coproporphyria in a patient with HTLV-I associated T-cell leukaemia treated with zidovudine.","11518007","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53401,D53401)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53401,M53401)","v":"Peripheral Nervous System Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53401,N53401)","v":"DTXSID8020127"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53401,J53401)","v":"12403023"},"A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.","12403023","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53402,D53402)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53402,M53402)","v":"Psychomotor Disorders"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53402,N53402)","v":"DTXSID8020127"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53402,J53402)","v":"17304745"},"[Zidovudine-associated mitochondriopathy: three possible observations in Abidjan, Côte d'Ivoire].","17304745","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53403,D53403)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53403,M53403)","v":"Seizures"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53403,N53403)","v":"DTXSID8020127"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53403,J53403)","v":"7623605"},"Seizure associated with zidovudine.","7623605","Neurologic Manifestations","D012640","Seizures","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53404,D53404)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53404,M53404)","v":"Spinal Cord Diseases"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53404,N53404)","v":"DTXSID8020127"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53404,J53404)","v":"2899263"},"Myelopathy after stopping zidovudine.","2899263","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53405,D53405)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53405,M53405)","v":"Vision Disorders"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53405,N53405)","v":"DTXSID8020127"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53405,J53405)","v":"1987876"},"Zidovudine-induced macular edema.","1987876","Neurologic Manifestations","D014786","Vision Disorders","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53406,D53406)","v":"Zidovudine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53406,M53406)","v":"Wernicke Encephalopathy"},"D015215","Zidovudine","30516-87-1",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53406,N53406)","v":"DTXSID8020127"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53406,J53406)","v":"2882316"},"Wernicke's encephalopathy in AIDS patient treated with zidovudine.","2882316","Central Nervous System Diseases","D014899","Wernicke Encephalopathy","DTXSID8020127"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53407,D53407)","v":"Zimeldine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53407,M53407)","v":"Basal Ganglia Diseases"},"D015031","Zimeldine","56775-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53407,N53407)","v":"DTXSID6048462"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53407,J53407)","v":"2933428"},"Extrapyramidal signs following zimelidine overdose.","2933428","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID6048462"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53408,D53408)","v":"Zimeldine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53408,M53408)","v":"Epilepsy, Tonic-Clonic"},"D015031","Zimeldine","56775-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53408,N53408)","v":"DTXSID6048462"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53408,J53408)","v":"6227370"},"Convulsions after self poisoning with zimeldine.","6227370","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID6048462"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53409,D53409)","v":"Zimeldine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53409,M53409)","v":"Muscular Diseases"},"D015031","Zimeldine","56775-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53409,N53409)","v":"DTXSID6048462"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53409,J53409)","v":"6236235"},"Myalgia and elevation in muscle creatine phosphokinase during zimelidine treatment.","6236235","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID6048462"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53410,D53410)","v":"Zimeldine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53410,M53410)","v":"Nervous System Diseases"},"D015031","Zimeldine","56775-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53410,N53410)","v":"DTXSID6048462"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53410,J53410)","v":"6227367"},"Safety of zimeldine in overdose.","6227367","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID6048462"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53411,D53411)","v":"Zimeldine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53411,M53411)","v":"Peripheral Nervous System Diseases"},"D015031","Zimeldine","56775-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53411,N53411)","v":"DTXSID6048462"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53411,J53411)","v":"6327502"},"Zimeldine induced neuropathies.","6327502","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID6048462"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53412,D53412)","v":"Zimeldine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53412,M53412)","v":"Polyradiculoneuropathy"},"D015031","Zimeldine","56775-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53412,N53412)","v":"DTXSID6048462"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53412,J53412)","v":"3156214"},"Guillain-Barré syndrome following zimeldine treatment.","3156214","Demyelinating Diseases","D011129","Polyradiculoneuropathy","DTXSID6048462"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53413,D53413)","v":"Zimeldine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53413,M53413)","v":"Polyradiculoneuropathy"},"D015031","Zimeldine","56775-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53413,N53413)","v":"DTXSID6048462"},1989,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53413,J53413)","v":"2531772"},"The specificity of the zimelidine reaction.","2531772","Demyelinating Diseases","D011129","Polyradiculoneuropathy","DTXSID6048462"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53414,D53414)","v":"Zimeldine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53414,M53414)","v":"Polyradiculoneuropathy"},"D015031","Zimeldine","56775-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53414,N53414)","v":"DTXSID6048462"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53414,J53414)","v":"2138168"},"A Bayesian assessment of idiosyncratic adverse reactions to new drugs: Guillain-Barré syndrome and zimeldine.","2138168","Demyelinating Diseases","D011129","Polyradiculoneuropathy","DTXSID6048462"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53415,D53415)","v":"Zimeldine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53415,M53415)","v":"Sleep Initiation and Maintenance Disorders"},"D015031","Zimeldine","56775-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53415,N53415)","v":"DTXSID6048462"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53415,J53415)","v":"6448650"},"Event recording in a clinical trial of a new medicine.","6448650","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID6048462"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53416,D53416)","v":"Zimeldine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53416,M53416)","v":"Sleep Wake Disorders"},"D015031","Zimeldine","56775-88-3",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53416,N53416)","v":"DTXSID6048462"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53416,J53416)","v":"6230889"},"The safety of zimeldine in long-term use in depressive illness.","6230889","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID6048462"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53417,D53417)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53417,M53417)","v":"Alzheimer Disease"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53417,N53417)","v":"DTXSID7035012"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53417,J53417)","v":"24213606"},"The molecular mechanisms of zinc neurotoxicity and the pathogenesis of vascular type senile dementia.","24213606","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53418,D53418)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53418,M53418)","v":"Autonomic Nervous System Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53418,N53418)","v":"DTXSID7035012"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53418,J53418)","v":"1665313"},"Autonomic nervous system dysfunction in workers exposed to lead, zinc, and copper in relation to peripheral nerve conduction: a study of R-R interval variability.","1665313","Autonomic Nervous System Diseases","D001342","Autonomic Nervous System Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53419,D53419)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53419,M53419)","v":"Brain Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53419,N53419)","v":"DTXSID7035012"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53419,J53419)","v":"3796893"},"Brief exposure to zinc is toxic to cortical neurons.","3796893","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53420,D53420)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53420,M53420)","v":"Brain Ischemia"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53420,N53420)","v":"DTXSID7035012"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53420,J53420)","v":"14746904"},"Effect of zinc in ischemic brain injury in an embolic model of stroke in rats.","14746904","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53421,D53421)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53421,M53421)","v":"Brain Neoplasms"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53421,N53421)","v":"DTXSID7035012"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53421,J53421)","v":"6466053"},"[Effect of orally administered zinc on the inducibility of experimental brain tumors in the rat].","6466053","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53422,D53422)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53422,M53422)","v":"Central Nervous System Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53422,N53422)","v":"DTXSID7035012"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53422,J53422)","v":"10762525"},"CNS demyelination from zinc toxicity?","10762525","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53423,D53423)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53423,M53423)","v":"Coma"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53423,N53423)","v":"DTXSID7035012"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53423,J53423)","v":"1126763"},"Aerosol metallic paints: deliberate inhalation. A study of inhalation and or ingestion of copper and zinc particles.","1126763","Neurologic Manifestations","D003128","Coma","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53424,D53424)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53424,M53424)","v":"Dementia, Vascular"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53424,N53424)","v":"DTXSID7035012"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53424,J53424)","v":"25846004"},"Protective activity of carnosine and anserine against zinc-induced neurotoxicity: a possible treatment for vascular dementia.","25846004","Central Nervous System Diseases","D015140","Dementia, Vascular","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53425,D53425)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53425,M53425)","v":"Dementia, Vascular"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53425,N53425)","v":"DTXSID7035012"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53425,J53425)","v":"24213606"},"The molecular mechanisms of zinc neurotoxicity and the pathogenesis of vascular type senile dementia.","24213606","Central Nervous System Diseases","D015140","Dementia, Vascular","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53426,D53426)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53426,M53426)","v":"Demyelinating Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53426,N53426)","v":"DTXSID7035012"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53426,J53426)","v":"10762525"},"CNS demyelination from zinc toxicity?","10762525","Demyelinating Diseases","D003711","Demyelinating Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53427,D53427)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53427,M53427)","v":"Gait Ataxia"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53427,N53427)","v":"DTXSID7035012"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53427,J53427)","v":"21799109"},"Commentary.","21799109","Neurologic Manifestations","D020234","Gait Ataxia","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53428,D53428)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53428,M53428)","v":"Gait Ataxia"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53428,N53428)","v":"DTXSID7035012"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53428,J53428)","v":"21799107"},"Anemia, paresthesias, and gait ataxia in a 57-year-old denture wearer.","21799107","Neurologic Manifestations","D020234","Gait Ataxia","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53429,D53429)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53429,M53429)","v":"Gait Ataxia"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53429,N53429)","v":"DTXSID7035012"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53429,J53429)","v":"21799108"},"Commentary.","21799108","Neurologic Manifestations","D020234","Gait Ataxia","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53430,D53430)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53430,M53430)","v":"Gait Disorders, Neurologic"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53430,N53430)","v":"DTXSID7035012"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53430,J53430)","v":"22609346"},"Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.","22609346","Neurologic Manifestations","D020233","Gait Disorders, Neurologic","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53431,D53431)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53431,M53431)","v":"Gait Disorders, Neurologic"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53431,N53431)","v":"DTXSID7035012"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53431,J53431)","v":"12874423"},"Myelopathy due to copper deficiency.","12874423","Neurologic Manifestations","D020233","Gait Disorders, Neurologic","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53432,D53432)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53432,M53432)","v":"Hallucinations"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53432,N53432)","v":"DTXSID7035012"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53432,J53432)","v":"1126763"},"Aerosol metallic paints: deliberate inhalation. A study of inhalation and or ingestion of copper and zinc particles.","1126763","Neurologic Manifestations","D006212","Hallucinations","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53433,D53433)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53433,M53433)","v":"Hepatolenticular Degeneration"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53433,N53433)","v":"DTXSID7035012"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53433,J53433)","v":"8280286"},"Fatal deterioration of Wilson's disease after institution of oral zinc therapy.","8280286","Basal Ganglia Diseases","D006527","Hepatolenticular Degeneration","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53434,D53434)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53434,M53434)","v":"Hepatolenticular Degeneration"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53434,N53434)","v":"DTXSID7035012"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53434,J53434)","v":"2873435"},"Compliance in Wilson's disease and in copper toxicosis of Bedlington terriers.","2873435","Basal Ganglia Diseases","D006527","Hepatolenticular Degeneration","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53435,D53435)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53435,M53435)","v":"Hepatolenticular Degeneration"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53435,N53435)","v":"DTXSID7035012"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53435,J53435)","v":"3341945"},"Wilson's disease.","3341945","Basal Ganglia Diseases","D006527","Hepatolenticular Degeneration","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53436,D53436)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53436,M53436)","v":"Hypesthesia"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53436,N53436)","v":"DTXSID7035012"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53436,J53436)","v":"3268418"},"Painful dysesthesia of the inferior alveolar nerve following use of a paraformaldehyde-containing root canal sealer.","3268418","Neurologic Manifestations","D006987","Hypesthesia","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53437,D53437)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53437,M53437)","v":"Intracranial Embolism"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53437,N53437)","v":"DTXSID7035012"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53437,J53437)","v":"14746904"},"Effect of zinc in ischemic brain injury in an embolic model of stroke in rats.","14746904","Central Nervous System Diseases","D020766","Intracranial Embolism","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53438,D53438)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53438,M53438)","v":"Memory Disorders"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53438,N53438)","v":"DTXSID7035012"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53438,J53438)","v":"23383172"},"High dose zinc supplementation induces hippocampal zinc deficiency and memory impairment with inhibition of BDNF signaling.","23383172","Neurologic Manifestations","D008569","Memory Disorders","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53439,D53439)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53439,M53439)","v":"Multiple Sclerosis"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53439,N53439)","v":"DTXSID7035012"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53439,J53439)","v":"7936271"},"Zinc and multiple sclerosis.","7936271","Demyelinating Diseases","D009103","Multiple Sclerosis","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53440,D53440)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53440,M53440)","v":"Muscular Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53440,N53440)","v":"DTXSID7035012"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53440,J53440)","v":"3734720"},"Skeletal muscle and myocardial injury associated with metal fume fever.","3734720","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53441,D53441)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53441,M53441)","v":"Nervous System Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53441,N53441)","v":"DTXSID7035012"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53441,J53441)","v":"7678965"},"AMPA receptor activation potentiates zinc neurotoxicity.","7678965","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53442,D53442)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53442,M53442)","v":"Nervous System Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53442,N53442)","v":"DTXSID7035012"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53442,J53442)","v":"1670027"},"[Experimental study of heavy metal interactions in mice].","1670027","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53443,D53443)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53443,M53443)","v":"Nervous System Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53443,N53443)","v":"DTXSID7035012"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53443,J53443)","v":"1399024"},"Clinical studies in workers engaged in maintenance of watermark moulds in a paper mill.","1399024","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53444,D53444)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53444,M53444)","v":"Neuritis"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53444,N53444)","v":"DTXSID7035012"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53444,J53444)","v":"75471"},"Zinc pyrithione and peripheral neuritis.","75471","Neuromuscular Diseases","D009443","Neuritis","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53445,D53445)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53445,M53445)","v":"Neurodegenerative Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53445,N53445)","v":"DTXSID7035012"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53445,J53445)","v":"15707694"},"The effects of 17beta-estradiol and ethanol on zinc- or manganese-induced toxicity in SK-N-SH cells.","15707694","Neurodegenerative Diseases","D019636","Neurodegenerative Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53446,D53446)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53446,M53446)","v":"Neuromuscular Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53446,N53446)","v":"DTXSID7035012"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53446,J53446)","v":"2333068"},"ZPT-related distal axonopathy: behavioral and electrophysiologic correlates in rats.","2333068","Neuromuscular Diseases","D009468","Neuromuscular Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53447,D53447)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53447,M53447)","v":"Olfaction Disorders"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53447,N53447)","v":"DTXSID7035012"},1977,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53447,J53447)","v":"893754"},"Evaluation of intranasal zinc sulfate treatment on olfactory discrimination in rats.","893754","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53448,D53448)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53448,M53448)","v":"Olfaction Disorders"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53448,N53448)","v":"DTXSID7035012"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53448,J53448)","v":"26386292"},"Position on zinc delivery to olfactory nerves in intranasal insulin phase I-III clinical trials.","26386292","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53449,D53449)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53449,M53449)","v":"Olfaction Disorders"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53449,N53449)","v":"DTXSID7035012"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53449,J53449)","v":"3448494"},"[Morphofunctional research on the olfactory organ of the mouse after zinc sulfate exposure].","3448494","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53450,D53450)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53450,M53450)","v":"Olfaction Disorders"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53450,N53450)","v":"DTXSID7035012"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53450,J53450)","v":"16955018"},"Re: Alexander TH, Davidson TM. Intranasal zinc and anosmia: the zinc-induced anosmia syndrome. Laryngoscope 2006;116:217-220.","16955018","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53451,D53451)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53451,M53451)","v":"Olfaction Disorders"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53451,N53451)","v":"DTXSID7035012"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53451,J53451)","v":"16955017"},"RE: Alexander TH, Davidson TM. Intranasal zinc and anosmia: the zinc-induced anosmia syndrome. Laryngoscope 2006;116:217-220.","16955017","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53452,D53452)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53452,M53452)","v":"Olfaction Disorders"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53452,N53452)","v":"DTXSID7035012"},1975,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53452,J53452)","v":"1122203"},"Peripheral anosmia and the discrimination of poisoned food by Rattus rattus L.","1122203","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53453,D53453)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53453,M53453)","v":"Paralysis"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53453,N53453)","v":"DTXSID7035012"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53453,J53453)","v":"224150"},"Ultrastructural study of zinc pyridinethione-induced peripheral neuropathy.","224150","Neurologic Manifestations","D010243","Paralysis","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53454,D53454)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53454,M53454)","v":"Paresthesia"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53454,N53454)","v":"DTXSID7035012"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53454,J53454)","v":"3268418"},"Painful dysesthesia of the inferior alveolar nerve following use of a paraformaldehyde-containing root canal sealer.","3268418","Neurologic Manifestations","D010292","Paresthesia","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53455,D53455)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53455,M53455)","v":"Paresthesia"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53455,N53455)","v":"DTXSID7035012"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53455,J53455)","v":"3462160"},"Paraesthesia--a consequence of a controversial root-filling material? A case report.","3462160","Neurologic Manifestations","D010292","Paresthesia","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53456,D53456)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53456,M53456)","v":"Paresthesia"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53456,N53456)","v":"DTXSID7035012"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53456,J53456)","v":"21799108"},"Commentary.","21799108","Neurologic Manifestations","D010292","Paresthesia","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53457,D53457)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53457,M53457)","v":"Paresthesia"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53457,N53457)","v":"DTXSID7035012"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53457,J53457)","v":"21799109"},"Commentary.","21799109","Neurologic Manifestations","D010292","Paresthesia","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53458,D53458)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53458,M53458)","v":"Paresthesia"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53458,N53458)","v":"DTXSID7035012"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53458,J53458)","v":"21799107"},"Anemia, paresthesias, and gait ataxia in a 57-year-old denture wearer.","21799107","Neurologic Manifestations","D010292","Paresthesia","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53459,D53459)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53459,M53459)","v":"Paresthesia"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53459,N53459)","v":"DTXSID7035012"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53459,J53459)","v":"12874423"},"Myelopathy due to copper deficiency.","12874423","Neurologic Manifestations","D010292","Paresthesia","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53460,D53460)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53460,M53460)","v":"Peripheral Nervous System Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53460,N53460)","v":"DTXSID7035012"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53460,J53460)","v":"3017104"},"Psychological performance in relation to central and peripheral nerve conduction in workers exposed to lead, zinc, and copper.","3017104","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53461,D53461)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53461,M53461)","v":"Peripheral Nervous System Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53461,N53461)","v":"DTXSID7035012"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53461,J53461)","v":"18525032"},"Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease.","18525032","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53462,D53462)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53462,M53462)","v":"Peripheral Nervous System Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53462,N53462)","v":"DTXSID7035012"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53462,J53462)","v":"1665313"},"Autonomic nervous system dysfunction in workers exposed to lead, zinc, and copper in relation to peripheral nerve conduction: a study of R-R interval variability.","1665313","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53463,D53463)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53463,M53463)","v":"Peripheral Nervous System Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53463,N53463)","v":"DTXSID7035012"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53463,J53463)","v":"19564591"},"Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease.","19564591","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53464,D53464)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53464,M53464)","v":"Peripheral Nervous System Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53464,N53464)","v":"DTXSID7035012"},1979,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53464,J53464)","v":"224150"},"Ultrastructural study of zinc pyridinethione-induced peripheral neuropathy.","224150","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53465,D53465)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53465,M53465)","v":"Polyneuropathies"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53465,N53465)","v":"DTXSID7035012"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53465,J53465)","v":"20493327"},"Hyperzincemia from ingestion of denture adhesives.","20493327","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53466,D53466)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53466,M53466)","v":"Polyneuropathies"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53466,N53466)","v":"DTXSID7035012"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53466,J53466)","v":"22609346"},"Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.","22609346","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53467,D53467)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53467,M53467)","v":"Polyneuropathies"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53467,N53467)","v":"DTXSID7035012"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53467,J53467)","v":"21525151"},"Zinc poisoning from excessive denture fixative use masquerading as myelopolyneuropathy and hypocupraemia.","21525151","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53468,D53468)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53468,M53468)","v":"Pupil Disorders"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53468,N53468)","v":"DTXSID7035012"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53468,J53468)","v":"10919908"},"Unexpected corneal endothelial cell decompensation after intraocular surgery with instruments sterilized by plasma gas.","10919908","Neurologic Manifestations","D011681","Pupil Disorders","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53469,D53469)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53469,M53469)","v":"Seizures"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53469,N53469)","v":"DTXSID7035012"},1978,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53469,J53469)","v":"689968"},"Zinc phosphide poisoning in dogs.","689968","Neurologic Manifestations","D012640","Seizures","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53470,D53470)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53470,M53470)","v":"Seizures"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53470,N53470)","v":"DTXSID7035012"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53470,J53470)","v":"9666092"},"Diverse effects of metal chelating agents on the neuronal cytotoxicity of zinc in the hippocampus.","9666092","Neurologic Manifestations","D012640","Seizures","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53471,D53471)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53471,M53471)","v":"Seizures"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53471,N53471)","v":"DTXSID7035012"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53471,J53471)","v":"2318167"},"Effects of subcutaneous injections of zinc chloride on seizures induced by noise and by kainic acid.","2318167","Neurologic Manifestations","D012640","Seizures","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53472,D53472)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53472,M53472)","v":"Seizures"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53472,N53472)","v":"DTXSID7035012"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53472,J53472)","v":"10213688"},"Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator.","10213688","Neurologic Manifestations","D012640","Seizures","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53473,D53473)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53473,M53473)","v":"Sensation Disorders"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53473,N53473)","v":"DTXSID7035012"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53473,J53473)","v":"22609346"},"Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.","22609346","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53474,D53474)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53474,M53474)","v":"Spinal Cord Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53474,N53474)","v":"DTXSID7035012"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53474,J53474)","v":"18525032"},"Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease.","18525032","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53475,D53475)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53475,M53475)","v":"Spinal Cord Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53475,N53475)","v":"DTXSID7035012"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53475,J53475)","v":"24688096"},"Myelopathy among zinc-smelter workers in Upper Silesia during the late 19th century.","24688096","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53476,D53476)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53476,M53476)","v":"Spinal Cord Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53476,N53476)","v":"DTXSID7035012"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53476,J53476)","v":"19564591"},"Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease.","19564591","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53477,D53477)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53477,M53477)","v":"Spinal Cord Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53477,N53477)","v":"DTXSID7035012"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53477,J53477)","v":"22609346"},"Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.","22609346","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53478,D53478)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53478,M53478)","v":"Spinal Cord Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53478,N53478)","v":"DTXSID7035012"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53478,J53478)","v":"21799109"},"Commentary.","21799109","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53479,D53479)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53479,M53479)","v":"Spinal Cord Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53479,N53479)","v":"DTXSID7035012"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53479,J53479)","v":"21799108"},"Commentary.","21799108","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53480,D53480)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53480,M53480)","v":"Spinal Cord Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53480,N53480)","v":"DTXSID7035012"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53480,J53480)","v":"21799107"},"Anemia, paresthesias, and gait ataxia in a 57-year-old denture wearer.","21799107","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53481,D53481)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53481,M53481)","v":"Spinal Cord Diseases"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53481,N53481)","v":"DTXSID7035012"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53481,J53481)","v":"12874423"},"Myelopathy due to copper deficiency.","12874423","Central Nervous System Diseases","D013118","Spinal Cord Diseases","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53482,D53482)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53482,M53482)","v":"Stroke"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53482,N53482)","v":"DTXSID7035012"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53482,J53482)","v":"14746904"},"Effect of zinc in ischemic brain injury in an embolic model of stroke in rats.","14746904","Central Nervous System Diseases","D020521","Stroke","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53483,D53483)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53483,M53483)","v":"Taste Disorders"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53483,N53483)","v":"DTXSID7035012"},1980,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53483,J53483)","v":"6988119"},"Effects of zinc in chronic hemodialysis.","6988119","Neurologic Manifestations","D013651","Taste Disorders","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53484,D53484)","v":"Zinc"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53484,M53484)","v":"Unconsciousness"},"D015032","Zinc","7440-66-6",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53484,N53484)","v":"DTXSID7035012"},1972,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53484,J53484)","v":"4656552"},"[Zinc intoxication. Is it dangerous to use zinc tablets?].","4656552","Neurologic Manifestations","D014474","Unconsciousness","DTXSID7035012"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53485,D53485)","v":"Zinc Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53485,M53485)","v":"Hypesthesia"},"D015034","Zinc Oxide","1314-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53485,N53485)","v":"DTXSID7035016"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53485,J53485)","v":"3268418"},"Painful dysesthesia of the inferior alveolar nerve following use of a paraformaldehyde-containing root canal sealer.","3268418","Neurologic Manifestations","D006987","Hypesthesia","DTXSID7035016"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53486,D53486)","v":"Zinc Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53486,M53486)","v":"Meningitis, Aseptic"},"D015034","Zinc Oxide","1314-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53486,N53486)","v":"DTXSID7035016"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53486,J53486)","v":"16314334"},"Metal fume fever presenting as aseptic meningitis with pericarditis, pleuritis and pneumonitis.","16314334","Central Nervous System Diseases","D008582","Meningitis, Aseptic","DTXSID7035016"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53487,D53487)","v":"Zinc Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53487,M53487)","v":"Muscular Diseases"},"D015034","Zinc Oxide","1314-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53487,N53487)","v":"DTXSID7035016"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53487,J53487)","v":"3734720"},"Skeletal muscle and myocardial injury associated with metal fume fever.","3734720","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID7035016"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53488,D53488)","v":"Zinc Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53488,M53488)","v":"Paresthesia"},"D015034","Zinc Oxide","1314-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53488,N53488)","v":"DTXSID7035016"},1988,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53488,J53488)","v":"3268418"},"Painful dysesthesia of the inferior alveolar nerve following use of a paraformaldehyde-containing root canal sealer.","3268418","Neurologic Manifestations","D010292","Paresthesia","DTXSID7035016"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53489,D53489)","v":"Zinc Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53489,M53489)","v":"Paresthesia"},"D015034","Zinc Oxide","1314-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53489,N53489)","v":"DTXSID7035016"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53489,J53489)","v":"3462160"},"Paraesthesia--a consequence of a controversial root-filling material? A case report.","3462160","Neurologic Manifestations","D010292","Paresthesia","DTXSID7035016"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53490,D53490)","v":"Zinc Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53490,M53490)","v":"Paresthesia"},"D015034","Zinc Oxide","1314-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53490,N53490)","v":"DTXSID7035016"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53490,J53490)","v":"1820855"},"Neurotoxic effect of two root canal sealers with calcium hydroxide on rat phrenic nerve in vitro.","1820855","Neurologic Manifestations","D010292","Paresthesia","DTXSID7035016"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53491,D53491)","v":"Zinc Oxide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53491,M53491)","v":"Psychomotor Disorders"},"D015034","Zinc Oxide","1314-13-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53491,N53491)","v":"DTXSID7035016"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53491,J53491)","v":"1453950"},"[An atypical case of acute zinc poisoning].","1453950","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID7035016"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53492,D53492)","v":"Zinc Sulfate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53492,M53492)","v":"Hepatolenticular Degeneration"},"D019287","Zinc Sulfate","7733-02-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53492,N53492)","v":"DTXSID2040315"},1986,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53492,J53492)","v":"2873435"},"Compliance in Wilson's disease and in copper toxicosis of Bedlington terriers.","2873435","Basal Ganglia Diseases","D006527","Hepatolenticular Degeneration","DTXSID2040315"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53493,D53493)","v":"Zinc Sulfate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53493,M53493)","v":"Muscular Atrophy"},"D019287","Zinc Sulfate","7733-02-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53493,N53493)","v":"DTXSID2040315"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53493,J53493)","v":"21449011"},"Copper deficiency in Wilson's disease: peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment.","21449011","Neurologic Manifestations","D009133","Muscular Atrophy","DTXSID2040315"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53494,D53494)","v":"Zinc Sulfate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53494,M53494)","v":"Olfaction Disorders"},"D019287","Zinc Sulfate","7733-02-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53494,N53494)","v":"DTXSID2040315"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53494,J53494)","v":"27993691"},"Effects of ZnSO4-induced peripheral anosmia on zebrafish behavior and physiology.","27993691","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID2040315"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53495,D53495)","v":"Zinc Sulfate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53495,M53495)","v":"Olfaction Disorders"},"D019287","Zinc Sulfate","7733-02-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53495,N53495)","v":"DTXSID2040315"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53495,J53495)","v":"3448494"},"[Morphofunctional research on the olfactory organ of the mouse after zinc sulfate exposure].","3448494","Neurologic Manifestations","D000857","Olfaction Disorders","DTXSID2040315"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53496,D53496)","v":"Zinc Sulfate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53496,M53496)","v":"Peripheral Nervous System Diseases"},"D019287","Zinc Sulfate","7733-02-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53496,N53496)","v":"DTXSID2040315"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53496,J53496)","v":"21956703"},"Copper deficiency in Wilson's disease: an avoidable complication of treatment.","21956703","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID2040315"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53497,D53497)","v":"Zinc Sulfate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53497,M53497)","v":"Peripheral Nervous System Diseases"},"D019287","Zinc Sulfate","7733-02-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53497,N53497)","v":"DTXSID2040315"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53497,J53497)","v":"21449011"},"Copper deficiency in Wilson's disease: peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment.","21449011","Neuromuscular Diseases","D010523","Peripheral Nervous System Diseases","DTXSID2040315"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53498,D53498)","v":"Zinc Sulfate"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53498,M53498)","v":"Polyneuropathies"},"D019287","Zinc Sulfate","7733-02-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53498,N53498)","v":"DTXSID2040315"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53498,J53498)","v":"20921535"},"Zinc-induced copper deficiency in Wilson disease.","20921535","Neuromuscular Diseases","D011115","Polyneuropathies","DTXSID2040315"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53499,D53499)","v":"Zineb"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53499,M53499)","v":"Autonomic Nervous System Diseases"},"D015038","Zineb","12122-67-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53499,N53499)","v":"DTXSID5021465"},1981,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53499,J53499)","v":"6455855"},"[Clinical and functional changes on exposure to Zineb].","6455855","Autonomic Nervous System Diseases","D001342","Autonomic Nervous System Diseases","DTXSID5021465"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53500,D53500)","v":"Zineb"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53500,M53500)","v":"Brain Diseases"},"D015038","Zineb","12122-67-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53500,N53500)","v":"DTXSID5021465"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53500,J53500)","v":"6578728"},"Acute central nervous system changes due to intoxication by Manzidan (a combined dithiocarbamate of Maneb and Zineb).","6578728","Central Nervous System Diseases","D001927","Brain Diseases","DTXSID5021465"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53501,D53501)","v":"Zineb"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53501,M53501)","v":"Hemiplegia"},"D015038","Zineb","12122-67-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53501,N53501)","v":"DTXSID5021465"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53501,J53501)","v":"6857188"},"Acute intoxication due to exposure to maneb and zineb. A case with behavioral and central nervous system changes.","6857188","Neurologic Manifestations","D006429","Hemiplegia","DTXSID5021465"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53502,D53502)","v":"Zineb"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53502,M53502)","v":"Hyperkinesis"},"D015038","Zineb","12122-67-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53502,N53502)","v":"DTXSID5021465"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53502,J53502)","v":"16198425"},"Effects of prenatal paraquat and mancozeb exposure on amino acid synaptic transmission in developing mouse cerebellar cortex.","16198425","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID5021465"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53503,D53503)","v":"Zineb"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53503,M53503)","v":"Neural Tube Defects"},"D015038","Zineb","12122-67-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53503,N53503)","v":"DTXSID5021465"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53503,J53503)","v":"15864902"},"Indicators of mancozeb exposure in relation to thyroid cancer and neural tube defects in farmers' families.","15864902","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID5021465"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53504,D53504)","v":"Zineb"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53504,M53504)","v":"Parkinsonian Disorders"},"D015038","Zineb","12122-67-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53504,N53504)","v":"DTXSID5021465"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53504,J53504)","v":"20960484"},"Reversible Parkinsonism after accidental oral intake of mancozeb.","20960484","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID5021465"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53505,D53505)","v":"Zineb"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53505,M53505)","v":"Seizures"},"D015038","Zineb","12122-67-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53505,N53505)","v":"DTXSID5021465"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53505,J53505)","v":"6578728"},"Acute central nervous system changes due to intoxication by Manzidan (a combined dithiocarbamate of Maneb and Zineb).","6578728","Neurologic Manifestations","D012640","Seizures","DTXSID5021465"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53506,D53506)","v":"Zineb"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53506,M53506)","v":"Seizures"},"D015038","Zineb","12122-67-7",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53506,N53506)","v":"DTXSID5021465"},1983,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53506,J53506)","v":"6857188"},"Acute intoxication due to exposure to maneb and zineb. A case with behavioral and central nervous system changes.","6857188","Neurologic Manifestations","D012640","Seizures","DTXSID5021465"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53507,D53507)","v":"zipeprol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53507,M53507)","v":"Hallucinations"},"C013341","zipeprol",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53507,N53507)","v":"DTXSID00865732"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53507,J53507)","v":"2055160"},"Zipeprol is a newly abused antitussive with an opioid spectrum and hallucinogenic effects.","2055160","Neurologic Manifestations","D006212","Hallucinations","DTXSID00865732"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53508,D53508)","v":"zipeprol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53508,M53508)","v":"Nervous System Diseases"},"C013341","zipeprol",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53508,N53508)","v":"DTXSID00865732"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53508,J53508)","v":"7740233"},"[Neuropsychic side-effects of therapeutic doses of zipeprol]].","7740233","Nervous System Diseases","D009422","Nervous System Diseases","DTXSID00865732"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53509,D53509)","v":"zipeprol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53509,M53509)","v":"Seizures"},"C013341","zipeprol",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53509,N53509)","v":"DTXSID00865732"},1985,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53509,J53509)","v":"4026148"},"[Convulsions with 3 antitussive substituted derivatives of piperazine (zipeprol, eprazinone, eprozinol)].","4026148","Neurologic Manifestations","D012640","Seizures","DTXSID00865732"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53510,D53510)","v":"zipeprol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53510,M53510)","v":"Seizures"},"C013341","zipeprol",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53510,N53510)","v":"DTXSID00865732"},1984,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53510,J53510)","v":"6140366"},"Overdosage of zipeprol, a non-opiod antitussive agent.","6140366","Neurologic Manifestations","D012640","Seizures","DTXSID00865732"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53511,D53511)","v":"zipeprol"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53511,M53511)","v":"Seizures"},"C013341","zipeprol",null,{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53511,N53511)","v":"DTXSID00865732"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53511,J53511)","v":"11082743"},"Zipeprol (Zinolta) abuse among American adolescents in Korea: a discussion of the problem, clinical presentation, and treatment.","11082743","Neurologic Manifestations","D012640","Seizures","DTXSID00865732"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53512,D53512)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53512,M53512)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53512,N53512)","v":"DTXSID00160855"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53512,J53512)","v":"17541882"},"Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels.","17541882","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53513,D53513)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53513,M53513)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53513,N53513)","v":"DTXSID00160855"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53513,J53513)","v":"24930580"},"Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.","24930580","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53514,D53514)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53514,M53514)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53514,N53514)","v":"DTXSID00160855"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53514,J53514)","v":"15741487"},"Ziprasidone-induced acute dystonia.","15741487","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53515,D53515)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53515,M53515)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53515,N53515)","v":"DTXSID00160855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53515,J53515)","v":"15465997"},"Prolactin elevation with ziprasidone.","15465997","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53516,D53516)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53516,M53516)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53516,N53516)","v":"DTXSID00160855"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53516,J53516)","v":"16199834"},"Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.","16199834","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53517,D53517)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53517,M53517)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53517,N53517)","v":"DTXSID00160855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53517,J53517)","v":"15517847"},"The utility of intramuscular ziprasidone in the management of acute psychotic agitation.","15517847","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53518,D53518)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53518,M53518)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53518,N53518)","v":"DTXSID00160855"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53518,J53518)","v":"19673087"},"Tardive dyskinesia in a patient treated with quetiapine.","19673087","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53519,D53519)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53519,M53519)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53519,N53519)","v":"DTXSID00160855"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53519,J53519)","v":"19542525"},"Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial.","19542525","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53520,D53520)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53520,M53520)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53520,N53520)","v":"DTXSID00160855"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53520,J53520)","v":"22290206"},"Efficacy and tolerability of ziprasidone vs. olanzapine in naive first-episode schizophrenia: a 6-week, randomized, open-label, flexible-dose study.","22290206","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53521,D53521)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53521,M53521)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53521,N53521)","v":"DTXSID00160855"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53521,J53521)","v":"23218157"},"Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.","23218157","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53522,D53522)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53522,M53522)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53522,N53522)","v":"DTXSID00160855"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53522,J53522)","v":"11978164"},"Ziprasidone: the fifth atypical antipsychotic.","11978164","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53523,D53523)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53523,M53523)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53523,N53523)","v":"DTXSID00160855"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53523,J53523)","v":"14624190"},"Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone.","14624190","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53524,D53524)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53524,M53524)","v":"Basal Ganglia Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53524,N53524)","v":"DTXSID00160855"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53524,J53524)","v":"14624205"},"Extrapyramidal symptoms in children on atypical antipsychotic drugs.","14624205","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53525,D53525)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53525,M53525)","v":"Catatonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53525,N53525)","v":"DTXSID00160855"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53525,J53525)","v":"18070860"},"A case report with ziprasidone-induced catatonic symptoms.","18070860","Neurologic Manifestations","D002389","Catatonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53526,D53526)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53526,M53526)","v":"Central Nervous System Diseases"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53526,N53526)","v":"DTXSID00160855"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53526,J53526)","v":"12665274"},"Comparing the side effect profile of the atypical antipsychotics.","12665274","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53527,D53527)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53527,M53527)","v":"Coma"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53527,N53527)","v":"DTXSID00160855"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53527,J53527)","v":"19369840"},"Pediatric ziprasidone overdose.","19369840","Neurologic Manifestations","D003128","Coma","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53528,D53528)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53528,M53528)","v":"Delirium"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53528,N53528)","v":"DTXSID00160855"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53528,J53528)","v":"12042202"},"Overdose of ziprasidone.","12042202","Neurologic Manifestations","D003693","Delirium","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53529,D53529)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53529,M53529)","v":"Disorders of Excessive Somnolence"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53529,N53529)","v":"DTXSID00160855"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53529,J53529)","v":"16983187"},"An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia.","16983187","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53530,D53530)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53530,M53530)","v":"Disorders of Excessive Somnolence"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53530,N53530)","v":"DTXSID00160855"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53530,J53530)","v":"25483358"},"Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.","25483358","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53531,D53531)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53531,M53531)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53531,N53531)","v":"DTXSID00160855"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53531,J53531)","v":"17123682"},"High-dose ziprasidone-induced acute dystonia.","17123682","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53532,D53532)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53532,M53532)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53532,N53532)","v":"DTXSID00160855"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53532,J53532)","v":"17414248"},"Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports.","17414248","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53533,D53533)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53533,M53533)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53533,N53533)","v":"DTXSID00160855"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53533,J53533)","v":"17484950"},"Cocaine use as a risk factor for ziprasidone-induced acute dystonia.","17484950","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53534,D53534)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53534,M53534)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53534,N53534)","v":"DTXSID00160855"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53534,J53534)","v":"17343967"},"Ziprasidone-induced acute laryngeal dystonia.","17343967","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53535,D53535)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53535,M53535)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53535,N53535)","v":"DTXSID00160855"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53535,J53535)","v":"18433661"},"Ziprasidone-induced tardive laryngeal dystonia: a case report.","18433661","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53536,D53536)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53536,M53536)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53536,N53536)","v":"DTXSID00160855"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53536,J53536)","v":"18315450"},"Ziprasidone in adolescents with autism: an open-label pilot study.","18315450","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53537,D53537)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53537,M53537)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53537,N53537)","v":"DTXSID00160855"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53537,J53537)","v":"18305296"},"Acute pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone.","18305296","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53538,D53538)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53538,M53538)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53538,N53538)","v":"DTXSID00160855"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53538,J53538)","v":"18597910"},"Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.","18597910","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53539,D53539)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53539,M53539)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53539,N53539)","v":"DTXSID00160855"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53539,J53539)","v":"23698184"},"Acute dystonia, akathisia, and parkinsonism induced by ziprasidone.","23698184","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53540,D53540)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53540,M53540)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53540,N53540)","v":"DTXSID00160855"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53540,J53540)","v":"16566635"},"Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder.","16566635","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53541,D53541)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53541,M53541)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53541,N53541)","v":"DTXSID00160855"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53541,J53541)","v":"16580766"},"Acute dystonia after initial doses of ziprasidone: a case report.","16580766","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53542,D53542)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53542,M53542)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53542,N53542)","v":"DTXSID00160855"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53542,J53542)","v":"15741487"},"Ziprasidone-induced acute dystonia.","15741487","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53543,D53543)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53543,M53543)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53543,N53543)","v":"DTXSID00160855"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53543,J53543)","v":"15960579"},"An African patient with ziprasidone intolerance.","15960579","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53544,D53544)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53544,M53544)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53544,N53544)","v":"DTXSID00160855"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53544,J53544)","v":"20520306"},"A nearly overlooked mild case of ziprasidone-induced lingual dystonia.","20520306","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53545,D53545)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53545,M53545)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53545,N53545)","v":"DTXSID00160855"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53545,J53545)","v":"19028541"},"Chronic Pisa syndrome associated with switching antipsychotics from olanzapine to ziprasidone.","19028541","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53546,D53546)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53546,M53546)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53546,N53546)","v":"DTXSID00160855"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53546,J53546)","v":"14627778"},"Ziprasidone-induced Pisa syndrome after clozapine treatment.","14627778","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53547,D53547)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53547,M53547)","v":"Dystonia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53547,N53547)","v":"DTXSID00160855"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53547,J53547)","v":"12964566"},"Ziprasidone-induced oculogyric crisis.","12964566","Neurologic Manifestations","D004421","Dystonia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53548,D53548)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53548,M53548)","v":"Dystonic Disorders"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53548,N53548)","v":"DTXSID00160855"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53548,J53548)","v":"16263868"},"Tardive dystonia associated with ziprasidone.","16263868","Central Nervous System Diseases","D020821","Dystonic Disorders","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53549,D53549)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53549,M53549)","v":"Dystonic Disorders"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53549,N53549)","v":"DTXSID00160855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53549,J53549)","v":"15349021"},"Acute dystonic reaction with moderate-dose ziprasidone.","15349021","Central Nervous System Diseases","D020821","Dystonic Disorders","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53550,D53550)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53550,M53550)","v":"Hallucinations"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53550,N53550)","v":"DTXSID00160855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53550,J53550)","v":"15349021"},"Acute dystonic reaction with moderate-dose ziprasidone.","15349021","Neurologic Manifestations","D006212","Hallucinations","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53551,D53551)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53551,M53551)","v":"Hallucinations"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53551,N53551)","v":"DTXSID00160855"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53551,J53551)","v":"22249643"},"Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone.","22249643","Neurologic Manifestations","D006212","Hallucinations","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53552,D53552)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53552,M53552)","v":"Hoarseness"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53552,N53552)","v":"DTXSID00160855"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53552,J53552)","v":"18433661"},"Ziprasidone-induced tardive laryngeal dystonia: a case report.","18433661","Neurologic Manifestations","D006685","Hoarseness","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53553,D53553)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53553,M53553)","v":"Hyperprolactinemia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53553,N53553)","v":"DTXSID00160855"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53553,J53553)","v":"17489723"},"Ziprasidone-associated galactorrhea in an adolescent female.","17489723","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53554,D53554)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53554,M53554)","v":"Hyperprolactinemia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53554,N53554)","v":"DTXSID00160855"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53554,J53554)","v":"18276052"},"Ziprasidone-induced hyperprolactinemia: a case report.","18276052","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53555,D53555)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53555,M53555)","v":"Hyperprolactinemia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53555,N53555)","v":"DTXSID00160855"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53555,J53555)","v":"18950388"},"Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.","18950388","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53556,D53556)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53556,M53556)","v":"Hyperprolactinemia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53556,N53556)","v":"DTXSID00160855"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53556,J53556)","v":"23727135"},"Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.","23727135","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53557,D53557)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53557,M53557)","v":"Hyperprolactinemia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53557,N53557)","v":"DTXSID00160855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53557,J53557)","v":"15641867"},"Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.","15641867","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53558,D53558)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53558,M53558)","v":"Hyperprolactinemia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53558,N53558)","v":"DTXSID00160855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53558,J53558)","v":"15465997"},"Prolactin elevation with ziprasidone.","15465997","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53559,D53559)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53559,M53559)","v":"Hyperprolactinemia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53559,N53559)","v":"DTXSID00160855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53559,J53559)","v":"15367061"},"Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report.","15367061","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53560,D53560)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53560,M53560)","v":"Hyperprolactinemia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53560,N53560)","v":"DTXSID00160855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53560,J53560)","v":"15243877"},"[Ziprasidone-augmentation of clozapine].","15243877","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53561,D53561)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53561,M53561)","v":"Hyperprolactinemia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53561,N53561)","v":"DTXSID00160855"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53561,J53561)","v":"20502130"},"Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.","20502130","Central Nervous System Diseases","D006966","Hyperprolactinemia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53562,D53562)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53562,M53562)","v":"Hypotension, Orthostatic"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53562,N53562)","v":"DTXSID00160855"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53562,J53562)","v":"19369840"},"Pediatric ziprasidone overdose.","19369840","Autonomic Nervous System Diseases","D007024","Hypotension, Orthostatic","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53563,D53563)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53563,M53563)","v":"Miosis"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53563,N53563)","v":"DTXSID00160855"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53563,J53563)","v":"19369840"},"Pediatric ziprasidone overdose.","19369840","Neurologic Manifestations","D015877","Miosis","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53564,D53564)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53564,M53564)","v":"Muscle Rigidity"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53564,N53564)","v":"DTXSID00160855"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53564,J53564)","v":"12153844"},"Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone.","12153844","Neurologic Manifestations","D009127","Muscle Rigidity","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53565,D53565)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53565,M53565)","v":"Ocular Motility Disorders"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53565,N53565)","v":"DTXSID00160855"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53565,J53565)","v":"19717224"},"Ziprasidone-related oculogyric crisis in an adult.","19717224","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53566,D53566)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53566,M53566)","v":"Ocular Motility Disorders"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53566,N53566)","v":"DTXSID00160855"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53566,J53566)","v":"12964566"},"Ziprasidone-induced oculogyric crisis.","12964566","Cranial Nerve Diseases","D015835","Ocular Motility Disorders","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53567,D53567)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53567,M53567)","v":"Parasomnias"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53567,N53567)","v":"DTXSID00160855"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53567,J53567)","v":"27281388"},"A Case of Sleepwalking With Sleep-Related Eating Associated With Ziprasidone Therapy in a Patient With Schizoaffective Disorder.","27281388","Sleep Wake Disorders","D020447","Parasomnias","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53568,D53568)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53568,M53568)","v":"Parkinson Disease, Secondary"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53568,N53568)","v":"DTXSID00160855"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53568,J53568)","v":"16949733"},"Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.","16949733","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53569,D53569)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53569,M53569)","v":"Parkinson Disease, Secondary"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53569,N53569)","v":"DTXSID00160855"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53569,J53569)","v":"16983187"},"An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia.","16983187","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53570,D53570)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53570,M53570)","v":"Parkinson Disease, Secondary"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53570,N53570)","v":"DTXSID00160855"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53570,J53570)","v":"16330610"},"Parkinsonism with intramuscular ziprasidone.","16330610","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53571,D53571)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53571,M53571)","v":"Parkinsonian Disorders"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53571,N53571)","v":"DTXSID00160855"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53571,J53571)","v":"17366349"},"Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.","17366349","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53572,D53572)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53572,M53572)","v":"Parkinsonian Disorders"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53572,N53572)","v":"DTXSID00160855"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53572,J53572)","v":"23698184"},"Acute dystonia, akathisia, and parkinsonism induced by ziprasidone.","23698184","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53573,D53573)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53573,M53573)","v":"Parkinsonian Disorders"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53573,N53573)","v":"DTXSID00160855"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53573,J53573)","v":"19752843"},"Switching to duloxetine remits ziprasidone - associated urinary incontinence and improves neuropsychiatric behavior in dementia: possible relationship of incontinence to 5HT2 receptor blockade.","19752843","Basal Ganglia Diseases","D020734","Parkinsonian Disorders","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53574,D53574)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53574,M53574)","v":"Photophobia"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53574,N53574)","v":"DTXSID00160855"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53574,J53574)","v":"12153843"},"Ziprasidone and migraine headache.","12153843","Neurologic Manifestations","D020795","Photophobia","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53575,D53575)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53575,M53575)","v":"Seizures"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53575,N53575)","v":"DTXSID00160855"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53575,J53575)","v":"16820256"},"A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis.","16820256","Neurologic Manifestations","D012640","Seizures","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53576,D53576)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53576,M53576)","v":"Sleep Initiation and Maintenance Disorders"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53576,N53576)","v":"DTXSID00160855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53576,J53576)","v":"15641867"},"Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.","15641867","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53577,D53577)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53577,M53577)","v":"Sleep Initiation and Maintenance Disorders"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53577,N53577)","v":"DTXSID00160855"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53577,J53577)","v":"12088164"},"A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia.","12088164","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53578,D53578)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53578,M53578)","v":"Somnambulism"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53578,N53578)","v":"DTXSID00160855"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53578,J53578)","v":"27281388"},"A Case of Sleepwalking With Sleep-Related Eating Associated With Ziprasidone Therapy in a Patient With Schizoaffective Disorder.","27281388","Sleep Wake Disorders","D013009","Somnambulism","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53579,D53579)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53579,M53579)","v":"Stroke"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53579,N53579)","v":"DTXSID00160855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53579,J53579)","v":"15334150"},"[Ziprasidone and dementia].","15334150","Central Nervous System Diseases","D020521","Stroke","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53580,D53580)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53580,M53580)","v":"Tics"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53580,N53580)","v":"DTXSID00160855"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53580,J53580)","v":"19910734"},"Vocal tics associated with ziprasidone.","19910734","Neurologic Manifestations","D020323","Tics","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53581,D53581)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53581,M53581)","v":"Torticollis"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53581,N53581)","v":"DTXSID00160855"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53581,J53581)","v":"15349021"},"Acute dystonic reaction with moderate-dose ziprasidone.","15349021","Central Nervous System Diseases","D014103","Torticollis","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53582,D53582)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53582,M53582)","v":"Torticollis"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53582,N53582)","v":"DTXSID00160855"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53582,J53582)","v":"19164500"},"Ziprasidone-induced spontaneous orgasm.","19164500","Central Nervous System Diseases","D014103","Torticollis","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53583,D53583)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53583,M53583)","v":"Tourette Syndrome"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53583,N53583)","v":"DTXSID00160855"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53583,J53583)","v":"19910734"},"Vocal tics associated with ziprasidone.","19910734","Basal Ganglia Diseases","D005879","Tourette Syndrome","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53584,D53584)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53584,M53584)","v":"Trismus"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53584,N53584)","v":"DTXSID00160855"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53584,J53584)","v":"12153843"},"Ziprasidone and migraine headache.","12153843","Neurologic Manifestations","D014313","Trismus","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53585,D53585)","v":"ziprasidone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53585,M53585)","v":"Voice Disorders"},"C092292","ziprasidone","138982-67-9",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53585,N53585)","v":"DTXSID00160855"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53585,J53585)","v":"18433661"},"Ziprasidone-induced tardive laryngeal dystonia: a case report.","18433661","Neurologic Manifestations","D014832","Voice Disorders","DTXSID00160855"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53586,D53586)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53586,M53586)","v":"Cranial Nerve Diseases"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53586,N53586)","v":"DTXSID0042668"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53586,J53586)","v":"26980457"},"Multiple cranial neuropathies following zoledronic acid infusion: a relationship? Clinical features and pathogenic discussion concerning a case.","26980457","Cranial Nerve Diseases","D003389","Cranial Nerve Diseases","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53587,D53587)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53587,M53587)","v":"Dermatomyositis"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53587,N53587)","v":"DTXSID0042668"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53587,J53587)","v":"23157790"},"Drug-induced dermatomyositis after zoledronic acid.","23157790","Neuromuscular Diseases","D003882","Dermatomyositis","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53588,D53588)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53588,M53588)","v":"Dermatomyositis"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53588,N53588)","v":"DTXSID0042668"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53588,J53588)","v":"22007911"},"Possible zoledronic acid-induced dermatomyositis.","22007911","Neuromuscular Diseases","D003882","Dermatomyositis","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53589,D53589)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53589,M53589)","v":"Giant Cell Arteritis"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53589,N53589)","v":"DTXSID0042668"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53589,J53589)","v":"24472274"},"Giant cell arteritis with visual loss following zoledronic acid infusion.","24472274","Autoimmune Diseases of the Nervous System","D013700","Giant Cell Arteritis","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53590,D53590)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53590,M53590)","v":"Intracranial Hypertension"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53590,N53590)","v":"DTXSID0042668"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53590,J53590)","v":"23076294"},"Symptomatic intracranial hypertension and prolonged hypocalcemia following treatment of Paget's disease of the skull with zoledronic acid.","23076294","Central Nervous System Diseases","D019586","Intracranial Hypertension","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53591,D53591)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53591,M53591)","v":"Mandibular Fractures"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53591,N53591)","v":"DTXSID0042668"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53591,J53591)","v":"17970689"},"Intravenous bisphosphonate-associated osteonecrosis of the jaw.","17970689","Trauma, Nervous System","D008337","Mandibular Fractures","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53592,D53592)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53592,M53592)","v":"Optic Neuritis"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53592,N53592)","v":"DTXSID0042668"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53592,J53592)","v":"23357194"},"Zolendronic acid-induced retrobulbar optic neuritis: a case report.","23357194","Cranial Nerve Diseases","D009902","Optic Neuritis","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53593,D53593)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53593,M53593)","v":"Optic Neuropathy, Ischemic"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53593,N53593)","v":"DTXSID0042668"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53593,J53593)","v":"19606178"},"Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer.","19606178","Cranial Nerve Diseases","D018917","Optic Neuropathy, Ischemic","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53594,D53594)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53594,M53594)","v":"Orbital Myositis"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53594,N53594)","v":"DTXSID0042668"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53594,J53594)","v":"26540241"},"Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review.","26540241","Neuromuscular Diseases","D055622","Orbital Myositis","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53595,D53595)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53595,M53595)","v":"Seizures"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53595,N53595)","v":"DTXSID0042668"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53595,J53595)","v":"21508139"},"Seizures associated with zoledronic acid for osteoporosis.","21508139","Neurologic Manifestations","D012640","Seizures","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53596,D53596)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53596,M53596)","v":"Vision Disorders"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53596,N53596)","v":"DTXSID0042668"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53596,J53596)","v":"25372538"},"Severe visual loss secondary to retinal toxicity after intravenous use of bisphosphonate in an eye with known chloroquine maculopathy.","25372538","Neurologic Manifestations","D014786","Vision Disorders","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53597,D53597)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53597,M53597)","v":"Vision Disorders"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53597,N53597)","v":"DTXSID0042668"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53597,J53597)","v":"24472274"},"Giant cell arteritis with visual loss following zoledronic acid infusion.","24472274","Neurologic Manifestations","D014786","Vision Disorders","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53598,D53598)","v":"zoledronic acid"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53598,M53598)","v":"Vision Disorders"},"C088658","zoledronic acid","118072-93-8",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53598,N53598)","v":"DTXSID0042668"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53598,J53598)","v":"22489855"},"Bisphosphonate-associated orbital inflammation--a case report and review.","22489855","Neurologic Manifestations","D014786","Vision Disorders","DTXSID0042668"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53599,D53599)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53599,M53599)","v":"Alzheimer Disease"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53599,N53599)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53599,J53599)","v":"25929937"},"An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study.","25929937","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53600,D53600)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53600,M53600)","v":"Alzheimer Disease"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53600,N53600)","v":"DTXSID7045946"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53600,J53600)","v":"28884784"},"The Association Between the Use of Zolpidem and the Risk of Alzheimer's Disease Among Older People.","28884784","Neurodegenerative Diseases","D000544","Alzheimer Disease","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53601,D53601)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53601,M53601)","v":"Amnesia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53601,N53601)","v":"DTXSID7045946"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53601,J53601)","v":"8840378"},"Amnesia possibly associated with zolpidem administration.","8840378","Neurologic Manifestations","D000647","Amnesia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53602,D53602)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53602,M53602)","v":"Amnesia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53602,N53602)","v":"DTXSID7045946"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53602,J53602)","v":"8832310"},"Visual hallucinations and amnesia associated with the use of zolpidem.","8832310","Neurologic Manifestations","D000647","Amnesia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53603,D53603)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53603,M53603)","v":"Amnesia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53603,N53603)","v":"DTXSID7045946"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53603,J53603)","v":"2887188"},"Assessment of a new hypnotic imidazo-pyridine (zolpidem) as oral premedication.","2887188","Neurologic Manifestations","D000647","Amnesia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53604,D53604)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53604,M53604)","v":"Amnesia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53604,N53604)","v":"DTXSID7045946"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53604,J53604)","v":"17026779"},"Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction.","17026779","Neurologic Manifestations","D000647","Amnesia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53605,D53605)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53605,M53605)","v":"Amnesia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53605,N53605)","v":"DTXSID7045946"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53605,J53605)","v":"18468314"},"Report of two cases where sleep related eating behavior occurred with the extended-release formulation but not the immediate-release formulation of a sedative-hypnotic agent.","18468314","Neurologic Manifestations","D000647","Amnesia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53606,D53606)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53606,M53606)","v":"Amnesia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53606,N53606)","v":"DTXSID7045946"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53606,J53606)","v":"18819779"},"Zolpidem-induced amnesia and somnambulism: rare occurrences?","18819779","Neurologic Manifestations","D000647","Amnesia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53607,D53607)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53607,M53607)","v":"Amnesia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53607,N53607)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53607,J53607)","v":"24770472"},"Sleep self-intoxication and sleep driving as rare zolpidem-induced complex behaviour.","24770472","Neurologic Manifestations","D000647","Amnesia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53608,D53608)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53608,M53608)","v":"Amnesia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53608,N53608)","v":"DTXSID7045946"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53608,J53608)","v":"19901811"},"Drug-facilitated sexual assault provoked by the victim's religious beliefs: a case report.","19901811","Neurologic Manifestations","D000647","Amnesia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53609,D53609)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53609,M53609)","v":"Amnesia, Anterograde"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53609,N53609)","v":"DTXSID7045946"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53609,J53609)","v":"17364638"},"Compulsive activity and anterograde amnesia after zolpidem use.","17364638","Neurologic Manifestations","D020324","Amnesia, Anterograde","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53610,D53610)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53610,M53610)","v":"Amnesia, Anterograde"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53610,N53610)","v":"DTXSID7045946"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53610,J53610)","v":"17993047"},"Zolpidem and amnestic sleep related eating disorder.","17993047","Neurologic Manifestations","D020324","Amnesia, Anterograde","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53611,D53611)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53611,M53611)","v":"Amnesia, Anterograde"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53611,N53611)","v":"DTXSID7045946"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53611,J53611)","v":"23352047"},"Para-suicidal amnestic behavior associated with chronic zolpidem use: implications for patient safety.","23352047","Neurologic Manifestations","D020324","Amnesia, Anterograde","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53612,D53612)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53612,M53612)","v":"Amnesia, Transient Global"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53612,N53612)","v":"DTXSID7045946"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53612,J53612)","v":"19920437"},"Transient global amnesia-like episode due to mistaken intake of zolpidem: drug safety concern in the elderly.","19920437","Central Nervous System Diseases","D020236","Amnesia, Transient Global","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53613,D53613)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53613,M53613)","v":"Ataxia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53613,N53613)","v":"DTXSID7045946"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53613,J53613)","v":"20633172"},"Zolpidem poisoning in a cat.","20633172","Neurologic Manifestations","D001259","Ataxia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53614,D53614)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53614,M53614)","v":"Ataxia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53614,N53614)","v":"DTXSID7045946"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53614,J53614)","v":"19116499"},"Pattern of pediatric zolpidem ingestions reported to Texas poison control centers, 2000 to 2006.","19116499","Neurologic Manifestations","D001259","Ataxia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53615,D53615)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53615,M53615)","v":"Ataxia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53615,N53615)","v":"DTXSID7045946"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53615,J53615)","v":"11015689"},"Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.","11015689","Neurologic Manifestations","D001259","Ataxia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53616,D53616)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53616,M53616)","v":"Ataxia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53616,N53616)","v":"DTXSID7045946"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53616,J53616)","v":"11899040"},"Clinical syndrome associated with zolpidem ingestion in dogs: 33 cases (January 1998-July 2000).","11899040","Neurologic Manifestations","D001259","Ataxia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53617,D53617)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53617,M53617)","v":"Ataxia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53617,N53617)","v":"DTXSID7045946"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53617,J53617)","v":"12404077"},"Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.","12404077","Neurologic Manifestations","D001259","Ataxia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53618,D53618)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53618,M53618)","v":"Ataxia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53618,N53618)","v":"DTXSID7045946"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53618,J53618)","v":"14643976"},"Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin.","14643976","Neurologic Manifestations","D001259","Ataxia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53619,D53619)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53619,M53619)","v":"Brain Ischemia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53619,N53619)","v":"DTXSID7045946"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53619,J53619)","v":"23759463"},"Relationship between zolpidem use and stroke risk: a Taiwanese population-based case-control study.","23759463","Central Nervous System Diseases","D002545","Brain Ischemia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53620,D53620)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53620,M53620)","v":"Brain Neoplasms"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53620,N53620)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53620,J53620)","v":"25923854"},"Higher-dose uses of zolpidem will increase the subsequent risk of developing benign brain tumors.","25923854","Central Nervous System Diseases","D001932","Brain Neoplasms","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53621,D53621)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53621,M53621)","v":"Catalepsy"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53621,N53621)","v":"DTXSID7045946"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53621,J53621)","v":"24135337"},"Pharmacological characteristics of zolpidem-induced catalepsy in the rat.","24135337","Neurologic Manifestations","D002375","Catalepsy","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53622,D53622)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53622,M53622)","v":"Catatonia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53622,N53622)","v":"DTXSID7045946"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53622,J53622)","v":"21907070"},"Zolpidem-related withdrawal catatonia: a case report.","21907070","Neurologic Manifestations","D002389","Catatonia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53623,D53623)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53623,M53623)","v":"Central Nervous System Diseases"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53623,N53623)","v":"DTXSID7045946"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53623,J53623)","v":"9279301"},"Zolpidem (Ambien): a pediatric case series.","9279301","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53624,D53624)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53624,M53624)","v":"Central Nervous System Diseases"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53624,N53624)","v":"DTXSID7045946"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53624,J53624)","v":"15555480"},"Zolpidem prescribing and adverse drug reactions in hospitalized general medicine patients at a Veterans Affairs hospital.","15555480","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53625,D53625)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53625,M53625)","v":"Central Nervous System Diseases"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53625,N53625)","v":"DTXSID7045946"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53625,J53625)","v":"10682233"},"Central nervous system side effects associated with zolpidem treatment.","10682233","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53626,D53626)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53626,M53626)","v":"Chorea"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53626,N53626)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53626,J53626)","v":"25999122"},"Drug-induced hemichorea.","25999122","Central Nervous System Diseases","D002819","Chorea","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53627,D53627)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53627,M53627)","v":"Coma"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53627,N53627)","v":"DTXSID7045946"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53627,J53627)","v":"8693299"},"[Acute overdose of Zolpidem (Stilnox)].","8693299","Neurologic Manifestations","D003128","Coma","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53628,D53628)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53628,M53628)","v":"Coma"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53628,N53628)","v":"DTXSID7045946"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53628,J53628)","v":"8116589"},"A fatality involving two unusual compounds--zolpidem and acepromazine.","8116589","Neurologic Manifestations","D003128","Coma","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53629,D53629)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53629,M53629)","v":"Coma"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53629,N53629)","v":"DTXSID7045946"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53629,J53629)","v":"24196090"},"Pediatric zolpidem ingestion demonstrating zero-order kinetics treated with flumazenil.","24196090","Neurologic Manifestations","D003128","Coma","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53630,D53630)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53630,M53630)","v":"Coma"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53630,N53630)","v":"DTXSID7045946"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53630,J53630)","v":"20862780"},"Coma with absent brainstem reflexes resulting from zolpidem overdose.","20862780","Neurologic Manifestations","D003128","Coma","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53631,D53631)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53631,M53631)","v":"Coma"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53631,N53631)","v":"DTXSID7045946"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53631,J53631)","v":"2111156"},"Zolpidem intoxication mimicking narcotic overdose: response to flumazenil.","2111156","Neurologic Manifestations","D003128","Coma","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53632,D53632)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53632,M53632)","v":"Coma"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53632,N53632)","v":"DTXSID7045946"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53632,J53632)","v":"11534578"},"Acute zolpidem overdose leading to coma and respiratory failure.","11534578","Neurologic Manifestations","D003128","Coma","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53633,D53633)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53633,M53633)","v":"Confusion"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53633,N53633)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53633,J53633)","v":"25702187"},"In-flight emergency.","25702187","Neurologic Manifestations","D003221","Confusion","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53634,D53634)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53634,M53634)","v":"Confusion"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53634,N53634)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53634,J53634)","v":"25671536"},"Daily episodes of confusion · altered behavior · chronic sleep deprivation · Dx?","25671536","Neurologic Manifestations","D003221","Confusion","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53635,D53635)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53635,M53635)","v":"Confusion"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53635,N53635)","v":"DTXSID7045946"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53635,J53635)","v":"23865280"},"The impact of zolpidem on the mental status of hospitalized patients older than age 50.","23865280","Neurologic Manifestations","D003221","Confusion","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53636,D53636)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53636,M53636)","v":"Delirium"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53636,N53636)","v":"DTXSID7045946"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53636,J53636)","v":"7485639"},"Possible paroxetine-zolpidem interaction.","7485639","Neurologic Manifestations","D003693","Delirium","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53637,D53637)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53637,M53637)","v":"Delirium"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53637,N53637)","v":"DTXSID7045946"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53637,J53637)","v":"26539907"},"Zolpidem Overdose: A Medical and Ethical Dilemma.","26539907","Neurologic Manifestations","D003693","Delirium","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53638,D53638)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53638,M53638)","v":"Delirium"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53638,N53638)","v":"DTXSID7045946"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53638,J53638)","v":"18085123"},"Dependence syndrome and intoxication delirium associated with zolpidem.","18085123","Neurologic Manifestations","D003693","Delirium","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53639,D53639)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53639,M53639)","v":"Delirium"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53639,N53639)","v":"DTXSID7045946"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53639,J53639)","v":"21037147"},"Zolpidem withdrawal delirium: a case report.","21037147","Neurologic Manifestations","D003693","Delirium","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53640,D53640)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53640,M53640)","v":"Delirium"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53640,N53640)","v":"DTXSID7045946"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53640,J53640)","v":"11793620"},"Delirium associated with zolpidem.","11793620","Neurologic Manifestations","D003693","Delirium","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53641,D53641)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53641,M53641)","v":"Delirium"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53641,N53641)","v":"DTXSID7045946"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53641,J53641)","v":"10901348"},"Zolpidem-related delirium: a case report.","10901348","Neurologic Manifestations","D003693","Delirium","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53642,D53642)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53642,M53642)","v":"Delirium"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53642,N53642)","v":"DTXSID7045946"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53642,J53642)","v":"14709766"},"Zolpidem-induced delirium with mania in an elderly woman.","14709766","Neurologic Manifestations","D003693","Delirium","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53643,D53643)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53643,M53643)","v":"Dementia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53643,N53643)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53643,J53643)","v":"25929937"},"An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study.","25929937","Central Nervous System Diseases","D003704","Dementia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53644,D53644)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53644,M53644)","v":"Dyssomnias"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53644,N53644)","v":"DTXSID7045946"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53644,J53644)","v":"18164949"},"Zolpidem, somnambulism, and nocturnal eating.","18164949","Sleep Wake Disorders","D020920","Dyssomnias","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53645,D53645)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53645,M53645)","v":"Dyssomnias"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53645,N53645)","v":"DTXSID7045946"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53645,J53645)","v":"18468314"},"Report of two cases where sleep related eating behavior occurred with the extended-release formulation but not the immediate-release formulation of a sedative-hypnotic agent.","18468314","Sleep Wake Disorders","D020920","Dyssomnias","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53646,D53646)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53646,M53646)","v":"Dystonia"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53646,N53646)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53646,J53646)","v":"25829071"},"Zolpidem withdrawal status dystonicus in the patient with advanced Parkinson's disease.","25829071","Neurologic Manifestations","D004421","Dystonia","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53647,D53647)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53647,M53647)","v":"Epilepsy"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53647,N53647)","v":"DTXSID7045946"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53647,J53647)","v":"25373122"},"Association of zolpidem use and subsequent increased risk of epilepsy: a population-based, case-control study.","25373122","Central Nervous System Diseases","D004827","Epilepsy","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53648,D53648)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53648,M53648)","v":"Epilepsy"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53648,N53648)","v":"DTXSID7045946"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53648,J53648)","v":"11154097"},"Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report.","11154097","Central Nervous System Diseases","D004827","Epilepsy","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53649,D53649)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53649,M53649)","v":"Epilepsy, Generalized"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53649,N53649)","v":"DTXSID7045946"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53649,J53649)","v":"21448102"},"Zolpidem dependence and withdrawal seizure--report of two cases.","21448102","Central Nervous System Diseases","D004829","Epilepsy, Generalized","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53650,D53650)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53650,M53650)","v":"Epilepsy, Tonic-Clonic"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53650,N53650)","v":"DTXSID7045946"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53650,J53650)","v":"21448102"},"Zolpidem dependence and withdrawal seizure--report of two cases.","21448102","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53651,D53651)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53651,M53651)","v":"Epilepsy, Tonic-Clonic"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53651,N53651)","v":"DTXSID7045946"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53651,J53651)","v":"12724513"},"Seizures associated with venlafaxine, methylphenidate, and zolpidem.","12724513","Central Nervous System Diseases","D004830","Epilepsy, Tonic-Clonic","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53652,D53652)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53652,M53652)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53652,N53652)","v":"DTXSID7045946"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53652,J53652)","v":"7836339"},"Dose-related sensory distortions with zolpidem.","7836339","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53653,D53653)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53653,M53653)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53653,N53653)","v":"DTXSID7045946"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53653,J53653)","v":"7902519"},"More on zolpidem side-effects.","7902519","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53654,D53654)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53654,M53654)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53654,N53654)","v":"DTXSID7045946"},1993,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53654,J53654)","v":"8104297"},"Zolpidem side-effects.","8104297","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53655,D53655)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53655,M53655)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53655,N53655)","v":"DTXSID7045946"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53655,J53655)","v":"9018205"},"Zolpidem and hallucinations.","9018205","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53656,D53656)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53656,M53656)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53656,N53656)","v":"DTXSID7045946"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53656,J53656)","v":"8832310"},"Visual hallucinations and amnesia associated with the use of zolpidem.","8832310","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53657,D53657)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53657,M53657)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53657,N53657)","v":"DTXSID7045946"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53657,J53657)","v":"8807033"},"Zolpidem-induced psychosis.","8807033","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53658,D53658)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53658,M53658)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53658,N53658)","v":"DTXSID7045946"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53658,J53658)","v":"9656974"},"Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction.","9656974","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53659,D53659)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53659,M53659)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53659,N53659)","v":"DTXSID7045946"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53659,J53659)","v":"27253658"},"Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study.","27253658","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53660,D53660)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53660,M53660)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53660,N53660)","v":"DTXSID7045946"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53660,J53660)","v":"17026779"},"Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction.","17026779","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53661,D53661)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53661,M53661)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53661,N53661)","v":"DTXSID7045946"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53661,J53661)","v":"18004155"},"Pseudohallucinations after zolpidem intake: a case report.","18004155","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53662,D53662)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53662,M53662)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53662,N53662)","v":"DTXSID7045946"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53662,J53662)","v":"25314809"},"[The differences in the contents of the leaflets of medicines containing zolpidem].","25314809","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53663,D53663)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53663,M53663)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53663,N53663)","v":"DTXSID7045946"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53663,J53663)","v":"19116499"},"Pattern of pediatric zolpidem ingestions reported to Texas poison control centers, 2000 to 2006.","19116499","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53664,D53664)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53664,M53664)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53664,N53664)","v":"DTXSID7045946"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53664,J53664)","v":"20129012"},"Command hallucinations with self-stabbing associated with zolpidem overdose.","20129012","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53665,D53665)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53665,M53665)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53665,N53665)","v":"DTXSID7045946"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53665,J53665)","v":"22772691"},"Zolpidem misuse in two women with no psychiatric history: a crucial role of pleasant visual hallucinations.","22772691","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53666,D53666)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53666,M53666)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53666,N53666)","v":"DTXSID7045946"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53666,J53666)","v":"2260045"},"[Zolpidem and hypnotic hallucinations].","2260045","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53667,D53667)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53667,M53667)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53667,N53667)","v":"DTXSID7045946"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53667,J53667)","v":"12060196"},"Zolpidem, vascular headache, and hallucinations in an adolescent.","12060196","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53668,D53668)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53668,M53668)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53668,N53668)","v":"DTXSID7045946"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53668,J53668)","v":"15066092"},"Charles Bonnet syndrome and GABAergic drugs--a case report.","15066092","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53669,D53669)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53669,M53669)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53669,N53669)","v":"DTXSID7045946"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53669,J53669)","v":"15027567"},"Hallucinations with zolpidem and fluoxetine in an impaired driver.","15027567","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53670,D53670)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53670,M53670)","v":"Hallucinations"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53670,N53670)","v":"DTXSID7045946"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53670,J53670)","v":"14677799"},"A novel clinical pattern of visual hallucination after zolpidem use.","14677799","Neurologic Manifestations","D006212","Hallucinations","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53671,D53671)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53671,M53671)","v":"Hepatic Encephalopathy"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53671,N53671)","v":"DTXSID7045946"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53671,J53671)","v":"18719775"},"Delayed-onset hepatic encephalopathy induced by zolpidem: a case report.","18719775","Central Nervous System Diseases","D006501","Hepatic Encephalopathy","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53672,D53672)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53672,M53672)","v":"Hyperkinesis"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53672,N53672)","v":"DTXSID7045946"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53672,J53672)","v":"20633172"},"Zolpidem poisoning in a cat.","20633172","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53673,D53673)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53673,M53673)","v":"Hyperkinesis"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53673,N53673)","v":"DTXSID7045946"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53673,J53673)","v":"11899040"},"Clinical syndrome associated with zolpidem ingestion in dogs: 33 cases (January 1998-July 2000).","11899040","Neurologic Manifestations","D006948","Hyperkinesis","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53674,D53674)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53674,M53674)","v":"Memory Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53674,N53674)","v":"DTXSID7045946"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53674,J53674)","v":"16516111"},"Abnormal auditory N400 in a case of zolpidem dependence, during a working memory test.","16516111","Neurologic Manifestations","D008569","Memory Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53675,D53675)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53675,M53675)","v":"Memory Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53675,N53675)","v":"DTXSID7045946"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53675,J53675)","v":"19452384"},"Total absence of recall of discussion occurred shortly after ingestion of 10 mg zolpidem.","19452384","Neurologic Manifestations","D008569","Memory Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53676,D53676)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53676,M53676)","v":"Memory Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53676,N53676)","v":"DTXSID7045946"},2004,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53676,J53676)","v":"14985932"},"Zolpidem and memory: a study using the process-dissociation procedure.","14985932","Neurologic Manifestations","D008569","Memory Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53677,D53677)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53677,M53677)","v":"Neural Tube Defects"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53677,N53677)","v":"DTXSID7045946"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53677,J53677)","v":"21385155"},"High dose zolpidem induced fetal neural tube defects.","21385155","Nervous System Malformations","D009436","Neural Tube Defects","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53678,D53678)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53678,M53678)","v":"Parasomnias"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53678,N53678)","v":"DTXSID7045946"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53678,J53678)","v":"24045611"},"Zolpidem-induced compulsive evening eating behavior.","24045611","Sleep Wake Disorders","D020447","Parasomnias","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53679,D53679)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53679,M53679)","v":"Parasomnias"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53679,N53679)","v":"DTXSID7045946"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53679,J53679)","v":"25470097"},"Clinical correlates of zolpidem-associated complex sleep-related behaviors: age effect.","25470097","Sleep Wake Disorders","D020447","Parasomnias","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53680,D53680)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53680,M53680)","v":"Parasomnias"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53680,N53680)","v":"DTXSID7045946"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53680,J53680)","v":"21300202"},"Zolpidem-associated parasomnia with serious self-injury: a shot in the dark.","21300202","Sleep Wake Disorders","D020447","Parasomnias","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53681,D53681)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53681,M53681)","v":"Parkinson Disease, Secondary"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53681,N53681)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53681,J53681)","v":"25650675"},"Risk of Parkinson's disease following zolpidem use: a retrospective, population-based cohort study.","25650675","Basal Ganglia Diseases","D010302","Parkinson Disease, Secondary","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53682,D53682)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53682,M53682)","v":"Psychomotor Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53682,N53682)","v":"DTXSID7045946"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53682,J53682)","v":"23456542"},"In the Zzz zone: the effects of Z-drugs on human performance and driving.","23456542","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53683,D53683)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53683,M53683)","v":"Seizures"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53683,N53683)","v":"DTXSID7045946"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53683,J53683)","v":"7966909"},"Chronic abuse of zolpidem.","7966909","Neurologic Manifestations","D012640","Seizures","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53684,D53684)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53684,M53684)","v":"Seizures"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53684,N53684)","v":"DTXSID7045946"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53684,J53684)","v":"9262041"},"Seizure after withdrawal from supratherapeutic doses of zolpidem tartrate, a selective omega I benzodiazepine receptor agonist.","9262041","Neurologic Manifestations","D012640","Seizures","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53685,D53685)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53685,M53685)","v":"Seizures"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53685,N53685)","v":"DTXSID7045946"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53685,J53685)","v":"16950552"},"Seizure following sudden zolpidem withdrawal.","16950552","Neurologic Manifestations","D012640","Seizures","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53686,D53686)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53686,M53686)","v":"Seizures"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53686,N53686)","v":"DTXSID7045946"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53686,J53686)","v":"18289154"},"Dependence on zolpidem: is pharmacokinetics important?","18289154","Neurologic Manifestations","D012640","Seizures","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53687,D53687)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53687,M53687)","v":"Seizures"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53687,N53687)","v":"DTXSID7045946"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53687,J53687)","v":"15847035"},"Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure.","15847035","Neurologic Manifestations","D012640","Seizures","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53688,D53688)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53688,M53688)","v":"Seizures"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53688,N53688)","v":"DTXSID7045946"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53688,J53688)","v":"19777922"},"[Zolpidem dependence and withdrawal seizure].","19777922","Neurologic Manifestations","D012640","Seizures","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53689,D53689)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53689,M53689)","v":"Sensation Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53689,N53689)","v":"DTXSID7045946"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53689,J53689)","v":"23165956"},"Zolpidem is independently associated with increased risk of inpatient falls.","23165956","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53690,D53690)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53690,M53690)","v":"Sensation Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53690,N53690)","v":"DTXSID7045946"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53690,J53690)","v":"12756510"},"Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.","12756510","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53691,D53691)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53691,M53691)","v":"Sleep Deprivation"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53691,N53691)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53691,J53691)","v":"25671536"},"Daily episodes of confusion · altered behavior · chronic sleep deprivation · Dx?","25671536","Sleep Wake Disorders","D012892","Sleep Deprivation","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53692,D53692)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53692,M53692)","v":"Sleep Initiation and Maintenance Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53692,N53692)","v":"DTXSID7045946"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53692,J53692)","v":"9099463"},"Minimal rebound insomnia after treatment with 10-mg zolpidem.","9099463","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53693,D53693)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53693,M53693)","v":"Sleep Initiation and Maintenance Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53693,N53693)","v":"DTXSID7045946"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53693,J53693)","v":"25455931"},"Hypnotics in insomnia: the experience of zolpidem.","25455931","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53694,D53694)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53694,M53694)","v":"Sleep Initiation and Maintenance Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53694,N53694)","v":"DTXSID7045946"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53694,J53694)","v":"15725964"},"Medication-associated somnambulism.","15725964","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53695,D53695)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53695,M53695)","v":"Sleep Initiation and Maintenance Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53695,N53695)","v":"DTXSID7045946"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53695,J53695)","v":"21448102"},"Zolpidem dependence and withdrawal seizure--report of two cases.","21448102","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53696,D53696)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53696,M53696)","v":"Sleep Initiation and Maintenance Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53696,N53696)","v":"DTXSID7045946"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53696,J53696)","v":"11215153"},"The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance.","11215153","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53697,D53697)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53697,M53697)","v":"Sleep Initiation and Maintenance Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53697,N53697)","v":"DTXSID7045946"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53697,J53697)","v":"11697572"},"A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.","11697572","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53698,D53698)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53698,M53698)","v":"Sleep Wake Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53698,N53698)","v":"DTXSID7045946"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53698,J53698)","v":"23436890"},"Sleep-related eating disorder secondary to zolpidem.","23436890","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53699,D53699)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53699,M53699)","v":"Sleep Wake Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53699,N53699)","v":"DTXSID7045946"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53699,J53699)","v":"19822330"},"Zolpidem-induced sleep-related eating disorder.","19822330","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53700,D53700)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53700,M53700)","v":"Sleep Wake Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53700,N53700)","v":"DTXSID7045946"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53700,J53700)","v":"20441722"},"Risk predictors for hypnosedative-related complex sleep behaviors: a retrospective, cross-sectional pilot study.","20441722","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53701,D53701)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53701,M53701)","v":"Sleep Wake Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53701,N53701)","v":"DTXSID7045946"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53701,J53701)","v":"20965000"},"[Zolpidem-induced sleep-related behavioural disorders].","20965000","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53702,D53702)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53702,M53702)","v":"Sleep Wake Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53702,N53702)","v":"DTXSID7045946"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53702,J53702)","v":"21140069"},"[Zolpidem induced sleep related eating disorder].","21140069","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53703,D53703)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53703,M53703)","v":"Sleep Wake Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53703,N53703)","v":"DTXSID7045946"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53703,J53703)","v":"11041533"},"Comparison of the effects of zolpidem and triazolam on nocturnal sleep and sleep latency in the morning: a cross-over study in healthy young volunteers.","11041533","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53704,D53704)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53704,M53704)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53704,N53704)","v":"DTXSID7045946"},1994,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53704,J53704)","v":"8195460"},"Sleepwalking associated with zolpidem.","8195460","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53705,D53705)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53705,M53705)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53705,N53705)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53705,J53705)","v":"26529448"},"Check That Ambien Dose.","26529448","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53706,D53706)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53706,M53706)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53706,N53706)","v":"DTXSID7045946"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53706,J53706)","v":"26147892"},"Drugs for Insomnia.","26147892","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53707,D53707)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53707,M53707)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53707,N53707)","v":"DTXSID7045946"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53707,J53707)","v":"18164949"},"Zolpidem, somnambulism, and nocturnal eating.","18164949","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53708,D53708)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53708,M53708)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53708,N53708)","v":"DTXSID7045946"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53708,J53708)","v":"17022187"},"[Stilnoct and sleepwalking].","17022187","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53709,D53709)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53709,M53709)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53709,N53709)","v":"DTXSID7045946"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53709,J53709)","v":"18819779"},"Zolpidem-induced amnesia and somnambulism: rare occurrences?","18819779","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53710,D53710)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53710,M53710)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53710,N53710)","v":"DTXSID7045946"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53710,J53710)","v":"24380165"},"[Zolpidem and drunk driving].","24380165","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53711,D53711)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53711,M53711)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53711,N53711)","v":"DTXSID7045946"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53711,J53711)","v":"15725964"},"Medication-associated somnambulism.","15725964","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53712,D53712)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53712,M53712)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53712,N53712)","v":"DTXSID7045946"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53712,J53712)","v":"16579351"},"Perchance to...eat?","16579351","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53713,D53713)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53713,M53713)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53713,N53713)","v":"DTXSID7045946"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53713,J53713)","v":"16579498"},"Sleeping-pill puzzler.","16579498","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53714,D53714)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53714,M53714)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53714,N53714)","v":"DTXSID7045946"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53714,J53714)","v":"15954071"},"One rare side effect of zolpidem--sleepwalking: a case report.","15954071","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53715,D53715)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53715,M53715)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53715,N53715)","v":"DTXSID7045946"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53715,J53715)","v":"19598143"},"[Cooking in dreams: a peculiar side effect of zolpidem].","19598143","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53716,D53716)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53716,M53716)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53716,N53716)","v":"DTXSID7045946"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53716,J53716)","v":"19961034"},"Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.","19961034","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53717,D53717)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53717,M53717)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53717,N53717)","v":"DTXSID7045946"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53717,J53717)","v":"19059805"},"Writing emails as part of sleepwalking after increase in Zolpidem.","19059805","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53718,D53718)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53718,M53718)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53718,N53718)","v":"DTXSID7045946"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53718,J53718)","v":"20529770"},"[Sleep related eating disorders as a side effect of zolpidem].","20529770","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53719,D53719)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53719,M53719)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53719,N53719)","v":"DTXSID7045946"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53719,J53719)","v":"21367628"},"Sleep driving: sleepwalking variant or misuse of z-drugs?","21367628","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53720,D53720)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53720,M53720)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53720,N53720)","v":"DTXSID7045946"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53720,J53720)","v":"21641242"},"Z drug zombies: parasomnia, drug effect or both?","21641242","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53721,D53721)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53721,M53721)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53721,N53721)","v":"DTXSID7045946"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53721,J53721)","v":"22171202"},"Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case series.","22171202","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53722,D53722)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53722,M53722)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53722,N53722)","v":"DTXSID7045946"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53722,J53722)","v":"22159981"},"\"I did what?\" Zolpidem and the courts.","22159981","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53723,D53723)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53723,M53723)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53723,N53723)","v":"DTXSID7045946"},1999,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53723,J53723)","v":"10495642"},"Zolpidem tartrate and somnambulism.","10495642","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53724,D53724)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53724,M53724)","v":"Somnambulism"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53724,N53724)","v":"DTXSID7045946"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53724,J53724)","v":"14622563"},"[Sleep-walking linked to zolpidem].","14622563","Sleep Wake Disorders","D013009","Somnambulism","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53725,D53725)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53725,M53725)","v":"Stroke"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53725,N53725)","v":"DTXSID7045946"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53725,J53725)","v":"23759463"},"Relationship between zolpidem use and stroke risk: a Taiwanese population-based case-control study.","23759463","Central Nervous System Diseases","D020521","Stroke","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53726,D53726)","v":"zolpidem"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53726,M53726)","v":"Vision Disorders"},"C049109","zolpidem","82626-48-0",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53726,N53726)","v":"DTXSID7045946"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53726,J53726)","v":"12708947"},"Zolpidem-induced distortion in visual perception.","12708947","Neurologic Manifestations","D014786","Vision Disorders","DTXSID7045946"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53727,D53727)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53727,M53727)","v":"Anencephaly"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53727,N53727)","v":"DTXSID9046023"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53727,J53727)","v":"8956859"},"Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy.","8956859","Nervous System Malformations","D000757","Anencephaly","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53728,D53728)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53728,M53728)","v":"Ataxia"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53728,N53728)","v":"DTXSID9046023"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53728,J53728)","v":"11015160"},"Zonisamide (Zonegran) for epilepsy.","11015160","Neurologic Manifestations","D001259","Ataxia","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53729,D53729)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53729,M53729)","v":"Central Nervous System Diseases"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53729,N53729)","v":"DTXSID9046023"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53729,J53729)","v":"21463969"},"Moderate toxic effects following acute zonisamide overdose.","21463969","Central Nervous System Diseases","D002493","Central Nervous System Diseases","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53730,D53730)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53730,M53730)","v":"Communication Disorders"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53730,N53730)","v":"DTXSID9046023"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53730,J53730)","v":"12755059"},"[A five-year-old girl with epilepsy showing forced normalization due to zonisamide].","12755059","Neurologic Manifestations","D003147","Communication Disorders","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53731,D53731)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53731,M53731)","v":"Confusion"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53731,N53731)","v":"DTXSID9046023"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53731,J53731)","v":"21688720"},"Our clinical experience with zonisamide in resistant generalized epilepsy syndromes.","21688720","Neurologic Manifestations","D003221","Confusion","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53732,D53732)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53732,M53732)","v":"Consciousness Disorders"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53732,N53732)","v":"DTXSID9046023"},2008,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53732,J53732)","v":"18754763"},"Effects of zonisamide on isolated head tremor.","18754763","Neurologic Manifestations","D003244","Consciousness Disorders","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53733,D53733)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53733,M53733)","v":"Disorders of Excessive Somnolence"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53733,N53733)","v":"DTXSID9046023"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53733,J53733)","v":"21688720"},"Our clinical experience with zonisamide in resistant generalized epilepsy syndromes.","21688720","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53734,D53734)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53734,M53734)","v":"Hypokinesia"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53734,N53734)","v":"DTXSID9046023"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53734,J53734)","v":"10655757"},"[Three cases of hypoactivity and poor appetite with zonisamide-induced metabolic acidosis].","10655757","Neurologic Manifestations","D018476","Hypokinesia","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53735,D53735)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53735,M53735)","v":"Intracranial Hemorrhages"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53735,N53735)","v":"DTXSID9046023"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53735,J53735)","v":"12776795"},"Acute zonisamide overdose: a death revisited.","12776795","Central Nervous System Diseases","D020300","Intracranial Hemorrhages","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53736,D53736)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53736,M53736)","v":"Language Disorders"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53736,N53736)","v":"DTXSID9046023"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53736,J53736)","v":"25583590"},"[Reversible neuropsychological deterioration associated to zonisamide in a paediatric patient with tuberous sclerosis].","25583590","Neurologic Manifestations","D007806","Language Disorders","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53737,D53737)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53737,M53737)","v":"Learning Disorders"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53737,N53737)","v":"DTXSID9046023"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53737,J53737)","v":"25583590"},"[Reversible neuropsychological deterioration associated to zonisamide in a paediatric patient with tuberous sclerosis].","25583590","Neurologic Manifestations","D007859","Learning Disorders","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53738,D53738)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53738,M53738)","v":"Memory Disorders"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53738,N53738)","v":"DTXSID9046023"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53738,J53738)","v":"25583590"},"[Reversible neuropsychological deterioration associated to zonisamide in a paediatric patient with tuberous sclerosis].","25583590","Neurologic Manifestations","D008569","Memory Disorders","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53739,D53739)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53739,M53739)","v":"Mutism"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53739,N53739)","v":"DTXSID9046023"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53739,J53739)","v":"12237077"},"Selective mutism and obsessive compulsive disorders associated with zonisamide.","12237077","Neurologic Manifestations","D009155","Mutism","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53740,D53740)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53740,M53740)","v":"Paresthesia"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53740,N53740)","v":"DTXSID9046023"},2014,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53740,J53740)","v":"25101297"},"Efficacy of zonisamide in migraineurs with nonresponse to topiramate.","25101297","Neurologic Manifestations","D010292","Paresthesia","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53741,D53741)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53741,M53741)","v":"Paresthesia"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53741,N53741)","v":"DTXSID9046023"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53741,J53741)","v":"21738025"},"Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.","21738025","Neurologic Manifestations","D010292","Paresthesia","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53742,D53742)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53742,M53742)","v":"Paresthesia"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53742,N53742)","v":"DTXSID9046023"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53742,J53742)","v":"21284610"},"Zonisamide for migraine prophylaxis in topiramate-intolerant patients: an observational study.","21284610","Neurologic Manifestations","D010292","Paresthesia","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53743,D53743)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53743,M53743)","v":"Restless Legs Syndrome"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53743,N53743)","v":"DTXSID9046023"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53743,J53743)","v":"17486608"},"Restless legs syndrome induced by zonisamide.","17486608","Sleep Wake Disorders","D012148","Restless Legs Syndrome","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53744,D53744)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53744,M53744)","v":"Restless Legs Syndrome"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53744,N53744)","v":"DTXSID9046023"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53744,J53744)","v":"12525743"},"Zonisamide-induced restless legs syndrome.","12525743","Sleep Wake Disorders","D012148","Restless Legs Syndrome","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53745,D53745)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53745,M53745)","v":"Seizures"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53745,N53745)","v":"DTXSID9046023"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53745,J53745)","v":"29190192"},"Suspected zonisamide-related anticonvulsant hypersensitivity syndrome in a cat.","29190192","Neurologic Manifestations","D012640","Seizures","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53746,D53746)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53746,M53746)","v":"Sleep Wake Disorders"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53746,N53746)","v":"DTXSID9046023"},1995,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53746,J53746)","v":"8534517"},"[A case of behavior disorder with gait and sleep disturbances induced by zonisamide].","8534517","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53747,D53747)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53747,M53747)","v":"Sleep Wake Disorders"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53747,N53747)","v":"DTXSID9046023"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53747,J53747)","v":"15660766"},"Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.","15660766","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53748,D53748)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53748,M53748)","v":"Tremor"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53748,N53748)","v":"DTXSID9046023"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53748,J53748)","v":"1562387"},"[Zonisamide induced tremor--report of two cases].","1562387","Neurologic Manifestations","D014202","Tremor","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53749,D53749)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53749,M53749)","v":"Vertigo"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53749,N53749)","v":"DTXSID9046023"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53749,J53749)","v":"18343174"},"Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.","18343174","Neurologic Manifestations","D014717","Vertigo","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53750,D53750)","v":"zonisamide"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53750,M53750)","v":"Vision Disorders"},"C022189","zonisamide","68291-97-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53750,N53750)","v":"DTXSID9046023"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53750,J53750)","v":"23503550"},"Palinopsia induced by topiramate and zonisamide in a patient with migraine.","23503550","Neurologic Manifestations","D014786","Vision Disorders","DTXSID9046023"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53751,D53751)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53751,M53751)","v":"Amnesia"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53751,N53751)","v":"DTXSID4041155"},1996,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53751,J53751)","v":"8858280"},"Amnestic syndrome induced by zoplclone.","8858280","Neurologic Manifestations","D000647","Amnesia","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53752,D53752)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53752,M53752)","v":"Chorea"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53752,N53752)","v":"DTXSID4041155"},2015,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53752,J53752)","v":"25999122"},"Drug-induced hemichorea.","25999122","Central Nervous System Diseases","D002819","Chorea","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53753,D53753)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53753,M53753)","v":"Coma"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53753,N53753)","v":"DTXSID4041155"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53753,J53753)","v":"17606111"},"Prolonged coma after eszopiclone overdose.","17606111","Neurologic Manifestations","D003128","Coma","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53754,D53754)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53754,M53754)","v":"Coma"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53754,N53754)","v":"DTXSID4041155"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53754,J53754)","v":"20090535"},"Intralipid reverses coma associated with zopiclone and venlafaxine overdose.","20090535","Neurologic Manifestations","D003128","Coma","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53755,D53755)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53755,M53755)","v":"Coma"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53755,N53755)","v":"DTXSID4041155"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53755,J53755)","v":"22494238"},"Coma after single dose of zopiclone.","22494238","Neurologic Manifestations","D003128","Coma","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53756,D53756)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53756,M53756)","v":"Confusion"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53756,N53756)","v":"DTXSID4041155"},2007,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53756,J53756)","v":"17668690"},"Extreme agitation occurring with zopiclone.","17668690","Neurologic Manifestations","D003221","Confusion","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53757,D53757)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53757,M53757)","v":"Delirium"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53757,N53757)","v":"DTXSID4041155"},1998,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53757,J53757)","v":"9773104"},"[Zopiclone and delirium: a case report].","9773104","Neurologic Manifestations","D003693","Delirium","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53758,D53758)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53758,M53758)","v":"Delirium"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53758,N53758)","v":"DTXSID4041155"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53758,J53758)","v":"16107464"},"Zopiclone withdrawal: an unusual cause of delirium in the elderly.","16107464","Neurologic Manifestations","D003693","Delirium","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53759,D53759)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53759,M53759)","v":"Disorders of Excessive Somnolence"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53759,N53759)","v":"DTXSID4041155"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53759,J53759)","v":"11905433"},"Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.","11905433","Sleep Wake Disorders","D006970","Disorders of Excessive Somnolence","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53760,D53760)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53760,M53760)","v":"Dysgeusia"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53760,N53760)","v":"DTXSID4041155"},2016,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53760,J53760)","v":"26872077"},"Eszopiclone versus zopiclone in the treatment of insomnia.","26872077","Neurologic Manifestations","D004408","Dysgeusia","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53761,D53761)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53761,M53761)","v":"Psychomotor Disorders"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53761,N53761)","v":"DTXSID4041155"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53761,J53761)","v":"23456542"},"In the Zzz zone: the effects of Z-drugs on human performance and driving.","23456542","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53762,D53762)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53762,M53762)","v":"Psychomotor Disorders"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53762,N53762)","v":"DTXSID4041155"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53762,J53762)","v":"22008377"},"Individual psychomotor impairment in relation to zopiclone and ethanol concentrations in blood--a randomized controlled double-blinded trial.","22008377","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53763,D53763)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53763,M53763)","v":"Psychomotor Disorders"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53763,N53763)","v":"DTXSID4041155"},2002,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53763,J53763)","v":"11905433"},"Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.","11905433","Neurologic Manifestations","D011596","Psychomotor Disorders","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53764,D53764)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53764,M53764)","v":"Seizures"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53764,N53764)","v":"DTXSID4041155"},1991,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53764,J53764)","v":"1754610"},"Misuse of zopiclone and convulsions during withdrawal.","1754610","Neurologic Manifestations","D012640","Seizures","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53765,D53765)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53765,M53765)","v":"Seizures"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53765,N53765)","v":"DTXSID4041155"},2006,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53765,J53765)","v":"16696635"},"Dependence on zopiclone.","16696635","Neurologic Manifestations","D012640","Seizures","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53766,D53766)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53766,M53766)","v":"Seizures"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53766,N53766)","v":"DTXSID4041155"},2010,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53766,J53766)","v":"20567267"},"[Zopiclone and convulsions].","20567267","Neurologic Manifestations","D012640","Seizures","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53767,D53767)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53767,M53767)","v":"Seizures"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53767,N53767)","v":"DTXSID4041155"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53767,J53767)","v":"2290609"},"Cyclopyrrolones, unlike some benzodiazepines, do not induce physical dependence in mice.","2290609","Neurologic Manifestations","D012640","Seizures","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53768,D53768)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53768,M53768)","v":"Sensation Disorders"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53768,N53768)","v":"DTXSID4041155"},2003,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53768,J53768)","v":"12756510"},"Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.","12756510","Neurologic Manifestations","D012678","Sensation Disorders","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53769,D53769)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53769,M53769)","v":"Sleep Initiation and Maintenance Disorders"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53769,N53769)","v":"DTXSID4041155"},2017,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53769,J53769)","v":"28104722"},"Paradoxical insomnia in a patient taking zopiclone.","28104722","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53770,D53770)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53770,M53770)","v":"Sleep Initiation and Maintenance Disorders"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53770,N53770)","v":"DTXSID4041155"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53770,J53770)","v":"2884682"},"Subjective effects during administration and on discontinuation of zopiclone and temazepam in normal subjects.","2884682","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53771,D53771)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53771,M53771)","v":"Sleep Initiation and Maintenance Disorders"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53771,N53771)","v":"DTXSID4041155"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53771,J53771)","v":"2387981"},"Zopiclone discontinuation: review of 25 studies assessing withdrawal and rebound phenomena.","2387981","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53772,D53772)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53772,M53772)","v":"Sleep Initiation and Maintenance Disorders"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53772,N53772)","v":"DTXSID4041155"},1990,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53772,J53772)","v":"1968530"},"Zopiclone: another carriage on the tranquilliser train.","1968530","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53773,D53773)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53773,M53773)","v":"Sleep Initiation and Maintenance Disorders"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53773,N53773)","v":"DTXSID4041155"},2000,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53773,J53773)","v":"11215153"},"The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance.","11215153","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53774,D53774)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53774,M53774)","v":"Sleep Initiation and Maintenance Disorders"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53774,N53774)","v":"DTXSID4041155"},2001,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53774,J53774)","v":"11697572"},"A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.","11697572","Sleep Wake Disorders","D007319","Sleep Initiation and Maintenance Disorders","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53775,D53775)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53775,M53775)","v":"Somnambulism"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53775,N53775)","v":"DTXSID4041155"},2009,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53775,J53775)","v":"18925983"},"Zopiclone and sleepwalking.","18925983","Sleep Wake Disorders","D013009","Somnambulism","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53776,D53776)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53776,M53776)","v":"Somnambulism"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53776,N53776)","v":"DTXSID4041155"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53776,J53776)","v":"21367628"},"Sleep driving: sleepwalking variant or misuse of z-drugs?","21367628","Sleep Wake Disorders","D013009","Somnambulism","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53777,D53777)","v":"zopiclone"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53777,M53777)","v":"Somnambulism"},"C515050","zopiclone","43200-80-2",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53777,N53777)","v":"DTXSID4041155"},2011,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53777,J53777)","v":"21641242"},"Z drug zombies: parasomnia, drug effect or both?","21641242","Sleep Wake Disorders","D013009","Somnambulism","DTXSID4041155"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53778,D53778)","v":"zotepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53778,M53778)","v":"Basal Ganglia Diseases"},"C022172","zotepine","26615-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53778,N53778)","v":"DTXSID9023756"},1997,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53778,J53778)","v":"9307690"},"Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients.","9307690","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID9023756"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53779,D53779)","v":"zotepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53779,M53779)","v":"Basal Ganglia Diseases"},"C022172","zotepine","26615-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53779,N53779)","v":"DTXSID9023756"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53779,J53779)","v":"2883683"},"Zotepine, a neuroleptic drug with a bipolar therapeutic profile.","2883683","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID9023756"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53780,D53780)","v":"zotepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53780,M53780)","v":"Basal Ganglia Diseases"},"C022172","zotepine","26615-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53780,N53780)","v":"DTXSID9023756"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53780,J53780)","v":"2883681"},"Profiles of clinical efficacy and pharmacological action of zotepine.","2883681","Basal Ganglia Diseases","D001480","Basal Ganglia Diseases","DTXSID9023756"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53781,D53781)","v":"zotepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53781,M53781)","v":"Catatonia"},"C022172","zotepine","26615-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53781,N53781)","v":"DTXSID9023756"},2005,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53781,J53781)","v":"16207109"},"Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.","16207109","Neurologic Manifestations","D002389","Catatonia","DTXSID9023756"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53782,D53782)","v":"zotepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53782,M53782)","v":"Delirium"},"C022172","zotepine","26615-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53782,N53782)","v":"DTXSID9023756"},2012,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53782,J53782)","v":"21988532"},"Valproate and high dosage of zotepine induced acute delirium: a case report.","21988532","Neurologic Manifestations","D003693","Delirium","DTXSID9023756"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53783,D53783)","v":"zotepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53783,M53783)","v":"Hallucinations"},"C022172","zotepine","26615-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53783,N53783)","v":"DTXSID9023756"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53783,J53783)","v":"23543675"},"Zotepine-induced convulsive seizures in a chronic case of treatment resistant paranoid schizophrenia.","23543675","Neurologic Manifestations","D006212","Hallucinations","DTXSID9023756"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53784,D53784)","v":"zotepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53784,M53784)","v":"Muscular Diseases"},"C022172","zotepine","26615-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53784,N53784)","v":"DTXSID9023756"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53784,J53784)","v":"22797903"},"Zotepine-related myopathy in a patient with schizophrenia.","22797903","Neuromuscular Diseases","D009135","Muscular Diseases","DTXSID9023756"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53785,D53785)","v":"zotepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53785,M53785)","v":"Seizures"},"C022172","zotepine","26615-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53785,N53785)","v":"DTXSID9023756"},2013,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53785,J53785)","v":"23543675"},"Zotepine-induced convulsive seizures in a chronic case of treatment resistant paranoid schizophrenia.","23543675","Neurologic Manifestations","D012640","Seizures","DTXSID9023756"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53786,D53786)","v":"zotepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53786,M53786)","v":"Seizures"},"C022172","zotepine","26615-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53786,N53786)","v":"DTXSID9023756"},1992,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53786,J53786)","v":"1353125"},"Convulsive seizures in schizophrenic patients induced by zotepine administration.","1353125","Neurologic Manifestations","D012640","Seizures","DTXSID9023756"]
[{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & C53787,D53787)","v":"zotepine"},{"$f":"HYPERLINK(\"https://meshb.nlm.nih.gov/record/ui?ui=\" & L53787,M53787)","v":"Sleep Wake Disorders"},"C022172","zotepine","26615-21-4",{"$f":"HYPERLINK(\"https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=\" & N53787,N53787)","v":"DTXSID9023756"},1987,{"$f":"HYPERLINK(\"https://www.ncbi.nlm.nih.gov/pubmed/\" & J53787,J53787)","v":"2883679"},"Clinical experience with the neuroleptic zotepine--first results.","2883679","Sleep Wake Disorders","D012893","Sleep Wake Disorders","DTXSID9023756"]